data_1a9v_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1a9v _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.452 ' OE1' ' HD2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 120.838 0.352 . . . . 0.0 111.209 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.598 ' CG1' ' HA ' ' A' ' 22' ' ' HIS 0.256 1.4 m -145.72 173.08 3.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.91 142.19 33.8 Favored 'General case' 0 CA--C 1.475 -1.921 0 O-C-N 120.281 -1.512 . . . . 0.0 107.741 176.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.57 ' CG1' ' N ' ' A' ' 6' ' ' LYS 0.406 0.4 OUTLIER -161.3 -50.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 C-N-CA 117.226 -1.79 . . . . 0.0 112.097 -170.121 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.57 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 28.6 mmtm 84.86 139.46 0.06 Allowed 'General case' 0 N--CA 1.508 2.429 0 CA-C-O 124.315 2.007 . . . . 0.0 113.97 178.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.3 26.4 t70 -93.37 153.99 18.21 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 111.491 -2.595 . . . . 0.0 109.381 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.669 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.7 p -138.01 17.12 2.83 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.961 -1.087 . . . . 0.0 109.372 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.583 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -124.43 -85.81 0.64 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 118.55 -1.26 . . . . 0.0 109.722 -176.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.562 ' O ' ' N ' ' A' ' 12' ' ' GLU . 4.4 t30 -159.96 65.04 0.35 Allowed 'General case' 0 C--N 1.265 -3.07 0 C-N-CA 117.774 -1.57 . . . . 0.0 112.142 177.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.466 ' C ' ' O ' ' A' ' 10' ' ' ASN . 9.0 m-70 33.3 32.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.778 0.799 . . . . 0.0 110.507 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.562 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.1 OUTLIER -95.23 24.74 4.76 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.0 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.603 ' CG2' ' N ' ' A' ' 14' ' ' LYS 0.28 0.0 OUTLIER -117.14 -165.24 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-O 122.213 1.006 . . . . 0.0 110.993 -178.624 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.603 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 14.8 ptpt -162.31 -48.03 0.04 OUTLIER 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.873 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.63 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 12.1 tttm -144.0 135.47 25.87 Favored 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 116.344 -2.142 . . . . 0.0 112.896 178.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.494 HG12 ' HB3' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -133.46 102.26 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-O 122.845 1.307 . . . . 0.0 110.603 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 mt -93.41 123.44 36.71 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 114.172 -1.377 . . . . 0.0 111.253 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.458 HG12 ' HD2' ' A' ' 19' ' ' PRO . 23.7 t -143.13 145.82 34.26 Favored Pre-proline 0 N--CA 1.502 2.147 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.931 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.458 ' HD2' HG12 ' A' ' 18' ' ' VAL . 43.7 Cg_endo -68.72 109.88 2.2 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.83 1.437 . . . . 0.0 110.978 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.11 -94.99 0.12 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.1 m -93.82 174.82 6.98 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.108 -1.231 . . . . 0.0 111.415 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.598 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -142.01 7.13 1.81 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.198 -0.939 . . . . 0.0 110.491 178.36 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.287 -2.147 0 C-N-CA 118.958 -1.591 . . . . 0.0 110.212 177.4 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.801 ' HA2' ' HA ' ' A' ' 96' ' ' LYS . . . . . . . . 0 C--O 1.214 -1.139 0 N-CA-C 105.61 -2.996 . . . . 0.0 105.61 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.587 ' HB2' HG11 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -118.41 96.8 50.27 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 121.281 2.54 . . . . 0.0 117.089 -174.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.556 ' HD3' ' O ' ' A' ' 32' ' ' GLY . 61.2 Cg_endo -107.11 144.87 0.08 OUTLIER 'Trans proline' 0 C--N 1.29 -2.504 0 C-N-CA 124.289 3.326 . . . . 0.0 107.416 175.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.543 ' O ' ' CE1' ' A' ' 90' ' ' TYR . 30.4 m-85 -119.05 97.53 5.73 Favored 'General case' 0 C--N 1.291 -1.972 0 C-N-CA 118.603 -1.239 . . . . 0.0 108.839 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.591 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 28.1 mp0 -117.65 99.8 7.2 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.668 -0.645 . . . . 0.0 109.896 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.543 ' CD1' HG22 ' A' ' 108' ' ' VAL . 2.0 mt -109.67 139.24 44.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.403 -1.436 . . . . 0.0 108.741 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -140.24 128.65 22.67 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.564 -1.335 . . . . 0.0 107.764 179.241 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.494 ' HB3' HG12 ' A' ' 16' ' ' VAL . . . -143.75 150.14 38.16 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-O 123.119 1.437 . . . . 0.0 113.485 -176.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.63 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -115.49 138.22 46.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-N 113.696 -1.593 . . . . 0.0 107.84 177.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.614 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 8.4 p90 -159.58 130.01 5.71 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -177.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 15.2 tt0 -73.02 155.25 40.0 Favored 'General case' 0 C--N 1.281 -2.381 0 O-C-N 120.464 -1.398 . . . . 0.0 109.127 177.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.594 ' HB1' ' CE2' ' A' ' 86' ' ' TYR . . . -88.97 136.56 32.95 Favored 'General case' 0 C--N 1.269 -2.924 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.65 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.545 ' ND2' ' HG2' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -117.32 50.51 1.1 Allowed 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 125.408 2.528 . . . . 0.0 114.071 179.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.614 ' C ' ' HB2' ' A' ' 82' ' ' LYS . 7.0 pt20 166.87 -159.44 0.01 OUTLIER 'General case' 0 C--N 1.257 -3.416 0 CA-C-N 108.947 -3.751 . . . . 0.0 112.816 175.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.403 ' H ' ' HB2' ' A' ' 45' ' ' GLN 0.275 21.1 t-20 -110.1 154.25 23.54 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-O 122.53 1.157 . . . . 0.0 108.389 -178.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.635 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -171.84 151.05 2.73 Favored 'General case' 0 C--N 1.251 -3.675 0 C-N-CA 118.366 -1.333 . . . . 0.0 112.508 -178.25 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.676 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -111.66 6.52 19.96 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 120.668 -1.27 . . . . 0.0 110.817 178.511 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.573 ' CG2' ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.41 147.43 4.41 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 120.712 -1.243 . . . . 0.0 111.089 179.373 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.536 ' O ' ' O ' ' A' ' 70' ' ' PRO . . . -146.71 106.17 3.92 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-O 122.271 1.034 . . . . 0.0 109.981 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -75.99 -175.73 3.17 Favored 'General case' 0 N--CA 1.505 2.292 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.353 179.447 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.7 ' CD1' ' CG1' ' A' ' 88' ' ' ILE . 26.7 mt -140.19 135.08 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.688 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.485 ' O ' HG11 ' A' ' 108' ' ' VAL . 15.9 tt0 -141.4 114.55 8.67 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 123.428 1.585 . . . . 0.0 111.854 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.647 ' HA ' ' CG1' ' A' ' 108' ' ' VAL . 0.5 OUTLIER -90.28 125.91 43.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-N 112.705 -2.043 . . . . 0.0 108.904 178.15 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -117.69 98.69 6.5 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 177.344 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.483 ' HB3' ' CG2' ' A' ' 106' ' ' VAL . . . -112.86 126.8 55.85 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 118.459 -1.296 . . . . 0.0 112.889 -175.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.688 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.4 p -104.28 98.37 8.18 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 177.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.736 ' HA ' ' CG1' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -108.76 107.38 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.882 0 CA-C-O 122.905 1.336 . . . . 0.0 110.916 -176.676 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 103' ' ' ASN . 1.8 p30 35.84 62.35 0.65 Allowed 'General case' 0 N--CA 1.522 3.126 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.78 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.05 -12.04 10.16 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.284 -0.885 . . . . 0.0 111.365 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.514 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.279 0.3 OUTLIER -108.13 57.02 0.62 Allowed 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.079 -1.248 . . . . 0.0 111.162 -178.6 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.488 ' O ' ' CG ' ' A' ' 62' ' ' GLU 0.364 0.0 OUTLIER -60.79 115.09 3.41 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 122.049 0.928 . . . . 0.0 111.366 -179.411 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.429 HG21 ' O ' ' A' ' 63' ' ' VAL . 15.2 m -75.77 143.64 12.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-O 122.494 1.14 . . . . 0.0 110.352 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.527 ' C ' ' CG2' ' A' ' 65' ' ' VAL 0.435 20.9 t0 -138.27 60.0 1.63 Allowed 'General case' 0 C--N 1.277 -2.572 0 CA-C-O 122.752 1.263 . . . . 0.0 110.901 -176.169 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.527 ' CG2' ' C ' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -157.39 151.86 20.49 Favored Pre-proline 0 C--N 1.269 -2.929 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.742 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.453 ' HD2' HG11 ' A' ' 65' ' ' VAL . 44.9 Cg_endo -84.47 137.38 6.9 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 CA-C-O 123.763 1.485 . . . . 0.0 111.013 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.604 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -116.66 42.52 1.85 Allowed Glycine 0 C--N 1.27 -3.136 0 CA-C-N 112.574 -2.103 . . . . 0.0 111.774 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 69' ' ' ASP . 3.0 tp 174.3 -163.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 O-C-N 120.379 -1.659 . . . . 0.0 108.93 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.574 ' N ' HG22 ' A' ' 68' ' ' ILE . 1.5 t70 -107.62 135.01 19.8 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 174.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.7 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 23.6 Cg_endo -106.16 -4.69 0.13 Allowed 'Trans proline' 0 C--N 1.278 -3.176 0 C-N-CA 123.445 2.763 . . . . 0.0 114.07 -173.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.608 ' O ' ' CE1' ' A' ' 75' ' ' TYR . 9.1 p30 -114.93 92.9 4.09 Favored 'General case' 0 C--N 1.285 -2.224 0 O-C-N 120.491 -1.381 . . . . 0.0 108.695 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.571 ' HA ' ' CD1' ' A' ' 75' ' ' TYR . . . -77.91 12.08 1.92 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.071 -1.018 . . . . 0.0 109.095 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.405 ' C ' ' H ' ' A' ' 75' ' ' TYR . 1.9 t -76.35 -25.22 54.46 Favored 'General case' 0 C--O 1.214 -0.773 0 O-C-N 120.802 -1.186 . . . . 0.0 107.951 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.592 ' CD2' ' OD1' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -88.1 18.68 4.1 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 174.421 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.62 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.2 OUTLIER -134.06 -10.93 2.61 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.38 179.631 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.482 ' CE ' ' HB2' ' A' ' 72' ' ' ALA . 2.0 ptt? -164.04 133.48 3.93 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-O 123.897 1.808 . . . . 0.0 113.277 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.524 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -12.08 95.51 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 111.761 -2.472 . . . . 0.0 113.732 -178.638 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.5 ' HA ' HD12 ' A' ' 80' ' ' LEU 0.312 1.2 t -104.86 145.13 30.12 Favored Pre-proline 0 C--N 1.268 -2.949 0 CA-C-N 111.428 -2.623 . . . . 0.0 108.491 178.341 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.676 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 36.8 Cg_endo -80.52 166.62 75.33 Favored 'Cis proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.562 -1.849 . . . . 0.0 112.513 0.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.653 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -90.95 127.76 36.52 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.816 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.52 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.4 t -104.58 141.35 20.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-O 124.253 1.977 . . . . 0.0 112.377 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.614 ' HB2' ' C ' ' A' ' 45' ' ' GLN . 1.7 tmmt? -46.55 118.32 1.95 Allowed 'General case' 0 C--N 1.272 -2.772 0 CA-C-N 111.531 -2.577 . . . . 0.0 116.578 -175.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.27 -16.84 19.67 Favored Glycine 0 C--N 1.29 -2.022 0 CA-C-N 111.827 -2.442 . . . . 0.0 107.811 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.592 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 17.7 mt-30 -72.83 126.61 30.32 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-O 123.198 1.475 . . . . 0.0 111.598 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.605 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -63.81 144.95 56.64 Favored 'General case' 0 C--N 1.271 -2.834 0 CA-C-N 113.341 -1.754 . . . . 0.0 107.074 178.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.632 ' CE1' ' HG ' ' A' ' 80' ' ' LEU . 16.1 m-85 -143.43 125.3 15.16 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.532 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 8.4 p30 -117.06 127.2 53.92 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-O 122.572 1.177 . . . . 0.0 109.291 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.7 ' CG1' ' CD1' ' A' ' 52' ' ' ILE . 0.6 OUTLIER -109.95 159.77 9.4 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.202 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -151.06 156.84 41.93 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 122.046 0.927 . . . . 0.0 111.807 -177.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.591 ' O ' ' HA ' ' A' ' 36' ' ' GLN . 3.7 t80 -150.48 138.46 20.1 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.561 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 1.5 t -154.95 116.43 4.06 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 119.595 1.089 . . . . 0.0 108.102 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.604 ' CD1' ' O ' ' A' ' 67' ' ' GLY 0.27 1.5 t90 -143.03 115.87 8.76 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 119.809 -0.756 . . . . 0.0 110.021 -177.468 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.51 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.6 OUTLIER -74.91 160.29 30.8 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 119.249 -2.157 . . . . 0.0 110.135 -178.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.587 HG11 ' HB2' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -153.76 166.09 16.45 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.151 -0.968 . . . . 0.0 108.47 -179.274 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.501 ' O ' ' O ' ' A' ' 94' ' ' VAL . 18.4 Cg_endo -37.03 150.16 0.05 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.136 0 O-C-N 123.587 1.309 . . . . 0.0 110.64 -177.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.801 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.5 OUTLIER -79.27 -24.69 42.77 Favored 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 116.94 -1.904 . . . . 0.0 114.33 -173.311 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.582 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -138.52 42.85 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 O-C-N 121.658 -0.651 . . . . 0.0 112.25 -179.161 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.619 ' CB ' ' CD ' ' A' ' 99' ' ' PRO . . . -74.14 -67.67 0.39 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 120.641 -1.287 . . . . 0.0 110.025 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.665 ' C ' ' HD2' ' A' ' 100' ' ' LYS . 50.3 Cg_endo -67.55 160.09 49.54 Favored 'Trans proline' 0 CA--C 1.463 -3.042 0 O-C-N 123.615 1.323 . . . . 0.0 110.106 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.711 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -107.78 103.09 12.28 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 112.482 -2.144 . . . . 0.0 109.849 -169.689 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.478 ' C ' ' O ' ' A' ' 100' ' ' LYS . 6.5 p -42.96 99.62 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.723 0 CA-C-O 123.635 1.683 . . . . 0.0 108.661 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.405 88.5 mt-10 -163.67 -51.45 0.03 OUTLIER 'General case' 0 CA--C 1.45 -2.882 0 CA-C-N 113.024 -1.898 . . . . 0.0 111.674 -179.237 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.553 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.492 0.8 OUTLIER -159.3 79.22 0.74 Allowed 'General case' 0 C--N 1.283 -2.311 0 CA-C-N 110.952 -2.84 . . . . 0.0 113.378 -162.32 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.736 ' CG1' ' HA ' ' A' ' 58' ' ' ILE . 26.2 t -141.2 134.12 30.45 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.437 0 C-N-CA 119.811 -0.756 . . . . 0.0 111.234 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.493 HG11 HD12 ' A' ' 121' ' ' ILE . 53.0 t -136.55 125.03 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.524 ' O ' HG12 ' A' ' 121' ' ' ILE . 0.3 OUTLIER -107.15 138.12 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 CA-C-O 122.58 1.181 . . . . 0.0 111.92 -178.805 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.615 ' CG2' ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -131.39 110.35 10.98 Favored 'General case' 0 C--N 1.276 -2.623 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.204 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.647 ' CG1' ' HA ' ' A' ' 54' ' ' ILE . 3.2 t -123.42 142.19 40.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 C-N-CA 117.182 -1.807 . . . . 0.0 108.811 -177.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.99 ' HB2' ' HB2' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -138.22 145.02 40.91 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 122.485 1.136 . . . . 0.0 111.874 -176.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.582 ' CG2' HD12 ' A' ' 88' ' ' ILE . 5.6 t -96.6 125.67 49.48 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.558 ' CG ' ' HA2' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -105.68 119.24 38.62 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -179.291 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -75.75 -135.55 0.52 Allowed Glycine 0 N--CA 1.497 2.72 0 C-N-CA 119.091 -1.528 . . . . 0.0 113.856 -176.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.635 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 5.1 p-10 -88.59 -0.77 57.6 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.1 0.953 . . . . 0.0 112.267 -176.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -133.94 -4.31 2.81 Favored 'General case' 0 C--N 1.269 -2.914 0 CA-C-O 121.429 0.633 . . . . 0.0 110.954 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.604 ' O ' ' HB ' ' A' ' 116' ' ' VAL . . . 95.54 83.36 1.64 Allowed Glycine 0 CA--C 1.47 -2.765 0 CA-C-O 124.636 2.242 . . . . 0.0 111.024 178.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.604 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 14.6 p 136.21 152.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.254 -3.586 0 CA-C-N 108.371 -3.915 . . . . 0.0 112.72 176.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.552 ' CB ' ' O ' ' A' ' 110' ' ' VAL . 0.1 OUTLIER -162.22 -59.51 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.414 0.626 . . . . 0.0 110.281 179.109 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.44 ' HB2' HG13 ' A' ' 13' ' ' ILE . . . -164.75 126.01 2.11 Favored 'General case' 0 N--CA 1.51 2.569 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.99 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 0.8 OUTLIER -134.11 135.74 43.42 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 117.918 -1.513 . . . . 0.0 113.112 -177.424 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.449 ' HB2' HG13 ' A' ' 16' ' ' VAL . . . -143.62 136.51 27.51 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 122.925 1.345 . . . . 0.0 112.406 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.615 ' HB ' ' CG2' ' A' ' 107' ' ' THR 0.26 0.0 OUTLIER -107.33 162.46 5.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 114.122 -1.399 . . . . 0.0 111.076 -179.589 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.612 ' N ' ' CD1' ' A' ' 121' ' ' ILE . . . . . . . . 0 C--N 1.3 -1.546 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.517 ' OE1' ' N ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 120.818 0.342 . . . . 0.0 111.345 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.557 ' CG1' ' HA ' ' A' ' 22' ' ' HIS . 1.4 m -144.65 -177.72 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.456 ' O ' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -78.89 134.78 36.89 Favored 'General case' 0 CA--C 1.481 -1.684 0 C-N-CA 117.723 -1.591 . . . . 0.0 108.758 178.211 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.47 ' O ' ' HG3' ' A' ' 6' ' ' LYS 0.439 0.4 OUTLIER -171.91 164.28 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 113.923 -1.49 . . . . 0.0 109.416 -169.629 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.559 ' HB2' ' CG2' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -144.37 136.98 26.78 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 123.644 1.687 . . . . 0.0 113.143 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.259 13.5 t70 -70.72 148.97 47.41 Favored 'General case' 0 C--N 1.269 -2.907 0 CA-C-N 113.249 -1.796 . . . . 0.0 109.278 178.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.635 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.5 p -137.59 14.62 2.95 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.94 -1.1 . . . . 0.0 109.488 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.593 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -125.94 -84.54 0.63 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.687 -1.205 . . . . 0.0 110.162 -177.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 12' ' ' GLU . 2.3 t30 -159.46 66.69 0.39 Allowed 'General case' 0 C--N 1.267 -2.998 0 C-N-CA 118.649 -1.221 . . . . 0.0 111.987 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.473 ' C ' ' O ' ' A' ' 10' ' ' ASN . 9.7 m-70 33.57 33.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.848 0.832 . . . . 0.0 110.275 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.0 OUTLIER -91.78 22.0 4.46 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.324 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.613 ' CG2' ' N ' ' A' ' 14' ' ' LYS 0.28 0.0 OUTLIER -121.15 -167.39 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-O 122.31 1.052 . . . . 0.0 111.323 -178.439 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.613 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 7.2 ptpt -162.34 -45.04 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.445 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.593 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 2.9 tttt -145.58 140.29 27.3 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 116.569 -2.052 . . . . 0.0 112.595 178.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.524 ' CG1' ' HB3' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -138.42 104.75 2.73 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 CA-C-O 122.929 1.347 . . . . 0.0 111.109 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.492 ' O ' ' HG2' ' A' ' 38' ' ' GLU . 0.9 OUTLIER -97.95 128.18 44.36 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 114.044 -1.434 . . . . 0.0 111.45 178.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.517 ' CG2' ' HA ' ' A' ' 37' ' ' LEU . 43.1 t -142.16 146.26 39.13 Favored Pre-proline 0 N--CA 1.499 2.006 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.517 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.542 ' CD ' ' O ' ' A' ' 36' ' ' GLN . 42.5 Cg_endo -67.63 93.83 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.821 1.432 . . . . 0.0 110.025 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.89 -93.87 0.1 OUTLIER Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.513 -1.327 . . . . 0.0 110.084 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 37.1 m -94.73 162.21 13.87 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.161 -1.2 . . . . 0.0 111.392 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.557 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 0.8 OUTLIER -136.71 9.28 3.09 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.897 -1.127 . . . . 0.0 109.697 178.027 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 4' ' ' ASP . . . . . . . . 0 C--N 1.291 -1.956 0 C-N-CA 119.383 -1.389 . . . . 0.0 109.882 176.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.871 ' HA3' ' HA ' ' A' ' 96' ' ' LYS . . . . . . . . 0 C--O 1.213 -1.186 0 N-CA-C 107.457 -2.257 . . . . 0.0 107.457 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.551 ' NZ ' ' HG2' ' A' ' 99' ' ' PRO . 0.8 OUTLIER -125.34 91.6 48.64 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 120.883 2.342 . . . . 0.0 115.334 -179.306 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 60.6 Cg_endo -108.2 145.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.291 -2.458 0 C-N-CA 124.291 3.327 . . . . 0.0 109.594 177.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.546 ' CE2' HG13 ' A' ' 94' ' ' VAL . 4.9 m-85 -119.8 90.79 3.4 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.571 ' HG2' ' CB ' ' A' ' 91' ' ' THR . 0.3 OUTLIER -116.17 88.64 2.93 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 122.006 -0.434 . . . . 0.0 110.223 -178.353 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.517 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 0.6 OUTLIER -108.68 133.53 52.65 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.526 -1.359 . . . . 0.0 108.383 178.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -140.2 127.62 21.38 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.533 -1.354 . . . . 0.0 107.452 179.242 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.524 ' HB3' ' CG1' ' A' ' 16' ' ' VAL . . . -142.75 152.94 42.82 Favored 'General case' 0 C--N 1.274 -2.708 0 CA-C-O 122.97 1.367 . . . . 0.0 113.263 -175.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.593 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.46 139.87 32.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 113.821 -1.536 . . . . 0.0 108.711 177.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.579 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 3.5 p90 -156.87 124.07 5.26 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -178.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 13.6 tt0 -69.68 155.85 39.88 Favored 'General case' 0 C--N 1.288 -2.107 0 O-C-N 120.407 -1.433 . . . . 0.0 108.508 177.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.592 ' HB1' ' CE2' ' A' ' 86' ' ' TYR . . . -91.28 134.69 34.37 Favored 'General case' 0 C--N 1.265 -3.069 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.162 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.599 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -114.87 51.26 0.91 Allowed 'General case' 0 CA--C 1.486 -1.498 0 CA-C-O 125.327 2.489 . . . . 0.0 114.067 179.004 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.601 ' N ' ' CG ' ' A' ' 82' ' ' LYS . 7.0 pt20 167.34 -160.95 0.01 OUTLIER 'General case' 0 C--N 1.263 -3.173 0 CA-C-N 109.149 -3.659 . . . . 0.0 113.729 174.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.415 ' H ' ' HB2' ' A' ' 45' ' ' GLN 0.277 6.3 t30 -110.36 153.65 24.64 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-O 122.617 1.199 . . . . 0.0 108.872 -178.483 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.664 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -173.22 157.04 3.31 Favored 'General case' 0 C--N 1.255 -3.526 0 C-N-CA 118.727 -1.189 . . . . 0.0 112.746 -178.307 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.679 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 0.4 OUTLIER -112.5 5.87 18.22 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 120.694 -1.254 . . . . 0.0 111.522 178.434 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.563 ' CG2' ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.16 149.06 5.01 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.659 -1.276 . . . . 0.0 111.215 179.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.5 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . . . -141.37 101.64 4.05 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 122.924 1.345 . . . . 0.0 110.863 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 23.3 mmtp -73.15 -178.23 2.8 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.939 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.806 HG12 HD13 ' A' ' 88' ' ' ILE . 28.4 mt -140.14 136.43 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.544 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.945 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.538 ' C ' HG11 ' A' ' 108' ' ' VAL . 31.9 tt0 -141.44 110.87 6.39 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 123.267 1.508 . . . . 0.0 111.3 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.648 ' HA ' ' CG1' ' A' ' 108' ' ' VAL . 0.5 OUTLIER -89.99 127.07 42.8 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 CA-C-N 112.793 -2.003 . . . . 0.0 109.64 179.524 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.493 ' NZ ' ' HB2' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -120.25 98.62 6.15 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 176.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.531 ' HB3' ' CG2' ' A' ' 106' ' ' VAL . . . -114.53 133.61 55.66 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 118.919 -1.112 . . . . 0.0 113.187 -175.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.672 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.0 OUTLIER -105.53 100.3 9.87 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 177.595 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.739 ' HA ' ' CG2' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -111.55 102.96 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.838 0 CA-C-O 123.004 1.383 . . . . 0.0 110.729 -176.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER 34.86 65.2 0.37 Allowed 'General case' 0 N--CA 1.519 3.003 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.829 179.306 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.47 -16.56 10.0 Favored Glycine 0 N--CA 1.489 2.212 0 O-C-N 121.351 -0.843 . . . . 0.0 111.761 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.53 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.268 0.5 OUTLIER -108.3 57.94 0.61 Allowed 'General case' 0 C--N 1.292 -1.896 0 O-C-N 121.027 -1.278 . . . . 0.0 111.818 -178.256 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.49 ' O ' ' CG ' ' A' ' 62' ' ' GLU 0.367 0.0 OUTLIER -59.25 115.8 3.46 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.064 0.935 . . . . 0.0 111.258 -179.913 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.48 HG23 ' HB2' ' A' ' 56' ' ' ALA . 17.7 m -80.3 146.73 7.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 122.517 1.151 . . . . 0.0 110.971 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.429 7.1 t70 -138.06 59.11 1.66 Allowed 'General case' 0 C--N 1.28 -2.428 0 CA-C-O 122.831 1.301 . . . . 0.0 111.013 -176.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.473 HG21 ' HD2' ' A' ' 66' ' ' PRO . 4.0 p -165.31 151.8 9.03 Favored Pre-proline 0 C--N 1.269 -2.927 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.053 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.473 ' HD2' HG21 ' A' ' 65' ' ' VAL . 44.5 Cg_endo -87.7 139.56 4.82 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 CA-C-O 123.706 1.461 . . . . 0.0 111.804 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -105.83 48.77 0.94 Allowed Glycine 0 C--N 1.272 -2.99 0 CA-C-N 112.568 -2.106 . . . . 0.0 109.101 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.578 ' CG2' ' N ' ' A' ' 69' ' ' ASP 0.293 0.0 OUTLIER 179.63 -168.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 O-C-N 119.669 -2.077 . . . . 0.0 108.544 -178.247 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.578 ' N ' ' CG2' ' A' ' 68' ' ' ILE . 10.0 t0 -108.86 90.61 7.85 Favored Pre-proline 0 N--CA 1.504 2.232 0 O-C-N 120.731 -1.231 . . . . 0.0 108.364 176.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.721 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 20.0 Cg_endo -48.39 -5.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.289 -2.584 0 C-N-CA 124.182 3.254 . . . . 0.0 115.461 177.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.575 ' HB2' ' NE2' ' A' ' 74' ' ' HIS . 0.6 OUTLIER -107.63 92.86 4.25 Favored 'General case' 0 C--N 1.289 -2.03 0 O-C-N 120.134 -1.604 . . . . 0.0 109.484 -179.209 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.713 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . . . -78.27 10.41 3.05 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.101 -0.999 . . . . 0.0 109.332 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.1 t -78.16 -24.53 47.24 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 120.992 -1.067 . . . . 0.0 108.944 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.575 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 0.3 OUTLIER -79.52 7.62 7.85 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 118.911 -1.116 . . . . 0.0 108.797 176.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.713 ' CD2' ' HA ' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -132.98 -1.38 3.31 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 121.488 -0.758 . . . . 0.0 110.11 177.62 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.514 ' CE ' HD22 ' A' ' 80' ' ' LEU . 1.5 ptt? -153.45 128.65 9.75 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 124.042 1.877 . . . . 0.0 113.745 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.515 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -19.88 95.98 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 111.74 -2.482 . . . . 0.0 113.213 -178.676 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.493 ' HA ' HD12 ' A' ' 80' ' ' LEU 0.32 0.3 OUTLIER -99.93 142.17 24.11 Favored Pre-proline 0 C--N 1.268 -2.948 0 CA-C-N 111.36 -2.654 . . . . 0.0 108.776 178.495 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.679 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 36.3 Cg_endo -79.58 168.27 73.86 Favored 'Cis proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.848 -1.73 . . . . 0.0 112.521 0.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.693 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -94.71 128.39 41.36 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.17 -179.731 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.53 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.4 t -105.9 139.38 27.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 124.1 1.905 . . . . 0.0 112.07 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.601 ' CG ' ' N ' ' A' ' 45' ' ' GLN . 1.2 tmmt? -44.59 118.33 1.54 Allowed 'General case' 0 C--N 1.271 -2.823 0 CA-C-N 111.816 -2.447 . . . . 0.0 116.652 -175.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.95 -18.01 12.72 Favored Glycine 0 C--N 1.292 -1.878 0 CA-C-N 111.787 -2.461 . . . . 0.0 107.924 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 18.3 mt-30 -71.79 127.74 33.54 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-O 123.221 1.486 . . . . 0.0 111.349 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.611 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 3.2 mt-30 -66.02 144.6 56.64 Favored 'General case' 0 C--N 1.27 -2.861 0 CA-C-N 113.282 -1.781 . . . . 0.0 107.485 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.652 ' CE1' ' HG ' ' A' ' 80' ' ' LEU . 17.8 m-85 -142.72 126.07 16.62 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.539 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 0.7 OUTLIER -117.46 130.19 56.3 Favored 'General case' 0 C--N 1.279 -2.489 0 CA-C-O 122.737 1.256 . . . . 0.0 110.034 -178.34 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.806 HD13 HG12 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -101.95 156.22 4.73 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.152 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.188 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.17 143.22 30.99 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 121.465 0.65 . . . . 0.0 111.343 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.62 ' CE1' ' HB2' ' A' ' 92' ' ' TRP . 2.1 t80 -143.89 99.66 3.44 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.412 -0.805 . . . . 0.0 109.123 178.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.571 ' CB ' ' HG2' ' A' ' 36' ' ' GLN . 1.3 t -122.81 116.29 23.44 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.91 -1.119 . . . . 0.0 108.616 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.62 ' HB2' ' CE1' ' A' ' 90' ' ' TYR 0.271 0.3 OUTLIER -142.64 102.31 4.03 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.035 -177.635 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.8 OUTLIER -75.62 153.66 37.12 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 119.607 -1.933 . . . . 0.0 109.461 -178.757 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.546 HG13 ' CE2' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -153.11 175.38 3.01 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.781 -1.199 . . . . 0.0 108.606 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.525 ' O ' ' O ' ' A' ' 94' ' ' VAL . 18.6 Cg_endo -37.96 154.07 0.03 OUTLIER 'Trans proline' 0 CA--C 1.498 -1.321 0 O-C-N 123.64 1.337 . . . . 0.0 110.701 -177.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.871 ' HA ' ' HA3' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -79.54 -25.3 41.72 Favored 'General case' 0 C--N 1.284 -2.277 0 C-N-CA 116.614 -2.035 . . . . 0.0 115.526 -173.173 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.548 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -140.27 39.71 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 -177.658 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.608 ' CB ' ' CD ' ' A' ' 99' ' ' PRO . . . -62.89 -64.48 2.98 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.519 -1.363 . . . . 0.0 108.353 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.693 ' C ' ' HD2' ' A' ' 100' ' ' LYS . 51.5 Cg_endo -69.96 163.74 37.3 Favored 'Trans proline' 0 CA--C 1.46 -3.206 0 O-C-N 123.87 1.458 . . . . 0.0 108.852 177.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.693 ' HD2' ' C ' ' A' ' 99' ' ' PRO . 1.0 OUTLIER -105.14 103.7 13.3 Favored 'General case' 0 C--N 1.269 -2.902 0 CA-C-N 112.704 -2.044 . . . . 0.0 110.92 -168.596 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.465 ' C ' ' O ' ' A' ' 100' ' ' LYS . 7.5 p -43.43 96.78 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 123.566 1.65 . . . . 0.0 108.859 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.601 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.413 78.0 mt-10 -163.64 -50.77 0.03 OUTLIER 'General case' 0 CA--C 1.451 -2.832 0 CA-C-N 112.729 -2.032 . . . . 0.0 112.01 -179.331 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.491 0.8 OUTLIER -159.07 81.58 0.78 Allowed 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 111.283 -2.69 . . . . 0.0 113.781 -162.15 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.739 ' CG2' ' HA ' ' A' ' 58' ' ' ILE . 34.0 t -143.22 133.91 22.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.122 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.555 ' CG1' HD13 ' A' ' 121' ' ' ILE . 60.9 t -142.48 134.56 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.531 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 1.3 p -112.65 146.84 16.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 122.956 1.36 . . . . 0.0 113.367 -178.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.623 ' CG2' ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -132.82 108.52 9.02 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 178.272 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.648 ' CG1' ' HA ' ' A' ' 54' ' ' ILE . 3.6 t -125.29 141.9 43.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 120.094 -1.629 . . . . 0.0 109.056 -177.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.687 ' HB2' ' HB3' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -133.84 152.35 51.84 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.712 1.244 . . . . 0.0 113.047 -178.336 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.683 ' CG2' ' CD1' ' A' ' 88' ' ' ILE . 8.8 t -99.83 127.35 52.79 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.255 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 177.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.484 ' HG3' ' N ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -108.82 121.79 45.82 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.31 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -78.14 -137.36 1.11 Allowed Glycine 0 N--CA 1.497 2.742 0 C-N-CA 119.079 -1.534 . . . . 0.0 114.093 -175.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.664 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 10.0 p-10 -80.19 -5.11 55.52 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 122.366 1.079 . . . . 0.0 112.07 -177.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 9.7 p30 -130.05 -4.6 4.48 Favored 'General case' 0 C--N 1.266 -3.065 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.145 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.579 ' O ' ' CB ' ' A' ' 116' ' ' VAL . . . 88.59 85.55 1.24 Allowed Glycine 0 CA--C 1.469 -2.808 0 CA-C-O 124.886 2.381 . . . . 0.0 109.813 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.579 ' CB ' ' O ' ' A' ' 115' ' ' GLY . 4.5 p 145.41 145.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.245 -3.952 0 CA-C-N 108.43 -3.885 . . . . 0.0 111.833 177.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.529 ' CB ' ' O ' ' A' ' 110' ' ' VAL . 0.1 OUTLIER -162.27 -57.43 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.495 -0.753 . . . . 0.0 110.755 179.605 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -173.81 130.09 0.41 Allowed 'General case' 0 N--CA 1.51 2.56 0 O-C-N 121.158 -0.964 . . . . 0.0 108.84 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.687 ' HB3' ' HB2' ' A' ' 109' ' ' LYS . 0.8 OUTLIER -134.44 144.31 48.06 Favored 'General case' 0 C--N 1.285 -2.23 0 C-N-CA 117.544 -1.662 . . . . 0.0 113.86 -177.469 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.24 138.18 23.7 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 123.034 1.397 . . . . 0.0 112.239 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.623 ' HB ' ' CG2' ' A' ' 107' ' ' THR 0.279 0.0 OUTLIER -109.37 132.31 57.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 CA-C-N 114.025 -1.443 . . . . 0.0 111.198 -179.19 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 O-C-N 120.874 -1.141 . . . . 0.0 108.681 179.544 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 120.781 0.324 . . . . 0.0 111.006 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.522 ' CG1' ' HA ' ' A' ' 22' ' ' HIS . 1.4 m -145.59 179.56 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 O-C-N 120.836 -1.165 . . . . 0.0 108.174 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.468 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -79.47 137.02 37.08 Favored 'General case' 0 CA--C 1.48 -1.723 0 C-N-CA 118.117 -1.433 . . . . 0.0 108.693 177.881 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.555 ' O ' ' CG ' ' A' ' 6' ' ' LYS 0.436 0.4 OUTLIER -169.44 -171.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.48 -169.858 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.555 ' CG ' ' O ' ' A' ' 5' ' ' VAL . 5.2 mtpp -166.2 146.95 6.46 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 123.931 1.824 . . . . 0.0 113.096 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.281 3.0 t70 -84.88 148.84 26.06 Favored 'General case' 0 C--N 1.264 -3.11 0 CA-C-N 112.58 -2.1 . . . . 0.0 109.043 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.667 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.7 p -137.27 15.95 2.99 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.94 -1.1 . . . . 0.0 109.226 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.595 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -125.65 -84.32 0.63 Allowed 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.137 -176.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.567 ' O ' ' N ' ' A' ' 12' ' ' GLU . 2.4 t30 -156.35 65.19 0.55 Allowed 'General case' 0 C--N 1.268 -2.968 0 C-N-CA 118.523 -1.271 . . . . 0.0 111.783 177.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.468 ' C ' ' O ' ' A' ' 10' ' ' ASN . 10.4 m80 33.72 31.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.773 0.796 . . . . 0.0 110.73 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.4 OUTLIER -90.8 21.26 4.2 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.002 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.602 ' CG2' ' N ' ' A' ' 14' ' ' LYS 0.272 0.1 OUTLIER -119.82 -170.31 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 122.211 1.005 . . . . 0.0 110.611 -178.785 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.602 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 11.2 ptmm? -162.09 -46.83 0.04 OUTLIER 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.143 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.559 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 21.6 tttt -142.81 135.15 27.51 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 116.045 -2.262 . . . . 0.0 113.178 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.538 ' CG1' ' HB3' ' A' ' 39' ' ' ALA . 0.6 OUTLIER -132.98 101.29 4.25 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 CA-C-O 123.03 1.395 . . . . 0.0 110.76 179.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.471 ' O ' HG21 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -95.04 129.04 42.28 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 113.987 -1.461 . . . . 0.0 111.857 179.282 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.511 ' CG2' ' HA ' ' A' ' 37' ' ' LEU . 78.4 t -142.21 145.57 36.08 Favored Pre-proline 0 N--CA 1.5 2.049 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.105 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.504 ' HD2' ' CG1' ' A' ' 18' ' ' VAL . 42.1 Cg_endo -68.81 105.93 1.4 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.677 1.357 . . . . 0.0 110.624 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.44 -91.13 0.11 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 38.2 m -90.74 159.16 16.48 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.295 -1.121 . . . . 0.0 110.78 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.522 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 3.8 p80 -137.25 11.76 3.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.665 -1.272 . . . . 0.0 109.528 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 4' ' ' ASP . . . . . . . . 0 C--N 1.29 -2.026 0 C-N-CA 119.288 -1.434 . . . . 0.0 109.883 177.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.899 ' HA3' ' HA ' ' A' ' 96' ' ' LYS . . . . . . . . 0 C--O 1.213 -1.168 0 N-CA-C 108.09 -2.004 . . . . 0.0 108.09 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.524 ' CD ' ' O ' ' A' ' 32' ' ' GLY . 2.3 mmmt -125.37 90.98 49.79 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 120.585 2.192 . . . . 0.0 115.302 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 65.0 Cg_endo -108.65 143.39 0.06 OUTLIER 'Trans proline' 0 C--N 1.291 -2.466 0 C-N-CA 124.378 3.385 . . . . 0.0 109.735 177.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.477 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 12.7 m-85 -125.05 95.68 4.58 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.07 -1.052 . . . . 0.0 109.737 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.566 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 28.2 mp0 -116.37 96.64 5.63 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.569 -0.707 . . . . 0.0 110.81 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.511 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -109.3 136.31 48.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.355 -1.466 . . . . 0.0 108.638 178.93 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -140.27 125.16 18.35 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.496 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.538 ' HB3' ' CG1' ' A' ' 16' ' ' VAL . . . -143.54 152.52 41.55 Favored 'General case' 0 C--N 1.274 -2.694 0 CA-C-O 122.955 1.36 . . . . 0.0 113.878 -175.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.559 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.71 140.34 30.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-N 113.766 -1.561 . . . . 0.0 108.305 177.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.584 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 4.0 p90 -159.33 125.04 4.29 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 5.5 tt0 -70.55 157.09 38.52 Favored 'General case' 0 C--N 1.286 -2.154 0 O-C-N 120.39 -1.444 . . . . 0.0 109.07 178.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.581 ' HB1' ' CE2' ' A' ' 86' ' ' TYR . . . -90.94 141.95 28.29 Favored 'General case' 0 C--N 1.267 -2.981 0 CA-C-N 114.217 -1.356 . . . . 0.0 108.847 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.57 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -121.49 50.42 1.4 Allowed 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 125.281 2.467 . . . . 0.0 114.31 178.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.584 ' N ' ' CG ' ' A' ' 82' ' ' LYS . 6.5 pt20 167.15 -161.49 0.01 OUTLIER 'General case' 0 C--N 1.258 -3.386 0 CA-C-N 109.109 -3.678 . . . . 0.0 113.073 175.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.418 ' H ' ' HB2' ' A' ' 45' ' ' GLN 0.277 48.5 t30 -110.11 153.51 24.59 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-O 122.572 1.177 . . . . 0.0 108.952 -178.68 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.65 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -173.26 156.64 3.19 Favored 'General case' 0 C--N 1.254 -3.581 0 C-N-CA 118.558 -1.257 . . . . 0.0 112.53 -178.394 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.699 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -115.9 9.27 14.93 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 120.811 -1.18 . . . . 0.0 111.077 178.596 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.559 ' CG2' ' O ' ' A' ' 48' ' ' LYS . 0.9 OUTLIER -166.5 147.54 6.28 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.768 -1.207 . . . . 0.0 110.723 179.491 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.506 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . . . -148.41 102.22 3.31 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 122.76 1.267 . . . . 0.0 110.366 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 12.3 mmtt -75.11 -174.68 2.36 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.716 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.781 HG12 HD13 ' A' ' 88' ' ' ILE . 45.7 mt -140.54 139.03 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.535 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.489 ' C ' HG11 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -140.37 110.09 6.39 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 123.349 1.547 . . . . 0.0 110.56 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.624 ' HA ' ' CG1' ' A' ' 108' ' ' VAL . 0.5 OUTLIER -89.77 126.06 42.69 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.332 0 CA-C-N 112.527 -2.124 . . . . 0.0 108.979 179.29 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.1 tttp -121.68 103.18 8.7 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 177.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.508 ' HB3' ' CG2' ' A' ' 106' ' ' VAL . . . -110.03 126.58 54.12 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.527 -1.269 . . . . 0.0 111.86 -176.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.701 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 4.7 p -101.48 100.86 11.36 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.71 ' HA ' ' CG2' ' A' ' 104' ' ' VAL . 0.6 OUTLIER -111.31 111.78 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.679 0 CA-C-O 122.695 1.236 . . . . 0.0 110.313 -177.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.57 ' N ' ' O ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER 30.74 62.54 0.2 Allowed 'General case' 0 N--CA 1.52 3.069 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.954 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.43 -12.43 7.63 Favored Glycine 0 N--CA 1.49 2.278 0 O-C-N 121.339 -0.851 . . . . 0.0 111.379 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.514 ' O ' HG13 ' A' ' 58' ' ' ILE 0.284 0.2 OUTLIER -107.9 56.32 0.63 Allowed 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.12 -1.223 . . . . 0.0 111.171 -178.655 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.362 0.0 OUTLIER -53.95 114.09 1.46 Allowed 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 122.16 0.981 . . . . 0.0 110.565 -179.754 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.449 HG12 HG22 ' A' ' 58' ' ' ILE . 19.0 m -76.98 140.46 17.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-O 122.759 1.266 . . . . 0.0 111.499 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.45 21.7 t0 -139.32 85.08 2.03 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.435 -176.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.566 ' CG2' ' HD2' ' A' ' 66' ' ' PRO . 9.9 p -159.31 150.35 16.18 Favored Pre-proline 0 C--N 1.275 -2.631 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.888 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.566 ' HD2' ' CG2' ' A' ' 65' ' ' VAL . 43.5 Cg_endo -73.18 138.04 27.16 Favored 'Trans proline' 0 C--N 1.319 -0.992 0 CA-C-O 123.725 1.469 . . . . 0.0 111.342 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.598 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -117.45 -53.51 0.31 Allowed Glycine 0 N--CA 1.51 3.574 0 CA-C-N 112.542 -2.117 . . . . 0.0 113.588 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.467 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 1.3 tp -117.28 -155.65 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-N 120.643 2.221 . . . . 0.0 110.22 -178.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.558 ' OD2' ' ND2' ' A' ' 71' ' ' ASN . 1.1 t70 -107.92 89.17 5.17 Favored Pre-proline 0 N--CA 1.508 2.44 0 CA-C-O 122.82 1.295 . . . . 0.0 108.983 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.735 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 20.8 Cg_endo -49.05 -12.77 0.25 Allowed 'Trans proline' 0 C--N 1.285 -2.773 0 C-N-CA 124.121 3.214 . . . . 0.0 115.885 178.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.648 ' ND2' ' CD2' ' A' ' 74' ' ' HIS . 0.5 OUTLIER -111.59 85.65 2.17 Favored 'General case' 0 C--N 1.288 -2.074 0 O-C-N 119.843 -1.785 . . . . 0.0 108.965 -179.297 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.613 ' HA ' ' CD1' ' A' ' 75' ' ' TYR . . . -78.38 12.1 2.11 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.644 -0.66 . . . . 0.0 109.313 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.408 ' C ' ' H ' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -77.25 -20.6 54.95 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 120.666 -1.271 . . . . 0.0 108.002 -179.593 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.648 ' CD2' ' ND2' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -87.84 19.04 3.7 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 173.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.4 OUTLIER -133.13 -9.78 2.97 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.032 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.486 ' O ' ' HG2' ' A' ' 76' ' ' MET . 2.3 ptt? -166.55 126.77 1.61 Allowed 'General case' 0 C--O 1.215 -0.74 0 CA-C-O 123.761 1.743 . . . . 0.0 113.219 178.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.55 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 0.0 OUTLIER 3.87 91.71 0.01 OUTLIER 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 111.999 -2.364 . . . . 0.0 114.134 -179.422 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.504 ' HA ' ' CD1' ' A' ' 80' ' ' LEU 0.331 7.3 t -110.21 139.26 21.26 Favored Pre-proline 0 C--N 1.269 -2.932 0 CA-C-N 111.441 -2.618 . . . . 0.0 107.614 177.519 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.699 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 36.7 Cg_endo -76.79 169.62 73.92 Favored 'Cis proline' 0 C--N 1.308 -1.555 0 C-N-CA 123.095 -1.627 . . . . 0.0 112.992 1.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.727 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -96.9 128.39 43.81 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.051 -179.4 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.523 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.9 t -106.96 138.67 31.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 124.169 1.938 . . . . 0.0 111.916 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.584 ' CG ' ' N ' ' A' ' 45' ' ' GLN . 1.6 tmmt? -44.2 117.19 1.17 Allowed 'General case' 0 C--N 1.271 -2.837 0 CA-C-N 111.832 -2.44 . . . . 0.0 116.596 -175.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.431 ' O ' ' OE2' ' A' ' 42' ' ' GLU . . . 115.83 -17.09 15.76 Favored Glycine 0 C--N 1.292 -1.905 0 CA-C-N 111.752 -2.476 . . . . 0.0 107.963 178.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.601 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 10.4 mt-30 -71.43 127.76 33.63 Favored 'General case' 0 C--N 1.278 -2.542 0 CA-C-O 123.22 1.486 . . . . 0.0 111.766 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.596 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 0.3 OUTLIER -64.7 143.73 57.72 Favored 'General case' 0 C--N 1.272 -2.794 0 CA-C-N 113.326 -1.761 . . . . 0.0 107.072 178.454 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.657 ' CE1' ' HG ' ' A' ' 80' ' ' LEU . 17.9 m-85 -143.33 126.68 16.7 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 10.0 p30 -117.66 132.93 56.42 Favored 'General case' 0 C--N 1.275 -2.655 0 CA-C-O 122.703 1.239 . . . . 0.0 109.913 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.781 HD13 HG12 ' A' ' 52' ' ' ILE . 0.4 OUTLIER -102.58 157.7 4.73 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 CA-C-N 114.629 -1.168 . . . . 0.0 108.265 179.477 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -147.94 142.61 26.62 Favored 'General case' 0 C--N 1.283 -2.3 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.526 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.577 ' CE2' ' HA3' ' A' ' 67' ' ' GLY . 17.4 t80 -151.54 108.57 3.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.148 -0.97 . . . . 0.0 110.401 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.566 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 0.4 OUTLIER -125.11 122.26 36.63 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 120.515 -1.365 . . . . 0.0 108.093 179.163 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.598 ' CD1' ' O ' ' A' ' 67' ' ' GLY 0.27 0.1 OUTLIER -142.44 102.78 4.14 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.128 -176.933 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.51 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.6 OUTLIER -74.93 157.15 35.48 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 119.676 -1.89 . . . . 0.0 108.829 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.545 ' O ' ' O ' ' A' ' 95' ' ' PRO . 1.1 t -153.99 171.78 6.58 Favored Pre-proline 0 N--CA 1.486 1.333 0 O-C-N 120.792 -1.193 . . . . 0.0 109.13 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.545 ' O ' ' O ' ' A' ' 94' ' ' VAL . 18.8 Cg_endo -38.74 157.7 0.03 OUTLIER 'Trans proline' 0 CA--C 1.498 -1.294 0 O-C-N 123.833 1.439 . . . . 0.0 110.352 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.899 ' HA ' ' HA3' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -79.54 -21.8 44.72 Favored 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 116.282 -2.167 . . . . 0.0 115.558 -173.477 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.537 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -136.73 39.16 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -177.497 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.653 ' CB ' ' CD ' ' A' ' 99' ' ' PRO . . . -64.89 -73.51 0.21 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 120.483 -1.385 . . . . 0.0 108.562 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.697 ' C ' ' HD2' ' A' ' 100' ' ' LYS . 53.8 Cg_endo -70.25 162.31 42.77 Favored 'Trans proline' 0 CA--C 1.463 -3.034 0 CA-C-O 123.177 1.24 . . . . 0.0 109.659 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.718 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.9 OUTLIER -105.72 99.23 8.84 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 112.697 -2.047 . . . . 0.0 110.735 -169.003 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.455 ' C ' ' O ' ' A' ' 100' ' ' LYS . 12.8 p -46.77 99.84 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 123.654 1.692 . . . . 0.0 108.463 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.413 95.9 mt-10 -163.43 -51.65 0.04 OUTLIER 'General case' 0 CA--C 1.449 -2.911 0 CA-C-N 112.72 -2.036 . . . . 0.0 110.562 -179.474 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.57 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.499 0.7 OUTLIER -158.31 74.76 0.71 Allowed 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 110.504 -3.043 . . . . 0.0 111.295 -163.278 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.71 ' CG2' ' HA ' ' A' ' 58' ' ' ILE . 14.3 t -142.1 141.06 29.25 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.543 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.924 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.541 ' CG1' HD13 ' A' ' 121' ' ' ILE . 1.2 t -145.5 131.21 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.524 ' O ' HG12 ' A' ' 121' ' ' ILE . 0.3 OUTLIER -103.91 140.9 20.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 122.288 1.042 . . . . 0.0 111.704 -178.778 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.63 ' CG2' ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -132.47 110.75 10.73 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 179.427 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.624 ' CG1' ' HA ' ' A' ' 54' ' ' ILE . 3.6 t -125.73 140.83 47.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 O-C-N 120.133 -1.604 . . . . 0.0 109.229 -177.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.863 ' HB2' ' CB ' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -130.78 148.27 52.54 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 122.526 1.155 . . . . 0.0 112.057 -178.748 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.648 ' CG2' ' CD1' ' A' ' 88' ' ' ILE . 3.0 t -96.35 125.24 49.28 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 176.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.507 ' HG2' ' O ' ' A' ' 111' ' ' MET . 2.2 ptm -105.4 121.2 43.41 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -80.35 -139.31 2.21 Favored Glycine 0 N--CA 1.496 2.665 0 C-N-CA 119.031 -1.557 . . . . 0.0 114.311 -175.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.65 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 14.9 p-10 -77.8 -5.74 51.79 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 122.41 1.1 . . . . 0.0 112.051 -177.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 8.3 p30 -129.35 -5.27 4.83 Favored 'General case' 0 C--N 1.266 -3.057 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.097 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.597 ' O ' ' CB ' ' A' ' 116' ' ' VAL . . . 88.69 85.77 1.24 Allowed Glycine 0 CA--C 1.469 -2.844 0 CA-C-O 124.821 2.345 . . . . 0.0 109.745 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.597 ' CB ' ' O ' ' A' ' 115' ' ' GLY . 4.3 p 143.04 145.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.246 -3.91 0 CA-C-N 108.37 -3.915 . . . . 0.0 111.631 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.553 ' CB ' ' O ' ' A' ' 110' ' ' VAL . 0.1 OUTLIER -162.05 -58.57 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.479 -0.763 . . . . 0.0 110.9 179.682 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -167.97 131.84 1.68 Allowed 'General case' 0 N--CA 1.514 2.747 0 O-C-N 121.31 -0.869 . . . . 0.0 109.161 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.863 ' CB ' ' HB2' ' A' ' 109' ' ' LYS . 0.8 OUTLIER -134.14 138.27 45.09 Favored 'General case' 0 C--N 1.28 -2.436 0 C-N-CA 117.428 -1.709 . . . . 0.0 113.595 -177.69 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -143.59 135.66 26.73 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 122.912 1.339 . . . . 0.0 112.248 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.63 ' HB ' ' CG2' ' A' ' 107' ' ' THR 0.277 0.0 OUTLIER -111.13 134.76 52.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 114.182 -1.372 . . . . 0.0 111.808 -178.863 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.656 0 O-C-N 120.819 -1.176 . . . . 0.0 109.022 178.969 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.47 ' O ' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 120.628 0.251 . . . . 0.0 110.786 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.568 ' CG1' ' HA ' ' A' ' 22' ' ' HIS . 1.4 m -145.19 177.66 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 O-C-N 120.758 -1.214 . . . . 0.0 108.118 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.48 ' O ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -79.62 137.78 37.22 Favored 'General case' 0 CA--C 1.479 -1.761 0 C-N-CA 117.978 -1.489 . . . . 0.0 108.521 177.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.482 ' O ' ' HG2' ' A' ' 6' ' ' LYS 0.429 0.4 OUTLIER -166.16 168.67 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 C-N-CA 118.033 -1.467 . . . . 0.0 110.814 -169.785 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -147.37 137.13 22.91 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 123.664 1.697 . . . . 0.0 112.312 -179.466 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.273 0.8 OUTLIER -80.17 146.28 31.87 Favored 'General case' 0 C--N 1.267 -2.987 0 CA-C-N 113.378 -1.737 . . . . 0.0 109.71 178.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.658 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.4 p -137.31 15.9 2.98 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.958 -1.089 . . . . 0.0 109.303 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.584 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -125.54 -85.26 0.63 Allowed 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.706 -1.197 . . . . 0.0 109.941 -177.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.565 ' O ' ' N ' ' A' ' 12' ' ' GLU . 2.3 t30 -159.95 65.23 0.35 Allowed 'General case' 0 C--N 1.265 -3.07 0 C-N-CA 118.219 -1.392 . . . . 0.0 112.174 177.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.474 ' C ' ' O ' ' A' ' 10' ' ' ASN . 28.8 m170 33.79 31.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.777 0.799 . . . . 0.0 110.807 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.1 OUTLIER -90.51 23.26 3.07 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.908 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.618 ' CG2' ' N ' ' A' ' 14' ' ' LYS 0.28 0.0 OUTLIER -119.22 -168.75 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-O 121.978 0.894 . . . . 0.0 110.733 -178.616 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.618 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 7.0 ptpt -162.54 -44.31 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.994 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.553 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 28.9 tttp -149.0 139.02 22.11 Favored 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 116.556 -2.057 . . . . 0.0 113.28 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.449 HG11 ' CB ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -133.21 107.41 11.29 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-O 122.841 1.305 . . . . 0.0 110.21 179.029 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 mt -106.77 129.25 54.67 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.124 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.532 ' CG1' ' HD2' ' A' ' 19' ' ' PRO . 11.9 t -141.41 144.84 35.5 Favored Pre-proline 0 C--N 1.294 -1.816 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.949 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.532 ' HD2' ' CG1' ' A' ' 18' ' ' VAL . 46.9 Cg_endo -71.26 112.77 3.41 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.725 1.381 . . . . 0.0 111.42 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 128.86 -84.95 0.32 Allowed Glycine 0 N--CA 1.488 2.148 0 C-N-CA 119.486 -1.34 . . . . 0.0 109.775 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.402 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 3.5 m -74.56 108.76 7.53 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.596 -0.943 . . . . 0.0 110.12 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.568 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 1.0 OUTLIER -121.75 17.59 11.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.037 -1.664 . . . . 0.0 110.887 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 C-N-CA 118.43 -1.843 . . . . 0.0 110.877 177.183 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.852 ' HA3' ' HA ' ' A' ' 96' ' ' LYS . . . . . . . . 0 C--O 1.215 -1.038 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.57 ' HB2' HG21 ' A' ' 94' ' ' VAL . 1.5 mmmp? -126.21 89.87 51.35 Favored Pre-proline 0 C--O 1.22 -0.448 0 CA-C-N 120.83 2.315 . . . . 0.0 115.734 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.554 ' C ' ' CD1' ' A' ' 35' ' ' PHE . 60.8 Cg_endo -109.32 141.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.29 -2.515 0 C-N-CA 124.673 3.582 . . . . 0.0 108.743 177.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.554 ' CD1' ' C ' ' A' ' 34' ' ' PRO . 1.0 OUTLIER -124.14 98.22 5.68 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 118.075 -1.45 . . . . 0.0 110.311 179.358 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.561 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 26.3 mp0 -114.15 81.28 1.51 Allowed 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.452 ' HA ' HG21 ' A' ' 18' ' ' VAL . 3.4 pp -113.07 142.46 45.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.674 -1.266 . . . . 0.0 110.181 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -140.47 138.01 34.31 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 122.595 1.188 . . . . 0.0 108.451 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 87' ' ' ASP . . . -142.07 153.11 43.93 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-O 123.03 1.395 . . . . 0.0 113.292 -176.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.561 ' CG1' ' HB3' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -110.41 141.21 26.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 113.697 -1.592 . . . . 0.0 109.007 178.47 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.578 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 3.5 p90 -155.79 121.78 5.06 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 8.8 tt0 -68.22 156.38 37.73 Favored 'General case' 0 C--N 1.287 -2.125 0 O-C-N 120.35 -1.469 . . . . 0.0 109.178 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.561 ' HB1' ' CE2' ' A' ' 86' ' ' TYR . . . -92.22 136.36 33.25 Favored 'General case' 0 C--N 1.269 -2.921 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.807 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.537 ' C ' ' HG2' ' A' ' 45' ' ' GLN . 0.3 OUTLIER -116.65 49.73 1.13 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 125.376 2.512 . . . . 0.0 113.78 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.583 ' N ' ' CG ' ' A' ' 82' ' ' LYS . 6.4 pt20 166.59 -158.35 0.01 OUTLIER 'General case' 0 C--N 1.258 -3.401 0 CA-C-N 108.999 -3.728 . . . . 0.0 112.97 175.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.417 ' H ' ' HB2' ' A' ' 45' ' ' GLN 0.285 28.7 t-20 -109.99 154.78 22.69 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-O 122.596 1.188 . . . . 0.0 108.97 -178.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.632 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.1 OUTLIER -172.85 150.97 2.15 Favored 'General case' 0 C--N 1.255 -3.535 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.202 -178.275 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.672 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -112.28 11.16 20.1 Favored 'General case' 0 N--CA 1.506 2.371 0 C-N-CA 118.16 -1.416 . . . . 0.0 110.185 178.406 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.559 ' CG2' ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.61 145.49 3.81 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 120.706 -1.246 . . . . 0.0 111.069 178.6 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.488 ' O ' ' O ' ' A' ' 70' ' ' PRO . . . -139.73 95.13 2.86 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-O 122.988 1.375 . . . . 0.0 109.544 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -65.92 -178.27 0.57 Allowed 'General case' 0 C--N 1.281 -2.374 0 CA-C-N 113.836 -1.529 . . . . 0.0 109.711 178.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.755 ' CG1' ' HA ' ' A' ' 70' ' ' PRO . 35.7 mt -142.14 144.18 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.357 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.497 ' O ' HG11 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -140.52 104.01 4.66 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 123.425 1.583 . . . . 0.0 109.75 178.397 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.751 ' HA ' ' CG1' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -93.06 126.29 45.51 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 CA-C-N 112.503 -2.135 . . . . 0.0 107.301 179.252 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.505 ' N ' HD12 ' A' ' 54' ' ' ILE . 0.5 OUTLIER -129.86 149.84 51.42 Favored 'General case' 0 C--N 1.272 -2.802 0 C-N-CA 118.448 -1.301 . . . . 0.0 108.145 178.836 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.524 ' HB1' ' CG2' ' A' ' 63' ' ' VAL . . . -135.58 127.46 29.41 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 117.694 -1.603 . . . . 0.0 111.475 -178.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.684 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 2.2 p -101.3 100.3 10.78 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 177.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.733 ' HA ' ' CG2' ' A' ' 104' ' ' VAL . 0.8 OUTLIER -115.47 102.4 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.738 0 CA-C-O 123.089 1.423 . . . . 0.0 110.983 -176.613 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 103' ' ' ASN . 0.1 OUTLIER 38.28 64.95 0.65 Allowed 'General case' 0 N--CA 1.521 3.121 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.326 179.055 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.53 -13.66 7.91 Favored Glycine 0 N--CA 1.489 2.176 0 O-C-N 121.263 -0.898 . . . . 0.0 111.311 177.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.492 ' HB3' HG13 ' A' ' 58' ' ' ILE 0.278 0.3 OUTLIER -108.14 54.88 0.65 Allowed 'General case' 0 C--N 1.294 -1.841 0 O-C-N 121.205 -1.173 . . . . 0.0 111.495 -178.528 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.584 ' HG3' ' O ' ' A' ' 62' ' ' GLU 0.366 0.0 OUTLIER -59.4 117.5 4.91 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 122.527 1.156 . . . . 0.0 111.397 -179.531 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.524 ' CG2' ' HB1' ' A' ' 56' ' ' ALA . 18.8 m -80.19 148.22 5.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-O 122.56 1.172 . . . . 0.0 111.103 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.441 5.9 t70 -137.8 82.11 1.9 Allowed 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.319 -176.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.531 ' CG2' ' HD2' ' A' ' 66' ' ' PRO . 9.8 p -164.23 151.46 10.25 Favored Pre-proline 0 C--N 1.277 -2.565 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.427 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 65' ' ' VAL . 45.5 Cg_endo -85.43 139.14 6.72 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 CA-C-O 123.643 1.435 . . . . 0.0 111.719 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.588 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -127.66 48.08 0.99 Allowed Glycine 0 N--CA 1.501 3.02 0 CA-C-N 112.69 -2.05 . . . . 0.0 110.77 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.529 ' CD1' ' HA ' ' A' ' 90' ' ' TYR 0.302 5.8 tp 179.68 -174.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 CA-C-N 119.476 1.638 . . . . 0.0 110.024 -178.607 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.585 ' OD2' ' CZ ' ' A' ' 75' ' ' TYR . 1.1 t70 -109.71 84.25 3.18 Favored Pre-proline 0 N--CA 1.504 2.252 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 175.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.755 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 21.0 Cg_endo -48.92 -9.64 0.1 OUTLIER 'Trans proline' 0 C--N 1.279 -3.097 0 C-N-CA 123.556 2.837 . . . . 0.0 115.312 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.527 ' HB2' ' NE2' ' A' ' 74' ' ' HIS . 1.2 m120 -105.42 83.8 2.01 Favored 'General case' 0 C--N 1.287 -2.151 0 O-C-N 120.212 -1.555 . . . . 0.0 108.699 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.601 ' HA ' ' CD1' ' A' ' 75' ' ' TYR . . . -78.44 10.79 2.84 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.505 -0.747 . . . . 0.0 109.402 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.61 -19.92 54.76 Favored 'General case' 0 C--N 1.317 -0.842 0 O-C-N 120.507 -1.371 . . . . 0.0 108.177 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.578 ' ND1' ' N ' ' A' ' 74' ' ' HIS . 0.1 OUTLIER -88.24 18.85 4.06 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 174.203 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.626 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.4 OUTLIER -133.18 -9.38 2.97 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.241 179.774 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.485 ' O ' ' C ' ' A' ' 77' ' ' LYS . 1.6 ptt? -162.62 128.18 3.33 Favored 'General case' 0 C--O 1.215 -0.749 0 CA-C-O 123.6 1.667 . . . . 0.0 112.859 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.578 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 0.6 OUTLIER -4.47 86.93 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 112.042 -2.345 . . . . 0.0 113.559 -178.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.506 ' HA ' HD12 ' A' ' 80' ' ' LEU 0.297 11.1 t -99.02 136.92 20.43 Favored Pre-proline 0 C--N 1.262 -3.197 0 CA-C-N 111.364 -2.653 . . . . 0.0 108.714 178.094 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.672 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 37.3 Cg_endo -78.48 165.95 81.24 Favored 'Cis proline' 0 C--N 1.312 -1.343 0 C-N-CA 123.007 -1.664 . . . . 0.0 112.906 1.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.662 ' HB3' ' CE2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -89.1 127.39 35.71 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.44 179.445 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.528 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.7 t -106.32 139.47 27.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-O 124.129 1.918 . . . . 0.0 111.616 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.583 ' CG ' ' N ' ' A' ' 45' ' ' GLN . 1.6 tmmt? -44.38 117.97 1.4 Allowed 'General case' 0 C--N 1.271 -2.842 0 CA-C-N 111.686 -2.507 . . . . 0.0 116.924 -175.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.19 -17.6 16.77 Favored Glycine 0 C--N 1.293 -1.808 0 CA-C-N 111.693 -2.503 . . . . 0.0 107.845 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 14.7 mt-30 -72.63 128.63 36.14 Favored 'General case' 0 C--N 1.277 -2.56 0 CA-C-O 123.215 1.483 . . . . 0.0 111.585 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.581 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 0.7 OUTLIER -66.47 145.87 55.18 Favored 'General case' 0 C--N 1.27 -2.859 0 CA-C-N 113.336 -1.756 . . . . 0.0 107.437 178.341 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.662 ' CE2' ' HB3' ' A' ' 80' ' ' LEU . 19.4 m-85 -142.53 124.92 15.59 Favored 'General case' 0 C--N 1.275 -2.64 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -178.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.561 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 4.5 p30 -116.93 133.29 56.2 Favored 'General case' 0 C--N 1.278 -2.543 0 CA-C-O 122.772 1.272 . . . . 0.0 110.233 -177.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.669 ' CG1' ' CD1' ' A' ' 52' ' ' ILE . 1.1 tp -108.73 159.4 8.15 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 CA-C-N 114.46 -1.246 . . . . 0.0 108.335 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.525 ' HG2' ' N ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -143.24 149.63 38.18 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 120.125 -0.63 . . . . 0.0 112.182 -176.935 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.555 ' CE1' ' HB2' ' A' ' 92' ' ' TRP . 25.5 t80 -147.22 105.62 3.79 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.421 -0.799 . . . . 0.0 110.489 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.561 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 1.1 t -123.93 110.9 15.4 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.588 ' CD1' ' O ' ' A' ' 67' ' ' GLY 0.272 0.0 OUTLIER -142.41 109.11 5.39 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.719 -176.662 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.505 ' C ' ' CG1' ' A' ' 94' ' ' VAL . 0.6 OUTLIER -77.29 153.09 34.23 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 119.735 -1.853 . . . . 0.0 109.496 -179.476 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.57 HG21 ' HB2' ' A' ' 33' ' ' LYS . 0.8 OUTLIER -154.31 175.36 3.11 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 120.682 -1.261 . . . . 0.0 108.999 -179.73 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 94' ' ' VAL . 18.3 Cg_endo -38.12 156.38 0.03 OUTLIER 'Trans proline' 0 CA--C 1.495 -1.464 0 O-C-N 123.589 1.31 . . . . 0.0 111.127 -177.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.852 ' HA ' ' HA3' ' A' ' 32' ' ' GLY . 2.4 mptt -80.12 -27.97 39.05 Favored 'General case' 0 C--N 1.285 -2.218 0 C-N-CA 116.555 -2.058 . . . . 0.0 116.04 -173.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.586 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -145.42 43.22 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 -177.348 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.512 ' N ' ' HD2' ' A' ' 99' ' ' PRO . . . -60.33 -53.27 66.49 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 120.367 -1.458 . . . . 0.0 109.736 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.665 ' C ' ' HD2' ' A' ' 100' ' ' LYS . 55.6 Cg_endo -73.67 160.78 43.3 Favored 'Trans proline' 0 CA--C 1.466 -2.904 0 O-C-N 124.145 1.603 . . . . 0.0 111.13 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.722 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -110.27 106.37 15.75 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 112.236 -2.256 . . . . 0.0 111.104 -169.392 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.473 ' C ' ' O ' ' A' ' 100' ' ' LYS . 1.5 p -40.88 95.32 0.01 OUTLIER 'General case' 0 N--CA 1.519 3.021 0 CA-C-O 123.496 1.617 . . . . 0.0 110.469 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.581 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.387 84.7 mt-10 -164.93 -52.72 0.03 OUTLIER 'General case' 0 CA--C 1.448 -2.952 0 CA-C-N 112.959 -1.928 . . . . 0.0 111.214 178.468 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.486 0.8 OUTLIER -161.25 77.62 0.56 Allowed 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 110.583 -3.008 . . . . 0.0 113.466 -162.016 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.733 ' CG2' ' HA ' ' A' ' 58' ' ' ILE . 21.8 t -144.28 141.44 24.37 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.63 0 C-N-CA 119.32 -0.952 . . . . 0.0 111.907 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.547 HG11 ' CD1' ' A' ' 121' ' ' ILE . 0.3 OUTLIER -153.75 133.26 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.505 ' O ' HG12 ' A' ' 121' ' ' ILE . 0.4 OUTLIER -94.32 143.56 11.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-O 122.357 1.075 . . . . 0.0 110.994 -179.287 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.619 ' CG2' ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -131.75 116.65 17.56 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 179.642 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.751 ' CG1' ' HA ' ' A' ' 54' ' ' ILE . 3.5 t -132.19 139.37 50.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 O-C-N 120.247 -1.533 . . . . 0.0 108.481 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.94 ' HB2' ' HB2' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -132.96 146.49 51.83 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.364 1.078 . . . . 0.0 111.187 -178.44 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.557 ' CG2' HD12 ' A' ' 88' ' ' ILE . 2.9 t -99.94 127.8 52.47 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 178.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.481 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -108.29 121.99 46.03 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -179.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -74.62 -131.34 0.24 Allowed Glycine 0 C--N 1.283 -2.39 0 C-N-CA 119.22 -1.467 . . . . 0.0 114.625 -175.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.632 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 6.2 p-10 -97.76 9.56 42.3 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -175.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 32.7 p30 -167.17 -13.68 0.02 OUTLIER 'General case' 0 C--N 1.263 -3.156 0 C-N-CA 117.224 -1.791 . . . . 0.0 114.464 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -153.66 -88.15 0.06 OUTLIER Glycine 0 CA--C 1.475 -2.463 0 CA-C-O 125.879 2.933 . . . . 0.0 112.338 -177.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.1 p -141.51 178.93 2.39 Favored 'Isoleucine or valine' 1 C--N 1.228 -4.692 1 CA-C-N 108.155 -4.022 . . . . 0.0 111.014 -176.785 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.525 ' CB ' ' O ' ' A' ' 110' ' ' VAL . 0.1 OUTLIER -149.3 -62.72 0.23 Allowed 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.255 -179.422 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.562 ' CB ' HG13 ' A' ' 13' ' ' ILE . . . -164.15 129.66 2.91 Favored 'General case' 0 N--CA 1.51 2.526 0 O-C-N 120.872 -1.142 . . . . 0.0 109.756 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.94 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 1.5 p -133.98 134.73 42.85 Favored 'General case' 0 C--N 1.283 -2.321 0 C-N-CA 117.975 -1.49 . . . . 0.0 113.35 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -144.17 136.3 26.42 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 122.913 1.339 . . . . 0.0 112.153 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.619 ' HB ' ' CG2' ' A' ' 107' ' ' THR 0.268 0.1 OUTLIER -110.79 130.78 63.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.176 -179.495 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.542 ' N ' HD12 ' A' ' 121' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.536 0 O-C-N 120.862 -1.149 . . . . 0.0 108.977 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 120.715 0.293 . . . . 0.0 111.042 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.572 ' CG1' ' HA ' ' A' ' 22' ' ' HIS . 1.4 m -145.58 177.6 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 O-C-N 120.892 -1.13 . . . . 0.0 108.032 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.469 ' O ' HG22 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -80.22 139.3 36.78 Favored 'General case' 0 CA--C 1.477 -1.864 0 C-N-CA 118.007 -1.477 . . . . 0.0 108.823 177.502 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.484 ' O ' ' HG2' ' A' ' 6' ' ' LYS 0.425 0.4 OUTLIER -168.58 160.71 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 CA-C-N 114.029 -1.442 . . . . 0.0 110.057 -170.22 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 5' ' ' VAL . 3.5 mtpt -144.44 140.12 28.77 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 123.785 1.755 . . . . 0.0 113.116 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.27 4.4 t0 -76.36 147.81 37.83 Favored 'General case' 0 C--N 1.267 -2.994 0 CA-C-N 112.932 -1.94 . . . . 0.0 109.786 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.648 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.0 p -137.04 16.01 3.04 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.968 -1.082 . . . . 0.0 109.162 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.596 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -125.03 -82.71 0.64 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.033 -176.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.574 ' O ' ' N ' ' A' ' 12' ' ' GLU . 2.4 t30 -155.79 63.56 0.59 Allowed 'General case' 0 C--N 1.267 -2.991 0 C-N-CA 118.319 -1.352 . . . . 0.0 111.81 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.478 ' C ' ' O ' ' A' ' 10' ' ' ASN . 59.2 m-70 32.02 33.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.854 0.835 . . . . 0.0 110.573 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.6 OUTLIER -95.09 22.47 6.61 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.72 -0.792 . . . . 0.0 111.591 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.601 ' CG2' ' N ' ' A' ' 14' ' ' LYS 0.276 0.2 OUTLIER -118.42 -170.36 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.413 -0.804 . . . . 0.0 110.001 -179.116 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.601 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 0.3 OUTLIER -161.86 -41.43 0.04 OUTLIER 'General case' 0 C--N 1.29 -2.011 0 O-C-N 121.731 -0.605 . . . . 0.0 111.492 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.567 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 11.6 tttm -147.72 138.13 23.08 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 115.89 -2.324 . . . . 0.0 113.145 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.516 HG12 ' CB ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -134.52 104.11 5.25 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 CA-C-O 122.897 1.332 . . . . 0.0 110.363 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.452 ' HB2' ' OE2' ' A' ' 38' ' ' GLU . 1.2 mt -99.52 125.65 45.32 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.776 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.549 ' CG1' ' HD2' ' A' ' 19' ' ' PRO . 40.5 t -141.72 145.4 36.85 Favored Pre-proline 0 N--CA 1.5 2.03 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.025 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.549 ' HD2' ' CG1' ' A' ' 18' ' ' VAL . 44.7 Cg_endo -68.64 134.87 31.6 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 O-C-N 123.772 1.406 . . . . 0.0 111.312 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.48 -76.24 0.22 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.2 m -85.7 134.05 33.99 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.468 -1.019 . . . . 0.0 109.651 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.572 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 4.0 p80 -142.26 12.55 1.98 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 119.998 -1.689 . . . . 0.0 110.948 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 C-N-CA 118.364 -1.874 . . . . 0.0 110.931 177.102 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.853 ' HA2' ' HA ' ' A' ' 96' ' ' LYS . . . . . . . . 0 C--O 1.213 -1.178 0 N-CA-C 105.887 -2.885 . . . . 0.0 105.887 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.545 ' HB2' ' CG1' ' A' ' 94' ' ' VAL . 0.7 OUTLIER -117.28 96.77 49.84 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 120.66 2.23 . . . . 0.0 116.577 -175.059 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.575 ' HD3' ' O ' ' A' ' 32' ' ' GLY . 60.8 Cg_endo -107.02 145.39 0.08 OUTLIER 'Trans proline' 0 C--N 1.288 -2.631 0 C-N-CA 123.864 3.042 . . . . 0.0 108.546 176.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -120.53 96.52 5.17 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 118.582 -1.247 . . . . 0.0 109.182 179.002 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.568 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 28.0 mp0 -113.82 83.71 1.9 Allowed 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.471 ' HB2' HG23 ' A' ' 18' ' ' VAL . 2.1 pp -110.17 144.68 38.45 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.686 -1.258 . . . . 0.0 109.768 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.521 ' CB ' ' HG2' ' A' ' 89' ' ' LYS . 1.5 pp20? -140.44 139.07 35.14 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 122.7 1.238 . . . . 0.0 108.816 -178.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.516 ' CB ' HG12 ' A' ' 16' ' ' VAL . . . -142.56 148.74 38.04 Favored 'General case' 0 C--N 1.275 -2.649 0 CA-C-O 122.986 1.374 . . . . 0.0 112.968 -176.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.567 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.35 140.07 31.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 113.817 -1.538 . . . . 0.0 108.87 178.535 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.607 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 6.7 p90 -157.19 126.93 6.17 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -178.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 17.3 tt0 -70.41 156.96 38.64 Favored 'General case' 0 C--N 1.283 -2.319 0 O-C-N 120.388 -1.445 . . . . 0.0 108.815 178.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.574 ' HB1' ' CE2' ' A' ' 86' ' ' TYR . . . -89.41 136.07 33.24 Favored 'General case' 0 C--N 1.265 -3.089 0 CA-C-N 114.21 -1.359 . . . . 0.0 107.996 178.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.586 ' C ' ' HG2' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -117.43 49.93 1.16 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 125.398 2.523 . . . . 0.0 114.242 179.535 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.661 ' N ' ' HG3' ' A' ' 82' ' ' LYS . 7.0 pt20 167.54 -159.18 0.01 OUTLIER 'General case' 0 C--N 1.258 -3.393 0 CA-C-N 108.77 -3.832 . . . . 0.0 112.901 174.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.459 ' H ' ' HB2' ' A' ' 45' ' ' GLN 0.274 20.3 t-20 -108.78 153.55 23.32 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-O 122.622 1.201 . . . . 0.0 108.408 -178.884 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.618 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -172.65 154.33 3.01 Favored 'General case' 0 C--N 1.254 -3.569 0 C-N-CA 118.588 -1.245 . . . . 0.0 112.836 -178.215 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.672 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 1.2 mtpm? -115.07 7.03 15.35 Favored 'General case' 0 N--CA 1.508 2.452 0 O-C-N 120.74 -1.225 . . . . 0.0 110.926 178.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.57 ' CG2' ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.93 149.81 4.45 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.608 -1.307 . . . . 0.0 111.194 179.862 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 70' ' ' PRO . . . -150.59 109.07 3.8 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-O 122.55 1.167 . . . . 0.0 110.954 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 1.2 ptpt -77.24 -173.39 2.81 Favored 'General case' 0 N--CA 1.506 2.327 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.368 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.723 ' CG1' ' HA ' ' A' ' 70' ' ' PRO . 35.0 mt -141.84 139.92 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.368 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.419 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.505 ' O ' HG11 ' A' ' 108' ' ' VAL . 3.5 tp10 -140.79 110.03 6.22 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 123.343 1.544 . . . . 0.0 111.168 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.641 ' HA ' ' CG1' ' A' ' 108' ' ' VAL . 0.5 OUTLIER -91.12 128.59 42.82 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 CA-C-N 112.746 -2.024 . . . . 0.0 109.934 179.373 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.431 ' HD2' ' C ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -123.77 103.85 8.62 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 176.84 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.504 ' HB2' ' CG2' ' A' ' 63' ' ' VAL . . . -113.75 134.41 54.78 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 118.708 -1.197 . . . . 0.0 113.183 -175.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.651 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.1 p -106.64 100.79 10.28 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 178.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.748 ' HA ' ' CG1' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -110.68 107.84 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.939 0 CA-C-O 122.986 1.374 . . . . 0.0 110.774 -177.259 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 103' ' ' ASN . 0.5 OUTLIER 33.06 63.49 0.33 Allowed 'General case' 0 N--CA 1.519 2.992 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.977 179.634 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.72 -14.31 10.3 Favored Glycine 0 N--CA 1.489 2.2 0 O-C-N 121.352 -0.842 . . . . 0.0 111.525 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.507 ' O ' HG12 ' A' ' 58' ' ' ILE 0.274 0.3 OUTLIER -108.19 57.68 0.62 Allowed 'General case' 0 C--N 1.292 -1.897 0 O-C-N 121.087 -1.243 . . . . 0.0 111.175 -178.536 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.519 ' O ' ' CG ' ' A' ' 62' ' ' GLU 0.366 0.0 OUTLIER -58.61 114.44 2.49 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 122.1 0.952 . . . . 0.0 111.139 -179.696 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.504 ' CG2' ' HB2' ' A' ' 56' ' ' ALA . 15.0 m -74.95 144.89 11.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 122.586 1.184 . . . . 0.0 110.573 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.435 19.2 t0 -138.07 68.94 1.39 Allowed 'General case' 0 C--N 1.278 -2.526 0 CA-C-O 122.621 1.2 . . . . 0.0 110.572 -176.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.529 ' CG2' ' HD2' ' A' ' 66' ' ' PRO . 4.8 p -164.03 151.89 10.87 Favored Pre-proline 0 C--N 1.272 -2.797 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.952 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.529 ' HD2' ' CG2' ' A' ' 65' ' ' VAL . 43.4 Cg_endo -83.26 137.84 8.49 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 CA-C-O 123.804 1.502 . . . . 0.0 111.719 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -125.19 50.14 0.88 Allowed Glycine 0 C--N 1.273 -2.963 0 CA-C-N 112.461 -2.154 . . . . 0.0 110.253 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.563 ' HB ' ' CD2' ' A' ' 90' ' ' TYR 0.304 6.4 tp -178.78 -176.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 O-C-N 120.532 -1.569 . . . . 0.0 110.061 -178.56 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.504 ' HA ' ' HD2' ' A' ' 70' ' ' PRO . 29.9 t0 -112.35 83.64 5.45 Favored Pre-proline 0 N--CA 1.502 2.154 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 175.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.723 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 19.1 Cg_endo -47.68 -8.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.289 -2.601 0 C-N-CA 124.275 3.317 . . . . 0.0 115.826 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.577 ' CB ' ' NE2' ' A' ' 74' ' ' HIS . 2.4 m-80 -101.62 90.41 4.04 Favored 'General case' 0 C--N 1.286 -2.167 0 O-C-N 120.2 -1.562 . . . . 0.0 109.74 -178.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.76 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . . . -78.02 7.14 6.52 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.295 -0.878 . . . . 0.0 109.478 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.9 t -79.11 -26.58 42.9 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 121.034 -1.041 . . . . 0.0 109.044 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.577 ' NE2' ' CB ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -79.71 6.78 9.9 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.895 -1.122 . . . . 0.0 108.943 177.217 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.76 ' CD2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -133.68 -0.48 3.17 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 121.364 -0.835 . . . . 0.0 109.966 177.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.522 ' HE1' ' CD2' ' A' ' 80' ' ' LEU . 2.6 ptt? -150.34 126.81 10.79 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 123.89 1.805 . . . . 0.0 112.86 178.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.525 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -20.07 95.25 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 112.006 -2.361 . . . . 0.0 113.159 -178.255 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.493 ' HA ' ' CD1' ' A' ' 80' ' ' LEU 0.311 0.5 OUTLIER -100.77 144.47 28.58 Favored Pre-proline 0 C--N 1.268 -2.968 0 CA-C-N 111.437 -2.62 . . . . 0.0 109.128 179.01 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.672 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 35.8 Cg_endo -81.37 168.81 68.08 Favored 'Cis proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.792 -1.753 . . . . 0.0 112.16 0.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.722 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -96.75 130.25 44.03 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.25 -179.389 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.544 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.8 t -106.35 139.41 27.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-O 124.109 1.909 . . . . 0.0 111.954 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.661 ' HG3' ' N ' ' A' ' 45' ' ' GLN . 2.3 tmpt? -42.65 120.96 1.86 Allowed 'General case' 0 C--N 1.271 -2.841 0 CA-C-N 111.902 -2.408 . . . . 0.0 115.955 -175.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.35 -16.63 24.43 Favored Glycine 0 C--N 1.291 -1.957 0 CA-C-N 111.97 -2.377 . . . . 0.0 108.38 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 16.6 mt-30 -73.61 126.42 30.25 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-O 123.223 1.487 . . . . 0.0 111.786 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.608 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -64.04 143.18 58.07 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 113.271 -1.786 . . . . 0.0 107.539 179.084 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.659 ' CE1' ' HG ' ' A' ' 80' ' ' LEU . 18.7 m-85 -143.29 126.01 16.02 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.566 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 1.2 p-10 -117.12 132.55 56.64 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-O 122.712 1.244 . . . . 0.0 109.902 -178.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.684 ' CG1' ' CD1' ' A' ' 52' ' ' ILE . 0.9 OUTLIER -110.55 160.79 9.46 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.24 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.521 ' HG2' ' CB ' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -148.15 161.15 42.03 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-O 122.031 0.92 . . . . 0.0 113.203 -177.209 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.563 ' CD2' ' HB ' ' A' ' 68' ' ' ILE . 28.0 t80 -151.17 105.62 3.24 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.559 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.568 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 0.6 OUTLIER -122.3 111.51 17.0 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 178.806 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.577 ' CD1' ' O ' ' A' ' 67' ' ' GLY 0.271 0.3 OUTLIER -141.99 116.81 9.84 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.446 -176.824 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.3 OUTLIER -75.16 161.72 29.13 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 119.237 -2.164 . . . . 0.0 109.795 -179.014 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.545 ' CG1' ' HB2' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -151.48 165.84 16.5 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.528 ' O ' ' O ' ' A' ' 94' ' ' VAL . 19.8 Cg_endo -38.26 154.26 0.03 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.178 0 O-C-N 123.586 1.309 . . . . 0.0 110.505 -177.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.853 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 8.5 mptt -79.35 -28.15 42.03 Favored 'General case' 0 C--N 1.285 -2.228 0 C-N-CA 116.566 -2.053 . . . . 0.0 114.725 -173.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.564 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -143.41 43.07 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 CA-C-O 121.402 0.62 . . . . 0.0 112.541 -178.695 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.61 ' CB ' ' CD ' ' A' ' 99' ' ' PRO . . . -76.53 -64.48 0.48 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 120.562 -1.336 . . . . 0.0 109.903 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.671 ' C ' ' HD2' ' A' ' 100' ' ' LYS . 47.2 Cg_endo -66.13 159.87 47.48 Favored 'Trans proline' 0 CA--C 1.463 -3.057 0 O-C-N 123.94 1.495 . . . . 0.0 110.045 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.672 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -108.58 105.39 14.99 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-N 112.517 -2.129 . . . . 0.0 109.874 -169.587 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.472 ' C ' ' O ' ' A' ' 100' ' ' LYS . 5.5 p -46.2 98.62 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 123.37 1.557 . . . . 0.0 108.195 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.593 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.402 88.1 mt-10 -164.0 -51.54 0.03 OUTLIER 'General case' 0 CA--C 1.448 -2.945 0 CA-C-N 113.195 -1.82 . . . . 0.0 111.987 -179.115 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.539 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.481 0.8 OUTLIER -159.52 78.27 0.71 Allowed 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 111.159 -2.746 . . . . 0.0 114.01 -162.073 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.748 ' CG1' ' HA ' ' A' ' 58' ' ' ILE . 28.5 t -142.31 137.8 29.45 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.875 178.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.539 ' CG1' HD13 ' A' ' 121' ' ' ILE . 22.0 t -147.14 133.93 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.506 ' O ' HG12 ' A' ' 121' ' ' ILE . 0.3 OUTLIER -106.87 146.73 12.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-O 122.806 1.288 . . . . 0.0 113.033 -178.26 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.634 ' CG2' ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -132.86 109.57 9.71 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.432 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.641 ' CG1' ' HA ' ' A' ' 54' ' ' ILE . 3.9 t -127.07 144.88 35.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 119.954 -1.716 . . . . 0.0 109.043 -177.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.976 ' HB2' ' HB2' ' A' ' 119' ' ' CYS . 0.1 OUTLIER -136.48 143.05 43.61 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.137 0.97 . . . . 0.0 111.571 -178.018 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.575 ' CG2' HD12 ' A' ' 88' ' ' ILE . 20.9 t -96.28 130.97 44.2 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.612 ' CG ' ' HA2' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -110.69 119.53 39.45 Favored 'General case' 0 N--CA 1.509 2.506 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -178.717 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -81.69 -140.41 3.12 Favored Glycine 0 N--CA 1.5 2.946 0 C-N-CA 119.449 -1.357 . . . . 0.0 115.195 -174.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.618 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 4.4 p-10 -82.38 -6.44 59.27 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 122.267 1.032 . . . . 0.0 112.743 -176.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -128.86 -5.24 5.1 Favored 'General case' 0 C--N 1.262 -3.218 0 CA-C-O 121.747 0.784 . . . . 0.0 110.3 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.612 ' HA2' ' CG ' ' A' ' 111' ' ' MET . . . 94.43 85.3 1.64 Allowed Glycine 0 CA--C 1.471 -2.662 0 CA-C-O 124.595 2.219 . . . . 0.0 110.871 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.611 ' CB ' ' O ' ' A' ' 115' ' ' GLY . 7.5 p 137.11 153.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.251 -3.695 0 CA-C-N 108.409 -3.895 . . . . 0.0 112.451 176.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.555 ' CB ' ' O ' ' A' ' 110' ' ' VAL . 0.2 OUTLIER -160.94 -59.97 0.06 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.284 0.564 . . . . 0.0 110.232 179.376 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.539 ' CB ' HG13 ' A' ' 13' ' ' ILE . . . -170.86 130.1 0.8 Allowed 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.204 -0.935 . . . . 0.0 109.085 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.976 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 0.9 OUTLIER -132.92 131.68 41.15 Favored 'General case' 0 C--N 1.28 -2.455 0 C-N-CA 117.769 -1.573 . . . . 0.0 112.52 -178.131 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.455 ' HB1' ' CD1' ' A' ' 13' ' ' ILE . . . -143.05 138.22 29.79 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 123.105 1.431 . . . . 0.0 111.866 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.634 ' HB ' ' CG2' ' A' ' 107' ' ' THR 0.274 0.0 OUTLIER -111.03 132.39 59.65 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 113.891 -1.504 . . . . 0.0 111.634 -178.837 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.523 0 O-C-N 120.936 -1.102 . . . . 0.0 109.022 179.566 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.473 ' OE1' ' N ' ' A' ' 2' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 120.703 0.287 . . . . 0.0 111.418 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.545 ' HA ' ' C ' ' A' ' 22' ' ' HIS . 1.5 m -147.41 178.51 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.446 ' O ' HG22 ' A' ' 3' ' ' VAL . 7.1 t0 -80.01 137.17 36.76 Favored 'General case' 0 CA--C 1.473 -1.999 0 C-N-CA 117.509 -1.677 . . . . 0.0 108.681 177.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.5 ' C ' ' CG ' ' A' ' 6' ' ' LYS 0.434 0.4 OUTLIER -167.49 178.81 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.101 -169.795 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.534 ' HB2' ' CG2' ' A' ' 121' ' ' ILE . 19.4 mtpt -153.31 132.68 12.83 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 123.657 1.694 . . . . 0.0 112.46 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.264 2.2 t70 -71.95 146.5 47.73 Favored 'General case' 0 C--N 1.267 -3.014 0 CA-C-N 113.42 -1.718 . . . . 0.0 109.224 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.657 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.8 p -137.32 16.07 2.98 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.03 -1.044 . . . . 0.0 109.519 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.593 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -125.3 -84.91 0.64 Allowed 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 118.815 -1.154 . . . . 0.0 110.024 -176.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 12' ' ' GLU . 2.7 t30 -158.74 65.1 0.42 Allowed 'General case' 0 C--N 1.266 -3.04 0 C-N-CA 118.249 -1.38 . . . . 0.0 112.529 177.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.608 ' CG ' ' O ' ' A' ' 11' ' ' HIS . 30.1 t-80 36.44 30.79 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 122.053 0.93 . . . . 0.0 110.266 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.539 ' CG ' ' OD1' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -92.07 21.99 4.66 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.403 -0.811 . . . . 0.0 111.847 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.608 ' CG2' ' N ' ' A' ' 14' ' ' LYS 0.268 0.0 OUTLIER -120.1 -170.31 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 122.151 0.977 . . . . 0.0 111.133 -178.794 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.608 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 0.8 OUTLIER -162.59 -48.07 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.223 -179.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.608 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 20.5 tttp -142.28 135.8 29.13 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 116.436 -2.106 . . . . 0.0 112.621 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.543 HG11 ' CB ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -133.2 102.75 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 122.903 1.335 . . . . 0.0 110.928 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.41 ' HG ' ' NZ ' ' A' ' 15' ' ' LYS . 0.6 OUTLIER -92.56 126.11 37.5 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 114.096 -1.411 . . . . 0.0 111.52 178.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.453 HG21 ' HA ' ' A' ' 37' ' ' LEU . 59.6 t -142.85 140.96 18.84 Favored Pre-proline 0 N--CA 1.498 1.973 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.347 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.413 ' HD2' HG11 ' A' ' 18' ' ' VAL . 47.7 Cg_endo -70.72 132.73 22.35 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.629 1.331 . . . . 0.0 111.039 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 118.3 -75.37 0.29 Allowed Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.9 m -91.16 139.27 30.91 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.541 -0.976 . . . . 0.0 110.192 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.545 ' C ' ' HA ' ' A' ' 3' ' ' VAL . 7.2 p80 -139.66 6.38 2.26 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.112 -1.617 . . . . 0.0 110.774 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 C-N-CA 118.506 -1.807 . . . . 0.0 111.126 176.981 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.814 ' HA2' ' HA ' ' A' ' 96' ' ' LYS . . . . . . . . 0 C--O 1.214 -1.111 0 N-CA-C 105.321 -3.112 . . . . 0.0 105.321 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.555 ' HB2' HG21 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -118.26 97.07 50.52 Favored Pre-proline 0 C--O 1.218 -0.554 0 CA-C-N 121.278 2.539 . . . . 0.0 116.927 -174.538 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.554 ' HD3' ' O ' ' A' ' 32' ' ' GLY . 62.1 Cg_endo -106.15 144.53 0.1 OUTLIER 'Trans proline' 0 C--N 1.29 -2.531 0 C-N-CA 123.754 2.969 . . . . 0.0 108.142 176.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.602 ' CE2' HG13 ' A' ' 94' ' ' VAL . 14.6 m-85 -116.11 92.46 3.9 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 119.347 -0.941 . . . . 0.0 108.868 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.548 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 25.5 mp0 -115.9 88.86 2.97 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.06 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.453 ' HA ' HG21 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -108.83 138.46 45.13 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 120.672 -1.268 . . . . 0.0 108.479 179.115 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -139.76 128.42 23.12 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.543 ' CB ' HG11 ' A' ' 16' ' ' VAL . . . -143.33 151.49 40.53 Favored 'General case' 0 C--N 1.274 -2.678 0 CA-C-O 123.212 1.482 . . . . 0.0 113.801 -175.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.608 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -112.49 140.61 31.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 113.627 -1.624 . . . . 0.0 107.862 177.623 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.59 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 4.0 p90 -156.54 123.04 5.06 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -177.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 14.9 tt0 -68.07 154.84 40.83 Favored 'General case' 0 C--N 1.288 -2.087 0 O-C-N 120.425 -1.422 . . . . 0.0 108.521 178.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.587 ' HB1' ' CE2' ' A' ' 86' ' ' TYR . . . -90.47 131.61 36.12 Favored 'General case' 0 C--N 1.265 -3.082 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.821 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.54 ' C ' ' HG2' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -113.66 49.87 0.95 Allowed 'General case' 0 CA--C 1.482 -1.654 0 CA-C-O 125.508 2.575 . . . . 0.0 113.847 179.221 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.649 ' N ' ' HG3' ' A' ' 82' ' ' LYS . 5.7 pt20 167.0 -158.61 0.01 OUTLIER 'General case' 0 C--N 1.259 -3.344 0 CA-C-N 108.732 -3.849 . . . . 0.0 112.796 174.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.411 ' H ' ' HB2' ' A' ' 45' ' ' GLN 0.278 16.7 t-20 -110.11 155.63 21.66 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-O 122.64 1.209 . . . . 0.0 108.959 -178.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.627 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -172.36 154.57 3.27 Favored 'General case' 0 C--N 1.254 -3.574 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.511 -178.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.657 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 9.5 mtpt -112.36 5.8 18.4 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 120.763 -1.211 . . . . 0.0 110.996 178.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.562 ' CG2' ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.15 147.84 4.73 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.417 -1.427 . . . . 0.0 111.351 179.19 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 111' ' ' MET . . . -138.51 98.06 3.5 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-O 122.757 1.265 . . . . 0.0 110.481 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 0.9 OUTLIER -69.3 -179.71 1.71 Allowed 'General case' 0 N--CA 1.505 2.321 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.138 178.511 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.718 ' CG1' ' HA ' ' A' ' 70' ' ' PRO . 23.7 mt -141.6 136.72 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.514 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.418 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.499 ' O ' HG11 ' A' ' 108' ' ' VAL . 5.5 tp10 -142.61 113.44 7.49 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 123.276 1.512 . . . . 0.0 111.807 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.63 ' HA ' ' CG1' ' A' ' 108' ' ' VAL . 0.5 OUTLIER -88.93 126.96 41.97 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 CA-C-N 112.783 -2.008 . . . . 0.0 109.012 178.283 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -119.81 97.43 5.62 Favored 'General case' 0 C--N 1.278 -2.518 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 177.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.534 ' HB2' ' CG2' ' A' ' 63' ' ' VAL . . . -110.1 127.37 54.84 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.126 -1.03 . . . . 0.0 111.79 -176.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.698 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.3 p -106.48 102.83 12.19 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.758 ' HA ' ' CG2' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -114.32 95.17 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.897 0 CA-C-O 123.531 1.634 . . . . 0.0 110.143 -177.811 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER 36.71 69.11 0.22 Allowed 'General case' 0 N--CA 1.523 3.183 0 CA-C-N 114.463 -1.244 . . . . 0.0 113.58 179.37 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.54 -22.03 12.11 Favored Glycine 0 N--CA 1.488 2.113 0 O-C-N 121.136 -0.977 . . . . 0.0 111.864 176.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.531 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.265 0.4 OUTLIER -107.96 57.84 0.62 Allowed 'General case' 0 C--N 1.292 -1.919 0 O-C-N 121.137 -1.213 . . . . 0.0 111.877 -178.137 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.514 ' O ' ' CG ' ' A' ' 62' ' ' GLU 0.372 0.0 OUTLIER -67.97 113.59 5.79 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 122.035 0.922 . . . . 0.0 110.944 -179.573 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.534 ' CG2' ' HB2' ' A' ' 56' ' ' ALA . 10.2 m -78.91 145.6 9.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 122.612 1.196 . . . . 0.0 110.852 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.529 ' C ' ' CG2' ' A' ' 65' ' ' VAL 0.434 7.3 t70 -137.89 59.27 1.66 Allowed 'General case' 0 C--N 1.28 -2.444 0 CA-C-O 122.855 1.312 . . . . 0.0 110.897 -176.156 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.529 ' CG2' ' C ' ' A' ' 64' ' ' ASP . 1.4 t -157.28 150.41 18.6 Favored Pre-proline 0 C--N 1.271 -2.842 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.682 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.438 ' HD2' HG13 ' A' ' 65' ' ' VAL . 46.3 Cg_endo -88.04 141.53 5.21 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 CA-C-O 123.728 1.47 . . . . 0.0 111.814 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.587 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -110.83 50.36 0.78 Allowed Glycine 0 C--N 1.271 -3.075 0 CA-C-N 112.495 -2.139 . . . . 0.0 109.33 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.491 ' HB ' ' O ' ' A' ' 67' ' ' GLY 0.289 2.4 tp -179.35 -164.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 O-C-N 120.03 -1.865 . . . . 0.0 109.944 -178.158 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.533 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 11.1 t70 -114.38 85.02 10.18 Favored Pre-proline 0 N--CA 1.499 1.998 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 175.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.718 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 19.3 Cg_endo -47.52 -5.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.289 -2.583 0 C-N-CA 124.381 3.387 . . . . 0.0 115.763 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.593 ' ND2' ' N ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -109.44 93.03 4.29 Favored 'General case' 0 C--N 1.285 -2.197 0 O-C-N 119.809 -1.807 . . . . 0.0 108.843 -179.495 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.729 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . . . -78.22 12.2 2.0 Allowed 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.357 -0.84 . . . . 0.0 109.202 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.5 t -76.74 -25.26 53.29 Favored 'General case' 0 C--N 1.311 -1.104 0 O-C-N 120.904 -1.123 . . . . 0.0 108.581 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.544 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 0.6 OUTLIER -78.75 4.13 14.69 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 118.615 -1.234 . . . . 0.0 108.546 176.114 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.729 ' CD2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -135.29 7.26 3.35 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 121.344 -0.847 . . . . 0.0 109.275 177.589 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.508 ' O ' ' N ' ' A' ' 78' ' ' CYS . 1.0 OUTLIER -148.21 125.65 11.65 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 123.859 1.79 . . . . 0.0 112.555 178.763 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.529 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -32.16 91.95 0.01 OUTLIER 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 112.453 -2.158 . . . . 0.0 111.499 -178.373 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.508 ' N ' ' O ' ' A' ' 76' ' ' MET 0.311 0.1 OUTLIER -91.95 142.28 26.28 Favored Pre-proline 0 C--N 1.264 -3.126 0 CA-C-N 111.408 -2.633 . . . . 0.0 109.926 179.968 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.657 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 35.1 Cg_endo -82.54 166.41 69.59 Favored 'Cis proline' 0 C--N 1.314 -1.247 0 C-N-CA 123.094 -1.627 . . . . 0.0 111.861 0.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.676 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -93.67 129.75 39.86 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.352 -179.637 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.523 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.3 t -105.85 141.54 20.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-O 124.325 2.012 . . . . 0.0 112.697 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.649 ' HG3' ' N ' ' A' ' 45' ' ' GLN . 2.5 tmpt? -43.86 122.61 2.87 Favored 'General case' 0 C--N 1.273 -2.759 0 CA-C-N 111.556 -2.565 . . . . 0.0 115.933 -176.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.56 -13.61 35.76 Favored Glycine 0 C--N 1.291 -1.921 0 CA-C-N 111.98 -2.373 . . . . 0.0 108.472 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 11.3 mt-30 -78.74 126.8 31.21 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-O 123.207 1.479 . . . . 0.0 112.016 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.604 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 0.3 OUTLIER -63.84 142.11 58.52 Favored 'General case' 0 C--N 1.271 -2.805 0 CA-C-N 113.363 -1.744 . . . . 0.0 107.791 179.035 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.66 ' CE1' ' HG ' ' A' ' 80' ' ' LEU . 19.6 m-85 -142.74 126.12 16.65 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.534 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 28.4 p-10 -117.9 136.43 53.47 Favored 'General case' 0 C--N 1.277 -2.56 0 CA-C-O 122.745 1.26 . . . . 0.0 110.077 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.677 ' CG1' ' CD1' ' A' ' 52' ' ' ILE . 0.8 OUTLIER -113.88 160.26 13.42 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.726 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -145.63 153.54 41.15 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.522 0.677 . . . . 0.0 112.211 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.634 ' CE1' ' HB2' ' A' ' 92' ' ' TRP . 3.1 t80 -151.65 100.38 2.69 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.628 -0.67 . . . . 0.0 110.638 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.548 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 1.4 t -122.6 114.43 20.61 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-N 119.689 1.131 . . . . 0.0 108.234 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.634 ' HB2' ' CE1' ' A' ' 90' ' ' TYR 0.273 0.9 OUTLIER -143.12 112.72 6.9 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.508 -177.365 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.51 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.5 OUTLIER -74.88 157.13 35.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 119.217 -2.177 . . . . 0.0 110.321 -178.78 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.602 HG13 ' CE2' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -154.14 172.6 5.6 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.0 -1.063 . . . . 0.0 108.752 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.501 ' HD2' ' HB ' ' A' ' 94' ' ' VAL . 17.2 Cg_endo -36.1 149.5 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.133 0 O-C-N 123.502 1.264 . . . . 0.0 111.11 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.814 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 9.2 mptt -80.41 -25.67 38.89 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 117.332 -1.747 . . . . 0.0 115.152 -173.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.6 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -145.31 45.95 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 O-C-N 121.455 -0.778 . . . . 0.0 112.721 -178.084 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.563 ' N ' ' HD2' ' A' ' 99' ' ' PRO . . . -73.86 -47.07 6.8 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 120.544 -1.348 . . . . 0.0 111.325 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.661 ' C ' ' HD2' ' A' ' 100' ' ' LYS . 44.9 Cg_endo -67.73 160.16 49.44 Favored 'Trans proline' 0 CA--C 1.468 -2.813 0 CA-C-O 123.547 1.394 . . . . 0.0 111.648 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.672 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.3 OUTLIER -107.74 106.98 17.55 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 112.031 -2.35 . . . . 0.0 110.949 -169.083 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.451 ' C ' ' O ' ' A' ' 100' ' ' LYS . 2.2 p -42.12 93.72 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.912 0 CA-C-O 123.496 1.617 . . . . 0.0 110.457 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.607 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.381 46.8 mt-10 -165.35 -52.58 0.03 OUTLIER 'General case' 0 CA--C 1.449 -2.915 0 CA-C-N 113.114 -1.857 . . . . 0.0 111.897 178.198 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.484 0.8 OUTLIER -162.03 88.65 0.68 Allowed 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 111.095 -2.775 . . . . 0.0 115.011 -161.345 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.758 ' CG2' ' HA ' ' A' ' 58' ' ' ILE . 22.0 t -142.89 141.31 27.1 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.537 0 C-N-CA 118.87 -1.132 . . . . 0.0 111.961 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.546 ' CG1' HD13 ' A' ' 121' ' ' ILE . 7.9 t -153.03 134.15 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.552 ' O ' HG12 ' A' ' 121' ' ' ILE . 0.3 OUTLIER -109.58 140.08 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-O 122.488 1.137 . . . . 0.0 112.467 -178.713 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.631 ' CG2' ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -133.13 111.29 10.8 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.55 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.63 ' CG1' ' HA ' ' A' ' 54' ' ' ILE . 6.1 t -125.82 142.06 43.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 119.821 -1.8 . . . . 0.0 108.969 -177.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.719 ' HB2' ' HB3' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -132.58 153.3 51.15 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.788 1.28 . . . . 0.0 112.937 -178.183 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.56 ' CG2' HD12 ' A' ' 88' ' ' ILE . 2.7 t -102.62 123.75 56.16 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.512 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 177.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.508 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -101.75 127.97 48.29 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -83.72 -129.42 1.63 Allowed Glycine 0 C--N 1.279 -2.638 0 C-N-CA 118.632 -1.746 . . . . 0.0 114.414 -176.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.627 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 4.1 p-10 -98.22 7.47 46.21 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -175.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 22.6 p30 -167.49 -13.04 0.02 OUTLIER 'General case' 0 C--N 1.261 -3.259 0 C-N-CA 117.429 -1.708 . . . . 0.0 114.437 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.42 ' O ' ' SD ' ' A' ' 111' ' ' MET . . . -153.85 -86.84 0.06 OUTLIER Glycine 0 CA--C 1.473 -2.57 0 CA-C-O 125.916 2.953 . . . . 0.0 111.723 -177.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.4 p -141.49 177.54 3.38 Favored 'Isoleucine or valine' 1 C--N 1.228 -4.714 1 CA-C-N 108.054 -4.073 . . . . 0.0 110.929 -177.283 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.519 ' HB3' ' O ' ' A' ' 110' ' ' VAL . 0.2 OUTLIER -145.96 -64.02 0.31 Allowed 'General case' 0 C--N 1.289 -2.064 0 O-C-N 121.793 -0.567 . . . . 0.0 110.849 -179.561 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.459 ' CB ' HG13 ' A' ' 13' ' ' ILE . . . -164.51 127.82 2.45 Favored 'General case' 0 N--CA 1.51 2.552 0 O-C-N 120.96 -1.088 . . . . 0.0 109.134 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.719 ' HB3' ' HB2' ' A' ' 109' ' ' LYS . 1.6 p -134.57 142.15 46.87 Favored 'General case' 0 C--N 1.285 -2.197 0 C-N-CA 117.823 -1.551 . . . . 0.0 113.482 -177.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.552 ' HB1' ' CD1' ' A' ' 13' ' ' ILE . . . -144.96 138.2 26.67 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 123.035 1.398 . . . . 0.0 112.11 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.631 ' HB ' ' CG2' ' A' ' 107' ' ' THR 0.284 0.0 OUTLIER -113.03 142.3 25.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 114.09 -1.413 . . . . 0.0 111.982 -178.697 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.389 0 O-C-N 120.983 -1.073 . . . . 0.0 108.131 178.461 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.513 ' CD ' ' CE ' ' A' ' 15' ' ' LYS . 10.9 mp0 . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 120.528 0.204 . . . . 0.0 110.97 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.528 HG11 ' HA ' ' A' ' 22' ' ' HIS 0.257 1.3 m -145.68 174.91 2.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 O-C-N 120.634 -1.291 . . . . 0.0 108.902 -179.151 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.451 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -81.83 148.13 29.0 Favored 'General case' 0 CA--C 1.477 -1.829 0 CA-C-O 122.83 1.3 . . . . 0.0 109.115 176.782 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.485 ' O ' ' HG2' ' A' ' 6' ' ' LYS 0.428 0.4 OUTLIER -164.29 -167.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 CA-C-N 113.668 -1.605 . . . . 0.0 109.589 -170.856 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 5' ' ' VAL . 2.7 mttt -156.33 146.57 21.42 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 124.065 1.888 . . . . 0.0 113.173 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.287 8.1 t70 -86.32 147.71 25.93 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-N 112.335 -2.211 . . . . 0.0 109.771 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.654 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.1 p -136.84 14.67 3.11 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.887 -1.133 . . . . 0.0 109.07 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.594 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -126.04 -84.36 0.63 Allowed 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.075 -1.05 . . . . 0.0 109.931 -177.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.538 ' ND2' ' O ' ' A' ' 10' ' ' ASN . 2.6 t30 -158.65 66.51 0.44 Allowed 'General case' 0 C--N 1.269 -2.901 0 C-N-CA 118.632 -1.227 . . . . 0.0 112.265 177.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.586 ' CG ' ' O ' ' A' ' 11' ' ' HIS . 10.2 t-160 36.27 30.84 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 121.958 0.885 . . . . 0.0 110.276 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.54 ' HB3' ' O ' ' A' ' 117' ' ' LEU . 0.4 OUTLIER -84.84 18.17 2.53 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 121.356 0.598 . . . . 0.0 111.428 -179.553 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.601 ' CG2' ' N ' ' A' ' 14' ' ' LYS 0.281 0.1 OUTLIER -122.91 -171.69 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-O 122.04 0.924 . . . . 0.0 110.856 -178.333 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.601 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -162.21 -47.42 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.336 -179.562 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.551 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -142.71 133.24 25.06 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 116.192 -2.203 . . . . 0.0 113.317 179.116 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.525 HG13 ' CB ' ' A' ' 39' ' ' ALA . 3.2 m -131.78 107.15 12.64 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.323 0 CA-C-O 122.876 1.322 . . . . 0.0 111.498 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.75 120.54 39.36 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 114.319 -1.31 . . . . 0.0 111.302 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.559 ' CG1' ' HD2' ' A' ' 19' ' ' PRO . 16.1 t -142.72 146.07 36.56 Favored Pre-proline 0 C--N 1.295 -1.794 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.097 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.559 ' HD2' ' CG1' ' A' ' 18' ' ' VAL . 43.9 Cg_endo -69.66 132.34 23.29 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 O-C-N 123.834 1.439 . . . . 0.0 111.211 -178.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.41 -88.82 0.2 Allowed Glycine 0 N--CA 1.495 2.57 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.487 ' O ' HG13 ' A' ' 3' ' ' VAL . 19.3 m -94.27 173.27 7.73 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.243 -1.151 . . . . 0.0 110.433 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.528 ' HA ' HG11 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -142.01 8.42 1.87 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.764 -1.21 . . . . 0.0 110.723 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.451 ' O ' ' HB3' ' A' ' 4' ' ' ASP . . . . . . . . 0 C--N 1.286 -2.244 0 C-N-CA 118.792 -1.67 . . . . 0.0 110.221 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.876 ' HA2' ' HA ' ' A' ' 96' ' ' LYS . . . . . . . . 0 C--O 1.214 -1.112 0 N-CA-C 105.329 -3.108 . . . . 0.0 105.329 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.549 ' HB2' HG11 ' A' ' 94' ' ' VAL . 2.4 mmmm -118.85 98.0 50.94 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 120.761 2.281 . . . . 0.0 116.391 -174.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 32' ' ' GLY . 60.3 Cg_endo -105.17 144.71 0.11 Allowed 'Trans proline' 0 C--N 1.291 -2.477 0 C-N-CA 123.642 2.894 . . . . 0.0 108.898 177.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.526 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 3.7 m-85 -117.85 91.01 3.46 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.302 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.553 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 25.6 mp0 -113.47 79.28 1.22 Allowed 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.545 ' HB2' ' CG2' ' A' ' 18' ' ' VAL . 3.1 pp -111.68 141.57 45.12 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.851 -1.156 . . . . 0.0 109.837 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.457 ' HB3' ' HE2' ' A' ' 89' ' ' LYS . 2.2 pp20? -140.33 137.53 34.19 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.759 1.266 . . . . 0.0 108.396 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.525 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -142.65 153.31 43.32 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-O 123.137 1.446 . . . . 0.0 113.237 -176.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.551 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -109.92 141.37 25.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 113.798 -1.547 . . . . 0.0 108.133 178.242 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.582 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 3.0 p90 -156.3 121.91 4.85 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -177.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 13.4 tt0 -69.71 153.6 43.16 Favored 'General case' 0 C--N 1.285 -2.233 0 O-C-N 120.441 -1.412 . . . . 0.0 108.661 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.557 ' HB1' ' CE2' ' A' ' 86' ' ' TYR . . . -89.01 133.38 34.36 Favored 'General case' 0 C--N 1.266 -3.049 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.302 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.546 ' C ' ' HG2' ' A' ' 45' ' ' GLN . 0.4 OUTLIER -114.2 49.24 1.02 Allowed 'General case' 0 CA--C 1.484 -1.572 0 CA-C-O 125.534 2.588 . . . . 0.0 113.576 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.583 ' N ' ' CG ' ' A' ' 82' ' ' LYS . 6.7 pt20 167.1 -158.95 0.01 OUTLIER 'General case' 0 C--N 1.255 -3.514 0 CA-C-N 108.83 -3.804 . . . . 0.0 112.793 175.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.418 ' H ' ' HB2' ' A' ' 45' ' ' GLN 0.276 7.4 t30 -110.17 154.68 23.0 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-O 122.701 1.239 . . . . 0.0 108.912 -178.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.623 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -172.38 151.78 2.58 Favored 'General case' 0 C--N 1.256 -3.489 0 CA-C-N 114.667 -1.151 . . . . 0.0 112.487 -178.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.654 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -111.01 9.45 22.13 Favored 'General case' 0 N--CA 1.508 2.444 0 C-N-CA 118.507 -1.277 . . . . 0.0 110.28 178.408 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.561 ' CG2' ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.66 146.56 4.0 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 120.653 -1.279 . . . . 0.0 111.084 178.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.513 ' O ' ' O ' ' A' ' 70' ' ' PRO . . . -140.66 94.79 2.77 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-O 122.844 1.307 . . . . 0.0 109.814 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 1.3 mmtp -65.2 -179.49 0.59 Allowed 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.193 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.836 HG12 HD13 ' A' ' 88' ' ' ILE . 28.7 mt -141.65 140.19 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.446 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.501 ' O ' HG11 ' A' ' 108' ' ' VAL . 2.3 tm-20 -141.14 104.78 4.7 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 123.265 1.507 . . . . 0.0 109.733 178.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.747 ' HA ' ' CG1' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -92.11 127.64 44.23 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.458 0 CA-C-N 112.604 -2.089 . . . . 0.0 107.602 179.271 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.512 ' N ' HD12 ' A' ' 54' ' ' ILE . 3.5 ttpt -129.75 147.27 51.51 Favored 'General case' 0 C--N 1.271 -2.823 0 C-N-CA 118.45 -1.3 . . . . 0.0 108.193 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.524 ' CB ' HG21 ' A' ' 63' ' ' VAL . . . -135.54 130.35 34.44 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 117.579 -1.648 . . . . 0.0 111.565 -178.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.645 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 2.8 p -103.17 95.97 6.47 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.338 -1.726 . . . . 0.0 106.338 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.733 ' HA ' ' CG1' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -106.93 107.05 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.711 0 CA-C-O 123.008 1.385 . . . . 0.0 110.339 -176.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.641 ' N ' ' O ' ' A' ' 103' ' ' ASN . 0.4 OUTLIER 33.74 62.77 0.41 Allowed 'General case' 0 N--CA 1.519 3.002 0 CA-C-N 115.097 -0.956 . . . . 0.0 113.08 179.427 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.59 -15.54 9.48 Favored Glycine 0 N--CA 1.487 2.061 0 O-C-N 121.335 -0.853 . . . . 0.0 111.239 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.514 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.271 0.4 OUTLIER -107.99 59.05 0.61 Allowed 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.204 -1.174 . . . . 0.0 111.353 -178.486 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.519 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.373 0.0 OUTLIER -55.09 117.17 3.24 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.975 0.893 . . . . 0.0 110.79 179.902 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.541 ' CG1' HD12 ' A' ' 58' ' ' ILE . 19.0 m -79.53 143.16 12.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-O 122.741 1.258 . . . . 0.0 111.657 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.447 25.1 t0 -138.78 85.27 2.07 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.193 -176.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.56 ' CG2' ' HD2' ' A' ' 66' ' ' PRO . 12.2 p -153.62 149.73 21.78 Favored Pre-proline 0 C--N 1.277 -2.573 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.684 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.56 ' HD2' ' CG2' ' A' ' 65' ' ' VAL . 42.3 Cg_endo -71.37 138.06 32.11 Favored 'Trans proline' 0 CA--C 1.501 -1.139 0 CA-C-O 123.748 1.478 . . . . 0.0 111.073 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.651 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -110.02 -71.8 0.68 Allowed Glycine 0 N--CA 1.504 3.225 0 CA-C-N 112.587 -2.097 . . . . 0.0 112.0 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' A' ' 69' ' ' ASP . 0.8 OUTLIER -116.64 -150.66 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.013 -1.875 . . . . 0.0 109.433 -178.603 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.538 ' N ' ' CG2' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -105.81 143.29 26.57 Favored Pre-proline 0 C--N 1.295 -1.773 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 177.21 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.711 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 22.9 Cg_endo -106.21 -3.32 0.14 Allowed 'Trans proline' 0 C--N 1.274 -3.383 0 C-N-CA 123.18 2.587 . . . . 0.0 113.908 -173.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.567 ' HB2' ' NE2' ' A' ' 74' ' ' HIS . 0.4 OUTLIER -110.34 88.78 2.85 Favored 'General case' 0 C--N 1.285 -2.222 0 O-C-N 120.839 -1.163 . . . . 0.0 108.459 -179.501 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.734 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . . . -78.45 10.77 2.86 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.222 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.4 t -77.29 -26.8 52.67 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 120.947 -1.096 . . . . 0.0 108.184 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.567 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -81.19 8.37 9.02 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 118.919 -1.113 . . . . 0.0 108.343 175.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.734 ' CD2' ' HA ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -132.36 -2.52 3.48 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 121.76 -0.587 . . . . 0.0 109.939 178.163 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.484 ' CE ' ' HB2' ' A' ' 72' ' ' ALA . 1.8 ptt? -157.74 132.25 8.4 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 123.866 1.793 . . . . 0.0 113.824 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.564 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -16.29 94.29 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 111.786 -2.461 . . . . 0.0 113.276 -179.136 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 48' ' ' LYS 0.327 1.8 t -106.84 144.79 29.78 Favored Pre-proline 0 C--N 1.267 -3.003 0 CA-C-N 111.596 -2.547 . . . . 0.0 109.234 179.165 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.654 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 37.5 Cg_endo -79.95 167.82 74.06 Favored 'Cis proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.847 -1.73 . . . . 0.0 111.833 0.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.713 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -93.4 127.9 39.22 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.103 -179.423 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.516 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.3 t -105.0 140.67 22.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-O 124.207 1.956 . . . . 0.0 112.211 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.583 ' CG ' ' N ' ' A' ' 45' ' ' GLN . 1.8 tmmt? -45.08 119.42 2.01 Favored 'General case' 0 C--N 1.273 -2.741 0 CA-C-N 111.534 -2.576 . . . . 0.0 116.776 -175.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.1 -16.19 22.82 Favored Glycine 0 C--N 1.293 -1.86 0 CA-C-N 111.772 -2.467 . . . . 0.0 107.98 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 16.2 mt-30 -75.56 126.39 30.93 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-O 123.292 1.52 . . . . 0.0 111.496 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.593 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 6.1 mt-30 -65.12 144.97 56.88 Favored 'General case' 0 C--N 1.271 -2.81 0 CA-C-N 113.299 -1.773 . . . . 0.0 107.692 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.661 ' CE1' ' HG ' ' A' ' 80' ' ' LEU . 19.6 m-85 -142.56 126.7 17.45 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.512 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 1.4 p30 -117.15 132.46 56.65 Favored 'General case' 0 C--N 1.276 -2.611 0 CA-C-O 122.925 1.345 . . . . 0.0 110.358 -177.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.836 HD13 HG12 ' A' ' 52' ' ' ILE . 0.4 OUTLIER -104.79 158.55 5.57 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 CA-C-N 114.186 -1.37 . . . . 0.0 108.42 179.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.457 ' HE2' ' HB3' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -144.39 145.27 31.84 Favored 'General case' 0 C--N 1.29 -2.021 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.465 -178.293 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.575 ' CE1' ' HB2' ' A' ' 92' ' ' TRP . 12.7 t80 -145.21 108.89 4.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.171 -0.956 . . . . 0.0 109.913 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.553 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 1.2 t -127.07 111.26 13.83 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.651 ' CD1' ' O ' ' A' ' 67' ' ' GLY 0.278 0.7 OUTLIER -142.83 114.46 8.03 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.173 -177.277 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 2.4 p-10 -75.08 157.08 35.35 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 119.172 -2.205 . . . . 0.0 109.411 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.549 HG11 ' HB2' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -147.49 167.65 13.02 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.128 -0.982 . . . . 0.0 108.457 -179.158 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.524 ' O ' ' O ' ' A' ' 94' ' ' VAL . 18.3 Cg_endo -37.33 152.83 0.03 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.188 0 O-C-N 123.835 1.439 . . . . 0.0 110.677 -177.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.876 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -79.81 -25.9 40.71 Favored 'General case' 0 C--N 1.286 -2.189 0 C-N-CA 116.508 -2.077 . . . . 0.0 115.175 -173.181 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.595 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -144.9 45.47 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 O-C-N 121.517 -0.74 . . . . 0.0 112.968 -178.224 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.52 ' CB ' ' CD ' ' A' ' 99' ' ' PRO . . . -74.0 -59.4 1.79 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.53 -1.356 . . . . 0.0 110.627 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.675 ' C ' ' HD2' ' A' ' 100' ' ' LYS . 47.9 Cg_endo -67.2 160.32 48.06 Favored 'Trans proline' 0 CA--C 1.462 -3.084 0 O-C-N 123.897 1.472 . . . . 0.0 110.474 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.685 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -107.28 102.29 11.6 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 112.493 -2.139 . . . . 0.0 110.136 -169.229 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.465 ' C ' ' O ' ' A' ' 100' ' ' LYS . 2.5 p -42.06 97.67 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 123.592 1.663 . . . . 0.0 110.042 -178.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.561 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.389 47.8 mt-10 -164.4 -53.0 0.03 OUTLIER 'General case' 0 CA--C 1.45 -2.877 0 CA-C-N 112.963 -1.926 . . . . 0.0 111.543 178.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.641 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.483 0.8 OUTLIER -161.25 82.05 0.62 Allowed 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 110.876 -2.875 . . . . 0.0 113.911 -161.879 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.733 ' CG1' ' HA ' ' A' ' 58' ' ' ILE . 20.1 t -143.39 139.1 26.46 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.65 0 C-N-CA 118.952 -1.099 . . . . 0.0 111.912 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.548 HG21 ' CD1' ' A' ' 121' ' ' ILE . 0.6 OUTLIER -142.5 132.07 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.392 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.517 ' O ' HG12 ' A' ' 121' ' ' ILE . 0.4 OUTLIER -99.1 143.46 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 122.594 1.188 . . . . 0.0 111.57 -179.028 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.636 ' CG2' ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -131.59 118.34 19.96 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 179.556 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.747 ' CG1' ' HA ' ' A' ' 54' ' ' ILE . 3.4 t -132.38 139.53 49.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 120.22 -1.55 . . . . 0.0 108.583 -178.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.863 ' HB2' ' CB ' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -130.16 154.2 47.76 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.883 1.325 . . . . 0.0 111.623 -178.63 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.655 ' CG2' ' CD1' ' A' ' 88' ' ' ILE . 2.6 t -107.69 124.54 63.83 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.58 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 177.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 1.5 tmt? -103.71 120.39 40.85 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.493 ' HA3' HD22 ' A' ' 117' ' ' LEU . . . -74.93 -131.17 0.25 Allowed Glycine 0 C--N 1.281 -2.51 0 C-N-CA 119.06 -1.543 . . . . 0.0 114.671 -175.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.623 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 4.7 p-10 -97.94 8.65 44.4 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -175.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 33.5 p-10 -167.41 -14.89 0.02 OUTLIER 'General case' 0 C--N 1.265 -3.08 0 C-N-CA 117.475 -1.69 . . . . 0.0 114.428 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.429 ' O ' ' HG2' ' A' ' 111' ' ' MET . . . -152.39 -86.74 0.06 OUTLIER Glycine 0 CA--C 1.473 -2.572 0 CA-C-O 125.937 2.965 . . . . 0.0 111.971 -177.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.2 p -141.23 178.67 2.7 Favored 'Isoleucine or valine' 1 C--N 1.228 -4.696 1 CA-C-N 108.168 -4.016 . . . . 0.0 110.807 -177.226 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.54 ' O ' ' HB3' ' A' ' 12' ' ' GLU . 0.1 OUTLIER -148.55 -61.85 0.24 Allowed 'General case' 0 C--N 1.289 -2.06 0 O-C-N 121.873 -0.517 . . . . 0.0 111.277 -179.44 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.506 ' CB ' HG13 ' A' ' 13' ' ' ILE . . . -165.35 129.85 2.42 Favored 'General case' 0 N--CA 1.512 2.669 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.543 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.863 ' CB ' ' HB2' ' A' ' 109' ' ' LYS . 1.4 p -134.52 135.44 42.37 Favored 'General case' 0 C--N 1.284 -2.266 0 C-N-CA 118.064 -1.455 . . . . 0.0 113.09 -178.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 6' ' ' LYS . . . -143.62 135.06 26.09 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 122.992 1.377 . . . . 0.0 112.599 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.636 ' HB ' ' CG2' ' A' ' 107' ' ' THR 0.272 0.0 OUTLIER -111.14 138.41 39.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 CA-C-N 114.143 -1.39 . . . . 0.0 110.961 -179.549 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.469 ' O ' HG21 ' A' ' 105' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.367 0 O-C-N 120.858 -1.151 . . . . 0.0 109.062 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.472 ' C ' HG11 ' A' ' 3' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 120.646 0.26 . . . . 0.0 110.828 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.543 ' CG1' ' HA ' ' A' ' 22' ' ' HIS . 1.3 m -145.22 -175.64 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.68 133.68 38.3 Favored 'General case' 0 CA--C 1.48 -1.714 0 C-N-CA 117.839 -1.544 . . . . 0.0 108.84 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.503 ' O ' ' HG2' ' A' ' 6' ' ' LYS 0.435 0.4 OUTLIER -170.14 156.48 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 113.972 -1.467 . . . . 0.0 110.058 -169.627 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -146.76 145.77 30.06 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 123.772 1.749 . . . . 0.0 113.515 -178.671 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.276 1.9 t70 -74.28 149.3 40.78 Favored 'General case' 0 C--N 1.268 -2.956 0 CA-C-N 112.792 -2.004 . . . . 0.0 109.312 177.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.632 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 5.7 p -137.33 14.44 3.01 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.852 -1.155 . . . . 0.0 109.058 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.592 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -125.5 -82.52 0.63 Allowed 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 118.962 -1.095 . . . . 0.0 109.952 -177.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 12' ' ' GLU . 2.9 t30 -157.86 66.45 0.48 Allowed 'General case' 0 C--N 1.268 -2.952 0 C-N-CA 118.684 -1.206 . . . . 0.0 111.882 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.487 ' C ' ' O ' ' A' ' 10' ' ' ASN . 49.7 m170 33.4 33.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.845 0.831 . . . . 0.0 110.468 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 10' ' ' ASN . 38.1 mt-10 -93.77 21.12 6.79 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.68 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.61 ' CG2' ' N ' ' A' ' 14' ' ' LYS 0.297 0.1 OUTLIER -124.39 -167.3 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.895 0.855 . . . . 0.0 110.056 -178.685 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.61 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 13.1 ptpt -162.15 -44.89 0.04 OUTLIER 'General case' 0 C--N 1.29 -1.997 0 O-C-N 121.792 -0.567 . . . . 0.0 111.503 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.539 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 36.4 tttt -148.49 142.57 25.97 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 115.881 -2.328 . . . . 0.0 114.21 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.4 ' CG1' ' CB ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -134.45 103.07 4.48 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 CA-C-O 122.983 1.373 . . . . 0.0 110.578 178.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.47 ' C ' HG21 ' A' ' 18' ' ' VAL . 1.3 mt -96.11 133.18 40.7 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 113.994 -1.457 . . . . 0.0 111.465 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.547 ' CG1' ' HD2' ' A' ' 19' ' ' PRO . 93.1 t -140.83 145.71 40.9 Favored Pre-proline 0 N--CA 1.499 2.018 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.514 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.547 ' HD2' ' CG1' ' A' ' 18' ' ' VAL . 45.9 Cg_endo -72.42 101.23 1.23 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.815 1.429 . . . . 0.0 110.76 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 157.79 -92.21 0.12 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.0 m -83.95 162.04 20.59 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.32 -1.106 . . . . 0.0 111.196 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.543 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 1.6 p-80 -142.41 16.89 2.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.903 -1.123 . . . . 0.0 109.206 178.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.081 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 177.734 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.846 ' HA3' ' HA ' ' A' ' 96' ' ' LYS . . . . . . . . 0 C--O 1.215 -1.073 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.567 ' HB2' HG11 ' A' ' 94' ' ' VAL . 0.6 OUTLIER -125.58 88.97 53.36 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 120.983 2.392 . . . . 0.0 115.62 -179.149 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.508 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 60.7 Cg_endo -108.13 142.35 0.06 OUTLIER 'Trans proline' 0 C--N 1.291 -2.488 0 C-N-CA 124.521 3.481 . . . . 0.0 107.719 176.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.481 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 10.1 m-85 -124.25 93.73 4.0 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 118.553 -1.259 . . . . 0.0 109.99 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.583 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 28.1 mp0 -112.8 86.22 2.32 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.521 ' HB3' HG23 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -110.33 141.33 43.51 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 120.576 -1.328 . . . . 0.0 109.093 179.294 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.92 132.49 28.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 87' ' ' ASP . . . -142.14 154.39 44.84 Favored 'General case' 0 C--N 1.271 -2.829 0 CA-C-O 123.219 1.485 . . . . 0.0 113.404 -175.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.539 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.38 141.06 26.8 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 CA-C-N 113.43 -1.714 . . . . 0.0 108.805 178.714 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.556 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 3.7 p90 -157.96 124.58 4.87 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 21.8 tt0 -69.29 154.79 41.47 Favored 'General case' 0 C--N 1.285 -2.213 0 O-C-N 120.305 -1.497 . . . . 0.0 108.606 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.566 ' HB1' ' CE2' ' A' ' 86' ' ' TYR . . . -85.69 131.39 34.34 Favored 'General case' 0 C--N 1.265 -3.068 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.447 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.587 ' C ' ' HG2' ' A' ' 45' ' ' GLN . 0.3 OUTLIER -113.8 48.79 1.04 Allowed 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 125.775 2.702 . . . . 0.0 114.358 179.816 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.587 ' HG2' ' C ' ' A' ' 44' ' ' ASN . 4.2 pt20 166.57 -161.63 0.01 OUTLIER 'General case' 0 C--N 1.26 -3.324 0 CA-C-N 108.502 -3.954 . . . . 0.0 112.845 175.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.442 ' H ' ' HB2' ' A' ' 45' ' ' GLN 0.273 60.0 t30 -110.82 151.33 27.94 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-O 122.537 1.16 . . . . 0.0 108.958 -178.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.653 ' OG1' ' HB3' ' A' ' 113' ' ' ASP 0.252 0.0 OUTLIER -173.22 151.77 2.13 Favored 'General case' 0 C--N 1.255 -3.511 0 C-N-CA 118.581 -1.248 . . . . 0.0 112.545 -178.418 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.616 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 0.8 OUTLIER -111.59 10.69 21.18 Favored 'General case' 0 N--CA 1.51 2.568 0 C-N-CA 118.194 -1.402 . . . . 0.0 110.301 178.371 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.562 ' CG2' ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -169.12 148.46 4.02 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 120.622 -1.299 . . . . 0.0 110.837 179.091 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.508 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . . . -149.74 103.8 3.27 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 122.765 1.269 . . . . 0.0 110.949 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 0.7 OUTLIER -68.86 -174.94 0.64 Allowed 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.432 178.664 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.796 HG12 HD13 ' A' ' 88' ' ' ILE . 35.7 mt -141.93 140.84 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.388 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.489 ' O ' HG11 ' A' ' 108' ' ' VAL . 5.6 tm-20 -139.92 107.58 5.62 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 123.284 1.516 . . . . 0.0 110.186 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.751 ' HA ' ' CG1' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -92.63 128.38 44.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 CA-C-N 112.644 -2.071 . . . . 0.0 107.362 178.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.537 ' N ' HD12 ' A' ' 54' ' ' ILE . 1.1 tttt -128.09 141.86 51.37 Favored 'General case' 0 C--N 1.272 -2.802 0 C-N-CA 118.75 -1.18 . . . . 0.0 107.855 178.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 62' ' ' GLU . . . -135.44 134.35 39.53 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 119.917 -1.739 . . . . 0.0 112.309 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.677 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 0.5 OUTLIER -107.22 99.5 9.04 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 177.285 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.727 ' HA ' ' CG2' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -112.12 101.41 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.803 0 CA-C-O 123.305 1.526 . . . . 0.0 110.758 -176.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.616 ' N ' ' O ' ' A' ' 103' ' ' ASN . 1.4 p30 37.59 64.36 0.66 Allowed 'General case' 0 N--CA 1.521 3.077 0 CA-C-N 114.991 -1.004 . . . . 0.0 113.06 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.73 -17.04 9.41 Favored Glycine 0 N--CA 1.488 2.114 0 O-C-N 121.264 -0.897 . . . . 0.0 111.546 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.518 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.272 0.2 OUTLIER -107.87 58.16 0.62 Allowed 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.197 -1.178 . . . . 0.0 111.576 -178.336 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.367 0.0 OUTLIER -60.01 116.75 4.38 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.958 0.885 . . . . 0.0 111.012 -179.904 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.465 ' CG2' ' CB ' ' A' ' 56' ' ' ALA . 13.8 m -75.8 146.61 8.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-O 122.547 1.165 . . . . 0.0 110.805 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.441 6.7 t70 -138.16 76.89 1.6 Allowed 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.192 -176.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.468 ' CG2' ' HD2' ' A' ' 66' ' ' PRO . 8.6 p -164.37 150.75 9.52 Favored Pre-proline 0 C--N 1.274 -2.692 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.42 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.468 ' HD2' ' CG2' ' A' ' 65' ' ' VAL . 44.6 Cg_endo -86.68 139.23 5.58 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 CA-C-O 123.887 1.536 . . . . 0.0 111.531 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.614 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -127.82 52.49 0.82 Allowed Glycine 0 C--N 1.273 -2.946 0 CA-C-N 112.498 -2.137 . . . . 0.0 110.432 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.622 ' HB ' ' CD2' ' A' ' 90' ' ' TYR 0.296 4.4 tp 179.96 -177.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 120.194 -1.768 . . . . 0.0 110.534 -178.677 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.524 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 12.9 t0 -112.3 83.47 5.26 Favored Pre-proline 0 N--CA 1.504 2.237 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 175.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.722 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 20.9 Cg_endo -48.59 -6.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.287 -2.706 0 C-N-CA 124.453 3.435 . . . . 0.0 116.245 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.554 ' HB2' ' NE2' ' A' ' 74' ' ' HIS . 5.1 m-80 -101.77 91.77 4.54 Favored 'General case' 0 C--N 1.284 -2.266 0 O-C-N 120.167 -1.583 . . . . 0.0 109.006 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.701 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . . . -76.33 7.29 4.47 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.431 -0.793 . . . . 0.0 109.52 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 8.3 t -79.05 -24.15 43.76 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 120.886 -1.134 . . . . 0.0 108.94 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.554 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 1.1 m-70 -80.1 8.11 7.85 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.022 -1.071 . . . . 0.0 109.066 176.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.701 ' CD2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -133.19 -2.83 3.13 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 121.365 -0.834 . . . . 0.0 110.217 177.547 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.488 ' CE ' HD22 ' A' ' 80' ' ' LEU . 2.4 ptt? -155.07 129.61 9.14 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 123.984 1.849 . . . . 0.0 113.678 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.465 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 13.9 pttt -21.85 102.6 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 111.89 -2.414 . . . . 0.0 113.365 -178.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 48' ' ' LYS 0.318 0.1 OUTLIER -99.04 146.64 32.03 Favored Pre-proline 0 C--N 1.265 -3.066 0 CA-C-N 111.522 -2.581 . . . . 0.0 108.79 178.609 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.616 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 37.2 Cg_endo -86.66 167.35 46.64 Favored 'Cis proline' 0 C--N 1.311 -1.412 0 C-N-CA 123.1 -1.625 . . . . 0.0 111.447 0.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.658 ' HB3' ' CE2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -90.54 125.96 35.78 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 122.02 0.914 . . . . 0.0 110.95 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.505 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.3 t -104.47 137.76 32.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-O 124.248 1.975 . . . . 0.0 111.779 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.574 ' HB2' ' C ' ' A' ' 45' ' ' GLN . 1.6 tmmt? -43.37 115.62 0.8 Allowed 'General case' 0 C--N 1.271 -2.844 0 CA-C-N 111.737 -2.483 . . . . 0.0 116.243 -175.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 118.2 -18.34 11.26 Favored Glycine 0 C--N 1.29 -1.983 0 CA-C-N 111.74 -2.482 . . . . 0.0 108.198 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.584 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 8.4 mt-30 -73.3 126.27 29.74 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-O 123.124 1.44 . . . . 0.0 111.797 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.583 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -63.3 143.03 58.15 Favored 'General case' 0 C--N 1.271 -2.818 0 CA-C-N 113.57 -1.65 . . . . 0.0 107.855 179.225 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.658 ' CE2' ' HB3' ' A' ' 80' ' ' LEU . 21.3 m-85 -143.58 127.5 17.34 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 1.4 p-10 -117.51 132.53 56.53 Favored 'General case' 0 C--N 1.277 -2.561 0 CA-C-O 122.775 1.274 . . . . 0.0 110.401 -178.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.796 HD13 HG12 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -102.31 159.98 4.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.402 179.368 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.75 144.84 32.8 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.941 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.622 ' CD2' ' HB ' ' A' ' 68' ' ' ILE . 32.3 t80 -149.02 102.36 3.25 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.772 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.583 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 0.6 OUTLIER -121.68 114.76 21.59 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 179.253 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.614 ' CD1' ' O ' ' A' ' 67' ' ' GLY 0.264 0.2 OUTLIER -141.86 108.42 5.33 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.913 -177.405 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 11.7 m120 -75.46 155.54 36.15 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 119.696 -1.878 . . . . 0.0 109.753 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.567 HG11 ' HB2' ' A' ' 33' ' ' LYS . 1.0 OUTLIER -153.79 169.98 9.07 Favored Pre-proline 0 N--CA 1.487 1.389 0 O-C-N 120.746 -1.221 . . . . 0.0 108.676 -178.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.519 ' O ' ' O ' ' A' ' 94' ' ' VAL . 17.8 Cg_endo -38.29 154.73 0.03 OUTLIER 'Trans proline' 0 CA--C 1.497 -1.332 0 O-C-N 123.424 1.223 . . . . 0.0 110.853 -177.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.846 ' HA ' ' HA3' ' A' ' 32' ' ' GLY . 3.1 mptt -80.73 -27.22 36.94 Favored 'General case' 0 C--N 1.283 -2.32 0 C-N-CA 116.622 -2.031 . . . . 0.0 116.201 -173.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.576 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -141.89 42.02 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.559 ' CB ' ' HD3' ' A' ' 99' ' ' PRO . . . -62.65 -56.93 25.08 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 120.419 -1.425 . . . . 0.0 109.562 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.689 ' C ' ' HD2' ' A' ' 100' ' ' LYS . 56.9 Cg_endo -78.12 162.78 28.53 Favored 'Trans proline' 0 CA--C 1.463 -3.063 0 O-C-N 123.896 1.472 . . . . 0.0 110.57 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.725 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.5 OUTLIER -107.21 112.43 25.3 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-N 112.095 -2.32 . . . . 0.0 110.28 -169.755 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 100' ' ' LYS . 2.5 p -45.35 97.7 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.612 0 CA-C-O 123.606 1.669 . . . . 0.0 109.342 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.402 40.9 mt-10 -163.54 -52.01 0.04 OUTLIER 'General case' 0 CA--C 1.448 -2.975 0 CA-C-N 112.818 -1.992 . . . . 0.0 111.304 179.442 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.616 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.482 0.8 OUTLIER -160.29 79.73 0.67 Allowed 'General case' 0 C--N 1.285 -2.202 0 CA-C-N 110.949 -2.842 . . . . 0.0 113.932 -162.311 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.727 ' CG2' ' HA ' ' A' ' 58' ' ' ILE . 22.0 t -145.13 141.24 22.88 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.65 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.743 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.605 ' CG1' ' CD1' ' A' ' 121' ' ' ILE . 3.0 t -153.89 137.63 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.547 ' O ' HG12 ' A' ' 121' ' ' ILE . 0.3 OUTLIER -105.58 148.3 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 122.653 1.216 . . . . 0.0 112.675 -178.409 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.593 ' CG2' ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -132.04 118.98 20.4 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 178.099 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.751 ' CG1' ' HA ' ' A' ' 54' ' ' ILE . 3.4 t -132.54 138.72 51.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 120.186 -1.571 . . . . 0.0 108.389 -177.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.897 ' HB2' ' HB2' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -135.6 148.64 49.11 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 122.414 1.102 . . . . 0.0 111.549 -178.072 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.669 ' CG2' ' CD1' ' A' ' 88' ' ' ILE . 3.5 t -97.76 129.81 47.38 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.522 ' HG3' ' HA2' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -107.7 118.2 36.12 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.508 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -78.92 -138.13 1.43 Allowed Glycine 0 N--CA 1.498 2.778 0 C-N-CA 119.177 -1.487 . . . . 0.0 114.917 -174.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.653 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 6.8 p-10 -80.79 -3.66 51.81 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 122.275 1.036 . . . . 0.0 112.323 -176.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.403 ' OD2' ' OD1' ' A' ' 113' ' ' ASP . 1.4 p30 -133.21 -4.65 3.05 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.738 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.605 ' O ' ' CB ' ' A' ' 116' ' ' VAL . . . 92.29 85.9 1.51 Allowed Glycine 0 CA--C 1.471 -2.688 0 CA-C-O 124.797 2.332 . . . . 0.0 110.399 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.605 ' CB ' ' O ' ' A' ' 115' ' ' GLY . 7.2 p 137.9 148.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.25 -3.757 0 CA-C-N 108.27 -3.965 . . . . 0.0 111.837 177.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.538 ' CB ' ' O ' ' A' ' 110' ' ' VAL . 0.3 OUTLIER -161.45 -59.8 0.05 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.479 -0.763 . . . . 0.0 110.739 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.49 ' CB ' HG13 ' A' ' 13' ' ' ILE . . . -169.88 134.29 1.3 Allowed 'General case' 0 N--CA 1.513 2.705 0 O-C-N 121.124 -0.985 . . . . 0.0 109.489 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.897 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 0.8 OUTLIER -133.71 139.76 46.6 Favored 'General case' 0 C--N 1.28 -2.418 0 C-N-CA 117.624 -1.63 . . . . 0.0 113.744 -178.02 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -142.61 131.58 23.01 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 123.066 1.413 . . . . 0.0 111.489 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.605 ' CD1' ' CG1' ' A' ' 105' ' ' VAL 0.272 0.0 OUTLIER -108.7 131.06 60.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.613 -179.218 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 O-C-N 120.827 -1.17 . . . . 0.0 108.895 179.894 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.48 ' O ' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 120.681 0.277 . . . . 0.0 111.003 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.562 ' CG1' ' HA ' ' A' ' 22' ' ' HIS . 1.3 m -145.8 174.03 3.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 O-C-N 120.884 -1.135 . . . . 0.0 107.967 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.458 ' O ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -80.82 140.05 35.66 Favored 'General case' 0 CA--C 1.478 -1.82 0 C-N-CA 117.968 -1.493 . . . . 0.0 108.66 177.31 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.484 ' O ' ' HG2' ' A' ' 6' ' ' LYS 0.422 0.4 OUTLIER -166.44 -178.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 C-N-CA 118.021 -1.472 . . . . 0.0 110.933 -170.135 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 5' ' ' VAL . 18.5 mtmt -153.69 141.65 20.24 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 123.812 1.767 . . . . 0.0 112.823 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.271 13.8 t70 -79.09 149.45 32.08 Favored 'General case' 0 C--N 1.266 -3.049 0 CA-C-N 113.032 -1.894 . . . . 0.0 109.442 178.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.642 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 7.3 p -137.27 14.26 3.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.981 -1.074 . . . . 0.0 109.529 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.614 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -126.16 -83.98 0.62 Allowed 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 119.014 -1.074 . . . . 0.0 110.17 -177.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 12' ' ' GLU . 2.4 t30 -155.97 64.73 0.58 Allowed 'General case' 0 C--N 1.269 -2.898 0 C-N-CA 118.519 -1.272 . . . . 0.0 111.62 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.473 ' C ' ' O ' ' A' ' 10' ' ' ASN . 6.2 m80 32.57 32.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.725 0.774 . . . . 0.0 110.697 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.9 OUTLIER -93.42 22.35 5.37 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.485 -0.886 . . . . 0.0 111.889 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.604 ' CG2' ' N ' ' A' ' 14' ' ' LYS 0.272 0.1 OUTLIER -116.76 -168.09 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 CA-C-O 122.027 0.918 . . . . 0.0 110.741 -179.035 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.604 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 0.1 OUTLIER -162.2 -45.46 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.732 179.831 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.552 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 28.9 tttt -146.59 136.12 22.99 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 116.116 -2.234 . . . . 0.0 113.246 178.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.534 ' CG1' ' HB3' ' A' ' 39' ' ' ALA . 0.9 OUTLIER -132.61 102.9 5.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 CA-C-O 123.041 1.4 . . . . 0.0 110.817 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.497 ' O ' HG21 ' A' ' 18' ' ' VAL . 1.4 mt -93.62 126.04 38.57 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.933 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.497 HG21 ' O ' ' A' ' 17' ' ' LEU . 75.3 t -142.52 145.08 33.07 Favored Pre-proline 0 N--CA 1.502 2.137 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.756 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.485 ' HD2' ' CG1' ' A' ' 18' ' ' VAL . 47.4 Cg_endo -72.0 137.08 28.56 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 O-C-N 123.691 1.364 . . . . 0.0 110.893 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.99 -80.1 0.27 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.4 m -87.81 131.31 34.57 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.553 -0.969 . . . . 0.0 109.557 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.562 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 0.2 OUTLIER -137.4 14.83 2.99 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 119.905 -1.747 . . . . 0.0 110.865 179.489 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 C-N-CA 118.287 -1.911 . . . . 0.0 110.815 177.115 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.842 ' HA2' ' HA ' ' A' ' 96' ' ' LYS . . . . . . . . 0 C--O 1.212 -1.242 0 N-CA-C 106.112 -2.795 . . . . 0.0 106.112 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.569 ' HB2' HG11 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -116.76 96.59 48.9 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 120.666 2.233 . . . . 0.0 116.354 -175.103 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.585 ' HD3' ' O ' ' A' ' 32' ' ' GLY . 61.6 Cg_endo -107.6 144.97 0.08 OUTLIER 'Trans proline' 0 C--N 1.289 -2.588 0 C-N-CA 124.081 3.187 . . . . 0.0 109.021 177.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 91' ' ' THR . 2.8 m-85 -117.69 98.35 6.33 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.022 -1.071 . . . . 0.0 108.538 178.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.578 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 25.6 mp0 -117.39 91.25 3.52 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.53 -0.731 . . . . 0.0 109.687 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.439 HD21 HG23 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -108.31 135.72 49.15 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.489 -1.382 . . . . 0.0 108.341 179.496 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' A' ' 17' ' ' LEU . 0.1 OUTLIER -139.31 128.11 23.41 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.534 ' HB3' ' CG1' ' A' ' 16' ' ' VAL . . . -142.48 152.05 42.32 Favored 'General case' 0 C--N 1.276 -2.602 0 CA-C-O 123.067 1.413 . . . . 0.0 113.405 -175.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.552 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.74 140.77 28.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 113.763 -1.562 . . . . 0.0 108.612 178.286 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.582 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 3.5 p90 -157.21 121.47 4.32 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -178.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 12.3 tt0 -68.72 155.12 40.7 Favored 'General case' 0 C--N 1.288 -2.089 0 O-C-N 120.416 -1.428 . . . . 0.0 108.918 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.582 ' HB1' ' CE2' ' A' ' 86' ' ' TYR . . . -88.14 136.84 32.79 Favored 'General case' 0 C--N 1.267 -3.01 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.402 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.552 ' C ' ' HG2' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -117.81 49.96 1.18 Allowed 'General case' 0 CA--C 1.486 -1.506 0 CA-C-O 125.454 2.55 . . . . 0.0 114.033 179.318 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.586 ' N ' ' CG ' ' A' ' 82' ' ' LYS . 7.1 pt20 167.12 -160.52 0.01 OUTLIER 'General case' 0 C--N 1.258 -3.37 0 CA-C-N 108.914 -3.767 . . . . 0.0 112.92 175.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.457 ' OD1' ' N ' ' A' ' 47' ' ' THR 0.265 41.2 t-20 -109.2 153.69 23.43 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-O 122.588 1.185 . . . . 0.0 108.754 -178.901 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.635 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -173.14 156.21 3.16 Favored 'General case' 0 C--N 1.255 -3.541 0 C-N-CA 118.473 -1.291 . . . . 0.0 112.5 -178.28 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.662 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 9.5 mtpt -112.41 5.8 18.32 Favored 'General case' 0 N--CA 1.509 2.501 0 O-C-N 120.747 -1.221 . . . . 0.0 111.184 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.568 ' CG2' ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.41 149.13 4.79 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.369 -1.457 . . . . 0.0 111.611 179.653 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.542 ' O ' ' O ' ' A' ' 70' ' ' PRO . . . -142.82 99.76 3.53 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 122.574 1.178 . . . . 0.0 110.871 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 9.9 mttt -69.31 -178.01 1.25 Allowed 'General case' 0 N--CA 1.506 2.338 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.913 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.796 HG12 HD13 ' A' ' 88' ' ' ILE . 35.8 mt -140.99 137.8 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.665 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.665 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.553 ' HB3' ' CE ' ' A' ' 109' ' ' LYS . 4.0 tt0 -141.51 112.19 7.13 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 123.261 1.505 . . . . 0.0 111.239 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.648 ' HA ' ' CG1' ' A' ' 108' ' ' VAL . 0.4 OUTLIER -91.88 127.54 44.1 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 CA-C-N 112.79 -2.005 . . . . 0.0 110.296 179.476 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -122.9 101.7 7.59 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 176.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.514 ' CB ' HG21 ' A' ' 106' ' ' VAL . . . -112.81 133.31 54.87 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.843 -1.16 . . . . 0.0 113.178 -175.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.671 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 0.3 OUTLIER -109.49 102.35 11.23 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 177.811 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.76 ' HA ' ' CG2' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -112.55 97.81 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.863 0 CA-C-O 123.423 1.582 . . . . 0.0 110.746 -177.258 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.569 ' N ' ' O ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER 39.14 65.37 0.68 Allowed 'General case' 0 N--CA 1.52 3.061 0 CA-C-N 114.641 -1.163 . . . . 0.0 113.112 179.236 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.16 -18.34 10.22 Favored Glycine 0 N--CA 1.487 2.093 0 O-C-N 121.378 -0.826 . . . . 0.0 111.481 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.505 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.267 0.3 OUTLIER -107.7 58.67 0.62 Allowed 'General case' 0 C--N 1.293 -1.873 0 O-C-N 121.092 -1.24 . . . . 0.0 111.513 -178.453 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.49 ' O ' ' CG ' ' A' ' 62' ' ' GLU 0.365 0.0 OUTLIER -63.42 113.19 3.11 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.045 0.926 . . . . 0.0 110.912 -179.78 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.451 HG23 ' HB2' ' A' ' 56' ' ' ALA . 15.3 m -72.73 142.56 14.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-O 122.504 1.145 . . . . 0.0 110.731 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.434 7.9 t70 -138.3 64.88 1.48 Allowed 'General case' 0 C--N 1.277 -2.552 0 CA-C-O 122.619 1.199 . . . . 0.0 110.73 -176.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.549 ' CG2' ' HD2' ' A' ' 66' ' ' PRO . 8.2 p -164.47 151.64 10.04 Favored Pre-proline 0 C--N 1.269 -2.918 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.005 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.549 ' HD2' ' CG2' ' A' ' 65' ' ' VAL . 45.5 Cg_endo -82.39 139.64 10.43 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 CA-C-O 123.886 1.536 . . . . 0.0 112.221 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.615 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -133.36 60.11 0.67 Allowed Glycine 0 N--CA 1.501 2.991 0 CA-C-N 112.291 -2.231 . . . . 0.0 109.0 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.606 ' HB ' ' CE2' ' A' ' 90' ' ' TYR 0.272 0.2 OUTLIER 163.93 -177.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.326 -1.103 . . . . 0.0 108.179 -178.074 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.575 ' N ' ' CG2' ' A' ' 68' ' ' ILE . 0.4 OUTLIER -107.53 140.43 21.52 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 105.728 -1.952 . . . . 0.0 105.728 175.084 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.717 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 23.2 Cg_endo -105.39 -3.02 0.17 Allowed 'Trans proline' 0 C--N 1.273 -3.427 0 C-N-CA 122.945 2.43 . . . . 0.0 114.155 -173.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.551 ' HB2' ' NE2' ' A' ' 74' ' ' HIS . 0.2 OUTLIER -107.91 96.6 6.49 Favored 'General case' 0 C--N 1.285 -2.234 0 O-C-N 120.765 -1.209 . . . . 0.0 108.532 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.755 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . . . -77.4 10.7 2.36 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.195 -0.94 . . . . 0.0 108.897 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.7 t -77.34 -24.96 50.66 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 120.984 -1.072 . . . . 0.0 108.209 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.551 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 0.5 OUTLIER -83.25 11.62 6.37 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.444 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.755 ' CD2' ' HA ' ' A' ' 72' ' ' ALA . 1.3 m-85 -132.03 -6.18 3.5 Favored 'General case' 0 C--O 1.215 -0.731 0 O-C-N 121.744 -0.598 . . . . 0.0 110.151 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.46 ' O ' ' HG2' ' A' ' 76' ' ' MET . 2.8 ptt? -161.1 131.26 5.03 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 123.915 1.817 . . . . 0.0 113.973 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.55 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 9.3 pttt -16.76 99.36 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 111.801 -2.454 . . . . 0.0 113.462 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 48' ' ' LYS 0.325 0.5 OUTLIER -99.12 140.22 21.55 Favored Pre-proline 0 C--N 1.264 -3.124 0 CA-C-N 111.548 -2.569 . . . . 0.0 108.613 178.272 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.662 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 36.0 Cg_endo -82.68 170.01 58.21 Favored 'Cis proline' 0 C--N 1.312 -1.384 0 C-N-CA 123.457 -1.476 . . . . 0.0 112.277 0.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.69 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -95.28 129.67 42.33 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.771 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.535 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 2.4 p -108.3 138.21 36.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 124.299 2.0 . . . . 0.0 112.05 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.586 ' CG ' ' N ' ' A' ' 45' ' ' GLN . 1.7 tmmt? -42.09 117.42 0.97 Allowed 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 111.606 -2.543 . . . . 0.0 116.614 -175.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.25 -17.6 14.44 Favored Glycine 0 C--N 1.293 -1.83 0 CA-C-N 111.714 -2.494 . . . . 0.0 107.945 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 8.2 mt-30 -72.52 126.36 29.66 Favored 'General case' 0 C--N 1.278 -2.525 0 CA-C-O 123.199 1.476 . . . . 0.0 111.633 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.607 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 3.5 mt-30 -64.57 143.31 58.01 Favored 'General case' 0 C--N 1.27 -2.872 0 CA-C-N 113.385 -1.734 . . . . 0.0 107.927 178.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.663 ' CE2' ' HB3' ' A' ' 80' ' ' LEU . 19.9 m-85 -142.3 125.25 16.16 Favored 'General case' 0 C--N 1.279 -2.472 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.532 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 1.1 p30 -117.4 132.46 56.57 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-O 122.776 1.274 . . . . 0.0 110.088 -177.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.796 HD13 HG12 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -101.29 157.84 4.25 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.196 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.422 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -147.24 141.37 26.09 Favored 'General case' 0 C--N 1.286 -2.189 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.133 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.606 ' CE2' ' HB ' ' A' ' 68' ' ' ILE . 3.0 t80 -144.04 112.52 6.5 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.276 -0.89 . . . . 0.0 108.894 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.566 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 0.6 OUTLIER -131.41 115.68 16.53 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 179.09 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.615 ' CD1' ' O ' ' A' ' 67' ' ' GLY 0.266 0.5 OUTLIER -141.89 111.81 6.78 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.513 -176.666 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 2.5 p-10 -74.67 159.49 32.02 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 119.378 -2.077 . . . . 0.0 109.361 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.569 HG11 ' HB2' ' A' ' 33' ' ' LYS . 0.8 OUTLIER -153.0 172.16 5.94 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.083 -1.011 . . . . 0.0 108.835 -178.296 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.532 ' HD2' ' CG2' ' A' ' 94' ' ' VAL . 17.0 Cg_endo -37.53 152.32 0.04 OUTLIER 'Trans proline' 0 CA--C 1.498 -1.286 0 O-C-N 123.785 1.413 . . . . 0.0 110.045 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.842 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -79.04 -23.22 44.44 Favored 'General case' 0 C--N 1.282 -2.362 0 C-N-CA 116.622 -2.031 . . . . 0.0 115.068 -172.721 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.567 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -138.75 43.07 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-O 121.398 0.618 . . . . 0.0 112.618 -178.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.617 ' CB ' ' CD ' ' A' ' 99' ' ' PRO . . . -70.04 -67.62 0.65 Allowed Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 120.686 -1.259 . . . . 0.0 110.654 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.663 ' C ' ' HD2' ' A' ' 100' ' ' LYS . 47.7 Cg_endo -66.51 160.4 46.01 Favored 'Trans proline' 0 CA--C 1.461 -3.133 0 O-C-N 123.676 1.356 . . . . 0.0 110.228 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.691 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -109.16 106.49 16.39 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-N 112.497 -2.138 . . . . 0.0 110.301 -169.453 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.441 ' C ' ' HG3' ' A' ' 102' ' ' GLU . 5.3 p -46.25 97.16 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 CA-C-O 123.612 1.673 . . . . 0.0 109.031 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.392 84.8 mt-10 -164.95 -52.4 0.03 OUTLIER 'General case' 0 CA--C 1.45 -2.893 0 CA-C-N 112.975 -1.921 . . . . 0.0 111.461 179.659 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.569 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.489 0.7 OUTLIER -160.73 83.5 0.67 Allowed 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 110.681 -2.963 . . . . 0.0 113.608 -162.045 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.76 ' CG2' ' HA ' ' A' ' 58' ' ' ILE . 32.4 t -143.21 134.23 23.0 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 C-N-CA 119.103 -1.039 . . . . 0.0 112.308 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.443 HG11 HD13 ' A' ' 121' ' ' ILE . 0.6 OUTLIER -140.54 130.61 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.555 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 121' ' ' ILE . 0.3 OUTLIER -105.46 141.9 19.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-O 122.344 1.069 . . . . 0.0 111.393 -179.271 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.632 ' CG2' ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -132.6 109.14 9.53 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 179.509 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.648 ' CG1' ' HA ' ' A' ' 54' ' ' ILE . 3.4 t -127.61 141.91 45.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 117.802 -1.559 . . . . 0.0 109.16 -177.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.753 ' HB2' ' CB ' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -131.03 152.84 49.9 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 122.904 1.335 . . . . 0.0 112.938 -178.774 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.671 ' CG2' ' CD1' ' A' ' 88' ' ' ILE . 3.8 t -102.61 124.55 56.67 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 176.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.522 ' HG2' ' O ' ' A' ' 111' ' ' MET . 2.1 ptm -104.86 121.76 44.35 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.507 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -79.83 -137.35 1.62 Allowed Glycine 0 N--CA 1.496 2.662 0 C-N-CA 118.931 -1.604 . . . . 0.0 114.01 -175.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.635 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 13.4 p-10 -79.8 -4.93 54.23 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 122.393 1.092 . . . . 0.0 111.986 -177.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 10.8 p30 -128.9 -4.61 5.12 Favored 'General case' 0 C--N 1.268 -2.96 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.933 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.575 ' O ' ' HB ' ' A' ' 116' ' ' VAL . . . 86.81 84.0 1.13 Allowed Glycine 0 CA--C 1.471 -2.718 0 CA-C-O 124.875 2.375 . . . . 0.0 109.669 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.575 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 6.9 p 145.97 145.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.246 -3.913 0 CA-C-N 108.281 -3.96 . . . . 0.0 111.204 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.547 ' CB ' ' O ' ' A' ' 110' ' ' VAL . 0.1 OUTLIER -162.21 -59.51 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.378 -0.826 . . . . 0.0 110.651 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.442 ' CB ' HG13 ' A' ' 13' ' ' ILE . . . -168.25 129.17 1.33 Allowed 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.753 ' CB ' ' HB2' ' A' ' 109' ' ' LYS . 0.8 OUTLIER -134.29 141.32 46.91 Favored 'General case' 0 C--N 1.284 -2.274 0 C-N-CA 118.004 -1.478 . . . . 0.0 113.097 -177.703 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.436 ' HB3' HD11 ' A' ' 13' ' ' ILE . . . -146.53 137.28 24.07 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 123.159 1.456 . . . . 0.0 112.468 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.632 ' HB ' ' CG2' ' A' ' 107' ' ' THR 0.265 0.1 OUTLIER -112.23 133.24 58.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 113.908 -1.497 . . . . 0.0 110.912 -179.78 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.48 ' HB3' HG21 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.367 0 O-C-N 120.743 -1.223 . . . . 0.0 108.858 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.492 ' O ' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 120.75 0.31 . . . . 0.0 110.851 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.561 ' CG1' ' HA ' ' A' ' 22' ' ' HIS . 1.4 m -148.72 174.7 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.475 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -80.12 139.86 36.66 Favored 'General case' 0 CA--C 1.482 -1.647 0 C-N-CA 118.097 -1.441 . . . . 0.0 108.396 177.042 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.503 ' C ' ' CG ' ' A' ' 6' ' ' LYS 0.434 0.4 OUTLIER -166.33 -175.31 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.406 -169.992 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.553 ' HB2' ' CG2' ' A' ' 121' ' ' ILE . 1.6 mttt -153.91 138.86 17.22 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 123.565 1.65 . . . . 0.0 112.577 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.285 3.5 t70 -84.67 148.83 26.2 Favored 'General case' 0 C--N 1.27 -2.881 0 CA-C-N 113.381 -1.736 . . . . 0.0 109.732 178.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.621 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 5.3 p -137.43 13.14 3.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.007 -1.058 . . . . 0.0 109.469 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.607 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -126.33 -85.58 0.61 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 118.586 -1.246 . . . . 0.0 110.026 -177.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 12' ' ' GLU . 2.5 t30 -160.29 67.1 0.35 Allowed 'General case' 0 C--N 1.265 -3.083 0 C-N-CA 118.578 -1.249 . . . . 0.0 111.935 177.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.467 ' C ' ' O ' ' A' ' 10' ' ' ASN . 11.0 m-70 34.36 32.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.765 0.793 . . . . 0.0 110.42 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.1 OUTLIER -86.92 20.4 2.64 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.475 0.655 . . . . 0.0 110.739 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.614 ' CG2' ' N ' ' A' ' 14' ' ' LYS 0.289 0.0 OUTLIER -121.79 -166.89 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-O 121.989 0.9 . . . . 0.0 110.834 -178.215 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.614 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 1.7 pttt -161.88 -44.08 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.996 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.553 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 11.3 tttm -149.85 140.31 22.42 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 116.375 -2.13 . . . . 0.0 113.371 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.491 HG12 ' CB ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -132.92 108.85 13.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 CA-C-O 122.873 1.321 . . . . 0.0 110.936 179.705 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 mt -102.0 122.57 44.32 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 114.164 -1.38 . . . . 0.0 110.949 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.524 ' CG2' ' HB2' ' A' ' 37' ' ' LEU . 58.3 t -142.11 142.51 24.73 Favored Pre-proline 0 C--N 1.292 -1.906 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.549 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.451 ' HD2' HG12 ' A' ' 18' ' ' VAL . 40.7 Cg_endo -66.19 126.65 16.08 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.752 1.396 . . . . 0.0 110.69 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 123.19 -78.69 0.35 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.6 m -90.37 133.86 34.71 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.476 -1.014 . . . . 0.0 109.965 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.561 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -140.79 10.52 2.22 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.019 -1.675 . . . . 0.0 110.847 178.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 4' ' ' ASP . . . . . . . . 0 C--N 1.285 -2.258 0 C-N-CA 118.592 -1.766 . . . . 0.0 110.62 176.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.827 ' HA2' ' HA ' ' A' ' 96' ' ' LYS . . . . . . . . 0 C--O 1.213 -1.165 0 N-CA-C 105.413 -3.075 . . . . 0.0 105.413 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.529 ' HB2' HG13 ' A' ' 94' ' ' VAL . 4.5 mmmm -116.3 94.82 43.6 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 120.593 2.196 . . . . 0.0 116.57 -174.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.619 ' HD3' ' O ' ' A' ' 32' ' ' GLY . 61.3 Cg_endo -106.91 144.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.288 -2.621 0 C-N-CA 124.086 3.191 . . . . 0.0 108.136 176.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.495 ' CD1' ' C ' ' A' ' 34' ' ' PRO . 2.2 m-85 -120.8 94.59 4.4 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.002 -1.079 . . . . 0.0 109.429 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.582 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 28.1 mp0 -113.3 84.41 2.0 Allowed 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.524 ' HB2' ' CG2' ' A' ' 18' ' ' VAL . 3.6 pp -110.24 140.97 43.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.652 -1.28 . . . . 0.0 109.718 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -140.76 139.27 34.6 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 122.73 1.252 . . . . 0.0 109.151 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.491 ' CB ' HG12 ' A' ' 16' ' ' VAL . . . -142.68 151.64 41.58 Favored 'General case' 0 C--N 1.277 -2.576 0 CA-C-O 123.007 1.384 . . . . 0.0 112.546 -177.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.553 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.15 141.57 25.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 113.996 -1.457 . . . . 0.0 108.908 178.89 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.593 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 3.1 p90 -155.94 121.21 4.82 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 17.0 tt0 -68.82 152.82 44.81 Favored 'General case' 0 C--N 1.286 -2.159 0 O-C-N 120.392 -1.443 . . . . 0.0 108.267 178.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.597 ' HB1' ' CE2' ' A' ' 86' ' ' TYR . . . -85.64 131.52 34.33 Favored 'General case' 0 C--N 1.264 -3.109 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.445 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.579 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -113.36 50.8 0.88 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 125.638 2.637 . . . . 0.0 114.074 179.454 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.592 ' C ' ' HB2' ' A' ' 82' ' ' LYS . 4.4 pt20 167.33 -162.39 0.01 OUTLIER 'General case' 0 C--N 1.266 -3.023 0 CA-C-N 108.641 -3.89 . . . . 0.0 113.462 175.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.419 ' H ' ' HB2' ' A' ' 45' ' ' GLN 0.279 36.6 t30 -110.37 152.44 26.24 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 122.466 1.127 . . . . 0.0 108.712 -178.482 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.669 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -173.25 155.52 2.94 Favored 'General case' 0 C--N 1.255 -3.534 0 C-N-CA 118.01 -1.476 . . . . 0.0 113.257 -178.527 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.74 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 9.9 mttt -110.63 7.21 22.26 Favored 'General case' 0 N--CA 1.509 2.495 0 O-C-N 120.734 -1.229 . . . . 0.0 110.646 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.568 ' CG2' ' O ' ' A' ' 48' ' ' LYS . 0.8 OUTLIER -168.01 146.1 4.43 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 120.557 -1.339 . . . . 0.0 111.262 179.255 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.529 ' O ' ' O ' ' A' ' 70' ' ' PRO . . . -143.21 97.93 3.17 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-O 122.619 1.199 . . . . 0.0 109.641 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 12.3 mtmt -68.71 -179.09 1.31 Allowed 'General case' 0 N--CA 1.504 2.237 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.719 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.812 HG12 HD13 ' A' ' 88' ' ' ILE . 35.6 mt -140.19 140.4 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.425 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.368 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.49 ' O ' HG11 ' A' ' 108' ' ' VAL . 16.3 tp10 -140.47 107.88 5.55 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 123.374 1.559 . . . . 0.0 110.313 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.626 ' HA ' ' CG1' ' A' ' 108' ' ' VAL . 0.5 OUTLIER -91.16 125.6 43.89 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 CA-C-N 112.572 -2.103 . . . . 0.0 109.271 179.327 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -121.36 103.4 8.93 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 177.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.482 ' HB3' ' CG2' ' A' ' 106' ' ' VAL . . . -110.31 128.77 55.71 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 118.814 -1.155 . . . . 0.0 112.005 -176.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.659 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 0.4 OUTLIER -107.09 102.93 12.23 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.74 ' HA ' ' CG2' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -114.51 101.91 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.868 0 CA-C-O 123.197 1.475 . . . . 0.0 110.811 -177.454 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER 37.46 65.16 0.56 Allowed 'General case' 0 N--CA 1.522 3.132 0 CA-C-N 114.932 -1.031 . . . . 0.0 113.074 179.304 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.87 -15.49 8.1 Favored Glycine 0 N--CA 1.488 2.133 0 O-C-N 121.278 -0.889 . . . . 0.0 111.363 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.513 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.274 0.3 OUTLIER -108.02 56.73 0.63 Allowed 'General case' 0 C--N 1.293 -1.85 0 O-C-N 121.108 -1.23 . . . . 0.0 111.417 -178.384 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.512 ' O ' ' CG ' ' A' ' 62' ' ' GLU 0.376 0.0 OUTLIER -60.38 117.48 5.29 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.918 0.866 . . . . 0.0 110.661 179.928 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.1 m -80.62 135.46 25.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-O 122.816 1.293 . . . . 0.0 111.736 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.447 26.0 t0 -140.08 67.65 1.37 Allowed 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.833 -177.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.536 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -150.52 175.85 2.61 Favored Pre-proline 0 C--N 1.268 -2.952 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.001 -178.152 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.536 ' HD2' ' CB ' ' A' ' 65' ' ' VAL . 38.3 Cg_endo -65.98 139.91 58.29 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.395 1.734 . . . . 0.0 111.382 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.603 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -134.57 -73.01 0.08 OUTLIER Glycine 0 N--CA 1.503 3.11 0 CA-C-N 112.459 -2.155 . . . . 0.0 111.121 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.47 ' CG2' ' N ' ' A' ' 69' ' ' ASP . 2.0 tp -117.42 -157.83 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.225 -1.75 . . . . 0.0 108.789 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.48 ' O ' HD13 ' A' ' 52' ' ' ILE . 0.6 OUTLIER -106.69 141.85 23.71 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 177.136 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.732 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 24.5 Cg_endo -105.76 -3.76 0.15 Allowed 'Trans proline' 0 C--N 1.276 -3.289 0 C-N-CA 123.196 2.597 . . . . 0.0 114.309 -173.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.576 ' O ' ' CE1' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -110.37 87.58 2.56 Favored 'General case' 0 C--N 1.287 -2.132 0 O-C-N 120.717 -1.24 . . . . 0.0 108.121 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.59 ' HA ' ' CD1' ' A' ' 75' ' ' TYR . . . -74.47 8.45 2.27 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.734 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.11 -19.87 53.27 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 120.536 -1.352 . . . . 0.0 108.243 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.568 ' C ' ' CD1' ' A' ' 75' ' ' TYR . 0.2 OUTLIER -88.76 19.75 3.86 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 173.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.615 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.2 OUTLIER -132.57 -9.07 3.22 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.798 179.703 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.468 ' O ' ' C ' ' A' ' 77' ' ' LYS . 2.1 ptt? -167.93 129.59 1.46 Allowed 'General case' 0 C--O 1.215 -0.757 0 CA-C-O 123.621 1.677 . . . . 0.0 112.489 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.484 ' O ' HD11 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -9.16 94.92 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 111.99 -2.368 . . . . 0.0 113.833 -178.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 48' ' ' LYS 0.312 7.9 t -98.87 140.3 21.66 Favored Pre-proline 0 C--N 1.271 -2.813 0 CA-C-N 111.278 -2.692 . . . . 0.0 108.093 177.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.74 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 36.2 Cg_endo -78.74 171.21 66.85 Favored 'Cis proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.987 -1.672 . . . . 0.0 113.177 1.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.687 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.3 OUTLIER -99.33 129.3 45.53 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.066 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.505 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.4 t -105.12 138.68 28.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 124.202 1.953 . . . . 0.0 112.287 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.592 ' HB2' ' C ' ' A' ' 45' ' ' GLN . 1.4 tmmt? -43.96 118.08 1.36 Allowed 'General case' 0 C--N 1.273 -2.748 0 CA-C-N 111.762 -2.472 . . . . 0.0 116.517 -175.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.26 -18.26 12.23 Favored Glycine 0 C--N 1.29 -1.988 0 CA-C-N 111.746 -2.479 . . . . 0.0 107.931 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.602 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 11.0 mt-30 -71.84 125.39 27.05 Favored 'General case' 0 C--N 1.278 -2.5 0 CA-C-O 123.13 1.443 . . . . 0.0 111.543 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.593 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -63.67 142.89 58.23 Favored 'General case' 0 C--N 1.268 -2.938 0 CA-C-N 113.424 -1.716 . . . . 0.0 107.355 178.887 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.638 ' CE2' ' HB3' ' A' ' 80' ' ' LEU . 17.7 m-85 -142.21 126.1 17.16 Favored 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 87' ' ' ASP . 19.9 p30 -117.35 132.6 56.56 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-O 122.856 1.312 . . . . 0.0 110.107 -177.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.812 HD13 HG12 ' A' ' 52' ' ' ILE . 0.4 OUTLIER -101.99 159.16 4.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 CA-C-N 114.324 -1.307 . . . . 0.0 108.13 179.513 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.458 ' HG2' ' N ' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -148.95 151.2 34.19 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.909 -178.031 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.478 ' O ' ' HA ' ' A' ' 36' ' ' GLN . 49.3 t80 -147.92 104.1 3.55 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.335 178.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.582 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 1.1 t -121.2 113.93 20.68 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.603 ' CD1' ' O ' ' A' ' 67' ' ' GLY 0.272 0.4 OUTLIER -142.17 113.86 7.92 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.611 -177.107 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 18.7 p-10 -75.07 159.1 32.11 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 119.423 -2.048 . . . . 0.0 109.696 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.556 ' CG2' ' HD2' ' A' ' 95' ' ' PRO . 0.5 OUTLIER -155.59 169.19 10.77 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.05 -1.031 . . . . 0.0 108.484 -178.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.556 ' HD2' ' CG2' ' A' ' 94' ' ' VAL . 17.2 Cg_endo -36.65 154.74 0.02 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.16 0 O-C-N 123.488 1.257 . . . . 0.0 110.887 -177.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.827 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -78.71 -25.41 44.7 Favored 'General case' 0 C--N 1.285 -2.219 0 C-N-CA 116.903 -1.919 . . . . 0.0 114.889 -172.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.606 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -145.85 47.24 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 CA-C-O 121.802 0.81 . . . . 0.0 111.941 -178.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.519 ' O ' ' NZ ' ' A' ' 100' ' ' LYS . . . -76.06 -60.1 1.03 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.731 -1.23 . . . . 0.0 111.31 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.672 ' C ' ' HD2' ' A' ' 100' ' ' LYS . 45.0 Cg_endo -64.36 159.05 45.74 Favored 'Trans proline' 0 CA--C 1.466 -2.897 0 O-C-N 123.912 1.48 . . . . 0.0 111.161 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.696 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -109.88 105.28 14.41 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 112.404 -2.18 . . . . 0.0 110.564 -169.146 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 100' ' ' LYS . 4.2 p -46.49 95.24 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.5 0 CA-C-O 123.509 1.623 . . . . 0.0 109.363 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.622 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.399 92.3 mt-10 -164.26 -51.83 0.03 OUTLIER 'General case' 0 CA--C 1.453 -2.787 0 CA-C-N 112.981 -1.918 . . . . 0.0 112.029 179.8 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.552 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.49 0.8 OUTLIER -160.49 79.45 0.65 Allowed 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 115.016 -2.674 . . . . 0.0 114.221 -161.939 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.74 ' CG2' ' HA ' ' A' ' 58' ' ' ILE . 36.1 t -142.44 153.53 17.99 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.577 0 C-N-CA 119.703 -0.799 . . . . 0.0 111.203 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.431 HG12 HD13 ' A' ' 121' ' ' ILE . 0.4 OUTLIER -167.44 134.6 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -179.651 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 121' ' ' ILE . 0.3 OUTLIER -105.02 142.84 17.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.717 0 CA-C-O 122.391 1.091 . . . . 0.0 111.772 -179.044 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.634 ' CG2' ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -132.32 107.92 8.86 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.626 ' CG1' ' HA ' ' A' ' 54' ' ' ILE . 3.2 t -125.13 142.74 41.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 117.628 -1.629 . . . . 0.0 109.136 -177.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 1.025 ' HB2' ' HB2' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -135.36 146.03 47.96 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.229 1.014 . . . . 0.0 111.169 -178.104 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.652 ' CG2' ' CD1' ' A' ' 88' ' ' ILE . 14.9 t -101.07 132.35 47.0 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.506 ' HB3' ' HA2' ' A' ' 115' ' ' GLY . 2.6 mtm -109.69 121.6 45.58 Favored 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -80.1 -141.66 2.65 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 119.109 -1.519 . . . . 0.0 113.846 -176.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.669 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 11.0 p-10 -77.28 -6.49 53.35 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 122.414 1.102 . . . . 0.0 111.951 -177.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.432 ' OD1' HG21 ' A' ' 116' ' ' VAL . 3.3 p30 -125.89 -4.98 6.91 Favored 'General case' 0 C--N 1.268 -2.961 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.703 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.658 ' O ' ' CG1' ' A' ' 116' ' ' VAL . . . 85.02 82.16 1.06 Allowed Glycine 0 CA--C 1.47 -2.722 0 CA-C-O 124.814 2.341 . . . . 0.0 109.834 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.658 ' CG1' ' O ' ' A' ' 115' ' ' GLY . 0.5 OUTLIER 152.59 143.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.247 -3.884 0 CA-C-N 108.204 -3.998 . . . . 0.0 111.622 177.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.53 ' CB ' ' O ' ' A' ' 110' ' ' VAL . 0.0 OUTLIER -160.44 -57.45 0.06 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.331 -0.856 . . . . 0.0 111.319 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.446 ' HB3' HG13 ' A' ' 13' ' ' ILE . . . -174.87 131.87 0.33 Allowed 'General case' 0 N--CA 1.511 2.58 0 O-C-N 121.125 -0.984 . . . . 0.0 109.467 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 1.025 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 0.8 OUTLIER -133.97 137.94 45.14 Favored 'General case' 0 C--N 1.283 -2.283 0 C-N-CA 118.184 -1.406 . . . . 0.0 113.07 -177.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.405 ' HB1' ' CD1' ' A' ' 13' ' ' ILE . . . -148.52 136.93 21.28 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 123.077 1.418 . . . . 0.0 111.908 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.634 ' HB ' ' CG2' ' A' ' 107' ' ' THR 0.262 0.0 OUTLIER -110.54 130.29 64.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.97 -179.593 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.431 ' O ' HG21 ' A' ' 105' ' ' VAL . . . . . . . . 0 N--CA 1.488 1.436 0 O-C-N 120.931 -1.105 . . . . 0.0 109.19 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.226 0.536 . . . . 0.0 110.218 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.452 ' OE1' ' HD2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER 64.0 157.02 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 111.209 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.598 ' CG1' ' HA ' ' A' ' 22' ' ' HIS 0.256 1.4 m -145.72 173.08 3.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.91 142.19 33.8 Favored 'General case' 0 CA--C 1.475 -1.921 0 O-C-N 120.281 -1.512 . . . . 0.0 107.741 176.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.57 ' CG1' ' N ' ' A' ' 6' ' ' LYS 0.406 0.4 OUTLIER -161.3 -50.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 C-N-CA 117.226 -1.79 . . . . 0.0 112.097 -170.121 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.57 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 28.6 mmtm 84.86 139.46 0.06 Allowed 'General case' 0 N--CA 1.508 2.429 0 CA-C-O 124.315 2.007 . . . . 0.0 113.97 178.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.3 26.4 t70 -93.37 153.99 18.21 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 111.491 -2.595 . . . . 0.0 109.381 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.669 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.7 p -138.01 17.12 2.83 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.961 -1.087 . . . . 0.0 109.372 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.583 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -124.43 -85.81 0.64 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 118.55 -1.26 . . . . 0.0 109.722 -176.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.562 ' O ' ' N ' ' A' ' 12' ' ' GLU . 4.4 t30 -159.96 65.04 0.35 Allowed 'General case' 0 C--N 1.265 -3.07 0 C-N-CA 117.774 -1.57 . . . . 0.0 112.142 177.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.466 ' C ' ' O ' ' A' ' 10' ' ' ASN . 9.0 m-70 33.3 32.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.778 0.799 . . . . 0.0 110.507 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.562 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.1 OUTLIER -95.23 24.74 4.76 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.0 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.603 ' CG2' ' N ' ' A' ' 14' ' ' LYS 0.28 0.0 OUTLIER -117.14 -165.24 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-O 122.213 1.006 . . . . 0.0 110.993 -178.624 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.603 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 14.8 ptpt -162.31 -48.03 0.04 OUTLIER 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.873 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.63 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 12.1 tttm -144.0 135.47 25.87 Favored 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 116.344 -2.142 . . . . 0.0 112.896 178.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.494 HG12 ' HB3' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -133.46 102.26 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-O 122.845 1.307 . . . . 0.0 110.603 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 mt -93.41 123.44 36.71 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 114.172 -1.377 . . . . 0.0 111.253 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.458 HG12 ' HD2' ' A' ' 19' ' ' PRO . 23.7 t -143.13 145.82 34.26 Favored Pre-proline 0 N--CA 1.502 2.147 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.931 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.458 ' HD2' HG12 ' A' ' 18' ' ' VAL . 43.7 Cg_endo -68.72 109.88 2.2 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.83 1.437 . . . . 0.0 110.978 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.11 -94.99 0.12 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.503 ' SG ' ' HB3' ' A' ' 124' ' ' HIS . 14.1 m -93.82 174.82 6.98 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.108 -1.231 . . . . 0.0 111.415 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.598 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -142.01 7.13 1.81 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.198 -0.939 . . . . 0.0 110.491 178.36 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.68 -151.21 10.19 Favored Glycine 0 C--N 1.287 -2.147 0 C-N-CA 118.958 -1.591 . . . . 0.0 110.212 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.75 -8.8 23.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.739 -1.448 . . . . 0.0 110.055 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.795 ' CB ' ' HD3' ' A' ' 26' ' ' PRO . 1.2 mt-10 -64.46 176.35 0.74 Allowed Pre-proline 0 C--N 1.299 -1.622 0 CA-C-O 124.962 2.315 . . . . 0.0 115.077 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.795 ' HD3' ' CB ' ' A' ' 25' ' ' GLU . 25.8 Cg_endo -107.25 123.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.267 -3.738 1 C-N-CA 127.714 5.609 . . . . 0.0 111.14 -175.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.5 ' SG ' ' N ' ' A' ' 21' ' ' CYS . 25.0 p -137.32 120.56 16.82 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 122.816 1.293 . . . . 0.0 111.639 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.465 HG21 ' O ' ' A' ' 126' ' ' LYS 0.335 46.9 mm -79.37 -166.03 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.443 ' H ' ' CG2' ' A' ' 28' ' ' ILE . 0.3 OUTLIER -115.06 121.6 67.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 CA-C-O 122.584 1.183 . . . . 0.0 111.059 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.449 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 1.1 p-80 -70.36 33.19 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.836 -178.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 30' ' ' HIS . 43.6 mtt85 58.1 170.39 0.05 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.471 -1.393 . . . . 0.0 110.225 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.801 ' HA2' ' HA ' ' A' ' 96' ' ' LYS . . . 69.19 117.58 0.03 OUTLIER Glycine 0 C--O 1.214 -1.139 0 N-CA-C 105.61 -2.996 . . . . 0.0 105.61 -178.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.587 ' HB2' HG11 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -118.41 96.8 50.27 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 121.281 2.54 . . . . 0.0 117.089 -174.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.556 ' HD3' ' O ' ' A' ' 32' ' ' GLY . 61.2 Cg_endo -107.11 144.87 0.08 OUTLIER 'Trans proline' 0 C--N 1.29 -2.504 0 C-N-CA 124.289 3.326 . . . . 0.0 107.416 175.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.543 ' O ' ' CE1' ' A' ' 90' ' ' TYR . 30.4 m-85 -119.05 97.53 5.73 Favored 'General case' 0 C--N 1.291 -1.972 0 C-N-CA 118.603 -1.239 . . . . 0.0 108.839 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.591 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 28.1 mp0 -117.65 99.8 7.2 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.668 -0.645 . . . . 0.0 109.896 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.543 ' CD1' HG22 ' A' ' 108' ' ' VAL . 2.0 mt -109.67 139.24 44.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.403 -1.436 . . . . 0.0 108.741 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -140.24 128.65 22.67 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.564 -1.335 . . . . 0.0 107.764 179.241 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.494 ' HB3' HG12 ' A' ' 16' ' ' VAL . . . -143.75 150.14 38.16 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-O 123.119 1.437 . . . . 0.0 113.485 -176.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.63 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -115.49 138.22 46.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-N 113.696 -1.593 . . . . 0.0 107.84 177.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.614 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 8.4 p90 -159.58 130.01 5.71 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -177.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 15.2 tt0 -73.02 155.25 40.0 Favored 'General case' 0 C--N 1.281 -2.381 0 O-C-N 120.464 -1.398 . . . . 0.0 109.127 177.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.594 ' HB1' ' CE2' ' A' ' 86' ' ' TYR . . . -88.97 136.56 32.95 Favored 'General case' 0 C--N 1.269 -2.924 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.65 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.545 ' ND2' ' HG2' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -117.32 50.51 1.1 Allowed 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 125.408 2.528 . . . . 0.0 114.071 179.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.614 ' C ' ' HB2' ' A' ' 82' ' ' LYS . 7.0 pt20 166.87 -159.44 0.01 OUTLIER 'General case' 0 C--N 1.257 -3.416 0 CA-C-N 108.947 -3.751 . . . . 0.0 112.816 175.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.403 ' H ' ' HB2' ' A' ' 45' ' ' GLN 0.275 21.1 t-20 -110.1 154.25 23.54 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-O 122.53 1.157 . . . . 0.0 108.389 -178.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.635 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -171.84 151.05 2.73 Favored 'General case' 0 C--N 1.251 -3.675 0 C-N-CA 118.366 -1.333 . . . . 0.0 112.508 -178.25 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.676 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -111.66 6.52 19.96 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 120.668 -1.27 . . . . 0.0 110.817 178.511 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.573 ' CG2' ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.41 147.43 4.41 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 120.712 -1.243 . . . . 0.0 111.089 179.373 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.536 ' O ' ' O ' ' A' ' 70' ' ' PRO . . . -146.71 106.17 3.92 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-O 122.271 1.034 . . . . 0.0 109.981 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -75.99 -175.73 3.17 Favored 'General case' 0 N--CA 1.505 2.292 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.353 179.447 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.7 ' CD1' ' CG1' ' A' ' 88' ' ' ILE . 26.7 mt -140.19 135.08 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.688 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.485 ' O ' HG11 ' A' ' 108' ' ' VAL . 15.9 tt0 -141.4 114.55 8.67 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 123.428 1.585 . . . . 0.0 111.854 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.647 ' HA ' ' CG1' ' A' ' 108' ' ' VAL . 0.5 OUTLIER -90.28 125.91 43.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-N 112.705 -2.043 . . . . 0.0 108.904 178.15 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -117.69 98.69 6.5 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 177.344 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.483 ' HB3' ' CG2' ' A' ' 106' ' ' VAL . . . -112.86 126.8 55.85 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 118.459 -1.296 . . . . 0.0 112.889 -175.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.688 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.4 p -104.28 98.37 8.18 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 177.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.736 ' HA ' ' CG1' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -108.76 107.38 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.882 0 CA-C-O 122.905 1.336 . . . . 0.0 110.916 -176.676 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 103' ' ' ASN . 1.8 p30 35.84 62.35 0.65 Allowed 'General case' 0 N--CA 1.522 3.126 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.78 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.05 -12.04 10.16 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.284 -0.885 . . . . 0.0 111.365 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.514 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.279 0.3 OUTLIER -108.13 57.02 0.62 Allowed 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.079 -1.248 . . . . 0.0 111.162 -178.6 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.488 ' O ' ' CG ' ' A' ' 62' ' ' GLU 0.364 0.0 OUTLIER -60.79 115.09 3.41 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 122.049 0.928 . . . . 0.0 111.366 -179.411 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.429 HG21 ' O ' ' A' ' 63' ' ' VAL . 15.2 m -75.77 143.64 12.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-O 122.494 1.14 . . . . 0.0 110.352 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.527 ' C ' ' CG2' ' A' ' 65' ' ' VAL 0.435 20.9 t0 -138.27 60.0 1.63 Allowed 'General case' 0 C--N 1.277 -2.572 0 CA-C-O 122.752 1.263 . . . . 0.0 110.901 -176.169 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.527 ' CG2' ' C ' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -157.39 151.86 20.49 Favored Pre-proline 0 C--N 1.269 -2.929 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.742 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.453 ' HD2' HG11 ' A' ' 65' ' ' VAL . 44.9 Cg_endo -84.47 137.38 6.9 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 CA-C-O 123.763 1.485 . . . . 0.0 111.013 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.604 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -116.66 42.52 1.85 Allowed Glycine 0 C--N 1.27 -3.136 0 CA-C-N 112.574 -2.103 . . . . 0.0 111.774 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 69' ' ' ASP . 3.0 tp 174.3 -163.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 O-C-N 120.379 -1.659 . . . . 0.0 108.93 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.574 ' N ' HG22 ' A' ' 68' ' ' ILE . 1.5 t70 -107.62 135.01 19.8 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 174.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.7 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 23.6 Cg_endo -106.16 -4.69 0.13 Allowed 'Trans proline' 0 C--N 1.278 -3.176 0 C-N-CA 123.445 2.763 . . . . 0.0 114.07 -173.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.608 ' O ' ' CE1' ' A' ' 75' ' ' TYR . 9.1 p30 -114.93 92.9 4.09 Favored 'General case' 0 C--N 1.285 -2.224 0 O-C-N 120.491 -1.381 . . . . 0.0 108.695 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.571 ' HA ' ' CD1' ' A' ' 75' ' ' TYR . . . -77.91 12.08 1.92 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.071 -1.018 . . . . 0.0 109.095 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.405 ' C ' ' H ' ' A' ' 75' ' ' TYR . 1.9 t -76.35 -25.22 54.46 Favored 'General case' 0 C--O 1.214 -0.773 0 O-C-N 120.802 -1.186 . . . . 0.0 107.951 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.592 ' CD2' ' OD1' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -88.1 18.68 4.1 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 174.421 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.62 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.2 OUTLIER -134.06 -10.93 2.61 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.38 179.631 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.482 ' CE ' ' HB2' ' A' ' 72' ' ' ALA . 2.0 ptt? -164.04 133.48 3.93 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-O 123.897 1.808 . . . . 0.0 113.277 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.524 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -12.08 95.51 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 111.761 -2.472 . . . . 0.0 113.732 -178.638 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.5 ' HA ' HD12 ' A' ' 80' ' ' LEU 0.312 1.2 t -104.86 145.13 30.12 Favored Pre-proline 0 C--N 1.268 -2.949 0 CA-C-N 111.428 -2.623 . . . . 0.0 108.491 178.341 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.676 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 36.8 Cg_endo -80.52 166.62 75.33 Favored 'Cis proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.562 -1.849 . . . . 0.0 112.513 0.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.653 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -90.95 127.76 36.52 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.816 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.52 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.4 t -104.58 141.35 20.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-O 124.253 1.977 . . . . 0.0 112.377 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.614 ' HB2' ' C ' ' A' ' 45' ' ' GLN . 1.7 tmmt? -46.55 118.32 1.95 Allowed 'General case' 0 C--N 1.272 -2.772 0 CA-C-N 111.531 -2.577 . . . . 0.0 116.578 -175.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.27 -16.84 19.67 Favored Glycine 0 C--N 1.29 -2.022 0 CA-C-N 111.827 -2.442 . . . . 0.0 107.811 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.592 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 17.7 mt-30 -72.83 126.61 30.32 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-O 123.198 1.475 . . . . 0.0 111.598 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.605 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -63.81 144.95 56.64 Favored 'General case' 0 C--N 1.271 -2.834 0 CA-C-N 113.341 -1.754 . . . . 0.0 107.074 178.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.632 ' CE1' ' HG ' ' A' ' 80' ' ' LEU . 16.1 m-85 -143.43 125.3 15.16 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.532 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 8.4 p30 -117.06 127.2 53.92 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-O 122.572 1.177 . . . . 0.0 109.291 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.7 ' CG1' ' CD1' ' A' ' 52' ' ' ILE . 0.6 OUTLIER -109.95 159.77 9.4 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.202 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -151.06 156.84 41.93 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 122.046 0.927 . . . . 0.0 111.807 -177.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.591 ' O ' ' HA ' ' A' ' 36' ' ' GLN . 3.7 t80 -150.48 138.46 20.1 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.561 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 1.5 t -154.95 116.43 4.06 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 119.595 1.089 . . . . 0.0 108.102 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.604 ' CD1' ' O ' ' A' ' 67' ' ' GLY 0.27 1.5 t90 -143.03 115.87 8.76 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 119.809 -0.756 . . . . 0.0 110.021 -177.468 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.51 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.6 OUTLIER -74.91 160.29 30.8 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 119.249 -2.157 . . . . 0.0 110.135 -178.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.587 HG11 ' HB2' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -153.76 166.09 16.45 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.151 -0.968 . . . . 0.0 108.47 -179.274 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.501 ' O ' ' O ' ' A' ' 94' ' ' VAL . 18.4 Cg_endo -37.03 150.16 0.05 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.136 0 O-C-N 123.587 1.309 . . . . 0.0 110.64 -177.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.801 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.5 OUTLIER -79.27 -24.69 42.77 Favored 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 116.94 -1.904 . . . . 0.0 114.33 -173.311 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.582 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -138.52 42.85 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 O-C-N 121.658 -0.651 . . . . 0.0 112.25 -179.161 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.619 ' CB ' ' CD ' ' A' ' 99' ' ' PRO . . . -74.14 -67.67 0.39 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 120.641 -1.287 . . . . 0.0 110.025 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.665 ' C ' ' HD2' ' A' ' 100' ' ' LYS . 50.3 Cg_endo -67.55 160.09 49.54 Favored 'Trans proline' 0 CA--C 1.463 -3.042 0 O-C-N 123.615 1.323 . . . . 0.0 110.106 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.711 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -107.78 103.09 12.28 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 112.482 -2.144 . . . . 0.0 109.849 -169.689 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.537 ' CB ' ' HB ' ' A' ' 127' ' ' ILE . 6.5 p -42.96 99.62 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.723 0 CA-C-O 123.635 1.683 . . . . 0.0 108.661 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.405 88.5 mt-10 -163.67 -51.45 0.03 OUTLIER 'General case' 0 CA--C 1.45 -2.882 0 CA-C-N 113.024 -1.898 . . . . 0.0 111.674 -179.237 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.553 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.492 0.8 OUTLIER -159.3 79.22 0.74 Allowed 'General case' 0 C--N 1.283 -2.311 0 CA-C-N 110.952 -2.84 . . . . 0.0 113.378 -162.32 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.736 ' CG1' ' HA ' ' A' ' 58' ' ' ILE . 26.2 t -141.2 134.12 30.45 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.437 0 C-N-CA 119.811 -0.756 . . . . 0.0 111.234 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.586 ' CG1' ' CG2' ' A' ' 123' ' ' THR . 53.0 t -136.55 125.03 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.524 ' O ' HG12 ' A' ' 121' ' ' ILE . 0.3 OUTLIER -107.15 138.12 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 CA-C-O 122.58 1.181 . . . . 0.0 111.92 -178.805 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.615 ' CG2' ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -131.39 110.35 10.98 Favored 'General case' 0 C--N 1.276 -2.623 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.204 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.647 ' CG1' ' HA ' ' A' ' 54' ' ' ILE . 3.2 t -123.42 142.19 40.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 C-N-CA 117.182 -1.807 . . . . 0.0 108.811 -177.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.99 ' HB2' ' HB2' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -138.22 145.02 40.91 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 122.485 1.136 . . . . 0.0 111.874 -176.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.582 ' CG2' HD12 ' A' ' 88' ' ' ILE . 5.6 t -96.6 125.67 49.48 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.558 ' CG ' ' HA2' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -105.68 119.24 38.62 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -179.291 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -75.75 -135.55 0.52 Allowed Glycine 0 N--CA 1.497 2.72 0 C-N-CA 119.091 -1.528 . . . . 0.0 113.856 -176.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.635 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 5.1 p-10 -88.59 -0.77 57.6 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.1 0.953 . . . . 0.0 112.267 -176.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -133.94 -4.31 2.81 Favored 'General case' 0 C--N 1.269 -2.914 0 CA-C-O 121.429 0.633 . . . . 0.0 110.954 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.604 ' O ' ' HB ' ' A' ' 116' ' ' VAL . . . 95.54 83.36 1.64 Allowed Glycine 0 CA--C 1.47 -2.765 0 CA-C-O 124.636 2.242 . . . . 0.0 111.024 178.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.604 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 14.6 p 136.21 152.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.254 -3.586 0 CA-C-N 108.371 -3.915 . . . . 0.0 112.72 176.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.552 ' CB ' ' O ' ' A' ' 110' ' ' VAL . 0.1 OUTLIER -162.22 -59.51 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.414 0.626 . . . . 0.0 110.281 179.109 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.44 ' HB2' HG13 ' A' ' 13' ' ' ILE . . . -164.75 126.01 2.11 Favored 'General case' 0 N--CA 1.51 2.569 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.99 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 0.8 OUTLIER -134.11 135.74 43.42 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 117.918 -1.513 . . . . 0.0 113.112 -177.424 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.449 ' HB2' HG13 ' A' ' 16' ' ' VAL . . . -143.62 136.51 27.51 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 122.925 1.345 . . . . 0.0 112.406 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.615 ' HB ' ' CG2' ' A' ' 107' ' ' THR 0.26 0.0 OUTLIER -107.33 162.46 5.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 114.122 -1.399 . . . . 0.0 111.076 -179.589 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.612 ' N ' ' CD1' ' A' ' 121' ' ' ILE . . . -152.28 157.88 42.01 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.586 ' CG2' ' CG1' ' A' ' 105' ' ' VAL . 32.1 p -148.7 -87.31 0.09 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.346 -1.471 . . . . 0.0 110.5 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.568 ' C ' ' O ' ' A' ' 123' ' ' THR . 8.4 m-70 8.68 82.69 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.866 0 CA-C-O 121.438 0.637 . . . . 0.0 112.438 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.466 ' C ' ' HG3' ' A' ' 126' ' ' LYS . . . -173.51 79.2 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.466 ' HG3' ' C ' ' A' ' 125' ' ' ALA . 2.9 mtpt -130.63 -155.81 0.72 Allowed 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 122.065 0.936 . . . . 0.0 109.965 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.537 ' HB ' ' CB ' ' A' ' 101' ' ' SER . 0.6 OUTLIER -147.93 134.46 12.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 121.763 0.792 . . . . 0.0 111.551 -179.37 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.49 ' HD3' ' O ' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -168.91 152.92 5.46 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.132 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 128' ' ' ARG . 2.9 m-20 . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.046 -1.033 . . . . 0.0 110.618 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 27.0 t . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.382 0.61 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.517 ' OE1' ' N ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -52.82 166.1 0.23 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.338 -0.851 . . . . 0.0 111.345 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.557 ' CG1' ' HA ' ' A' ' 22' ' ' HIS . 1.4 m -144.65 -177.72 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.456 ' O ' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -78.89 134.78 36.89 Favored 'General case' 0 CA--C 1.481 -1.684 0 C-N-CA 117.723 -1.591 . . . . 0.0 108.758 178.211 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.47 ' O ' ' HG3' ' A' ' 6' ' ' LYS 0.439 0.4 OUTLIER -171.91 164.28 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 113.923 -1.49 . . . . 0.0 109.416 -169.629 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.559 ' HB2' ' CG2' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -144.37 136.98 26.78 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 123.644 1.687 . . . . 0.0 113.143 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.259 13.5 t70 -70.72 148.97 47.41 Favored 'General case' 0 C--N 1.269 -2.907 0 CA-C-N 113.249 -1.796 . . . . 0.0 109.278 178.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.635 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.5 p -137.59 14.62 2.95 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.94 -1.1 . . . . 0.0 109.488 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.593 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -125.94 -84.54 0.63 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.687 -1.205 . . . . 0.0 110.162 -177.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 12' ' ' GLU . 2.3 t30 -159.46 66.69 0.39 Allowed 'General case' 0 C--N 1.267 -2.998 0 C-N-CA 118.649 -1.221 . . . . 0.0 111.987 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.473 ' C ' ' O ' ' A' ' 10' ' ' ASN . 9.7 m-70 33.57 33.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.848 0.832 . . . . 0.0 110.275 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.0 OUTLIER -91.78 22.0 4.46 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.324 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.613 ' CG2' ' N ' ' A' ' 14' ' ' LYS 0.28 0.0 OUTLIER -121.15 -167.39 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-O 122.31 1.052 . . . . 0.0 111.323 -178.439 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.613 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 7.2 ptpt -162.34 -45.04 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.445 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.593 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 2.9 tttt -145.58 140.29 27.3 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 116.569 -2.052 . . . . 0.0 112.595 178.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.524 ' CG1' ' HB3' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -138.42 104.75 2.73 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 CA-C-O 122.929 1.347 . . . . 0.0 111.109 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.492 ' O ' ' HG2' ' A' ' 38' ' ' GLU . 0.9 OUTLIER -97.95 128.18 44.36 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 114.044 -1.434 . . . . 0.0 111.45 178.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.517 ' CG2' ' HA ' ' A' ' 37' ' ' LEU . 43.1 t -142.16 146.26 39.13 Favored Pre-proline 0 N--CA 1.499 2.006 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.517 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.542 ' CD ' ' O ' ' A' ' 36' ' ' GLN . 42.5 Cg_endo -67.63 93.83 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.821 1.432 . . . . 0.0 110.025 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.476 ' O ' ' CB ' ' A' ' 27' ' ' CYS . . . 173.89 -93.87 0.1 OUTLIER Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.513 -1.327 . . . . 0.0 110.084 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.557 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 37.1 m -94.73 162.21 13.87 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.161 -1.2 . . . . 0.0 111.392 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.557 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 0.8 OUTLIER -136.71 9.28 3.09 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.897 -1.127 . . . . 0.0 109.697 178.027 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 4' ' ' ASP . . . -178.68 -151.18 9.33 Favored Glycine 0 C--N 1.291 -1.956 0 C-N-CA 119.383 -1.389 . . . . 0.0 109.882 176.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.1 m -65.59 -9.57 27.9 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.744 -1.445 . . . . 0.0 109.954 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.781 ' CB ' ' HD3' ' A' ' 26' ' ' PRO . 1.2 mt-10 -64.51 176.35 0.75 Allowed Pre-proline 0 C--N 1.297 -1.708 0 CA-C-O 125.06 2.362 . . . . 0.0 115.256 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.781 ' HD3' ' CB ' ' A' ' 25' ' ' GLU . 25.1 Cg_endo -106.76 124.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.269 -3.641 1 C-N-CA 127.846 5.697 . . . . 0.0 110.716 -176.324 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.557 ' SG ' ' N ' ' A' ' 21' ' ' CYS . 25.7 p -126.82 129.11 47.65 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 122.705 1.241 . . . . 0.0 111.41 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.531 ' CG2' ' H ' ' A' ' 29' ' ' ILE 0.333 41.7 mm -80.68 -146.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 178.591 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.592 ' CG1' ' CB ' ' A' ' 125' ' ' ALA . 0.2 OUTLIER -127.7 117.29 46.05 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.74 0 CA-C-O 122.377 1.084 . . . . 0.0 111.074 179.504 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.63 ' CG ' ' N ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -67.05 -90.98 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.49 -179.066 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.63 ' N ' ' CG ' ' A' ' 30' ' ' HIS . 27.7 mtt85 -60.04 171.69 0.93 Allowed 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.871 ' HA3' ' HA ' ' A' ' 96' ' ' LYS . . . -62.13 -95.75 0.01 OUTLIER Glycine 0 C--N 1.296 -1.677 0 C-N-CA 117.361 -2.352 . . . . 0.0 107.457 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.551 ' NZ ' ' HG2' ' A' ' 99' ' ' PRO . 0.8 OUTLIER -125.34 91.6 48.64 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 120.883 2.342 . . . . 0.0 115.334 -179.306 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.54 ' HG3' ' HB2' ' A' ' 31' ' ' ARG . 60.6 Cg_endo -108.2 145.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.291 -2.458 0 C-N-CA 124.291 3.327 . . . . 0.0 109.594 177.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.546 ' CE2' HG13 ' A' ' 94' ' ' VAL . 4.9 m-85 -119.8 90.79 3.4 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.571 ' HG2' ' CB ' ' A' ' 91' ' ' THR . 0.3 OUTLIER -116.17 88.64 2.93 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 122.006 -0.434 . . . . 0.0 110.223 -178.353 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.517 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 0.6 OUTLIER -108.68 133.53 52.65 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.526 -1.359 . . . . 0.0 108.383 178.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -140.2 127.62 21.38 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.533 -1.354 . . . . 0.0 107.452 179.242 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.524 ' HB3' ' CG1' ' A' ' 16' ' ' VAL . . . -142.75 152.94 42.82 Favored 'General case' 0 C--N 1.274 -2.708 0 CA-C-O 122.97 1.367 . . . . 0.0 113.263 -175.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.593 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.46 139.87 32.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 113.821 -1.536 . . . . 0.0 108.711 177.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.579 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 3.5 p90 -156.87 124.07 5.26 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -178.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 13.6 tt0 -69.68 155.85 39.88 Favored 'General case' 0 C--N 1.288 -2.107 0 O-C-N 120.407 -1.433 . . . . 0.0 108.508 177.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.592 ' HB1' ' CE2' ' A' ' 86' ' ' TYR . . . -91.28 134.69 34.37 Favored 'General case' 0 C--N 1.265 -3.069 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.162 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.599 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -114.87 51.26 0.91 Allowed 'General case' 0 CA--C 1.486 -1.498 0 CA-C-O 125.327 2.489 . . . . 0.0 114.067 179.004 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.601 ' N ' ' CG ' ' A' ' 82' ' ' LYS . 7.0 pt20 167.34 -160.95 0.01 OUTLIER 'General case' 0 C--N 1.263 -3.173 0 CA-C-N 109.149 -3.659 . . . . 0.0 113.729 174.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.415 ' H ' ' HB2' ' A' ' 45' ' ' GLN 0.277 6.3 t30 -110.36 153.65 24.64 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-O 122.617 1.199 . . . . 0.0 108.872 -178.483 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.664 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -173.22 157.04 3.31 Favored 'General case' 0 C--N 1.255 -3.526 0 C-N-CA 118.727 -1.189 . . . . 0.0 112.746 -178.307 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.679 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 0.4 OUTLIER -112.5 5.87 18.22 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 120.694 -1.254 . . . . 0.0 111.522 178.434 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.563 ' CG2' ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.16 149.06 5.01 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.659 -1.276 . . . . 0.0 111.215 179.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.5 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . . . -141.37 101.64 4.05 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 122.924 1.345 . . . . 0.0 110.863 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 23.3 mmtp -73.15 -178.23 2.8 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.939 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.806 HG12 HD13 ' A' ' 88' ' ' ILE . 28.4 mt -140.14 136.43 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.544 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.945 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.538 ' C ' HG11 ' A' ' 108' ' ' VAL . 31.9 tt0 -141.44 110.87 6.39 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 123.267 1.508 . . . . 0.0 111.3 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.648 ' HA ' ' CG1' ' A' ' 108' ' ' VAL . 0.5 OUTLIER -89.99 127.07 42.8 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 CA-C-N 112.793 -2.003 . . . . 0.0 109.64 179.524 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.493 ' NZ ' ' HB2' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -120.25 98.62 6.15 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 176.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.531 ' HB3' ' CG2' ' A' ' 106' ' ' VAL . . . -114.53 133.61 55.66 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 118.919 -1.112 . . . . 0.0 113.187 -175.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.672 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.0 OUTLIER -105.53 100.3 9.87 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 177.595 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.739 ' HA ' ' CG2' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -111.55 102.96 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.838 0 CA-C-O 123.004 1.383 . . . . 0.0 110.729 -176.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER 34.86 65.2 0.37 Allowed 'General case' 0 N--CA 1.519 3.003 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.829 179.306 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.47 -16.56 10.0 Favored Glycine 0 N--CA 1.489 2.212 0 O-C-N 121.351 -0.843 . . . . 0.0 111.761 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.53 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.268 0.5 OUTLIER -108.3 57.94 0.61 Allowed 'General case' 0 C--N 1.292 -1.896 0 O-C-N 121.027 -1.278 . . . . 0.0 111.818 -178.256 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.49 ' O ' ' CG ' ' A' ' 62' ' ' GLU 0.367 0.0 OUTLIER -59.25 115.8 3.46 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.064 0.935 . . . . 0.0 111.258 -179.913 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.48 HG23 ' HB2' ' A' ' 56' ' ' ALA . 17.7 m -80.3 146.73 7.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 122.517 1.151 . . . . 0.0 110.971 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.429 7.1 t70 -138.06 59.11 1.66 Allowed 'General case' 0 C--N 1.28 -2.428 0 CA-C-O 122.831 1.301 . . . . 0.0 111.013 -176.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.473 HG21 ' HD2' ' A' ' 66' ' ' PRO . 4.0 p -165.31 151.8 9.03 Favored Pre-proline 0 C--N 1.269 -2.927 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.053 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.473 ' HD2' HG21 ' A' ' 65' ' ' VAL . 44.5 Cg_endo -87.7 139.56 4.82 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 CA-C-O 123.706 1.461 . . . . 0.0 111.804 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -105.83 48.77 0.94 Allowed Glycine 0 C--N 1.272 -2.99 0 CA-C-N 112.568 -2.106 . . . . 0.0 109.101 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.578 ' CG2' ' N ' ' A' ' 69' ' ' ASP 0.293 0.0 OUTLIER 179.63 -168.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 O-C-N 119.669 -2.077 . . . . 0.0 108.544 -178.247 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.578 ' N ' ' CG2' ' A' ' 68' ' ' ILE . 10.0 t0 -108.86 90.61 7.85 Favored Pre-proline 0 N--CA 1.504 2.232 0 O-C-N 120.731 -1.231 . . . . 0.0 108.364 176.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.721 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 20.0 Cg_endo -48.39 -5.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.289 -2.584 0 C-N-CA 124.182 3.254 . . . . 0.0 115.461 177.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.575 ' HB2' ' NE2' ' A' ' 74' ' ' HIS . 0.6 OUTLIER -107.63 92.86 4.25 Favored 'General case' 0 C--N 1.289 -2.03 0 O-C-N 120.134 -1.604 . . . . 0.0 109.484 -179.209 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.713 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . . . -78.27 10.41 3.05 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.101 -0.999 . . . . 0.0 109.332 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.1 t -78.16 -24.53 47.24 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 120.992 -1.067 . . . . 0.0 108.944 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.575 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 0.3 OUTLIER -79.52 7.62 7.85 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 118.911 -1.116 . . . . 0.0 108.797 176.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.713 ' CD2' ' HA ' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -132.98 -1.38 3.31 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 121.488 -0.758 . . . . 0.0 110.11 177.62 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.514 ' CE ' HD22 ' A' ' 80' ' ' LEU . 1.5 ptt? -153.45 128.65 9.75 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 124.042 1.877 . . . . 0.0 113.745 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.515 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -19.88 95.98 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 111.74 -2.482 . . . . 0.0 113.213 -178.676 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.493 ' HA ' HD12 ' A' ' 80' ' ' LEU 0.32 0.3 OUTLIER -99.93 142.17 24.11 Favored Pre-proline 0 C--N 1.268 -2.948 0 CA-C-N 111.36 -2.654 . . . . 0.0 108.776 178.495 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.679 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 36.3 Cg_endo -79.58 168.27 73.86 Favored 'Cis proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.848 -1.73 . . . . 0.0 112.521 0.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.693 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -94.71 128.39 41.36 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.17 -179.731 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.53 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.4 t -105.9 139.38 27.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 124.1 1.905 . . . . 0.0 112.07 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.601 ' CG ' ' N ' ' A' ' 45' ' ' GLN . 1.2 tmmt? -44.59 118.33 1.54 Allowed 'General case' 0 C--N 1.271 -2.823 0 CA-C-N 111.816 -2.447 . . . . 0.0 116.652 -175.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.95 -18.01 12.72 Favored Glycine 0 C--N 1.292 -1.878 0 CA-C-N 111.787 -2.461 . . . . 0.0 107.924 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 18.3 mt-30 -71.79 127.74 33.54 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-O 123.221 1.486 . . . . 0.0 111.349 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.611 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 3.2 mt-30 -66.02 144.6 56.64 Favored 'General case' 0 C--N 1.27 -2.861 0 CA-C-N 113.282 -1.781 . . . . 0.0 107.485 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.652 ' CE1' ' HG ' ' A' ' 80' ' ' LEU . 17.8 m-85 -142.72 126.07 16.62 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.539 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 0.7 OUTLIER -117.46 130.19 56.3 Favored 'General case' 0 C--N 1.279 -2.489 0 CA-C-O 122.737 1.256 . . . . 0.0 110.034 -178.34 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.806 HD13 HG12 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -101.95 156.22 4.73 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.152 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.188 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.17 143.22 30.99 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 121.465 0.65 . . . . 0.0 111.343 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.62 ' CE1' ' HB2' ' A' ' 92' ' ' TRP . 2.1 t80 -143.89 99.66 3.44 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.412 -0.805 . . . . 0.0 109.123 178.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.571 ' CB ' ' HG2' ' A' ' 36' ' ' GLN . 1.3 t -122.81 116.29 23.44 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.91 -1.119 . . . . 0.0 108.616 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.62 ' HB2' ' CE1' ' A' ' 90' ' ' TYR 0.271 0.3 OUTLIER -142.64 102.31 4.03 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.035 -177.635 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.8 OUTLIER -75.62 153.66 37.12 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 119.607 -1.933 . . . . 0.0 109.461 -178.757 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.546 HG13 ' CE2' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -153.11 175.38 3.01 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.781 -1.199 . . . . 0.0 108.606 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.525 ' O ' ' O ' ' A' ' 94' ' ' VAL . 18.6 Cg_endo -37.96 154.07 0.03 OUTLIER 'Trans proline' 0 CA--C 1.498 -1.321 0 O-C-N 123.64 1.337 . . . . 0.0 110.701 -177.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.871 ' HA ' ' HA3' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -79.54 -25.3 41.72 Favored 'General case' 0 C--N 1.284 -2.277 0 C-N-CA 116.614 -2.035 . . . . 0.0 115.526 -173.173 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.548 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -140.27 39.71 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 -177.658 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.608 ' CB ' ' CD ' ' A' ' 99' ' ' PRO . . . -62.89 -64.48 2.98 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.519 -1.363 . . . . 0.0 108.353 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.693 ' C ' ' HD2' ' A' ' 100' ' ' LYS . 51.5 Cg_endo -69.96 163.74 37.3 Favored 'Trans proline' 0 CA--C 1.46 -3.206 0 O-C-N 123.87 1.458 . . . . 0.0 108.852 177.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.693 ' HD2' ' C ' ' A' ' 99' ' ' PRO . 1.0 OUTLIER -105.14 103.7 13.3 Favored 'General case' 0 C--N 1.269 -2.902 0 CA-C-N 112.704 -2.044 . . . . 0.0 110.92 -168.596 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.576 ' HB2' ' CB ' ' A' ' 127' ' ' ILE . 7.5 p -43.43 96.78 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 123.566 1.65 . . . . 0.0 108.859 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.601 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.413 78.0 mt-10 -163.64 -50.77 0.03 OUTLIER 'General case' 0 CA--C 1.451 -2.832 0 CA-C-N 112.729 -2.032 . . . . 0.0 112.01 -179.331 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.491 0.8 OUTLIER -159.07 81.58 0.78 Allowed 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 111.283 -2.69 . . . . 0.0 113.781 -162.15 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.739 ' CG2' ' HA ' ' A' ' 58' ' ' ILE . 34.0 t -143.22 133.91 22.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.122 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.555 ' CG1' HD13 ' A' ' 121' ' ' ILE . 60.9 t -142.48 134.56 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.536 HG13 ' CD2' ' A' ' 124' ' ' HIS . 1.3 p -112.65 146.84 16.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 122.956 1.36 . . . . 0.0 113.367 -178.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.623 ' CG2' ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -132.82 108.52 9.02 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 178.272 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.648 ' CG1' ' HA ' ' A' ' 54' ' ' ILE . 3.6 t -125.29 141.9 43.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 120.094 -1.629 . . . . 0.0 109.056 -177.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.687 ' HB2' ' HB3' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -133.84 152.35 51.84 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.712 1.244 . . . . 0.0 113.047 -178.336 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.683 ' CG2' ' CD1' ' A' ' 88' ' ' ILE . 8.8 t -99.83 127.35 52.79 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.255 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 177.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.484 ' HG3' ' N ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -108.82 121.79 45.82 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.31 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -78.14 -137.36 1.11 Allowed Glycine 0 N--CA 1.497 2.742 0 C-N-CA 119.079 -1.534 . . . . 0.0 114.093 -175.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.664 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 10.0 p-10 -80.19 -5.11 55.52 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 122.366 1.079 . . . . 0.0 112.07 -177.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 9.7 p30 -130.05 -4.6 4.48 Favored 'General case' 0 C--N 1.266 -3.065 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.145 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.579 ' O ' ' CB ' ' A' ' 116' ' ' VAL . . . 88.59 85.55 1.24 Allowed Glycine 0 CA--C 1.469 -2.808 0 CA-C-O 124.886 2.381 . . . . 0.0 109.813 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.579 ' CB ' ' O ' ' A' ' 115' ' ' GLY . 4.5 p 145.41 145.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.245 -3.952 0 CA-C-N 108.43 -3.885 . . . . 0.0 111.833 177.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.529 ' CB ' ' O ' ' A' ' 110' ' ' VAL . 0.1 OUTLIER -162.27 -57.43 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.495 -0.753 . . . . 0.0 110.755 179.605 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -173.81 130.09 0.41 Allowed 'General case' 0 N--CA 1.51 2.56 0 O-C-N 121.158 -0.964 . . . . 0.0 108.84 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.687 ' HB3' ' HB2' ' A' ' 109' ' ' LYS . 0.8 OUTLIER -134.44 144.31 48.06 Favored 'General case' 0 C--N 1.285 -2.23 0 C-N-CA 117.544 -1.662 . . . . 0.0 113.86 -177.469 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.24 138.18 23.7 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 123.034 1.397 . . . . 0.0 112.239 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.623 ' HB ' ' CG2' ' A' ' 107' ' ' THR 0.279 0.0 OUTLIER -109.37 132.31 57.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 CA-C-N 114.025 -1.443 . . . . 0.0 111.198 -179.19 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -131.05 -173.37 3.08 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.874 -1.141 . . . . 0.0 108.681 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 125' ' ' ALA . 13.8 p -104.39 -7.6 19.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.441 -1.412 . . . . 0.0 111.676 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.536 ' CD2' HG13 ' A' ' 106' ' ' VAL . 23.8 m170 61.6 -72.29 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.626 0 O-C-N 121.236 -0.915 . . . . 0.0 110.428 -178.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.592 ' CB ' ' CG1' ' A' ' 29' ' ' ILE . . . -136.96 146.49 45.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.496 -0.753 . . . . 0.0 109.397 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 1.3 mmpt? -131.6 93.43 3.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.132 -0.98 . . . . 0.0 109.368 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.576 ' CB ' ' HB2' ' A' ' 101' ' ' SER . 1.0 OUTLIER -88.69 135.91 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.317 -1.49 . . . . 0.0 111.743 -179.544 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.486 ' HD2' ' N ' ' A' ' 129' ' ' ASP . 0.0 OUTLIER -168.16 -140.75 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.47 0.652 . . . . 0.0 111.625 179.291 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.486 ' N ' ' HD2' ' A' ' 128' ' ' ARG . 1.3 m-20 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.926 -1.035 . . . . 0.0 110.856 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.196 0.522 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -82.9 167.62 17.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -0.888 . . . . 0.0 111.006 -179.757 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.522 ' CG1' ' HA ' ' A' ' 22' ' ' HIS . 1.4 m -145.59 179.56 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 O-C-N 120.836 -1.165 . . . . 0.0 108.174 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.468 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -79.47 137.02 37.08 Favored 'General case' 0 CA--C 1.48 -1.723 0 C-N-CA 118.117 -1.433 . . . . 0.0 108.693 177.881 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.555 ' O ' ' CG ' ' A' ' 6' ' ' LYS 0.436 0.4 OUTLIER -169.44 -171.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.48 -169.858 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.555 ' CG ' ' O ' ' A' ' 5' ' ' VAL . 5.2 mtpp -166.2 146.95 6.46 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 123.931 1.824 . . . . 0.0 113.096 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.281 3.0 t70 -84.88 148.84 26.06 Favored 'General case' 0 C--N 1.264 -3.11 0 CA-C-N 112.58 -2.1 . . . . 0.0 109.043 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.667 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.7 p -137.27 15.95 2.99 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.94 -1.1 . . . . 0.0 109.226 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.595 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -125.65 -84.32 0.63 Allowed 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.137 -176.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.567 ' O ' ' N ' ' A' ' 12' ' ' GLU . 2.4 t30 -156.35 65.19 0.55 Allowed 'General case' 0 C--N 1.268 -2.968 0 C-N-CA 118.523 -1.271 . . . . 0.0 111.783 177.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.468 ' C ' ' O ' ' A' ' 10' ' ' ASN . 10.4 m80 33.72 31.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.773 0.796 . . . . 0.0 110.73 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.4 OUTLIER -90.8 21.26 4.2 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.002 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.602 ' CG2' ' N ' ' A' ' 14' ' ' LYS 0.272 0.1 OUTLIER -119.82 -170.31 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 122.211 1.005 . . . . 0.0 110.611 -178.785 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.602 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 11.2 ptmm? -162.09 -46.83 0.04 OUTLIER 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.143 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.559 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 21.6 tttt -142.81 135.15 27.51 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 116.045 -2.262 . . . . 0.0 113.178 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.538 ' CG1' ' HB3' ' A' ' 39' ' ' ALA . 0.6 OUTLIER -132.98 101.29 4.25 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 CA-C-O 123.03 1.395 . . . . 0.0 110.76 179.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.471 ' O ' HG21 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -95.04 129.04 42.28 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 113.987 -1.461 . . . . 0.0 111.857 179.282 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.511 ' CG2' ' HA ' ' A' ' 37' ' ' LEU . 78.4 t -142.21 145.57 36.08 Favored Pre-proline 0 N--CA 1.5 2.049 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.105 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.504 ' HD2' ' CG1' ' A' ' 18' ' ' VAL . 42.1 Cg_endo -68.81 105.93 1.4 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.677 1.357 . . . . 0.0 110.624 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.433 ' C ' ' CB ' ' A' ' 27' ' ' CYS . . . 160.44 -91.13 0.11 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.552 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 38.2 m -90.74 159.16 16.48 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.295 -1.121 . . . . 0.0 110.78 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.522 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 3.8 p80 -137.25 11.76 3.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.665 -1.272 . . . . 0.0 109.528 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 4' ' ' ASP . . . 176.4 -148.85 9.37 Favored Glycine 0 C--N 1.29 -2.026 0 C-N-CA 119.288 -1.434 . . . . 0.0 109.883 177.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.7 -9.33 26.73 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.704 -1.468 . . . . 0.0 109.895 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.783 ' CB ' ' HD3' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -64.44 176.04 0.8 Allowed Pre-proline 0 C--N 1.298 -1.635 0 CA-C-O 124.953 2.311 . . . . 0.0 115.178 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.783 ' HD3' ' CB ' ' A' ' 25' ' ' GLU . 25.3 Cg_endo -107.11 124.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.268 -3.661 1 C-N-CA 127.709 5.606 . . . . 0.0 110.98 -176.021 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.552 ' SG ' ' N ' ' A' ' 21' ' ' CYS . 28.2 p -127.69 127.71 44.19 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.659 1.218 . . . . 0.0 110.906 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.521 ' CG2' ' H ' ' A' ' 29' ' ' ILE 0.331 44.1 mm -79.55 -152.37 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.308 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.596 ' CG1' ' CB ' ' A' ' 125' ' ' ALA . 0.3 OUTLIER -126.87 116.62 45.39 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.59 0 CA-C-O 122.45 1.119 . . . . 0.0 111.45 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.1 m80 -67.32 -101.6 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.283 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.493 ' HB2' ' HG3' ' A' ' 34' ' ' PRO . 60.3 mtt-85 -51.62 171.8 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.899 ' HA3' ' HA ' ' A' ' 96' ' ' LYS . . . -61.5 -93.04 0.01 OUTLIER Glycine 0 C--N 1.298 -1.548 0 C-N-CA 117.756 -2.164 . . . . 0.0 108.09 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.524 ' CD ' ' O ' ' A' ' 32' ' ' GLY . 2.3 mmmt -125.37 90.98 49.79 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 120.585 2.192 . . . . 0.0 115.302 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 65.0 Cg_endo -108.65 143.39 0.06 OUTLIER 'Trans proline' 0 C--N 1.291 -2.466 0 C-N-CA 124.378 3.385 . . . . 0.0 109.735 177.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.477 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 12.7 m-85 -125.05 95.68 4.58 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.07 -1.052 . . . . 0.0 109.737 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.566 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 28.2 mp0 -116.37 96.64 5.63 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.569 -0.707 . . . . 0.0 110.81 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.57 HD21 ' CE1' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -109.3 136.31 48.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.355 -1.466 . . . . 0.0 108.638 178.93 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -140.27 125.16 18.35 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.496 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.538 ' HB3' ' CG1' ' A' ' 16' ' ' VAL . . . -143.54 152.52 41.55 Favored 'General case' 0 C--N 1.274 -2.694 0 CA-C-O 122.955 1.36 . . . . 0.0 113.878 -175.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.559 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.71 140.34 30.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-N 113.766 -1.561 . . . . 0.0 108.305 177.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.584 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 4.0 p90 -159.33 125.04 4.29 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 5.5 tt0 -70.55 157.09 38.52 Favored 'General case' 0 C--N 1.286 -2.154 0 O-C-N 120.39 -1.444 . . . . 0.0 109.07 178.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.581 ' HB1' ' CE2' ' A' ' 86' ' ' TYR . . . -90.94 141.95 28.29 Favored 'General case' 0 C--N 1.267 -2.981 0 CA-C-N 114.217 -1.356 . . . . 0.0 108.847 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.57 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -121.49 50.42 1.4 Allowed 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 125.281 2.467 . . . . 0.0 114.31 178.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.584 ' N ' ' CG ' ' A' ' 82' ' ' LYS . 6.5 pt20 167.15 -161.49 0.01 OUTLIER 'General case' 0 C--N 1.258 -3.386 0 CA-C-N 109.109 -3.678 . . . . 0.0 113.073 175.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.418 ' H ' ' HB2' ' A' ' 45' ' ' GLN 0.277 48.5 t30 -110.11 153.51 24.59 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-O 122.572 1.177 . . . . 0.0 108.952 -178.68 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.65 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -173.26 156.64 3.19 Favored 'General case' 0 C--N 1.254 -3.581 0 C-N-CA 118.558 -1.257 . . . . 0.0 112.53 -178.394 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.699 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -115.9 9.27 14.93 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 120.811 -1.18 . . . . 0.0 111.077 178.596 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.559 ' CG2' ' O ' ' A' ' 48' ' ' LYS . 0.9 OUTLIER -166.5 147.54 6.28 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.768 -1.207 . . . . 0.0 110.723 179.491 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.506 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . . . -148.41 102.22 3.31 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 122.76 1.267 . . . . 0.0 110.366 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 12.3 mmtt -75.11 -174.68 2.36 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.716 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.781 HG12 HD13 ' A' ' 88' ' ' ILE . 45.7 mt -140.54 139.03 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.535 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.489 ' C ' HG11 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -140.37 110.09 6.39 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 123.349 1.547 . . . . 0.0 110.56 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.624 ' HA ' ' CG1' ' A' ' 108' ' ' VAL . 0.5 OUTLIER -89.77 126.06 42.69 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.332 0 CA-C-N 112.527 -2.124 . . . . 0.0 108.979 179.29 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.1 tttp -121.68 103.18 8.7 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 177.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.508 ' HB3' ' CG2' ' A' ' 106' ' ' VAL . . . -110.03 126.58 54.12 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.527 -1.269 . . . . 0.0 111.86 -176.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.701 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 4.7 p -101.48 100.86 11.36 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.71 ' HA ' ' CG2' ' A' ' 104' ' ' VAL . 0.6 OUTLIER -111.31 111.78 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.679 0 CA-C-O 122.695 1.236 . . . . 0.0 110.313 -177.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.57 ' N ' ' O ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER 30.74 62.54 0.2 Allowed 'General case' 0 N--CA 1.52 3.069 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.954 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.43 -12.43 7.63 Favored Glycine 0 N--CA 1.49 2.278 0 O-C-N 121.339 -0.851 . . . . 0.0 111.379 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.514 ' O ' HG13 ' A' ' 58' ' ' ILE 0.284 0.2 OUTLIER -107.9 56.32 0.63 Allowed 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.12 -1.223 . . . . 0.0 111.171 -178.655 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.362 0.0 OUTLIER -53.95 114.09 1.46 Allowed 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 122.16 0.981 . . . . 0.0 110.565 -179.754 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.449 HG12 HG22 ' A' ' 58' ' ' ILE . 19.0 m -76.98 140.46 17.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-O 122.759 1.266 . . . . 0.0 111.499 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.45 21.7 t0 -139.32 85.08 2.03 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.435 -176.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.566 ' CG2' ' HD2' ' A' ' 66' ' ' PRO . 9.9 p -159.31 150.35 16.18 Favored Pre-proline 0 C--N 1.275 -2.631 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.888 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.566 ' HD2' ' CG2' ' A' ' 65' ' ' VAL . 43.5 Cg_endo -73.18 138.04 27.16 Favored 'Trans proline' 0 C--N 1.319 -0.992 0 CA-C-O 123.725 1.469 . . . . 0.0 111.342 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.598 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -117.45 -53.51 0.31 Allowed Glycine 0 N--CA 1.51 3.574 0 CA-C-N 112.542 -2.117 . . . . 0.0 113.588 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.467 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 1.3 tp -117.28 -155.65 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-N 120.643 2.221 . . . . 0.0 110.22 -178.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.558 ' OD2' ' ND2' ' A' ' 71' ' ' ASN . 1.1 t70 -107.92 89.17 5.17 Favored Pre-proline 0 N--CA 1.508 2.44 0 CA-C-O 122.82 1.295 . . . . 0.0 108.983 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.735 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 20.8 Cg_endo -49.05 -12.77 0.25 Allowed 'Trans proline' 0 C--N 1.285 -2.773 0 C-N-CA 124.121 3.214 . . . . 0.0 115.885 178.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.648 ' ND2' ' CD2' ' A' ' 74' ' ' HIS . 0.5 OUTLIER -111.59 85.65 2.17 Favored 'General case' 0 C--N 1.288 -2.074 0 O-C-N 119.843 -1.785 . . . . 0.0 108.965 -179.297 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.613 ' HA ' ' CD1' ' A' ' 75' ' ' TYR . . . -78.38 12.1 2.11 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.644 -0.66 . . . . 0.0 109.313 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.408 ' C ' ' H ' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -77.25 -20.6 54.95 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 120.666 -1.271 . . . . 0.0 108.002 -179.593 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.648 ' CD2' ' ND2' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -87.84 19.04 3.7 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 173.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.4 OUTLIER -133.13 -9.78 2.97 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.032 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.486 ' O ' ' HG2' ' A' ' 76' ' ' MET . 2.3 ptt? -166.55 126.77 1.61 Allowed 'General case' 0 C--O 1.215 -0.74 0 CA-C-O 123.761 1.743 . . . . 0.0 113.219 178.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.55 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 0.0 OUTLIER 3.87 91.71 0.01 OUTLIER 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 111.999 -2.364 . . . . 0.0 114.134 -179.422 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.504 ' HA ' ' CD1' ' A' ' 80' ' ' LEU 0.331 7.3 t -110.21 139.26 21.26 Favored Pre-proline 0 C--N 1.269 -2.932 0 CA-C-N 111.441 -2.618 . . . . 0.0 107.614 177.519 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.699 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 36.7 Cg_endo -76.79 169.62 73.92 Favored 'Cis proline' 0 C--N 1.308 -1.555 0 C-N-CA 123.095 -1.627 . . . . 0.0 112.992 1.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.727 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -96.9 128.39 43.81 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.051 -179.4 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.523 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.9 t -106.96 138.67 31.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 124.169 1.938 . . . . 0.0 111.916 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.584 ' CG ' ' N ' ' A' ' 45' ' ' GLN . 1.6 tmmt? -44.2 117.19 1.17 Allowed 'General case' 0 C--N 1.271 -2.837 0 CA-C-N 111.832 -2.44 . . . . 0.0 116.596 -175.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.431 ' O ' ' OE2' ' A' ' 42' ' ' GLU . . . 115.83 -17.09 15.76 Favored Glycine 0 C--N 1.292 -1.905 0 CA-C-N 111.752 -2.476 . . . . 0.0 107.963 178.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.601 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 10.4 mt-30 -71.43 127.76 33.63 Favored 'General case' 0 C--N 1.278 -2.542 0 CA-C-O 123.22 1.486 . . . . 0.0 111.766 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.596 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 0.3 OUTLIER -64.7 143.73 57.72 Favored 'General case' 0 C--N 1.272 -2.794 0 CA-C-N 113.326 -1.761 . . . . 0.0 107.072 178.454 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.657 ' CE1' ' HG ' ' A' ' 80' ' ' LEU . 17.9 m-85 -143.33 126.68 16.7 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 10.0 p30 -117.66 132.93 56.42 Favored 'General case' 0 C--N 1.275 -2.655 0 CA-C-O 122.703 1.239 . . . . 0.0 109.913 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.781 HD13 HG12 ' A' ' 52' ' ' ILE . 0.4 OUTLIER -102.58 157.7 4.73 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 CA-C-N 114.629 -1.168 . . . . 0.0 108.265 179.477 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -147.94 142.61 26.62 Favored 'General case' 0 C--N 1.283 -2.3 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.526 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.577 ' CE2' ' HA3' ' A' ' 67' ' ' GLY . 17.4 t80 -151.54 108.57 3.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.148 -0.97 . . . . 0.0 110.401 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.566 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 0.4 OUTLIER -125.11 122.26 36.63 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 120.515 -1.365 . . . . 0.0 108.093 179.163 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.598 ' CD1' ' O ' ' A' ' 67' ' ' GLY 0.27 0.1 OUTLIER -142.44 102.78 4.14 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.128 -176.933 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.51 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.6 OUTLIER -74.93 157.15 35.48 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 119.676 -1.89 . . . . 0.0 108.829 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.545 ' O ' ' O ' ' A' ' 95' ' ' PRO . 1.1 t -153.99 171.78 6.58 Favored Pre-proline 0 N--CA 1.486 1.333 0 O-C-N 120.792 -1.193 . . . . 0.0 109.13 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.545 ' O ' ' O ' ' A' ' 94' ' ' VAL . 18.8 Cg_endo -38.74 157.7 0.03 OUTLIER 'Trans proline' 0 CA--C 1.498 -1.294 0 O-C-N 123.833 1.439 . . . . 0.0 110.352 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.899 ' HA ' ' HA3' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -79.54 -21.8 44.72 Favored 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 116.282 -2.167 . . . . 0.0 115.558 -173.477 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.537 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -136.73 39.16 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -177.497 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.653 ' CB ' ' CD ' ' A' ' 99' ' ' PRO . . . -64.89 -73.51 0.21 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 120.483 -1.385 . . . . 0.0 108.562 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.697 ' C ' ' HD2' ' A' ' 100' ' ' LYS . 53.8 Cg_endo -70.25 162.31 42.77 Favored 'Trans proline' 0 CA--C 1.463 -3.034 0 CA-C-O 123.177 1.24 . . . . 0.0 109.659 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.718 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.9 OUTLIER -105.72 99.23 8.84 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 112.697 -2.047 . . . . 0.0 110.735 -169.003 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.613 ' HB2' ' HB ' ' A' ' 127' ' ' ILE . 12.8 p -46.77 99.84 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 123.654 1.692 . . . . 0.0 108.463 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.413 95.9 mt-10 -163.43 -51.65 0.04 OUTLIER 'General case' 0 CA--C 1.449 -2.911 0 CA-C-N 112.72 -2.036 . . . . 0.0 110.562 -179.474 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.57 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.499 0.7 OUTLIER -158.31 74.76 0.71 Allowed 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 110.504 -3.043 . . . . 0.0 111.295 -163.278 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.71 ' CG2' ' HA ' ' A' ' 58' ' ' ILE . 14.3 t -142.1 141.06 29.25 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.543 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.924 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.541 ' CG1' HD13 ' A' ' 121' ' ' ILE . 1.2 t -145.5 131.21 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.524 ' O ' HG12 ' A' ' 121' ' ' ILE . 0.3 OUTLIER -103.91 140.9 20.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 122.288 1.042 . . . . 0.0 111.704 -178.778 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.63 ' CG2' ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -132.47 110.75 10.73 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 179.427 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.624 ' CG1' ' HA ' ' A' ' 54' ' ' ILE . 3.6 t -125.73 140.83 47.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 O-C-N 120.133 -1.604 . . . . 0.0 109.229 -177.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.863 ' HB2' ' CB ' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -130.78 148.27 52.54 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 122.526 1.155 . . . . 0.0 112.057 -178.748 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.648 ' CG2' ' CD1' ' A' ' 88' ' ' ILE . 3.0 t -96.35 125.24 49.28 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 176.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.507 ' HG2' ' O ' ' A' ' 111' ' ' MET . 2.2 ptm -105.4 121.2 43.41 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -80.35 -139.31 2.21 Favored Glycine 0 N--CA 1.496 2.665 0 C-N-CA 119.031 -1.557 . . . . 0.0 114.311 -175.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.65 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 14.9 p-10 -77.8 -5.74 51.79 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 122.41 1.1 . . . . 0.0 112.051 -177.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 8.3 p30 -129.35 -5.27 4.83 Favored 'General case' 0 C--N 1.266 -3.057 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.097 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.597 ' O ' ' CB ' ' A' ' 116' ' ' VAL . . . 88.69 85.77 1.24 Allowed Glycine 0 CA--C 1.469 -2.844 0 CA-C-O 124.821 2.345 . . . . 0.0 109.745 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.597 ' CB ' ' O ' ' A' ' 115' ' ' GLY . 4.3 p 143.04 145.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.246 -3.91 0 CA-C-N 108.37 -3.915 . . . . 0.0 111.631 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.553 ' CB ' ' O ' ' A' ' 110' ' ' VAL . 0.1 OUTLIER -162.05 -58.57 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.479 -0.763 . . . . 0.0 110.9 179.682 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -167.97 131.84 1.68 Allowed 'General case' 0 N--CA 1.514 2.747 0 O-C-N 121.31 -0.869 . . . . 0.0 109.161 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.863 ' CB ' ' HB2' ' A' ' 109' ' ' LYS . 0.8 OUTLIER -134.14 138.27 45.09 Favored 'General case' 0 C--N 1.28 -2.436 0 C-N-CA 117.428 -1.709 . . . . 0.0 113.595 -177.69 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -143.59 135.66 26.73 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 122.912 1.339 . . . . 0.0 112.248 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.63 ' HB ' ' CG2' ' A' ' 107' ' ' THR 0.277 0.0 OUTLIER -111.13 134.76 52.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 114.182 -1.372 . . . . 0.0 111.808 -178.863 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -131.61 -176.56 4.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.819 -1.176 . . . . 0.0 109.022 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.591 ' O ' ' HB2' ' A' ' 124' ' ' HIS . 5.7 p -106.34 -21.93 12.96 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.342 -1.474 . . . . 0.0 110.824 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.591 ' HB2' ' O ' ' A' ' 123' ' ' THR . 0.3 OUTLIER 67.09 -74.52 0.07 Allowed 'General case' 0 N--CA 1.513 2.717 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.596 ' CB ' ' CG1' ' A' ' 29' ' ' ILE . . . -122.07 146.91 46.74 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.07 -1.019 . . . . 0.0 111.268 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.5 mmmm -132.54 86.04 2.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.278 -0.889 . . . . 0.0 110.406 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.613 ' HB ' ' HB2' ' A' ' 101' ' ' SER . 1.0 OUTLIER -90.33 119.58 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.169 -1.582 . . . . 0.0 111.203 179.476 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.494 ' HD3' ' O ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -169.48 150.87 4.27 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.98 -0.45 . . . . 0.0 111.089 179.142 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.468 ' C ' ' O ' ' A' ' 128' ' ' ARG . 3.7 m-20 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.84 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.254 0.55 . . . . 0.0 110.261 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.47 ' O ' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER 176.79 169.25 0.51 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.185 -0.947 . . . . 0.0 110.786 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.568 ' CG1' ' HA ' ' A' ' 22' ' ' HIS . 1.4 m -145.19 177.66 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 O-C-N 120.758 -1.214 . . . . 0.0 108.118 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.48 ' O ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -79.62 137.78 37.22 Favored 'General case' 0 CA--C 1.479 -1.761 0 C-N-CA 117.978 -1.489 . . . . 0.0 108.521 177.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.482 ' O ' ' HG2' ' A' ' 6' ' ' LYS 0.429 0.4 OUTLIER -166.16 168.67 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 C-N-CA 118.033 -1.467 . . . . 0.0 110.814 -169.785 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -147.37 137.13 22.91 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 123.664 1.697 . . . . 0.0 112.312 -179.466 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.273 0.8 OUTLIER -80.17 146.28 31.87 Favored 'General case' 0 C--N 1.267 -2.987 0 CA-C-N 113.378 -1.737 . . . . 0.0 109.71 178.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.658 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.4 p -137.31 15.9 2.98 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.958 -1.089 . . . . 0.0 109.303 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.584 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -125.54 -85.26 0.63 Allowed 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.706 -1.197 . . . . 0.0 109.941 -177.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.565 ' O ' ' N ' ' A' ' 12' ' ' GLU . 2.3 t30 -159.95 65.23 0.35 Allowed 'General case' 0 C--N 1.265 -3.07 0 C-N-CA 118.219 -1.392 . . . . 0.0 112.174 177.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.474 ' C ' ' O ' ' A' ' 10' ' ' ASN . 28.8 m170 33.79 31.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.777 0.799 . . . . 0.0 110.807 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.1 OUTLIER -90.51 23.26 3.07 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.908 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.618 ' CG2' ' N ' ' A' ' 14' ' ' LYS 0.28 0.0 OUTLIER -119.22 -168.75 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-O 121.978 0.894 . . . . 0.0 110.733 -178.616 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.618 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 7.0 ptpt -162.54 -44.31 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.994 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.553 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 28.9 tttp -149.0 139.02 22.11 Favored 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 116.556 -2.057 . . . . 0.0 113.28 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.449 HG11 ' CB ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -133.21 107.41 11.29 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-O 122.841 1.305 . . . . 0.0 110.21 179.029 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 mt -106.77 129.25 54.67 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.124 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.532 ' CG1' ' HD2' ' A' ' 19' ' ' PRO . 11.9 t -141.41 144.84 35.5 Favored Pre-proline 0 C--N 1.294 -1.816 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.949 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.532 ' HD2' ' CG1' ' A' ' 18' ' ' VAL . 46.9 Cg_endo -71.26 112.77 3.41 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.725 1.381 . . . . 0.0 111.42 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.474 ' C ' ' HB3' ' A' ' 27' ' ' CYS . . . 128.86 -84.95 0.32 Allowed Glycine 0 N--CA 1.488 2.148 0 C-N-CA 119.486 -1.34 . . . . 0.0 109.775 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.561 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 3.5 m -74.56 108.76 7.53 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.596 -0.943 . . . . 0.0 110.12 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.568 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 1.0 OUTLIER -121.75 17.59 11.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.037 -1.664 . . . . 0.0 110.887 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.43 -156.34 21.91 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 118.43 -1.843 . . . . 0.0 110.877 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.53 -9.89 30.16 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.943 -1.327 . . . . 0.0 109.722 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.784 ' CB ' ' CD ' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -64.07 178.27 0.45 Allowed Pre-proline 0 C--N 1.295 -1.795 0 CA-C-O 125.034 2.35 . . . . 0.0 114.562 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.784 ' CD ' ' CB ' ' A' ' 25' ' ' GLU . 20.9 Cg_endo -104.05 113.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.264 -3.917 1 C-N-CA 127.524 5.483 . . . . 0.0 109.057 -177.126 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.561 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 1.7 p -94.75 107.19 19.2 Favored 'General case' 0 N--CA 1.505 2.295 0 CA-C-O 123.068 1.413 . . . . 0.0 112.366 -177.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.404 HG23 ' O ' ' A' ' 28' ' ' ILE 0.303 33.5 mm -79.94 61.14 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-N 113.816 -1.538 . . . . 0.0 109.249 178.696 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.617 ' CG2' ' CB ' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -43.39 129.98 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-O 122.845 1.307 . . . . 0.0 110.285 -179.138 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.504 ' O ' ' O ' ' A' ' 31' ' ' ARG . 19.0 m80 -65.49 -86.82 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 114.53 -1.213 . . . . 0.0 112.39 -177.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.509 ' O ' HD11 ' A' ' 29' ' ' ILE . 48.6 mtt-85 -43.36 165.83 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.46 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.417 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.852 ' HA3' ' HA ' ' A' ' 96' ' ' LYS . . . -62.88 -88.46 0.04 OUTLIER Glycine 0 C--N 1.297 -1.631 0 C-N-CA 118.062 -2.018 . . . . 0.0 108.922 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.57 ' HB2' HG21 ' A' ' 94' ' ' VAL . 1.5 mmmp? -126.21 89.87 51.35 Favored Pre-proline 0 C--O 1.22 -0.448 0 CA-C-N 120.83 2.315 . . . . 0.0 115.734 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.569 ' CD ' ' CD1' ' A' ' 29' ' ' ILE . 60.8 Cg_endo -109.32 141.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.29 -2.515 0 C-N-CA 124.673 3.582 . . . . 0.0 108.743 177.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.554 ' CD1' ' C ' ' A' ' 34' ' ' PRO . 1.0 OUTLIER -124.14 98.22 5.68 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 118.075 -1.45 . . . . 0.0 110.311 179.358 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.561 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 26.3 mp0 -114.15 81.28 1.51 Allowed 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.522 HD21 ' NE2' ' A' ' 124' ' ' HIS . 3.4 pp -113.07 142.46 45.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.674 -1.266 . . . . 0.0 110.181 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -140.47 138.01 34.31 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 122.595 1.188 . . . . 0.0 108.451 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 87' ' ' ASP . . . -142.07 153.11 43.93 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-O 123.03 1.395 . . . . 0.0 113.292 -176.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.561 ' CG1' ' HB3' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -110.41 141.21 26.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 113.697 -1.592 . . . . 0.0 109.007 178.47 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.578 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 3.5 p90 -155.79 121.78 5.06 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 8.8 tt0 -68.22 156.38 37.73 Favored 'General case' 0 C--N 1.287 -2.125 0 O-C-N 120.35 -1.469 . . . . 0.0 109.178 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.561 ' HB1' ' CE2' ' A' ' 86' ' ' TYR . . . -92.22 136.36 33.25 Favored 'General case' 0 C--N 1.269 -2.921 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.807 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.537 ' C ' ' HG2' ' A' ' 45' ' ' GLN . 0.3 OUTLIER -116.65 49.73 1.13 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 125.376 2.512 . . . . 0.0 113.78 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.583 ' N ' ' CG ' ' A' ' 82' ' ' LYS . 6.4 pt20 166.59 -158.35 0.01 OUTLIER 'General case' 0 C--N 1.258 -3.401 0 CA-C-N 108.999 -3.728 . . . . 0.0 112.97 175.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.417 ' H ' ' HB2' ' A' ' 45' ' ' GLN 0.285 28.7 t-20 -109.99 154.78 22.69 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-O 122.596 1.188 . . . . 0.0 108.97 -178.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.632 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.1 OUTLIER -172.85 150.97 2.15 Favored 'General case' 0 C--N 1.255 -3.535 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.202 -178.275 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.672 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -112.28 11.16 20.1 Favored 'General case' 0 N--CA 1.506 2.371 0 C-N-CA 118.16 -1.416 . . . . 0.0 110.185 178.406 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.559 ' CG2' ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.61 145.49 3.81 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 120.706 -1.246 . . . . 0.0 111.069 178.6 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.488 ' O ' ' O ' ' A' ' 70' ' ' PRO . . . -139.73 95.13 2.86 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-O 122.988 1.375 . . . . 0.0 109.544 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -65.92 -178.27 0.57 Allowed 'General case' 0 C--N 1.281 -2.374 0 CA-C-N 113.836 -1.529 . . . . 0.0 109.711 178.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.755 ' CG1' ' HA ' ' A' ' 70' ' ' PRO . 35.7 mt -142.14 144.18 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.357 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.497 ' O ' HG11 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -140.52 104.01 4.66 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 123.425 1.583 . . . . 0.0 109.75 178.397 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.751 ' HA ' ' CG1' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -93.06 126.29 45.51 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 CA-C-N 112.503 -2.135 . . . . 0.0 107.301 179.252 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.505 ' N ' HD12 ' A' ' 54' ' ' ILE . 0.5 OUTLIER -129.86 149.84 51.42 Favored 'General case' 0 C--N 1.272 -2.802 0 C-N-CA 118.448 -1.301 . . . . 0.0 108.145 178.836 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.524 ' HB1' ' CG2' ' A' ' 63' ' ' VAL . . . -135.58 127.46 29.41 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 117.694 -1.603 . . . . 0.0 111.475 -178.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.684 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 2.2 p -101.3 100.3 10.78 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 177.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.733 ' HA ' ' CG2' ' A' ' 104' ' ' VAL . 0.8 OUTLIER -115.47 102.4 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.738 0 CA-C-O 123.089 1.423 . . . . 0.0 110.983 -176.613 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 103' ' ' ASN . 0.1 OUTLIER 38.28 64.95 0.65 Allowed 'General case' 0 N--CA 1.521 3.121 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.326 179.055 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.53 -13.66 7.91 Favored Glycine 0 N--CA 1.489 2.176 0 O-C-N 121.263 -0.898 . . . . 0.0 111.311 177.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.492 ' HB3' HG13 ' A' ' 58' ' ' ILE 0.278 0.3 OUTLIER -108.14 54.88 0.65 Allowed 'General case' 0 C--N 1.294 -1.841 0 O-C-N 121.205 -1.173 . . . . 0.0 111.495 -178.528 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.584 ' HG3' ' O ' ' A' ' 62' ' ' GLU 0.366 0.0 OUTLIER -59.4 117.5 4.91 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 122.527 1.156 . . . . 0.0 111.397 -179.531 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.524 ' CG2' ' HB1' ' A' ' 56' ' ' ALA . 18.8 m -80.19 148.22 5.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-O 122.56 1.172 . . . . 0.0 111.103 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.441 5.9 t70 -137.8 82.11 1.9 Allowed 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.319 -176.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.531 ' CG2' ' HD2' ' A' ' 66' ' ' PRO . 9.8 p -164.23 151.46 10.25 Favored Pre-proline 0 C--N 1.277 -2.565 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.427 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 65' ' ' VAL . 45.5 Cg_endo -85.43 139.14 6.72 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 CA-C-O 123.643 1.435 . . . . 0.0 111.719 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.588 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -127.66 48.08 0.99 Allowed Glycine 0 N--CA 1.501 3.02 0 CA-C-N 112.69 -2.05 . . . . 0.0 110.77 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.529 ' CD1' ' HA ' ' A' ' 90' ' ' TYR 0.302 5.8 tp 179.68 -174.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 CA-C-N 119.476 1.638 . . . . 0.0 110.024 -178.607 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.585 ' OD2' ' CZ ' ' A' ' 75' ' ' TYR . 1.1 t70 -109.71 84.25 3.18 Favored Pre-proline 0 N--CA 1.504 2.252 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 175.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.755 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 21.0 Cg_endo -48.92 -9.64 0.1 OUTLIER 'Trans proline' 0 C--N 1.279 -3.097 0 C-N-CA 123.556 2.837 . . . . 0.0 115.312 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.527 ' HB2' ' NE2' ' A' ' 74' ' ' HIS . 1.2 m120 -105.42 83.8 2.01 Favored 'General case' 0 C--N 1.287 -2.151 0 O-C-N 120.212 -1.555 . . . . 0.0 108.699 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.601 ' HA ' ' CD1' ' A' ' 75' ' ' TYR . . . -78.44 10.79 2.84 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.505 -0.747 . . . . 0.0 109.402 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.61 -19.92 54.76 Favored 'General case' 0 C--N 1.317 -0.842 0 O-C-N 120.507 -1.371 . . . . 0.0 108.177 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.578 ' ND1' ' N ' ' A' ' 74' ' ' HIS . 0.1 OUTLIER -88.24 18.85 4.06 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 174.203 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.626 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.4 OUTLIER -133.18 -9.38 2.97 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.241 179.774 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.485 ' O ' ' C ' ' A' ' 77' ' ' LYS . 1.6 ptt? -162.62 128.18 3.33 Favored 'General case' 0 C--O 1.215 -0.749 0 CA-C-O 123.6 1.667 . . . . 0.0 112.859 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.578 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 0.6 OUTLIER -4.47 86.93 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 112.042 -2.345 . . . . 0.0 113.559 -178.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.506 ' HA ' HD12 ' A' ' 80' ' ' LEU 0.297 11.1 t -99.02 136.92 20.43 Favored Pre-proline 0 C--N 1.262 -3.197 0 CA-C-N 111.364 -2.653 . . . . 0.0 108.714 178.094 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.672 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 37.3 Cg_endo -78.48 165.95 81.24 Favored 'Cis proline' 0 C--N 1.312 -1.343 0 C-N-CA 123.007 -1.664 . . . . 0.0 112.906 1.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.662 ' HB3' ' CE2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -89.1 127.39 35.71 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.44 179.445 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.528 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.7 t -106.32 139.47 27.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-O 124.129 1.918 . . . . 0.0 111.616 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.583 ' CG ' ' N ' ' A' ' 45' ' ' GLN . 1.6 tmmt? -44.38 117.97 1.4 Allowed 'General case' 0 C--N 1.271 -2.842 0 CA-C-N 111.686 -2.507 . . . . 0.0 116.924 -175.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.19 -17.6 16.77 Favored Glycine 0 C--N 1.293 -1.808 0 CA-C-N 111.693 -2.503 . . . . 0.0 107.845 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 14.7 mt-30 -72.63 128.63 36.14 Favored 'General case' 0 C--N 1.277 -2.56 0 CA-C-O 123.215 1.483 . . . . 0.0 111.585 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.581 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 0.7 OUTLIER -66.47 145.87 55.18 Favored 'General case' 0 C--N 1.27 -2.859 0 CA-C-N 113.336 -1.756 . . . . 0.0 107.437 178.341 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.662 ' CE2' ' HB3' ' A' ' 80' ' ' LEU . 19.4 m-85 -142.53 124.92 15.59 Favored 'General case' 0 C--N 1.275 -2.64 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -178.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.561 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 4.5 p30 -116.93 133.29 56.2 Favored 'General case' 0 C--N 1.278 -2.543 0 CA-C-O 122.772 1.272 . . . . 0.0 110.233 -177.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.669 ' CG1' ' CD1' ' A' ' 52' ' ' ILE . 1.1 tp -108.73 159.4 8.15 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 CA-C-N 114.46 -1.246 . . . . 0.0 108.335 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.525 ' HG2' ' N ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -143.24 149.63 38.18 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 120.125 -0.63 . . . . 0.0 112.182 -176.935 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.555 ' CE1' ' HB2' ' A' ' 92' ' ' TRP . 25.5 t80 -147.22 105.62 3.79 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.421 -0.799 . . . . 0.0 110.489 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.561 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 1.1 t -123.93 110.9 15.4 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.588 ' CD1' ' O ' ' A' ' 67' ' ' GLY 0.272 0.0 OUTLIER -142.41 109.11 5.39 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.719 -176.662 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.505 ' C ' ' CG1' ' A' ' 94' ' ' VAL . 0.6 OUTLIER -77.29 153.09 34.23 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 119.735 -1.853 . . . . 0.0 109.496 -179.476 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.57 HG21 ' HB2' ' A' ' 33' ' ' LYS . 0.8 OUTLIER -154.31 175.36 3.11 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 120.682 -1.261 . . . . 0.0 108.999 -179.73 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 94' ' ' VAL . 18.3 Cg_endo -38.12 156.38 0.03 OUTLIER 'Trans proline' 0 CA--C 1.495 -1.464 0 O-C-N 123.589 1.31 . . . . 0.0 111.127 -177.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.852 ' HA ' ' HA3' ' A' ' 32' ' ' GLY . 2.4 mptt -80.12 -27.97 39.05 Favored 'General case' 0 C--N 1.285 -2.218 0 C-N-CA 116.555 -2.058 . . . . 0.0 116.04 -173.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.586 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -145.42 43.22 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 -177.348 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.512 ' N ' ' HD2' ' A' ' 99' ' ' PRO . . . -60.33 -53.27 66.49 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 120.367 -1.458 . . . . 0.0 109.736 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.665 ' C ' ' HD2' ' A' ' 100' ' ' LYS . 55.6 Cg_endo -73.67 160.78 43.3 Favored 'Trans proline' 0 CA--C 1.466 -2.904 0 O-C-N 124.145 1.603 . . . . 0.0 111.13 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.722 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -110.27 106.37 15.75 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 112.236 -2.256 . . . . 0.0 111.104 -169.392 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.595 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 1.5 p -40.88 95.32 0.01 OUTLIER 'General case' 0 N--CA 1.519 3.021 0 CA-C-O 123.496 1.617 . . . . 0.0 110.469 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.581 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.387 84.7 mt-10 -164.93 -52.72 0.03 OUTLIER 'General case' 0 CA--C 1.448 -2.952 0 CA-C-N 112.959 -1.928 . . . . 0.0 111.214 178.468 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.486 0.8 OUTLIER -161.25 77.62 0.56 Allowed 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 110.583 -3.008 . . . . 0.0 113.466 -162.016 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.733 ' CG2' ' HA ' ' A' ' 58' ' ' ILE . 21.8 t -144.28 141.44 24.37 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.63 0 C-N-CA 119.32 -0.952 . . . . 0.0 111.907 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.547 HG11 ' CD1' ' A' ' 121' ' ' ILE . 0.3 OUTLIER -153.75 133.26 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.52 HG12 ' CD2' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -94.32 143.56 11.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-O 122.357 1.075 . . . . 0.0 110.994 -179.287 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.619 ' CG2' ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -131.75 116.65 17.56 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 179.642 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.751 ' CG1' ' HA ' ' A' ' 54' ' ' ILE . 3.5 t -132.19 139.37 50.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 O-C-N 120.247 -1.533 . . . . 0.0 108.481 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.94 ' HB2' ' HB2' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -132.96 146.49 51.83 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.364 1.078 . . . . 0.0 111.187 -178.44 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.557 ' CG2' HD12 ' A' ' 88' ' ' ILE . 2.9 t -99.94 127.8 52.47 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 178.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.481 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -108.29 121.99 46.03 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -179.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -74.62 -131.34 0.24 Allowed Glycine 0 C--N 1.283 -2.39 0 C-N-CA 119.22 -1.467 . . . . 0.0 114.625 -175.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.632 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 6.2 p-10 -97.76 9.56 42.3 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -175.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 32.7 p30 -167.17 -13.68 0.02 OUTLIER 'General case' 0 C--N 1.263 -3.156 0 C-N-CA 117.224 -1.791 . . . . 0.0 114.464 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -153.66 -88.15 0.06 OUTLIER Glycine 0 CA--C 1.475 -2.463 0 CA-C-O 125.879 2.933 . . . . 0.0 112.338 -177.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.1 p -141.51 178.93 2.39 Favored 'Isoleucine or valine' 1 C--N 1.228 -4.692 1 CA-C-N 108.155 -4.022 . . . . 0.0 111.014 -176.785 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.525 ' CB ' ' O ' ' A' ' 110' ' ' VAL . 0.1 OUTLIER -149.3 -62.72 0.23 Allowed 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.255 -179.422 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.562 ' CB ' HG13 ' A' ' 13' ' ' ILE . . . -164.15 129.66 2.91 Favored 'General case' 0 N--CA 1.51 2.526 0 O-C-N 120.872 -1.142 . . . . 0.0 109.756 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.94 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 1.5 p -133.98 134.73 42.85 Favored 'General case' 0 C--N 1.283 -2.321 0 C-N-CA 117.975 -1.49 . . . . 0.0 113.35 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -144.17 136.3 26.42 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 122.913 1.339 . . . . 0.0 112.153 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.619 ' HB ' ' CG2' ' A' ' 107' ' ' THR 0.268 0.1 OUTLIER -110.79 130.78 63.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.176 -179.495 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.542 ' N ' HD12 ' A' ' 121' ' ' ILE . . . -131.6 178.57 6.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.862 -1.149 . . . . 0.0 108.977 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.48 ' O ' ' HB2' ' A' ' 124' ' ' HIS . 15.9 p -82.61 -43.98 16.35 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.211 -1.556 . . . . 0.0 109.963 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.522 ' NE2' HD21 ' A' ' 37' ' ' LEU . 0.3 OUTLIER 59.53 107.92 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.386 0 O-C-N 121.554 -0.716 . . . . 0.0 112.224 179.327 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.617 ' CB ' ' CG2' ' A' ' 29' ' ' ILE . . . 49.89 109.71 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.41 0 O-C-N 121.731 -0.606 . . . . 0.0 111.665 178.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.47 ' O ' ' C ' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -110.23 62.46 0.6 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.809 -1.182 . . . . 0.0 108.616 178.411 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.595 ' CG2' ' HB3' ' A' ' 101' ' ' SER . 0.8 OUTLIER -31.03 130.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.668 0 CA-C-O 122.13 0.967 . . . . 0.0 112.579 -178.565 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.476 ' O ' ' C ' ' A' ' 129' ' ' ASP . 0.0 OUTLIER -169.76 150.19 3.93 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.967 178.483 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' ' 128' ' ' ARG . 3.1 m-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.869 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.455 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 1.3 m . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 121.34 0.591 . . . . 0.0 110.393 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -92.63 169.51 10.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.386 -0.821 . . . . 0.0 111.042 -179.693 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.572 ' CG1' ' HA ' ' A' ' 22' ' ' HIS . 1.4 m -145.58 177.6 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 O-C-N 120.892 -1.13 . . . . 0.0 108.032 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.469 ' O ' HG22 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -80.22 139.3 36.78 Favored 'General case' 0 CA--C 1.477 -1.864 0 C-N-CA 118.007 -1.477 . . . . 0.0 108.823 177.502 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.484 ' O ' ' HG2' ' A' ' 6' ' ' LYS 0.425 0.4 OUTLIER -168.58 160.71 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 CA-C-N 114.029 -1.442 . . . . 0.0 110.057 -170.22 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 5' ' ' VAL . 3.5 mtpt -144.44 140.12 28.77 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 123.785 1.755 . . . . 0.0 113.116 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.27 4.4 t0 -76.36 147.81 37.83 Favored 'General case' 0 C--N 1.267 -2.994 0 CA-C-N 112.932 -1.94 . . . . 0.0 109.786 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.648 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.0 p -137.04 16.01 3.04 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.968 -1.082 . . . . 0.0 109.162 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.596 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -125.03 -82.71 0.64 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.033 -176.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.574 ' O ' ' N ' ' A' ' 12' ' ' GLU . 2.4 t30 -155.79 63.56 0.59 Allowed 'General case' 0 C--N 1.267 -2.991 0 C-N-CA 118.319 -1.352 . . . . 0.0 111.81 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.478 ' C ' ' O ' ' A' ' 10' ' ' ASN . 59.2 m-70 32.02 33.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.854 0.835 . . . . 0.0 110.573 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.6 OUTLIER -95.09 22.47 6.61 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.72 -0.792 . . . . 0.0 111.591 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.601 ' CG2' ' N ' ' A' ' 14' ' ' LYS 0.276 0.2 OUTLIER -118.42 -170.36 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.413 -0.804 . . . . 0.0 110.001 -179.116 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.601 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 0.3 OUTLIER -161.86 -41.43 0.04 OUTLIER 'General case' 0 C--N 1.29 -2.011 0 O-C-N 121.731 -0.605 . . . . 0.0 111.492 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.567 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 11.6 tttm -147.72 138.13 23.08 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 115.89 -2.324 . . . . 0.0 113.145 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.516 HG12 ' CB ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -134.52 104.11 5.25 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 CA-C-O 122.897 1.332 . . . . 0.0 110.363 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 1' ' ' SER . 1.2 mt -99.52 125.65 45.32 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.776 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.552 HG13 ' CE1' ' A' ' 124' ' ' HIS . 40.5 t -141.72 145.4 36.85 Favored Pre-proline 0 N--CA 1.5 2.03 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.025 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.549 ' HD2' ' CG1' ' A' ' 18' ' ' VAL . 44.7 Cg_endo -68.64 134.87 31.6 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 O-C-N 123.772 1.406 . . . . 0.0 111.312 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.454 ' C ' ' HB3' ' A' ' 27' ' ' CYS . . . 110.48 -76.24 0.22 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.616 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 2.2 m -85.7 134.05 33.99 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.468 -1.019 . . . . 0.0 109.651 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.572 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 4.0 p80 -142.26 12.55 1.98 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 119.998 -1.689 . . . . 0.0 110.948 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.41 -154.89 13.81 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 118.364 -1.874 . . . . 0.0 110.931 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.96 -12.16 46.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.822 -1.399 . . . . 0.0 109.414 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.784 ' CB ' ' CD ' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -64.36 177.44 0.56 Allowed Pre-proline 0 C--N 1.297 -1.696 0 CA-C-O 124.974 2.321 . . . . 0.0 114.454 179.292 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.784 ' CD ' ' CB ' ' A' ' 25' ' ' GLU . 23.7 Cg_endo -106.11 117.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.263 -3.953 1 C-N-CA 127.531 5.488 . . . . 0.0 110.102 -176.53 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.616 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 1.8 p -93.42 98.18 11.04 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-O 123.357 1.551 . . . . 0.0 111.227 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.524 HG22 HD11 ' A' ' 28' ' ' ILE 0.317 36.3 mm -82.93 66.3 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 CA-C-N 113.36 -1.745 . . . . 0.0 109.663 179.328 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.513 HD11 ' CE ' ' A' ' 33' ' ' LYS . 16.4 tt -43.05 129.27 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 122.616 1.198 . . . . 0.0 109.952 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.522 ' NE2' ' NH2' ' A' ' 31' ' ' ARG . 16.3 t-160 -66.37 -87.15 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.205 -177.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.522 ' NH2' ' NE2' ' A' ' 30' ' ' HIS . 63.7 mtt180 -150.06 166.88 28.41 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.335 -0.853 . . . . 0.0 110.681 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.853 ' HA2' ' HA ' ' A' ' 96' ' ' LYS . . . 78.12 122.04 0.26 Allowed Glycine 0 C--O 1.213 -1.178 0 N-CA-C 105.887 -2.885 . . . . 0.0 105.887 -178.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.545 ' HB2' ' CG1' ' A' ' 94' ' ' VAL . 0.7 OUTLIER -117.28 96.77 49.84 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 120.66 2.23 . . . . 0.0 116.577 -175.059 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.575 ' HD3' ' O ' ' A' ' 32' ' ' GLY . 60.8 Cg_endo -107.02 145.39 0.08 OUTLIER 'Trans proline' 0 C--N 1.288 -2.631 0 C-N-CA 123.864 3.042 . . . . 0.0 108.546 176.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -120.53 96.52 5.17 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 118.582 -1.247 . . . . 0.0 109.182 179.002 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.568 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 28.0 mp0 -113.82 83.71 1.9 Allowed 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.489 HD21 ' NE2' ' A' ' 124' ' ' HIS . 2.1 pp -110.17 144.68 38.45 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.686 -1.258 . . . . 0.0 109.768 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.521 ' CB ' ' HG2' ' A' ' 89' ' ' LYS . 1.5 pp20? -140.44 139.07 35.14 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 122.7 1.238 . . . . 0.0 108.816 -178.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.516 ' CB ' HG12 ' A' ' 16' ' ' VAL . . . -142.56 148.74 38.04 Favored 'General case' 0 C--N 1.275 -2.649 0 CA-C-O 122.986 1.374 . . . . 0.0 112.968 -176.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.567 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.35 140.07 31.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 113.817 -1.538 . . . . 0.0 108.87 178.535 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.607 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 6.7 p90 -157.19 126.93 6.17 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -178.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 17.3 tt0 -70.41 156.96 38.64 Favored 'General case' 0 C--N 1.283 -2.319 0 O-C-N 120.388 -1.445 . . . . 0.0 108.815 178.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.574 ' HB1' ' CE2' ' A' ' 86' ' ' TYR . . . -89.41 136.07 33.24 Favored 'General case' 0 C--N 1.265 -3.089 0 CA-C-N 114.21 -1.359 . . . . 0.0 107.996 178.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.586 ' C ' ' HG2' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -117.43 49.93 1.16 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 125.398 2.523 . . . . 0.0 114.242 179.535 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.661 ' N ' ' HG3' ' A' ' 82' ' ' LYS . 7.0 pt20 167.54 -159.18 0.01 OUTLIER 'General case' 0 C--N 1.258 -3.393 0 CA-C-N 108.77 -3.832 . . . . 0.0 112.901 174.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.459 ' H ' ' HB2' ' A' ' 45' ' ' GLN 0.274 20.3 t-20 -108.78 153.55 23.32 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-O 122.622 1.201 . . . . 0.0 108.408 -178.884 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.618 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -172.65 154.33 3.01 Favored 'General case' 0 C--N 1.254 -3.569 0 C-N-CA 118.588 -1.245 . . . . 0.0 112.836 -178.215 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.672 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 1.2 mtpm? -115.07 7.03 15.35 Favored 'General case' 0 N--CA 1.508 2.452 0 O-C-N 120.74 -1.225 . . . . 0.0 110.926 178.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.57 ' CG2' ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.93 149.81 4.45 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.608 -1.307 . . . . 0.0 111.194 179.862 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 70' ' ' PRO . . . -150.59 109.07 3.8 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-O 122.55 1.167 . . . . 0.0 110.954 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 1.2 ptpt -77.24 -173.39 2.81 Favored 'General case' 0 N--CA 1.506 2.327 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.368 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.723 ' CG1' ' HA ' ' A' ' 70' ' ' PRO . 35.0 mt -141.84 139.92 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.368 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.419 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.505 ' O ' HG11 ' A' ' 108' ' ' VAL . 3.5 tp10 -140.79 110.03 6.22 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 123.343 1.544 . . . . 0.0 111.168 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.641 ' HA ' ' CG1' ' A' ' 108' ' ' VAL . 0.5 OUTLIER -91.12 128.59 42.82 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 CA-C-N 112.746 -2.024 . . . . 0.0 109.934 179.373 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.431 ' HD2' ' C ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -123.77 103.85 8.62 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 176.84 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.504 ' HB2' ' CG2' ' A' ' 63' ' ' VAL . . . -113.75 134.41 54.78 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 118.708 -1.197 . . . . 0.0 113.183 -175.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.651 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.1 p -106.64 100.79 10.28 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 178.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.748 ' HA ' ' CG1' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -110.68 107.84 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.939 0 CA-C-O 122.986 1.374 . . . . 0.0 110.774 -177.259 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 103' ' ' ASN . 0.5 OUTLIER 33.06 63.49 0.33 Allowed 'General case' 0 N--CA 1.519 2.992 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.977 179.634 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.72 -14.31 10.3 Favored Glycine 0 N--CA 1.489 2.2 0 O-C-N 121.352 -0.842 . . . . 0.0 111.525 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.507 ' O ' HG12 ' A' ' 58' ' ' ILE 0.274 0.3 OUTLIER -108.19 57.68 0.62 Allowed 'General case' 0 C--N 1.292 -1.897 0 O-C-N 121.087 -1.243 . . . . 0.0 111.175 -178.536 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.519 ' O ' ' CG ' ' A' ' 62' ' ' GLU 0.366 0.0 OUTLIER -58.61 114.44 2.49 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 122.1 0.952 . . . . 0.0 111.139 -179.696 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.504 ' CG2' ' HB2' ' A' ' 56' ' ' ALA . 15.0 m -74.95 144.89 11.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 122.586 1.184 . . . . 0.0 110.573 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.435 19.2 t0 -138.07 68.94 1.39 Allowed 'General case' 0 C--N 1.278 -2.526 0 CA-C-O 122.621 1.2 . . . . 0.0 110.572 -176.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.529 ' CG2' ' HD2' ' A' ' 66' ' ' PRO . 4.8 p -164.03 151.89 10.87 Favored Pre-proline 0 C--N 1.272 -2.797 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.952 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.529 ' HD2' ' CG2' ' A' ' 65' ' ' VAL . 43.4 Cg_endo -83.26 137.84 8.49 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 CA-C-O 123.804 1.502 . . . . 0.0 111.719 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -125.19 50.14 0.88 Allowed Glycine 0 C--N 1.273 -2.963 0 CA-C-N 112.461 -2.154 . . . . 0.0 110.253 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.563 ' HB ' ' CD2' ' A' ' 90' ' ' TYR 0.304 6.4 tp -178.78 -176.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 O-C-N 120.532 -1.569 . . . . 0.0 110.061 -178.56 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.504 ' HA ' ' HD2' ' A' ' 70' ' ' PRO . 29.9 t0 -112.35 83.64 5.45 Favored Pre-proline 0 N--CA 1.502 2.154 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 175.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.723 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 19.1 Cg_endo -47.68 -8.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.289 -2.601 0 C-N-CA 124.275 3.317 . . . . 0.0 115.826 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.577 ' CB ' ' NE2' ' A' ' 74' ' ' HIS . 2.4 m-80 -101.62 90.41 4.04 Favored 'General case' 0 C--N 1.286 -2.167 0 O-C-N 120.2 -1.562 . . . . 0.0 109.74 -178.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.76 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . . . -78.02 7.14 6.52 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.295 -0.878 . . . . 0.0 109.478 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.9 t -79.11 -26.58 42.9 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 121.034 -1.041 . . . . 0.0 109.044 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.577 ' NE2' ' CB ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -79.71 6.78 9.9 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.895 -1.122 . . . . 0.0 108.943 177.217 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.76 ' CD2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -133.68 -0.48 3.17 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 121.364 -0.835 . . . . 0.0 109.966 177.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.522 ' HE1' ' CD2' ' A' ' 80' ' ' LEU . 2.6 ptt? -150.34 126.81 10.79 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 123.89 1.805 . . . . 0.0 112.86 178.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.525 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -20.07 95.25 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 112.006 -2.361 . . . . 0.0 113.159 -178.255 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.493 ' HA ' ' CD1' ' A' ' 80' ' ' LEU 0.311 0.5 OUTLIER -100.77 144.47 28.58 Favored Pre-proline 0 C--N 1.268 -2.968 0 CA-C-N 111.437 -2.62 . . . . 0.0 109.128 179.01 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.672 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 35.8 Cg_endo -81.37 168.81 68.08 Favored 'Cis proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.792 -1.753 . . . . 0.0 112.16 0.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.722 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -96.75 130.25 44.03 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.25 -179.389 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.544 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.8 t -106.35 139.41 27.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-O 124.109 1.909 . . . . 0.0 111.954 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.661 ' HG3' ' N ' ' A' ' 45' ' ' GLN . 2.3 tmpt? -42.65 120.96 1.86 Allowed 'General case' 0 C--N 1.271 -2.841 0 CA-C-N 111.902 -2.408 . . . . 0.0 115.955 -175.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.35 -16.63 24.43 Favored Glycine 0 C--N 1.291 -1.957 0 CA-C-N 111.97 -2.377 . . . . 0.0 108.38 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 16.6 mt-30 -73.61 126.42 30.25 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-O 123.223 1.487 . . . . 0.0 111.786 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.608 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -64.04 143.18 58.07 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 113.271 -1.786 . . . . 0.0 107.539 179.084 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.659 ' CE1' ' HG ' ' A' ' 80' ' ' LEU . 18.7 m-85 -143.29 126.01 16.02 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.566 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 1.2 p-10 -117.12 132.55 56.64 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-O 122.712 1.244 . . . . 0.0 109.902 -178.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.684 ' CG1' ' CD1' ' A' ' 52' ' ' ILE . 0.9 OUTLIER -110.55 160.79 9.46 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.24 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.521 ' HG2' ' CB ' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -148.15 161.15 42.03 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-O 122.031 0.92 . . . . 0.0 113.203 -177.209 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.563 ' CD2' ' HB ' ' A' ' 68' ' ' ILE . 28.0 t80 -151.17 105.62 3.24 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.559 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.568 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 0.6 OUTLIER -122.3 111.51 17.0 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 178.806 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.577 ' CD1' ' O ' ' A' ' 67' ' ' GLY 0.271 0.3 OUTLIER -141.99 116.81 9.84 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.446 -176.824 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.3 OUTLIER -75.16 161.72 29.13 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 119.237 -2.164 . . . . 0.0 109.795 -179.014 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.545 ' CG1' ' HB2' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -151.48 165.84 16.5 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.528 ' O ' ' O ' ' A' ' 94' ' ' VAL . 19.8 Cg_endo -38.26 154.26 0.03 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.178 0 O-C-N 123.586 1.309 . . . . 0.0 110.505 -177.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.853 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 8.5 mptt -79.35 -28.15 42.03 Favored 'General case' 0 C--N 1.285 -2.228 0 C-N-CA 116.566 -2.053 . . . . 0.0 114.725 -173.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.564 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -143.41 43.07 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 CA-C-O 121.402 0.62 . . . . 0.0 112.541 -178.695 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.61 ' CB ' ' CD ' ' A' ' 99' ' ' PRO . . . -76.53 -64.48 0.48 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 120.562 -1.336 . . . . 0.0 109.903 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.671 ' C ' ' HD2' ' A' ' 100' ' ' LYS . 47.2 Cg_endo -66.13 159.87 47.48 Favored 'Trans proline' 0 CA--C 1.463 -3.057 0 O-C-N 123.94 1.495 . . . . 0.0 110.045 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.672 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -108.58 105.39 14.99 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-N 112.517 -2.129 . . . . 0.0 109.874 -169.587 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.548 ' O ' ' CG2' ' A' ' 127' ' ' ILE . 5.5 p -46.2 98.62 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 123.37 1.557 . . . . 0.0 108.195 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.593 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.402 88.1 mt-10 -164.0 -51.54 0.03 OUTLIER 'General case' 0 CA--C 1.448 -2.945 0 CA-C-N 113.195 -1.82 . . . . 0.0 111.987 -179.115 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.539 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.481 0.8 OUTLIER -159.52 78.27 0.71 Allowed 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 111.159 -2.746 . . . . 0.0 114.01 -162.073 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.748 ' CG1' ' HA ' ' A' ' 58' ' ' ILE . 28.5 t -142.31 137.8 29.45 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.875 178.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.539 ' CG1' HD13 ' A' ' 121' ' ' ILE . 22.0 t -147.14 133.93 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.53 HG12 ' NE2' ' A' ' 124' ' ' HIS . 0.3 OUTLIER -106.87 146.73 12.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-O 122.806 1.288 . . . . 0.0 113.033 -178.26 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.634 ' CG2' ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -132.86 109.57 9.71 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.432 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.641 ' CG1' ' HA ' ' A' ' 54' ' ' ILE . 3.9 t -127.07 144.88 35.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 119.954 -1.716 . . . . 0.0 109.043 -177.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.976 ' HB2' ' HB2' ' A' ' 119' ' ' CYS . 0.1 OUTLIER -136.48 143.05 43.61 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.137 0.97 . . . . 0.0 111.571 -178.018 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.575 ' CG2' HD12 ' A' ' 88' ' ' ILE . 20.9 t -96.28 130.97 44.2 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.612 ' CG ' ' HA2' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -110.69 119.53 39.45 Favored 'General case' 0 N--CA 1.509 2.506 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -178.717 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -81.69 -140.41 3.12 Favored Glycine 0 N--CA 1.5 2.946 0 C-N-CA 119.449 -1.357 . . . . 0.0 115.195 -174.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.618 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 4.4 p-10 -82.38 -6.44 59.27 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 122.267 1.032 . . . . 0.0 112.743 -176.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -128.86 -5.24 5.1 Favored 'General case' 0 C--N 1.262 -3.218 0 CA-C-O 121.747 0.784 . . . . 0.0 110.3 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.612 ' HA2' ' CG ' ' A' ' 111' ' ' MET . . . 94.43 85.3 1.64 Allowed Glycine 0 CA--C 1.471 -2.662 0 CA-C-O 124.595 2.219 . . . . 0.0 110.871 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.611 ' CB ' ' O ' ' A' ' 115' ' ' GLY . 7.5 p 137.11 153.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.251 -3.695 0 CA-C-N 108.409 -3.895 . . . . 0.0 112.451 176.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.555 ' CB ' ' O ' ' A' ' 110' ' ' VAL . 0.2 OUTLIER -160.94 -59.97 0.06 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.284 0.564 . . . . 0.0 110.232 179.376 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.539 ' CB ' HG13 ' A' ' 13' ' ' ILE . . . -170.86 130.1 0.8 Allowed 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.204 -0.935 . . . . 0.0 109.085 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.976 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 0.9 OUTLIER -132.92 131.68 41.15 Favored 'General case' 0 C--N 1.28 -2.455 0 C-N-CA 117.769 -1.573 . . . . 0.0 112.52 -178.131 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.455 ' HB1' ' CD1' ' A' ' 13' ' ' ILE . . . -143.05 138.22 29.79 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 123.105 1.431 . . . . 0.0 111.866 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.634 ' HB ' ' CG2' ' A' ' 107' ' ' THR 0.274 0.0 OUTLIER -111.03 132.39 59.65 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 113.891 -1.504 . . . . 0.0 111.634 -178.837 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -131.28 -178.03 4.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.936 -1.102 . . . . 0.0 109.022 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.549 ' O ' ' HB2' ' A' ' 124' ' ' HIS . 12.9 p -93.43 -30.69 14.94 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.365 -1.459 . . . . 0.0 111.1 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.552 ' CE1' HG13 ' A' ' 18' ' ' VAL . 0.3 OUTLIER 63.44 -57.79 0.18 Allowed 'General case' 0 N--CA 1.508 2.468 0 O-C-N 121.499 -0.751 . . . . 0.0 112.07 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 123' ' ' THR . . . -158.29 115.31 2.86 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.653 -1.279 . . . . 0.0 111.633 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -130.74 -174.16 3.29 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 120.84 -1.162 . . . . 0.0 108.043 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.548 ' CG2' ' O ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -153.72 137.21 8.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 120.893 -1.129 . . . . 0.0 112.391 -179.391 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.474 ' HD3' ' O ' ' A' ' 127' ' ' ILE . 1.3 tpp180 -168.94 151.48 4.89 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.011 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 128' ' ' ARG . 4.4 m-20 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.581 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 4.6 m . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.159 0.504 . . . . 0.0 110.424 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.473 ' OE1' ' N ' ' A' ' 2' ' ' GLN . 0.5 OUTLIER 62.31 157.06 0.05 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.405 -0.809 . . . . 0.0 111.418 179.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.545 ' HA ' ' C ' ' A' ' 22' ' ' HIS . 1.5 m -147.41 178.51 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.446 ' O ' HG22 ' A' ' 3' ' ' VAL . 7.1 t0 -80.01 137.17 36.76 Favored 'General case' 0 CA--C 1.473 -1.999 0 C-N-CA 117.509 -1.677 . . . . 0.0 108.681 177.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.5 ' C ' ' CG ' ' A' ' 6' ' ' LYS 0.434 0.4 OUTLIER -167.49 178.81 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.101 -169.795 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.534 ' HB2' ' CG2' ' A' ' 121' ' ' ILE . 19.4 mtpt -153.31 132.68 12.83 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 123.657 1.694 . . . . 0.0 112.46 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.264 2.2 t70 -71.95 146.5 47.73 Favored 'General case' 0 C--N 1.267 -3.014 0 CA-C-N 113.42 -1.718 . . . . 0.0 109.224 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.657 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.8 p -137.32 16.07 2.98 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.03 -1.044 . . . . 0.0 109.519 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.593 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -125.3 -84.91 0.64 Allowed 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 118.815 -1.154 . . . . 0.0 110.024 -176.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 12' ' ' GLU . 2.7 t30 -158.74 65.1 0.42 Allowed 'General case' 0 C--N 1.266 -3.04 0 C-N-CA 118.249 -1.38 . . . . 0.0 112.529 177.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.608 ' CG ' ' O ' ' A' ' 11' ' ' HIS . 30.1 t-80 36.44 30.79 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 122.053 0.93 . . . . 0.0 110.266 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.539 ' CG ' ' OD1' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -92.07 21.99 4.66 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.403 -0.811 . . . . 0.0 111.847 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.608 ' CG2' ' N ' ' A' ' 14' ' ' LYS 0.268 0.0 OUTLIER -120.1 -170.31 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 122.151 0.977 . . . . 0.0 111.133 -178.794 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.608 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 0.8 OUTLIER -162.59 -48.07 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.223 -179.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.608 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 20.5 tttp -142.28 135.8 29.13 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 116.436 -2.106 . . . . 0.0 112.621 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.543 HG11 ' CB ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -133.2 102.75 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 122.903 1.335 . . . . 0.0 110.928 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.41 ' HG ' ' NZ ' ' A' ' 15' ' ' LYS . 0.6 OUTLIER -92.56 126.11 37.5 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 114.096 -1.411 . . . . 0.0 111.52 178.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.453 HG21 ' HA ' ' A' ' 37' ' ' LEU . 59.6 t -142.85 140.96 18.84 Favored Pre-proline 0 N--CA 1.498 1.973 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.347 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.413 ' HD2' HG11 ' A' ' 18' ' ' VAL . 47.7 Cg_endo -70.72 132.73 22.35 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.629 1.331 . . . . 0.0 111.039 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 118.3 -75.37 0.29 Allowed Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.564 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 1.9 m -91.16 139.27 30.91 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.541 -0.976 . . . . 0.0 110.192 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.545 ' C ' ' HA ' ' A' ' 3' ' ' VAL . 7.2 p80 -139.66 6.38 2.26 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.112 -1.617 . . . . 0.0 110.774 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.21 -152.53 9.39 Favored Glycine 0 N--CA 1.489 2.224 0 C-N-CA 118.506 -1.807 . . . . 0.0 111.126 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.39 -9.49 25.56 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.755 -1.438 . . . . 0.0 109.909 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.777 ' CB ' ' HD3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -64.07 176.99 0.58 Allowed Pre-proline 0 C--N 1.296 -1.758 0 CA-C-O 125.006 2.336 . . . . 0.0 114.54 179.797 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.777 ' HD3' ' CB ' ' A' ' 25' ' ' GLU . 22.8 Cg_endo -105.69 115.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.265 -3.865 1 C-N-CA 127.463 5.442 . . . . 0.0 110.162 -176.322 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.564 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 4.3 p -102.6 100.37 10.44 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-O 123.079 1.419 . . . . 0.0 111.603 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.439 ' O ' ' C ' ' A' ' 29' ' ' ILE 0.315 34.4 mm -82.95 73.74 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 CA-C-N 113.798 -1.546 . . . . 0.0 108.974 178.272 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.439 ' C ' ' O ' ' A' ' 28' ' ' ILE . 13.1 tt -40.53 119.33 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-O 122.911 1.339 . . . . 0.0 109.77 -178.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.599 ' CD2' ' O ' ' A' ' 30' ' ' HIS . 33.0 p-80 -66.82 48.51 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.148 -1.387 . . . . 0.0 112.524 -177.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.564 ' HB2' ' O ' ' A' ' 30' ' ' HIS . 14.9 mtt180 62.06 169.9 0.12 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.991 -1.068 . . . . 0.0 110.479 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.814 ' HA2' ' HA ' ' A' ' 96' ' ' LYS . . . 79.76 120.26 0.35 Allowed Glycine 0 C--N 1.305 -1.149 0 N-CA-C 105.321 -3.112 . . . . 0.0 105.321 -178.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.555 ' HB2' HG21 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -118.26 97.07 50.52 Favored Pre-proline 0 C--O 1.218 -0.554 0 CA-C-N 121.278 2.539 . . . . 0.0 116.927 -174.538 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.554 ' HD3' ' O ' ' A' ' 32' ' ' GLY . 62.1 Cg_endo -106.15 144.53 0.1 OUTLIER 'Trans proline' 0 C--N 1.29 -2.531 0 C-N-CA 123.754 2.969 . . . . 0.0 108.142 176.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.602 ' CE2' HG13 ' A' ' 94' ' ' VAL . 14.6 m-85 -116.11 92.46 3.9 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 119.347 -0.941 . . . . 0.0 108.868 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.548 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 25.5 mp0 -115.9 88.86 2.97 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.06 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.453 ' HA ' HG21 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -108.83 138.46 45.13 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 120.672 -1.268 . . . . 0.0 108.479 179.115 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -139.76 128.42 23.12 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.543 ' CB ' HG11 ' A' ' 16' ' ' VAL . . . -143.33 151.49 40.53 Favored 'General case' 0 C--N 1.274 -2.678 0 CA-C-O 123.212 1.482 . . . . 0.0 113.801 -175.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.608 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -112.49 140.61 31.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 113.627 -1.624 . . . . 0.0 107.862 177.623 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.59 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 4.0 p90 -156.54 123.04 5.06 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -177.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 14.9 tt0 -68.07 154.84 40.83 Favored 'General case' 0 C--N 1.288 -2.087 0 O-C-N 120.425 -1.422 . . . . 0.0 108.521 178.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.587 ' HB1' ' CE2' ' A' ' 86' ' ' TYR . . . -90.47 131.61 36.12 Favored 'General case' 0 C--N 1.265 -3.082 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.821 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.54 ' C ' ' HG2' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -113.66 49.87 0.95 Allowed 'General case' 0 CA--C 1.482 -1.654 0 CA-C-O 125.508 2.575 . . . . 0.0 113.847 179.221 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.649 ' N ' ' HG3' ' A' ' 82' ' ' LYS . 5.7 pt20 167.0 -158.61 0.01 OUTLIER 'General case' 0 C--N 1.259 -3.344 0 CA-C-N 108.732 -3.849 . . . . 0.0 112.796 174.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.411 ' H ' ' HB2' ' A' ' 45' ' ' GLN 0.278 16.7 t-20 -110.11 155.63 21.66 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-O 122.64 1.209 . . . . 0.0 108.959 -178.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.627 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -172.36 154.57 3.27 Favored 'General case' 0 C--N 1.254 -3.574 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.511 -178.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.657 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 9.5 mtpt -112.36 5.8 18.4 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 120.763 -1.211 . . . . 0.0 110.996 178.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.562 ' CG2' ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.15 147.84 4.73 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.417 -1.427 . . . . 0.0 111.351 179.19 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 111' ' ' MET . . . -138.51 98.06 3.5 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-O 122.757 1.265 . . . . 0.0 110.481 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 0.9 OUTLIER -69.3 -179.71 1.71 Allowed 'General case' 0 N--CA 1.505 2.321 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.138 178.511 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.718 ' CG1' ' HA ' ' A' ' 70' ' ' PRO . 23.7 mt -141.6 136.72 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.514 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.418 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.499 ' O ' HG11 ' A' ' 108' ' ' VAL . 5.5 tp10 -142.61 113.44 7.49 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 123.276 1.512 . . . . 0.0 111.807 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.63 ' HA ' ' CG1' ' A' ' 108' ' ' VAL . 0.5 OUTLIER -88.93 126.96 41.97 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 CA-C-N 112.783 -2.008 . . . . 0.0 109.012 178.283 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -119.81 97.43 5.62 Favored 'General case' 0 C--N 1.278 -2.518 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 177.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.534 ' HB2' ' CG2' ' A' ' 63' ' ' VAL . . . -110.1 127.37 54.84 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.126 -1.03 . . . . 0.0 111.79 -176.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.698 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.3 p -106.48 102.83 12.19 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.758 ' HA ' ' CG2' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -114.32 95.17 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.897 0 CA-C-O 123.531 1.634 . . . . 0.0 110.143 -177.811 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER 36.71 69.11 0.22 Allowed 'General case' 0 N--CA 1.523 3.183 0 CA-C-N 114.463 -1.244 . . . . 0.0 113.58 179.37 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.54 -22.03 12.11 Favored Glycine 0 N--CA 1.488 2.113 0 O-C-N 121.136 -0.977 . . . . 0.0 111.864 176.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.531 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.265 0.4 OUTLIER -107.96 57.84 0.62 Allowed 'General case' 0 C--N 1.292 -1.919 0 O-C-N 121.137 -1.213 . . . . 0.0 111.877 -178.137 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.514 ' O ' ' CG ' ' A' ' 62' ' ' GLU 0.372 0.0 OUTLIER -67.97 113.59 5.79 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 122.035 0.922 . . . . 0.0 110.944 -179.573 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.534 ' CG2' ' HB2' ' A' ' 56' ' ' ALA . 10.2 m -78.91 145.6 9.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 122.612 1.196 . . . . 0.0 110.852 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.529 ' C ' ' CG2' ' A' ' 65' ' ' VAL 0.434 7.3 t70 -137.89 59.27 1.66 Allowed 'General case' 0 C--N 1.28 -2.444 0 CA-C-O 122.855 1.312 . . . . 0.0 110.897 -176.156 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.529 ' CG2' ' C ' ' A' ' 64' ' ' ASP . 1.4 t -157.28 150.41 18.6 Favored Pre-proline 0 C--N 1.271 -2.842 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.682 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.438 ' HD2' HG13 ' A' ' 65' ' ' VAL . 46.3 Cg_endo -88.04 141.53 5.21 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 CA-C-O 123.728 1.47 . . . . 0.0 111.814 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.587 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -110.83 50.36 0.78 Allowed Glycine 0 C--N 1.271 -3.075 0 CA-C-N 112.495 -2.139 . . . . 0.0 109.33 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.491 ' HB ' ' O ' ' A' ' 67' ' ' GLY 0.289 2.4 tp -179.35 -164.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 O-C-N 120.03 -1.865 . . . . 0.0 109.944 -178.158 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.533 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 11.1 t70 -114.38 85.02 10.18 Favored Pre-proline 0 N--CA 1.499 1.998 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 175.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.718 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 19.3 Cg_endo -47.52 -5.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.289 -2.583 0 C-N-CA 124.381 3.387 . . . . 0.0 115.763 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.593 ' ND2' ' N ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -109.44 93.03 4.29 Favored 'General case' 0 C--N 1.285 -2.197 0 O-C-N 119.809 -1.807 . . . . 0.0 108.843 -179.495 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.729 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . . . -78.22 12.2 2.0 Allowed 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.357 -0.84 . . . . 0.0 109.202 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.5 t -76.74 -25.26 53.29 Favored 'General case' 0 C--N 1.311 -1.104 0 O-C-N 120.904 -1.123 . . . . 0.0 108.581 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.544 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 0.6 OUTLIER -78.75 4.13 14.69 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 118.615 -1.234 . . . . 0.0 108.546 176.114 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.729 ' CD2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -135.29 7.26 3.35 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 121.344 -0.847 . . . . 0.0 109.275 177.589 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.508 ' O ' ' N ' ' A' ' 78' ' ' CYS . 1.0 OUTLIER -148.21 125.65 11.65 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 123.859 1.79 . . . . 0.0 112.555 178.763 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.529 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -32.16 91.95 0.01 OUTLIER 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 112.453 -2.158 . . . . 0.0 111.499 -178.373 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.508 ' N ' ' O ' ' A' ' 76' ' ' MET 0.311 0.1 OUTLIER -91.95 142.28 26.28 Favored Pre-proline 0 C--N 1.264 -3.126 0 CA-C-N 111.408 -2.633 . . . . 0.0 109.926 179.968 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.657 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 35.1 Cg_endo -82.54 166.41 69.59 Favored 'Cis proline' 0 C--N 1.314 -1.247 0 C-N-CA 123.094 -1.627 . . . . 0.0 111.861 0.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.676 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -93.67 129.75 39.86 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.352 -179.637 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.523 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.3 t -105.85 141.54 20.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-O 124.325 2.012 . . . . 0.0 112.697 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.649 ' HG3' ' N ' ' A' ' 45' ' ' GLN . 2.5 tmpt? -43.86 122.61 2.87 Favored 'General case' 0 C--N 1.273 -2.759 0 CA-C-N 111.556 -2.565 . . . . 0.0 115.933 -176.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.56 -13.61 35.76 Favored Glycine 0 C--N 1.291 -1.921 0 CA-C-N 111.98 -2.373 . . . . 0.0 108.472 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 11.3 mt-30 -78.74 126.8 31.21 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-O 123.207 1.479 . . . . 0.0 112.016 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.604 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 0.3 OUTLIER -63.84 142.11 58.52 Favored 'General case' 0 C--N 1.271 -2.805 0 CA-C-N 113.363 -1.744 . . . . 0.0 107.791 179.035 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.66 ' CE1' ' HG ' ' A' ' 80' ' ' LEU . 19.6 m-85 -142.74 126.12 16.65 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.534 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 28.4 p-10 -117.9 136.43 53.47 Favored 'General case' 0 C--N 1.277 -2.56 0 CA-C-O 122.745 1.26 . . . . 0.0 110.077 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.677 ' CG1' ' CD1' ' A' ' 52' ' ' ILE . 0.8 OUTLIER -113.88 160.26 13.42 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.726 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -145.63 153.54 41.15 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.522 0.677 . . . . 0.0 112.211 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.634 ' CE1' ' HB2' ' A' ' 92' ' ' TRP . 3.1 t80 -151.65 100.38 2.69 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.628 -0.67 . . . . 0.0 110.638 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.548 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 1.4 t -122.6 114.43 20.61 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-N 119.689 1.131 . . . . 0.0 108.234 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.634 ' HB2' ' CE1' ' A' ' 90' ' ' TYR 0.273 0.9 OUTLIER -143.12 112.72 6.9 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.508 -177.365 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.51 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.5 OUTLIER -74.88 157.13 35.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 119.217 -2.177 . . . . 0.0 110.321 -178.78 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.602 HG13 ' CE2' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -154.14 172.6 5.6 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.0 -1.063 . . . . 0.0 108.752 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.501 ' HD2' ' HB ' ' A' ' 94' ' ' VAL . 17.2 Cg_endo -36.1 149.5 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.133 0 O-C-N 123.502 1.264 . . . . 0.0 111.11 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.814 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 9.2 mptt -80.41 -25.67 38.89 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 117.332 -1.747 . . . . 0.0 115.152 -173.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.6 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -145.31 45.95 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 O-C-N 121.455 -0.778 . . . . 0.0 112.721 -178.084 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.563 ' N ' ' HD2' ' A' ' 99' ' ' PRO . . . -73.86 -47.07 6.8 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 120.544 -1.348 . . . . 0.0 111.325 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.661 ' C ' ' HD2' ' A' ' 100' ' ' LYS . 44.9 Cg_endo -67.73 160.16 49.44 Favored 'Trans proline' 0 CA--C 1.468 -2.813 0 CA-C-O 123.547 1.394 . . . . 0.0 111.648 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.672 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.3 OUTLIER -107.74 106.98 17.55 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 112.031 -2.35 . . . . 0.0 110.949 -169.083 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.543 ' HB3' HG23 ' A' ' 127' ' ' ILE . 2.2 p -42.12 93.72 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.912 0 CA-C-O 123.496 1.617 . . . . 0.0 110.457 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.607 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.381 46.8 mt-10 -165.35 -52.58 0.03 OUTLIER 'General case' 0 CA--C 1.449 -2.915 0 CA-C-N 113.114 -1.857 . . . . 0.0 111.897 178.198 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.484 0.8 OUTLIER -162.03 88.65 0.68 Allowed 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 111.095 -2.775 . . . . 0.0 115.011 -161.345 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.758 ' CG2' ' HA ' ' A' ' 58' ' ' ILE . 22.0 t -142.89 141.31 27.1 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.537 0 C-N-CA 118.87 -1.132 . . . . 0.0 111.961 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.59 ' CG2' ' CG2' ' A' ' 123' ' ' THR . 7.9 t -153.03 134.15 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.552 ' O ' HG12 ' A' ' 121' ' ' ILE . 0.3 OUTLIER -109.58 140.08 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-O 122.488 1.137 . . . . 0.0 112.467 -178.713 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.631 ' CG2' ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -133.13 111.29 10.8 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.55 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.63 ' CG1' ' HA ' ' A' ' 54' ' ' ILE . 6.1 t -125.82 142.06 43.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 119.821 -1.8 . . . . 0.0 108.969 -177.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.719 ' HB2' ' HB3' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -132.58 153.3 51.15 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.788 1.28 . . . . 0.0 112.937 -178.183 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.56 ' CG2' HD12 ' A' ' 88' ' ' ILE . 2.7 t -102.62 123.75 56.16 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.512 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 177.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.508 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -101.75 127.97 48.29 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -83.72 -129.42 1.63 Allowed Glycine 0 C--N 1.279 -2.638 0 C-N-CA 118.632 -1.746 . . . . 0.0 114.414 -176.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.627 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 4.1 p-10 -98.22 7.47 46.21 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -175.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 22.6 p30 -167.49 -13.04 0.02 OUTLIER 'General case' 0 C--N 1.261 -3.259 0 C-N-CA 117.429 -1.708 . . . . 0.0 114.437 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.42 ' O ' ' SD ' ' A' ' 111' ' ' MET . . . -153.85 -86.84 0.06 OUTLIER Glycine 0 CA--C 1.473 -2.57 0 CA-C-O 125.916 2.953 . . . . 0.0 111.723 -177.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.4 p -141.49 177.54 3.38 Favored 'Isoleucine or valine' 1 C--N 1.228 -4.714 1 CA-C-N 108.054 -4.073 . . . . 0.0 110.929 -177.283 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.519 ' HB3' ' O ' ' A' ' 110' ' ' VAL . 0.2 OUTLIER -145.96 -64.02 0.31 Allowed 'General case' 0 C--N 1.289 -2.064 0 O-C-N 121.793 -0.567 . . . . 0.0 110.849 -179.561 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.459 ' CB ' HG13 ' A' ' 13' ' ' ILE . . . -164.51 127.82 2.45 Favored 'General case' 0 N--CA 1.51 2.552 0 O-C-N 120.96 -1.088 . . . . 0.0 109.134 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.719 ' HB3' ' HB2' ' A' ' 109' ' ' LYS . 1.6 p -134.57 142.15 46.87 Favored 'General case' 0 C--N 1.285 -2.197 0 C-N-CA 117.823 -1.551 . . . . 0.0 113.482 -177.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.552 ' HB1' ' CD1' ' A' ' 13' ' ' ILE . . . -144.96 138.2 26.67 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 123.035 1.398 . . . . 0.0 112.11 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.631 ' HB ' ' CG2' ' A' ' 107' ' ' THR 0.284 0.0 OUTLIER -113.03 142.3 25.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 114.09 -1.413 . . . . 0.0 111.982 -178.697 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.514 ' O ' ' CG2' ' A' ' 123' ' ' THR . . . -130.96 167.65 18.65 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.983 -1.073 . . . . 0.0 108.131 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.59 ' CG2' ' CG2' ' A' ' 105' ' ' VAL . 67.7 p -154.08 -128.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.423 -1.423 . . . . 0.0 110.377 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.576 ' O ' ' N ' ' A' ' 126' ' ' LYS . 57.5 m-70 60.75 -52.91 0.09 Allowed 'General case' 0 N--CA 1.516 2.833 0 O-C-N 121.043 -1.035 . . . . 0.0 112.906 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -46.87 86.92 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.991 -1.068 . . . . 0.0 110.56 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.581 ' O ' ' O ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -110.75 55.99 0.64 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.311 -0.868 . . . . 0.0 110.089 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.581 ' O ' ' O ' ' A' ' 126' ' ' LYS . 0.6 OUTLIER 9.38 120.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.903 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -179.735 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.513 ' O ' ' C ' ' A' ' 129' ' ' ASP . 0.5 OUTLIER -167.5 147.08 5.1 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.643 -0.66 . . . . 0.0 111.338 178.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.513 ' C ' ' O ' ' A' ' 128' ' ' ARG . 3.8 m-20 . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 117.939 -1.029 . . . . 0.0 111.379 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 7.5 t . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.122 0.487 . . . . 0.0 110.151 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.513 ' CD ' ' CE ' ' A' ' 15' ' ' LYS . 10.9 mp0 58.69 165.47 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.265 -0.897 . . . . 0.0 110.97 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.528 HG11 ' HA ' ' A' ' 22' ' ' HIS 0.257 1.3 m -145.68 174.91 2.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 O-C-N 120.634 -1.291 . . . . 0.0 108.902 -179.151 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.451 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -81.83 148.13 29.0 Favored 'General case' 0 CA--C 1.477 -1.829 0 CA-C-O 122.83 1.3 . . . . 0.0 109.115 176.782 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.485 ' O ' ' HG2' ' A' ' 6' ' ' LYS 0.428 0.4 OUTLIER -164.29 -167.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 CA-C-N 113.668 -1.605 . . . . 0.0 109.589 -170.856 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 5' ' ' VAL . 2.7 mttt -156.33 146.57 21.42 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 124.065 1.888 . . . . 0.0 113.173 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.287 8.1 t70 -86.32 147.71 25.93 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-N 112.335 -2.211 . . . . 0.0 109.771 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.654 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.1 p -136.84 14.67 3.11 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.887 -1.133 . . . . 0.0 109.07 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.594 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -126.04 -84.36 0.63 Allowed 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.075 -1.05 . . . . 0.0 109.931 -177.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.538 ' ND2' ' O ' ' A' ' 10' ' ' ASN . 2.6 t30 -158.65 66.51 0.44 Allowed 'General case' 0 C--N 1.269 -2.901 0 C-N-CA 118.632 -1.227 . . . . 0.0 112.265 177.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.586 ' CG ' ' O ' ' A' ' 11' ' ' HIS . 10.2 t-160 36.27 30.84 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 121.958 0.885 . . . . 0.0 110.276 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.54 ' HB3' ' O ' ' A' ' 117' ' ' LEU . 0.4 OUTLIER -84.84 18.17 2.53 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 121.356 0.598 . . . . 0.0 111.428 -179.553 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.601 ' CG2' ' N ' ' A' ' 14' ' ' LYS 0.281 0.1 OUTLIER -122.91 -171.69 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-O 122.04 0.924 . . . . 0.0 110.856 -178.333 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.601 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -162.21 -47.42 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.336 -179.562 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.551 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -142.71 133.24 25.06 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 116.192 -2.203 . . . . 0.0 113.317 179.116 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.525 HG13 ' CB ' ' A' ' 39' ' ' ALA . 3.2 m -131.78 107.15 12.64 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.323 0 CA-C-O 122.876 1.322 . . . . 0.0 111.498 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.75 120.54 39.36 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 114.319 -1.31 . . . . 0.0 111.302 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.584 ' HB ' ' NE2' ' A' ' 124' ' ' HIS . 16.1 t -142.72 146.07 36.56 Favored Pre-proline 0 C--N 1.295 -1.794 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.097 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.559 ' HD2' ' CG1' ' A' ' 18' ' ' VAL . 43.9 Cg_endo -69.66 132.34 23.29 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 O-C-N 123.834 1.439 . . . . 0.0 111.211 -178.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.41 -88.82 0.2 Allowed Glycine 0 N--CA 1.495 2.57 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.519 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 19.3 m -94.27 173.27 7.73 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.243 -1.151 . . . . 0.0 110.433 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.528 ' HA ' HG11 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -142.01 8.42 1.87 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.764 -1.21 . . . . 0.0 110.723 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.451 ' O ' ' HB3' ' A' ' 4' ' ' ASP . . . 173.99 -146.38 8.69 Favored Glycine 0 C--N 1.286 -2.244 0 C-N-CA 118.792 -1.67 . . . . 0.0 110.221 177.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.98 -12.65 52.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.678 -1.484 . . . . 0.0 109.35 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.787 ' CB ' ' HD3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -65.01 175.45 1.01 Allowed Pre-proline 0 C--N 1.298 -1.653 0 CA-C-O 125.054 2.359 . . . . 0.0 114.884 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.787 ' HD3' ' CB ' ' A' ' 25' ' ' GLU . 28.7 Cg_endo -109.32 127.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.266 -3.809 1 C-N-CA 127.607 5.538 . . . . 0.0 111.037 -175.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 21' ' ' CYS . 23.8 p -123.27 108.03 12.33 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 123.157 1.456 . . . . 0.0 111.304 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.442 ' O ' ' C ' ' A' ' 29' ' ' ILE 0.305 32.2 mm -68.9 72.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.856 179.166 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.538 ' CD1' ' HE3' ' A' ' 33' ' ' LYS . 6.5 tt -42.32 122.07 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 122.773 1.273 . . . . 0.0 109.091 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.505 ' CG ' ' H ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -66.65 -120.27 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.204 -177.402 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.505 ' H ' ' CG ' ' A' ' 30' ' ' HIS . 50.9 mtt85 -128.91 168.93 15.26 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.088 -1.008 . . . . 0.0 110.15 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.876 ' HA2' ' HA ' ' A' ' 96' ' ' LYS . . . 83.55 118.52 0.67 Allowed Glycine 0 C--N 1.302 -1.313 0 N-CA-C 105.329 -3.108 . . . . 0.0 105.329 -177.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.549 ' HB2' HG11 ' A' ' 94' ' ' VAL . 2.4 mmmm -118.85 98.0 50.94 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 120.761 2.281 . . . . 0.0 116.391 -174.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 32' ' ' GLY . 60.3 Cg_endo -105.17 144.71 0.11 Allowed 'Trans proline' 0 C--N 1.291 -2.477 0 C-N-CA 123.642 2.894 . . . . 0.0 108.898 177.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.526 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 3.7 m-85 -117.85 91.01 3.46 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.302 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.553 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 25.6 mp0 -113.47 79.28 1.22 Allowed 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.545 ' HB2' ' CG2' ' A' ' 18' ' ' VAL . 3.1 pp -111.68 141.57 45.12 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.851 -1.156 . . . . 0.0 109.837 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.457 ' HB3' ' HE2' ' A' ' 89' ' ' LYS . 2.2 pp20? -140.33 137.53 34.19 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.759 1.266 . . . . 0.0 108.396 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.525 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -142.65 153.31 43.32 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-O 123.137 1.446 . . . . 0.0 113.237 -176.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.551 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -109.92 141.37 25.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 113.798 -1.547 . . . . 0.0 108.133 178.242 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.582 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 3.0 p90 -156.3 121.91 4.85 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -177.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 13.4 tt0 -69.71 153.6 43.16 Favored 'General case' 0 C--N 1.285 -2.233 0 O-C-N 120.441 -1.412 . . . . 0.0 108.661 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.557 ' HB1' ' CE2' ' A' ' 86' ' ' TYR . . . -89.01 133.38 34.36 Favored 'General case' 0 C--N 1.266 -3.049 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.302 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.546 ' C ' ' HG2' ' A' ' 45' ' ' GLN . 0.4 OUTLIER -114.2 49.24 1.02 Allowed 'General case' 0 CA--C 1.484 -1.572 0 CA-C-O 125.534 2.588 . . . . 0.0 113.576 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.583 ' N ' ' CG ' ' A' ' 82' ' ' LYS . 6.7 pt20 167.1 -158.95 0.01 OUTLIER 'General case' 0 C--N 1.255 -3.514 0 CA-C-N 108.83 -3.804 . . . . 0.0 112.793 175.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.418 ' H ' ' HB2' ' A' ' 45' ' ' GLN 0.276 7.4 t30 -110.17 154.68 23.0 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-O 122.701 1.239 . . . . 0.0 108.912 -178.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.623 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -172.38 151.78 2.58 Favored 'General case' 0 C--N 1.256 -3.489 0 CA-C-N 114.667 -1.151 . . . . 0.0 112.487 -178.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.654 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -111.01 9.45 22.13 Favored 'General case' 0 N--CA 1.508 2.444 0 C-N-CA 118.507 -1.277 . . . . 0.0 110.28 178.408 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.561 ' CG2' ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.66 146.56 4.0 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 120.653 -1.279 . . . . 0.0 111.084 178.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.513 ' O ' ' O ' ' A' ' 70' ' ' PRO . . . -140.66 94.79 2.77 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-O 122.844 1.307 . . . . 0.0 109.814 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 1.3 mmtp -65.2 -179.49 0.59 Allowed 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.193 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.836 HG12 HD13 ' A' ' 88' ' ' ILE . 28.7 mt -141.65 140.19 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.446 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.501 ' O ' HG11 ' A' ' 108' ' ' VAL . 2.3 tm-20 -141.14 104.78 4.7 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 123.265 1.507 . . . . 0.0 109.733 178.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.747 ' HA ' ' CG1' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -92.11 127.64 44.23 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.458 0 CA-C-N 112.604 -2.089 . . . . 0.0 107.602 179.271 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.512 ' N ' HD12 ' A' ' 54' ' ' ILE . 3.5 ttpt -129.75 147.27 51.51 Favored 'General case' 0 C--N 1.271 -2.823 0 C-N-CA 118.45 -1.3 . . . . 0.0 108.193 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.524 ' CB ' HG21 ' A' ' 63' ' ' VAL . . . -135.54 130.35 34.44 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 117.579 -1.648 . . . . 0.0 111.565 -178.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.645 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 2.8 p -103.17 95.97 6.47 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.338 -1.726 . . . . 0.0 106.338 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.733 ' HA ' ' CG1' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -106.93 107.05 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.711 0 CA-C-O 123.008 1.385 . . . . 0.0 110.339 -176.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.641 ' N ' ' O ' ' A' ' 103' ' ' ASN . 0.4 OUTLIER 33.74 62.77 0.41 Allowed 'General case' 0 N--CA 1.519 3.002 0 CA-C-N 115.097 -0.956 . . . . 0.0 113.08 179.427 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.59 -15.54 9.48 Favored Glycine 0 N--CA 1.487 2.061 0 O-C-N 121.335 -0.853 . . . . 0.0 111.239 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.514 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.271 0.4 OUTLIER -107.99 59.05 0.61 Allowed 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.204 -1.174 . . . . 0.0 111.353 -178.486 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.519 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.373 0.0 OUTLIER -55.09 117.17 3.24 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.975 0.893 . . . . 0.0 110.79 179.902 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.541 ' CG1' HD12 ' A' ' 58' ' ' ILE . 19.0 m -79.53 143.16 12.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-O 122.741 1.258 . . . . 0.0 111.657 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.447 25.1 t0 -138.78 85.27 2.07 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.193 -176.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.56 ' CG2' ' HD2' ' A' ' 66' ' ' PRO . 12.2 p -153.62 149.73 21.78 Favored Pre-proline 0 C--N 1.277 -2.573 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.684 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.56 ' HD2' ' CG2' ' A' ' 65' ' ' VAL . 42.3 Cg_endo -71.37 138.06 32.11 Favored 'Trans proline' 0 CA--C 1.501 -1.139 0 CA-C-O 123.748 1.478 . . . . 0.0 111.073 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.651 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -110.02 -71.8 0.68 Allowed Glycine 0 N--CA 1.504 3.225 0 CA-C-N 112.587 -2.097 . . . . 0.0 112.0 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' A' ' 69' ' ' ASP . 0.8 OUTLIER -116.64 -150.66 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.013 -1.875 . . . . 0.0 109.433 -178.603 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.538 ' N ' ' CG2' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -105.81 143.29 26.57 Favored Pre-proline 0 C--N 1.295 -1.773 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 177.21 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.711 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 22.9 Cg_endo -106.21 -3.32 0.14 Allowed 'Trans proline' 0 C--N 1.274 -3.383 0 C-N-CA 123.18 2.587 . . . . 0.0 113.908 -173.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.567 ' HB2' ' NE2' ' A' ' 74' ' ' HIS . 0.4 OUTLIER -110.34 88.78 2.85 Favored 'General case' 0 C--N 1.285 -2.222 0 O-C-N 120.839 -1.163 . . . . 0.0 108.459 -179.501 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.734 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . . . -78.45 10.77 2.86 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.222 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.4 t -77.29 -26.8 52.67 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 120.947 -1.096 . . . . 0.0 108.184 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.567 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -81.19 8.37 9.02 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 118.919 -1.113 . . . . 0.0 108.343 175.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.734 ' CD2' ' HA ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -132.36 -2.52 3.48 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 121.76 -0.587 . . . . 0.0 109.939 178.163 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.484 ' CE ' ' HB2' ' A' ' 72' ' ' ALA . 1.8 ptt? -157.74 132.25 8.4 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 123.866 1.793 . . . . 0.0 113.824 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.564 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -16.29 94.29 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 111.786 -2.461 . . . . 0.0 113.276 -179.136 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 48' ' ' LYS 0.327 1.8 t -106.84 144.79 29.78 Favored Pre-proline 0 C--N 1.267 -3.003 0 CA-C-N 111.596 -2.547 . . . . 0.0 109.234 179.165 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.654 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 37.5 Cg_endo -79.95 167.82 74.06 Favored 'Cis proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.847 -1.73 . . . . 0.0 111.833 0.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.713 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -93.4 127.9 39.22 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.103 -179.423 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.516 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.3 t -105.0 140.67 22.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-O 124.207 1.956 . . . . 0.0 112.211 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.583 ' CG ' ' N ' ' A' ' 45' ' ' GLN . 1.8 tmmt? -45.08 119.42 2.01 Favored 'General case' 0 C--N 1.273 -2.741 0 CA-C-N 111.534 -2.576 . . . . 0.0 116.776 -175.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.1 -16.19 22.82 Favored Glycine 0 C--N 1.293 -1.86 0 CA-C-N 111.772 -2.467 . . . . 0.0 107.98 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 16.2 mt-30 -75.56 126.39 30.93 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-O 123.292 1.52 . . . . 0.0 111.496 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.593 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 6.1 mt-30 -65.12 144.97 56.88 Favored 'General case' 0 C--N 1.271 -2.81 0 CA-C-N 113.299 -1.773 . . . . 0.0 107.692 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.661 ' CE1' ' HG ' ' A' ' 80' ' ' LEU . 19.6 m-85 -142.56 126.7 17.45 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.512 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 1.4 p30 -117.15 132.46 56.65 Favored 'General case' 0 C--N 1.276 -2.611 0 CA-C-O 122.925 1.345 . . . . 0.0 110.358 -177.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.836 HD13 HG12 ' A' ' 52' ' ' ILE . 0.4 OUTLIER -104.79 158.55 5.57 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 CA-C-N 114.186 -1.37 . . . . 0.0 108.42 179.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.457 ' HE2' ' HB3' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -144.39 145.27 31.84 Favored 'General case' 0 C--N 1.29 -2.021 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.465 -178.293 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.575 ' CE1' ' HB2' ' A' ' 92' ' ' TRP . 12.7 t80 -145.21 108.89 4.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.171 -0.956 . . . . 0.0 109.913 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.553 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 1.2 t -127.07 111.26 13.83 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.651 ' CD1' ' O ' ' A' ' 67' ' ' GLY 0.278 0.7 OUTLIER -142.83 114.46 8.03 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.173 -177.277 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 2.4 p-10 -75.08 157.08 35.35 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 119.172 -2.205 . . . . 0.0 109.411 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.549 HG11 ' HB2' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -147.49 167.65 13.02 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.128 -0.982 . . . . 0.0 108.457 -179.158 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.524 ' O ' ' O ' ' A' ' 94' ' ' VAL . 18.3 Cg_endo -37.33 152.83 0.03 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.188 0 O-C-N 123.835 1.439 . . . . 0.0 110.677 -177.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.876 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -79.81 -25.9 40.71 Favored 'General case' 0 C--N 1.286 -2.189 0 C-N-CA 116.508 -2.077 . . . . 0.0 115.175 -173.181 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.595 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -144.9 45.47 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 O-C-N 121.517 -0.74 . . . . 0.0 112.968 -178.224 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.52 ' CB ' ' CD ' ' A' ' 99' ' ' PRO . . . -74.0 -59.4 1.79 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.53 -1.356 . . . . 0.0 110.627 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.675 ' C ' ' HD2' ' A' ' 100' ' ' LYS . 47.9 Cg_endo -67.2 160.32 48.06 Favored 'Trans proline' 0 CA--C 1.462 -3.084 0 O-C-N 123.897 1.472 . . . . 0.0 110.474 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.685 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -107.28 102.29 11.6 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 112.493 -2.139 . . . . 0.0 110.136 -169.229 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.575 ' HB2' ' CB ' ' A' ' 127' ' ' ILE . 2.5 p -42.06 97.67 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 123.592 1.663 . . . . 0.0 110.042 -178.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.561 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.389 47.8 mt-10 -164.4 -53.0 0.03 OUTLIER 'General case' 0 CA--C 1.45 -2.877 0 CA-C-N 112.963 -1.926 . . . . 0.0 111.543 178.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.641 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.483 0.8 OUTLIER -161.25 82.05 0.62 Allowed 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 110.876 -2.875 . . . . 0.0 113.911 -161.879 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.733 ' CG1' ' HA ' ' A' ' 58' ' ' ILE . 20.1 t -143.39 139.1 26.46 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.65 0 C-N-CA 118.952 -1.099 . . . . 0.0 111.912 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.552 HG22 ' CG2' ' A' ' 123' ' ' THR . 0.6 OUTLIER -142.5 132.07 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.392 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.517 ' O ' HG12 ' A' ' 121' ' ' ILE . 0.4 OUTLIER -99.1 143.46 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 122.594 1.188 . . . . 0.0 111.57 -179.028 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.636 ' CG2' ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -131.59 118.34 19.96 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 179.556 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.747 ' CG1' ' HA ' ' A' ' 54' ' ' ILE . 3.4 t -132.38 139.53 49.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 120.22 -1.55 . . . . 0.0 108.583 -178.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.863 ' HB2' ' CB ' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -130.16 154.2 47.76 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.883 1.325 . . . . 0.0 111.623 -178.63 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.655 ' CG2' ' CD1' ' A' ' 88' ' ' ILE . 2.6 t -107.69 124.54 63.83 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.58 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 177.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 1.5 tmt? -103.71 120.39 40.85 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.493 ' HA3' HD22 ' A' ' 117' ' ' LEU . . . -74.93 -131.17 0.25 Allowed Glycine 0 C--N 1.281 -2.51 0 C-N-CA 119.06 -1.543 . . . . 0.0 114.671 -175.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.623 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 4.7 p-10 -97.94 8.65 44.4 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -175.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 33.5 p-10 -167.41 -14.89 0.02 OUTLIER 'General case' 0 C--N 1.265 -3.08 0 C-N-CA 117.475 -1.69 . . . . 0.0 114.428 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.429 ' O ' ' HG2' ' A' ' 111' ' ' MET . . . -152.39 -86.74 0.06 OUTLIER Glycine 0 CA--C 1.473 -2.572 0 CA-C-O 125.937 2.965 . . . . 0.0 111.971 -177.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.2 p -141.23 178.67 2.7 Favored 'Isoleucine or valine' 1 C--N 1.228 -4.696 1 CA-C-N 108.168 -4.016 . . . . 0.0 110.807 -177.226 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.54 ' O ' ' HB3' ' A' ' 12' ' ' GLU . 0.1 OUTLIER -148.55 -61.85 0.24 Allowed 'General case' 0 C--N 1.289 -2.06 0 O-C-N 121.873 -0.517 . . . . 0.0 111.277 -179.44 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.506 ' CB ' HG13 ' A' ' 13' ' ' ILE . . . -165.35 129.85 2.42 Favored 'General case' 0 N--CA 1.512 2.669 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.543 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.863 ' CB ' ' HB2' ' A' ' 109' ' ' LYS . 1.4 p -134.52 135.44 42.37 Favored 'General case' 0 C--N 1.284 -2.266 0 C-N-CA 118.064 -1.455 . . . . 0.0 113.09 -178.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 6' ' ' LYS . . . -143.62 135.06 26.09 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 122.992 1.377 . . . . 0.0 112.599 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.636 ' HB ' ' CG2' ' A' ' 107' ' ' THR 0.272 0.0 OUTLIER -111.14 138.41 39.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 CA-C-N 114.143 -1.39 . . . . 0.0 110.961 -179.549 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.469 ' O ' HG21 ' A' ' 105' ' ' VAL . . . -131.14 159.76 36.73 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.858 -1.151 . . . . 0.0 109.062 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.552 ' CG2' HG22 ' A' ' 105' ' ' VAL . 25.6 p -94.15 -61.11 1.59 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.297 -1.502 . . . . 0.0 109.985 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.584 ' NE2' ' HB ' ' A' ' 18' ' ' VAL . 1.6 m-70 62.02 -55.77 0.13 Allowed 'General case' 0 N--CA 1.509 2.484 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.534 ' CB ' HG23 ' A' ' 29' ' ' ILE . . . -97.71 85.65 3.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.566 -1.334 . . . . 0.0 111.591 -178.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.528 ' HD3' ' HA ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -119.09 71.45 0.86 Allowed 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.794 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.575 ' CB ' ' HB2' ' A' ' 101' ' ' SER . 0.9 OUTLIER -64.52 120.99 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 O-C-N 120.669 -1.269 . . . . 0.0 111.245 -178.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.47 ' O ' ' C ' ' A' ' 129' ' ' ASP . 0.0 OUTLIER -169.55 150.0 4.04 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.139 179.059 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.47 ' C ' ' O ' ' A' ' 128' ' ' ARG . 3.2 m-20 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.835 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.172 0.511 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.472 ' C ' HG11 ' A' ' 3' ' ' VAL . 0.0 OUTLIER 61.63 166.04 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 110.828 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.543 ' CG1' ' HA ' ' A' ' 22' ' ' HIS . 1.3 m -145.22 -175.64 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.68 133.68 38.3 Favored 'General case' 0 CA--C 1.48 -1.714 0 C-N-CA 117.839 -1.544 . . . . 0.0 108.84 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.503 ' O ' ' HG2' ' A' ' 6' ' ' LYS 0.435 0.4 OUTLIER -170.14 156.48 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 113.972 -1.467 . . . . 0.0 110.058 -169.627 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -146.76 145.77 30.06 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 123.772 1.749 . . . . 0.0 113.515 -178.671 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.276 1.9 t70 -74.28 149.3 40.78 Favored 'General case' 0 C--N 1.268 -2.956 0 CA-C-N 112.792 -2.004 . . . . 0.0 109.312 177.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.632 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 5.7 p -137.33 14.44 3.01 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.852 -1.155 . . . . 0.0 109.058 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.592 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -125.5 -82.52 0.63 Allowed 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 118.962 -1.095 . . . . 0.0 109.952 -177.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 12' ' ' GLU . 2.9 t30 -157.86 66.45 0.48 Allowed 'General case' 0 C--N 1.268 -2.952 0 C-N-CA 118.684 -1.206 . . . . 0.0 111.882 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.487 ' C ' ' O ' ' A' ' 10' ' ' ASN . 49.7 m170 33.4 33.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.845 0.831 . . . . 0.0 110.468 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 10' ' ' ASN . 38.1 mt-10 -93.77 21.12 6.79 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.68 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.61 ' CG2' ' N ' ' A' ' 14' ' ' LYS 0.297 0.1 OUTLIER -124.39 -167.3 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.895 0.855 . . . . 0.0 110.056 -178.685 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.61 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 13.1 ptpt -162.15 -44.89 0.04 OUTLIER 'General case' 0 C--N 1.29 -1.997 0 O-C-N 121.792 -0.567 . . . . 0.0 111.503 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.539 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 36.4 tttt -148.49 142.57 25.97 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 115.881 -2.328 . . . . 0.0 114.21 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.4 ' CG1' ' CB ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -134.45 103.07 4.48 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 CA-C-O 122.983 1.373 . . . . 0.0 110.578 178.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.47 ' C ' HG21 ' A' ' 18' ' ' VAL . 1.3 mt -96.11 133.18 40.7 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 113.994 -1.457 . . . . 0.0 111.465 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.547 ' CG1' ' HD2' ' A' ' 19' ' ' PRO . 93.1 t -140.83 145.71 40.9 Favored Pre-proline 0 N--CA 1.499 2.018 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.514 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.547 ' HD2' ' CG1' ' A' ' 18' ' ' VAL . 45.9 Cg_endo -72.42 101.23 1.23 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.815 1.429 . . . . 0.0 110.76 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.412 ' C ' ' CB ' ' A' ' 27' ' ' CYS . . . 157.79 -92.21 0.12 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.519 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 33.0 m -83.95 162.04 20.59 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.32 -1.106 . . . . 0.0 111.196 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.543 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 1.6 p-80 -142.41 16.89 2.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.903 -1.123 . . . . 0.0 109.206 178.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 173.18 -152.8 16.67 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.12 -8.76 25.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.571 -1.547 . . . . 0.0 109.805 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.771 ' HB3' ' CD ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -64.15 176.97 0.59 Allowed Pre-proline 0 C--N 1.3 -1.563 0 CA-C-O 125.012 2.339 . . . . 0.0 115.22 -179.81 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.771 ' CD ' ' HB3' ' A' ' 25' ' ' GLU . 25.6 Cg_endo -106.51 125.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.269 -3.647 1 C-N-CA 127.866 5.711 . . . . 0.0 110.736 -176.137 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 21' ' ' CYS . 21.4 p -124.45 119.36 28.96 Favored 'General case' 0 N--CA 1.505 2.28 0 CA-C-O 123.036 1.398 . . . . 0.0 112.648 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.454 HD11 HG21 ' A' ' 28' ' ' ILE 0.315 32.2 mm -80.1 74.33 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-N 113.888 -1.506 . . . . 0.0 109.139 178.562 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.483 HD13 ' HG2' ' A' ' 34' ' ' PRO . 17.1 tt -42.84 121.74 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 122.78 1.276 . . . . 0.0 110.806 -178.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.578 ' CD2' ' HG3' ' A' ' 31' ' ' ARG . 34.8 p-80 -68.27 26.31 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 114.53 -1.213 . . . . 0.0 113.148 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.578 ' HG3' ' CD2' ' A' ' 30' ' ' HIS . 23.2 mtt85 -154.67 166.6 32.9 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.646 -1.284 . . . . 0.0 108.213 178.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.846 ' HA3' ' HA ' ' A' ' 96' ' ' LYS . . . -70.36 -94.28 0.06 OUTLIER Glycine 0 C--N 1.302 -1.348 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.567 ' HB2' HG11 ' A' ' 94' ' ' VAL . 0.6 OUTLIER -125.58 88.97 53.36 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 120.983 2.392 . . . . 0.0 115.62 -179.149 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.508 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 60.7 Cg_endo -108.13 142.35 0.06 OUTLIER 'Trans proline' 0 C--N 1.291 -2.488 0 C-N-CA 124.521 3.481 . . . . 0.0 107.719 176.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.481 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 10.1 m-85 -124.25 93.73 4.0 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 118.553 -1.259 . . . . 0.0 109.99 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.583 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 28.1 mp0 -112.8 86.22 2.32 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.521 ' HB3' HG23 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -110.33 141.33 43.51 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 120.576 -1.328 . . . . 0.0 109.093 179.294 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.92 132.49 28.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 87' ' ' ASP . . . -142.14 154.39 44.84 Favored 'General case' 0 C--N 1.271 -2.829 0 CA-C-O 123.219 1.485 . . . . 0.0 113.404 -175.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.539 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.38 141.06 26.8 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 CA-C-N 113.43 -1.714 . . . . 0.0 108.805 178.714 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.556 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 3.7 p90 -157.96 124.58 4.87 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 21.8 tt0 -69.29 154.79 41.47 Favored 'General case' 0 C--N 1.285 -2.213 0 O-C-N 120.305 -1.497 . . . . 0.0 108.606 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.566 ' HB1' ' CE2' ' A' ' 86' ' ' TYR . . . -85.69 131.39 34.34 Favored 'General case' 0 C--N 1.265 -3.068 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.447 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.587 ' C ' ' HG2' ' A' ' 45' ' ' GLN . 0.3 OUTLIER -113.8 48.79 1.04 Allowed 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 125.775 2.702 . . . . 0.0 114.358 179.816 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.587 ' HG2' ' C ' ' A' ' 44' ' ' ASN . 4.2 pt20 166.57 -161.63 0.01 OUTLIER 'General case' 0 C--N 1.26 -3.324 0 CA-C-N 108.502 -3.954 . . . . 0.0 112.845 175.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.442 ' H ' ' HB2' ' A' ' 45' ' ' GLN 0.273 60.0 t30 -110.82 151.33 27.94 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-O 122.537 1.16 . . . . 0.0 108.958 -178.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.653 ' OG1' ' HB3' ' A' ' 113' ' ' ASP 0.252 0.0 OUTLIER -173.22 151.77 2.13 Favored 'General case' 0 C--N 1.255 -3.511 0 C-N-CA 118.581 -1.248 . . . . 0.0 112.545 -178.418 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.616 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 0.8 OUTLIER -111.59 10.69 21.18 Favored 'General case' 0 N--CA 1.51 2.568 0 C-N-CA 118.194 -1.402 . . . . 0.0 110.301 178.371 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.562 ' CG2' ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -169.12 148.46 4.02 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 120.622 -1.299 . . . . 0.0 110.837 179.091 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.508 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . . . -149.74 103.8 3.27 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 122.765 1.269 . . . . 0.0 110.949 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 0.7 OUTLIER -68.86 -174.94 0.64 Allowed 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.432 178.664 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.796 HG12 HD13 ' A' ' 88' ' ' ILE . 35.7 mt -141.93 140.84 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.388 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.489 ' O ' HG11 ' A' ' 108' ' ' VAL . 5.6 tm-20 -139.92 107.58 5.62 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 123.284 1.516 . . . . 0.0 110.186 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.751 ' HA ' ' CG1' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -92.63 128.38 44.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 CA-C-N 112.644 -2.071 . . . . 0.0 107.362 178.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.537 ' N ' HD12 ' A' ' 54' ' ' ILE . 1.1 tttt -128.09 141.86 51.37 Favored 'General case' 0 C--N 1.272 -2.802 0 C-N-CA 118.75 -1.18 . . . . 0.0 107.855 178.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 62' ' ' GLU . . . -135.44 134.35 39.53 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 119.917 -1.739 . . . . 0.0 112.309 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.677 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 0.5 OUTLIER -107.22 99.5 9.04 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 177.285 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.727 ' HA ' ' CG2' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -112.12 101.41 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.803 0 CA-C-O 123.305 1.526 . . . . 0.0 110.758 -176.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.616 ' N ' ' O ' ' A' ' 103' ' ' ASN . 1.4 p30 37.59 64.36 0.66 Allowed 'General case' 0 N--CA 1.521 3.077 0 CA-C-N 114.991 -1.004 . . . . 0.0 113.06 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.73 -17.04 9.41 Favored Glycine 0 N--CA 1.488 2.114 0 O-C-N 121.264 -0.897 . . . . 0.0 111.546 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.518 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.272 0.2 OUTLIER -107.87 58.16 0.62 Allowed 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.197 -1.178 . . . . 0.0 111.576 -178.336 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.367 0.0 OUTLIER -60.01 116.75 4.38 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.958 0.885 . . . . 0.0 111.012 -179.904 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.465 ' CG2' ' CB ' ' A' ' 56' ' ' ALA . 13.8 m -75.8 146.61 8.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-O 122.547 1.165 . . . . 0.0 110.805 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.441 6.7 t70 -138.16 76.89 1.6 Allowed 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.192 -176.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.468 ' CG2' ' HD2' ' A' ' 66' ' ' PRO . 8.6 p -164.37 150.75 9.52 Favored Pre-proline 0 C--N 1.274 -2.692 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.42 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.468 ' HD2' ' CG2' ' A' ' 65' ' ' VAL . 44.6 Cg_endo -86.68 139.23 5.58 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 CA-C-O 123.887 1.536 . . . . 0.0 111.531 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.614 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -127.82 52.49 0.82 Allowed Glycine 0 C--N 1.273 -2.946 0 CA-C-N 112.498 -2.137 . . . . 0.0 110.432 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.622 ' HB ' ' CD2' ' A' ' 90' ' ' TYR 0.296 4.4 tp 179.96 -177.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 120.194 -1.768 . . . . 0.0 110.534 -178.677 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.524 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 12.9 t0 -112.3 83.47 5.26 Favored Pre-proline 0 N--CA 1.504 2.237 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 175.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.722 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 20.9 Cg_endo -48.59 -6.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.287 -2.706 0 C-N-CA 124.453 3.435 . . . . 0.0 116.245 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.554 ' HB2' ' NE2' ' A' ' 74' ' ' HIS . 5.1 m-80 -101.77 91.77 4.54 Favored 'General case' 0 C--N 1.284 -2.266 0 O-C-N 120.167 -1.583 . . . . 0.0 109.006 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.701 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . . . -76.33 7.29 4.47 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.431 -0.793 . . . . 0.0 109.52 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 8.3 t -79.05 -24.15 43.76 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 120.886 -1.134 . . . . 0.0 108.94 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.554 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 1.1 m-70 -80.1 8.11 7.85 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.022 -1.071 . . . . 0.0 109.066 176.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.701 ' CD2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -133.19 -2.83 3.13 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 121.365 -0.834 . . . . 0.0 110.217 177.547 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.488 ' CE ' HD22 ' A' ' 80' ' ' LEU . 2.4 ptt? -155.07 129.61 9.14 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 123.984 1.849 . . . . 0.0 113.678 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.465 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 13.9 pttt -21.85 102.6 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 111.89 -2.414 . . . . 0.0 113.365 -178.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 48' ' ' LYS 0.318 0.1 OUTLIER -99.04 146.64 32.03 Favored Pre-proline 0 C--N 1.265 -3.066 0 CA-C-N 111.522 -2.581 . . . . 0.0 108.79 178.609 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.616 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 37.2 Cg_endo -86.66 167.35 46.64 Favored 'Cis proline' 0 C--N 1.311 -1.412 0 C-N-CA 123.1 -1.625 . . . . 0.0 111.447 0.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.658 ' HB3' ' CE2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -90.54 125.96 35.78 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 122.02 0.914 . . . . 0.0 110.95 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.505 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.3 t -104.47 137.76 32.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-O 124.248 1.975 . . . . 0.0 111.779 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.574 ' HB2' ' C ' ' A' ' 45' ' ' GLN . 1.6 tmmt? -43.37 115.62 0.8 Allowed 'General case' 0 C--N 1.271 -2.844 0 CA-C-N 111.737 -2.483 . . . . 0.0 116.243 -175.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 118.2 -18.34 11.26 Favored Glycine 0 C--N 1.29 -1.983 0 CA-C-N 111.74 -2.482 . . . . 0.0 108.198 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.584 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 8.4 mt-30 -73.3 126.27 29.74 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-O 123.124 1.44 . . . . 0.0 111.797 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.583 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -63.3 143.03 58.15 Favored 'General case' 0 C--N 1.271 -2.818 0 CA-C-N 113.57 -1.65 . . . . 0.0 107.855 179.225 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.658 ' CE2' ' HB3' ' A' ' 80' ' ' LEU . 21.3 m-85 -143.58 127.5 17.34 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 1.4 p-10 -117.51 132.53 56.53 Favored 'General case' 0 C--N 1.277 -2.561 0 CA-C-O 122.775 1.274 . . . . 0.0 110.401 -178.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.796 HD13 HG12 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -102.31 159.98 4.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.402 179.368 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.75 144.84 32.8 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.941 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.622 ' CD2' ' HB ' ' A' ' 68' ' ' ILE . 32.3 t80 -149.02 102.36 3.25 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.772 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.583 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 0.6 OUTLIER -121.68 114.76 21.59 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 179.253 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.614 ' CD1' ' O ' ' A' ' 67' ' ' GLY 0.264 0.2 OUTLIER -141.86 108.42 5.33 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.913 -177.405 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 11.7 m120 -75.46 155.54 36.15 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 119.696 -1.878 . . . . 0.0 109.753 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.567 HG11 ' HB2' ' A' ' 33' ' ' LYS . 1.0 OUTLIER -153.79 169.98 9.07 Favored Pre-proline 0 N--CA 1.487 1.389 0 O-C-N 120.746 -1.221 . . . . 0.0 108.676 -178.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.519 ' O ' ' O ' ' A' ' 94' ' ' VAL . 17.8 Cg_endo -38.29 154.73 0.03 OUTLIER 'Trans proline' 0 CA--C 1.497 -1.332 0 O-C-N 123.424 1.223 . . . . 0.0 110.853 -177.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.846 ' HA ' ' HA3' ' A' ' 32' ' ' GLY . 3.1 mptt -80.73 -27.22 36.94 Favored 'General case' 0 C--N 1.283 -2.32 0 C-N-CA 116.622 -2.031 . . . . 0.0 116.201 -173.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.576 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -141.89 42.02 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.559 ' CB ' ' HD3' ' A' ' 99' ' ' PRO . . . -62.65 -56.93 25.08 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 120.419 -1.425 . . . . 0.0 109.562 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.689 ' C ' ' HD2' ' A' ' 100' ' ' LYS . 56.9 Cg_endo -78.12 162.78 28.53 Favored 'Trans proline' 0 CA--C 1.463 -3.063 0 O-C-N 123.896 1.472 . . . . 0.0 110.57 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.725 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.5 OUTLIER -107.21 112.43 25.3 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-N 112.095 -2.32 . . . . 0.0 110.28 -169.755 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.521 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 2.5 p -45.35 97.7 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.612 0 CA-C-O 123.606 1.669 . . . . 0.0 109.342 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.402 40.9 mt-10 -163.54 -52.01 0.04 OUTLIER 'General case' 0 CA--C 1.448 -2.975 0 CA-C-N 112.818 -1.992 . . . . 0.0 111.304 179.442 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.616 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.482 0.8 OUTLIER -160.29 79.73 0.67 Allowed 'General case' 0 C--N 1.285 -2.202 0 CA-C-N 110.949 -2.842 . . . . 0.0 113.932 -162.311 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.727 ' CG2' ' HA ' ' A' ' 58' ' ' ILE . 22.0 t -145.13 141.24 22.88 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.65 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.743 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.605 ' CG1' ' CD1' ' A' ' 121' ' ' ILE . 3.0 t -153.89 137.63 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.547 ' O ' HG12 ' A' ' 121' ' ' ILE . 0.3 OUTLIER -105.58 148.3 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 122.653 1.216 . . . . 0.0 112.675 -178.409 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.593 ' CG2' ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -132.04 118.98 20.4 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 178.099 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.751 ' CG1' ' HA ' ' A' ' 54' ' ' ILE . 3.4 t -132.54 138.72 51.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 120.186 -1.571 . . . . 0.0 108.389 -177.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.897 ' HB2' ' HB2' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -135.6 148.64 49.11 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 122.414 1.102 . . . . 0.0 111.549 -178.072 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.669 ' CG2' ' CD1' ' A' ' 88' ' ' ILE . 3.5 t -97.76 129.81 47.38 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.522 ' HG3' ' HA2' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -107.7 118.2 36.12 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.508 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -78.92 -138.13 1.43 Allowed Glycine 0 N--CA 1.498 2.778 0 C-N-CA 119.177 -1.487 . . . . 0.0 114.917 -174.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.653 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 6.8 p-10 -80.79 -3.66 51.81 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 122.275 1.036 . . . . 0.0 112.323 -176.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.403 ' OD2' ' OD1' ' A' ' 113' ' ' ASP . 1.4 p30 -133.21 -4.65 3.05 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.738 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.605 ' O ' ' CB ' ' A' ' 116' ' ' VAL . . . 92.29 85.9 1.51 Allowed Glycine 0 CA--C 1.471 -2.688 0 CA-C-O 124.797 2.332 . . . . 0.0 110.399 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.605 ' CB ' ' O ' ' A' ' 115' ' ' GLY . 7.2 p 137.9 148.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.25 -3.757 0 CA-C-N 108.27 -3.965 . . . . 0.0 111.837 177.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.538 ' CB ' ' O ' ' A' ' 110' ' ' VAL . 0.3 OUTLIER -161.45 -59.8 0.05 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.479 -0.763 . . . . 0.0 110.739 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.49 ' CB ' HG13 ' A' ' 13' ' ' ILE . . . -169.88 134.29 1.3 Allowed 'General case' 0 N--CA 1.513 2.705 0 O-C-N 121.124 -0.985 . . . . 0.0 109.489 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.897 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 0.8 OUTLIER -133.71 139.76 46.6 Favored 'General case' 0 C--N 1.28 -2.418 0 C-N-CA 117.624 -1.63 . . . . 0.0 113.744 -178.02 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -142.61 131.58 23.01 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 123.066 1.413 . . . . 0.0 111.489 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.605 ' CD1' ' CG1' ' A' ' 105' ' ' VAL 0.272 0.0 OUTLIER -108.7 131.06 60.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.613 -179.218 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -131.63 -175.04 3.58 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.827 -1.17 . . . . 0.0 108.895 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.637 ' O ' ' CG ' ' A' ' 124' ' ' HIS . 5.5 p -90.51 -65.84 0.98 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.308 -1.495 . . . . 0.0 110.307 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.637 ' CG ' ' O ' ' A' ' 123' ' ' THR . 21.2 m170 132.82 -84.88 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.253 0 C-N-CA 123.759 0.823 . . . . 0.0 110.043 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.46 ' HB2' HG23 ' A' ' 29' ' ' ILE . . . -167.7 171.71 9.89 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.383 0.611 . . . . 0.0 109.429 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -108.63 -177.08 3.22 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.521 ' CG2' ' HB3' ' A' ' 101' ' ' SER . 0.3 OUTLIER -153.22 130.07 2.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 O-C-N 120.706 -1.246 . . . . 0.0 113.061 -178.13 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.462 ' HD3' ' O ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -169.5 151.7 4.51 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.589 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.459 ' C ' ' O ' ' A' ' 128' ' ' ARG . 2.7 m-20 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.667 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.7 t . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.321 0.581 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.48 ' O ' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -47.43 169.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.321 -0.862 . . . . 0.0 111.003 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.562 ' CG1' ' HA ' ' A' ' 22' ' ' HIS . 1.3 m -145.8 174.03 3.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 O-C-N 120.884 -1.135 . . . . 0.0 107.967 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.458 ' O ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -80.82 140.05 35.66 Favored 'General case' 0 CA--C 1.478 -1.82 0 C-N-CA 117.968 -1.493 . . . . 0.0 108.66 177.31 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.484 ' O ' ' HG2' ' A' ' 6' ' ' LYS 0.422 0.4 OUTLIER -166.44 -178.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 C-N-CA 118.021 -1.472 . . . . 0.0 110.933 -170.135 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 5' ' ' VAL . 18.5 mtmt -153.69 141.65 20.24 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 123.812 1.767 . . . . 0.0 112.823 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.271 13.8 t70 -79.09 149.45 32.08 Favored 'General case' 0 C--N 1.266 -3.049 0 CA-C-N 113.032 -1.894 . . . . 0.0 109.442 178.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.642 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 7.3 p -137.27 14.26 3.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.981 -1.074 . . . . 0.0 109.529 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.614 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -126.16 -83.98 0.62 Allowed 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 119.014 -1.074 . . . . 0.0 110.17 -177.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 12' ' ' GLU . 2.4 t30 -155.97 64.73 0.58 Allowed 'General case' 0 C--N 1.269 -2.898 0 C-N-CA 118.519 -1.272 . . . . 0.0 111.62 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.473 ' C ' ' O ' ' A' ' 10' ' ' ASN . 6.2 m80 32.57 32.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.725 0.774 . . . . 0.0 110.697 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.9 OUTLIER -93.42 22.35 5.37 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.485 -0.886 . . . . 0.0 111.889 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.604 ' CG2' ' N ' ' A' ' 14' ' ' LYS 0.272 0.1 OUTLIER -116.76 -168.09 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 CA-C-O 122.027 0.918 . . . . 0.0 110.741 -179.035 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.604 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 0.1 OUTLIER -162.2 -45.46 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.732 179.831 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.552 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 28.9 tttt -146.59 136.12 22.99 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 116.116 -2.234 . . . . 0.0 113.246 178.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.534 ' CG1' ' HB3' ' A' ' 39' ' ' ALA . 0.9 OUTLIER -132.61 102.9 5.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 CA-C-O 123.041 1.4 . . . . 0.0 110.817 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.497 ' O ' HG21 ' A' ' 18' ' ' VAL . 1.4 mt -93.62 126.04 38.57 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.933 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.497 HG21 ' O ' ' A' ' 17' ' ' LEU . 75.3 t -142.52 145.08 33.07 Favored Pre-proline 0 N--CA 1.502 2.137 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.756 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.485 ' HD2' ' CG1' ' A' ' 18' ' ' VAL . 47.4 Cg_endo -72.0 137.08 28.56 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 O-C-N 123.691 1.364 . . . . 0.0 110.893 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.433 ' C ' ' HB3' ' A' ' 27' ' ' CYS . . . 112.99 -80.1 0.27 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.591 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 2.4 m -87.81 131.31 34.57 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.553 -0.969 . . . . 0.0 109.557 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.562 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 0.2 OUTLIER -137.4 14.83 2.99 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 119.905 -1.747 . . . . 0.0 110.865 179.489 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.88 -154.58 15.4 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 118.287 -1.911 . . . . 0.0 110.815 177.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.18 -10.84 34.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.819 -1.401 . . . . 0.0 109.457 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.763 ' HB3' ' CD ' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -64.11 177.01 0.58 Allowed Pre-proline 0 C--N 1.299 -1.61 0 CA-C-O 124.946 2.308 . . . . 0.0 114.431 179.546 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.763 ' CD ' ' HB3' ' A' ' 25' ' ' GLU . 24.7 Cg_endo -105.73 115.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.263 -3.969 1 C-N-CA 127.459 5.44 . . . . 0.0 110.333 -176.336 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.591 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 1.9 p -94.94 103.37 15.23 Favored 'General case' 0 N--CA 1.505 2.319 0 CA-C-O 123.171 1.462 . . . . 0.0 110.821 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.423 ' O ' ' C ' ' A' ' 29' ' ' ILE 0.304 28.9 mm -82.17 68.25 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 113.706 -1.588 . . . . 0.0 110.369 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.538 HG23 ' CB ' ' A' ' 125' ' ' ALA . 9.4 tt -43.49 115.48 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-O 122.632 1.206 . . . . 0.0 109.481 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -66.69 -89.97 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 114.704 -1.134 . . . . 0.0 111.283 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.7 mtt-85 -149.9 165.65 31.94 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.374 -0.829 . . . . 0.0 110.292 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.842 ' HA2' ' HA ' ' A' ' 96' ' ' LYS . . . 85.42 121.61 1.12 Allowed Glycine 0 C--N 1.303 -1.291 0 N-CA-C 106.112 -2.795 . . . . 0.0 106.112 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.569 ' HB2' HG11 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -116.76 96.59 48.9 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 120.666 2.233 . . . . 0.0 116.354 -175.103 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.585 ' HD3' ' O ' ' A' ' 32' ' ' GLY . 61.6 Cg_endo -107.6 144.97 0.08 OUTLIER 'Trans proline' 0 C--N 1.289 -2.588 0 C-N-CA 124.081 3.187 . . . . 0.0 109.021 177.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 91' ' ' THR . 2.8 m-85 -117.69 98.35 6.33 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.022 -1.071 . . . . 0.0 108.538 178.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.578 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 25.6 mp0 -117.39 91.25 3.52 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.53 -0.731 . . . . 0.0 109.687 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.581 ' CD2' ' NE2' ' A' ' 124' ' ' HIS . 0.1 OUTLIER -108.31 135.72 49.15 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.489 -1.382 . . . . 0.0 108.341 179.496 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' A' ' 17' ' ' LEU . 0.1 OUTLIER -139.31 128.11 23.41 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.534 ' HB3' ' CG1' ' A' ' 16' ' ' VAL . . . -142.48 152.05 42.32 Favored 'General case' 0 C--N 1.276 -2.602 0 CA-C-O 123.067 1.413 . . . . 0.0 113.405 -175.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.552 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.74 140.77 28.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 113.763 -1.562 . . . . 0.0 108.612 178.286 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.582 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 3.5 p90 -157.21 121.47 4.32 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -178.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 12.3 tt0 -68.72 155.12 40.7 Favored 'General case' 0 C--N 1.288 -2.089 0 O-C-N 120.416 -1.428 . . . . 0.0 108.918 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.582 ' HB1' ' CE2' ' A' ' 86' ' ' TYR . . . -88.14 136.84 32.79 Favored 'General case' 0 C--N 1.267 -3.01 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.402 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.552 ' C ' ' HG2' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -117.81 49.96 1.18 Allowed 'General case' 0 CA--C 1.486 -1.506 0 CA-C-O 125.454 2.55 . . . . 0.0 114.033 179.318 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.586 ' N ' ' CG ' ' A' ' 82' ' ' LYS . 7.1 pt20 167.12 -160.52 0.01 OUTLIER 'General case' 0 C--N 1.258 -3.37 0 CA-C-N 108.914 -3.767 . . . . 0.0 112.92 175.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.457 ' OD1' ' N ' ' A' ' 47' ' ' THR 0.265 41.2 t-20 -109.2 153.69 23.43 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-O 122.588 1.185 . . . . 0.0 108.754 -178.901 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.635 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -173.14 156.21 3.16 Favored 'General case' 0 C--N 1.255 -3.541 0 C-N-CA 118.473 -1.291 . . . . 0.0 112.5 -178.28 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.662 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 9.5 mtpt -112.41 5.8 18.32 Favored 'General case' 0 N--CA 1.509 2.501 0 O-C-N 120.747 -1.221 . . . . 0.0 111.184 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.568 ' CG2' ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.41 149.13 4.79 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.369 -1.457 . . . . 0.0 111.611 179.653 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.542 ' O ' ' O ' ' A' ' 70' ' ' PRO . . . -142.82 99.76 3.53 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 122.574 1.178 . . . . 0.0 110.871 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 9.9 mttt -69.31 -178.01 1.25 Allowed 'General case' 0 N--CA 1.506 2.338 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.913 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.796 HG12 HD13 ' A' ' 88' ' ' ILE . 35.8 mt -140.99 137.8 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.665 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.665 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.553 ' HB3' ' CE ' ' A' ' 109' ' ' LYS . 4.0 tt0 -141.51 112.19 7.13 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 123.261 1.505 . . . . 0.0 111.239 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.648 ' HA ' ' CG1' ' A' ' 108' ' ' VAL . 0.4 OUTLIER -91.88 127.54 44.1 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 CA-C-N 112.79 -2.005 . . . . 0.0 110.296 179.476 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -122.9 101.7 7.59 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 176.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.514 ' CB ' HG21 ' A' ' 106' ' ' VAL . . . -112.81 133.31 54.87 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.843 -1.16 . . . . 0.0 113.178 -175.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.671 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 0.3 OUTLIER -109.49 102.35 11.23 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 177.811 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.76 ' HA ' ' CG2' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -112.55 97.81 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.863 0 CA-C-O 123.423 1.582 . . . . 0.0 110.746 -177.258 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.569 ' N ' ' O ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER 39.14 65.37 0.68 Allowed 'General case' 0 N--CA 1.52 3.061 0 CA-C-N 114.641 -1.163 . . . . 0.0 113.112 179.236 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.16 -18.34 10.22 Favored Glycine 0 N--CA 1.487 2.093 0 O-C-N 121.378 -0.826 . . . . 0.0 111.481 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.505 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.267 0.3 OUTLIER -107.7 58.67 0.62 Allowed 'General case' 0 C--N 1.293 -1.873 0 O-C-N 121.092 -1.24 . . . . 0.0 111.513 -178.453 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.49 ' O ' ' CG ' ' A' ' 62' ' ' GLU 0.365 0.0 OUTLIER -63.42 113.19 3.11 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.045 0.926 . . . . 0.0 110.912 -179.78 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.451 HG23 ' HB2' ' A' ' 56' ' ' ALA . 15.3 m -72.73 142.56 14.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-O 122.504 1.145 . . . . 0.0 110.731 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.434 7.9 t70 -138.3 64.88 1.48 Allowed 'General case' 0 C--N 1.277 -2.552 0 CA-C-O 122.619 1.199 . . . . 0.0 110.73 -176.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.549 ' CG2' ' HD2' ' A' ' 66' ' ' PRO . 8.2 p -164.47 151.64 10.04 Favored Pre-proline 0 C--N 1.269 -2.918 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.005 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.549 ' HD2' ' CG2' ' A' ' 65' ' ' VAL . 45.5 Cg_endo -82.39 139.64 10.43 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 CA-C-O 123.886 1.536 . . . . 0.0 112.221 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.615 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -133.36 60.11 0.67 Allowed Glycine 0 N--CA 1.501 2.991 0 CA-C-N 112.291 -2.231 . . . . 0.0 109.0 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.606 ' HB ' ' CE2' ' A' ' 90' ' ' TYR 0.272 0.2 OUTLIER 163.93 -177.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.326 -1.103 . . . . 0.0 108.179 -178.074 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.575 ' N ' ' CG2' ' A' ' 68' ' ' ILE . 0.4 OUTLIER -107.53 140.43 21.52 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 105.728 -1.952 . . . . 0.0 105.728 175.084 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.717 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 23.2 Cg_endo -105.39 -3.02 0.17 Allowed 'Trans proline' 0 C--N 1.273 -3.427 0 C-N-CA 122.945 2.43 . . . . 0.0 114.155 -173.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.551 ' HB2' ' NE2' ' A' ' 74' ' ' HIS . 0.2 OUTLIER -107.91 96.6 6.49 Favored 'General case' 0 C--N 1.285 -2.234 0 O-C-N 120.765 -1.209 . . . . 0.0 108.532 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.755 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . . . -77.4 10.7 2.36 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.195 -0.94 . . . . 0.0 108.897 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.7 t -77.34 -24.96 50.66 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 120.984 -1.072 . . . . 0.0 108.209 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.551 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 0.5 OUTLIER -83.25 11.62 6.37 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.444 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.755 ' CD2' ' HA ' ' A' ' 72' ' ' ALA . 1.3 m-85 -132.03 -6.18 3.5 Favored 'General case' 0 C--O 1.215 -0.731 0 O-C-N 121.744 -0.598 . . . . 0.0 110.151 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.46 ' O ' ' HG2' ' A' ' 76' ' ' MET . 2.8 ptt? -161.1 131.26 5.03 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 123.915 1.817 . . . . 0.0 113.973 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.55 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 9.3 pttt -16.76 99.36 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 111.801 -2.454 . . . . 0.0 113.462 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 48' ' ' LYS 0.325 0.5 OUTLIER -99.12 140.22 21.55 Favored Pre-proline 0 C--N 1.264 -3.124 0 CA-C-N 111.548 -2.569 . . . . 0.0 108.613 178.272 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.662 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 36.0 Cg_endo -82.68 170.01 58.21 Favored 'Cis proline' 0 C--N 1.312 -1.384 0 C-N-CA 123.457 -1.476 . . . . 0.0 112.277 0.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.69 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -95.28 129.67 42.33 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.771 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.535 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 2.4 p -108.3 138.21 36.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 124.299 2.0 . . . . 0.0 112.05 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.586 ' CG ' ' N ' ' A' ' 45' ' ' GLN . 1.7 tmmt? -42.09 117.42 0.97 Allowed 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 111.606 -2.543 . . . . 0.0 116.614 -175.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.25 -17.6 14.44 Favored Glycine 0 C--N 1.293 -1.83 0 CA-C-N 111.714 -2.494 . . . . 0.0 107.945 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 8.2 mt-30 -72.52 126.36 29.66 Favored 'General case' 0 C--N 1.278 -2.525 0 CA-C-O 123.199 1.476 . . . . 0.0 111.633 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.607 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 3.5 mt-30 -64.57 143.31 58.01 Favored 'General case' 0 C--N 1.27 -2.872 0 CA-C-N 113.385 -1.734 . . . . 0.0 107.927 178.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.663 ' CE2' ' HB3' ' A' ' 80' ' ' LEU . 19.9 m-85 -142.3 125.25 16.16 Favored 'General case' 0 C--N 1.279 -2.472 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.532 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 1.1 p30 -117.4 132.46 56.57 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-O 122.776 1.274 . . . . 0.0 110.088 -177.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.796 HD13 HG12 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -101.29 157.84 4.25 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.196 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.422 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -147.24 141.37 26.09 Favored 'General case' 0 C--N 1.286 -2.189 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.133 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.606 ' CE2' ' HB ' ' A' ' 68' ' ' ILE . 3.0 t80 -144.04 112.52 6.5 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.276 -0.89 . . . . 0.0 108.894 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.566 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 0.6 OUTLIER -131.41 115.68 16.53 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 179.09 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.615 ' CD1' ' O ' ' A' ' 67' ' ' GLY 0.266 0.5 OUTLIER -141.89 111.81 6.78 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.513 -176.666 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 2.5 p-10 -74.67 159.49 32.02 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 119.378 -2.077 . . . . 0.0 109.361 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.569 HG11 ' HB2' ' A' ' 33' ' ' LYS . 0.8 OUTLIER -153.0 172.16 5.94 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.083 -1.011 . . . . 0.0 108.835 -178.296 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.532 ' HD2' ' CG2' ' A' ' 94' ' ' VAL . 17.0 Cg_endo -37.53 152.32 0.04 OUTLIER 'Trans proline' 0 CA--C 1.498 -1.286 0 O-C-N 123.785 1.413 . . . . 0.0 110.045 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.842 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -79.04 -23.22 44.44 Favored 'General case' 0 C--N 1.282 -2.362 0 C-N-CA 116.622 -2.031 . . . . 0.0 115.068 -172.721 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.567 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -138.75 43.07 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-O 121.398 0.618 . . . . 0.0 112.618 -178.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.617 ' CB ' ' CD ' ' A' ' 99' ' ' PRO . . . -70.04 -67.62 0.65 Allowed Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 120.686 -1.259 . . . . 0.0 110.654 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.663 ' C ' ' HD2' ' A' ' 100' ' ' LYS . 47.7 Cg_endo -66.51 160.4 46.01 Favored 'Trans proline' 0 CA--C 1.461 -3.133 0 O-C-N 123.676 1.356 . . . . 0.0 110.228 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.691 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -109.16 106.49 16.39 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-N 112.497 -2.138 . . . . 0.0 110.301 -169.453 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.555 ' HB2' ' CB ' ' A' ' 127' ' ' ILE . 5.3 p -46.25 97.16 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 CA-C-O 123.612 1.673 . . . . 0.0 109.031 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.392 84.8 mt-10 -164.95 -52.4 0.03 OUTLIER 'General case' 0 CA--C 1.45 -2.893 0 CA-C-N 112.975 -1.921 . . . . 0.0 111.461 179.659 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.569 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.489 0.7 OUTLIER -160.73 83.5 0.67 Allowed 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 110.681 -2.963 . . . . 0.0 113.608 -162.045 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.76 ' CG2' ' HA ' ' A' ' 58' ' ' ILE . 32.4 t -143.21 134.23 23.0 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 C-N-CA 119.103 -1.039 . . . . 0.0 112.308 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.45 HG21 ' HA ' ' A' ' 123' ' ' THR . 0.6 OUTLIER -140.54 130.61 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.555 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 121' ' ' ILE . 0.3 OUTLIER -105.46 141.9 19.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-O 122.344 1.069 . . . . 0.0 111.393 -179.271 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.632 ' CG2' ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -132.6 109.14 9.53 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 179.509 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.648 ' CG1' ' HA ' ' A' ' 54' ' ' ILE . 3.4 t -127.61 141.91 45.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 117.802 -1.559 . . . . 0.0 109.16 -177.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.753 ' HB2' ' CB ' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -131.03 152.84 49.9 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 122.904 1.335 . . . . 0.0 112.938 -178.774 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.671 ' CG2' ' CD1' ' A' ' 88' ' ' ILE . 3.8 t -102.61 124.55 56.67 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 176.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.522 ' HG2' ' O ' ' A' ' 111' ' ' MET . 2.1 ptm -104.86 121.76 44.35 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.507 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -79.83 -137.35 1.62 Allowed Glycine 0 N--CA 1.496 2.662 0 C-N-CA 118.931 -1.604 . . . . 0.0 114.01 -175.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.635 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 13.4 p-10 -79.8 -4.93 54.23 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 122.393 1.092 . . . . 0.0 111.986 -177.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 10.8 p30 -128.9 -4.61 5.12 Favored 'General case' 0 C--N 1.268 -2.96 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.933 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.575 ' O ' ' HB ' ' A' ' 116' ' ' VAL . . . 86.81 84.0 1.13 Allowed Glycine 0 CA--C 1.471 -2.718 0 CA-C-O 124.875 2.375 . . . . 0.0 109.669 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.575 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 6.9 p 145.97 145.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.246 -3.913 0 CA-C-N 108.281 -3.96 . . . . 0.0 111.204 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.547 ' CB ' ' O ' ' A' ' 110' ' ' VAL . 0.1 OUTLIER -162.21 -59.51 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.378 -0.826 . . . . 0.0 110.651 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.442 ' CB ' HG13 ' A' ' 13' ' ' ILE . . . -168.25 129.17 1.33 Allowed 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.753 ' CB ' ' HB2' ' A' ' 109' ' ' LYS . 0.8 OUTLIER -134.29 141.32 46.91 Favored 'General case' 0 C--N 1.284 -2.274 0 C-N-CA 118.004 -1.478 . . . . 0.0 113.097 -177.703 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.436 ' HB3' HD11 ' A' ' 13' ' ' ILE . . . -146.53 137.28 24.07 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 123.159 1.456 . . . . 0.0 112.468 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.632 ' HB ' ' CG2' ' A' ' 107' ' ' THR 0.265 0.1 OUTLIER -112.23 133.24 58.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 113.908 -1.497 . . . . 0.0 110.912 -179.78 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.48 ' HB3' HG21 ' A' ' 5' ' ' VAL . . . -130.56 177.87 7.05 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.743 -1.223 . . . . 0.0 108.858 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.556 ' O ' ' HB2' ' A' ' 124' ' ' HIS . 16.0 p -95.78 -33.14 12.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.409 -1.432 . . . . 0.0 110.565 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.581 ' NE2' ' CD2' ' A' ' 37' ' ' LEU . 24.5 m80 63.09 -56.17 0.17 Allowed 'General case' 0 N--CA 1.511 2.602 0 O-C-N 121.795 -0.566 . . . . 0.0 111.687 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.538 ' CB ' HG23 ' A' ' 29' ' ' ILE . . . -128.88 106.22 8.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.023 -1.048 . . . . 0.0 110.695 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -114.9 79.45 1.27 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.924 -1.11 . . . . 0.0 109.296 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.555 ' CB ' ' HB2' ' A' ' 101' ' ' SER . 0.8 OUTLIER -85.0 123.79 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 120.51 -1.368 . . . . 0.0 111.279 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.492 ' HD3' ' O ' ' A' ' 127' ' ' ILE . 4.2 tpp180 -169.08 151.01 4.59 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.162 179.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 1.3 m-20 . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.151 -0.968 . . . . 0.0 110.93 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 121.218 0.532 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.492 ' O ' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -73.98 168.18 20.01 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.209 -0.932 . . . . 0.0 110.851 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.561 ' CG1' ' HA ' ' A' ' 22' ' ' HIS . 1.4 m -148.72 174.7 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.475 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -80.12 139.86 36.66 Favored 'General case' 0 CA--C 1.482 -1.647 0 C-N-CA 118.097 -1.441 . . . . 0.0 108.396 177.042 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.503 ' C ' ' CG ' ' A' ' 6' ' ' LYS 0.434 0.4 OUTLIER -166.33 -175.31 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.406 -169.992 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.553 ' HB2' ' CG2' ' A' ' 121' ' ' ILE . 1.6 mttt -153.91 138.86 17.22 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 123.565 1.65 . . . . 0.0 112.577 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.285 3.5 t70 -84.67 148.83 26.2 Favored 'General case' 0 C--N 1.27 -2.881 0 CA-C-N 113.381 -1.736 . . . . 0.0 109.732 178.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.621 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 5.3 p -137.43 13.14 3.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.007 -1.058 . . . . 0.0 109.469 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.607 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -126.33 -85.58 0.61 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 118.586 -1.246 . . . . 0.0 110.026 -177.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 12' ' ' GLU . 2.5 t30 -160.29 67.1 0.35 Allowed 'General case' 0 C--N 1.265 -3.083 0 C-N-CA 118.578 -1.249 . . . . 0.0 111.935 177.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.467 ' C ' ' O ' ' A' ' 10' ' ' ASN . 11.0 m-70 34.36 32.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.765 0.793 . . . . 0.0 110.42 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.1 OUTLIER -86.92 20.4 2.64 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.475 0.655 . . . . 0.0 110.739 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.614 ' CG2' ' N ' ' A' ' 14' ' ' LYS 0.289 0.0 OUTLIER -121.79 -166.89 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-O 121.989 0.9 . . . . 0.0 110.834 -178.215 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.614 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 1.7 pttt -161.88 -44.08 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.996 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.553 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 11.3 tttm -149.85 140.31 22.42 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 116.375 -2.13 . . . . 0.0 113.371 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.491 HG12 ' CB ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -132.92 108.85 13.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 CA-C-O 122.873 1.321 . . . . 0.0 110.936 179.705 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 mt -102.0 122.57 44.32 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 114.164 -1.38 . . . . 0.0 110.949 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.527 HG13 ' CD2' ' A' ' 124' ' ' HIS . 58.3 t -142.11 142.51 24.73 Favored Pre-proline 0 C--N 1.292 -1.906 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.549 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.451 ' HD2' HG12 ' A' ' 18' ' ' VAL . 40.7 Cg_endo -66.19 126.65 16.08 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.752 1.396 . . . . 0.0 110.69 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 124' ' ' HIS . . . 123.19 -78.69 0.35 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.484 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 3.6 m -90.37 133.86 34.71 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.476 -1.014 . . . . 0.0 109.965 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.561 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -140.79 10.52 2.22 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.019 -1.675 . . . . 0.0 110.847 178.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 4' ' ' ASP . . . -178.47 -155.81 15.38 Favored Glycine 0 C--N 1.285 -2.258 0 C-N-CA 118.592 -1.766 . . . . 0.0 110.62 176.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.51 -8.27 18.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.877 -1.366 . . . . 0.0 109.82 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.782 ' CB ' ' HD3' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -63.3 177.07 0.49 Allowed Pre-proline 0 C--N 1.296 -1.746 0 CA-C-O 125.018 2.342 . . . . 0.0 114.341 179.599 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.782 ' HD3' ' CB ' ' A' ' 25' ' ' GLU . 21.5 Cg_endo -104.49 115.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.263 -3.943 1 C-N-CA 127.344 5.363 . . . . 0.0 110.765 -176.029 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.484 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 5.2 p -109.79 110.4 21.38 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-N 114.093 -1.412 . . . . 0.0 110.645 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.527 ' HA ' ' O ' ' A' ' 126' ' ' LYS 0.332 44.5 mm -83.0 -163.16 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.283 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.566 HG12 ' CB ' ' A' ' 125' ' ' ALA . 0.5 OUTLIER -126.56 114.89 39.98 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 CA-C-O 122.273 1.035 . . . . 0.0 110.216 179.168 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.603 ' CG ' ' N ' ' A' ' 31' ' ' ARG . 5.9 t-160 -67.3 -96.5 0.0 OUTLIER 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.007 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.603 ' N ' ' CG ' ' A' ' 30' ' ' HIS . 62.5 mtt-85 -161.74 165.58 27.83 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.512 -0.742 . . . . 0.0 109.788 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.827 ' HA2' ' HA ' ' A' ' 96' ' ' LYS . . . 68.43 124.74 0.03 OUTLIER Glycine 0 C--N 1.303 -1.268 0 N-CA-C 105.413 -3.075 . . . . 0.0 105.413 -178.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.529 ' HB2' HG13 ' A' ' 94' ' ' VAL . 4.5 mmmm -116.3 94.82 43.6 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 120.593 2.196 . . . . 0.0 116.57 -174.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.619 ' HD3' ' O ' ' A' ' 32' ' ' GLY . 61.3 Cg_endo -106.91 144.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.288 -2.621 0 C-N-CA 124.086 3.191 . . . . 0.0 108.136 176.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.495 ' CD1' ' C ' ' A' ' 34' ' ' PRO . 2.2 m-85 -120.8 94.59 4.4 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.002 -1.079 . . . . 0.0 109.429 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.582 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 28.1 mp0 -113.3 84.41 2.0 Allowed 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.578 ' HB3' ' CE1' ' A' ' 124' ' ' HIS . 3.6 pp -110.24 140.97 43.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.652 -1.28 . . . . 0.0 109.718 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -140.76 139.27 34.6 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 122.73 1.252 . . . . 0.0 109.151 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.491 ' CB ' HG12 ' A' ' 16' ' ' VAL . . . -142.68 151.64 41.58 Favored 'General case' 0 C--N 1.277 -2.576 0 CA-C-O 123.007 1.384 . . . . 0.0 112.546 -177.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.553 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.15 141.57 25.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 113.996 -1.457 . . . . 0.0 108.908 178.89 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.593 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 3.1 p90 -155.94 121.21 4.82 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 17.0 tt0 -68.82 152.82 44.81 Favored 'General case' 0 C--N 1.286 -2.159 0 O-C-N 120.392 -1.443 . . . . 0.0 108.267 178.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.597 ' HB1' ' CE2' ' A' ' 86' ' ' TYR . . . -85.64 131.52 34.33 Favored 'General case' 0 C--N 1.264 -3.109 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.445 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.579 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -113.36 50.8 0.88 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 125.638 2.637 . . . . 0.0 114.074 179.454 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.592 ' C ' ' HB2' ' A' ' 82' ' ' LYS . 4.4 pt20 167.33 -162.39 0.01 OUTLIER 'General case' 0 C--N 1.266 -3.023 0 CA-C-N 108.641 -3.89 . . . . 0.0 113.462 175.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.419 ' H ' ' HB2' ' A' ' 45' ' ' GLN 0.279 36.6 t30 -110.37 152.44 26.24 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 122.466 1.127 . . . . 0.0 108.712 -178.482 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.669 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -173.25 155.52 2.94 Favored 'General case' 0 C--N 1.255 -3.534 0 C-N-CA 118.01 -1.476 . . . . 0.0 113.257 -178.527 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.74 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 9.9 mttt -110.63 7.21 22.26 Favored 'General case' 0 N--CA 1.509 2.495 0 O-C-N 120.734 -1.229 . . . . 0.0 110.646 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.568 ' CG2' ' O ' ' A' ' 48' ' ' LYS . 0.8 OUTLIER -168.01 146.1 4.43 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 120.557 -1.339 . . . . 0.0 111.262 179.255 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.529 ' O ' ' O ' ' A' ' 70' ' ' PRO . . . -143.21 97.93 3.17 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-O 122.619 1.199 . . . . 0.0 109.641 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 12.3 mtmt -68.71 -179.09 1.31 Allowed 'General case' 0 N--CA 1.504 2.237 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.719 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.812 HG12 HD13 ' A' ' 88' ' ' ILE . 35.6 mt -140.19 140.4 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.425 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.368 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.49 ' O ' HG11 ' A' ' 108' ' ' VAL . 16.3 tp10 -140.47 107.88 5.55 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 123.374 1.559 . . . . 0.0 110.313 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.626 ' HA ' ' CG1' ' A' ' 108' ' ' VAL . 0.5 OUTLIER -91.16 125.6 43.89 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 CA-C-N 112.572 -2.103 . . . . 0.0 109.271 179.327 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -121.36 103.4 8.93 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 177.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.482 ' HB3' ' CG2' ' A' ' 106' ' ' VAL . . . -110.31 128.77 55.71 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 118.814 -1.155 . . . . 0.0 112.005 -176.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.659 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 0.4 OUTLIER -107.09 102.93 12.23 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.74 ' HA ' ' CG2' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -114.51 101.91 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.868 0 CA-C-O 123.197 1.475 . . . . 0.0 110.811 -177.454 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER 37.46 65.16 0.56 Allowed 'General case' 0 N--CA 1.522 3.132 0 CA-C-N 114.932 -1.031 . . . . 0.0 113.074 179.304 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.87 -15.49 8.1 Favored Glycine 0 N--CA 1.488 2.133 0 O-C-N 121.278 -0.889 . . . . 0.0 111.363 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.513 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.274 0.3 OUTLIER -108.02 56.73 0.63 Allowed 'General case' 0 C--N 1.293 -1.85 0 O-C-N 121.108 -1.23 . . . . 0.0 111.417 -178.384 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.512 ' O ' ' CG ' ' A' ' 62' ' ' GLU 0.376 0.0 OUTLIER -60.38 117.48 5.29 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.918 0.866 . . . . 0.0 110.661 179.928 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.1 m -80.62 135.46 25.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-O 122.816 1.293 . . . . 0.0 111.736 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.447 26.0 t0 -140.08 67.65 1.37 Allowed 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.833 -177.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.536 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -150.52 175.85 2.61 Favored Pre-proline 0 C--N 1.268 -2.952 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.001 -178.152 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.536 ' HD2' ' CB ' ' A' ' 65' ' ' VAL . 38.3 Cg_endo -65.98 139.91 58.29 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.395 1.734 . . . . 0.0 111.382 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.603 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -134.57 -73.01 0.08 OUTLIER Glycine 0 N--CA 1.503 3.11 0 CA-C-N 112.459 -2.155 . . . . 0.0 111.121 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.47 ' CG2' ' N ' ' A' ' 69' ' ' ASP . 2.0 tp -117.42 -157.83 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.225 -1.75 . . . . 0.0 108.789 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.48 ' O ' HD13 ' A' ' 52' ' ' ILE . 0.6 OUTLIER -106.69 141.85 23.71 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 177.136 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.732 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 24.5 Cg_endo -105.76 -3.76 0.15 Allowed 'Trans proline' 0 C--N 1.276 -3.289 0 C-N-CA 123.196 2.597 . . . . 0.0 114.309 -173.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.576 ' O ' ' CE1' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -110.37 87.58 2.56 Favored 'General case' 0 C--N 1.287 -2.132 0 O-C-N 120.717 -1.24 . . . . 0.0 108.121 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.59 ' HA ' ' CD1' ' A' ' 75' ' ' TYR . . . -74.47 8.45 2.27 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.734 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.11 -19.87 53.27 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 120.536 -1.352 . . . . 0.0 108.243 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.568 ' C ' ' CD1' ' A' ' 75' ' ' TYR . 0.2 OUTLIER -88.76 19.75 3.86 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 173.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.615 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.2 OUTLIER -132.57 -9.07 3.22 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.798 179.703 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.468 ' O ' ' C ' ' A' ' 77' ' ' LYS . 2.1 ptt? -167.93 129.59 1.46 Allowed 'General case' 0 C--O 1.215 -0.757 0 CA-C-O 123.621 1.677 . . . . 0.0 112.489 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.484 ' O ' HD11 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -9.16 94.92 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 111.99 -2.368 . . . . 0.0 113.833 -178.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 48' ' ' LYS 0.312 7.9 t -98.87 140.3 21.66 Favored Pre-proline 0 C--N 1.271 -2.813 0 CA-C-N 111.278 -2.692 . . . . 0.0 108.093 177.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.74 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 36.2 Cg_endo -78.74 171.21 66.85 Favored 'Cis proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.987 -1.672 . . . . 0.0 113.177 1.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.687 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.3 OUTLIER -99.33 129.3 45.53 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.066 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.505 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.4 t -105.12 138.68 28.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 124.202 1.953 . . . . 0.0 112.287 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.592 ' HB2' ' C ' ' A' ' 45' ' ' GLN . 1.4 tmmt? -43.96 118.08 1.36 Allowed 'General case' 0 C--N 1.273 -2.748 0 CA-C-N 111.762 -2.472 . . . . 0.0 116.517 -175.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.26 -18.26 12.23 Favored Glycine 0 C--N 1.29 -1.988 0 CA-C-N 111.746 -2.479 . . . . 0.0 107.931 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.602 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 11.0 mt-30 -71.84 125.39 27.05 Favored 'General case' 0 C--N 1.278 -2.5 0 CA-C-O 123.13 1.443 . . . . 0.0 111.543 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.593 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -63.67 142.89 58.23 Favored 'General case' 0 C--N 1.268 -2.938 0 CA-C-N 113.424 -1.716 . . . . 0.0 107.355 178.887 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.638 ' CE2' ' HB3' ' A' ' 80' ' ' LEU . 17.7 m-85 -142.21 126.1 17.16 Favored 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 87' ' ' ASP . 19.9 p30 -117.35 132.6 56.56 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-O 122.856 1.312 . . . . 0.0 110.107 -177.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.812 HD13 HG12 ' A' ' 52' ' ' ILE . 0.4 OUTLIER -101.99 159.16 4.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 CA-C-N 114.324 -1.307 . . . . 0.0 108.13 179.513 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.458 ' HG2' ' N ' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -148.95 151.2 34.19 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.909 -178.031 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.478 ' O ' ' HA ' ' A' ' 36' ' ' GLN . 49.3 t80 -147.92 104.1 3.55 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.335 178.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.582 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 1.1 t -121.2 113.93 20.68 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.603 ' CD1' ' O ' ' A' ' 67' ' ' GLY 0.272 0.4 OUTLIER -142.17 113.86 7.92 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.611 -177.107 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 18.7 p-10 -75.07 159.1 32.11 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 119.423 -2.048 . . . . 0.0 109.696 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.556 ' CG2' ' HD2' ' A' ' 95' ' ' PRO . 0.5 OUTLIER -155.59 169.19 10.77 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.05 -1.031 . . . . 0.0 108.484 -178.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.556 ' HD2' ' CG2' ' A' ' 94' ' ' VAL . 17.2 Cg_endo -36.65 154.74 0.02 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.16 0 O-C-N 123.488 1.257 . . . . 0.0 110.887 -177.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.827 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -78.71 -25.41 44.7 Favored 'General case' 0 C--N 1.285 -2.219 0 C-N-CA 116.903 -1.919 . . . . 0.0 114.889 -172.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.606 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -145.85 47.24 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 CA-C-O 121.802 0.81 . . . . 0.0 111.941 -178.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.519 ' O ' ' NZ ' ' A' ' 100' ' ' LYS . . . -76.06 -60.1 1.03 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.731 -1.23 . . . . 0.0 111.31 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.672 ' C ' ' HD2' ' A' ' 100' ' ' LYS . 45.0 Cg_endo -64.36 159.05 45.74 Favored 'Trans proline' 0 CA--C 1.466 -2.897 0 O-C-N 123.912 1.48 . . . . 0.0 111.161 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.696 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -109.88 105.28 14.41 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 112.404 -2.18 . . . . 0.0 110.564 -169.146 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.555 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . 4.2 p -46.49 95.24 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.5 0 CA-C-O 123.509 1.623 . . . . 0.0 109.363 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.622 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.399 92.3 mt-10 -164.26 -51.83 0.03 OUTLIER 'General case' 0 CA--C 1.453 -2.787 0 CA-C-N 112.981 -1.918 . . . . 0.0 112.029 179.8 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.552 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.49 0.8 OUTLIER -160.49 79.45 0.65 Allowed 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 115.016 -2.674 . . . . 0.0 114.221 -161.939 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.74 ' CG2' ' HA ' ' A' ' 58' ' ' ILE . 36.1 t -142.44 153.53 17.99 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.577 0 C-N-CA 119.703 -0.799 . . . . 0.0 111.203 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.431 HG12 HD13 ' A' ' 121' ' ' ILE . 0.4 OUTLIER -167.44 134.6 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -179.651 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 121' ' ' ILE . 0.3 OUTLIER -105.02 142.84 17.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.717 0 CA-C-O 122.391 1.091 . . . . 0.0 111.772 -179.044 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.634 ' CG2' ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -132.32 107.92 8.86 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.626 ' CG1' ' HA ' ' A' ' 54' ' ' ILE . 3.2 t -125.13 142.74 41.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 117.628 -1.629 . . . . 0.0 109.136 -177.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 1.025 ' HB2' ' HB2' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -135.36 146.03 47.96 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.229 1.014 . . . . 0.0 111.169 -178.104 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.652 ' CG2' ' CD1' ' A' ' 88' ' ' ILE . 14.9 t -101.07 132.35 47.0 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.506 ' HB3' ' HA2' ' A' ' 115' ' ' GLY . 2.6 mtm -109.69 121.6 45.58 Favored 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -80.1 -141.66 2.65 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 119.109 -1.519 . . . . 0.0 113.846 -176.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.669 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 11.0 p-10 -77.28 -6.49 53.35 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 122.414 1.102 . . . . 0.0 111.951 -177.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.432 ' OD1' HG21 ' A' ' 116' ' ' VAL . 3.3 p30 -125.89 -4.98 6.91 Favored 'General case' 0 C--N 1.268 -2.961 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.703 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.658 ' O ' ' CG1' ' A' ' 116' ' ' VAL . . . 85.02 82.16 1.06 Allowed Glycine 0 CA--C 1.47 -2.722 0 CA-C-O 124.814 2.341 . . . . 0.0 109.834 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.658 ' CG1' ' O ' ' A' ' 115' ' ' GLY . 0.5 OUTLIER 152.59 143.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.247 -3.884 0 CA-C-N 108.204 -3.998 . . . . 0.0 111.622 177.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.53 ' CB ' ' O ' ' A' ' 110' ' ' VAL . 0.0 OUTLIER -160.44 -57.45 0.06 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.331 -0.856 . . . . 0.0 111.319 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.446 ' HB3' HG13 ' A' ' 13' ' ' ILE . . . -174.87 131.87 0.33 Allowed 'General case' 0 N--CA 1.511 2.58 0 O-C-N 121.125 -0.984 . . . . 0.0 109.467 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 1.025 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 0.8 OUTLIER -133.97 137.94 45.14 Favored 'General case' 0 C--N 1.283 -2.283 0 C-N-CA 118.184 -1.406 . . . . 0.0 113.07 -177.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.405 ' HB1' ' CD1' ' A' ' 13' ' ' ILE . . . -148.52 136.93 21.28 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 123.077 1.418 . . . . 0.0 111.908 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.634 ' HB ' ' CG2' ' A' ' 107' ' ' THR 0.262 0.0 OUTLIER -110.54 130.29 64.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.97 -179.593 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.431 ' O ' HG21 ' A' ' 105' ' ' VAL . . . -131.42 -174.19 3.33 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.931 -1.105 . . . . 0.0 109.19 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.509 ' O ' ' HB2' ' A' ' 124' ' ' HIS . 14.3 p -113.35 -13.03 12.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.62 -1.3 . . . . 0.0 110.471 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.578 ' CE1' ' HB3' ' A' ' 37' ' ' LEU . 10.2 m-70 59.09 -79.01 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.561 0 O-C-N 121.416 -0.802 . . . . 0.0 110.715 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.566 ' CB ' HG12 ' A' ' 29' ' ' ILE . . . -159.26 108.85 1.9 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.572 ' CD ' ' HB ' ' A' ' 104' ' ' VAL . 0.6 OUTLIER -128.4 -143.7 0.28 Allowed 'General case' 0 N--CA 1.485 1.324 0 O-C-N 120.714 -1.241 . . . . 0.0 110.924 -178.377 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.555 ' CG1' ' HB2' ' A' ' 101' ' ' SER . 0.5 OUTLIER -133.9 124.27 46.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-O 121.873 0.844 . . . . 0.0 112.044 -179.287 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.474 ' HD3' ' O ' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -169.17 152.25 4.97 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.042 179.325 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.464 ' C ' ' O ' ' A' ' 128' ' ' ARG . 2.9 m-20 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.902 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.444 ' OE1' ' HD2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 120.838 0.352 . . . . 0.0 111.209 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.796 HG12 ' HA ' ' A' ' 22' ' ' HIS 0.256 1.4 m -145.72 173.08 3.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.561 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -80.91 142.19 33.8 Favored 'General case' 0 CA--C 1.475 -1.921 0 O-C-N 120.281 -1.512 . . . . 0.0 107.741 176.183 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.62 HG12 ' H ' ' A' ' 6' ' ' LYS 0.406 0.4 OUTLIER -161.3 -50.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 C-N-CA 117.226 -1.79 . . . . 0.0 112.097 -170.121 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.62 ' H ' HG12 ' A' ' 5' ' ' VAL . 28.6 mmtm 84.86 139.46 0.06 Allowed 'General case' 0 N--CA 1.508 2.429 0 CA-C-O 124.315 2.007 . . . . 0.0 113.97 178.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.3 26.4 t70 -93.37 153.99 18.21 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 111.491 -2.595 . . . . 0.0 109.381 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.669 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.7 p -138.01 17.12 2.83 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.961 -1.087 . . . . 0.0 109.372 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.868 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -124.43 -85.81 0.64 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 118.55 -1.26 . . . . 0.0 109.722 -176.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.562 ' O ' ' N ' ' A' ' 12' ' ' GLU . 1.4 t-20 -159.96 65.04 0.35 Allowed 'General case' 0 C--N 1.265 -3.07 0 C-N-CA 117.774 -1.57 . . . . 0.0 112.142 177.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.466 ' C ' ' O ' ' A' ' 10' ' ' ASN . 6.2 m80 33.3 32.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.778 0.799 . . . . 0.0 110.507 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.562 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.1 OUTLIER -95.23 24.74 4.76 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.0 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.756 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.28 0.0 OUTLIER -117.14 -165.24 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-O 122.213 1.006 . . . . 0.0 110.993 -178.624 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.721 ' N ' HG23 ' A' ' 13' ' ' ILE . 14.8 ptpt -162.31 -48.03 0.04 OUTLIER 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.873 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.648 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 12.1 tttm -144.0 135.47 25.87 Favored 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 116.344 -2.142 . . . . 0.0 112.896 178.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.562 ' CG1' ' HB2' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -133.46 102.26 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-O 122.845 1.307 . . . . 0.0 110.603 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 17' ' ' LEU . 2.0 mt -93.41 123.44 36.71 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 114.172 -1.377 . . . . 0.0 111.253 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.688 HG13 ' HD2' ' A' ' 19' ' ' PRO . 23.7 t -143.13 145.82 34.26 Favored Pre-proline 0 N--CA 1.502 2.147 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.931 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.688 ' HD2' HG13 ' A' ' 18' ' ' VAL . 43.7 Cg_endo -68.72 109.88 2.2 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.83 1.437 . . . . 0.0 110.978 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.11 -94.99 0.12 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.1 m -93.82 174.82 6.98 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.108 -1.231 . . . . 0.0 111.415 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.796 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.4 OUTLIER -142.01 7.13 1.81 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.198 -0.939 . . . . 0.0 110.491 178.36 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.287 -2.147 0 C-N-CA 118.958 -1.591 . . . . 0.0 110.212 177.4 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.809 ' HA2' ' HA ' ' A' ' 96' ' ' LYS . . . . . . . . 0 C--O 1.214 -1.139 0 N-CA-C 105.61 -2.996 . . . . 0.0 105.61 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.744 ' HB2' HG12 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -118.41 96.8 50.27 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 121.281 2.54 . . . . 0.0 117.089 -174.923 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.584 ' HD3' ' O ' ' A' ' 32' ' ' GLY . 61.2 Cg_endo -107.11 144.87 0.08 OUTLIER 'Trans proline' 0 C--N 1.29 -2.504 0 C-N-CA 124.289 3.326 . . . . 0.0 107.416 175.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.543 ' O ' ' CE1' ' A' ' 90' ' ' TYR . 30.4 m-85 -119.05 97.53 5.73 Favored 'General case' 0 C--N 1.291 -1.972 0 C-N-CA 118.603 -1.239 . . . . 0.0 108.839 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.653 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 28.1 mp0 -117.65 99.8 7.2 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.668 -0.645 . . . . 0.0 109.896 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.664 ' HA ' HG22 ' A' ' 18' ' ' VAL . 2.0 mt -109.67 139.24 44.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.403 -1.436 . . . . 0.0 108.741 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.402 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -140.24 128.65 22.67 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.564 -1.335 . . . . 0.0 107.764 179.241 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.562 ' HB2' ' CG1' ' A' ' 16' ' ' VAL . . . -143.75 150.14 38.16 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-O 123.119 1.437 . . . . 0.0 113.485 -176.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.728 HG12 ' HB3' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -115.49 138.22 46.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-N 113.696 -1.593 . . . . 0.0 107.84 177.853 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.688 ' HE2' HG22 ' A' ' 88' ' ' ILE . 8.4 p90 -159.58 130.01 5.71 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -177.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 15.2 tt0 -73.02 155.25 40.0 Favored 'General case' 0 C--N 1.281 -2.381 0 O-C-N 120.464 -1.398 . . . . 0.0 109.127 177.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.977 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -88.97 136.56 32.95 Favored 'General case' 0 C--N 1.269 -2.924 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.65 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.599 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 15.3 p-10 -117.32 50.51 1.1 Allowed 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 125.408 2.528 . . . . 0.0 114.071 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.631 ' C ' ' HB2' ' A' ' 82' ' ' LYS . 7.0 pt20 166.87 -159.44 0.01 OUTLIER 'General case' 0 C--N 1.257 -3.416 0 CA-C-N 108.947 -3.751 . . . . 0.0 112.816 175.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.463 ' H ' ' HB2' ' A' ' 45' ' ' GLN 0.275 21.1 t-20 -110.1 154.25 23.54 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-O 122.53 1.157 . . . . 0.0 108.389 -178.895 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.631 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -171.84 151.05 2.73 Favored 'General case' 0 C--N 1.251 -3.675 0 C-N-CA 118.366 -1.333 . . . . 0.0 112.508 -178.25 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.953 ' O ' HG23 ' A' ' 49' ' ' THR . 0.0 OUTLIER -111.66 6.52 19.96 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 120.668 -1.27 . . . . 0.0 110.817 178.511 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.953 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.41 147.43 4.41 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 120.712 -1.243 . . . . 0.0 111.089 179.373 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 111' ' ' MET . . . -146.71 106.17 3.92 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-O 122.271 1.034 . . . . 0.0 109.981 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.599 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -75.99 -175.73 3.17 Favored 'General case' 0 N--CA 1.505 2.292 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.353 179.447 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.829 ' CG1' HD11 ' A' ' 88' ' ' ILE . 26.7 mt -140.19 135.08 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.688 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.407 ' C ' HG13 ' A' ' 108' ' ' VAL . 15.9 tt0 -141.4 114.55 8.67 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 123.428 1.585 . . . . 0.0 111.854 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 1.031 HD12 HG21 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -90.28 125.91 43.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-N 112.705 -2.043 . . . . 0.0 108.904 178.15 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -117.69 98.69 6.5 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 177.344 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.895 ' HB3' HG22 ' A' ' 63' ' ' VAL . . . -112.86 126.8 55.85 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 118.459 -1.296 . . . . 0.0 112.889 -175.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.746 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.4 p -104.28 98.37 8.18 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 177.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.89 ' HA ' HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -108.76 107.38 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.882 0 CA-C-O 122.905 1.336 . . . . 0.0 110.916 -176.676 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.634 ' N ' HG22 ' A' ' 104' ' ' VAL . 1.8 p30 35.84 62.35 0.65 Allowed 'General case' 0 N--CA 1.522 3.126 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.78 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.05 -12.04 10.16 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.284 -0.885 . . . . 0.0 111.365 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.541 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.279 0.3 OUTLIER -108.13 57.02 0.62 Allowed 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.079 -1.248 . . . . 0.0 111.162 -178.6 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.364 0.0 OUTLIER -60.79 115.09 3.41 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 122.049 0.928 . . . . 0.0 111.366 -179.411 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.895 HG22 ' HB3' ' A' ' 56' ' ' ALA . 15.2 m -75.77 143.64 12.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-O 122.494 1.14 . . . . 0.0 110.352 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.527 ' C ' ' CG2' ' A' ' 65' ' ' VAL 0.435 20.9 t0 -138.27 60.0 1.63 Allowed 'General case' 0 C--N 1.277 -2.572 0 CA-C-O 122.752 1.263 . . . . 0.0 110.901 -176.169 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.809 HG12 ' HD2' ' A' ' 66' ' ' PRO . 1.0 OUTLIER -157.39 151.86 20.49 Favored Pre-proline 0 C--N 1.269 -2.929 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.742 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.809 ' HD2' HG12 ' A' ' 65' ' ' VAL . 44.9 Cg_endo -84.47 137.38 6.9 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 CA-C-O 123.763 1.485 . . . . 0.0 111.013 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.604 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -116.66 42.52 1.85 Allowed Glycine 0 C--N 1.27 -3.136 0 CA-C-N 112.574 -2.103 . . . . 0.0 111.774 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.733 HG23 ' N ' ' A' ' 69' ' ' ASP . 3.0 tp 174.3 -163.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 O-C-N 120.379 -1.659 . . . . 0.0 108.93 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.733 ' N ' HG23 ' A' ' 68' ' ' ILE . 1.5 t70 -107.62 135.01 19.8 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 174.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.723 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 23.6 Cg_endo -106.16 -4.69 0.13 Allowed 'Trans proline' 0 C--N 1.278 -3.176 0 C-N-CA 123.445 2.763 . . . . 0.0 114.07 -173.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.608 ' O ' ' CE1' ' A' ' 75' ' ' TYR . 9.1 p30 -114.93 92.9 4.09 Favored 'General case' 0 C--N 1.285 -2.224 0 O-C-N 120.491 -1.381 . . . . 0.0 108.695 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.609 ' HA ' ' CD1' ' A' ' 75' ' ' TYR . . . -77.91 12.08 1.92 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.071 -1.018 . . . . 0.0 109.095 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.9 t -76.35 -25.22 54.46 Favored 'General case' 0 C--O 1.214 -0.773 0 O-C-N 120.802 -1.186 . . . . 0.0 107.951 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.592 ' CD2' ' OD1' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -88.1 18.68 4.1 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 174.421 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.62 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.2 OUTLIER -134.06 -10.93 2.61 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.38 179.631 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.457 ' O ' ' C ' ' A' ' 77' ' ' LYS . 2.0 ptt? -164.04 133.48 3.93 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-O 123.897 1.808 . . . . 0.0 113.277 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.524 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -12.08 95.51 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 111.761 -2.472 . . . . 0.0 113.732 -178.638 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.51 ' HA ' HD13 ' A' ' 80' ' ' LEU 0.312 1.2 t -104.86 145.13 30.12 Favored Pre-proline 0 C--N 1.268 -2.949 0 CA-C-N 111.428 -2.623 . . . . 0.0 108.491 178.341 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.659 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 36.8 Cg_endo -80.52 166.62 75.33 Favored 'Cis proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.562 -1.849 . . . . 0.0 112.513 0.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.657 ' HG ' ' CE1' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -90.95 127.76 36.52 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.816 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.518 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.4 t -104.58 141.35 20.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-O 124.253 1.977 . . . . 0.0 112.377 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.631 ' HB2' ' C ' ' A' ' 45' ' ' GLN . 1.7 tmmt? -46.55 118.32 1.95 Allowed 'General case' 0 C--N 1.272 -2.772 0 CA-C-N 111.531 -2.577 . . . . 0.0 116.578 -175.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.27 -16.84 19.67 Favored Glycine 0 C--N 1.29 -2.022 0 CA-C-N 111.827 -2.442 . . . . 0.0 107.811 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 64.3 mt-30 -72.83 126.61 30.32 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-O 123.198 1.475 . . . . 0.0 111.598 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.605 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 5.8 pt20 -63.81 144.95 56.64 Favored 'General case' 0 C--N 1.271 -2.834 0 CA-C-N 113.341 -1.754 . . . . 0.0 107.074 178.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.977 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 16.1 m-85 -143.43 125.3 15.16 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.728 ' HB3' HG12 ' A' ' 40' ' ' VAL . 8.4 p30 -117.06 127.2 53.92 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-O 122.572 1.177 . . . . 0.0 109.291 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.829 HD11 ' CG1' ' A' ' 52' ' ' ILE . 0.6 OUTLIER -109.95 159.77 9.4 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.202 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -151.06 156.84 41.93 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 122.046 0.927 . . . . 0.0 111.807 -177.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.653 ' O ' ' HA ' ' A' ' 36' ' ' GLN . 3.7 t80 -150.48 138.46 20.1 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.59 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 1.5 t -154.95 116.43 4.06 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 119.595 1.089 . . . . 0.0 108.102 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.652 ' CZ3' HG23 ' A' ' 94' ' ' VAL 0.27 1.5 t90 -143.03 115.87 8.76 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 119.809 -0.756 . . . . 0.0 110.021 -177.468 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.518 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 10.9 p30 -74.91 160.29 30.8 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 119.249 -2.157 . . . . 0.0 110.135 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.81 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.7 OUTLIER -153.76 166.09 16.45 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.151 -0.968 . . . . 0.0 108.47 -179.274 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.81 ' HD2' HG22 ' A' ' 94' ' ' VAL . 18.4 Cg_endo -37.03 150.16 0.05 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.136 0 O-C-N 123.587 1.309 . . . . 0.0 110.64 -177.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.809 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.5 OUTLIER -79.27 -24.69 42.77 Favored 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 116.94 -1.904 . . . . 0.0 114.33 -173.311 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.767 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -138.52 42.85 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 O-C-N 121.658 -0.651 . . . . 0.0 112.25 -179.161 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.941 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . . . -74.14 -67.67 0.39 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 120.641 -1.287 . . . . 0.0 110.025 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.941 ' HD3' ' HB3' ' A' ' 98' ' ' ALA . 50.3 Cg_endo -67.55 160.09 49.54 Favored 'Trans proline' 0 CA--C 1.463 -3.042 0 O-C-N 123.615 1.323 . . . . 0.0 110.106 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.711 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -107.78 103.09 12.28 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 112.482 -2.144 . . . . 0.0 109.849 -169.689 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.478 ' C ' ' O ' ' A' ' 100' ' ' LYS . 6.5 p -42.96 99.62 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.723 0 CA-C-O 123.635 1.683 . . . . 0.0 108.661 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.405 88.5 mt-10 -163.67 -51.45 0.03 OUTLIER 'General case' 0 CA--C 1.45 -2.882 0 CA-C-N 113.024 -1.898 . . . . 0.0 111.674 -179.237 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.511 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.492 28.0 t30 -159.3 79.22 0.74 Allowed 'General case' 0 C--N 1.283 -2.311 0 CA-C-N 110.952 -2.84 . . . . 0.0 113.378 -162.32 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.89 HG22 ' HA ' ' A' ' 58' ' ' ILE . 26.2 t -141.2 134.12 30.45 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.437 0 C-N-CA 119.811 -0.756 . . . . 0.0 111.234 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.782 ' CG1' HD11 ' A' ' 121' ' ' ILE . 53.0 t -136.55 125.03 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.793 HG23 ' HB2' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -107.15 138.12 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 CA-C-O 122.58 1.181 . . . . 0.0 111.92 -178.805 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . 1.018 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -131.39 110.35 10.98 Favored 'General case' 0 C--N 1.276 -2.623 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.204 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.031 HG21 HD12 ' A' ' 54' ' ' ILE . 3.2 t -123.42 142.19 40.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 C-N-CA 117.182 -1.807 . . . . 0.0 108.811 -177.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 1.105 ' HB2' ' HB2' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -138.22 145.02 40.91 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 122.485 1.136 . . . . 0.0 111.874 -176.827 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.71 ' CG2' HG21 ' A' ' 88' ' ' ILE . 5.6 t -96.6 125.67 49.48 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.553 ' CG ' ' HA2' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -105.68 119.24 38.62 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -179.291 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.511 ' HA3' HD23 ' A' ' 117' ' ' LEU . . . -75.75 -135.55 0.52 Allowed Glycine 0 N--CA 1.497 2.72 0 C-N-CA 119.091 -1.528 . . . . 0.0 113.856 -176.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.631 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 5.1 p-10 -88.59 -0.77 57.6 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.1 0.953 . . . . 0.0 112.267 -176.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -133.94 -4.31 2.81 Favored 'General case' 0 C--N 1.269 -2.914 0 CA-C-O 121.429 0.633 . . . . 0.0 110.954 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.627 ' O ' ' HB ' ' A' ' 116' ' ' VAL . . . 95.54 83.36 1.64 Allowed Glycine 0 CA--C 1.47 -2.765 0 CA-C-O 124.636 2.242 . . . . 0.0 111.024 178.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.627 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 14.6 p 136.21 152.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.254 -3.586 0 CA-C-N 108.371 -3.915 . . . . 0.0 112.72 176.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.681 ' CB ' HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -162.22 -59.51 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.414 0.626 . . . . 0.0 110.281 179.109 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.756 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -164.75 126.01 2.11 Favored 'General case' 0 N--CA 1.51 2.569 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 1.105 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 0.8 OUTLIER -134.11 135.74 43.42 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 117.918 -1.513 . . . . 0.0 113.112 -177.424 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.472 ' HB3' HG11 ' A' ' 16' ' ' VAL . . . -143.62 136.51 27.51 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 122.925 1.345 . . . . 0.0 112.406 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 1.1 HD13 ' N ' ' A' ' 122' ' ' ALA 0.26 0.0 OUTLIER -107.33 162.46 5.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 114.122 -1.399 . . . . 0.0 111.076 -179.589 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 1.1 ' N ' HD13 ' A' ' 121' ' ' ILE . . . . . . . . 0 C--N 1.3 -1.546 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.517 ' OE1' ' N ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 120.818 0.342 . . . . 0.0 111.345 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.711 HG12 ' HA ' ' A' ' 22' ' ' HIS . 1.4 m -144.65 -177.72 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.473 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -78.89 134.78 36.89 Favored 'General case' 0 CA--C 1.481 -1.684 0 C-N-CA 117.723 -1.591 . . . . 0.0 108.758 178.211 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.468 ' O ' ' HG3' ' A' ' 6' ' ' LYS 0.439 0.4 OUTLIER -171.91 164.28 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 113.923 -1.49 . . . . 0.0 109.416 -169.629 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.844 ' O ' HG22 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -144.37 136.98 26.78 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 123.644 1.687 . . . . 0.0 113.143 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.259 13.5 t70 -70.72 148.97 47.41 Favored 'General case' 0 C--N 1.269 -2.907 0 CA-C-N 113.249 -1.796 . . . . 0.0 109.278 178.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.635 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.5 p -137.59 14.62 2.95 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.94 -1.1 . . . . 0.0 109.488 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.827 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -125.94 -84.54 0.63 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.687 -1.205 . . . . 0.0 110.162 -177.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 12' ' ' GLU . 3.6 t-20 -159.46 66.69 0.39 Allowed 'General case' 0 C--N 1.267 -2.998 0 C-N-CA 118.649 -1.221 . . . . 0.0 111.987 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.473 ' C ' ' O ' ' A' ' 10' ' ' ASN . 9.7 m-70 33.57 33.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.848 0.832 . . . . 0.0 110.275 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.0 OUTLIER -91.78 22.0 4.46 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.324 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.87 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.28 0.0 OUTLIER -121.15 -167.39 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-O 122.31 1.052 . . . . 0.0 111.323 -178.439 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.69 ' N ' HG23 ' A' ' 13' ' ' ILE . 7.2 ptpt -162.34 -45.04 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.445 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.612 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 2.9 tttt -145.58 140.29 27.3 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 116.569 -2.052 . . . . 0.0 112.595 178.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.941 HG13 ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -138.42 104.75 2.73 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 CA-C-O 122.929 1.347 . . . . 0.0 111.109 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 17' ' ' LEU . 0.9 OUTLIER -97.95 128.18 44.36 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 114.044 -1.434 . . . . 0.0 111.45 178.89 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.977 HG22 ' HA ' ' A' ' 37' ' ' LEU . 43.1 t -142.16 146.26 39.13 Favored Pre-proline 0 N--CA 1.499 2.006 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.517 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.716 ' HD2' HG13 ' A' ' 18' ' ' VAL . 42.5 Cg_endo -67.63 93.83 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.821 1.432 . . . . 0.0 110.025 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.89 -93.87 0.1 OUTLIER Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.513 -1.327 . . . . 0.0 110.084 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 37.1 m -94.73 162.21 13.87 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.161 -1.2 . . . . 0.0 111.392 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.711 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -136.71 9.28 3.09 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.897 -1.127 . . . . 0.0 109.697 178.027 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' ' 4' ' ' ASP . . . . . . . . 0 C--N 1.291 -1.956 0 C-N-CA 119.383 -1.389 . . . . 0.0 109.882 176.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.858 ' HA3' ' HA ' ' A' ' 96' ' ' LYS . . . . . . . . 0 C--O 1.213 -1.186 0 N-CA-C 107.457 -2.257 . . . . 0.0 107.457 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.881 ' O ' HG22 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -125.34 91.6 48.64 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 120.883 2.342 . . . . 0.0 115.334 -179.306 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.519 ' C ' ' CD1' ' A' ' 35' ' ' PHE . 60.6 Cg_endo -108.2 145.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.291 -2.458 0 C-N-CA 124.291 3.327 . . . . 0.0 109.594 177.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.591 ' CE2' HG11 ' A' ' 94' ' ' VAL . 4.9 m-85 -119.8 90.79 3.4 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.623 ' HG2' ' CB ' ' A' ' 91' ' ' THR . 0.3 OUTLIER -116.17 88.64 2.93 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 122.006 -0.434 . . . . 0.0 110.223 -178.353 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.977 ' HA ' HG22 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -108.68 133.53 52.65 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.526 -1.359 . . . . 0.0 108.383 178.986 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -140.2 127.62 21.38 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.533 -1.354 . . . . 0.0 107.452 179.242 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.941 ' HB2' HG13 ' A' ' 16' ' ' VAL . . . -142.75 152.94 42.82 Favored 'General case' 0 C--N 1.274 -2.708 0 CA-C-O 122.97 1.367 . . . . 0.0 113.263 -175.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.612 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.46 139.87 32.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 113.821 -1.536 . . . . 0.0 108.711 177.994 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.579 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 3.5 p90 -156.87 124.07 5.26 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -178.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 13.6 tt0 -69.68 155.85 39.88 Favored 'General case' 0 C--N 1.288 -2.107 0 O-C-N 120.407 -1.433 . . . . 0.0 108.508 177.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.965 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -91.28 134.69 34.37 Favored 'General case' 0 C--N 1.265 -3.069 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.162 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.634 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -114.87 51.26 0.91 Allowed 'General case' 0 CA--C 1.486 -1.498 0 CA-C-O 125.327 2.489 . . . . 0.0 114.067 179.004 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.601 ' N ' ' CG ' ' A' ' 82' ' ' LYS . 7.0 pt20 167.34 -160.95 0.01 OUTLIER 'General case' 0 C--N 1.263 -3.173 0 CA-C-N 109.149 -3.659 . . . . 0.0 113.729 174.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.46 ' C ' HG22 ' A' ' 47' ' ' THR 0.277 6.3 t30 -110.36 153.65 24.64 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-O 122.617 1.199 . . . . 0.0 108.872 -178.483 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.672 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -173.22 157.04 3.31 Favored 'General case' 0 C--N 1.255 -3.526 0 C-N-CA 118.727 -1.189 . . . . 0.0 112.746 -178.307 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.934 ' O ' HG23 ' A' ' 49' ' ' THR . 0.4 OUTLIER -112.5 5.87 18.22 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 120.694 -1.254 . . . . 0.0 111.522 178.434 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.934 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.16 149.06 5.01 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.659 -1.276 . . . . 0.0 111.215 179.383 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.475 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . . . -141.37 101.64 4.05 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 122.924 1.345 . . . . 0.0 110.863 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 23.3 mmtp -73.15 -178.23 2.8 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.939 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.976 ' CG2' HD11 ' A' ' 88' ' ' ILE . 28.4 mt -140.14 136.43 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.544 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.945 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.494 ' HB3' ' HD3' ' A' ' 109' ' ' LYS . 31.9 tt0 -141.44 110.87 6.39 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 123.267 1.508 . . . . 0.0 111.3 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 1.006 HD12 HG21 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -89.99 127.07 42.8 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 CA-C-N 112.793 -2.003 . . . . 0.0 109.64 179.524 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.491 ' NZ ' ' HB2' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -120.25 98.62 6.15 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 176.903 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.986 ' HB3' HG22 ' A' ' 63' ' ' VAL . . . -114.53 133.61 55.66 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 118.919 -1.112 . . . . 0.0 113.187 -175.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.714 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.0 OUTLIER -105.53 100.3 9.87 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 177.595 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.901 ' HA ' HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -111.55 102.96 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.838 0 CA-C-O 123.004 1.383 . . . . 0.0 110.729 -176.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.658 ' N ' HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER 34.86 65.2 0.37 Allowed 'General case' 0 N--CA 1.519 3.003 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.829 179.306 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.47 -16.56 10.0 Favored Glycine 0 N--CA 1.489 2.212 0 O-C-N 121.351 -0.843 . . . . 0.0 111.761 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.551 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.268 0.5 OUTLIER -108.3 57.94 0.61 Allowed 'General case' 0 C--N 1.292 -1.896 0 O-C-N 121.027 -1.278 . . . . 0.0 111.818 -178.256 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.603 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.367 0.0 OUTLIER -59.25 115.8 3.46 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.064 0.935 . . . . 0.0 111.258 -179.913 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.986 HG22 ' HB3' ' A' ' 56' ' ' ALA . 17.7 m -80.3 146.73 7.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 122.517 1.151 . . . . 0.0 110.971 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.429 7.1 t70 -138.06 59.11 1.66 Allowed 'General case' 0 C--N 1.28 -2.428 0 CA-C-O 122.831 1.301 . . . . 0.0 111.013 -176.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.701 HG22 ' HD2' ' A' ' 66' ' ' PRO . 4.0 p -165.31 151.8 9.03 Favored Pre-proline 0 C--N 1.269 -2.927 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.053 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.701 ' HD2' HG22 ' A' ' 65' ' ' VAL . 44.5 Cg_endo -87.7 139.56 4.82 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 CA-C-O 123.706 1.461 . . . . 0.0 111.804 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -105.83 48.77 0.94 Allowed Glycine 0 C--N 1.272 -2.99 0 CA-C-N 112.568 -2.106 . . . . 0.0 109.101 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.636 HG23 ' N ' ' A' ' 69' ' ' ASP 0.293 0.0 OUTLIER 179.63 -168.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 O-C-N 119.669 -2.077 . . . . 0.0 108.544 -178.247 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.636 ' N ' HG23 ' A' ' 68' ' ' ILE . 10.0 t0 -108.86 90.61 7.85 Favored Pre-proline 0 N--CA 1.504 2.232 0 O-C-N 120.731 -1.231 . . . . 0.0 108.364 176.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.719 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 20.0 Cg_endo -48.39 -5.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.289 -2.584 0 C-N-CA 124.182 3.254 . . . . 0.0 115.461 177.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.603 ' HB2' ' NE2' ' A' ' 74' ' ' HIS . 0.6 OUTLIER -107.63 92.86 4.25 Favored 'General case' 0 C--N 1.289 -2.03 0 O-C-N 120.134 -1.604 . . . . 0.0 109.484 -179.209 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.72 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . . . -78.27 10.41 3.05 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.101 -0.999 . . . . 0.0 109.332 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.1 t -78.16 -24.53 47.24 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 120.992 -1.067 . . . . 0.0 108.944 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.603 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 0.3 OUTLIER -79.52 7.62 7.85 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 118.911 -1.116 . . . . 0.0 108.797 176.85 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.72 ' CD2' ' HA ' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -132.98 -1.38 3.31 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 121.488 -0.758 . . . . 0.0 110.11 177.62 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.46 ' CE ' HD21 ' A' ' 80' ' ' LEU . 1.5 ptt? -153.45 128.65 9.75 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 124.042 1.877 . . . . 0.0 113.745 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.567 ' O ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -19.88 95.98 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 111.74 -2.482 . . . . 0.0 113.213 -178.676 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.498 ' HA ' HD13 ' A' ' 80' ' ' LEU 0.32 0.3 OUTLIER -99.93 142.17 24.11 Favored Pre-proline 0 C--N 1.268 -2.948 0 CA-C-N 111.36 -2.654 . . . . 0.0 108.776 178.495 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.653 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 36.3 Cg_endo -79.58 168.27 73.86 Favored 'Cis proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.848 -1.73 . . . . 0.0 112.521 0.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.693 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -94.71 128.39 41.36 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.17 -179.731 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.528 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.4 t -105.9 139.38 27.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 124.1 1.905 . . . . 0.0 112.07 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.634 ' HG2' ' HA ' ' A' ' 44' ' ' ASN . 1.2 tmmt? -44.59 118.33 1.54 Allowed 'General case' 0 C--N 1.271 -2.823 0 CA-C-N 111.816 -2.447 . . . . 0.0 116.652 -175.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.95 -18.01 12.72 Favored Glycine 0 C--N 1.292 -1.878 0 CA-C-N 111.787 -2.461 . . . . 0.0 107.924 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.62 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 65.1 mt-30 -71.79 127.74 33.54 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-O 123.221 1.486 . . . . 0.0 111.349 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.611 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 12.4 mt-30 -66.02 144.6 56.64 Favored 'General case' 0 C--N 1.27 -2.861 0 CA-C-N 113.282 -1.781 . . . . 0.0 107.485 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.965 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 17.8 m-85 -142.72 126.07 16.62 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.553 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 0.7 OUTLIER -117.46 130.19 56.3 Favored 'General case' 0 C--N 1.279 -2.489 0 CA-C-O 122.737 1.256 . . . . 0.0 110.034 -178.34 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 1.09 HD12 ' CG2' ' A' ' 110' ' ' VAL . 0.2 OUTLIER -101.95 156.22 4.73 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.152 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.188 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.17 143.22 30.99 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 121.465 0.65 . . . . 0.0 111.343 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.67 ' CE1' ' HB2' ' A' ' 92' ' ' TRP . 2.1 t80 -143.89 99.66 3.44 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.412 -0.805 . . . . 0.0 109.123 178.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.623 ' CB ' ' HG2' ' A' ' 36' ' ' GLN . 1.3 t -122.81 116.29 23.44 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.91 -1.119 . . . . 0.0 108.616 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.67 ' HB2' ' CE1' ' A' ' 90' ' ' TYR 0.271 0.3 OUTLIER -142.64 102.31 4.03 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.035 -177.635 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 13.3 p30 -75.62 153.66 37.12 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 119.607 -1.933 . . . . 0.0 109.461 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.881 HG22 ' O ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -153.11 175.38 3.01 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.781 -1.199 . . . . 0.0 108.606 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.563 ' HD2' ' HB ' ' A' ' 94' ' ' VAL . 18.6 Cg_endo -37.96 154.07 0.03 OUTLIER 'Trans proline' 0 CA--C 1.498 -1.321 0 O-C-N 123.64 1.337 . . . . 0.0 110.701 -177.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.858 ' HA ' ' HA3' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -79.54 -25.3 41.72 Favored 'General case' 0 C--N 1.284 -2.277 0 C-N-CA 116.614 -2.035 . . . . 0.0 115.526 -173.173 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.754 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -140.27 39.71 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 -177.658 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.93 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . . . -62.89 -64.48 2.98 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.519 -1.363 . . . . 0.0 108.353 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.93 ' HD3' ' HB3' ' A' ' 98' ' ' ALA . 51.5 Cg_endo -69.96 163.74 37.3 Favored 'Trans proline' 0 CA--C 1.46 -3.206 0 O-C-N 123.87 1.458 . . . . 0.0 108.852 177.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.735 ' HD2' ' C ' ' A' ' 99' ' ' PRO . 1.0 OUTLIER -105.14 103.7 13.3 Favored 'General case' 0 C--N 1.269 -2.902 0 CA-C-N 112.704 -2.044 . . . . 0.0 110.92 -168.596 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.465 ' C ' ' O ' ' A' ' 100' ' ' LYS . 7.5 p -43.43 96.78 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 123.566 1.65 . . . . 0.0 108.859 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.601 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.413 78.0 mt-10 -163.64 -50.77 0.03 OUTLIER 'General case' 0 CA--C 1.451 -2.832 0 CA-C-N 112.729 -2.032 . . . . 0.0 112.01 -179.331 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.491 21.9 t30 -159.07 81.58 0.78 Allowed 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 111.283 -2.69 . . . . 0.0 113.781 -162.15 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.901 HG22 ' HA ' ' A' ' 58' ' ' ILE . 34.0 t -143.22 133.91 22.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.122 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.851 ' CG1' HD11 ' A' ' 121' ' ' ILE . 60.9 t -142.48 134.56 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.967 HG23 ' HB2' ' A' ' 56' ' ' ALA . 1.3 p -112.65 146.84 16.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 122.956 1.36 . . . . 0.0 113.367 -178.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.98 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -132.82 108.52 9.02 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 178.272 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.006 HG21 HD12 ' A' ' 54' ' ' ILE . 3.6 t -125.29 141.9 43.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 120.094 -1.629 . . . . 0.0 109.056 -177.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.761 ' HB2' ' HB3' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -133.84 152.35 51.84 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.712 1.244 . . . . 0.0 113.047 -178.336 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 1.09 ' CG2' HD12 ' A' ' 88' ' ' ILE . 8.8 t -99.83 127.35 52.79 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.255 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 177.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.502 ' HG3' ' N ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -108.82 121.79 45.82 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.31 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.584 ' HA3' HD23 ' A' ' 117' ' ' LEU . . . -78.14 -137.36 1.11 Allowed Glycine 0 N--CA 1.497 2.742 0 C-N-CA 119.079 -1.534 . . . . 0.0 114.093 -175.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.672 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 10.0 p-10 -80.19 -5.11 55.52 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 122.366 1.079 . . . . 0.0 112.07 -177.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 9.7 p30 -130.05 -4.6 4.48 Favored 'General case' 0 C--N 1.266 -3.065 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.145 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.624 ' C ' HG12 ' A' ' 116' ' ' VAL . . . 88.59 85.55 1.24 Allowed Glycine 0 CA--C 1.469 -2.808 0 CA-C-O 124.886 2.381 . . . . 0.0 109.813 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.624 HG12 ' C ' ' A' ' 115' ' ' GLY . 4.5 p 145.41 145.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.245 -3.952 0 CA-C-N 108.43 -3.885 . . . . 0.0 111.833 177.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.805 ' CB ' HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -162.27 -57.43 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.495 -0.753 . . . . 0.0 110.755 179.605 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.87 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -173.81 130.09 0.41 Allowed 'General case' 0 N--CA 1.51 2.56 0 O-C-N 121.158 -0.964 . . . . 0.0 108.84 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.827 ' SG ' ' HB2' ' A' ' 9' ' ' ALA . 0.8 OUTLIER -134.44 144.31 48.06 Favored 'General case' 0 C--N 1.285 -2.23 0 C-N-CA 117.544 -1.662 . . . . 0.0 113.86 -177.469 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.541 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -147.24 138.18 23.7 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 123.034 1.397 . . . . 0.0 112.239 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.98 ' HB ' HG23 ' A' ' 107' ' ' THR 0.279 0.0 OUTLIER -109.37 132.31 57.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 CA-C-N 114.025 -1.443 . . . . 0.0 111.198 -179.19 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.753 ' N ' HD13 ' A' ' 121' ' ' ILE . . . . . . . . 0 N--CA 1.486 1.338 0 O-C-N 120.874 -1.141 . . . . 0.0 108.681 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 120.781 0.324 . . . . 0.0 111.006 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.745 HG12 ' HA ' ' A' ' 22' ' ' HIS . 1.4 m -145.59 179.56 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 O-C-N 120.836 -1.165 . . . . 0.0 108.174 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -79.47 137.02 37.08 Favored 'General case' 0 CA--C 1.48 -1.723 0 C-N-CA 118.117 -1.433 . . . . 0.0 108.693 177.881 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.584 HG11 ' CG2' ' A' ' 16' ' ' VAL 0.436 0.4 OUTLIER -169.44 -171.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.48 -169.858 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.555 ' CG ' ' O ' ' A' ' 5' ' ' VAL . 5.2 mtpp -166.2 146.95 6.46 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 123.931 1.824 . . . . 0.0 113.096 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.281 3.0 t70 -84.88 148.84 26.06 Favored 'General case' 0 C--N 1.264 -3.11 0 CA-C-N 112.58 -2.1 . . . . 0.0 109.043 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.667 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.7 p -137.27 15.95 2.99 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.94 -1.1 . . . . 0.0 109.226 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.846 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -125.65 -84.32 0.63 Allowed 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.137 -176.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.567 ' O ' ' N ' ' A' ' 12' ' ' GLU . 4.2 t-20 -156.35 65.19 0.55 Allowed 'General case' 0 C--N 1.268 -2.968 0 C-N-CA 118.523 -1.271 . . . . 0.0 111.783 177.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.468 ' C ' ' O ' ' A' ' 10' ' ' ASN . 10.4 m80 33.72 31.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.773 0.796 . . . . 0.0 110.73 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.4 OUTLIER -90.8 21.26 4.2 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.002 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.777 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.272 0.1 OUTLIER -119.82 -170.31 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 122.211 1.005 . . . . 0.0 110.611 -178.785 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.631 ' H ' HG23 ' A' ' 13' ' ' ILE . 11.2 ptmm? -162.09 -46.83 0.04 OUTLIER 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.143 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.577 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 21.6 tttt -142.81 135.15 27.51 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 116.045 -2.262 . . . . 0.0 113.178 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.973 HG12 ' HB2' ' A' ' 39' ' ' ALA . 0.6 OUTLIER -132.98 101.29 4.25 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 CA-C-O 123.03 1.395 . . . . 0.0 110.76 179.67 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.514 ' HA ' HD23 ' A' ' 17' ' ' LEU . 1.0 OUTLIER -95.04 129.04 42.28 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 113.987 -1.461 . . . . 0.0 111.857 179.282 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.995 HG22 ' HA ' ' A' ' 37' ' ' LEU . 78.4 t -142.21 145.57 36.08 Favored Pre-proline 0 N--CA 1.5 2.049 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.105 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.657 ' HD2' HG13 ' A' ' 18' ' ' VAL . 42.1 Cg_endo -68.81 105.93 1.4 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.677 1.357 . . . . 0.0 110.624 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.44 -91.13 0.11 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 38.2 m -90.74 159.16 16.48 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.295 -1.121 . . . . 0.0 110.78 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.745 ' HA ' HG12 ' A' ' 3' ' ' VAL . 6.8 p-80 -137.25 11.76 3.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.665 -1.272 . . . . 0.0 109.528 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.485 ' O ' ' HB3' ' A' ' 4' ' ' ASP . . . . . . . . 0 C--N 1.29 -2.026 0 C-N-CA 119.288 -1.434 . . . . 0.0 109.883 177.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.898 ' HA3' ' HA ' ' A' ' 96' ' ' LYS . . . . . . . . 0 C--O 1.213 -1.168 0 N-CA-C 108.09 -2.004 . . . . 0.0 108.09 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.846 ' HB2' HG12 ' A' ' 94' ' ' VAL . 2.3 mmmt -125.37 90.98 49.79 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 120.585 2.192 . . . . 0.0 115.302 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 65.0 Cg_endo -108.65 143.39 0.06 OUTLIER 'Trans proline' 0 C--N 1.291 -2.466 0 C-N-CA 124.378 3.385 . . . . 0.0 109.735 177.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.477 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 12.7 m-85 -125.05 95.68 4.58 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.07 -1.052 . . . . 0.0 109.737 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.602 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 28.2 mp0 -116.37 96.64 5.63 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.569 -0.707 . . . . 0.0 110.81 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.995 ' HA ' HG22 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -109.3 136.31 48.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.355 -1.466 . . . . 0.0 108.638 178.93 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -140.27 125.16 18.35 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.496 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.973 ' HB2' HG12 ' A' ' 16' ' ' VAL . . . -143.54 152.52 41.55 Favored 'General case' 0 C--N 1.274 -2.694 0 CA-C-O 122.955 1.36 . . . . 0.0 113.878 -175.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.581 ' O ' ' HG2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -110.71 140.34 30.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-N 113.766 -1.561 . . . . 0.0 108.305 177.834 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.584 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 4.0 p90 -159.33 125.04 4.29 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 5.5 tt0 -70.55 157.09 38.52 Favored 'General case' 0 C--N 1.286 -2.154 0 O-C-N 120.39 -1.444 . . . . 0.0 109.07 178.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.975 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -90.94 141.95 28.29 Favored 'General case' 0 C--N 1.267 -2.981 0 CA-C-N 114.217 -1.356 . . . . 0.0 108.847 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.65 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 17.5 p-10 -121.49 50.42 1.4 Allowed 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 125.281 2.467 . . . . 0.0 114.31 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.588 ' C ' ' HB2' ' A' ' 82' ' ' LYS . 6.5 pt20 167.15 -161.49 0.01 OUTLIER 'General case' 0 C--N 1.258 -3.386 0 CA-C-N 109.109 -3.678 . . . . 0.0 113.073 175.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.456 ' C ' HG22 ' A' ' 47' ' ' THR 0.277 48.5 t30 -110.11 153.51 24.59 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-O 122.572 1.177 . . . . 0.0 108.952 -178.68 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.658 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -173.26 156.64 3.19 Favored 'General case' 0 C--N 1.254 -3.581 0 C-N-CA 118.558 -1.257 . . . . 0.0 112.53 -178.394 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.944 ' O ' HG23 ' A' ' 49' ' ' THR . 0.0 OUTLIER -115.9 9.27 14.93 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 120.811 -1.18 . . . . 0.0 111.077 178.596 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.944 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.9 OUTLIER -166.5 147.54 6.28 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.768 -1.207 . . . . 0.0 110.723 179.491 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 70' ' ' PRO . . . -148.41 102.22 3.31 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 122.76 1.267 . . . . 0.0 110.366 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 12.3 mmtt -75.11 -174.68 2.36 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.716 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.975 ' CG2' HD11 ' A' ' 88' ' ' ILE . 45.7 mt -140.54 139.03 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.535 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.465 ' C ' HG13 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -140.37 110.09 6.39 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 123.349 1.547 . . . . 0.0 110.56 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.999 HD12 HG21 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -89.77 126.06 42.69 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.332 0 CA-C-N 112.527 -2.124 . . . . 0.0 108.979 179.29 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.1 tttp -121.68 103.18 8.7 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 177.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.892 ' HB3' HG22 ' A' ' 63' ' ' VAL . . . -110.03 126.58 54.12 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.527 -1.269 . . . . 0.0 111.86 -176.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.749 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 4.7 p -101.48 100.86 11.36 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.996 HD13 ' CB ' ' A' ' 99' ' ' PRO . 0.6 OUTLIER -111.31 111.78 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.679 0 CA-C-O 122.695 1.236 . . . . 0.0 110.313 -177.417 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.506 ' N ' HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER 30.74 62.54 0.2 Allowed 'General case' 0 N--CA 1.52 3.069 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.954 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.43 -12.43 7.63 Favored Glycine 0 N--CA 1.49 2.278 0 O-C-N 121.339 -0.851 . . . . 0.0 111.379 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.533 ' O ' HG13 ' A' ' 58' ' ' ILE 0.284 0.2 OUTLIER -107.9 56.32 0.63 Allowed 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.12 -1.223 . . . . 0.0 111.171 -178.655 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.605 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.362 0.0 OUTLIER -53.95 114.09 1.46 Allowed 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 122.16 0.981 . . . . 0.0 110.565 -179.754 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.892 HG22 ' HB3' ' A' ' 56' ' ' ALA . 19.0 m -76.98 140.46 17.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-O 122.759 1.266 . . . . 0.0 111.499 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.45 21.7 t0 -139.32 85.08 2.03 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.435 -176.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.581 ' CG2' ' HD2' ' A' ' 66' ' ' PRO . 9.9 p -159.31 150.35 16.18 Favored Pre-proline 0 C--N 1.275 -2.631 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.888 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.581 ' HD2' ' CG2' ' A' ' 65' ' ' VAL . 43.5 Cg_endo -73.18 138.04 27.16 Favored 'Trans proline' 0 C--N 1.319 -0.992 0 CA-C-O 123.725 1.469 . . . . 0.0 111.342 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.598 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -117.45 -53.51 0.31 Allowed Glycine 0 N--CA 1.51 3.574 0 CA-C-N 112.542 -2.117 . . . . 0.0 113.588 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.863 HD13 ' H ' ' A' ' 91' ' ' THR . 1.3 tp -117.28 -155.65 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-N 120.643 2.221 . . . . 0.0 110.22 -178.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.715 ' N ' HG23 ' A' ' 68' ' ' ILE . 1.1 t70 -107.92 89.17 5.17 Favored Pre-proline 0 N--CA 1.508 2.44 0 CA-C-O 122.82 1.295 . . . . 0.0 108.983 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.748 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 20.8 Cg_endo -49.05 -12.77 0.25 Allowed 'Trans proline' 0 C--N 1.285 -2.773 0 C-N-CA 124.121 3.214 . . . . 0.0 115.885 178.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.5 ' OD1' ' CD2' ' A' ' 74' ' ' HIS . 6.4 p30 -111.59 85.65 2.17 Favored 'General case' 0 C--N 1.288 -2.074 0 O-C-N 119.843 -1.785 . . . . 0.0 108.965 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.664 ' HA ' ' CD1' ' A' ' 75' ' ' TYR . . . -78.38 12.1 2.11 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.644 -0.66 . . . . 0.0 109.313 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.401 ' C ' ' H ' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -77.25 -20.6 54.95 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 120.666 -1.271 . . . . 0.0 108.002 -179.593 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.568 ' C ' ' CD1' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -87.84 19.04 3.7 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 173.885 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.664 ' CD1' ' HA ' ' A' ' 72' ' ' ALA . 0.4 OUTLIER -133.13 -9.78 2.97 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.032 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.475 ' O ' ' HG2' ' A' ' 76' ' ' MET . 2.3 ptt? -166.55 126.77 1.61 Allowed 'General case' 0 C--O 1.215 -0.74 0 CA-C-O 123.761 1.743 . . . . 0.0 113.219 178.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.659 ' O ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER 3.87 91.71 0.01 OUTLIER 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 111.999 -2.364 . . . . 0.0 114.134 -179.422 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.487 ' HA ' ' CD1' ' A' ' 80' ' ' LEU 0.331 7.3 t -110.21 139.26 21.26 Favored Pre-proline 0 C--N 1.269 -2.932 0 CA-C-N 111.441 -2.618 . . . . 0.0 107.614 177.519 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.671 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 36.7 Cg_endo -76.79 169.62 73.92 Favored 'Cis proline' 0 C--N 1.308 -1.555 0 C-N-CA 123.095 -1.627 . . . . 0.0 112.992 1.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.727 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -96.9 128.39 43.81 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.051 -179.4 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.527 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.9 t -106.96 138.67 31.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 124.169 1.938 . . . . 0.0 111.916 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.65 ' HG2' ' HA ' ' A' ' 44' ' ' ASN . 1.6 tmmt? -44.2 117.19 1.17 Allowed 'General case' 0 C--N 1.271 -2.837 0 CA-C-N 111.832 -2.44 . . . . 0.0 116.596 -175.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.431 ' O ' ' OE2' ' A' ' 42' ' ' GLU . . . 115.83 -17.09 15.76 Favored Glycine 0 C--N 1.292 -1.905 0 CA-C-N 111.752 -2.476 . . . . 0.0 107.963 178.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.619 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 31.8 mt-30 -71.43 127.76 33.63 Favored 'General case' 0 C--N 1.278 -2.542 0 CA-C-O 123.22 1.486 . . . . 0.0 111.766 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.596 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 3.0 pt20 -64.7 143.73 57.72 Favored 'General case' 0 C--N 1.272 -2.794 0 CA-C-N 113.326 -1.761 . . . . 0.0 107.072 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.975 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 17.9 m-85 -143.33 126.68 16.7 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 10.0 p30 -117.66 132.93 56.42 Favored 'General case' 0 C--N 1.275 -2.655 0 CA-C-O 122.703 1.239 . . . . 0.0 109.913 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 1.104 HD12 HG23 ' A' ' 110' ' ' VAL . 0.4 OUTLIER -102.58 157.7 4.73 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 CA-C-N 114.629 -1.168 . . . . 0.0 108.265 179.477 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -147.94 142.61 26.62 Favored 'General case' 0 C--N 1.283 -2.3 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.526 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.586 ' O ' ' HA ' ' A' ' 36' ' ' GLN . 17.4 t80 -151.54 108.57 3.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.148 -0.97 . . . . 0.0 110.401 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.863 ' H ' HD13 ' A' ' 68' ' ' ILE . 0.4 OUTLIER -125.11 122.26 36.63 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 120.515 -1.365 . . . . 0.0 108.093 179.163 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.598 ' CD1' ' O ' ' A' ' 67' ' ' GLY 0.27 0.1 OUTLIER -142.44 102.78 4.14 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.128 -176.933 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.504 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 12.1 p30 -74.93 157.15 35.48 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 119.676 -1.89 . . . . 0.0 108.829 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 33' ' ' LYS . 1.1 t -153.99 171.78 6.58 Favored Pre-proline 0 N--CA 1.486 1.333 0 O-C-N 120.792 -1.193 . . . . 0.0 109.13 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.827 ' CD ' HG13 ' A' ' 94' ' ' VAL . 18.8 Cg_endo -38.74 157.7 0.03 OUTLIER 'Trans proline' 0 CA--C 1.498 -1.294 0 O-C-N 123.833 1.439 . . . . 0.0 110.352 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.898 ' HA ' ' HA3' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -79.54 -21.8 44.72 Favored 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 116.282 -2.167 . . . . 0.0 115.558 -173.477 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.76 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -136.73 39.16 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -177.497 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.928 ' HB3' ' CD ' ' A' ' 99' ' ' PRO . . . -64.89 -73.51 0.21 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 120.483 -1.385 . . . . 0.0 108.562 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.996 ' CB ' HD13 ' A' ' 58' ' ' ILE . 53.8 Cg_endo -70.25 162.31 42.77 Favored 'Trans proline' 0 CA--C 1.463 -3.034 0 CA-C-O 123.177 1.24 . . . . 0.0 109.659 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.739 ' HD2' ' C ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -105.72 99.23 8.84 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 112.697 -2.047 . . . . 0.0 110.735 -169.003 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.455 ' C ' ' O ' ' A' ' 100' ' ' LYS . 12.8 p -46.77 99.84 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 123.654 1.692 . . . . 0.0 108.463 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.413 95.9 mt-10 -163.43 -51.65 0.04 OUTLIER 'General case' 0 CA--C 1.449 -2.911 0 CA-C-N 112.72 -2.036 . . . . 0.0 110.562 -179.474 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.445 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.499 31.3 t-20 -158.31 74.76 0.71 Allowed 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 110.504 -3.043 . . . . 0.0 111.295 -163.278 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.893 HG22 ' HA ' ' A' ' 58' ' ' ILE . 14.3 t -142.1 141.06 29.25 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.543 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.924 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.975 HG13 HD11 ' A' ' 121' ' ' ILE . 1.2 t -145.5 131.21 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.789 HG23 ' HB2' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -103.91 140.9 20.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 122.288 1.042 . . . . 0.0 111.704 -178.778 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . 1.023 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -132.47 110.75 10.73 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 179.427 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.999 HG21 HD12 ' A' ' 54' ' ' ILE . 3.6 t -125.73 140.83 47.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 O-C-N 120.133 -1.604 . . . . 0.0 109.229 -177.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.95 ' HB2' ' CB ' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -130.78 148.27 52.54 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 122.526 1.155 . . . . 0.0 112.057 -178.748 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 1.104 HG23 HD12 ' A' ' 88' ' ' ILE . 3.0 t -96.35 125.24 49.28 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 176.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.527 ' HG2' ' O ' ' A' ' 111' ' ' MET . 2.2 ptm -105.4 121.2 43.41 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.546 ' HA3' HD23 ' A' ' 117' ' ' LEU . . . -80.35 -139.31 2.21 Favored Glycine 0 N--CA 1.496 2.665 0 C-N-CA 119.031 -1.557 . . . . 0.0 114.311 -175.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.658 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 14.9 p-10 -77.8 -5.74 51.79 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 122.41 1.1 . . . . 0.0 112.051 -177.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 8.3 p30 -129.35 -5.27 4.83 Favored 'General case' 0 C--N 1.266 -3.057 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.097 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.692 ' C ' HG12 ' A' ' 116' ' ' VAL . . . 88.69 85.77 1.24 Allowed Glycine 0 CA--C 1.469 -2.844 0 CA-C-O 124.821 2.345 . . . . 0.0 109.745 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.692 HG12 ' C ' ' A' ' 115' ' ' GLY . 4.3 p 143.04 145.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.246 -3.91 0 CA-C-N 108.37 -3.915 . . . . 0.0 111.631 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.808 ' CB ' HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -162.05 -58.57 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.479 -0.763 . . . . 0.0 110.9 179.682 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.777 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -167.97 131.84 1.68 Allowed 'General case' 0 N--CA 1.514 2.747 0 O-C-N 121.31 -0.869 . . . . 0.0 109.161 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.95 ' CB ' ' HB2' ' A' ' 109' ' ' LYS . 0.8 OUTLIER -134.14 138.27 45.09 Favored 'General case' 0 C--N 1.28 -2.436 0 C-N-CA 117.428 -1.709 . . . . 0.0 113.595 -177.69 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.717 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -143.59 135.66 26.73 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 122.912 1.339 . . . . 0.0 112.248 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 1.023 ' HB ' HG23 ' A' ' 107' ' ' THR 0.277 0.0 OUTLIER -111.13 134.76 52.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 114.182 -1.372 . . . . 0.0 111.808 -178.863 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.757 ' N ' HD13 ' A' ' 121' ' ' ILE . . . . . . . . 0 N--CA 1.492 1.656 0 O-C-N 120.819 -1.176 . . . . 0.0 109.022 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.47 ' O ' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 120.628 0.251 . . . . 0.0 110.786 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.858 HG12 ' HA ' ' A' ' 22' ' ' HIS . 1.4 m -145.19 177.66 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 O-C-N 120.758 -1.214 . . . . 0.0 108.118 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.487 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -79.62 137.78 37.22 Favored 'General case' 0 CA--C 1.479 -1.761 0 C-N-CA 117.978 -1.489 . . . . 0.0 108.521 177.803 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.5 ' O ' ' HG2' ' A' ' 6' ' ' LYS 0.429 0.4 OUTLIER -166.16 168.67 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 C-N-CA 118.033 -1.467 . . . . 0.0 110.814 -169.785 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.52 ' HB2' HG22 ' A' ' 121' ' ' ILE . 0.8 OUTLIER -147.37 137.13 22.91 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 123.664 1.697 . . . . 0.0 112.312 -179.466 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.273 0.8 OUTLIER -80.17 146.28 31.87 Favored 'General case' 0 C--N 1.267 -2.987 0 CA-C-N 113.378 -1.737 . . . . 0.0 109.71 178.871 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.658 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.4 p -137.31 15.9 2.98 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.958 -1.089 . . . . 0.0 109.303 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.867 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -125.54 -85.26 0.63 Allowed 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.706 -1.197 . . . . 0.0 109.941 -177.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.565 ' O ' ' N ' ' A' ' 12' ' ' GLU . 3.9 t-20 -159.95 65.23 0.35 Allowed 'General case' 0 C--N 1.265 -3.07 0 C-N-CA 118.219 -1.392 . . . . 0.0 112.174 177.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.474 ' C ' ' O ' ' A' ' 10' ' ' ASN . 28.8 m170 33.79 31.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.777 0.799 . . . . 0.0 110.807 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.1 OUTLIER -90.51 23.26 3.07 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.908 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.079 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.28 0.0 OUTLIER -119.22 -168.75 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-O 121.978 0.894 . . . . 0.0 110.733 -178.616 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.636 ' N ' HG23 ' A' ' 13' ' ' ILE . 7.0 ptpt -162.54 -44.31 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.994 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.619 ' HB3' HG23 ' A' ' 40' ' ' VAL . 28.9 tttp -149.0 139.02 22.11 Favored 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 116.556 -2.057 . . . . 0.0 113.28 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 1.027 HG13 ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -133.21 107.41 11.29 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-O 122.841 1.305 . . . . 0.0 110.21 179.029 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.504 ' HA ' HD23 ' A' ' 17' ' ' LEU . 1.8 mt -106.77 129.25 54.67 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.124 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.683 HG22 ' HA ' ' A' ' 37' ' ' LEU . 11.9 t -141.41 144.84 35.5 Favored Pre-proline 0 C--N 1.294 -1.816 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.949 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.533 ' HD2' ' CG1' ' A' ' 18' ' ' VAL . 46.9 Cg_endo -71.26 112.77 3.41 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.725 1.381 . . . . 0.0 111.42 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 128.86 -84.95 0.32 Allowed Glycine 0 N--CA 1.488 2.148 0 C-N-CA 119.486 -1.34 . . . . 0.0 109.775 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.416 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 3.5 m -74.56 108.76 7.53 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.596 -0.943 . . . . 0.0 110.12 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.858 ' HA ' HG12 ' A' ' 3' ' ' VAL . 1.0 OUTLIER -121.75 17.59 11.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.037 -1.664 . . . . 0.0 110.887 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 C-N-CA 118.43 -1.843 . . . . 0.0 110.877 177.183 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.911 ' HA3' ' HA ' ' A' ' 96' ' ' LYS . . . . . . . . 0 C--O 1.215 -1.038 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.813 ' O ' HG22 ' A' ' 94' ' ' VAL . 1.5 mmmp? -126.21 89.87 51.35 Favored Pre-proline 0 C--O 1.22 -0.448 0 CA-C-N 120.83 2.315 . . . . 0.0 115.734 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.554 ' C ' ' CD1' ' A' ' 35' ' ' PHE . 60.8 Cg_endo -109.32 141.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.29 -2.515 0 C-N-CA 124.673 3.582 . . . . 0.0 108.743 177.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.554 ' CD1' ' C ' ' A' ' 34' ' ' PRO . 1.0 OUTLIER -124.14 98.22 5.68 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 118.075 -1.45 . . . . 0.0 110.311 179.358 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.588 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 26.3 mp0 -114.15 81.28 1.51 Allowed 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.683 ' HA ' HG22 ' A' ' 18' ' ' VAL . 3.4 pp -113.07 142.46 45.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.674 -1.266 . . . . 0.0 110.181 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -140.47 138.01 34.31 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 122.595 1.188 . . . . 0.0 108.451 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 1.027 ' HB2' HG13 ' A' ' 16' ' ' VAL . . . -142.07 153.11 43.93 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-O 123.03 1.395 . . . . 0.0 113.292 -176.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.619 HG23 ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.41 141.21 26.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 113.697 -1.592 . . . . 0.0 109.007 178.47 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.578 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 3.5 p90 -155.79 121.78 5.06 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 8.8 tt0 -68.22 156.38 37.73 Favored 'General case' 0 C--N 1.287 -2.125 0 O-C-N 120.35 -1.469 . . . . 0.0 109.178 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.936 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -92.22 136.36 33.25 Favored 'General case' 0 C--N 1.269 -2.921 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.807 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.584 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 16.6 p-10 -116.65 49.73 1.13 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 125.376 2.512 . . . . 0.0 113.78 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.586 ' C ' ' HB2' ' A' ' 82' ' ' LYS . 6.4 pt20 166.59 -158.35 0.01 OUTLIER 'General case' 0 C--N 1.258 -3.401 0 CA-C-N 108.999 -3.728 . . . . 0.0 112.97 175.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.538 ' C ' HG22 ' A' ' 47' ' ' THR 0.285 9.1 t30 -109.99 154.78 22.69 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-O 122.596 1.188 . . . . 0.0 108.97 -178.881 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.63 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.1 OUTLIER -172.85 150.97 2.15 Favored 'General case' 0 C--N 1.255 -3.535 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.202 -178.275 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.949 ' O ' HG23 ' A' ' 49' ' ' THR . 0.3 OUTLIER -112.28 11.16 20.1 Favored 'General case' 0 N--CA 1.506 2.371 0 C-N-CA 118.16 -1.416 . . . . 0.0 110.185 178.406 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.949 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.61 145.49 3.81 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 120.706 -1.246 . . . . 0.0 111.069 178.6 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 111' ' ' MET . . . -139.73 95.13 2.86 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-O 122.988 1.375 . . . . 0.0 109.544 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -65.92 -178.27 0.57 Allowed 'General case' 0 C--N 1.281 -2.374 0 CA-C-N 113.836 -1.529 . . . . 0.0 109.711 178.98 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.821 ' CG1' HD11 ' A' ' 88' ' ' ILE . 35.7 mt -142.14 144.18 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.357 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 0.4 OUTLIER -140.52 104.01 4.66 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 123.425 1.583 . . . . 0.0 109.75 178.397 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 1.057 ' HA ' HG13 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -93.06 126.29 45.51 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 CA-C-N 112.503 -2.135 . . . . 0.0 107.301 179.252 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.869 ' N ' HD13 ' A' ' 54' ' ' ILE . 0.5 OUTLIER -129.86 149.84 51.42 Favored 'General case' 0 C--N 1.272 -2.802 0 C-N-CA 118.448 -1.301 . . . . 0.0 108.145 178.836 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 1.05 ' HB3' HG22 ' A' ' 63' ' ' VAL . . . -135.58 127.46 29.41 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 117.694 -1.603 . . . . 0.0 111.475 -178.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.746 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 2.2 p -101.3 100.3 10.78 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 177.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.931 ' HA ' HG22 ' A' ' 104' ' ' VAL . 0.8 OUTLIER -115.47 102.4 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.738 0 CA-C-O 123.089 1.423 . . . . 0.0 110.983 -176.613 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.571 ' N ' HG22 ' A' ' 104' ' ' VAL . 0.1 OUTLIER 38.28 64.95 0.65 Allowed 'General case' 0 N--CA 1.521 3.121 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.326 179.055 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.53 -13.66 7.91 Favored Glycine 0 N--CA 1.489 2.176 0 O-C-N 121.263 -0.898 . . . . 0.0 111.311 177.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.495 ' HB3' HG13 ' A' ' 58' ' ' ILE 0.278 0.3 OUTLIER -108.14 54.88 0.65 Allowed 'General case' 0 C--N 1.294 -1.841 0 O-C-N 121.205 -1.173 . . . . 0.0 111.495 -178.528 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.635 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.366 0.0 OUTLIER -59.4 117.5 4.91 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 122.527 1.156 . . . . 0.0 111.397 -179.531 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 1.05 HG22 ' HB3' ' A' ' 56' ' ' ALA . 18.8 m -80.19 148.22 5.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-O 122.56 1.172 . . . . 0.0 111.103 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.441 5.9 t70 -137.8 82.11 1.9 Allowed 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.319 -176.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.602 HG22 ' HD2' ' A' ' 66' ' ' PRO . 9.8 p -164.23 151.46 10.25 Favored Pre-proline 0 C--N 1.277 -2.565 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.427 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.602 ' HD2' HG22 ' A' ' 65' ' ' VAL . 45.5 Cg_endo -85.43 139.14 6.72 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 CA-C-O 123.643 1.435 . . . . 0.0 111.719 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.588 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -127.66 48.08 0.99 Allowed Glycine 0 N--CA 1.501 3.02 0 CA-C-N 112.69 -2.05 . . . . 0.0 110.77 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.57 ' O ' ' HD2' ' A' ' 70' ' ' PRO 0.302 5.8 tp 179.68 -174.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 CA-C-N 119.476 1.638 . . . . 0.0 110.024 -178.607 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.585 ' OD2' ' CZ ' ' A' ' 75' ' ' TYR . 1.1 t70 -109.71 84.25 3.18 Favored Pre-proline 0 N--CA 1.504 2.252 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 175.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.786 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 21.0 Cg_endo -48.92 -9.64 0.1 OUTLIER 'Trans proline' 0 C--N 1.279 -3.097 0 C-N-CA 123.556 2.837 . . . . 0.0 115.312 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.551 ' HB2' ' NE2' ' A' ' 74' ' ' HIS . 1.7 m-20 -105.42 83.8 2.01 Favored 'General case' 0 C--N 1.287 -2.151 0 O-C-N 120.212 -1.555 . . . . 0.0 108.699 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.644 ' HA ' ' CD1' ' A' ' 75' ' ' TYR . . . -78.44 10.79 2.84 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.505 -0.747 . . . . 0.0 109.402 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.61 -19.92 54.76 Favored 'General case' 0 C--N 1.317 -0.842 0 O-C-N 120.507 -1.371 . . . . 0.0 108.177 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.578 ' ND1' ' N ' ' A' ' 74' ' ' HIS . 0.1 OUTLIER -88.24 18.85 4.06 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 174.203 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.644 ' CD1' ' HA ' ' A' ' 72' ' ' ALA . 0.4 OUTLIER -133.18 -9.38 2.97 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.241 179.774 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.485 ' O ' ' C ' ' A' ' 77' ' ' LYS . 1.6 ptt? -162.62 128.18 3.33 Favored 'General case' 0 C--O 1.215 -0.749 0 CA-C-O 123.6 1.667 . . . . 0.0 112.859 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.578 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 0.6 OUTLIER -4.47 86.93 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 112.042 -2.345 . . . . 0.0 113.559 -178.711 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.472 ' HA ' HD13 ' A' ' 80' ' ' LEU 0.297 11.1 t -99.02 136.92 20.43 Favored Pre-proline 0 C--N 1.262 -3.197 0 CA-C-N 111.364 -2.653 . . . . 0.0 108.714 178.094 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.701 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 37.3 Cg_endo -78.48 165.95 81.24 Favored 'Cis proline' 0 C--N 1.312 -1.343 0 C-N-CA 123.007 -1.664 . . . . 0.0 112.906 1.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.714 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -89.1 127.39 35.71 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.44 179.445 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.528 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.7 t -106.32 139.47 27.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-O 124.129 1.918 . . . . 0.0 111.616 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.586 ' HB2' ' C ' ' A' ' 45' ' ' GLN . 1.6 tmmt? -44.38 117.97 1.4 Allowed 'General case' 0 C--N 1.271 -2.842 0 CA-C-N 111.686 -2.507 . . . . 0.0 116.924 -175.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.19 -17.6 16.77 Favored Glycine 0 C--N 1.293 -1.808 0 CA-C-N 111.693 -2.503 . . . . 0.0 107.845 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.626 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 49.4 mt-30 -72.63 128.63 36.14 Favored 'General case' 0 C--N 1.277 -2.56 0 CA-C-O 123.215 1.483 . . . . 0.0 111.585 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.581 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 2.9 mt-30 -66.47 145.87 55.18 Favored 'General case' 0 C--N 1.27 -2.859 0 CA-C-N 113.336 -1.756 . . . . 0.0 107.437 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.936 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 19.4 m-85 -142.53 124.92 15.59 Favored 'General case' 0 C--N 1.275 -2.64 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -178.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.576 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 4.5 p30 -116.93 133.29 56.2 Favored 'General case' 0 C--N 1.278 -2.543 0 CA-C-O 122.772 1.272 . . . . 0.0 110.233 -177.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.821 HD11 ' CG1' ' A' ' 52' ' ' ILE . 1.1 tp -108.73 159.4 8.15 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 CA-C-N 114.46 -1.246 . . . . 0.0 108.335 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.521 ' HG2' ' N ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -143.24 149.63 38.18 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 120.125 -0.63 . . . . 0.0 112.182 -176.935 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.605 ' CE1' ' HB2' ' A' ' 92' ' ' TRP . 25.5 t80 -147.22 105.62 3.79 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.421 -0.799 . . . . 0.0 110.489 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.588 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 1.1 t -123.93 110.9 15.4 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.605 ' HB2' ' CE1' ' A' ' 90' ' ' TYR 0.272 0.0 OUTLIER -142.41 109.11 5.39 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.719 -176.662 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 12.3 p30 -77.29 153.09 34.23 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 119.735 -1.853 . . . . 0.0 109.496 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.813 HG22 ' O ' ' A' ' 33' ' ' LYS . 0.8 OUTLIER -154.31 175.36 3.11 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 120.682 -1.261 . . . . 0.0 108.999 -179.73 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.569 ' HD2' ' HB ' ' A' ' 94' ' ' VAL . 18.3 Cg_endo -38.12 156.38 0.03 OUTLIER 'Trans proline' 0 CA--C 1.495 -1.464 0 O-C-N 123.589 1.31 . . . . 0.0 111.127 -177.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.911 ' HA ' ' HA3' ' A' ' 32' ' ' GLY . 2.4 mptt -80.12 -27.97 39.05 Favored 'General case' 0 C--N 1.285 -2.218 0 C-N-CA 116.555 -2.058 . . . . 0.0 116.04 -173.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.774 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -145.42 43.22 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 -177.348 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.939 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . . . -60.33 -53.27 66.49 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 120.367 -1.458 . . . . 0.0 109.736 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.939 ' HD3' ' HB3' ' A' ' 98' ' ' ALA . 55.6 Cg_endo -73.67 160.78 43.3 Favored 'Trans proline' 0 CA--C 1.466 -2.904 0 O-C-N 124.145 1.603 . . . . 0.0 111.13 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.722 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -110.27 106.37 15.75 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 112.236 -2.256 . . . . 0.0 111.104 -169.392 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.473 ' C ' ' O ' ' A' ' 100' ' ' LYS . 1.5 p -40.88 95.32 0.01 OUTLIER 'General case' 0 N--CA 1.519 3.021 0 CA-C-O 123.496 1.617 . . . . 0.0 110.469 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.581 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.387 84.7 mt-10 -164.93 -52.72 0.03 OUTLIER 'General case' 0 CA--C 1.448 -2.952 0 CA-C-N 112.959 -1.928 . . . . 0.0 111.214 178.468 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.461 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.486 33.9 t-20 -161.25 77.62 0.56 Allowed 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 110.583 -3.008 . . . . 0.0 113.466 -162.016 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.931 HG22 ' HA ' ' A' ' 58' ' ' ILE . 21.8 t -144.28 141.44 24.37 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.63 0 C-N-CA 119.32 -0.952 . . . . 0.0 111.907 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.698 HG12 ' CD1' ' A' ' 121' ' ' ILE . 0.3 OUTLIER -153.75 133.26 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 121' ' ' ILE . 0.4 OUTLIER -94.32 143.56 11.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-O 122.357 1.075 . . . . 0.0 110.994 -179.287 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . 1.074 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -131.75 116.65 17.56 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 179.642 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.057 HG13 ' HA ' ' A' ' 54' ' ' ILE . 3.5 t -132.19 139.37 50.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 O-C-N 120.247 -1.533 . . . . 0.0 108.481 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 1.009 ' HB2' ' HB2' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -132.96 146.49 51.83 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.364 1.078 . . . . 0.0 111.187 -178.44 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.655 ' CG2' HD13 ' A' ' 88' ' ' ILE . 2.9 t -99.94 127.8 52.47 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 178.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.504 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -108.29 121.99 46.03 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -179.771 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -74.62 -131.34 0.24 Allowed Glycine 0 C--N 1.283 -2.39 0 C-N-CA 119.22 -1.467 . . . . 0.0 114.625 -175.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.63 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 6.2 p-10 -97.76 9.56 42.3 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -175.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 32.7 p30 -167.17 -13.68 0.02 OUTLIER 'General case' 0 C--N 1.263 -3.156 0 C-N-CA 117.224 -1.791 . . . . 0.0 114.464 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -153.66 -88.15 0.06 OUTLIER Glycine 0 CA--C 1.475 -2.463 0 CA-C-O 125.879 2.933 . . . . 0.0 112.338 -177.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.629 HG22 ' H ' ' A' ' 117' ' ' LEU . 4.1 p -141.51 178.93 2.39 Favored 'Isoleucine or valine' 1 C--N 1.228 -4.692 1 CA-C-N 108.155 -4.022 . . . . 0.0 111.014 -176.785 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.642 ' HB3' HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -149.3 -62.72 0.23 Allowed 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.255 -179.422 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 1.079 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -164.15 129.66 2.91 Favored 'General case' 0 N--CA 1.51 2.526 0 O-C-N 120.872 -1.142 . . . . 0.0 109.756 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 1.009 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 1.5 p -133.98 134.73 42.85 Favored 'General case' 0 C--N 1.283 -2.321 0 C-N-CA 117.975 -1.49 . . . . 0.0 113.35 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.4 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -144.17 136.3 26.42 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 122.913 1.339 . . . . 0.0 112.153 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 1.074 ' HB ' HG23 ' A' ' 107' ' ' THR 0.268 0.1 OUTLIER -110.79 130.78 63.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.176 -179.495 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.659 ' N ' HD13 ' A' ' 121' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.536 0 O-C-N 120.862 -1.149 . . . . 0.0 108.977 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 120.715 0.293 . . . . 0.0 111.042 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.744 HG12 ' HA ' ' A' ' 22' ' ' HIS . 1.4 m -145.58 177.6 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 O-C-N 120.892 -1.13 . . . . 0.0 108.032 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.49 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -80.22 139.3 36.78 Favored 'General case' 0 CA--C 1.477 -1.864 0 C-N-CA 118.007 -1.477 . . . . 0.0 108.823 177.502 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.517 HG11 HG23 ' A' ' 16' ' ' VAL 0.425 0.4 OUTLIER -168.58 160.71 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 CA-C-N 114.029 -1.442 . . . . 0.0 110.057 -170.22 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 5' ' ' VAL . 3.5 mtpt -144.44 140.12 28.77 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 123.785 1.755 . . . . 0.0 113.116 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.27 4.4 t0 -76.36 147.81 37.83 Favored 'General case' 0 C--N 1.267 -2.994 0 CA-C-N 112.932 -1.94 . . . . 0.0 109.786 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.648 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.0 p -137.04 16.01 3.04 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.968 -1.082 . . . . 0.0 109.162 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.876 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -125.03 -82.71 0.64 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.033 -176.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.574 ' O ' ' N ' ' A' ' 12' ' ' GLU . 3.8 t-20 -155.79 63.56 0.59 Allowed 'General case' 0 C--N 1.267 -2.991 0 C-N-CA 118.319 -1.352 . . . . 0.0 111.81 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.478 ' C ' ' O ' ' A' ' 10' ' ' ASN . 59.2 m-70 32.02 33.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.854 0.835 . . . . 0.0 110.573 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.6 OUTLIER -95.09 22.47 6.61 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.72 -0.792 . . . . 0.0 111.591 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.026 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.276 0.2 OUTLIER -118.42 -170.36 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.413 -0.804 . . . . 0.0 110.001 -179.116 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.62 ' H ' HG23 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -161.86 -41.43 0.04 OUTLIER 'General case' 0 C--N 1.29 -2.011 0 O-C-N 121.731 -0.605 . . . . 0.0 111.492 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.586 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 11.6 tttm -147.72 138.13 23.08 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 115.89 -2.324 . . . . 0.0 113.145 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.829 HG13 ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -134.52 104.11 5.25 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 CA-C-O 122.897 1.332 . . . . 0.0 110.363 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.501 ' HB2' ' OE2' ' A' ' 38' ' ' GLU . 1.2 mt -99.52 125.65 45.32 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.776 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.706 HG22 ' CB ' ' A' ' 37' ' ' LEU . 40.5 t -141.72 145.4 36.85 Favored Pre-proline 0 N--CA 1.5 2.03 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.025 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.542 ' HD2' ' CG1' ' A' ' 18' ' ' VAL . 44.7 Cg_endo -68.64 134.87 31.6 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 O-C-N 123.772 1.406 . . . . 0.0 111.312 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.48 -76.24 0.22 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.2 m -85.7 134.05 33.99 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.468 -1.019 . . . . 0.0 109.651 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.744 ' HA ' HG12 ' A' ' 3' ' ' VAL . 13.7 p-80 -142.26 12.55 1.98 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 119.998 -1.689 . . . . 0.0 110.948 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 C-N-CA 118.364 -1.874 . . . . 0.0 110.931 177.102 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.888 ' HA2' ' HA ' ' A' ' 96' ' ' LYS . . . . . . . . 0 C--O 1.213 -1.178 0 N-CA-C 105.887 -2.885 . . . . 0.0 105.887 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.973 ' HB2' HG12 ' A' ' 94' ' ' VAL . 0.7 OUTLIER -117.28 96.77 49.84 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 120.66 2.23 . . . . 0.0 116.577 -175.059 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.592 ' HD3' ' O ' ' A' ' 32' ' ' GLY . 60.8 Cg_endo -107.02 145.39 0.08 OUTLIER 'Trans proline' 0 C--N 1.288 -2.631 0 C-N-CA 123.864 3.042 . . . . 0.0 108.546 176.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.73 ' HZ ' HG11 ' A' ' 94' ' ' VAL . 0.5 OUTLIER -120.53 96.52 5.17 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 118.582 -1.247 . . . . 0.0 109.182 179.002 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.594 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 28.0 mp0 -113.82 83.71 1.9 Allowed 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.706 ' CB ' HG22 ' A' ' 18' ' ' VAL . 2.1 pp -110.17 144.68 38.45 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.686 -1.258 . . . . 0.0 109.768 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.546 ' CB ' ' HG2' ' A' ' 89' ' ' LYS . 1.5 pp20? -140.44 139.07 35.14 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 122.7 1.238 . . . . 0.0 108.816 -178.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.829 ' HB2' HG13 ' A' ' 16' ' ' VAL . . . -142.56 148.74 38.04 Favored 'General case' 0 C--N 1.275 -2.649 0 CA-C-O 122.986 1.374 . . . . 0.0 112.968 -176.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.586 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.35 140.07 31.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 113.817 -1.538 . . . . 0.0 108.87 178.535 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.607 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 6.7 p90 -157.19 126.93 6.17 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -178.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 17.3 tt0 -70.41 156.96 38.64 Favored 'General case' 0 C--N 1.283 -2.319 0 O-C-N 120.388 -1.445 . . . . 0.0 108.815 178.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.982 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -89.41 136.07 33.24 Favored 'General case' 0 C--N 1.265 -3.089 0 CA-C-N 114.21 -1.359 . . . . 0.0 107.996 178.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.569 ' C ' ' HG2' ' A' ' 45' ' ' GLN . 16.9 p-10 -117.43 49.93 1.16 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 125.398 2.523 . . . . 0.0 114.242 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.748 ' N ' ' HG3' ' A' ' 82' ' ' LYS . 7.0 pt20 167.54 -159.18 0.01 OUTLIER 'General case' 0 C--N 1.258 -3.393 0 CA-C-N 108.77 -3.832 . . . . 0.0 112.901 174.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.445 ' C ' HG22 ' A' ' 47' ' ' THR 0.274 20.3 t-20 -108.78 153.55 23.32 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-O 122.622 1.201 . . . . 0.0 108.408 -178.884 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.615 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -172.65 154.33 3.01 Favored 'General case' 0 C--N 1.254 -3.569 0 C-N-CA 118.588 -1.245 . . . . 0.0 112.836 -178.215 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.956 ' O ' HG23 ' A' ' 49' ' ' THR . 1.2 mtpm? -115.07 7.03 15.35 Favored 'General case' 0 N--CA 1.508 2.452 0 O-C-N 120.74 -1.225 . . . . 0.0 110.926 178.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.956 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.93 149.81 4.45 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.608 -1.307 . . . . 0.0 111.194 179.862 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 70' ' ' PRO . . . -150.59 109.07 3.8 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-O 122.55 1.167 . . . . 0.0 110.954 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 1.2 ptpt -77.24 -173.39 2.81 Favored 'General case' 0 N--CA 1.506 2.327 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.368 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.817 ' CG1' HD11 ' A' ' 88' ' ' ILE . 35.0 mt -141.84 139.92 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.368 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.419 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.428 ' C ' HG13 ' A' ' 108' ' ' VAL . 3.5 tp10 -140.79 110.03 6.22 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 123.343 1.544 . . . . 0.0 111.168 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 1.013 HD12 HG21 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -91.12 128.59 42.82 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 CA-C-N 112.746 -2.024 . . . . 0.0 109.934 179.373 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.418 ' HD2' ' C ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -123.77 103.85 8.62 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 176.84 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.847 ' HB2' HG23 ' A' ' 106' ' ' VAL . . . -113.75 134.41 54.78 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 118.708 -1.197 . . . . 0.0 113.183 -175.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.7 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.1 p -106.64 100.79 10.28 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 178.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.867 ' CA ' HG13 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -110.68 107.84 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.939 0 CA-C-O 122.986 1.374 . . . . 0.0 110.774 -177.259 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.655 ' N ' HG22 ' A' ' 104' ' ' VAL . 0.5 OUTLIER 33.06 63.49 0.33 Allowed 'General case' 0 N--CA 1.519 2.992 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.977 179.634 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.72 -14.31 10.3 Favored Glycine 0 N--CA 1.489 2.2 0 O-C-N 121.352 -0.842 . . . . 0.0 111.525 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.511 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.274 0.3 OUTLIER -108.19 57.68 0.62 Allowed 'General case' 0 C--N 1.292 -1.897 0 O-C-N 121.087 -1.243 . . . . 0.0 111.175 -178.536 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.519 ' O ' ' CG ' ' A' ' 62' ' ' GLU 0.366 0.0 OUTLIER -58.61 114.44 2.49 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 122.1 0.952 . . . . 0.0 111.139 -179.696 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.836 HG22 ' HB3' ' A' ' 56' ' ' ALA . 15.0 m -74.95 144.89 11.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 122.586 1.184 . . . . 0.0 110.573 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.435 19.2 t0 -138.07 68.94 1.39 Allowed 'General case' 0 C--N 1.278 -2.526 0 CA-C-O 122.621 1.2 . . . . 0.0 110.572 -176.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.722 HG22 ' HD2' ' A' ' 66' ' ' PRO . 4.8 p -164.03 151.89 10.87 Favored Pre-proline 0 C--N 1.272 -2.797 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.952 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.722 ' HD2' HG22 ' A' ' 65' ' ' VAL . 43.4 Cg_endo -83.26 137.84 8.49 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 CA-C-O 123.804 1.502 . . . . 0.0 111.719 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -125.19 50.14 0.88 Allowed Glycine 0 C--N 1.273 -2.963 0 CA-C-N 112.461 -2.154 . . . . 0.0 110.253 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.578 ' HB ' ' CD2' ' A' ' 90' ' ' TYR 0.304 6.4 tp -178.78 -176.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 O-C-N 120.532 -1.569 . . . . 0.0 110.061 -178.56 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.497 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 29.9 t0 -112.35 83.64 5.45 Favored Pre-proline 0 N--CA 1.502 2.154 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 175.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.71 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 19.1 Cg_endo -47.68 -8.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.289 -2.601 0 C-N-CA 124.275 3.317 . . . . 0.0 115.826 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.578 ' HB2' ' NE2' ' A' ' 74' ' ' HIS . 2.4 m-80 -101.62 90.41 4.04 Favored 'General case' 0 C--N 1.286 -2.167 0 O-C-N 120.2 -1.562 . . . . 0.0 109.74 -178.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.784 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . . . -78.02 7.14 6.52 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.295 -0.878 . . . . 0.0 109.478 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.9 t -79.11 -26.58 42.9 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 121.034 -1.041 . . . . 0.0 109.044 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.578 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -79.71 6.78 9.9 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.895 -1.122 . . . . 0.0 108.943 177.217 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.784 ' CD2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -133.68 -0.48 3.17 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 121.364 -0.835 . . . . 0.0 109.966 177.636 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.631 ' HE3' HD21 ' A' ' 80' ' ' LEU . 2.6 ptt? -150.34 126.81 10.79 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 123.89 1.805 . . . . 0.0 112.86 178.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.541 ' O ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -20.07 95.25 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 112.006 -2.361 . . . . 0.0 113.159 -178.255 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.508 ' HA ' HD13 ' A' ' 80' ' ' LEU 0.311 0.5 OUTLIER -100.77 144.47 28.58 Favored Pre-proline 0 C--N 1.268 -2.968 0 CA-C-N 111.437 -2.62 . . . . 0.0 109.128 179.01 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.647 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 35.8 Cg_endo -81.37 168.81 68.08 Favored 'Cis proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.792 -1.753 . . . . 0.0 112.16 0.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.722 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -96.75 130.25 44.03 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.25 -179.389 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.541 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.8 t -106.35 139.41 27.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-O 124.109 1.909 . . . . 0.0 111.954 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.748 ' HG3' ' N ' ' A' ' 45' ' ' GLN . 2.3 tmpt? -42.65 120.96 1.86 Allowed 'General case' 0 C--N 1.271 -2.841 0 CA-C-N 111.902 -2.408 . . . . 0.0 115.955 -175.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.35 -16.63 24.43 Favored Glycine 0 C--N 1.291 -1.957 0 CA-C-N 111.97 -2.377 . . . . 0.0 108.38 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 62.6 mt-30 -73.61 126.42 30.25 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-O 123.223 1.487 . . . . 0.0 111.786 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.608 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 2.4 pt20 -64.04 143.18 58.07 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 113.271 -1.786 . . . . 0.0 107.539 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.982 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 18.7 m-85 -143.29 126.01 16.02 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.58 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 1.2 p-10 -117.12 132.55 56.64 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-O 122.712 1.244 . . . . 0.0 109.902 -178.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.817 HD11 ' CG1' ' A' ' 52' ' ' ILE . 0.9 OUTLIER -110.55 160.79 9.46 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.24 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.546 ' HG2' ' CB ' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -148.15 161.15 42.03 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-O 122.031 0.92 . . . . 0.0 113.203 -177.209 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.578 ' CD2' ' HB ' ' A' ' 68' ' ' ILE . 28.0 t80 -151.17 105.62 3.24 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.559 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.594 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 0.6 OUTLIER -122.3 111.51 17.0 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 178.806 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.577 ' CD1' ' O ' ' A' ' 67' ' ' GLY 0.271 0.3 OUTLIER -141.99 116.81 9.84 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.446 -176.824 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 6.5 p30 -75.16 161.72 29.13 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 119.237 -2.164 . . . . 0.0 109.795 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.973 HG12 ' HB2' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -151.48 165.84 16.5 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.896 ' HD2' HG22 ' A' ' 94' ' ' VAL . 19.8 Cg_endo -38.26 154.26 0.03 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.178 0 O-C-N 123.586 1.309 . . . . 0.0 110.505 -177.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.888 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 8.5 mptt -79.35 -28.15 42.03 Favored 'General case' 0 C--N 1.285 -2.228 0 C-N-CA 116.566 -2.053 . . . . 0.0 114.725 -173.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.758 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -143.41 43.07 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 CA-C-O 121.402 0.62 . . . . 0.0 112.541 -178.695 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.941 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . . . -76.53 -64.48 0.48 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 120.562 -1.336 . . . . 0.0 109.903 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.941 ' HD3' ' HB3' ' A' ' 98' ' ' ALA . 47.2 Cg_endo -66.13 159.87 47.48 Favored 'Trans proline' 0 CA--C 1.463 -3.057 0 O-C-N 123.94 1.495 . . . . 0.0 110.045 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.71 ' HD2' ' C ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -108.58 105.39 14.99 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-N 112.517 -2.129 . . . . 0.0 109.874 -169.587 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.472 ' C ' ' O ' ' A' ' 100' ' ' LYS . 5.5 p -46.2 98.62 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 123.37 1.557 . . . . 0.0 108.195 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.593 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.402 88.1 mt-10 -164.0 -51.54 0.03 OUTLIER 'General case' 0 CA--C 1.448 -2.945 0 CA-C-N 113.195 -1.82 . . . . 0.0 111.987 -179.115 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.481 32.1 t-20 -159.52 78.27 0.71 Allowed 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 111.159 -2.746 . . . . 0.0 114.01 -162.073 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.867 HG13 ' CA ' ' A' ' 58' ' ' ILE . 28.5 t -142.31 137.8 29.45 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.875 178.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 1.092 HG12 HD11 ' A' ' 121' ' ' ILE . 22.0 t -147.14 133.93 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.847 HG23 ' HB2' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -106.87 146.73 12.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-O 122.806 1.288 . . . . 0.0 113.033 -178.26 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . 1.045 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -132.86 109.57 9.71 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.432 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.013 HG21 HD12 ' A' ' 54' ' ' ILE . 3.9 t -127.07 144.88 35.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 119.954 -1.716 . . . . 0.0 109.043 -177.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 1.014 ' HB2' ' HB2' ' A' ' 119' ' ' CYS . 0.1 OUTLIER -136.48 143.05 43.61 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.137 0.97 . . . . 0.0 111.571 -178.018 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.643 ' CG2' HD13 ' A' ' 88' ' ' ILE . 20.9 t -96.28 130.97 44.2 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.622 ' CG ' ' HA2' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -110.69 119.53 39.45 Favored 'General case' 0 N--CA 1.509 2.506 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -178.717 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.483 ' HA3' HD23 ' A' ' 117' ' ' LEU . . . -81.69 -140.41 3.12 Favored Glycine 0 N--CA 1.5 2.946 0 C-N-CA 119.449 -1.357 . . . . 0.0 115.195 -174.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.615 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 4.4 p-10 -82.38 -6.44 59.27 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 122.267 1.032 . . . . 0.0 112.743 -176.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -128.86 -5.24 5.1 Favored 'General case' 0 C--N 1.262 -3.218 0 CA-C-O 121.747 0.784 . . . . 0.0 110.3 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.622 ' HA2' ' CG ' ' A' ' 111' ' ' MET . . . 94.43 85.3 1.64 Allowed Glycine 0 CA--C 1.471 -2.662 0 CA-C-O 124.595 2.219 . . . . 0.0 110.871 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.612 HG12 ' C ' ' A' ' 115' ' ' GLY . 7.5 p 137.11 153.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.251 -3.695 0 CA-C-N 108.409 -3.895 . . . . 0.0 112.451 176.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.632 ' CB ' HG12 ' A' ' 110' ' ' VAL . 0.2 OUTLIER -160.94 -59.97 0.06 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.284 0.564 . . . . 0.0 110.232 179.376 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 1.026 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -170.86 130.1 0.8 Allowed 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.204 -0.935 . . . . 0.0 109.085 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 1.014 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 0.9 OUTLIER -132.92 131.68 41.15 Favored 'General case' 0 C--N 1.28 -2.455 0 C-N-CA 117.769 -1.573 . . . . 0.0 112.52 -178.131 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.704 ' HB2' HD13 ' A' ' 13' ' ' ILE . . . -143.05 138.22 29.79 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 123.105 1.431 . . . . 0.0 111.866 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 1.092 HD11 HG12 ' A' ' 105' ' ' VAL 0.274 0.0 OUTLIER -111.03 132.39 59.65 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 113.891 -1.504 . . . . 0.0 111.634 -178.837 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.76 ' N ' HD13 ' A' ' 121' ' ' ILE . . . . . . . . 0 N--CA 1.489 1.523 0 O-C-N 120.936 -1.102 . . . . 0.0 109.022 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.473 ' OE1' ' N ' ' A' ' 2' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 120.703 0.287 . . . . 0.0 111.418 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.761 HG12 ' HA ' ' A' ' 22' ' ' HIS . 1.5 m -147.41 178.51 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.475 ' O ' HG23 ' A' ' 3' ' ' VAL . 7.1 t0 -80.01 137.17 36.76 Favored 'General case' 0 CA--C 1.473 -1.999 0 C-N-CA 117.509 -1.677 . . . . 0.0 108.681 177.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.5 ' C ' ' CG ' ' A' ' 6' ' ' LYS 0.434 0.4 OUTLIER -167.49 178.81 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.101 -169.795 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.668 ' O ' HG22 ' A' ' 121' ' ' ILE . 19.4 mtpt -153.31 132.68 12.83 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 123.657 1.694 . . . . 0.0 112.46 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.264 2.2 t70 -71.95 146.5 47.73 Favored 'General case' 0 C--N 1.267 -3.014 0 CA-C-N 113.42 -1.718 . . . . 0.0 109.224 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.657 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.8 p -137.32 16.07 2.98 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.03 -1.044 . . . . 0.0 109.519 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.84 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -125.3 -84.91 0.64 Allowed 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 118.815 -1.154 . . . . 0.0 110.024 -176.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 12' ' ' GLU . 2.7 t30 -158.74 65.1 0.42 Allowed 'General case' 0 C--N 1.266 -3.04 0 C-N-CA 118.249 -1.38 . . . . 0.0 112.529 177.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.608 ' CG ' ' O ' ' A' ' 11' ' ' HIS . 30.1 t-80 36.44 30.79 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 122.053 0.93 . . . . 0.0 110.266 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.539 ' CG ' ' OD1' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -92.07 21.99 4.66 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.403 -0.811 . . . . 0.0 111.847 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.992 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.268 0.0 OUTLIER -120.1 -170.31 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 122.151 0.977 . . . . 0.0 111.133 -178.794 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.637 ' N ' HG23 ' A' ' 13' ' ' ILE . 0.8 OUTLIER -162.59 -48.07 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.223 -179.762 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.628 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 20.5 tttp -142.28 135.8 29.13 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 116.436 -2.106 . . . . 0.0 112.621 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.702 ' CG1' ' HB2' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -133.2 102.75 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 122.903 1.335 . . . . 0.0 110.928 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.513 ' HA ' HD23 ' A' ' 17' ' ' LEU . 0.6 OUTLIER -92.56 126.11 37.5 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 114.096 -1.411 . . . . 0.0 111.52 178.943 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.635 HG22 ' HA ' ' A' ' 37' ' ' LEU . 59.6 t -142.85 140.96 18.84 Favored Pre-proline 0 N--CA 1.498 1.973 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.347 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.418 ' HD2' HG13 ' A' ' 18' ' ' VAL . 47.7 Cg_endo -70.72 132.73 22.35 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.629 1.331 . . . . 0.0 111.039 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 118.3 -75.37 0.29 Allowed Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.9 m -91.16 139.27 30.91 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.541 -0.976 . . . . 0.0 110.192 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.761 ' HA ' HG12 ' A' ' 3' ' ' VAL . 27.9 p-80 -139.66 6.38 2.26 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.112 -1.617 . . . . 0.0 110.774 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 C-N-CA 118.506 -1.807 . . . . 0.0 111.126 176.981 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.768 ' HA2' ' HA ' ' A' ' 96' ' ' LYS . . . . . . . . 0 C--O 1.214 -1.111 0 N-CA-C 105.321 -3.112 . . . . 0.0 105.321 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.855 ' O ' HG22 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -118.26 97.07 50.52 Favored Pre-proline 0 C--O 1.218 -0.554 0 CA-C-N 121.278 2.539 . . . . 0.0 116.927 -174.538 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.575 ' HD3' ' O ' ' A' ' 32' ' ' GLY . 62.1 Cg_endo -106.15 144.53 0.1 OUTLIER 'Trans proline' 0 C--N 1.29 -2.531 0 C-N-CA 123.754 2.969 . . . . 0.0 108.142 176.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.675 ' CE2' HG11 ' A' ' 94' ' ' VAL . 14.6 m-85 -116.11 92.46 3.9 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 119.347 -0.941 . . . . 0.0 108.868 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.581 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 25.5 mp0 -115.9 88.86 2.97 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.06 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.635 ' HA ' HG22 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -108.83 138.46 45.13 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 120.672 -1.268 . . . . 0.0 108.479 179.115 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -139.76 128.42 23.12 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.702 ' HB2' ' CG1' ' A' ' 16' ' ' VAL . . . -143.33 151.49 40.53 Favored 'General case' 0 C--N 1.274 -2.678 0 CA-C-O 123.212 1.482 . . . . 0.0 113.801 -175.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.685 HG12 ' HB3' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -112.49 140.61 31.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 113.627 -1.624 . . . . 0.0 107.862 177.623 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.59 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 4.0 p90 -156.54 123.04 5.06 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -177.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 14.9 tt0 -68.07 154.84 40.83 Favored 'General case' 0 C--N 1.288 -2.087 0 O-C-N 120.425 -1.422 . . . . 0.0 108.521 178.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.972 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -90.47 131.61 36.12 Favored 'General case' 0 C--N 1.265 -3.082 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.821 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.539 ' OD1' ' CG ' ' A' ' 12' ' ' GLU . 0.1 OUTLIER -113.66 49.87 0.95 Allowed 'General case' 0 CA--C 1.482 -1.654 0 CA-C-O 125.508 2.575 . . . . 0.0 113.847 179.221 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.733 ' N ' ' HG3' ' A' ' 82' ' ' LYS . 5.7 pt20 167.0 -158.61 0.01 OUTLIER 'General case' 0 C--N 1.259 -3.344 0 CA-C-N 108.732 -3.849 . . . . 0.0 112.796 174.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.464 ' C ' HG22 ' A' ' 47' ' ' THR 0.278 16.7 t-20 -110.11 155.63 21.66 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-O 122.64 1.209 . . . . 0.0 108.959 -178.952 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.631 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -172.36 154.57 3.27 Favored 'General case' 0 C--N 1.254 -3.574 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.511 -178.831 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.952 ' O ' HG23 ' A' ' 49' ' ' THR . 9.5 mtpt -112.36 5.8 18.4 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 120.763 -1.211 . . . . 0.0 110.996 178.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.952 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.15 147.84 4.73 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.417 -1.427 . . . . 0.0 111.351 179.19 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 111' ' ' MET . . . -138.51 98.06 3.5 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-O 122.757 1.265 . . . . 0.0 110.481 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 0.9 OUTLIER -69.3 -179.71 1.71 Allowed 'General case' 0 N--CA 1.505 2.321 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.138 178.511 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.846 ' CG1' HD11 ' A' ' 88' ' ' ILE . 23.7 mt -141.6 136.72 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.514 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.418 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.476 ' C ' HG13 ' A' ' 108' ' ' VAL . 5.5 tp10 -142.61 113.44 7.49 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 123.276 1.512 . . . . 0.0 111.807 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.911 ' CA ' HG13 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -88.93 126.96 41.97 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 CA-C-N 112.783 -2.008 . . . . 0.0 109.012 178.283 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -119.81 97.43 5.62 Favored 'General case' 0 C--N 1.278 -2.518 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 177.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.93 ' HB3' HG22 ' A' ' 63' ' ' VAL . . . -110.1 127.37 54.84 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.126 -1.03 . . . . 0.0 111.79 -176.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.755 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.3 p -106.48 102.83 12.19 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.971 ' HA ' HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -114.32 95.17 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.897 0 CA-C-O 123.531 1.634 . . . . 0.0 110.143 -177.811 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.717 ' OD2' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER 36.71 69.11 0.22 Allowed 'General case' 0 N--CA 1.523 3.183 0 CA-C-N 114.463 -1.244 . . . . 0.0 113.58 179.37 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.54 -22.03 12.11 Favored Glycine 0 N--CA 1.488 2.113 0 O-C-N 121.136 -0.977 . . . . 0.0 111.864 176.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.545 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.265 0.4 OUTLIER -107.96 57.84 0.62 Allowed 'General case' 0 C--N 1.292 -1.919 0 O-C-N 121.137 -1.213 . . . . 0.0 111.877 -178.137 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.578 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.372 0.0 OUTLIER -67.97 113.59 5.79 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 122.035 0.922 . . . . 0.0 110.944 -179.573 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.93 HG22 ' HB3' ' A' ' 56' ' ' ALA . 10.2 m -78.91 145.6 9.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 122.612 1.196 . . . . 0.0 110.852 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.529 ' C ' ' CG2' ' A' ' 65' ' ' VAL 0.434 7.3 t70 -137.89 59.27 1.66 Allowed 'General case' 0 C--N 1.28 -2.444 0 CA-C-O 122.855 1.312 . . . . 0.0 110.897 -176.156 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.757 HG12 ' HD2' ' A' ' 66' ' ' PRO . 1.4 t -157.28 150.41 18.6 Favored Pre-proline 0 C--N 1.271 -2.842 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.682 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.757 ' HD2' HG12 ' A' ' 65' ' ' VAL . 46.3 Cg_endo -88.04 141.53 5.21 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 CA-C-O 123.728 1.47 . . . . 0.0 111.814 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.587 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -110.83 50.36 0.78 Allowed Glycine 0 C--N 1.271 -3.075 0 CA-C-N 112.495 -2.139 . . . . 0.0 109.33 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.636 HG23 ' N ' ' A' ' 69' ' ' ASP 0.289 2.4 tp -179.35 -164.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 O-C-N 120.03 -1.865 . . . . 0.0 109.944 -178.158 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.636 ' N ' HG23 ' A' ' 68' ' ' ILE . 11.1 t70 -114.38 85.02 10.18 Favored Pre-proline 0 N--CA 1.499 1.998 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 175.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.708 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 19.3 Cg_endo -47.52 -5.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.289 -2.583 0 C-N-CA 124.381 3.387 . . . . 0.0 115.763 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.593 ' ND2' ' N ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -109.44 93.03 4.29 Favored 'General case' 0 C--N 1.285 -2.197 0 O-C-N 119.809 -1.807 . . . . 0.0 108.843 -179.495 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.742 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . . . -78.22 12.2 2.0 Allowed 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.357 -0.84 . . . . 0.0 109.202 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.408 ' HA ' ' HG2' ' A' ' 76' ' ' MET . 7.5 t -76.74 -25.26 53.29 Favored 'General case' 0 C--N 1.311 -1.104 0 O-C-N 120.904 -1.123 . . . . 0.0 108.581 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.551 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 0.6 OUTLIER -78.75 4.13 14.69 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 118.615 -1.234 . . . . 0.0 108.546 176.114 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.742 ' CD2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -135.29 7.26 3.35 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 121.344 -0.847 . . . . 0.0 109.275 177.589 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.508 ' O ' ' N ' ' A' ' 78' ' ' CYS . 1.0 OUTLIER -148.21 125.65 11.65 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 123.859 1.79 . . . . 0.0 112.555 178.763 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.543 ' O ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -32.16 91.95 0.01 OUTLIER 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 112.453 -2.158 . . . . 0.0 111.499 -178.373 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.522 ' HA ' HD13 ' A' ' 80' ' ' LEU 0.311 0.1 OUTLIER -91.95 142.28 26.28 Favored Pre-proline 0 C--N 1.264 -3.126 0 CA-C-N 111.408 -2.633 . . . . 0.0 109.926 179.968 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.639 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 35.1 Cg_endo -82.54 166.41 69.59 Favored 'Cis proline' 0 C--N 1.314 -1.247 0 C-N-CA 123.094 -1.627 . . . . 0.0 111.861 0.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.683 ' HG ' ' CE1' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -93.67 129.75 39.86 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.352 -179.637 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.525 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.3 t -105.85 141.54 20.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-O 124.325 2.012 . . . . 0.0 112.697 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.733 ' HG3' ' N ' ' A' ' 45' ' ' GLN . 2.5 tmpt? -43.86 122.61 2.87 Favored 'General case' 0 C--N 1.273 -2.759 0 CA-C-N 111.556 -2.565 . . . . 0.0 115.933 -176.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.56 -13.61 35.76 Favored Glycine 0 C--N 1.291 -1.921 0 CA-C-N 111.98 -2.373 . . . . 0.0 108.472 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.623 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 35.7 mt-30 -78.74 126.8 31.21 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-O 123.207 1.479 . . . . 0.0 112.016 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.604 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 3.9 pt20 -63.84 142.11 58.52 Favored 'General case' 0 C--N 1.271 -2.805 0 CA-C-N 113.363 -1.744 . . . . 0.0 107.791 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.972 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 19.6 m-85 -142.74 126.12 16.65 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.685 ' HB3' HG12 ' A' ' 40' ' ' VAL . 28.4 p-10 -117.9 136.43 53.47 Favored 'General case' 0 C--N 1.277 -2.56 0 CA-C-O 122.745 1.26 . . . . 0.0 110.077 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.846 HD11 ' CG1' ' A' ' 52' ' ' ILE . 0.8 OUTLIER -113.88 160.26 13.42 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.726 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -145.63 153.54 41.15 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.522 0.677 . . . . 0.0 112.211 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.832 ' CE2' HD13 ' A' ' 54' ' ' ILE . 3.1 t80 -151.65 100.38 2.69 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.628 -0.67 . . . . 0.0 110.638 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.57 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 1.4 t -122.6 114.43 20.61 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-N 119.689 1.131 . . . . 0.0 108.234 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.686 ' HB2' ' CE1' ' A' ' 90' ' ' TYR 0.273 0.9 OUTLIER -143.12 112.72 6.9 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.508 -177.365 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 10.3 p30 -74.88 157.13 35.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 119.217 -2.177 . . . . 0.0 110.321 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.855 HG22 ' O ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -154.14 172.6 5.6 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.0 -1.063 . . . . 0.0 108.752 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.542 ' HD2' ' HB ' ' A' ' 94' ' ' VAL . 17.2 Cg_endo -36.1 149.5 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.133 0 O-C-N 123.502 1.264 . . . . 0.0 111.11 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.768 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 9.2 mptt -80.41 -25.67 38.89 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 117.332 -1.747 . . . . 0.0 115.152 -173.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.767 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -145.31 45.95 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 O-C-N 121.455 -0.778 . . . . 0.0 112.721 -178.084 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.585 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . . . -73.86 -47.07 6.8 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 120.544 -1.348 . . . . 0.0 111.325 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.701 ' C ' ' HD2' ' A' ' 100' ' ' LYS . 44.9 Cg_endo -67.73 160.16 49.44 Favored 'Trans proline' 0 CA--C 1.468 -2.813 0 CA-C-O 123.547 1.394 . . . . 0.0 111.648 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.701 ' HD2' ' C ' ' A' ' 99' ' ' PRO . 0.3 OUTLIER -107.74 106.98 17.55 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 112.031 -2.35 . . . . 0.0 110.949 -169.083 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.451 ' C ' ' O ' ' A' ' 100' ' ' LYS . 2.2 p -42.12 93.72 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.912 0 CA-C-O 123.496 1.617 . . . . 0.0 110.457 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.607 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.381 46.8 mt-10 -165.35 -52.58 0.03 OUTLIER 'General case' 0 CA--C 1.449 -2.915 0 CA-C-N 113.114 -1.857 . . . . 0.0 111.897 178.198 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.484 29.3 t30 -162.03 88.65 0.68 Allowed 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 111.095 -2.775 . . . . 0.0 115.011 -161.345 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.971 HG22 ' HA ' ' A' ' 58' ' ' ILE . 22.0 t -142.89 141.31 27.1 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.537 0 C-N-CA 118.87 -1.132 . . . . 0.0 111.961 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.858 ' CG1' HD11 ' A' ' 121' ' ' ILE . 7.9 t -153.03 134.15 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.686 HG23 ' HB2' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -109.58 140.08 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-O 122.488 1.137 . . . . 0.0 112.467 -178.713 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . 1.04 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -133.13 111.29 10.8 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.55 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.911 HG13 ' CA ' ' A' ' 54' ' ' ILE . 6.1 t -125.82 142.06 43.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 119.821 -1.8 . . . . 0.0 108.969 -177.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.797 ' HB2' ' HB3' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -132.58 153.3 51.15 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.788 1.28 . . . . 0.0 112.937 -178.183 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.68 HG12 ' HB3' ' A' ' 117' ' ' LEU . 2.7 t -102.62 123.75 56.16 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.512 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 177.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.533 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -101.75 127.97 48.29 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.523 ' HA3' HD23 ' A' ' 117' ' ' LEU . . . -83.72 -129.42 1.63 Allowed Glycine 0 C--N 1.279 -2.638 0 C-N-CA 118.632 -1.746 . . . . 0.0 114.414 -176.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.631 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 4.1 p-10 -98.22 7.47 46.21 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -175.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 22.6 p30 -167.49 -13.04 0.02 OUTLIER 'General case' 0 C--N 1.261 -3.259 0 C-N-CA 117.429 -1.708 . . . . 0.0 114.437 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.42 ' O ' ' SD ' ' A' ' 111' ' ' MET . . . -153.85 -86.84 0.06 OUTLIER Glycine 0 CA--C 1.473 -2.57 0 CA-C-O 125.916 2.953 . . . . 0.0 111.723 -177.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.517 HG22 ' H ' ' A' ' 117' ' ' LEU . 1.4 p -141.49 177.54 3.38 Favored 'Isoleucine or valine' 1 C--N 1.228 -4.714 1 CA-C-N 108.054 -4.073 . . . . 0.0 110.929 -177.283 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.68 ' HB3' HG12 ' A' ' 110' ' ' VAL . 0.2 OUTLIER -145.96 -64.02 0.31 Allowed 'General case' 0 C--N 1.289 -2.064 0 O-C-N 121.793 -0.567 . . . . 0.0 110.849 -179.561 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.992 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -164.51 127.82 2.45 Favored 'General case' 0 N--CA 1.51 2.552 0 O-C-N 120.96 -1.088 . . . . 0.0 109.134 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.84 ' SG ' ' HB2' ' A' ' 9' ' ' ALA . 1.6 p -134.57 142.15 46.87 Favored 'General case' 0 C--N 1.285 -2.197 0 C-N-CA 117.823 -1.551 . . . . 0.0 113.482 -177.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.472 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -144.96 138.2 26.67 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 123.035 1.398 . . . . 0.0 112.11 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 1.04 ' HB ' HG23 ' A' ' 107' ' ' THR 0.284 0.0 OUTLIER -113.03 142.3 25.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 114.09 -1.413 . . . . 0.0 111.982 -178.697 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.899 ' N ' HD13 ' A' ' 121' ' ' ILE . . . . . . . . 0 N--CA 1.487 1.389 0 O-C-N 120.983 -1.073 . . . . 0.0 108.131 178.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.513 ' CD ' ' CE ' ' A' ' 15' ' ' LYS . 1.9 mp0 . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 120.528 0.204 . . . . 0.0 110.97 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.765 HG12 ' HA ' ' A' ' 22' ' ' HIS 0.257 1.3 m -145.68 174.91 2.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 O-C-N 120.634 -1.291 . . . . 0.0 108.902 -179.151 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.582 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -81.83 148.13 29.0 Favored 'General case' 0 CA--C 1.477 -1.829 0 CA-C-O 122.83 1.3 . . . . 0.0 109.115 176.782 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.854 HG11 HG21 ' A' ' 16' ' ' VAL 0.428 0.4 OUTLIER -164.29 -167.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 CA-C-N 113.668 -1.605 . . . . 0.0 109.589 -170.856 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 5' ' ' VAL . 2.7 mttt -156.33 146.57 21.42 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 124.065 1.888 . . . . 0.0 113.173 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.287 8.1 t70 -86.32 147.71 25.93 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-N 112.335 -2.211 . . . . 0.0 109.771 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.654 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.1 p -136.84 14.67 3.11 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.887 -1.133 . . . . 0.0 109.07 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.846 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -126.04 -84.36 0.63 Allowed 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.075 -1.05 . . . . 0.0 109.931 -177.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 12' ' ' GLU . 4.3 t-20 -158.65 66.51 0.44 Allowed 'General case' 0 C--N 1.269 -2.901 0 C-N-CA 118.632 -1.227 . . . . 0.0 112.265 177.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.586 ' CG ' ' O ' ' A' ' 11' ' ' HIS . 10.2 t-160 36.27 30.84 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 121.958 0.885 . . . . 0.0 110.276 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.582 ' HB3' ' O ' ' A' ' 117' ' ' LEU . 0.4 OUTLIER -84.84 18.17 2.53 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 121.356 0.598 . . . . 0.0 111.428 -179.553 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.037 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.281 0.1 OUTLIER -122.91 -171.69 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-O 122.04 0.924 . . . . 0.0 110.856 -178.333 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.629 ' H ' HG23 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -162.21 -47.42 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.336 -179.562 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.561 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -142.71 133.24 25.06 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 116.192 -2.203 . . . . 0.0 113.317 179.116 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.879 HG12 ' HB2' ' A' ' 39' ' ' ALA . 3.2 m -131.78 107.15 12.64 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.323 0 CA-C-O 122.876 1.322 . . . . 0.0 111.498 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -98.75 120.54 39.36 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 114.319 -1.31 . . . . 0.0 111.302 178.883 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.725 HG22 ' HB2' ' A' ' 37' ' ' LEU . 16.1 t -142.72 146.07 36.56 Favored Pre-proline 0 C--N 1.295 -1.794 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.097 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.557 ' HD2' ' CG1' ' A' ' 18' ' ' VAL . 43.9 Cg_endo -69.66 132.34 23.29 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 O-C-N 123.834 1.439 . . . . 0.0 111.211 -178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.41 -88.82 0.2 Allowed Glycine 0 N--CA 1.495 2.57 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.3 m -94.27 173.27 7.73 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.243 -1.151 . . . . 0.0 110.433 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.765 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -142.01 8.42 1.87 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.764 -1.21 . . . . 0.0 110.723 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 4' ' ' ASP . . . . . . . . 0 C--N 1.286 -2.244 0 C-N-CA 118.792 -1.67 . . . . 0.0 110.221 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.894 ' HA2' ' HA ' ' A' ' 96' ' ' LYS . . . . . . . . 0 C--O 1.214 -1.112 0 N-CA-C 105.329 -3.108 . . . . 0.0 105.329 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.827 ' HB2' HG12 ' A' ' 94' ' ' VAL . 2.4 mmmm -118.85 98.0 50.94 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 120.761 2.281 . . . . 0.0 116.391 -174.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.545 ' HD3' ' O ' ' A' ' 32' ' ' GLY . 60.3 Cg_endo -105.17 144.71 0.11 Allowed 'Trans proline' 0 C--N 1.291 -2.477 0 C-N-CA 123.642 2.894 . . . . 0.0 108.898 177.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.538 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 3.7 m-85 -117.85 91.01 3.46 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.302 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.578 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 25.6 mp0 -113.47 79.28 1.22 Allowed 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.725 ' HB2' HG22 ' A' ' 18' ' ' VAL . 3.1 pp -111.68 141.57 45.12 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.851 -1.156 . . . . 0.0 109.837 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.474 ' HB3' ' HE2' ' A' ' 89' ' ' LYS . 2.2 pp20? -140.33 137.53 34.19 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.759 1.266 . . . . 0.0 108.396 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.879 ' HB2' HG12 ' A' ' 16' ' ' VAL . . . -142.65 153.31 43.32 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-O 123.137 1.446 . . . . 0.0 113.237 -176.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.595 HG12 ' HB3' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -109.92 141.37 25.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 113.798 -1.547 . . . . 0.0 108.133 178.242 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.582 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 3.0 p90 -156.3 121.91 4.85 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -177.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 13.4 tt0 -69.71 153.6 43.16 Favored 'General case' 0 C--N 1.285 -2.233 0 O-C-N 120.441 -1.412 . . . . 0.0 108.661 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.904 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -89.01 133.38 34.36 Favored 'General case' 0 C--N 1.266 -3.049 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.302 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.594 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 14.8 p-10 -114.2 49.24 1.02 Allowed 'General case' 0 CA--C 1.484 -1.572 0 CA-C-O 125.534 2.588 . . . . 0.0 113.576 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.593 ' C ' ' HB2' ' A' ' 82' ' ' LYS . 6.7 pt20 167.1 -158.95 0.01 OUTLIER 'General case' 0 C--N 1.255 -3.514 0 CA-C-N 108.83 -3.804 . . . . 0.0 112.793 175.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.479 ' C ' HG22 ' A' ' 47' ' ' THR 0.276 7.4 t30 -110.17 154.68 23.0 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-O 122.701 1.239 . . . . 0.0 108.912 -178.793 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.618 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -172.38 151.78 2.58 Favored 'General case' 0 C--N 1.256 -3.489 0 CA-C-N 114.667 -1.151 . . . . 0.0 112.487 -178.704 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.934 ' O ' HG23 ' A' ' 49' ' ' THR . 0.2 OUTLIER -111.01 9.45 22.13 Favored 'General case' 0 N--CA 1.508 2.444 0 C-N-CA 118.507 -1.277 . . . . 0.0 110.28 178.408 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.934 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.66 146.56 4.0 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 120.653 -1.279 . . . . 0.0 111.084 178.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 111' ' ' MET . . . -140.66 94.79 2.77 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-O 122.844 1.307 . . . . 0.0 109.814 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 1.3 mmtp -65.2 -179.49 0.59 Allowed 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.193 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.934 ' CG2' HD11 ' A' ' 88' ' ' ILE . 28.7 mt -141.65 140.19 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.446 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 2.3 tm-20 -141.14 104.78 4.7 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 123.265 1.507 . . . . 0.0 109.733 178.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 1.073 ' HA ' HG13 ' A' ' 108' ' ' VAL . 0.1 OUTLIER -92.11 127.64 44.23 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.458 0 CA-C-N 112.604 -2.089 . . . . 0.0 107.602 179.271 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.882 ' N ' HD13 ' A' ' 54' ' ' ILE . 3.5 ttpt -129.75 147.27 51.51 Favored 'General case' 0 C--N 1.271 -2.823 0 C-N-CA 118.45 -1.3 . . . . 0.0 108.193 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 1.094 ' HB3' HG22 ' A' ' 63' ' ' VAL . . . -135.54 130.35 34.44 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 117.579 -1.648 . . . . 0.0 111.565 -178.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.704 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 2.8 p -103.17 95.97 6.47 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.338 -1.726 . . . . 0.0 106.338 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.889 ' HA ' HG22 ' A' ' 104' ' ' VAL . 0.1 OUTLIER -106.93 107.05 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.711 0 CA-C-O 123.008 1.385 . . . . 0.0 110.339 -176.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 103' ' ' ASN . 0.4 OUTLIER 33.74 62.77 0.41 Allowed 'General case' 0 N--CA 1.519 3.002 0 CA-C-N 115.097 -0.956 . . . . 0.0 113.08 179.427 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.59 -15.54 9.48 Favored Glycine 0 N--CA 1.487 2.061 0 O-C-N 121.335 -0.853 . . . . 0.0 111.239 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.54 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.271 0.4 OUTLIER -107.99 59.05 0.61 Allowed 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.204 -1.174 . . . . 0.0 111.353 -178.486 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.651 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.373 0.0 OUTLIER -55.09 117.17 3.24 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.975 0.893 . . . . 0.0 110.79 179.902 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 1.094 HG22 ' HB3' ' A' ' 56' ' ' ALA . 19.0 m -79.53 143.16 12.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-O 122.741 1.258 . . . . 0.0 111.657 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.447 25.1 t0 -138.78 85.27 2.07 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.193 -176.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.572 ' CG2' ' HD2' ' A' ' 66' ' ' PRO . 12.2 p -153.62 149.73 21.78 Favored Pre-proline 0 C--N 1.277 -2.573 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.684 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.572 ' HD2' ' CG2' ' A' ' 65' ' ' VAL . 42.3 Cg_endo -71.37 138.06 32.11 Favored 'Trans proline' 0 CA--C 1.501 -1.139 0 CA-C-O 123.748 1.478 . . . . 0.0 111.073 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.651 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -110.02 -71.8 0.68 Allowed Glycine 0 N--CA 1.504 3.225 0 CA-C-N 112.587 -2.097 . . . . 0.0 112.0 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.767 HG23 ' N ' ' A' ' 69' ' ' ASP . 0.8 OUTLIER -116.64 -150.66 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.013 -1.875 . . . . 0.0 109.433 -178.603 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.767 ' N ' HG23 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -105.81 143.29 26.57 Favored Pre-proline 0 C--N 1.295 -1.773 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 177.21 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.753 ' HB2' ' H ' ' A' ' 52' ' ' ILE . 22.9 Cg_endo -106.21 -3.32 0.14 Allowed 'Trans proline' 0 C--N 1.274 -3.383 0 C-N-CA 123.18 2.587 . . . . 0.0 113.908 -173.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.598 ' HB2' ' NE2' ' A' ' 74' ' ' HIS . 0.5 OUTLIER -110.34 88.78 2.85 Favored 'General case' 0 C--N 1.285 -2.222 0 O-C-N 120.839 -1.163 . . . . 0.0 108.459 -179.501 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.741 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . . . -78.45 10.77 2.86 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.222 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.4 t -77.29 -26.8 52.67 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 120.947 -1.096 . . . . 0.0 108.184 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.598 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -81.19 8.37 9.02 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 118.919 -1.113 . . . . 0.0 108.343 175.893 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.741 ' CD2' ' HA ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -132.36 -2.52 3.48 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 121.76 -0.587 . . . . 0.0 109.939 178.163 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.596 ' SD ' ' HB1' ' A' ' 72' ' ' ALA . 1.8 ptt? -157.74 132.25 8.4 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 123.866 1.793 . . . . 0.0 113.824 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.57 ' O ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -16.29 94.29 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 111.786 -2.461 . . . . 0.0 113.276 -179.136 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 48' ' ' LYS 0.327 1.8 t -106.84 144.79 29.78 Favored Pre-proline 0 C--N 1.267 -3.003 0 CA-C-N 111.596 -2.547 . . . . 0.0 109.234 179.165 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.671 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 37.5 Cg_endo -79.95 167.82 74.06 Favored 'Cis proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.847 -1.73 . . . . 0.0 111.833 0.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.713 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -93.4 127.9 39.22 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.103 -179.423 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.513 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.3 t -105.0 140.67 22.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-O 124.207 1.956 . . . . 0.0 112.211 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.594 ' HG2' ' HA ' ' A' ' 44' ' ' ASN . 1.8 tmmt? -45.08 119.42 2.01 Favored 'General case' 0 C--N 1.273 -2.741 0 CA-C-N 111.534 -2.576 . . . . 0.0 116.776 -175.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.1 -16.19 22.82 Favored Glycine 0 C--N 1.293 -1.86 0 CA-C-N 111.772 -2.467 . . . . 0.0 107.98 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.63 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 56.7 mt-30 -75.56 126.39 30.93 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-O 123.292 1.52 . . . . 0.0 111.496 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.593 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 29.4 mt-30 -65.12 144.97 56.88 Favored 'General case' 0 C--N 1.271 -2.81 0 CA-C-N 113.299 -1.773 . . . . 0.0 107.692 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.904 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 19.6 m-85 -142.56 126.7 17.45 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.595 ' HB3' HG12 ' A' ' 40' ' ' VAL . 1.4 p30 -117.15 132.46 56.65 Favored 'General case' 0 C--N 1.276 -2.611 0 CA-C-O 122.925 1.345 . . . . 0.0 110.358 -177.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 1.121 HD12 ' CG2' ' A' ' 110' ' ' VAL . 0.4 OUTLIER -104.79 158.55 5.57 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 CA-C-N 114.186 -1.37 . . . . 0.0 108.42 179.778 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.474 ' HE2' ' HB3' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -144.39 145.27 31.84 Favored 'General case' 0 C--N 1.29 -2.021 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.465 -178.293 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.606 ' CE1' ' HB2' ' A' ' 92' ' ' TRP . 12.7 t80 -145.21 108.89 4.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.171 -0.956 . . . . 0.0 109.913 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.578 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 1.2 t -127.07 111.26 13.83 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.667 ' CZ3' HG23 ' A' ' 94' ' ' VAL 0.278 0.7 OUTLIER -142.83 114.46 8.03 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.173 -177.277 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 2.4 p-10 -75.08 157.08 35.35 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 119.172 -2.205 . . . . 0.0 109.411 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.827 HG12 ' HB2' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -147.49 167.65 13.02 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.128 -0.982 . . . . 0.0 108.457 -179.158 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.743 ' HD2' HG22 ' A' ' 94' ' ' VAL . 18.3 Cg_endo -37.33 152.83 0.03 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.188 0 O-C-N 123.835 1.439 . . . . 0.0 110.677 -177.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.894 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -79.81 -25.9 40.71 Favored 'General case' 0 C--N 1.286 -2.189 0 C-N-CA 116.508 -2.077 . . . . 0.0 115.175 -173.181 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.765 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -144.9 45.47 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 O-C-N 121.517 -0.74 . . . . 0.0 112.968 -178.224 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.927 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . . . -74.0 -59.4 1.79 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.53 -1.356 . . . . 0.0 110.627 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.927 ' HD3' ' HB3' ' A' ' 98' ' ' ALA . 47.9 Cg_endo -67.2 160.32 48.06 Favored 'Trans proline' 0 CA--C 1.462 -3.084 0 O-C-N 123.897 1.472 . . . . 0.0 110.474 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.716 ' HD2' ' C ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -107.28 102.29 11.6 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 112.493 -2.139 . . . . 0.0 110.136 -169.229 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.465 ' C ' ' O ' ' A' ' 100' ' ' LYS . 2.5 p -42.06 97.67 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 123.592 1.663 . . . . 0.0 110.042 -178.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.561 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.389 47.8 mt-10 -164.4 -53.0 0.03 OUTLIER 'General case' 0 CA--C 1.45 -2.877 0 CA-C-N 112.963 -1.926 . . . . 0.0 111.543 178.878 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.483 35.0 t-20 -161.25 82.05 0.62 Allowed 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 110.876 -2.875 . . . . 0.0 113.911 -161.879 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.889 HG22 ' HA ' ' A' ' 58' ' ' ILE . 20.1 t -143.39 139.1 26.46 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.65 0 C-N-CA 118.952 -1.099 . . . . 0.0 111.912 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.896 HG22 HD11 ' A' ' 121' ' ' ILE . 0.6 OUTLIER -142.5 132.07 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.392 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.552 ' O ' HG12 ' A' ' 121' ' ' ILE . 0.4 OUTLIER -99.1 143.46 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 122.594 1.188 . . . . 0.0 111.57 -179.028 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . 1.071 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -131.59 118.34 19.96 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 179.556 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.073 HG13 ' HA ' ' A' ' 54' ' ' ILE . 3.4 t -132.38 139.53 49.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 120.22 -1.55 . . . . 0.0 108.583 -178.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.902 ' HB2' ' CB ' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -130.16 154.2 47.76 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.883 1.325 . . . . 0.0 111.623 -178.63 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 1.121 ' CG2' HD12 ' A' ' 88' ' ' ILE . 2.6 t -107.69 124.54 63.83 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.58 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 177.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.513 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 1.5 tmt? -103.71 120.39 40.85 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.554 ' HA3' HD23 ' A' ' 117' ' ' LEU . . . -74.93 -131.17 0.25 Allowed Glycine 0 C--N 1.281 -2.51 0 C-N-CA 119.06 -1.543 . . . . 0.0 114.671 -175.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.618 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 4.7 p-10 -97.94 8.65 44.4 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -175.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 33.5 p-10 -167.41 -14.89 0.02 OUTLIER 'General case' 0 C--N 1.265 -3.08 0 C-N-CA 117.475 -1.69 . . . . 0.0 114.428 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.447 ' O ' ' HG2' ' A' ' 111' ' ' MET . . . -152.39 -86.74 0.06 OUTLIER Glycine 0 CA--C 1.473 -2.572 0 CA-C-O 125.937 2.965 . . . . 0.0 111.971 -177.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.642 HG22 ' H ' ' A' ' 117' ' ' LEU . 4.2 p -141.23 178.67 2.7 Favored 'Isoleucine or valine' 1 C--N 1.228 -4.696 1 CA-C-N 108.168 -4.016 . . . . 0.0 110.807 -177.226 . . . . . . . . 4 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.769 ' HB3' HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -148.55 -61.85 0.24 Allowed 'General case' 0 C--N 1.289 -2.06 0 O-C-N 121.873 -0.517 . . . . 0.0 111.277 -179.44 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 1.037 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -165.35 129.85 2.42 Favored 'General case' 0 N--CA 1.512 2.669 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.543 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.902 ' CB ' ' HB2' ' A' ' 109' ' ' LYS . 1.4 p -134.52 135.44 42.37 Favored 'General case' 0 C--N 1.284 -2.266 0 C-N-CA 118.064 -1.455 . . . . 0.0 113.09 -178.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.59 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -143.62 135.06 26.09 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 122.992 1.377 . . . . 0.0 112.599 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 1.071 ' HB ' HG23 ' A' ' 107' ' ' THR 0.272 0.0 OUTLIER -111.14 138.41 39.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 CA-C-N 114.143 -1.39 . . . . 0.0 110.961 -179.549 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.851 ' N ' HD13 ' A' ' 121' ' ' ILE . . . . . . . . 0 N--CA 1.486 1.367 0 O-C-N 120.858 -1.151 . . . . 0.0 109.062 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.463 ' O ' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 120.646 0.26 . . . . 0.0 110.828 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.858 HG12 ' HA ' ' A' ' 22' ' ' HIS . 1.3 m -145.22 -175.64 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.45 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -77.68 133.68 38.3 Favored 'General case' 0 CA--C 1.48 -1.714 0 C-N-CA 117.839 -1.544 . . . . 0.0 108.84 178.772 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.521 ' O ' ' HG2' ' A' ' 6' ' ' LYS 0.435 0.4 OUTLIER -170.14 156.48 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 113.972 -1.467 . . . . 0.0 110.058 -169.627 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -146.76 145.77 30.06 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 123.772 1.749 . . . . 0.0 113.515 -178.671 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.276 1.9 t70 -74.28 149.3 40.78 Favored 'General case' 0 C--N 1.268 -2.956 0 CA-C-N 112.792 -2.004 . . . . 0.0 109.312 177.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.632 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 5.7 p -137.33 14.44 3.01 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.852 -1.155 . . . . 0.0 109.058 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.864 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -125.5 -82.52 0.63 Allowed 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 118.962 -1.095 . . . . 0.0 109.952 -177.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 12' ' ' GLU . 2.9 t30 -157.86 66.45 0.48 Allowed 'General case' 0 C--N 1.268 -2.952 0 C-N-CA 118.684 -1.206 . . . . 0.0 111.882 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.487 ' C ' ' O ' ' A' ' 10' ' ' ASN . 2.4 m-70 33.4 33.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.845 0.831 . . . . 0.0 110.468 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 10' ' ' ASN . 38.1 mt-10 -93.77 21.12 6.79 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.68 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.027 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.297 0.1 OUTLIER -124.39 -167.3 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.895 0.855 . . . . 0.0 110.056 -178.685 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.649 ' H ' HG23 ' A' ' 13' ' ' ILE . 13.1 ptpt -162.15 -44.89 0.04 OUTLIER 'General case' 0 C--N 1.29 -1.997 0 O-C-N 121.792 -0.567 . . . . 0.0 111.503 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.553 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 36.4 tttt -148.49 142.57 25.97 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 115.881 -2.328 . . . . 0.0 114.21 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 1.094 HG13 ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -134.45 103.07 4.48 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 CA-C-O 122.983 1.373 . . . . 0.0 110.578 178.932 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.508 ' HA ' HD23 ' A' ' 17' ' ' LEU . 1.3 mt -96.11 133.18 40.7 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 113.994 -1.457 . . . . 0.0 111.465 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.894 HG22 ' HA ' ' A' ' 37' ' ' LEU . 93.1 t -140.83 145.71 40.9 Favored Pre-proline 0 N--CA 1.499 2.018 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.514 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.605 ' HD2' HG13 ' A' ' 18' ' ' VAL . 45.9 Cg_endo -72.42 101.23 1.23 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.815 1.429 . . . . 0.0 110.76 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 157.79 -92.21 0.12 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.0 m -83.95 162.04 20.59 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.32 -1.106 . . . . 0.0 111.196 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.858 ' HA ' HG12 ' A' ' 3' ' ' VAL . 1.1 p80 -142.41 16.89 2.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.903 -1.123 . . . . 0.0 109.206 178.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.081 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 177.734 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.893 ' HA3' ' HA ' ' A' ' 96' ' ' LYS . . . . . . . . 0 C--O 1.215 -1.073 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.754 ' HB2' HG12 ' A' ' 94' ' ' VAL . 0.6 OUTLIER -125.58 88.97 53.36 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 120.983 2.392 . . . . 0.0 115.62 -179.149 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 60.7 Cg_endo -108.13 142.35 0.06 OUTLIER 'Trans proline' 0 C--N 1.291 -2.488 0 C-N-CA 124.521 3.481 . . . . 0.0 107.719 176.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.481 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 10.1 m-85 -124.25 93.73 4.0 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 118.553 -1.259 . . . . 0.0 109.99 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.613 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 28.1 mp0 -112.8 86.22 2.32 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.894 ' HA ' HG22 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -110.33 141.33 43.51 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 120.576 -1.328 . . . . 0.0 109.093 179.294 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.92 132.49 28.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 1.094 ' HB2' HG13 ' A' ' 16' ' ' VAL . . . -142.14 154.39 44.84 Favored 'General case' 0 C--N 1.271 -2.829 0 CA-C-O 123.219 1.485 . . . . 0.0 113.404 -175.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.553 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.38 141.06 26.8 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 CA-C-N 113.43 -1.714 . . . . 0.0 108.805 178.714 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.556 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 3.7 p90 -157.96 124.58 4.87 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 21.8 tt0 -69.29 154.79 41.47 Favored 'General case' 0 C--N 1.285 -2.213 0 O-C-N 120.305 -1.497 . . . . 0.0 108.606 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.999 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -85.69 131.39 34.34 Favored 'General case' 0 C--N 1.265 -3.068 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.447 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.633 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 0.3 OUTLIER -113.8 48.79 1.04 Allowed 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 125.775 2.702 . . . . 0.0 114.358 179.816 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.581 ' C ' ' HB2' ' A' ' 82' ' ' LYS . 0.4 OUTLIER 166.57 -161.63 0.01 OUTLIER 'General case' 0 C--N 1.26 -3.324 0 CA-C-N 108.502 -3.954 . . . . 0.0 112.845 175.152 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.422 ' C ' HG22 ' A' ' 47' ' ' THR 0.273 60.0 t30 -110.82 151.33 27.94 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-O 122.537 1.16 . . . . 0.0 108.958 -178.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.657 ' OG1' ' HB3' ' A' ' 113' ' ' ASP 0.252 0.0 OUTLIER -173.22 151.77 2.13 Favored 'General case' 0 C--N 1.255 -3.511 0 C-N-CA 118.581 -1.248 . . . . 0.0 112.545 -178.418 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.955 ' O ' HG23 ' A' ' 49' ' ' THR . 0.8 OUTLIER -111.59 10.69 21.18 Favored 'General case' 0 N--CA 1.51 2.568 0 C-N-CA 118.194 -1.402 . . . . 0.0 110.301 178.371 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.955 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -169.12 148.46 4.02 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 120.622 -1.299 . . . . 0.0 110.837 179.091 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 111' ' ' MET . . . -149.74 103.8 3.27 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 122.765 1.269 . . . . 0.0 110.949 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 0.7 OUTLIER -68.86 -174.94 0.64 Allowed 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.432 178.664 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.955 ' CG2' HD11 ' A' ' 88' ' ' ILE . 35.7 mt -141.93 140.84 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.388 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 5.6 tm-20 -139.92 107.58 5.62 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 123.284 1.516 . . . . 0.0 110.186 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 1.057 ' HA ' HG13 ' A' ' 108' ' ' VAL . 0.1 OUTLIER -92.63 128.38 44.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 CA-C-N 112.644 -2.071 . . . . 0.0 107.362 178.843 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.897 ' N ' HD13 ' A' ' 54' ' ' ILE . 1.1 tttt -128.09 141.86 51.37 Favored 'General case' 0 C--N 1.272 -2.802 0 C-N-CA 118.75 -1.18 . . . . 0.0 107.855 178.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 1.071 ' HB3' HG22 ' A' ' 63' ' ' VAL . . . -135.44 134.35 39.53 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 119.917 -1.739 . . . . 0.0 112.309 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.742 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 0.5 OUTLIER -107.22 99.5 9.04 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 177.285 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.924 ' HA ' HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -112.12 101.41 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.803 0 CA-C-O 123.305 1.526 . . . . 0.0 110.758 -176.991 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.544 ' N ' HG22 ' A' ' 104' ' ' VAL . 1.4 p30 37.59 64.36 0.66 Allowed 'General case' 0 N--CA 1.521 3.077 0 CA-C-N 114.991 -1.004 . . . . 0.0 113.06 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.73 -17.04 9.41 Favored Glycine 0 N--CA 1.488 2.114 0 O-C-N 121.264 -0.897 . . . . 0.0 111.546 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.532 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.272 0.2 OUTLIER -107.87 58.16 0.62 Allowed 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.197 -1.178 . . . . 0.0 111.576 -178.336 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.605 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.367 0.0 OUTLIER -60.01 116.75 4.38 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.958 0.885 . . . . 0.0 111.012 -179.904 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 1.071 HG22 ' HB3' ' A' ' 56' ' ' ALA . 13.8 m -75.8 146.61 8.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-O 122.547 1.165 . . . . 0.0 110.805 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.441 6.7 t70 -138.16 76.89 1.6 Allowed 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.192 -176.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.56 HG22 ' HD2' ' A' ' 66' ' ' PRO . 8.6 p -164.37 150.75 9.52 Favored Pre-proline 0 C--N 1.274 -2.692 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.42 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.56 ' HD2' HG22 ' A' ' 65' ' ' VAL . 44.6 Cg_endo -86.68 139.23 5.58 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 CA-C-O 123.887 1.536 . . . . 0.0 111.531 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.614 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -127.82 52.49 0.82 Allowed Glycine 0 C--N 1.273 -2.946 0 CA-C-N 112.498 -2.137 . . . . 0.0 110.432 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.642 ' HB ' ' CD2' ' A' ' 90' ' ' TYR 0.296 4.4 tp 179.96 -177.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 120.194 -1.768 . . . . 0.0 110.534 -178.677 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.523 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 12.9 t0 -112.3 83.47 5.26 Favored Pre-proline 0 N--CA 1.504 2.237 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 175.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.711 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 20.9 Cg_endo -48.59 -6.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.287 -2.706 0 C-N-CA 124.453 3.435 . . . . 0.0 116.245 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.583 ' HB2' ' NE2' ' A' ' 74' ' ' HIS . 5.1 m-80 -101.77 91.77 4.54 Favored 'General case' 0 C--N 1.284 -2.266 0 O-C-N 120.167 -1.583 . . . . 0.0 109.006 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.724 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . . . -76.33 7.29 4.47 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.431 -0.793 . . . . 0.0 109.52 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 8.3 t -79.05 -24.15 43.76 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 120.886 -1.134 . . . . 0.0 108.94 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.583 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 1.1 m-70 -80.1 8.11 7.85 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.022 -1.071 . . . . 0.0 109.066 176.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.724 ' CD2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -133.19 -2.83 3.13 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 121.365 -0.834 . . . . 0.0 110.217 177.547 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.446 ' O ' ' HG2' ' A' ' 76' ' ' MET . 2.4 ptt? -155.07 129.61 9.14 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 123.984 1.849 . . . . 0.0 113.678 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.465 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 13.9 pttt -21.85 102.6 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 111.89 -2.414 . . . . 0.0 113.365 -178.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 48' ' ' LYS 0.318 0.1 OUTLIER -99.04 146.64 32.03 Favored Pre-proline 0 C--N 1.265 -3.066 0 CA-C-N 111.522 -2.581 . . . . 0.0 108.79 178.609 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.641 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 37.2 Cg_endo -86.66 167.35 46.64 Favored 'Cis proline' 0 C--N 1.311 -1.412 0 C-N-CA 123.1 -1.625 . . . . 0.0 111.447 0.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.724 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -90.54 125.96 35.78 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 122.02 0.914 . . . . 0.0 110.95 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.507 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.3 t -104.47 137.76 32.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-O 124.248 1.975 . . . . 0.0 111.779 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.633 ' HG2' ' HA ' ' A' ' 44' ' ' ASN . 1.6 tmmt? -43.37 115.62 0.8 Allowed 'General case' 0 C--N 1.271 -2.844 0 CA-C-N 111.737 -2.483 . . . . 0.0 116.243 -175.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 118.2 -18.34 11.26 Favored Glycine 0 C--N 1.29 -1.983 0 CA-C-N 111.74 -2.482 . . . . 0.0 108.198 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.609 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 27.5 mt-30 -73.3 126.27 29.74 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-O 123.124 1.44 . . . . 0.0 111.797 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.583 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 4.4 pt20 -63.3 143.03 58.15 Favored 'General case' 0 C--N 1.271 -2.818 0 CA-C-N 113.57 -1.65 . . . . 0.0 107.855 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.999 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 21.3 m-85 -143.58 127.5 17.34 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.534 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 1.4 p-10 -117.51 132.53 56.53 Favored 'General case' 0 C--N 1.277 -2.561 0 CA-C-O 122.775 1.274 . . . . 0.0 110.401 -178.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 1.043 HD12 ' CG2' ' A' ' 110' ' ' VAL . 0.3 OUTLIER -102.31 159.98 4.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.402 179.368 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.75 144.84 32.8 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.941 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.642 ' CD2' ' HB ' ' A' ' 68' ' ' ILE . 32.3 t80 -149.02 102.36 3.25 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.772 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.613 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 0.6 OUTLIER -121.68 114.76 21.59 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 179.253 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.614 ' CD1' ' O ' ' A' ' 67' ' ' GLY 0.264 0.2 OUTLIER -141.86 108.42 5.33 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.913 -177.405 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.524 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 11.7 m120 -75.46 155.54 36.15 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 119.696 -1.878 . . . . 0.0 109.753 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.754 HG12 ' HB2' ' A' ' 33' ' ' LYS . 1.0 OUTLIER -153.79 169.98 9.07 Favored Pre-proline 0 N--CA 1.487 1.389 0 O-C-N 120.746 -1.221 . . . . 0.0 108.676 -178.924 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.751 ' CD ' HG13 ' A' ' 94' ' ' VAL . 17.8 Cg_endo -38.29 154.73 0.03 OUTLIER 'Trans proline' 0 CA--C 1.497 -1.332 0 O-C-N 123.424 1.223 . . . . 0.0 110.853 -177.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.893 ' HA ' ' HA3' ' A' ' 32' ' ' GLY . 3.1 mptt -80.73 -27.22 36.94 Favored 'General case' 0 C--N 1.283 -2.32 0 C-N-CA 116.622 -2.031 . . . . 0.0 116.201 -173.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.762 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -141.89 42.02 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.923 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.977 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . . . -62.65 -56.93 25.08 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 120.419 -1.425 . . . . 0.0 109.562 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.977 ' HD3' ' HB3' ' A' ' 98' ' ' ALA . 56.9 Cg_endo -78.12 162.78 28.53 Favored 'Trans proline' 0 CA--C 1.463 -3.063 0 O-C-N 123.896 1.472 . . . . 0.0 110.57 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.73 ' HD2' ' C ' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -107.21 112.43 25.3 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-N 112.095 -2.32 . . . . 0.0 110.28 -169.755 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 100' ' ' LYS . 2.5 p -45.35 97.7 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.612 0 CA-C-O 123.606 1.669 . . . . 0.0 109.342 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.402 40.9 mt-10 -163.54 -52.01 0.04 OUTLIER 'General case' 0 CA--C 1.448 -2.975 0 CA-C-N 112.818 -1.992 . . . . 0.0 111.304 179.442 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.482 37.4 t-20 -160.29 79.73 0.67 Allowed 'General case' 0 C--N 1.285 -2.202 0 CA-C-N 110.949 -2.842 . . . . 0.0 113.932 -162.311 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.924 HG22 ' HA ' ' A' ' 58' ' ' ILE . 22.0 t -145.13 141.24 22.88 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.65 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.743 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 1.074 ' CG1' HD11 ' A' ' 121' ' ' ILE . 3.0 t -153.89 137.63 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.705 ' CG2' HD11 ' A' ' 54' ' ' ILE . 0.3 OUTLIER -105.58 148.3 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 122.653 1.216 . . . . 0.0 112.675 -178.409 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.974 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -132.04 118.98 20.4 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 178.099 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.057 HG13 ' HA ' ' A' ' 54' ' ' ILE . 3.4 t -132.54 138.72 51.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 120.186 -1.571 . . . . 0.0 108.389 -177.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 1.019 ' HB2' ' HB2' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -135.6 148.64 49.11 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 122.414 1.102 . . . . 0.0 111.549 -178.072 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 1.043 ' CG2' HD12 ' A' ' 88' ' ' ILE . 3.5 t -97.76 129.81 47.38 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.553 ' SD ' ' HA2' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -107.7 118.2 36.12 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -78.92 -138.13 1.43 Allowed Glycine 0 N--CA 1.498 2.778 0 C-N-CA 119.177 -1.487 . . . . 0.0 114.917 -174.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.657 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 6.8 p-10 -80.79 -3.66 51.81 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 122.275 1.036 . . . . 0.0 112.323 -176.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.403 ' OD2' ' OD1' ' A' ' 113' ' ' ASP . 1.4 p30 -133.21 -4.65 3.05 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.738 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.605 ' O ' ' CB ' ' A' ' 116' ' ' VAL . . . 92.29 85.9 1.51 Allowed Glycine 0 CA--C 1.471 -2.688 0 CA-C-O 124.797 2.332 . . . . 0.0 110.399 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.605 ' CB ' ' O ' ' A' ' 115' ' ' GLY . 7.2 p 137.9 148.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.25 -3.757 0 CA-C-N 108.27 -3.965 . . . . 0.0 111.837 177.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.807 ' CB ' HG12 ' A' ' 110' ' ' VAL . 0.3 OUTLIER -161.45 -59.8 0.05 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.479 -0.763 . . . . 0.0 110.739 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 1.027 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -169.88 134.29 1.3 Allowed 'General case' 0 N--CA 1.513 2.705 0 O-C-N 121.124 -0.985 . . . . 0.0 109.489 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 1.019 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 0.8 OUTLIER -133.71 139.76 46.6 Favored 'General case' 0 C--N 1.28 -2.418 0 C-N-CA 117.624 -1.63 . . . . 0.0 113.744 -178.02 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.742 ' HB2' HD13 ' A' ' 13' ' ' ILE . . . -142.61 131.58 23.01 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 123.066 1.413 . . . . 0.0 111.489 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 1.074 HD11 ' CG1' ' A' ' 105' ' ' VAL 0.272 0.0 OUTLIER -108.7 131.06 60.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.613 -179.218 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.63 ' N ' HD13 ' A' ' 121' ' ' ILE . . . . . . . . 0 N--CA 1.486 1.358 0 O-C-N 120.827 -1.17 . . . . 0.0 108.895 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.48 ' O ' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 120.681 0.277 . . . . 0.0 111.003 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.765 HG12 ' HA ' ' A' ' 22' ' ' HIS . 1.3 m -145.8 174.03 3.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 O-C-N 120.884 -1.135 . . . . 0.0 107.967 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.481 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -80.82 140.05 35.66 Favored 'General case' 0 CA--C 1.478 -1.82 0 C-N-CA 117.968 -1.493 . . . . 0.0 108.66 177.31 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.524 HG11 ' CG2' ' A' ' 16' ' ' VAL 0.422 0.4 OUTLIER -166.44 -178.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 C-N-CA 118.021 -1.472 . . . . 0.0 110.933 -170.135 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 5' ' ' VAL . 18.5 mtmt -153.69 141.65 20.24 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 123.812 1.767 . . . . 0.0 112.823 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.271 13.8 t70 -79.09 149.45 32.08 Favored 'General case' 0 C--N 1.266 -3.049 0 CA-C-N 113.032 -1.894 . . . . 0.0 109.442 178.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.642 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 7.3 p -137.27 14.26 3.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.981 -1.074 . . . . 0.0 109.529 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.806 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -126.16 -83.98 0.62 Allowed 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 119.014 -1.074 . . . . 0.0 110.17 -177.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 12' ' ' GLU . 4.2 t-20 -155.97 64.73 0.58 Allowed 'General case' 0 C--N 1.269 -2.898 0 C-N-CA 118.519 -1.272 . . . . 0.0 111.62 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.473 ' C ' ' O ' ' A' ' 10' ' ' ASN . 6.2 m80 32.57 32.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.725 0.774 . . . . 0.0 110.697 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.9 OUTLIER -93.42 22.35 5.37 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.485 -0.886 . . . . 0.0 111.889 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.973 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.272 0.1 OUTLIER -116.76 -168.09 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 CA-C-O 122.027 0.918 . . . . 0.0 110.741 -179.035 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.659 ' N ' HG23 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -162.2 -45.46 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.732 179.831 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.569 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 28.9 tttt -146.59 136.12 22.99 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 116.116 -2.234 . . . . 0.0 113.246 178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.971 HG12 ' HB2' ' A' ' 39' ' ' ALA . 0.9 OUTLIER -132.61 102.9 5.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 CA-C-O 123.041 1.4 . . . . 0.0 110.817 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.514 ' HA ' HD23 ' A' ' 17' ' ' LEU . 1.4 mt -93.62 126.04 38.57 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.933 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.8 HG22 ' HA ' ' A' ' 37' ' ' LEU . 75.3 t -142.52 145.08 33.07 Favored Pre-proline 0 N--CA 1.502 2.137 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.756 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.656 ' HD2' HG13 ' A' ' 18' ' ' VAL . 47.4 Cg_endo -72.0 137.08 28.56 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 O-C-N 123.691 1.364 . . . . 0.0 110.893 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.99 -80.1 0.27 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.4 m -87.81 131.31 34.57 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.553 -0.969 . . . . 0.0 109.557 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.765 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -137.4 14.83 2.99 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 119.905 -1.747 . . . . 0.0 110.865 179.489 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 C-N-CA 118.287 -1.911 . . . . 0.0 110.815 177.115 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.839 ' HA2' ' HA ' ' A' ' 96' ' ' LYS . . . . . . . . 0 C--O 1.212 -1.242 0 N-CA-C 106.112 -2.795 . . . . 0.0 106.112 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.81 ' HB2' HG12 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -116.76 96.59 48.9 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 120.666 2.233 . . . . 0.0 116.354 -175.103 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.607 ' HD3' ' O ' ' A' ' 32' ' ' GLY . 61.6 Cg_endo -107.6 144.97 0.08 OUTLIER 'Trans proline' 0 C--N 1.289 -2.588 0 C-N-CA 124.081 3.187 . . . . 0.0 109.021 177.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' A' ' 91' ' ' THR . 2.8 m-85 -117.69 98.35 6.33 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.022 -1.071 . . . . 0.0 108.538 178.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.636 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 25.6 mp0 -117.39 91.25 3.52 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.53 -0.731 . . . . 0.0 109.687 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.8 ' HA ' HG22 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -108.31 135.72 49.15 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.489 -1.382 . . . . 0.0 108.341 179.496 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' A' ' 17' ' ' LEU . 0.1 OUTLIER -139.31 128.11 23.41 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.971 ' HB2' HG12 ' A' ' 16' ' ' VAL . . . -142.48 152.05 42.32 Favored 'General case' 0 C--N 1.276 -2.602 0 CA-C-O 123.067 1.413 . . . . 0.0 113.405 -175.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.569 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.74 140.77 28.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 113.763 -1.562 . . . . 0.0 108.612 178.286 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.582 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 3.5 p90 -157.21 121.47 4.32 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -178.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 12.3 tt0 -68.72 155.12 40.7 Favored 'General case' 0 C--N 1.288 -2.089 0 O-C-N 120.416 -1.428 . . . . 0.0 108.918 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.951 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -88.14 136.84 32.79 Favored 'General case' 0 C--N 1.267 -3.01 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.402 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.623 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 17.7 p-10 -117.81 49.96 1.18 Allowed 'General case' 0 CA--C 1.486 -1.506 0 CA-C-O 125.454 2.55 . . . . 0.0 114.033 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.586 ' N ' ' CG ' ' A' ' 82' ' ' LYS . 7.1 pt20 167.12 -160.52 0.01 OUTLIER 'General case' 0 C--N 1.258 -3.37 0 CA-C-N 108.914 -3.767 . . . . 0.0 112.92 175.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.457 ' OD1' ' N ' ' A' ' 47' ' ' THR 0.265 41.2 t-20 -109.2 153.69 23.43 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-O 122.588 1.185 . . . . 0.0 108.754 -178.901 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.64 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -173.14 156.21 3.16 Favored 'General case' 0 C--N 1.255 -3.541 0 C-N-CA 118.473 -1.291 . . . . 0.0 112.5 -178.28 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.958 ' O ' HG23 ' A' ' 49' ' ' THR . 9.5 mtpt -112.41 5.8 18.32 Favored 'General case' 0 N--CA 1.509 2.501 0 O-C-N 120.747 -1.221 . . . . 0.0 111.184 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.958 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.41 149.13 4.79 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.369 -1.457 . . . . 0.0 111.611 179.653 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.542 ' O ' ' O ' ' A' ' 70' ' ' PRO . . . -142.82 99.76 3.53 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 122.574 1.178 . . . . 0.0 110.871 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 9.9 mttt -69.31 -178.01 1.25 Allowed 'General case' 0 N--CA 1.506 2.338 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.913 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.983 ' CG2' HD11 ' A' ' 88' ' ' ILE . 35.8 mt -140.99 137.8 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.665 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.665 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.583 ' HB3' ' CE ' ' A' ' 109' ' ' LYS . 4.0 tt0 -141.51 112.19 7.13 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 123.261 1.505 . . . . 0.0 111.239 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 1.027 HD12 HG21 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -91.88 127.54 44.1 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 CA-C-N 112.79 -2.005 . . . . 0.0 110.296 179.476 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.435 ' HD2' ' HG2' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -122.9 101.7 7.59 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 176.594 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.911 ' HB3' HG22 ' A' ' 63' ' ' VAL . . . -112.81 133.31 54.87 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.843 -1.16 . . . . 0.0 113.178 -175.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.722 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 0.3 OUTLIER -109.49 102.35 11.23 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 177.811 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.966 ' HA ' HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -112.55 97.81 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.863 0 CA-C-O 123.423 1.582 . . . . 0.0 110.746 -177.258 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.727 ' OD1' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER 39.14 65.37 0.68 Allowed 'General case' 0 N--CA 1.52 3.061 0 CA-C-N 114.641 -1.163 . . . . 0.0 113.112 179.236 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.16 -18.34 10.22 Favored Glycine 0 N--CA 1.487 2.093 0 O-C-N 121.378 -0.826 . . . . 0.0 111.481 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.53 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.267 0.3 OUTLIER -107.7 58.67 0.62 Allowed 'General case' 0 C--N 1.293 -1.873 0 O-C-N 121.092 -1.24 . . . . 0.0 111.513 -178.453 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.365 0.0 OUTLIER -63.42 113.19 3.11 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.045 0.926 . . . . 0.0 110.912 -179.78 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.911 HG22 ' HB3' ' A' ' 56' ' ' ALA . 15.3 m -72.73 142.56 14.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-O 122.504 1.145 . . . . 0.0 110.731 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.434 7.9 t70 -138.3 64.88 1.48 Allowed 'General case' 0 C--N 1.277 -2.552 0 CA-C-O 122.619 1.199 . . . . 0.0 110.73 -176.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.583 HG22 ' HD2' ' A' ' 66' ' ' PRO . 8.2 p -164.47 151.64 10.04 Favored Pre-proline 0 C--N 1.269 -2.918 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.005 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.583 ' HD2' HG22 ' A' ' 65' ' ' VAL . 45.5 Cg_endo -82.39 139.64 10.43 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 CA-C-O 123.886 1.536 . . . . 0.0 112.221 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.615 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -133.36 60.11 0.67 Allowed Glycine 0 N--CA 1.501 2.991 0 CA-C-N 112.291 -2.231 . . . . 0.0 109.0 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.641 ' HB ' ' CD2' ' A' ' 90' ' ' TYR 0.272 0.2 OUTLIER 163.93 -177.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.326 -1.103 . . . . 0.0 108.179 -178.074 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.575 ' N ' ' CG2' ' A' ' 68' ' ' ILE . 0.4 OUTLIER -107.53 140.43 21.52 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 105.728 -1.952 . . . . 0.0 105.728 175.084 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.76 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 23.2 Cg_endo -105.39 -3.02 0.17 Allowed 'Trans proline' 0 C--N 1.273 -3.427 0 C-N-CA 122.945 2.43 . . . . 0.0 114.155 -173.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.572 ' HB2' ' NE2' ' A' ' 74' ' ' HIS . 0.2 OUTLIER -107.91 96.6 6.49 Favored 'General case' 0 C--N 1.285 -2.234 0 O-C-N 120.765 -1.209 . . . . 0.0 108.532 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.761 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . . . -77.4 10.7 2.36 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.195 -0.94 . . . . 0.0 108.897 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.7 t -77.34 -24.96 50.66 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 120.984 -1.072 . . . . 0.0 108.209 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.572 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 0.5 OUTLIER -83.25 11.62 6.37 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.444 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.761 ' CD2' ' HA ' ' A' ' 72' ' ' ALA . 1.3 m-85 -132.03 -6.18 3.5 Favored 'General case' 0 C--O 1.215 -0.731 0 O-C-N 121.744 -0.598 . . . . 0.0 110.151 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.452 ' O ' ' C ' ' A' ' 77' ' ' LYS . 2.8 ptt? -161.1 131.26 5.03 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 123.915 1.817 . . . . 0.0 113.973 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.55 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 9.3 pttt -16.76 99.36 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 111.801 -2.454 . . . . 0.0 113.462 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 48' ' ' LYS 0.325 0.5 OUTLIER -99.12 140.22 21.55 Favored Pre-proline 0 C--N 1.264 -3.124 0 CA-C-N 111.548 -2.569 . . . . 0.0 108.613 178.272 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.64 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 36.0 Cg_endo -82.68 170.01 58.21 Favored 'Cis proline' 0 C--N 1.312 -1.384 0 C-N-CA 123.457 -1.476 . . . . 0.0 112.277 0.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.69 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -95.28 129.67 42.33 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.771 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.54 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 2.4 p -108.3 138.21 36.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 124.299 2.0 . . . . 0.0 112.05 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.623 ' HG2' ' HA ' ' A' ' 44' ' ' ASN . 1.7 tmmt? -42.09 117.42 0.97 Allowed 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 111.606 -2.543 . . . . 0.0 116.614 -175.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.25 -17.6 14.44 Favored Glycine 0 C--N 1.293 -1.83 0 CA-C-N 111.714 -2.494 . . . . 0.0 107.945 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 27.0 mt-30 -72.52 126.36 29.66 Favored 'General case' 0 C--N 1.278 -2.525 0 CA-C-O 123.199 1.476 . . . . 0.0 111.633 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.607 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 14.5 mt-30 -64.57 143.31 58.01 Favored 'General case' 0 C--N 1.27 -2.872 0 CA-C-N 113.385 -1.734 . . . . 0.0 107.927 178.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.951 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 19.9 m-85 -142.3 125.25 16.16 Favored 'General case' 0 C--N 1.279 -2.472 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.545 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 1.1 p30 -117.4 132.46 56.57 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-O 122.776 1.274 . . . . 0.0 110.088 -177.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 1.053 HD12 ' CG2' ' A' ' 110' ' ' VAL . 0.3 OUTLIER -101.29 157.84 4.25 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.196 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.422 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -147.24 141.37 26.09 Favored 'General case' 0 C--N 1.286 -2.189 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.133 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.645 ' CE1' ' HB2' ' A' ' 92' ' ' TRP . 3.0 t80 -144.04 112.52 6.5 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.276 -0.89 . . . . 0.0 108.894 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.596 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 0.6 OUTLIER -131.41 115.68 16.53 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 179.09 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.645 ' HB2' ' CE1' ' A' ' 90' ' ' TYR 0.266 0.5 OUTLIER -141.89 111.81 6.78 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.513 -176.666 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 2.5 p-10 -74.67 159.49 32.02 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 119.378 -2.077 . . . . 0.0 109.361 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.84 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.8 OUTLIER -153.0 172.16 5.94 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.083 -1.011 . . . . 0.0 108.835 -178.296 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.84 ' HD2' HG22 ' A' ' 94' ' ' VAL . 17.0 Cg_endo -37.53 152.32 0.04 OUTLIER 'Trans proline' 0 CA--C 1.498 -1.286 0 O-C-N 123.785 1.413 . . . . 0.0 110.045 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.839 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -79.04 -23.22 44.44 Favored 'General case' 0 C--N 1.282 -2.362 0 C-N-CA 116.622 -2.031 . . . . 0.0 115.068 -172.721 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.763 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -138.75 43.07 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-O 121.398 0.618 . . . . 0.0 112.618 -178.977 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.943 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . . . -70.04 -67.62 0.65 Allowed Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 120.686 -1.259 . . . . 0.0 110.654 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.943 ' HD3' ' HB3' ' A' ' 98' ' ' ALA . 47.7 Cg_endo -66.51 160.4 46.01 Favored 'Trans proline' 0 CA--C 1.461 -3.133 0 O-C-N 123.676 1.356 . . . . 0.0 110.228 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.707 ' HD2' ' C ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -109.16 106.49 16.39 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-N 112.497 -2.138 . . . . 0.0 110.301 -169.453 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.451 ' C ' ' HG3' ' A' ' 102' ' ' GLU . 5.3 p -46.25 97.16 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 CA-C-O 123.612 1.673 . . . . 0.0 109.031 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.392 84.8 mt-10 -164.95 -52.4 0.03 OUTLIER 'General case' 0 CA--C 1.45 -2.893 0 CA-C-N 112.975 -1.921 . . . . 0.0 111.461 179.659 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.569 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.489 36.8 t-20 -160.73 83.5 0.67 Allowed 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 110.681 -2.963 . . . . 0.0 113.608 -162.045 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.966 HG22 ' HA ' ' A' ' 58' ' ' ILE . 32.4 t -143.21 134.23 23.0 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 C-N-CA 119.103 -1.039 . . . . 0.0 112.308 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 1.073 HG13 HD11 ' A' ' 121' ' ' ILE . 0.6 OUTLIER -140.54 130.61 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.555 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.801 HG23 ' HB2' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -105.46 141.9 19.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-O 122.344 1.069 . . . . 0.0 111.393 -179.271 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . 1.068 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -132.6 109.14 9.53 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 179.509 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.027 HG21 HD12 ' A' ' 54' ' ' ILE . 3.4 t -127.61 141.91 45.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 117.802 -1.559 . . . . 0.0 109.16 -177.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.851 ' HB2' ' CB ' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -131.03 152.84 49.9 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 122.904 1.335 . . . . 0.0 112.938 -178.774 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 1.053 ' CG2' HD12 ' A' ' 88' ' ' ILE . 3.8 t -102.61 124.55 56.67 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 176.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.544 ' HG2' ' O ' ' A' ' 111' ' ' MET . 2.1 ptm -104.86 121.76 44.35 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.598 ' HA3' HD23 ' A' ' 117' ' ' LEU . . . -79.83 -137.35 1.62 Allowed Glycine 0 N--CA 1.496 2.662 0 C-N-CA 118.931 -1.604 . . . . 0.0 114.01 -175.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.64 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 13.4 p-10 -79.8 -4.93 54.23 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 122.393 1.092 . . . . 0.0 111.986 -177.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 10.8 p30 -128.9 -4.61 5.12 Favored 'General case' 0 C--N 1.268 -2.96 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.933 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.58 ' O ' ' HB ' ' A' ' 116' ' ' VAL . . . 86.81 84.0 1.13 Allowed Glycine 0 CA--C 1.471 -2.718 0 CA-C-O 124.875 2.375 . . . . 0.0 109.669 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.58 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 6.9 p 145.97 145.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.246 -3.913 0 CA-C-N 108.281 -3.96 . . . . 0.0 111.204 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.742 ' CB ' HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -162.21 -59.51 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.378 -0.826 . . . . 0.0 110.651 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.973 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -168.25 129.17 1.33 Allowed 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.851 ' CB ' ' HB2' ' A' ' 109' ' ' LYS . 0.8 OUTLIER -134.29 141.32 46.91 Favored 'General case' 0 C--N 1.284 -2.274 0 C-N-CA 118.004 -1.478 . . . . 0.0 113.097 -177.703 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.69 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -146.53 137.28 24.07 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 123.159 1.456 . . . . 0.0 112.468 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 1.073 HD11 HG13 ' A' ' 105' ' ' VAL 0.265 0.1 OUTLIER -112.23 133.24 58.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 113.908 -1.497 . . . . 0.0 110.912 -179.78 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.766 ' N ' HD13 ' A' ' 121' ' ' ILE . . . . . . . . 0 N--CA 1.486 1.367 0 O-C-N 120.743 -1.223 . . . . 0.0 108.858 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.492 ' O ' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 120.75 0.31 . . . . 0.0 110.851 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.667 HG12 ' HA ' ' A' ' 22' ' ' HIS . 1.4 m -148.72 174.7 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.496 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -80.12 139.86 36.66 Favored 'General case' 0 CA--C 1.482 -1.647 0 C-N-CA 118.097 -1.441 . . . . 0.0 108.396 177.042 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.503 ' C ' ' CG ' ' A' ' 6' ' ' LYS 0.434 0.4 OUTLIER -166.33 -175.31 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.406 -169.992 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.556 ' HB2' ' CG2' ' A' ' 121' ' ' ILE . 1.6 mttt -153.91 138.86 17.22 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 123.565 1.65 . . . . 0.0 112.577 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.285 3.5 t70 -84.67 148.83 26.2 Favored 'General case' 0 C--N 1.27 -2.881 0 CA-C-N 113.381 -1.736 . . . . 0.0 109.732 178.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.621 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 5.3 p -137.43 13.14 3.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.007 -1.058 . . . . 0.0 109.469 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.837 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -126.33 -85.58 0.61 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 118.586 -1.246 . . . . 0.0 110.026 -177.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 12' ' ' GLU . 4.1 t-20 -160.29 67.1 0.35 Allowed 'General case' 0 C--N 1.265 -3.083 0 C-N-CA 118.578 -1.249 . . . . 0.0 111.935 177.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.467 ' C ' ' O ' ' A' ' 10' ' ' ASN . 7.7 m80 34.36 32.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.765 0.793 . . . . 0.0 110.42 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.1 OUTLIER -86.92 20.4 2.64 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.475 0.655 . . . . 0.0 110.739 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.896 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.289 0.0 OUTLIER -121.79 -166.89 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-O 121.989 0.9 . . . . 0.0 110.834 -178.215 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.649 ' H ' HG23 ' A' ' 13' ' ' ILE . 1.7 pttt -161.88 -44.08 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.996 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.57 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 11.3 tttm -149.85 140.31 22.42 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 116.375 -2.13 . . . . 0.0 113.371 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 1.031 HG13 ' HB2' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -132.92 108.85 13.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 CA-C-O 122.873 1.321 . . . . 0.0 110.936 179.705 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.532 ' HA ' HD23 ' A' ' 17' ' ' LEU . 2.8 mt -102.0 122.57 44.32 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 114.164 -1.38 . . . . 0.0 110.949 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.638 HG22 ' HB2' ' A' ' 37' ' ' LEU . 58.3 t -142.11 142.51 24.73 Favored Pre-proline 0 C--N 1.292 -1.906 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.549 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.491 ' HD2' HG13 ' A' ' 18' ' ' VAL . 40.7 Cg_endo -66.19 126.65 16.08 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.752 1.396 . . . . 0.0 110.69 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 123.19 -78.69 0.35 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.6 m -90.37 133.86 34.71 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.476 -1.014 . . . . 0.0 109.965 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.667 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -140.79 10.52 2.22 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.019 -1.675 . . . . 0.0 110.847 178.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.489 ' O ' ' HB3' ' A' ' 4' ' ' ASP . . . . . . . . 0 C--N 1.285 -2.258 0 C-N-CA 118.592 -1.766 . . . . 0.0 110.62 176.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.864 ' HA2' ' HA ' ' A' ' 96' ' ' LYS . . . . . . . . 0 C--O 1.213 -1.165 0 N-CA-C 105.413 -3.075 . . . . 0.0 105.413 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.731 ' HB2' HG12 ' A' ' 94' ' ' VAL . 4.5 mmmm -116.3 94.82 43.6 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 120.593 2.196 . . . . 0.0 116.57 -174.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.645 ' HD3' ' O ' ' A' ' 32' ' ' GLY . 61.3 Cg_endo -106.91 144.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.288 -2.621 0 C-N-CA 124.086 3.191 . . . . 0.0 108.136 176.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.653 ' HZ ' HG11 ' A' ' 94' ' ' VAL . 2.2 m-85 -120.8 94.59 4.4 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.002 -1.079 . . . . 0.0 109.429 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.61 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 28.1 mp0 -113.3 84.41 2.0 Allowed 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.678 HD12 ' C ' ' A' ' 37' ' ' LEU . 3.6 pp -110.24 140.97 43.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.652 -1.28 . . . . 0.0 109.718 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -140.76 139.27 34.6 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 122.73 1.252 . . . . 0.0 109.151 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 1.031 ' HB2' HG13 ' A' ' 16' ' ' VAL . . . -142.68 151.64 41.58 Favored 'General case' 0 C--N 1.277 -2.576 0 CA-C-O 123.007 1.384 . . . . 0.0 112.546 -177.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.57 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.15 141.57 25.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 113.996 -1.457 . . . . 0.0 108.908 178.89 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.593 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 3.1 p90 -155.94 121.21 4.82 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 17.0 tt0 -68.82 152.82 44.81 Favored 'General case' 0 C--N 1.286 -2.159 0 O-C-N 120.392 -1.443 . . . . 0.0 108.267 178.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.995 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -85.64 131.52 34.33 Favored 'General case' 0 C--N 1.264 -3.109 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.445 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.63 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -113.36 50.8 0.88 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 125.638 2.637 . . . . 0.0 114.074 179.454 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.605 ' C ' ' HB2' ' A' ' 82' ' ' LYS . 4.4 pt20 167.33 -162.39 0.01 OUTLIER 'General case' 0 C--N 1.266 -3.023 0 CA-C-N 108.641 -3.89 . . . . 0.0 113.462 175.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . 0.279 36.6 t30 -110.37 152.44 26.24 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 122.466 1.127 . . . . 0.0 108.712 -178.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.673 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -173.25 155.52 2.94 Favored 'General case' 0 C--N 1.255 -3.534 0 C-N-CA 118.01 -1.476 . . . . 0.0 113.257 -178.527 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.968 ' O ' HG23 ' A' ' 49' ' ' THR . 9.9 mttt -110.63 7.21 22.26 Favored 'General case' 0 N--CA 1.509 2.495 0 O-C-N 120.734 -1.229 . . . . 0.0 110.646 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.968 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.8 OUTLIER -168.01 146.1 4.43 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 120.557 -1.339 . . . . 0.0 111.262 179.255 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.529 ' O ' ' O ' ' A' ' 70' ' ' PRO . . . -143.21 97.93 3.17 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-O 122.619 1.199 . . . . 0.0 109.641 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 12.3 mtmt -68.71 -179.09 1.31 Allowed 'General case' 0 N--CA 1.504 2.237 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.719 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.989 ' CG2' HD11 ' A' ' 88' ' ' ILE . 35.6 mt -140.19 140.4 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.425 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.368 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.501 ' HB3' ' HE1' ' A' ' 111' ' ' MET . 16.3 tp10 -140.47 107.88 5.55 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 123.374 1.559 . . . . 0.0 110.313 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 1.067 HD12 HG21 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -91.16 125.6 43.89 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 CA-C-N 112.572 -2.103 . . . . 0.0 109.271 179.327 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -121.36 103.4 8.93 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 177.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.937 ' HB3' HG22 ' A' ' 63' ' ' VAL . . . -110.31 128.77 55.71 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 118.814 -1.155 . . . . 0.0 112.005 -176.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.71 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 0.4 OUTLIER -107.09 102.93 12.23 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.943 ' HA ' HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -114.51 101.91 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.868 0 CA-C-O 123.197 1.475 . . . . 0.0 110.811 -177.454 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.666 ' N ' HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER 37.46 65.16 0.56 Allowed 'General case' 0 N--CA 1.522 3.132 0 CA-C-N 114.932 -1.031 . . . . 0.0 113.074 179.304 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.87 -15.49 8.1 Favored Glycine 0 N--CA 1.488 2.133 0 O-C-N 121.278 -0.889 . . . . 0.0 111.363 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.522 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.274 0.3 OUTLIER -108.02 56.73 0.63 Allowed 'General case' 0 C--N 1.293 -1.85 0 O-C-N 121.108 -1.23 . . . . 0.0 111.417 -178.384 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.376 0.0 OUTLIER -60.38 117.48 5.29 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.918 0.866 . . . . 0.0 110.661 179.928 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.937 HG22 ' HB3' ' A' ' 56' ' ' ALA . 17.1 m -80.62 135.46 25.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-O 122.816 1.293 . . . . 0.0 111.736 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.447 26.0 t0 -140.08 67.65 1.37 Allowed 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.833 -177.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.576 HG12 ' HD2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -150.52 175.85 2.61 Favored Pre-proline 0 C--N 1.268 -2.952 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.001 -178.152 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.576 ' HD2' HG12 ' A' ' 65' ' ' VAL . 38.3 Cg_endo -65.98 139.91 58.29 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.395 1.734 . . . . 0.0 111.382 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.603 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -134.57 -73.01 0.08 OUTLIER Glycine 0 N--CA 1.503 3.11 0 CA-C-N 112.459 -2.155 . . . . 0.0 111.121 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.757 HD13 ' H ' ' A' ' 91' ' ' THR . 2.0 tp -117.42 -157.83 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.225 -1.75 . . . . 0.0 108.789 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.716 ' N ' HG23 ' A' ' 68' ' ' ILE . 0.6 OUTLIER -106.69 141.85 23.71 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 177.136 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.777 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 24.5 Cg_endo -105.76 -3.76 0.15 Allowed 'Trans proline' 0 C--N 1.276 -3.289 0 C-N-CA 123.196 2.597 . . . . 0.0 114.309 -173.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.576 ' O ' ' CE1' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -110.37 87.58 2.56 Favored 'General case' 0 C--N 1.287 -2.132 0 O-C-N 120.717 -1.24 . . . . 0.0 108.121 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.626 ' HA ' ' CD1' ' A' ' 75' ' ' TYR . . . -74.47 8.45 2.27 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.734 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.4 ' C ' ' H ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -78.11 -19.87 53.27 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 120.536 -1.352 . . . . 0.0 108.243 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.574 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -88.76 19.75 3.86 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 173.717 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.626 ' CD1' ' HA ' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -132.57 -9.07 3.22 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.798 179.703 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.468 ' O ' ' C ' ' A' ' 77' ' ' LYS . 2.1 ptt? -167.93 129.59 1.46 Allowed 'General case' 0 C--O 1.215 -0.757 0 CA-C-O 123.621 1.677 . . . . 0.0 112.489 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.526 ' O ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -9.16 94.92 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 111.99 -2.368 . . . . 0.0 113.833 -178.935 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 48' ' ' LYS 0.312 7.9 t -98.87 140.3 21.66 Favored Pre-proline 0 C--N 1.271 -2.813 0 CA-C-N 111.278 -2.692 . . . . 0.0 108.093 177.939 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.728 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 36.2 Cg_endo -78.74 171.21 66.85 Favored 'Cis proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.987 -1.672 . . . . 0.0 113.177 1.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.687 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.3 OUTLIER -99.33 129.3 45.53 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.066 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.509 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.4 t -105.12 138.68 28.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 124.202 1.953 . . . . 0.0 112.287 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.63 ' HG2' ' HA ' ' A' ' 44' ' ' ASN . 1.4 tmmt? -43.96 118.08 1.36 Allowed 'General case' 0 C--N 1.273 -2.748 0 CA-C-N 111.762 -2.472 . . . . 0.0 116.517 -175.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.26 -18.26 12.23 Favored Glycine 0 C--N 1.29 -1.988 0 CA-C-N 111.746 -2.479 . . . . 0.0 107.931 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 11.0 mt-30 -71.84 125.39 27.05 Favored 'General case' 0 C--N 1.278 -2.5 0 CA-C-O 123.13 1.443 . . . . 0.0 111.543 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.593 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 3.4 pt20 -63.67 142.89 58.23 Favored 'General case' 0 C--N 1.268 -2.938 0 CA-C-N 113.424 -1.716 . . . . 0.0 107.355 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.995 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 17.7 m-85 -142.21 126.1 17.16 Favored 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.545 ' HB3' HG12 ' A' ' 40' ' ' VAL . 19.9 p30 -117.35 132.6 56.56 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-O 122.856 1.312 . . . . 0.0 110.107 -177.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 1.058 HD12 ' CG2' ' A' ' 110' ' ' VAL . 0.4 OUTLIER -101.99 159.16 4.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 CA-C-N 114.324 -1.307 . . . . 0.0 108.13 179.513 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.456 ' HG2' ' N ' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -148.95 151.2 34.19 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.909 -178.031 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.523 ' O ' ' HA ' ' A' ' 36' ' ' GLN . 49.3 t80 -147.92 104.1 3.55 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.335 178.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.757 ' H ' HD13 ' A' ' 68' ' ' ILE . 1.1 t -121.2 113.93 20.68 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.603 ' CD1' ' O ' ' A' ' 67' ' ' GLY 0.272 0.4 OUTLIER -142.17 113.86 7.92 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.611 -177.107 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 18.7 p-10 -75.07 159.1 32.11 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 119.423 -2.048 . . . . 0.0 109.696 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.875 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.5 OUTLIER -155.59 169.19 10.77 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.05 -1.031 . . . . 0.0 108.484 -178.961 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.875 ' HD2' HG22 ' A' ' 94' ' ' VAL . 17.2 Cg_endo -36.65 154.74 0.02 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.16 0 O-C-N 123.488 1.257 . . . . 0.0 110.887 -177.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.864 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -78.71 -25.41 44.7 Favored 'General case' 0 C--N 1.285 -2.219 0 C-N-CA 116.903 -1.919 . . . . 0.0 114.889 -172.926 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.763 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -145.85 47.24 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 CA-C-O 121.802 0.81 . . . . 0.0 111.941 -178.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.833 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . . . -76.06 -60.1 1.03 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.731 -1.23 . . . . 0.0 111.31 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.833 ' HD3' ' HB3' ' A' ' 98' ' ' ALA . 45.0 Cg_endo -64.36 159.05 45.74 Favored 'Trans proline' 0 CA--C 1.466 -2.897 0 O-C-N 123.912 1.48 . . . . 0.0 111.161 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.715 ' HD2' ' C ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -109.88 105.28 14.41 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 112.404 -2.18 . . . . 0.0 110.564 -169.146 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.422 ' C ' ' HG3' ' A' ' 102' ' ' GLU . 4.2 p -46.49 95.24 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.5 0 CA-C-O 123.509 1.623 . . . . 0.0 109.363 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.622 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.399 92.3 mt-10 -164.26 -51.83 0.03 OUTLIER 'General case' 0 CA--C 1.453 -2.787 0 CA-C-N 112.981 -1.918 . . . . 0.0 112.029 179.8 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.552 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.49 28.0 t30 -160.49 79.45 0.65 Allowed 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 115.016 -2.674 . . . . 0.0 114.221 -161.939 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.943 HG22 ' HA ' ' A' ' 58' ' ' ILE . 36.1 t -142.44 153.53 17.99 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.577 0 C-N-CA 119.703 -0.799 . . . . 0.0 111.203 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.832 HG13 HD11 ' A' ' 121' ' ' ILE . 0.4 OUTLIER -167.44 134.6 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -179.651 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.706 HG23 ' HB2' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -105.02 142.84 17.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.717 0 CA-C-O 122.391 1.091 . . . . 0.0 111.772 -179.044 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . 1.09 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -132.32 107.92 8.86 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.964 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.067 HG21 HD12 ' A' ' 54' ' ' ILE . 3.2 t -125.13 142.74 41.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 117.628 -1.629 . . . . 0.0 109.136 -177.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 1.039 ' HB2' ' HB2' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -135.36 146.03 47.96 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.229 1.014 . . . . 0.0 111.169 -178.104 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 1.058 ' CG2' HD12 ' A' ' 88' ' ' ILE . 14.9 t -101.07 132.35 47.0 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.524 ' N ' ' HE2' ' A' ' 111' ' ' MET . 2.6 mtm -109.69 121.6 45.58 Favored 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.727 ' CA ' HD23 ' A' ' 117' ' ' LEU . . . -80.1 -141.66 2.65 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 119.109 -1.519 . . . . 0.0 113.846 -176.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.673 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 11.0 p-10 -77.28 -6.49 53.35 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 122.414 1.102 . . . . 0.0 111.951 -177.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -125.89 -4.98 6.91 Favored 'General case' 0 C--N 1.268 -2.961 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.703 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.939 ' O ' HG13 ' A' ' 116' ' ' VAL . . . 85.02 82.16 1.06 Allowed Glycine 0 CA--C 1.47 -2.722 0 CA-C-O 124.814 2.341 . . . . 0.0 109.834 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.939 HG13 ' O ' ' A' ' 115' ' ' GLY . 0.5 OUTLIER 152.59 143.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.247 -3.884 0 CA-C-N 108.204 -3.998 . . . . 0.0 111.622 177.871 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.759 ' CB ' HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -160.44 -57.45 0.06 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.331 -0.856 . . . . 0.0 111.319 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.896 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -174.87 131.87 0.33 Allowed 'General case' 0 N--CA 1.511 2.58 0 O-C-N 121.125 -0.984 . . . . 0.0 109.467 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 1.039 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 0.8 OUTLIER -133.97 137.94 45.14 Favored 'General case' 0 C--N 1.283 -2.283 0 C-N-CA 118.184 -1.406 . . . . 0.0 113.07 -177.863 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.673 ' HB2' HD12 ' A' ' 13' ' ' ILE . . . -148.52 136.93 21.28 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 123.077 1.418 . . . . 0.0 111.908 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 1.09 ' HB ' HG23 ' A' ' 107' ' ' THR 0.262 0.0 OUTLIER -110.54 130.29 64.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.97 -179.593 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.649 ' N ' HD13 ' A' ' 121' ' ' ILE . . . . . . . . 0 N--CA 1.488 1.436 0 O-C-N 120.931 -1.105 . . . . 0.0 109.19 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.226 0.536 . . . . 0.0 110.218 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 1' ' ' SER . 0.0 OUTLIER 64.0 157.02 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 111.209 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.796 HG12 ' HA ' ' A' ' 22' ' ' HIS 0.256 1.4 m -145.72 173.08 3.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.561 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -80.91 142.19 33.8 Favored 'General case' 0 CA--C 1.475 -1.921 0 O-C-N 120.281 -1.512 . . . . 0.0 107.741 176.183 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.62 HG12 ' H ' ' A' ' 6' ' ' LYS 0.406 0.4 OUTLIER -161.3 -50.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 C-N-CA 117.226 -1.79 . . . . 0.0 112.097 -170.121 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.62 ' H ' HG12 ' A' ' 5' ' ' VAL . 28.6 mmtm 84.86 139.46 0.06 Allowed 'General case' 0 N--CA 1.508 2.429 0 CA-C-O 124.315 2.007 . . . . 0.0 113.97 178.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.3 26.4 t70 -93.37 153.99 18.21 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 111.491 -2.595 . . . . 0.0 109.381 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.669 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.7 p -138.01 17.12 2.83 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.961 -1.087 . . . . 0.0 109.372 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.868 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -124.43 -85.81 0.64 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 118.55 -1.26 . . . . 0.0 109.722 -176.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.562 ' O ' ' N ' ' A' ' 12' ' ' GLU . 1.4 t-20 -159.96 65.04 0.35 Allowed 'General case' 0 C--N 1.265 -3.07 0 C-N-CA 117.774 -1.57 . . . . 0.0 112.142 177.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.466 ' C ' ' O ' ' A' ' 10' ' ' ASN . 6.2 m80 33.3 32.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.778 0.799 . . . . 0.0 110.507 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.562 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.1 OUTLIER -95.23 24.74 4.76 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.0 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.756 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.28 0.0 OUTLIER -117.14 -165.24 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-O 122.213 1.006 . . . . 0.0 110.993 -178.624 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.721 ' N ' HG23 ' A' ' 13' ' ' ILE . 14.8 ptpt -162.31 -48.03 0.04 OUTLIER 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.873 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.648 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 12.1 tttm -144.0 135.47 25.87 Favored 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 116.344 -2.142 . . . . 0.0 112.896 178.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.562 ' CG1' ' HB2' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -133.46 102.26 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-O 122.845 1.307 . . . . 0.0 110.603 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 17' ' ' LEU . 2.0 mt -93.41 123.44 36.71 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 114.172 -1.377 . . . . 0.0 111.253 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.688 HG13 ' HD2' ' A' ' 19' ' ' PRO . 23.7 t -143.13 145.82 34.26 Favored Pre-proline 0 N--CA 1.502 2.147 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.931 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.688 ' HD2' HG13 ' A' ' 18' ' ' VAL . 43.7 Cg_endo -68.72 109.88 2.2 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.83 1.437 . . . . 0.0 110.978 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.11 -94.99 0.12 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.511 ' SG ' ' HB3' ' A' ' 124' ' ' HIS . 14.1 m -93.82 174.82 6.98 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.108 -1.231 . . . . 0.0 111.415 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.796 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.3 OUTLIER -142.01 7.13 1.81 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.198 -0.939 . . . . 0.0 110.491 178.36 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.68 -151.21 10.19 Favored Glycine 0 C--N 1.287 -2.147 0 C-N-CA 118.958 -1.591 . . . . 0.0 110.212 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.75 -8.8 23.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.739 -1.448 . . . . 0.0 110.055 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.819 ' CB ' ' HD3' ' A' ' 26' ' ' PRO . 1.2 mt-10 -64.46 176.35 0.74 Allowed Pre-proline 0 C--N 1.299 -1.622 0 CA-C-O 124.962 2.315 . . . . 0.0 115.077 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.819 ' HD3' ' CB ' ' A' ' 25' ' ' GLU . 25.8 Cg_endo -107.25 123.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.267 -3.738 1 C-N-CA 127.714 5.609 . . . . 0.0 111.14 -175.905 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.5 ' SG ' ' N ' ' A' ' 21' ' ' CYS . 25.0 p -137.32 120.56 16.82 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 122.816 1.293 . . . . 0.0 111.639 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.712 HG22 ' H ' ' A' ' 29' ' ' ILE 0.335 46.9 mm -79.37 -166.03 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.781 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.712 ' H ' HG22 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -115.06 121.6 67.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 CA-C-O 122.584 1.183 . . . . 0.0 111.059 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.457 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 1.1 p-80 -70.36 33.19 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.836 -178.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 30' ' ' HIS . 43.6 mtt85 58.1 170.39 0.05 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.471 -1.393 . . . . 0.0 110.225 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.809 ' HA2' ' HA ' ' A' ' 96' ' ' LYS . . . 69.19 117.58 0.03 OUTLIER Glycine 0 C--O 1.214 -1.139 0 N-CA-C 105.61 -2.996 . . . . 0.0 105.61 -178.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.744 ' HB2' HG12 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -118.41 96.8 50.27 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 121.281 2.54 . . . . 0.0 117.089 -174.923 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.584 ' HD3' ' O ' ' A' ' 32' ' ' GLY . 61.2 Cg_endo -107.11 144.87 0.08 OUTLIER 'Trans proline' 0 C--N 1.29 -2.504 0 C-N-CA 124.289 3.326 . . . . 0.0 107.416 175.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.543 ' O ' ' CE1' ' A' ' 90' ' ' TYR . 30.4 m-85 -119.05 97.53 5.73 Favored 'General case' 0 C--N 1.291 -1.972 0 C-N-CA 118.603 -1.239 . . . . 0.0 108.839 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.653 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 28.1 mp0 -117.65 99.8 7.2 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.668 -0.645 . . . . 0.0 109.896 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.664 ' HA ' HG22 ' A' ' 18' ' ' VAL . 2.0 mt -109.67 139.24 44.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.403 -1.436 . . . . 0.0 108.741 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.402 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -140.24 128.65 22.67 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.564 -1.335 . . . . 0.0 107.764 179.241 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.562 ' HB2' ' CG1' ' A' ' 16' ' ' VAL . . . -143.75 150.14 38.16 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-O 123.119 1.437 . . . . 0.0 113.485 -176.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.728 HG12 ' HB3' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -115.49 138.22 46.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-N 113.696 -1.593 . . . . 0.0 107.84 177.853 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.688 ' HE2' HG22 ' A' ' 88' ' ' ILE . 8.4 p90 -159.58 130.01 5.71 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -177.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 15.2 tt0 -73.02 155.25 40.0 Favored 'General case' 0 C--N 1.281 -2.381 0 O-C-N 120.464 -1.398 . . . . 0.0 109.127 177.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.977 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -88.97 136.56 32.95 Favored 'General case' 0 C--N 1.269 -2.924 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.65 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.599 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 15.3 p-10 -117.32 50.51 1.1 Allowed 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 125.408 2.528 . . . . 0.0 114.071 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.631 ' C ' ' HB2' ' A' ' 82' ' ' LYS . 7.0 pt20 166.87 -159.44 0.01 OUTLIER 'General case' 0 C--N 1.257 -3.416 0 CA-C-N 108.947 -3.751 . . . . 0.0 112.816 175.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.463 ' H ' ' HB2' ' A' ' 45' ' ' GLN 0.275 21.1 t-20 -110.1 154.25 23.54 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-O 122.53 1.157 . . . . 0.0 108.389 -178.895 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.631 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -171.84 151.05 2.73 Favored 'General case' 0 C--N 1.251 -3.675 0 C-N-CA 118.366 -1.333 . . . . 0.0 112.508 -178.25 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.953 ' O ' HG23 ' A' ' 49' ' ' THR . 0.0 OUTLIER -111.66 6.52 19.96 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 120.668 -1.27 . . . . 0.0 110.817 178.511 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.953 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.41 147.43 4.41 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 120.712 -1.243 . . . . 0.0 111.089 179.373 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 111' ' ' MET . . . -146.71 106.17 3.92 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-O 122.271 1.034 . . . . 0.0 109.981 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.599 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -75.99 -175.73 3.17 Favored 'General case' 0 N--CA 1.505 2.292 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.353 179.447 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.829 ' CG1' HD11 ' A' ' 88' ' ' ILE . 26.7 mt -140.19 135.08 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.688 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.407 ' C ' HG13 ' A' ' 108' ' ' VAL . 15.9 tt0 -141.4 114.55 8.67 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 123.428 1.585 . . . . 0.0 111.854 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 1.031 HD12 HG21 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -90.28 125.91 43.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-N 112.705 -2.043 . . . . 0.0 108.904 178.15 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -117.69 98.69 6.5 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 177.344 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.895 ' HB3' HG22 ' A' ' 63' ' ' VAL . . . -112.86 126.8 55.85 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 118.459 -1.296 . . . . 0.0 112.889 -175.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.746 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.4 p -104.28 98.37 8.18 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 177.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.89 ' HA ' HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -108.76 107.38 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.882 0 CA-C-O 122.905 1.336 . . . . 0.0 110.916 -176.676 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.634 ' N ' HG22 ' A' ' 104' ' ' VAL . 1.8 p30 35.84 62.35 0.65 Allowed 'General case' 0 N--CA 1.522 3.126 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.78 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.05 -12.04 10.16 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.284 -0.885 . . . . 0.0 111.365 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.541 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.279 0.3 OUTLIER -108.13 57.02 0.62 Allowed 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.079 -1.248 . . . . 0.0 111.162 -178.6 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.364 0.0 OUTLIER -60.79 115.09 3.41 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 122.049 0.928 . . . . 0.0 111.366 -179.411 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.895 HG22 ' HB3' ' A' ' 56' ' ' ALA . 15.2 m -75.77 143.64 12.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-O 122.494 1.14 . . . . 0.0 110.352 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.527 ' C ' ' CG2' ' A' ' 65' ' ' VAL 0.435 20.9 t0 -138.27 60.0 1.63 Allowed 'General case' 0 C--N 1.277 -2.572 0 CA-C-O 122.752 1.263 . . . . 0.0 110.901 -176.169 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.809 HG12 ' HD2' ' A' ' 66' ' ' PRO . 1.0 OUTLIER -157.39 151.86 20.49 Favored Pre-proline 0 C--N 1.269 -2.929 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.742 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.809 ' HD2' HG12 ' A' ' 65' ' ' VAL . 44.9 Cg_endo -84.47 137.38 6.9 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 CA-C-O 123.763 1.485 . . . . 0.0 111.013 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.604 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -116.66 42.52 1.85 Allowed Glycine 0 C--N 1.27 -3.136 0 CA-C-N 112.574 -2.103 . . . . 0.0 111.774 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.733 HG23 ' N ' ' A' ' 69' ' ' ASP . 3.0 tp 174.3 -163.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 O-C-N 120.379 -1.659 . . . . 0.0 108.93 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.733 ' N ' HG23 ' A' ' 68' ' ' ILE . 1.5 t70 -107.62 135.01 19.8 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 174.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.723 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 23.6 Cg_endo -106.16 -4.69 0.13 Allowed 'Trans proline' 0 C--N 1.278 -3.176 0 C-N-CA 123.445 2.763 . . . . 0.0 114.07 -173.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.608 ' O ' ' CE1' ' A' ' 75' ' ' TYR . 9.1 p30 -114.93 92.9 4.09 Favored 'General case' 0 C--N 1.285 -2.224 0 O-C-N 120.491 -1.381 . . . . 0.0 108.695 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.609 ' HA ' ' CD1' ' A' ' 75' ' ' TYR . . . -77.91 12.08 1.92 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.071 -1.018 . . . . 0.0 109.095 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.9 t -76.35 -25.22 54.46 Favored 'General case' 0 C--O 1.214 -0.773 0 O-C-N 120.802 -1.186 . . . . 0.0 107.951 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.592 ' CD2' ' OD1' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -88.1 18.68 4.1 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 174.421 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.62 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.2 OUTLIER -134.06 -10.93 2.61 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.38 179.631 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.457 ' O ' ' C ' ' A' ' 77' ' ' LYS . 2.0 ptt? -164.04 133.48 3.93 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-O 123.897 1.808 . . . . 0.0 113.277 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.524 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -12.08 95.51 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 111.761 -2.472 . . . . 0.0 113.732 -178.638 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.51 ' HA ' HD13 ' A' ' 80' ' ' LEU 0.312 1.2 t -104.86 145.13 30.12 Favored Pre-proline 0 C--N 1.268 -2.949 0 CA-C-N 111.428 -2.623 . . . . 0.0 108.491 178.341 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.659 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 36.8 Cg_endo -80.52 166.62 75.33 Favored 'Cis proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.562 -1.849 . . . . 0.0 112.513 0.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.657 ' HG ' ' CE1' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -90.95 127.76 36.52 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.816 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.518 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.4 t -104.58 141.35 20.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-O 124.253 1.977 . . . . 0.0 112.377 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.631 ' HB2' ' C ' ' A' ' 45' ' ' GLN . 1.7 tmmt? -46.55 118.32 1.95 Allowed 'General case' 0 C--N 1.272 -2.772 0 CA-C-N 111.531 -2.577 . . . . 0.0 116.578 -175.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.27 -16.84 19.67 Favored Glycine 0 C--N 1.29 -2.022 0 CA-C-N 111.827 -2.442 . . . . 0.0 107.811 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 64.3 mt-30 -72.83 126.61 30.32 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-O 123.198 1.475 . . . . 0.0 111.598 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.605 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 5.8 pt20 -63.81 144.95 56.64 Favored 'General case' 0 C--N 1.271 -2.834 0 CA-C-N 113.341 -1.754 . . . . 0.0 107.074 178.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.977 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 16.1 m-85 -143.43 125.3 15.16 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.728 ' HB3' HG12 ' A' ' 40' ' ' VAL . 8.4 p30 -117.06 127.2 53.92 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-O 122.572 1.177 . . . . 0.0 109.291 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.829 HD11 ' CG1' ' A' ' 52' ' ' ILE . 0.6 OUTLIER -109.95 159.77 9.4 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.202 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -151.06 156.84 41.93 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 122.046 0.927 . . . . 0.0 111.807 -177.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.653 ' O ' ' HA ' ' A' ' 36' ' ' GLN . 3.7 t80 -150.48 138.46 20.1 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.59 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 1.5 t -154.95 116.43 4.06 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 119.595 1.089 . . . . 0.0 108.102 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.652 ' CZ3' HG23 ' A' ' 94' ' ' VAL 0.27 1.5 t90 -143.03 115.87 8.76 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 119.809 -0.756 . . . . 0.0 110.021 -177.468 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.518 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 10.9 p30 -74.91 160.29 30.8 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 119.249 -2.157 . . . . 0.0 110.135 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.81 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.7 OUTLIER -153.76 166.09 16.45 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.151 -0.968 . . . . 0.0 108.47 -179.274 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.81 ' HD2' HG22 ' A' ' 94' ' ' VAL . 18.4 Cg_endo -37.03 150.16 0.05 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.136 0 O-C-N 123.587 1.309 . . . . 0.0 110.64 -177.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.809 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.5 OUTLIER -79.27 -24.69 42.77 Favored 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 116.94 -1.904 . . . . 0.0 114.33 -173.311 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.767 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -138.52 42.85 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 O-C-N 121.658 -0.651 . . . . 0.0 112.25 -179.161 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.941 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . . . -74.14 -67.67 0.39 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 120.641 -1.287 . . . . 0.0 110.025 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.941 ' HD3' ' HB3' ' A' ' 98' ' ' ALA . 50.3 Cg_endo -67.55 160.09 49.54 Favored 'Trans proline' 0 CA--C 1.463 -3.042 0 O-C-N 123.615 1.323 . . . . 0.0 110.106 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.711 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -107.78 103.09 12.28 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 112.482 -2.144 . . . . 0.0 109.849 -169.689 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.667 ' O ' ' HB ' ' A' ' 127' ' ' ILE . 6.5 p -42.96 99.62 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.723 0 CA-C-O 123.635 1.683 . . . . 0.0 108.661 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.405 88.5 mt-10 -163.67 -51.45 0.03 OUTLIER 'General case' 0 CA--C 1.45 -2.882 0 CA-C-N 113.024 -1.898 . . . . 0.0 111.674 -179.237 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.511 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.492 28.0 t30 -159.3 79.22 0.74 Allowed 'General case' 0 C--N 1.283 -2.311 0 CA-C-N 110.952 -2.84 . . . . 0.0 113.378 -162.32 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.89 HG22 ' HA ' ' A' ' 58' ' ' ILE . 26.2 t -141.2 134.12 30.45 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.437 0 C-N-CA 119.811 -0.756 . . . . 0.0 111.234 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.958 HG22 HG22 ' A' ' 123' ' ' THR . 53.0 t -136.55 125.03 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.793 HG23 ' HB2' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -107.15 138.12 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 CA-C-O 122.58 1.181 . . . . 0.0 111.92 -178.805 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . 1.018 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -131.39 110.35 10.98 Favored 'General case' 0 C--N 1.276 -2.623 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.204 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.031 HG21 HD12 ' A' ' 54' ' ' ILE . 3.2 t -123.42 142.19 40.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 C-N-CA 117.182 -1.807 . . . . 0.0 108.811 -177.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 1.105 ' HB2' ' HB2' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -138.22 145.02 40.91 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 122.485 1.136 . . . . 0.0 111.874 -176.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.71 ' CG2' HG21 ' A' ' 88' ' ' ILE . 5.6 t -96.6 125.67 49.48 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.553 ' CG ' ' HA2' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -105.68 119.24 38.62 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -179.291 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.511 ' HA3' HD23 ' A' ' 117' ' ' LEU . . . -75.75 -135.55 0.52 Allowed Glycine 0 N--CA 1.497 2.72 0 C-N-CA 119.091 -1.528 . . . . 0.0 113.856 -176.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.631 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 5.1 p-10 -88.59 -0.77 57.6 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.1 0.953 . . . . 0.0 112.267 -176.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -133.94 -4.31 2.81 Favored 'General case' 0 C--N 1.269 -2.914 0 CA-C-O 121.429 0.633 . . . . 0.0 110.954 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.627 ' O ' ' HB ' ' A' ' 116' ' ' VAL . . . 95.54 83.36 1.64 Allowed Glycine 0 CA--C 1.47 -2.765 0 CA-C-O 124.636 2.242 . . . . 0.0 111.024 178.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.627 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 14.6 p 136.21 152.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.254 -3.586 0 CA-C-N 108.371 -3.915 . . . . 0.0 112.72 176.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.681 ' CB ' HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -162.22 -59.51 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.414 0.626 . . . . 0.0 110.281 179.109 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.756 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -164.75 126.01 2.11 Favored 'General case' 0 N--CA 1.51 2.569 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 1.105 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 0.8 OUTLIER -134.11 135.74 43.42 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 117.918 -1.513 . . . . 0.0 113.112 -177.424 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.472 ' HB3' HG11 ' A' ' 16' ' ' VAL . . . -143.62 136.51 27.51 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 122.925 1.345 . . . . 0.0 112.406 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 1.1 HD13 ' N ' ' A' ' 122' ' ' ALA 0.26 0.0 OUTLIER -107.33 162.46 5.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 114.122 -1.399 . . . . 0.0 111.076 -179.589 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 1.1 ' N ' HD13 ' A' ' 121' ' ' ILE . . . -152.28 157.88 42.01 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.958 HG22 HG22 ' A' ' 105' ' ' VAL . 32.1 p -148.7 -87.31 0.09 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.346 -1.471 . . . . 0.0 110.5 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.568 ' C ' ' O ' ' A' ' 123' ' ' THR . 8.4 m-70 8.68 82.69 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.866 0 CA-C-O 121.438 0.637 . . . . 0.0 112.438 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.475 ' C ' ' HG3' ' A' ' 126' ' ' LYS . . . -173.51 79.2 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.622 ' O ' HG23 ' A' ' 28' ' ' ILE . 2.9 mtpt -130.63 -155.81 0.72 Allowed 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 122.065 0.936 . . . . 0.0 109.965 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.667 ' HB ' ' O ' ' A' ' 101' ' ' SER . 0.6 OUTLIER -147.93 134.46 12.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 121.763 0.792 . . . . 0.0 111.551 -179.37 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.476 ' HD3' ' O ' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -168.91 152.92 5.46 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.132 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 128' ' ' ARG . 2.9 m-20 . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.046 -1.033 . . . . 0.0 110.618 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 27.0 t . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.382 0.61 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.517 ' OE1' ' N ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -52.82 166.1 0.23 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.338 -0.851 . . . . 0.0 111.345 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.711 HG12 ' HA ' ' A' ' 22' ' ' HIS . 1.4 m -144.65 -177.72 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.473 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -78.89 134.78 36.89 Favored 'General case' 0 CA--C 1.481 -1.684 0 C-N-CA 117.723 -1.591 . . . . 0.0 108.758 178.211 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.468 ' O ' ' HG3' ' A' ' 6' ' ' LYS 0.439 0.4 OUTLIER -171.91 164.28 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 113.923 -1.49 . . . . 0.0 109.416 -169.629 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.844 ' O ' HG22 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -144.37 136.98 26.78 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 123.644 1.687 . . . . 0.0 113.143 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.259 13.5 t70 -70.72 148.97 47.41 Favored 'General case' 0 C--N 1.269 -2.907 0 CA-C-N 113.249 -1.796 . . . . 0.0 109.278 178.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.635 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.5 p -137.59 14.62 2.95 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.94 -1.1 . . . . 0.0 109.488 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.827 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -125.94 -84.54 0.63 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.687 -1.205 . . . . 0.0 110.162 -177.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 12' ' ' GLU . 3.6 t-20 -159.46 66.69 0.39 Allowed 'General case' 0 C--N 1.267 -2.998 0 C-N-CA 118.649 -1.221 . . . . 0.0 111.987 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.473 ' C ' ' O ' ' A' ' 10' ' ' ASN . 9.7 m-70 33.57 33.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.848 0.832 . . . . 0.0 110.275 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.0 OUTLIER -91.78 22.0 4.46 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.324 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.87 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.28 0.0 OUTLIER -121.15 -167.39 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-O 122.31 1.052 . . . . 0.0 111.323 -178.439 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.69 ' N ' HG23 ' A' ' 13' ' ' ILE . 7.2 ptpt -162.34 -45.04 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.445 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.612 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 2.9 tttt -145.58 140.29 27.3 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 116.569 -2.052 . . . . 0.0 112.595 178.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.941 HG13 ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -138.42 104.75 2.73 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 CA-C-O 122.929 1.347 . . . . 0.0 111.109 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 17' ' ' LEU . 0.9 OUTLIER -97.95 128.18 44.36 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 114.044 -1.434 . . . . 0.0 111.45 178.89 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.977 HG22 ' HA ' ' A' ' 37' ' ' LEU . 43.1 t -142.16 146.26 39.13 Favored Pre-proline 0 N--CA 1.499 2.006 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.517 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.716 ' HD2' HG13 ' A' ' 18' ' ' VAL . 42.5 Cg_endo -67.63 93.83 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.821 1.432 . . . . 0.0 110.025 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.476 ' O ' ' CB ' ' A' ' 27' ' ' CYS . . . 173.89 -93.87 0.1 OUTLIER Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.513 -1.327 . . . . 0.0 110.084 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.557 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 37.1 m -94.73 162.21 13.87 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.161 -1.2 . . . . 0.0 111.392 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.711 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -136.71 9.28 3.09 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.897 -1.127 . . . . 0.0 109.697 178.027 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' ' 4' ' ' ASP . . . -178.68 -151.18 9.33 Favored Glycine 0 C--N 1.291 -1.956 0 C-N-CA 119.383 -1.389 . . . . 0.0 109.882 176.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.1 m -65.59 -9.57 27.9 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.744 -1.445 . . . . 0.0 109.954 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.824 ' CB ' ' HD3' ' A' ' 26' ' ' PRO . 1.2 mt-10 -64.51 176.35 0.75 Allowed Pre-proline 0 C--N 1.297 -1.708 0 CA-C-O 125.06 2.362 . . . . 0.0 115.256 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.824 ' HD3' ' CB ' ' A' ' 25' ' ' GLU . 25.1 Cg_endo -106.76 124.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.269 -3.641 1 C-N-CA 127.846 5.697 . . . . 0.0 110.716 -176.324 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.557 ' SG ' ' N ' ' A' ' 21' ' ' CYS . 25.7 p -126.82 129.11 47.65 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 122.705 1.241 . . . . 0.0 111.41 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.87 HG22 ' H ' ' A' ' 29' ' ' ILE 0.333 41.7 mm -80.68 -146.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 178.591 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.87 ' H ' HG22 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -127.7 117.29 46.05 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.74 0 CA-C-O 122.377 1.084 . . . . 0.0 111.074 179.504 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.63 ' CG ' ' N ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -67.05 -90.98 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.49 -179.066 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.63 ' N ' ' CG ' ' A' ' 30' ' ' HIS . 27.7 mtt85 -60.04 171.69 0.93 Allowed 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.858 ' HA3' ' HA ' ' A' ' 96' ' ' LYS . . . -62.13 -95.75 0.01 OUTLIER Glycine 0 C--N 1.296 -1.677 0 C-N-CA 117.361 -2.352 . . . . 0.0 107.457 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.881 ' O ' HG22 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -125.34 91.6 48.64 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 120.883 2.342 . . . . 0.0 115.334 -179.306 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.597 ' HG3' ' HB2' ' A' ' 31' ' ' ARG . 60.6 Cg_endo -108.2 145.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.291 -2.458 0 C-N-CA 124.291 3.327 . . . . 0.0 109.594 177.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.591 ' CE2' HG11 ' A' ' 94' ' ' VAL . 4.9 m-85 -119.8 90.79 3.4 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.623 ' HG2' ' CB ' ' A' ' 91' ' ' THR . 0.3 OUTLIER -116.17 88.64 2.93 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 122.006 -0.434 . . . . 0.0 110.223 -178.353 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.977 ' HA ' HG22 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -108.68 133.53 52.65 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.526 -1.359 . . . . 0.0 108.383 178.986 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -140.2 127.62 21.38 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.533 -1.354 . . . . 0.0 107.452 179.242 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.941 ' HB2' HG13 ' A' ' 16' ' ' VAL . . . -142.75 152.94 42.82 Favored 'General case' 0 C--N 1.274 -2.708 0 CA-C-O 122.97 1.367 . . . . 0.0 113.263 -175.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.612 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.46 139.87 32.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 113.821 -1.536 . . . . 0.0 108.711 177.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.579 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 3.5 p90 -156.87 124.07 5.26 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -178.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 13.6 tt0 -69.68 155.85 39.88 Favored 'General case' 0 C--N 1.288 -2.107 0 O-C-N 120.407 -1.433 . . . . 0.0 108.508 177.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.965 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -91.28 134.69 34.37 Favored 'General case' 0 C--N 1.265 -3.069 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.162 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.634 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -114.87 51.26 0.91 Allowed 'General case' 0 CA--C 1.486 -1.498 0 CA-C-O 125.327 2.489 . . . . 0.0 114.067 179.004 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.601 ' N ' ' CG ' ' A' ' 82' ' ' LYS . 7.0 pt20 167.34 -160.95 0.01 OUTLIER 'General case' 0 C--N 1.263 -3.173 0 CA-C-N 109.149 -3.659 . . . . 0.0 113.729 174.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.46 ' C ' HG22 ' A' ' 47' ' ' THR 0.277 6.3 t30 -110.36 153.65 24.64 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-O 122.617 1.199 . . . . 0.0 108.872 -178.483 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.672 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -173.22 157.04 3.31 Favored 'General case' 0 C--N 1.255 -3.526 0 C-N-CA 118.727 -1.189 . . . . 0.0 112.746 -178.307 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.934 ' O ' HG23 ' A' ' 49' ' ' THR . 0.4 OUTLIER -112.5 5.87 18.22 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 120.694 -1.254 . . . . 0.0 111.522 178.434 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.934 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.16 149.06 5.01 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.659 -1.276 . . . . 0.0 111.215 179.383 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.475 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . . . -141.37 101.64 4.05 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 122.924 1.345 . . . . 0.0 110.863 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 23.3 mmtp -73.15 -178.23 2.8 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.939 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.976 ' CG2' HD11 ' A' ' 88' ' ' ILE . 28.4 mt -140.14 136.43 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.544 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.945 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.494 ' HB3' ' HD3' ' A' ' 109' ' ' LYS . 31.9 tt0 -141.44 110.87 6.39 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 123.267 1.508 . . . . 0.0 111.3 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 1.006 HD12 HG21 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -89.99 127.07 42.8 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 CA-C-N 112.793 -2.003 . . . . 0.0 109.64 179.524 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.491 ' NZ ' ' HB2' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -120.25 98.62 6.15 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 176.903 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.986 ' HB3' HG22 ' A' ' 63' ' ' VAL . . . -114.53 133.61 55.66 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 118.919 -1.112 . . . . 0.0 113.187 -175.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.714 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.0 OUTLIER -105.53 100.3 9.87 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 177.595 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.901 ' HA ' HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -111.55 102.96 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.838 0 CA-C-O 123.004 1.383 . . . . 0.0 110.729 -176.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.658 ' N ' HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER 34.86 65.2 0.37 Allowed 'General case' 0 N--CA 1.519 3.003 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.829 179.306 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.47 -16.56 10.0 Favored Glycine 0 N--CA 1.489 2.212 0 O-C-N 121.351 -0.843 . . . . 0.0 111.761 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.551 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.268 0.5 OUTLIER -108.3 57.94 0.61 Allowed 'General case' 0 C--N 1.292 -1.896 0 O-C-N 121.027 -1.278 . . . . 0.0 111.818 -178.256 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.603 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.367 0.0 OUTLIER -59.25 115.8 3.46 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.064 0.935 . . . . 0.0 111.258 -179.913 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.986 HG22 ' HB3' ' A' ' 56' ' ' ALA . 17.7 m -80.3 146.73 7.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 122.517 1.151 . . . . 0.0 110.971 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.429 7.1 t70 -138.06 59.11 1.66 Allowed 'General case' 0 C--N 1.28 -2.428 0 CA-C-O 122.831 1.301 . . . . 0.0 111.013 -176.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.701 HG22 ' HD2' ' A' ' 66' ' ' PRO . 4.0 p -165.31 151.8 9.03 Favored Pre-proline 0 C--N 1.269 -2.927 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.053 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.701 ' HD2' HG22 ' A' ' 65' ' ' VAL . 44.5 Cg_endo -87.7 139.56 4.82 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 CA-C-O 123.706 1.461 . . . . 0.0 111.804 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -105.83 48.77 0.94 Allowed Glycine 0 C--N 1.272 -2.99 0 CA-C-N 112.568 -2.106 . . . . 0.0 109.101 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.636 HG23 ' N ' ' A' ' 69' ' ' ASP 0.293 0.0 OUTLIER 179.63 -168.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 O-C-N 119.669 -2.077 . . . . 0.0 108.544 -178.247 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.636 ' N ' HG23 ' A' ' 68' ' ' ILE . 10.0 t0 -108.86 90.61 7.85 Favored Pre-proline 0 N--CA 1.504 2.232 0 O-C-N 120.731 -1.231 . . . . 0.0 108.364 176.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.719 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 20.0 Cg_endo -48.39 -5.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.289 -2.584 0 C-N-CA 124.182 3.254 . . . . 0.0 115.461 177.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.603 ' HB2' ' NE2' ' A' ' 74' ' ' HIS . 0.6 OUTLIER -107.63 92.86 4.25 Favored 'General case' 0 C--N 1.289 -2.03 0 O-C-N 120.134 -1.604 . . . . 0.0 109.484 -179.209 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.72 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . . . -78.27 10.41 3.05 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.101 -0.999 . . . . 0.0 109.332 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.1 t -78.16 -24.53 47.24 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 120.992 -1.067 . . . . 0.0 108.944 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.603 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 0.3 OUTLIER -79.52 7.62 7.85 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 118.911 -1.116 . . . . 0.0 108.797 176.85 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.72 ' CD2' ' HA ' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -132.98 -1.38 3.31 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 121.488 -0.758 . . . . 0.0 110.11 177.62 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.46 ' CE ' HD21 ' A' ' 80' ' ' LEU . 1.5 ptt? -153.45 128.65 9.75 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 124.042 1.877 . . . . 0.0 113.745 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.567 ' O ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -19.88 95.98 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 111.74 -2.482 . . . . 0.0 113.213 -178.676 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.498 ' HA ' HD13 ' A' ' 80' ' ' LEU 0.32 0.3 OUTLIER -99.93 142.17 24.11 Favored Pre-proline 0 C--N 1.268 -2.948 0 CA-C-N 111.36 -2.654 . . . . 0.0 108.776 178.495 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.653 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 36.3 Cg_endo -79.58 168.27 73.86 Favored 'Cis proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.848 -1.73 . . . . 0.0 112.521 0.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.693 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -94.71 128.39 41.36 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.17 -179.731 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.528 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.4 t -105.9 139.38 27.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 124.1 1.905 . . . . 0.0 112.07 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.634 ' HG2' ' HA ' ' A' ' 44' ' ' ASN . 1.2 tmmt? -44.59 118.33 1.54 Allowed 'General case' 0 C--N 1.271 -2.823 0 CA-C-N 111.816 -2.447 . . . . 0.0 116.652 -175.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.95 -18.01 12.72 Favored Glycine 0 C--N 1.292 -1.878 0 CA-C-N 111.787 -2.461 . . . . 0.0 107.924 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.62 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 65.1 mt-30 -71.79 127.74 33.54 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-O 123.221 1.486 . . . . 0.0 111.349 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.611 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 12.4 mt-30 -66.02 144.6 56.64 Favored 'General case' 0 C--N 1.27 -2.861 0 CA-C-N 113.282 -1.781 . . . . 0.0 107.485 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.965 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 17.8 m-85 -142.72 126.07 16.62 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.553 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 0.7 OUTLIER -117.46 130.19 56.3 Favored 'General case' 0 C--N 1.279 -2.489 0 CA-C-O 122.737 1.256 . . . . 0.0 110.034 -178.34 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 1.09 HD12 ' CG2' ' A' ' 110' ' ' VAL . 0.2 OUTLIER -101.95 156.22 4.73 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.152 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.188 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.17 143.22 30.99 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 121.465 0.65 . . . . 0.0 111.343 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.67 ' CE1' ' HB2' ' A' ' 92' ' ' TRP . 2.1 t80 -143.89 99.66 3.44 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.412 -0.805 . . . . 0.0 109.123 178.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.623 ' CB ' ' HG2' ' A' ' 36' ' ' GLN . 1.3 t -122.81 116.29 23.44 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.91 -1.119 . . . . 0.0 108.616 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.67 ' HB2' ' CE1' ' A' ' 90' ' ' TYR 0.271 0.3 OUTLIER -142.64 102.31 4.03 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.035 -177.635 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 13.3 p30 -75.62 153.66 37.12 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 119.607 -1.933 . . . . 0.0 109.461 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.881 HG22 ' O ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -153.11 175.38 3.01 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.781 -1.199 . . . . 0.0 108.606 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.563 ' HD2' ' HB ' ' A' ' 94' ' ' VAL . 18.6 Cg_endo -37.96 154.07 0.03 OUTLIER 'Trans proline' 0 CA--C 1.498 -1.321 0 O-C-N 123.64 1.337 . . . . 0.0 110.701 -177.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.858 ' HA ' ' HA3' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -79.54 -25.3 41.72 Favored 'General case' 0 C--N 1.284 -2.277 0 C-N-CA 116.614 -2.035 . . . . 0.0 115.526 -173.173 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.754 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -140.27 39.71 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 -177.658 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.93 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . . . -62.89 -64.48 2.98 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.519 -1.363 . . . . 0.0 108.353 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.93 ' HD3' ' HB3' ' A' ' 98' ' ' ALA . 51.5 Cg_endo -69.96 163.74 37.3 Favored 'Trans proline' 0 CA--C 1.46 -3.206 0 O-C-N 123.87 1.458 . . . . 0.0 108.852 177.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.735 ' HD2' ' C ' ' A' ' 99' ' ' PRO . 1.0 OUTLIER -105.14 103.7 13.3 Favored 'General case' 0 C--N 1.269 -2.902 0 CA-C-N 112.704 -2.044 . . . . 0.0 110.92 -168.596 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.615 ' CB ' HD12 ' A' ' 127' ' ' ILE . 7.5 p -43.43 96.78 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 123.566 1.65 . . . . 0.0 108.859 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.601 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.413 78.0 mt-10 -163.64 -50.77 0.03 OUTLIER 'General case' 0 CA--C 1.451 -2.832 0 CA-C-N 112.729 -2.032 . . . . 0.0 112.01 -179.331 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.491 21.9 t30 -159.07 81.58 0.78 Allowed 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 111.283 -2.69 . . . . 0.0 113.781 -162.15 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.901 HG22 ' HA ' ' A' ' 58' ' ' ILE . 34.0 t -143.22 133.91 22.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.122 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.851 ' CG1' HD11 ' A' ' 121' ' ' ILE . 60.9 t -142.48 134.56 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.967 HG23 ' HB2' ' A' ' 56' ' ' ALA . 1.3 p -112.65 146.84 16.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 122.956 1.36 . . . . 0.0 113.367 -178.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.98 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -132.82 108.52 9.02 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 178.272 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.006 HG21 HD12 ' A' ' 54' ' ' ILE . 3.6 t -125.29 141.9 43.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 120.094 -1.629 . . . . 0.0 109.056 -177.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.761 ' HB2' ' HB3' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -133.84 152.35 51.84 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.712 1.244 . . . . 0.0 113.047 -178.336 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 1.09 ' CG2' HD12 ' A' ' 88' ' ' ILE . 8.8 t -99.83 127.35 52.79 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.255 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 177.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.502 ' HG3' ' N ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -108.82 121.79 45.82 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.31 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.584 ' HA3' HD23 ' A' ' 117' ' ' LEU . . . -78.14 -137.36 1.11 Allowed Glycine 0 N--CA 1.497 2.742 0 C-N-CA 119.079 -1.534 . . . . 0.0 114.093 -175.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.672 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 10.0 p-10 -80.19 -5.11 55.52 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 122.366 1.079 . . . . 0.0 112.07 -177.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 9.7 p30 -130.05 -4.6 4.48 Favored 'General case' 0 C--N 1.266 -3.065 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.145 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.624 ' C ' HG12 ' A' ' 116' ' ' VAL . . . 88.59 85.55 1.24 Allowed Glycine 0 CA--C 1.469 -2.808 0 CA-C-O 124.886 2.381 . . . . 0.0 109.813 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.624 HG12 ' C ' ' A' ' 115' ' ' GLY . 4.5 p 145.41 145.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.245 -3.952 0 CA-C-N 108.43 -3.885 . . . . 0.0 111.833 177.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.805 ' CB ' HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -162.27 -57.43 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.495 -0.753 . . . . 0.0 110.755 179.605 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.87 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -173.81 130.09 0.41 Allowed 'General case' 0 N--CA 1.51 2.56 0 O-C-N 121.158 -0.964 . . . . 0.0 108.84 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.827 ' SG ' ' HB2' ' A' ' 9' ' ' ALA . 0.8 OUTLIER -134.44 144.31 48.06 Favored 'General case' 0 C--N 1.285 -2.23 0 C-N-CA 117.544 -1.662 . . . . 0.0 113.86 -177.469 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.541 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -147.24 138.18 23.7 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 123.034 1.397 . . . . 0.0 112.239 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.98 ' HB ' HG23 ' A' ' 107' ' ' THR 0.279 0.0 OUTLIER -109.37 132.31 57.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 CA-C-N 114.025 -1.443 . . . . 0.0 111.198 -179.19 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.753 ' N ' HD13 ' A' ' 121' ' ' ILE . . . -131.05 -173.37 3.08 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.874 -1.141 . . . . 0.0 108.681 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 125' ' ' ALA . 13.8 p -104.39 -7.6 19.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.441 -1.412 . . . . 0.0 111.676 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.908 ' NE2' HG11 ' A' ' 106' ' ' VAL . 23.8 m170 61.6 -72.29 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.626 0 O-C-N 121.236 -0.915 . . . . 0.0 110.428 -178.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.818 ' HB2' ' CG1' ' A' ' 29' ' ' ILE . . . -136.96 146.49 45.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.496 -0.753 . . . . 0.0 109.397 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.668 ' O ' HD13 ' A' ' 28' ' ' ILE . 1.3 mmpt? -131.6 93.43 3.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.132 -0.98 . . . . 0.0 109.368 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.615 HD12 ' CB ' ' A' ' 101' ' ' SER . 1.0 OUTLIER -88.69 135.91 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.317 -1.49 . . . . 0.0 111.743 -179.544 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.48 ' HD2' ' N ' ' A' ' 129' ' ' ASP . 0.0 OUTLIER -168.16 -140.75 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.47 0.652 . . . . 0.0 111.625 179.291 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.48 ' N ' ' HD2' ' A' ' 128' ' ' ARG . 1.3 m-20 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.926 -1.035 . . . . 0.0 110.856 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.196 0.522 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -82.9 167.62 17.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -0.888 . . . . 0.0 111.006 -179.757 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.745 HG12 ' HA ' ' A' ' 22' ' ' HIS . 1.4 m -145.59 179.56 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 O-C-N 120.836 -1.165 . . . . 0.0 108.174 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -79.47 137.02 37.08 Favored 'General case' 0 CA--C 1.48 -1.723 0 C-N-CA 118.117 -1.433 . . . . 0.0 108.693 177.881 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.584 HG11 ' CG2' ' A' ' 16' ' ' VAL 0.436 0.4 OUTLIER -169.44 -171.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.48 -169.858 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.555 ' CG ' ' O ' ' A' ' 5' ' ' VAL . 5.2 mtpp -166.2 146.95 6.46 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 123.931 1.824 . . . . 0.0 113.096 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.281 3.0 t70 -84.88 148.84 26.06 Favored 'General case' 0 C--N 1.264 -3.11 0 CA-C-N 112.58 -2.1 . . . . 0.0 109.043 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.667 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.7 p -137.27 15.95 2.99 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.94 -1.1 . . . . 0.0 109.226 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.846 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -125.65 -84.32 0.63 Allowed 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.137 -176.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.567 ' O ' ' N ' ' A' ' 12' ' ' GLU . 4.2 t-20 -156.35 65.19 0.55 Allowed 'General case' 0 C--N 1.268 -2.968 0 C-N-CA 118.523 -1.271 . . . . 0.0 111.783 177.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.468 ' C ' ' O ' ' A' ' 10' ' ' ASN . 10.4 m80 33.72 31.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.773 0.796 . . . . 0.0 110.73 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.4 OUTLIER -90.8 21.26 4.2 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.002 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.777 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.272 0.1 OUTLIER -119.82 -170.31 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 122.211 1.005 . . . . 0.0 110.611 -178.785 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.631 ' H ' HG23 ' A' ' 13' ' ' ILE . 11.2 ptmm? -162.09 -46.83 0.04 OUTLIER 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.143 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.577 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 21.6 tttt -142.81 135.15 27.51 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 116.045 -2.262 . . . . 0.0 113.178 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.973 HG12 ' HB2' ' A' ' 39' ' ' ALA . 0.6 OUTLIER -132.98 101.29 4.25 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 CA-C-O 123.03 1.395 . . . . 0.0 110.76 179.67 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.514 ' HA ' HD23 ' A' ' 17' ' ' LEU . 1.0 OUTLIER -95.04 129.04 42.28 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 113.987 -1.461 . . . . 0.0 111.857 179.282 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.995 HG22 ' HA ' ' A' ' 37' ' ' LEU . 78.4 t -142.21 145.57 36.08 Favored Pre-proline 0 N--CA 1.5 2.049 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.105 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.657 ' HD2' HG13 ' A' ' 18' ' ' VAL . 42.1 Cg_endo -68.81 105.93 1.4 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.677 1.357 . . . . 0.0 110.624 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.433 ' C ' ' CB ' ' A' ' 27' ' ' CYS . . . 160.44 -91.13 0.11 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.552 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 38.2 m -90.74 159.16 16.48 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.295 -1.121 . . . . 0.0 110.78 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.745 ' HA ' HG12 ' A' ' 3' ' ' VAL . 6.8 p-80 -137.25 11.76 3.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.665 -1.272 . . . . 0.0 109.528 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.485 ' O ' ' HB3' ' A' ' 4' ' ' ASP . . . 176.4 -148.85 9.37 Favored Glycine 0 C--N 1.29 -2.026 0 C-N-CA 119.288 -1.434 . . . . 0.0 109.883 177.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.7 -9.33 26.73 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.704 -1.468 . . . . 0.0 109.895 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.802 ' CB ' ' HD3' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -64.44 176.04 0.8 Allowed Pre-proline 0 C--N 1.298 -1.635 0 CA-C-O 124.953 2.311 . . . . 0.0 115.178 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.802 ' HD3' ' CB ' ' A' ' 25' ' ' GLU . 25.3 Cg_endo -107.11 124.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.268 -3.661 1 C-N-CA 127.709 5.606 . . . . 0.0 110.98 -176.021 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.552 ' SG ' ' N ' ' A' ' 21' ' ' CYS . 28.2 p -127.69 127.71 44.19 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.659 1.218 . . . . 0.0 110.906 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.876 HG22 ' H ' ' A' ' 29' ' ' ILE 0.331 44.1 mm -79.55 -152.37 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.308 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.876 ' H ' HG22 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -126.87 116.62 45.39 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.59 0 CA-C-O 122.45 1.119 . . . . 0.0 111.45 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.1 m80 -67.32 -101.6 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.283 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.538 ' HB2' ' HG3' ' A' ' 34' ' ' PRO . 60.3 mtt-85 -51.62 171.8 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.898 ' HA3' ' HA ' ' A' ' 96' ' ' LYS . . . -61.5 -93.04 0.01 OUTLIER Glycine 0 C--N 1.298 -1.548 0 C-N-CA 117.756 -2.164 . . . . 0.0 108.09 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.846 ' HB2' HG12 ' A' ' 94' ' ' VAL . 2.3 mmmt -125.37 90.98 49.79 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 120.585 2.192 . . . . 0.0 115.302 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.538 ' HG3' ' HB2' ' A' ' 31' ' ' ARG . 65.0 Cg_endo -108.65 143.39 0.06 OUTLIER 'Trans proline' 0 C--N 1.291 -2.466 0 C-N-CA 124.378 3.385 . . . . 0.0 109.735 177.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.477 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 12.7 m-85 -125.05 95.68 4.58 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.07 -1.052 . . . . 0.0 109.737 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.602 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 28.2 mp0 -116.37 96.64 5.63 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.569 -0.707 . . . . 0.0 110.81 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.995 ' HA ' HG22 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -109.3 136.31 48.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.355 -1.466 . . . . 0.0 108.638 178.93 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -140.27 125.16 18.35 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.496 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.973 ' HB2' HG12 ' A' ' 16' ' ' VAL . . . -143.54 152.52 41.55 Favored 'General case' 0 C--N 1.274 -2.694 0 CA-C-O 122.955 1.36 . . . . 0.0 113.878 -175.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.581 ' O ' ' HG2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -110.71 140.34 30.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-N 113.766 -1.561 . . . . 0.0 108.305 177.834 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.584 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 4.0 p90 -159.33 125.04 4.29 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 5.5 tt0 -70.55 157.09 38.52 Favored 'General case' 0 C--N 1.286 -2.154 0 O-C-N 120.39 -1.444 . . . . 0.0 109.07 178.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.975 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -90.94 141.95 28.29 Favored 'General case' 0 C--N 1.267 -2.981 0 CA-C-N 114.217 -1.356 . . . . 0.0 108.847 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.65 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 17.5 p-10 -121.49 50.42 1.4 Allowed 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 125.281 2.467 . . . . 0.0 114.31 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.588 ' C ' ' HB2' ' A' ' 82' ' ' LYS . 6.5 pt20 167.15 -161.49 0.01 OUTLIER 'General case' 0 C--N 1.258 -3.386 0 CA-C-N 109.109 -3.678 . . . . 0.0 113.073 175.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.456 ' C ' HG22 ' A' ' 47' ' ' THR 0.277 48.5 t30 -110.11 153.51 24.59 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-O 122.572 1.177 . . . . 0.0 108.952 -178.68 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.658 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -173.26 156.64 3.19 Favored 'General case' 0 C--N 1.254 -3.581 0 C-N-CA 118.558 -1.257 . . . . 0.0 112.53 -178.394 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.944 ' O ' HG23 ' A' ' 49' ' ' THR . 0.0 OUTLIER -115.9 9.27 14.93 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 120.811 -1.18 . . . . 0.0 111.077 178.596 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.944 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.9 OUTLIER -166.5 147.54 6.28 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.768 -1.207 . . . . 0.0 110.723 179.491 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 70' ' ' PRO . . . -148.41 102.22 3.31 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 122.76 1.267 . . . . 0.0 110.366 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 12.3 mmtt -75.11 -174.68 2.36 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.716 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.975 ' CG2' HD11 ' A' ' 88' ' ' ILE . 45.7 mt -140.54 139.03 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.535 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.465 ' C ' HG13 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -140.37 110.09 6.39 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 123.349 1.547 . . . . 0.0 110.56 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.999 HD12 HG21 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -89.77 126.06 42.69 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.332 0 CA-C-N 112.527 -2.124 . . . . 0.0 108.979 179.29 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.1 tttp -121.68 103.18 8.7 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 177.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.892 ' HB3' HG22 ' A' ' 63' ' ' VAL . . . -110.03 126.58 54.12 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.527 -1.269 . . . . 0.0 111.86 -176.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.749 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 4.7 p -101.48 100.86 11.36 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.996 HD13 ' CB ' ' A' ' 99' ' ' PRO . 0.6 OUTLIER -111.31 111.78 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.679 0 CA-C-O 122.695 1.236 . . . . 0.0 110.313 -177.417 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.506 ' N ' HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER 30.74 62.54 0.2 Allowed 'General case' 0 N--CA 1.52 3.069 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.954 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.43 -12.43 7.63 Favored Glycine 0 N--CA 1.49 2.278 0 O-C-N 121.339 -0.851 . . . . 0.0 111.379 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.533 ' O ' HG13 ' A' ' 58' ' ' ILE 0.284 0.2 OUTLIER -107.9 56.32 0.63 Allowed 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.12 -1.223 . . . . 0.0 111.171 -178.655 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.605 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.362 0.0 OUTLIER -53.95 114.09 1.46 Allowed 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 122.16 0.981 . . . . 0.0 110.565 -179.754 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.892 HG22 ' HB3' ' A' ' 56' ' ' ALA . 19.0 m -76.98 140.46 17.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-O 122.759 1.266 . . . . 0.0 111.499 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.45 21.7 t0 -139.32 85.08 2.03 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.435 -176.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.581 ' CG2' ' HD2' ' A' ' 66' ' ' PRO . 9.9 p -159.31 150.35 16.18 Favored Pre-proline 0 C--N 1.275 -2.631 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.888 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.581 ' HD2' ' CG2' ' A' ' 65' ' ' VAL . 43.5 Cg_endo -73.18 138.04 27.16 Favored 'Trans proline' 0 C--N 1.319 -0.992 0 CA-C-O 123.725 1.469 . . . . 0.0 111.342 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.598 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -117.45 -53.51 0.31 Allowed Glycine 0 N--CA 1.51 3.574 0 CA-C-N 112.542 -2.117 . . . . 0.0 113.588 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.863 HD13 ' H ' ' A' ' 91' ' ' THR . 1.3 tp -117.28 -155.65 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-N 120.643 2.221 . . . . 0.0 110.22 -178.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.715 ' N ' HG23 ' A' ' 68' ' ' ILE . 1.1 t70 -107.92 89.17 5.17 Favored Pre-proline 0 N--CA 1.508 2.44 0 CA-C-O 122.82 1.295 . . . . 0.0 108.983 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.748 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 20.8 Cg_endo -49.05 -12.77 0.25 Allowed 'Trans proline' 0 C--N 1.285 -2.773 0 C-N-CA 124.121 3.214 . . . . 0.0 115.885 178.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.5 ' OD1' ' CD2' ' A' ' 74' ' ' HIS . 6.4 p30 -111.59 85.65 2.17 Favored 'General case' 0 C--N 1.288 -2.074 0 O-C-N 119.843 -1.785 . . . . 0.0 108.965 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.664 ' HA ' ' CD1' ' A' ' 75' ' ' TYR . . . -78.38 12.1 2.11 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.644 -0.66 . . . . 0.0 109.313 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.401 ' C ' ' H ' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -77.25 -20.6 54.95 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 120.666 -1.271 . . . . 0.0 108.002 -179.593 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.568 ' C ' ' CD1' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -87.84 19.04 3.7 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 173.885 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.664 ' CD1' ' HA ' ' A' ' 72' ' ' ALA . 0.4 OUTLIER -133.13 -9.78 2.97 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.032 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.475 ' O ' ' HG2' ' A' ' 76' ' ' MET . 2.3 ptt? -166.55 126.77 1.61 Allowed 'General case' 0 C--O 1.215 -0.74 0 CA-C-O 123.761 1.743 . . . . 0.0 113.219 178.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.659 ' O ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER 3.87 91.71 0.01 OUTLIER 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 111.999 -2.364 . . . . 0.0 114.134 -179.422 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.487 ' HA ' ' CD1' ' A' ' 80' ' ' LEU 0.331 7.3 t -110.21 139.26 21.26 Favored Pre-proline 0 C--N 1.269 -2.932 0 CA-C-N 111.441 -2.618 . . . . 0.0 107.614 177.519 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.671 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 36.7 Cg_endo -76.79 169.62 73.92 Favored 'Cis proline' 0 C--N 1.308 -1.555 0 C-N-CA 123.095 -1.627 . . . . 0.0 112.992 1.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.727 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -96.9 128.39 43.81 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.051 -179.4 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.527 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.9 t -106.96 138.67 31.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 124.169 1.938 . . . . 0.0 111.916 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.65 ' HG2' ' HA ' ' A' ' 44' ' ' ASN . 1.6 tmmt? -44.2 117.19 1.17 Allowed 'General case' 0 C--N 1.271 -2.837 0 CA-C-N 111.832 -2.44 . . . . 0.0 116.596 -175.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.431 ' O ' ' OE2' ' A' ' 42' ' ' GLU . . . 115.83 -17.09 15.76 Favored Glycine 0 C--N 1.292 -1.905 0 CA-C-N 111.752 -2.476 . . . . 0.0 107.963 178.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.619 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 31.8 mt-30 -71.43 127.76 33.63 Favored 'General case' 0 C--N 1.278 -2.542 0 CA-C-O 123.22 1.486 . . . . 0.0 111.766 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.596 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 3.0 pt20 -64.7 143.73 57.72 Favored 'General case' 0 C--N 1.272 -2.794 0 CA-C-N 113.326 -1.761 . . . . 0.0 107.072 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.975 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 17.9 m-85 -143.33 126.68 16.7 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 10.0 p30 -117.66 132.93 56.42 Favored 'General case' 0 C--N 1.275 -2.655 0 CA-C-O 122.703 1.239 . . . . 0.0 109.913 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 1.104 HD12 HG23 ' A' ' 110' ' ' VAL . 0.4 OUTLIER -102.58 157.7 4.73 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 CA-C-N 114.629 -1.168 . . . . 0.0 108.265 179.477 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -147.94 142.61 26.62 Favored 'General case' 0 C--N 1.283 -2.3 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.526 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.586 ' O ' ' HA ' ' A' ' 36' ' ' GLN . 17.4 t80 -151.54 108.57 3.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.148 -0.97 . . . . 0.0 110.401 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.863 ' H ' HD13 ' A' ' 68' ' ' ILE . 0.4 OUTLIER -125.11 122.26 36.63 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 120.515 -1.365 . . . . 0.0 108.093 179.163 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.598 ' CD1' ' O ' ' A' ' 67' ' ' GLY 0.27 0.1 OUTLIER -142.44 102.78 4.14 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.128 -176.933 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.504 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 12.1 p30 -74.93 157.15 35.48 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 119.676 -1.89 . . . . 0.0 108.829 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 33' ' ' LYS . 1.1 t -153.99 171.78 6.58 Favored Pre-proline 0 N--CA 1.486 1.333 0 O-C-N 120.792 -1.193 . . . . 0.0 109.13 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.827 ' CD ' HG13 ' A' ' 94' ' ' VAL . 18.8 Cg_endo -38.74 157.7 0.03 OUTLIER 'Trans proline' 0 CA--C 1.498 -1.294 0 O-C-N 123.833 1.439 . . . . 0.0 110.352 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.898 ' HA ' ' HA3' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -79.54 -21.8 44.72 Favored 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 116.282 -2.167 . . . . 0.0 115.558 -173.477 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.76 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -136.73 39.16 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -177.497 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.928 ' HB3' ' CD ' ' A' ' 99' ' ' PRO . . . -64.89 -73.51 0.21 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 120.483 -1.385 . . . . 0.0 108.562 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.996 ' CB ' HD13 ' A' ' 58' ' ' ILE . 53.8 Cg_endo -70.25 162.31 42.77 Favored 'Trans proline' 0 CA--C 1.463 -3.034 0 CA-C-O 123.177 1.24 . . . . 0.0 109.659 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.739 ' HD2' ' C ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -105.72 99.23 8.84 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 112.697 -2.047 . . . . 0.0 110.735 -169.003 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.801 ' HB2' ' HB ' ' A' ' 127' ' ' ILE . 12.8 p -46.77 99.84 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 123.654 1.692 . . . . 0.0 108.463 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.413 95.9 mt-10 -163.43 -51.65 0.04 OUTLIER 'General case' 0 CA--C 1.449 -2.911 0 CA-C-N 112.72 -2.036 . . . . 0.0 110.562 -179.474 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.445 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.499 31.3 t-20 -158.31 74.76 0.71 Allowed 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 110.504 -3.043 . . . . 0.0 111.295 -163.278 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.893 HG22 ' HA ' ' A' ' 58' ' ' ILE . 14.3 t -142.1 141.06 29.25 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.543 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.924 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.975 HG13 HD11 ' A' ' 121' ' ' ILE . 1.2 t -145.5 131.21 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.789 HG23 ' HB2' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -103.91 140.9 20.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 122.288 1.042 . . . . 0.0 111.704 -178.778 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . 1.023 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -132.47 110.75 10.73 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 179.427 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.999 HG21 HD12 ' A' ' 54' ' ' ILE . 3.6 t -125.73 140.83 47.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 O-C-N 120.133 -1.604 . . . . 0.0 109.229 -177.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.95 ' HB2' ' CB ' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -130.78 148.27 52.54 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 122.526 1.155 . . . . 0.0 112.057 -178.748 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 1.104 HG23 HD12 ' A' ' 88' ' ' ILE . 3.0 t -96.35 125.24 49.28 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 176.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.527 ' HG2' ' O ' ' A' ' 111' ' ' MET . 2.2 ptm -105.4 121.2 43.41 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.546 ' HA3' HD23 ' A' ' 117' ' ' LEU . . . -80.35 -139.31 2.21 Favored Glycine 0 N--CA 1.496 2.665 0 C-N-CA 119.031 -1.557 . . . . 0.0 114.311 -175.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.658 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 14.9 p-10 -77.8 -5.74 51.79 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 122.41 1.1 . . . . 0.0 112.051 -177.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 8.3 p30 -129.35 -5.27 4.83 Favored 'General case' 0 C--N 1.266 -3.057 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.097 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.692 ' C ' HG12 ' A' ' 116' ' ' VAL . . . 88.69 85.77 1.24 Allowed Glycine 0 CA--C 1.469 -2.844 0 CA-C-O 124.821 2.345 . . . . 0.0 109.745 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.692 HG12 ' C ' ' A' ' 115' ' ' GLY . 4.3 p 143.04 145.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.246 -3.91 0 CA-C-N 108.37 -3.915 . . . . 0.0 111.631 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.808 ' CB ' HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -162.05 -58.57 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.479 -0.763 . . . . 0.0 110.9 179.682 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.777 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -167.97 131.84 1.68 Allowed 'General case' 0 N--CA 1.514 2.747 0 O-C-N 121.31 -0.869 . . . . 0.0 109.161 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.95 ' CB ' ' HB2' ' A' ' 109' ' ' LYS . 0.8 OUTLIER -134.14 138.27 45.09 Favored 'General case' 0 C--N 1.28 -2.436 0 C-N-CA 117.428 -1.709 . . . . 0.0 113.595 -177.69 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.717 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -143.59 135.66 26.73 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 122.912 1.339 . . . . 0.0 112.248 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 1.023 ' HB ' HG23 ' A' ' 107' ' ' THR 0.277 0.0 OUTLIER -111.13 134.76 52.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 114.182 -1.372 . . . . 0.0 111.808 -178.863 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.757 ' N ' HD13 ' A' ' 121' ' ' ILE . . . -131.61 -176.56 4.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.819 -1.176 . . . . 0.0 109.022 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.602 ' O ' ' HB2' ' A' ' 124' ' ' HIS . 5.7 p -106.34 -21.93 12.96 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.342 -1.474 . . . . 0.0 110.824 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.648 ' CE1' HD22 ' A' ' 37' ' ' LEU . 0.3 OUTLIER 67.09 -74.52 0.07 Allowed 'General case' 0 N--CA 1.513 2.717 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.836 ' HB2' ' CG1' ' A' ' 29' ' ' ILE . . . -122.07 146.91 46.74 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.07 -1.019 . . . . 0.0 111.268 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.5 mmmm -132.54 86.04 2.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.278 -0.889 . . . . 0.0 110.406 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.801 ' HB ' ' HB2' ' A' ' 101' ' ' SER . 1.0 OUTLIER -90.33 119.58 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.169 -1.582 . . . . 0.0 111.203 179.476 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.493 ' HD3' ' O ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -169.48 150.87 4.27 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.98 -0.45 . . . . 0.0 111.089 179.142 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.468 ' C ' ' O ' ' A' ' 128' ' ' ARG . 3.7 m-20 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.84 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.404 ' HB2' ' HZ1' ' A' ' 15' ' ' LYS . 70.1 m . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.254 0.55 . . . . 0.0 110.261 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.47 ' O ' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER 176.79 169.25 0.51 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.185 -0.947 . . . . 0.0 110.786 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.858 HG12 ' HA ' ' A' ' 22' ' ' HIS . 1.4 m -145.19 177.66 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 O-C-N 120.758 -1.214 . . . . 0.0 108.118 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.487 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -79.62 137.78 37.22 Favored 'General case' 0 CA--C 1.479 -1.761 0 C-N-CA 117.978 -1.489 . . . . 0.0 108.521 177.803 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.5 ' O ' ' HG2' ' A' ' 6' ' ' LYS 0.429 0.4 OUTLIER -166.16 168.67 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 C-N-CA 118.033 -1.467 . . . . 0.0 110.814 -169.785 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.52 ' HB2' HG22 ' A' ' 121' ' ' ILE . 0.8 OUTLIER -147.37 137.13 22.91 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 123.664 1.697 . . . . 0.0 112.312 -179.466 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.273 0.8 OUTLIER -80.17 146.28 31.87 Favored 'General case' 0 C--N 1.267 -2.987 0 CA-C-N 113.378 -1.737 . . . . 0.0 109.71 178.871 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.658 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.4 p -137.31 15.9 2.98 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.958 -1.089 . . . . 0.0 109.303 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.867 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -125.54 -85.26 0.63 Allowed 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.706 -1.197 . . . . 0.0 109.941 -177.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.565 ' O ' ' N ' ' A' ' 12' ' ' GLU . 3.9 t-20 -159.95 65.23 0.35 Allowed 'General case' 0 C--N 1.265 -3.07 0 C-N-CA 118.219 -1.392 . . . . 0.0 112.174 177.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.474 ' C ' ' O ' ' A' ' 10' ' ' ASN . 28.8 m170 33.79 31.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.777 0.799 . . . . 0.0 110.807 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.1 OUTLIER -90.51 23.26 3.07 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.908 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.079 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.28 0.0 OUTLIER -119.22 -168.75 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-O 121.978 0.894 . . . . 0.0 110.733 -178.616 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.636 ' N ' HG23 ' A' ' 13' ' ' ILE . 7.0 ptpt -162.54 -44.31 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.994 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.619 ' HB3' HG23 ' A' ' 40' ' ' VAL . 28.9 tttp -149.0 139.02 22.11 Favored 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 116.556 -2.057 . . . . 0.0 113.28 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 1.027 HG13 ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -133.21 107.41 11.29 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-O 122.841 1.305 . . . . 0.0 110.21 179.029 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.504 ' HA ' HD23 ' A' ' 17' ' ' LEU . 1.8 mt -106.77 129.25 54.67 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.124 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.683 HG22 ' HA ' ' A' ' 37' ' ' LEU . 11.9 t -141.41 144.84 35.5 Favored Pre-proline 0 C--N 1.294 -1.816 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.949 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.533 ' HD2' ' CG1' ' A' ' 18' ' ' VAL . 46.9 Cg_endo -71.26 112.77 3.41 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.725 1.381 . . . . 0.0 111.42 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.481 ' C ' ' HB3' ' A' ' 27' ' ' CYS . . . 128.86 -84.95 0.32 Allowed Glycine 0 N--CA 1.488 2.148 0 C-N-CA 119.486 -1.34 . . . . 0.0 109.775 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.555 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 3.5 m -74.56 108.76 7.53 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.596 -0.943 . . . . 0.0 110.12 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.858 ' HA ' HG12 ' A' ' 3' ' ' VAL . 1.0 OUTLIER -121.75 17.59 11.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.037 -1.664 . . . . 0.0 110.887 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.43 -156.34 21.91 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 118.43 -1.843 . . . . 0.0 110.877 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.53 -9.89 30.16 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.943 -1.327 . . . . 0.0 109.722 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.784 ' CB ' ' CD ' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -64.07 178.27 0.45 Allowed Pre-proline 0 C--N 1.295 -1.795 0 CA-C-O 125.034 2.35 . . . . 0.0 114.562 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.784 ' CD ' ' CB ' ' A' ' 25' ' ' GLU . 20.9 Cg_endo -104.05 113.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.264 -3.917 1 C-N-CA 127.524 5.483 . . . . 0.0 109.057 -177.126 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.555 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 1.7 p -94.75 107.19 19.2 Favored 'General case' 0 N--CA 1.505 2.295 0 CA-C-O 123.068 1.413 . . . . 0.0 112.366 -177.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.608 ' O ' HG22 ' A' ' 28' ' ' ILE 0.303 33.5 mm -79.94 61.14 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-N 113.816 -1.538 . . . . 0.0 109.249 178.696 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.05 HG21 ' HB1' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -43.39 129.98 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-O 122.845 1.307 . . . . 0.0 110.285 -179.138 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.504 ' O ' ' O ' ' A' ' 31' ' ' ARG . 19.0 m80 -65.49 -86.82 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 114.53 -1.213 . . . . 0.0 112.39 -177.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.637 ' O ' HD13 ' A' ' 29' ' ' ILE . 48.6 mtt-85 -43.36 165.83 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.46 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.417 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.911 ' HA3' ' HA ' ' A' ' 96' ' ' LYS . . . -62.88 -88.46 0.04 OUTLIER Glycine 0 C--N 1.297 -1.631 0 C-N-CA 118.062 -2.018 . . . . 0.0 108.922 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.813 ' O ' HG22 ' A' ' 94' ' ' VAL . 1.5 mmmp? -126.21 89.87 51.35 Favored Pre-proline 0 C--O 1.22 -0.448 0 CA-C-N 120.83 2.315 . . . . 0.0 115.734 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.77 ' CD ' HD11 ' A' ' 29' ' ' ILE . 60.8 Cg_endo -109.32 141.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.29 -2.515 0 C-N-CA 124.673 3.582 . . . . 0.0 108.743 177.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.554 ' CD1' ' C ' ' A' ' 34' ' ' PRO . 1.0 OUTLIER -124.14 98.22 5.68 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 118.075 -1.45 . . . . 0.0 110.311 179.358 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.588 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 26.3 mp0 -114.15 81.28 1.51 Allowed 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.683 ' HA ' HG22 ' A' ' 18' ' ' VAL . 3.4 pp -113.07 142.46 45.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.674 -1.266 . . . . 0.0 110.181 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -140.47 138.01 34.31 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 122.595 1.188 . . . . 0.0 108.451 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 1.027 ' HB2' HG13 ' A' ' 16' ' ' VAL . . . -142.07 153.11 43.93 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-O 123.03 1.395 . . . . 0.0 113.292 -176.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.619 HG23 ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.41 141.21 26.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 113.697 -1.592 . . . . 0.0 109.007 178.47 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.578 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 3.5 p90 -155.79 121.78 5.06 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 8.8 tt0 -68.22 156.38 37.73 Favored 'General case' 0 C--N 1.287 -2.125 0 O-C-N 120.35 -1.469 . . . . 0.0 109.178 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.936 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -92.22 136.36 33.25 Favored 'General case' 0 C--N 1.269 -2.921 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.807 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.584 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 16.6 p-10 -116.65 49.73 1.13 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 125.376 2.512 . . . . 0.0 113.78 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.586 ' C ' ' HB2' ' A' ' 82' ' ' LYS . 6.4 pt20 166.59 -158.35 0.01 OUTLIER 'General case' 0 C--N 1.258 -3.401 0 CA-C-N 108.999 -3.728 . . . . 0.0 112.97 175.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.538 ' C ' HG22 ' A' ' 47' ' ' THR 0.285 9.1 t30 -109.99 154.78 22.69 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-O 122.596 1.188 . . . . 0.0 108.97 -178.881 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.63 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.1 OUTLIER -172.85 150.97 2.15 Favored 'General case' 0 C--N 1.255 -3.535 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.202 -178.275 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.949 ' O ' HG23 ' A' ' 49' ' ' THR . 0.3 OUTLIER -112.28 11.16 20.1 Favored 'General case' 0 N--CA 1.506 2.371 0 C-N-CA 118.16 -1.416 . . . . 0.0 110.185 178.406 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.949 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.61 145.49 3.81 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 120.706 -1.246 . . . . 0.0 111.069 178.6 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 111' ' ' MET . . . -139.73 95.13 2.86 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-O 122.988 1.375 . . . . 0.0 109.544 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -65.92 -178.27 0.57 Allowed 'General case' 0 C--N 1.281 -2.374 0 CA-C-N 113.836 -1.529 . . . . 0.0 109.711 178.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.821 ' CG1' HD11 ' A' ' 88' ' ' ILE . 35.7 mt -142.14 144.18 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.357 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 0.4 OUTLIER -140.52 104.01 4.66 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 123.425 1.583 . . . . 0.0 109.75 178.397 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 1.057 ' HA ' HG13 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -93.06 126.29 45.51 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 CA-C-N 112.503 -2.135 . . . . 0.0 107.301 179.252 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.869 ' N ' HD13 ' A' ' 54' ' ' ILE . 0.5 OUTLIER -129.86 149.84 51.42 Favored 'General case' 0 C--N 1.272 -2.802 0 C-N-CA 118.448 -1.301 . . . . 0.0 108.145 178.836 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 1.05 ' HB3' HG22 ' A' ' 63' ' ' VAL . . . -135.58 127.46 29.41 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 117.694 -1.603 . . . . 0.0 111.475 -178.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.746 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 2.2 p -101.3 100.3 10.78 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 177.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.931 ' HA ' HG22 ' A' ' 104' ' ' VAL . 0.8 OUTLIER -115.47 102.4 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.738 0 CA-C-O 123.089 1.423 . . . . 0.0 110.983 -176.613 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.571 ' N ' HG22 ' A' ' 104' ' ' VAL . 0.1 OUTLIER 38.28 64.95 0.65 Allowed 'General case' 0 N--CA 1.521 3.121 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.326 179.055 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.53 -13.66 7.91 Favored Glycine 0 N--CA 1.489 2.176 0 O-C-N 121.263 -0.898 . . . . 0.0 111.311 177.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.495 ' HB3' HG13 ' A' ' 58' ' ' ILE 0.278 0.3 OUTLIER -108.14 54.88 0.65 Allowed 'General case' 0 C--N 1.294 -1.841 0 O-C-N 121.205 -1.173 . . . . 0.0 111.495 -178.528 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.635 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.366 0.0 OUTLIER -59.4 117.5 4.91 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 122.527 1.156 . . . . 0.0 111.397 -179.531 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 1.05 HG22 ' HB3' ' A' ' 56' ' ' ALA . 18.8 m -80.19 148.22 5.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-O 122.56 1.172 . . . . 0.0 111.103 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.441 5.9 t70 -137.8 82.11 1.9 Allowed 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.319 -176.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.602 HG22 ' HD2' ' A' ' 66' ' ' PRO . 9.8 p -164.23 151.46 10.25 Favored Pre-proline 0 C--N 1.277 -2.565 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.427 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.602 ' HD2' HG22 ' A' ' 65' ' ' VAL . 45.5 Cg_endo -85.43 139.14 6.72 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 CA-C-O 123.643 1.435 . . . . 0.0 111.719 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.588 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -127.66 48.08 0.99 Allowed Glycine 0 N--CA 1.501 3.02 0 CA-C-N 112.69 -2.05 . . . . 0.0 110.77 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.57 ' O ' ' HD2' ' A' ' 70' ' ' PRO 0.302 5.8 tp 179.68 -174.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 CA-C-N 119.476 1.638 . . . . 0.0 110.024 -178.607 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.585 ' OD2' ' CZ ' ' A' ' 75' ' ' TYR . 1.1 t70 -109.71 84.25 3.18 Favored Pre-proline 0 N--CA 1.504 2.252 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 175.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.786 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 21.0 Cg_endo -48.92 -9.64 0.1 OUTLIER 'Trans proline' 0 C--N 1.279 -3.097 0 C-N-CA 123.556 2.837 . . . . 0.0 115.312 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.551 ' HB2' ' NE2' ' A' ' 74' ' ' HIS . 1.7 m-20 -105.42 83.8 2.01 Favored 'General case' 0 C--N 1.287 -2.151 0 O-C-N 120.212 -1.555 . . . . 0.0 108.699 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.644 ' HA ' ' CD1' ' A' ' 75' ' ' TYR . . . -78.44 10.79 2.84 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.505 -0.747 . . . . 0.0 109.402 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.61 -19.92 54.76 Favored 'General case' 0 C--N 1.317 -0.842 0 O-C-N 120.507 -1.371 . . . . 0.0 108.177 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.578 ' ND1' ' N ' ' A' ' 74' ' ' HIS . 0.1 OUTLIER -88.24 18.85 4.06 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 174.203 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.644 ' CD1' ' HA ' ' A' ' 72' ' ' ALA . 0.4 OUTLIER -133.18 -9.38 2.97 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.241 179.774 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.485 ' O ' ' C ' ' A' ' 77' ' ' LYS . 1.6 ptt? -162.62 128.18 3.33 Favored 'General case' 0 C--O 1.215 -0.749 0 CA-C-O 123.6 1.667 . . . . 0.0 112.859 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.578 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 0.6 OUTLIER -4.47 86.93 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 112.042 -2.345 . . . . 0.0 113.559 -178.711 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.472 ' HA ' HD13 ' A' ' 80' ' ' LEU 0.297 11.1 t -99.02 136.92 20.43 Favored Pre-proline 0 C--N 1.262 -3.197 0 CA-C-N 111.364 -2.653 . . . . 0.0 108.714 178.094 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.701 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 37.3 Cg_endo -78.48 165.95 81.24 Favored 'Cis proline' 0 C--N 1.312 -1.343 0 C-N-CA 123.007 -1.664 . . . . 0.0 112.906 1.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.714 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -89.1 127.39 35.71 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.44 179.445 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.528 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.7 t -106.32 139.47 27.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-O 124.129 1.918 . . . . 0.0 111.616 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.586 ' HB2' ' C ' ' A' ' 45' ' ' GLN . 1.6 tmmt? -44.38 117.97 1.4 Allowed 'General case' 0 C--N 1.271 -2.842 0 CA-C-N 111.686 -2.507 . . . . 0.0 116.924 -175.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.19 -17.6 16.77 Favored Glycine 0 C--N 1.293 -1.808 0 CA-C-N 111.693 -2.503 . . . . 0.0 107.845 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.626 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 49.4 mt-30 -72.63 128.63 36.14 Favored 'General case' 0 C--N 1.277 -2.56 0 CA-C-O 123.215 1.483 . . . . 0.0 111.585 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.581 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 2.9 mt-30 -66.47 145.87 55.18 Favored 'General case' 0 C--N 1.27 -2.859 0 CA-C-N 113.336 -1.756 . . . . 0.0 107.437 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.936 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 19.4 m-85 -142.53 124.92 15.59 Favored 'General case' 0 C--N 1.275 -2.64 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -178.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.576 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 4.5 p30 -116.93 133.29 56.2 Favored 'General case' 0 C--N 1.278 -2.543 0 CA-C-O 122.772 1.272 . . . . 0.0 110.233 -177.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.821 HD11 ' CG1' ' A' ' 52' ' ' ILE . 1.1 tp -108.73 159.4 8.15 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 CA-C-N 114.46 -1.246 . . . . 0.0 108.335 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.521 ' HG2' ' N ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -143.24 149.63 38.18 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 120.125 -0.63 . . . . 0.0 112.182 -176.935 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.605 ' CE1' ' HB2' ' A' ' 92' ' ' TRP . 25.5 t80 -147.22 105.62 3.79 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.421 -0.799 . . . . 0.0 110.489 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.588 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 1.1 t -123.93 110.9 15.4 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.605 ' HB2' ' CE1' ' A' ' 90' ' ' TYR 0.272 0.0 OUTLIER -142.41 109.11 5.39 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.719 -176.662 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 12.3 p30 -77.29 153.09 34.23 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 119.735 -1.853 . . . . 0.0 109.496 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.813 HG22 ' O ' ' A' ' 33' ' ' LYS . 0.8 OUTLIER -154.31 175.36 3.11 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 120.682 -1.261 . . . . 0.0 108.999 -179.73 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.569 ' HD2' ' HB ' ' A' ' 94' ' ' VAL . 18.3 Cg_endo -38.12 156.38 0.03 OUTLIER 'Trans proline' 0 CA--C 1.495 -1.464 0 O-C-N 123.589 1.31 . . . . 0.0 111.127 -177.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.911 ' HA ' ' HA3' ' A' ' 32' ' ' GLY . 2.4 mptt -80.12 -27.97 39.05 Favored 'General case' 0 C--N 1.285 -2.218 0 C-N-CA 116.555 -2.058 . . . . 0.0 116.04 -173.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.774 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -145.42 43.22 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 -177.348 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.939 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . . . -60.33 -53.27 66.49 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 120.367 -1.458 . . . . 0.0 109.736 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.939 ' HD3' ' HB3' ' A' ' 98' ' ' ALA . 55.6 Cg_endo -73.67 160.78 43.3 Favored 'Trans proline' 0 CA--C 1.466 -2.904 0 O-C-N 124.145 1.603 . . . . 0.0 111.13 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.722 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -110.27 106.37 15.75 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 112.236 -2.256 . . . . 0.0 111.104 -169.392 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.614 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 1.5 p -40.88 95.32 0.01 OUTLIER 'General case' 0 N--CA 1.519 3.021 0 CA-C-O 123.496 1.617 . . . . 0.0 110.469 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.581 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.387 84.7 mt-10 -164.93 -52.72 0.03 OUTLIER 'General case' 0 CA--C 1.448 -2.952 0 CA-C-N 112.959 -1.928 . . . . 0.0 111.214 178.468 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.461 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.486 33.9 t-20 -161.25 77.62 0.56 Allowed 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 110.583 -3.008 . . . . 0.0 113.466 -162.016 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.931 HG22 ' HA ' ' A' ' 58' ' ' ILE . 21.8 t -144.28 141.44 24.37 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.63 0 C-N-CA 119.32 -0.952 . . . . 0.0 111.907 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.698 HG12 ' CD1' ' A' ' 121' ' ' ILE . 0.3 OUTLIER -153.75 133.26 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.597 HG11 ' CD2' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -94.32 143.56 11.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-O 122.357 1.075 . . . . 0.0 110.994 -179.287 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . 1.074 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -131.75 116.65 17.56 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 179.642 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.057 HG13 ' HA ' ' A' ' 54' ' ' ILE . 3.5 t -132.19 139.37 50.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 O-C-N 120.247 -1.533 . . . . 0.0 108.481 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 1.009 ' HB2' ' HB2' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -132.96 146.49 51.83 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.364 1.078 . . . . 0.0 111.187 -178.44 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.655 ' CG2' HD13 ' A' ' 88' ' ' ILE . 2.9 t -99.94 127.8 52.47 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 178.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.504 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -108.29 121.99 46.03 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -179.771 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -74.62 -131.34 0.24 Allowed Glycine 0 C--N 1.283 -2.39 0 C-N-CA 119.22 -1.467 . . . . 0.0 114.625 -175.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.63 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 6.2 p-10 -97.76 9.56 42.3 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -175.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 32.7 p30 -167.17 -13.68 0.02 OUTLIER 'General case' 0 C--N 1.263 -3.156 0 C-N-CA 117.224 -1.791 . . . . 0.0 114.464 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -153.66 -88.15 0.06 OUTLIER Glycine 0 CA--C 1.475 -2.463 0 CA-C-O 125.879 2.933 . . . . 0.0 112.338 -177.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.629 HG22 ' H ' ' A' ' 117' ' ' LEU . 4.1 p -141.51 178.93 2.39 Favored 'Isoleucine or valine' 1 C--N 1.228 -4.692 1 CA-C-N 108.155 -4.022 . . . . 0.0 111.014 -176.785 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.642 ' HB3' HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -149.3 -62.72 0.23 Allowed 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.255 -179.422 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 1.079 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -164.15 129.66 2.91 Favored 'General case' 0 N--CA 1.51 2.526 0 O-C-N 120.872 -1.142 . . . . 0.0 109.756 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 1.009 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 1.5 p -133.98 134.73 42.85 Favored 'General case' 0 C--N 1.283 -2.321 0 C-N-CA 117.975 -1.49 . . . . 0.0 113.35 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.4 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -144.17 136.3 26.42 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 122.913 1.339 . . . . 0.0 112.153 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 1.074 ' HB ' HG23 ' A' ' 107' ' ' THR 0.268 0.1 OUTLIER -110.79 130.78 63.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.176 -179.495 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.659 ' N ' HD13 ' A' ' 121' ' ' ILE . . . -131.6 178.57 6.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.862 -1.149 . . . . 0.0 108.977 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 124' ' ' HIS . 15.9 p -82.61 -43.98 16.35 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.211 -1.556 . . . . 0.0 109.963 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.597 ' CD2' HG11 ' A' ' 106' ' ' VAL . 0.3 OUTLIER 59.53 107.92 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.386 0 O-C-N 121.554 -0.716 . . . . 0.0 112.224 179.327 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 1.05 ' HB1' HG21 ' A' ' 29' ' ' ILE . . . 49.89 109.71 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.41 0 O-C-N 121.731 -0.606 . . . . 0.0 111.665 178.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.47 ' O ' ' C ' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -110.23 62.46 0.6 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.809 -1.182 . . . . 0.0 108.616 178.411 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.657 HD12 HG13 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -31.03 130.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.668 0 CA-C-O 122.13 0.967 . . . . 0.0 112.579 -178.565 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.476 ' O ' ' C ' ' A' ' 129' ' ' ASP . 0.0 OUTLIER -169.76 150.19 3.93 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.967 178.483 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' ' 128' ' ' ARG . 3.1 m-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.869 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.483 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 1.3 m . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 121.34 0.591 . . . . 0.0 110.393 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -92.63 169.51 10.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.386 -0.821 . . . . 0.0 111.042 -179.693 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.744 HG12 ' HA ' ' A' ' 22' ' ' HIS . 1.4 m -145.58 177.6 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 O-C-N 120.892 -1.13 . . . . 0.0 108.032 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.49 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -80.22 139.3 36.78 Favored 'General case' 0 CA--C 1.477 -1.864 0 C-N-CA 118.007 -1.477 . . . . 0.0 108.823 177.502 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.517 HG11 HG23 ' A' ' 16' ' ' VAL 0.425 0.4 OUTLIER -168.58 160.71 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 CA-C-N 114.029 -1.442 . . . . 0.0 110.057 -170.22 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 5' ' ' VAL . 3.5 mtpt -144.44 140.12 28.77 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 123.785 1.755 . . . . 0.0 113.116 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.27 4.4 t0 -76.36 147.81 37.83 Favored 'General case' 0 C--N 1.267 -2.994 0 CA-C-N 112.932 -1.94 . . . . 0.0 109.786 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.648 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.0 p -137.04 16.01 3.04 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.968 -1.082 . . . . 0.0 109.162 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.876 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -125.03 -82.71 0.64 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.033 -176.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.574 ' O ' ' N ' ' A' ' 12' ' ' GLU . 3.8 t-20 -155.79 63.56 0.59 Allowed 'General case' 0 C--N 1.267 -2.991 0 C-N-CA 118.319 -1.352 . . . . 0.0 111.81 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.478 ' C ' ' O ' ' A' ' 10' ' ' ASN . 59.2 m-70 32.02 33.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.854 0.835 . . . . 0.0 110.573 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.6 OUTLIER -95.09 22.47 6.61 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.72 -0.792 . . . . 0.0 111.591 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.026 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.276 0.2 OUTLIER -118.42 -170.36 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.413 -0.804 . . . . 0.0 110.001 -179.116 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.62 ' H ' HG23 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -161.86 -41.43 0.04 OUTLIER 'General case' 0 C--N 1.29 -2.011 0 O-C-N 121.731 -0.605 . . . . 0.0 111.492 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.586 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 11.6 tttm -147.72 138.13 23.08 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 115.89 -2.324 . . . . 0.0 113.145 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.829 HG13 ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -134.52 104.11 5.25 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 CA-C-O 122.897 1.332 . . . . 0.0 110.363 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.501 ' HB2' ' OE2' ' A' ' 38' ' ' GLU . 1.2 mt -99.52 125.65 45.32 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.776 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.706 HG22 ' CB ' ' A' ' 37' ' ' LEU . 40.5 t -141.72 145.4 36.85 Favored Pre-proline 0 N--CA 1.5 2.03 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.025 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.542 ' HD2' ' CG1' ' A' ' 18' ' ' VAL . 44.7 Cg_endo -68.64 134.87 31.6 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 O-C-N 123.772 1.406 . . . . 0.0 111.312 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.459 ' C ' ' HB3' ' A' ' 27' ' ' CYS . . . 110.48 -76.24 0.22 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.586 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 2.2 m -85.7 134.05 33.99 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.468 -1.019 . . . . 0.0 109.651 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.744 ' HA ' HG12 ' A' ' 3' ' ' VAL . 13.7 p-80 -142.26 12.55 1.98 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 119.998 -1.689 . . . . 0.0 110.948 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.41 -154.89 13.81 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 118.364 -1.874 . . . . 0.0 110.931 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.96 -12.16 46.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.822 -1.399 . . . . 0.0 109.414 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.798 ' CB ' ' HD3' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -64.36 177.44 0.56 Allowed Pre-proline 0 C--N 1.297 -1.696 0 CA-C-O 124.974 2.321 . . . . 0.0 114.454 179.292 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.798 ' HD3' ' CB ' ' A' ' 25' ' ' GLU . 23.7 Cg_endo -106.11 117.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.263 -3.953 1 C-N-CA 127.531 5.488 . . . . 0.0 110.102 -176.53 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.586 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 1.8 p -93.42 98.18 11.04 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-O 123.357 1.551 . . . . 0.0 111.227 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.484 ' O ' HG22 ' A' ' 28' ' ' ILE 0.317 36.3 mm -82.93 66.3 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 CA-C-N 113.36 -1.745 . . . . 0.0 109.663 179.328 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.804 HG21 ' HB1' ' A' ' 125' ' ' ALA . 16.4 tt -43.05 129.27 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 122.616 1.198 . . . . 0.0 109.952 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.522 ' NE2' ' NH2' ' A' ' 31' ' ' ARG . 16.3 t-160 -66.37 -87.15 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.205 -177.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.522 ' NH2' ' NE2' ' A' ' 30' ' ' HIS . 63.7 mtt180 -150.06 166.88 28.41 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.335 -0.853 . . . . 0.0 110.681 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.888 ' HA2' ' HA ' ' A' ' 96' ' ' LYS . . . 78.12 122.04 0.26 Allowed Glycine 0 C--O 1.213 -1.178 0 N-CA-C 105.887 -2.885 . . . . 0.0 105.887 -178.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.973 ' HB2' HG12 ' A' ' 94' ' ' VAL . 0.7 OUTLIER -117.28 96.77 49.84 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 120.66 2.23 . . . . 0.0 116.577 -175.059 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.592 ' HD3' ' O ' ' A' ' 32' ' ' GLY . 60.8 Cg_endo -107.02 145.39 0.08 OUTLIER 'Trans proline' 0 C--N 1.288 -2.631 0 C-N-CA 123.864 3.042 . . . . 0.0 108.546 176.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.73 ' HZ ' HG11 ' A' ' 94' ' ' VAL . 0.5 OUTLIER -120.53 96.52 5.17 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 118.582 -1.247 . . . . 0.0 109.182 179.002 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.594 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 28.0 mp0 -113.82 83.71 1.9 Allowed 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.706 ' CB ' HG22 ' A' ' 18' ' ' VAL . 2.1 pp -110.17 144.68 38.45 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.686 -1.258 . . . . 0.0 109.768 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.546 ' CB ' ' HG2' ' A' ' 89' ' ' LYS . 1.5 pp20? -140.44 139.07 35.14 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 122.7 1.238 . . . . 0.0 108.816 -178.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.829 ' HB2' HG13 ' A' ' 16' ' ' VAL . . . -142.56 148.74 38.04 Favored 'General case' 0 C--N 1.275 -2.649 0 CA-C-O 122.986 1.374 . . . . 0.0 112.968 -176.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.586 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.35 140.07 31.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 113.817 -1.538 . . . . 0.0 108.87 178.535 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.607 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 6.7 p90 -157.19 126.93 6.17 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -178.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 17.3 tt0 -70.41 156.96 38.64 Favored 'General case' 0 C--N 1.283 -2.319 0 O-C-N 120.388 -1.445 . . . . 0.0 108.815 178.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.982 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -89.41 136.07 33.24 Favored 'General case' 0 C--N 1.265 -3.089 0 CA-C-N 114.21 -1.359 . . . . 0.0 107.996 178.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.569 ' C ' ' HG2' ' A' ' 45' ' ' GLN . 16.9 p-10 -117.43 49.93 1.16 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 125.398 2.523 . . . . 0.0 114.242 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.748 ' N ' ' HG3' ' A' ' 82' ' ' LYS . 7.0 pt20 167.54 -159.18 0.01 OUTLIER 'General case' 0 C--N 1.258 -3.393 0 CA-C-N 108.77 -3.832 . . . . 0.0 112.901 174.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.445 ' C ' HG22 ' A' ' 47' ' ' THR 0.274 20.3 t-20 -108.78 153.55 23.32 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-O 122.622 1.201 . . . . 0.0 108.408 -178.884 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.615 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -172.65 154.33 3.01 Favored 'General case' 0 C--N 1.254 -3.569 0 C-N-CA 118.588 -1.245 . . . . 0.0 112.836 -178.215 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.956 ' O ' HG23 ' A' ' 49' ' ' THR . 1.2 mtpm? -115.07 7.03 15.35 Favored 'General case' 0 N--CA 1.508 2.452 0 O-C-N 120.74 -1.225 . . . . 0.0 110.926 178.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.956 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.93 149.81 4.45 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.608 -1.307 . . . . 0.0 111.194 179.862 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 70' ' ' PRO . . . -150.59 109.07 3.8 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-O 122.55 1.167 . . . . 0.0 110.954 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 1.2 ptpt -77.24 -173.39 2.81 Favored 'General case' 0 N--CA 1.506 2.327 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.368 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.817 ' CG1' HD11 ' A' ' 88' ' ' ILE . 35.0 mt -141.84 139.92 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.368 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.419 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.428 ' C ' HG13 ' A' ' 108' ' ' VAL . 3.5 tp10 -140.79 110.03 6.22 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 123.343 1.544 . . . . 0.0 111.168 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 1.013 HD12 HG21 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -91.12 128.59 42.82 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 CA-C-N 112.746 -2.024 . . . . 0.0 109.934 179.373 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.418 ' HD2' ' C ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -123.77 103.85 8.62 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 176.84 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.847 ' HB2' HG23 ' A' ' 106' ' ' VAL . . . -113.75 134.41 54.78 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 118.708 -1.197 . . . . 0.0 113.183 -175.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.7 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.1 p -106.64 100.79 10.28 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 178.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.867 ' CA ' HG13 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -110.68 107.84 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.939 0 CA-C-O 122.986 1.374 . . . . 0.0 110.774 -177.259 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.655 ' N ' HG22 ' A' ' 104' ' ' VAL . 0.5 OUTLIER 33.06 63.49 0.33 Allowed 'General case' 0 N--CA 1.519 2.992 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.977 179.634 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.72 -14.31 10.3 Favored Glycine 0 N--CA 1.489 2.2 0 O-C-N 121.352 -0.842 . . . . 0.0 111.525 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.511 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.274 0.3 OUTLIER -108.19 57.68 0.62 Allowed 'General case' 0 C--N 1.292 -1.897 0 O-C-N 121.087 -1.243 . . . . 0.0 111.175 -178.536 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.519 ' O ' ' CG ' ' A' ' 62' ' ' GLU 0.366 0.0 OUTLIER -58.61 114.44 2.49 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 122.1 0.952 . . . . 0.0 111.139 -179.696 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.836 HG22 ' HB3' ' A' ' 56' ' ' ALA . 15.0 m -74.95 144.89 11.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 122.586 1.184 . . . . 0.0 110.573 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.435 19.2 t0 -138.07 68.94 1.39 Allowed 'General case' 0 C--N 1.278 -2.526 0 CA-C-O 122.621 1.2 . . . . 0.0 110.572 -176.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.722 HG22 ' HD2' ' A' ' 66' ' ' PRO . 4.8 p -164.03 151.89 10.87 Favored Pre-proline 0 C--N 1.272 -2.797 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.952 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.722 ' HD2' HG22 ' A' ' 65' ' ' VAL . 43.4 Cg_endo -83.26 137.84 8.49 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 CA-C-O 123.804 1.502 . . . . 0.0 111.719 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -125.19 50.14 0.88 Allowed Glycine 0 C--N 1.273 -2.963 0 CA-C-N 112.461 -2.154 . . . . 0.0 110.253 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.578 ' HB ' ' CD2' ' A' ' 90' ' ' TYR 0.304 6.4 tp -178.78 -176.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 O-C-N 120.532 -1.569 . . . . 0.0 110.061 -178.56 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.497 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 29.9 t0 -112.35 83.64 5.45 Favored Pre-proline 0 N--CA 1.502 2.154 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 175.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.71 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 19.1 Cg_endo -47.68 -8.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.289 -2.601 0 C-N-CA 124.275 3.317 . . . . 0.0 115.826 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.578 ' HB2' ' NE2' ' A' ' 74' ' ' HIS . 2.4 m-80 -101.62 90.41 4.04 Favored 'General case' 0 C--N 1.286 -2.167 0 O-C-N 120.2 -1.562 . . . . 0.0 109.74 -178.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.784 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . . . -78.02 7.14 6.52 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.295 -0.878 . . . . 0.0 109.478 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.9 t -79.11 -26.58 42.9 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 121.034 -1.041 . . . . 0.0 109.044 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.578 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -79.71 6.78 9.9 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.895 -1.122 . . . . 0.0 108.943 177.217 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.784 ' CD2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -133.68 -0.48 3.17 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 121.364 -0.835 . . . . 0.0 109.966 177.636 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.631 ' HE3' HD21 ' A' ' 80' ' ' LEU . 2.6 ptt? -150.34 126.81 10.79 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 123.89 1.805 . . . . 0.0 112.86 178.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.541 ' O ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -20.07 95.25 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 112.006 -2.361 . . . . 0.0 113.159 -178.255 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.508 ' HA ' HD13 ' A' ' 80' ' ' LEU 0.311 0.5 OUTLIER -100.77 144.47 28.58 Favored Pre-proline 0 C--N 1.268 -2.968 0 CA-C-N 111.437 -2.62 . . . . 0.0 109.128 179.01 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.647 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 35.8 Cg_endo -81.37 168.81 68.08 Favored 'Cis proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.792 -1.753 . . . . 0.0 112.16 0.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.722 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -96.75 130.25 44.03 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.25 -179.389 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.541 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.8 t -106.35 139.41 27.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-O 124.109 1.909 . . . . 0.0 111.954 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.748 ' HG3' ' N ' ' A' ' 45' ' ' GLN . 2.3 tmpt? -42.65 120.96 1.86 Allowed 'General case' 0 C--N 1.271 -2.841 0 CA-C-N 111.902 -2.408 . . . . 0.0 115.955 -175.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.35 -16.63 24.43 Favored Glycine 0 C--N 1.291 -1.957 0 CA-C-N 111.97 -2.377 . . . . 0.0 108.38 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 62.6 mt-30 -73.61 126.42 30.25 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-O 123.223 1.487 . . . . 0.0 111.786 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.608 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 2.4 pt20 -64.04 143.18 58.07 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 113.271 -1.786 . . . . 0.0 107.539 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.982 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 18.7 m-85 -143.29 126.01 16.02 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.58 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 1.2 p-10 -117.12 132.55 56.64 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-O 122.712 1.244 . . . . 0.0 109.902 -178.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.817 HD11 ' CG1' ' A' ' 52' ' ' ILE . 0.9 OUTLIER -110.55 160.79 9.46 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.24 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.546 ' HG2' ' CB ' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -148.15 161.15 42.03 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-O 122.031 0.92 . . . . 0.0 113.203 -177.209 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.578 ' CD2' ' HB ' ' A' ' 68' ' ' ILE . 28.0 t80 -151.17 105.62 3.24 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.559 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.594 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 0.6 OUTLIER -122.3 111.51 17.0 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 178.806 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.577 ' CD1' ' O ' ' A' ' 67' ' ' GLY 0.271 0.3 OUTLIER -141.99 116.81 9.84 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.446 -176.824 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 6.5 p30 -75.16 161.72 29.13 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 119.237 -2.164 . . . . 0.0 109.795 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.973 HG12 ' HB2' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -151.48 165.84 16.5 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.896 ' HD2' HG22 ' A' ' 94' ' ' VAL . 19.8 Cg_endo -38.26 154.26 0.03 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.178 0 O-C-N 123.586 1.309 . . . . 0.0 110.505 -177.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.888 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 8.5 mptt -79.35 -28.15 42.03 Favored 'General case' 0 C--N 1.285 -2.228 0 C-N-CA 116.566 -2.053 . . . . 0.0 114.725 -173.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.758 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -143.41 43.07 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 CA-C-O 121.402 0.62 . . . . 0.0 112.541 -178.695 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.941 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . . . -76.53 -64.48 0.48 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 120.562 -1.336 . . . . 0.0 109.903 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.941 ' HD3' ' HB3' ' A' ' 98' ' ' ALA . 47.2 Cg_endo -66.13 159.87 47.48 Favored 'Trans proline' 0 CA--C 1.463 -3.057 0 O-C-N 123.94 1.495 . . . . 0.0 110.045 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.71 ' HD2' ' C ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -108.58 105.39 14.99 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-N 112.517 -2.129 . . . . 0.0 109.874 -169.587 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.943 ' OG ' HD12 ' A' ' 127' ' ' ILE . 5.5 p -46.2 98.62 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 123.37 1.557 . . . . 0.0 108.195 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.593 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.402 88.1 mt-10 -164.0 -51.54 0.03 OUTLIER 'General case' 0 CA--C 1.448 -2.945 0 CA-C-N 113.195 -1.82 . . . . 0.0 111.987 -179.115 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.481 32.1 t-20 -159.52 78.27 0.71 Allowed 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 111.159 -2.746 . . . . 0.0 114.01 -162.073 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.867 HG13 ' CA ' ' A' ' 58' ' ' ILE . 28.5 t -142.31 137.8 29.45 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.875 178.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 1.092 HG12 HD11 ' A' ' 121' ' ' ILE . 22.0 t -147.14 133.93 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.847 HG23 ' HB2' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -106.87 146.73 12.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-O 122.806 1.288 . . . . 0.0 113.033 -178.26 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . 1.045 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -132.86 109.57 9.71 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.432 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.013 HG21 HD12 ' A' ' 54' ' ' ILE . 3.9 t -127.07 144.88 35.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 119.954 -1.716 . . . . 0.0 109.043 -177.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 1.014 ' HB2' ' HB2' ' A' ' 119' ' ' CYS . 0.1 OUTLIER -136.48 143.05 43.61 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.137 0.97 . . . . 0.0 111.571 -178.018 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.643 ' CG2' HD13 ' A' ' 88' ' ' ILE . 20.9 t -96.28 130.97 44.2 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.622 ' CG ' ' HA2' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -110.69 119.53 39.45 Favored 'General case' 0 N--CA 1.509 2.506 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -178.717 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.483 ' HA3' HD23 ' A' ' 117' ' ' LEU . . . -81.69 -140.41 3.12 Favored Glycine 0 N--CA 1.5 2.946 0 C-N-CA 119.449 -1.357 . . . . 0.0 115.195 -174.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.615 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 4.4 p-10 -82.38 -6.44 59.27 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 122.267 1.032 . . . . 0.0 112.743 -176.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -128.86 -5.24 5.1 Favored 'General case' 0 C--N 1.262 -3.218 0 CA-C-O 121.747 0.784 . . . . 0.0 110.3 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.622 ' HA2' ' CG ' ' A' ' 111' ' ' MET . . . 94.43 85.3 1.64 Allowed Glycine 0 CA--C 1.471 -2.662 0 CA-C-O 124.595 2.219 . . . . 0.0 110.871 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.612 HG12 ' C ' ' A' ' 115' ' ' GLY . 7.5 p 137.11 153.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.251 -3.695 0 CA-C-N 108.409 -3.895 . . . . 0.0 112.451 176.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.632 ' CB ' HG12 ' A' ' 110' ' ' VAL . 0.2 OUTLIER -160.94 -59.97 0.06 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.284 0.564 . . . . 0.0 110.232 179.376 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 1.026 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -170.86 130.1 0.8 Allowed 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.204 -0.935 . . . . 0.0 109.085 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 1.014 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 0.9 OUTLIER -132.92 131.68 41.15 Favored 'General case' 0 C--N 1.28 -2.455 0 C-N-CA 117.769 -1.573 . . . . 0.0 112.52 -178.131 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.704 ' HB2' HD13 ' A' ' 13' ' ' ILE . . . -143.05 138.22 29.79 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 123.105 1.431 . . . . 0.0 111.866 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 1.092 HD11 HG12 ' A' ' 105' ' ' VAL 0.274 0.0 OUTLIER -111.03 132.39 59.65 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 113.891 -1.504 . . . . 0.0 111.634 -178.837 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.76 ' N ' HD13 ' A' ' 121' ' ' ILE . . . -131.28 -178.03 4.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.936 -1.102 . . . . 0.0 109.022 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.54 ' O ' ' HB2' ' A' ' 124' ' ' HIS . 12.9 p -93.43 -30.69 14.94 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.365 -1.459 . . . . 0.0 111.1 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.639 ' CE1' HG11 ' A' ' 18' ' ' VAL . 0.3 OUTLIER 63.44 -57.79 0.18 Allowed 'General case' 0 N--CA 1.508 2.468 0 O-C-N 121.499 -0.751 . . . . 0.0 112.07 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.804 ' HB1' HG21 ' A' ' 29' ' ' ILE . . . -158.29 115.31 2.86 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.653 -1.279 . . . . 0.0 111.633 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -130.74 -174.16 3.29 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 120.84 -1.162 . . . . 0.0 108.043 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.943 HD12 ' OG ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -153.72 137.21 8.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 120.893 -1.129 . . . . 0.0 112.391 -179.391 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.461 ' HD3' ' O ' ' A' ' 127' ' ' ILE . 1.3 tpp180 -168.94 151.48 4.89 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.011 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 128' ' ' ARG . 4.4 m-20 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.581 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 4.6 m . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.159 0.504 . . . . 0.0 110.424 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.48 ' HB2' ' O ' ' A' ' 1' ' ' SER . 0.5 OUTLIER 62.31 157.06 0.05 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.405 -0.809 . . . . 0.0 111.418 179.8 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.761 HG12 ' HA ' ' A' ' 22' ' ' HIS . 1.5 m -147.41 178.51 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.475 ' O ' HG23 ' A' ' 3' ' ' VAL . 7.1 t0 -80.01 137.17 36.76 Favored 'General case' 0 CA--C 1.473 -1.999 0 C-N-CA 117.509 -1.677 . . . . 0.0 108.681 177.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.5 ' C ' ' CG ' ' A' ' 6' ' ' LYS 0.434 0.4 OUTLIER -167.49 178.81 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.101 -169.795 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.668 ' O ' HG22 ' A' ' 121' ' ' ILE . 19.4 mtpt -153.31 132.68 12.83 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 123.657 1.694 . . . . 0.0 112.46 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.264 2.2 t70 -71.95 146.5 47.73 Favored 'General case' 0 C--N 1.267 -3.014 0 CA-C-N 113.42 -1.718 . . . . 0.0 109.224 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.657 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.8 p -137.32 16.07 2.98 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.03 -1.044 . . . . 0.0 109.519 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.84 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -125.3 -84.91 0.64 Allowed 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 118.815 -1.154 . . . . 0.0 110.024 -176.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 12' ' ' GLU . 2.7 t30 -158.74 65.1 0.42 Allowed 'General case' 0 C--N 1.266 -3.04 0 C-N-CA 118.249 -1.38 . . . . 0.0 112.529 177.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.608 ' CG ' ' O ' ' A' ' 11' ' ' HIS . 30.1 t-80 36.44 30.79 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 122.053 0.93 . . . . 0.0 110.266 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.539 ' CG ' ' OD1' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -92.07 21.99 4.66 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.403 -0.811 . . . . 0.0 111.847 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.992 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.268 0.0 OUTLIER -120.1 -170.31 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 122.151 0.977 . . . . 0.0 111.133 -178.794 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.637 ' N ' HG23 ' A' ' 13' ' ' ILE . 0.8 OUTLIER -162.59 -48.07 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.223 -179.762 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.628 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 20.5 tttp -142.28 135.8 29.13 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 116.436 -2.106 . . . . 0.0 112.621 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.702 ' CG1' ' HB2' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -133.2 102.75 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 122.903 1.335 . . . . 0.0 110.928 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.513 ' HA ' HD23 ' A' ' 17' ' ' LEU . 0.6 OUTLIER -92.56 126.11 37.5 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 114.096 -1.411 . . . . 0.0 111.52 178.943 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.635 HG22 ' HA ' ' A' ' 37' ' ' LEU . 59.6 t -142.85 140.96 18.84 Favored Pre-proline 0 N--CA 1.498 1.973 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.347 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.418 ' HD2' HG13 ' A' ' 18' ' ' VAL . 47.7 Cg_endo -70.72 132.73 22.35 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.629 1.331 . . . . 0.0 111.039 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 118.3 -75.37 0.29 Allowed Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.526 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 1.9 m -91.16 139.27 30.91 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.541 -0.976 . . . . 0.0 110.192 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.761 ' HA ' HG12 ' A' ' 3' ' ' VAL . 27.9 p-80 -139.66 6.38 2.26 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.112 -1.617 . . . . 0.0 110.774 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.21 -152.53 9.39 Favored Glycine 0 N--CA 1.489 2.224 0 C-N-CA 118.506 -1.807 . . . . 0.0 111.126 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.39 -9.49 25.56 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.755 -1.438 . . . . 0.0 109.909 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.789 ' CB ' ' HD3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -64.07 176.99 0.58 Allowed Pre-proline 0 C--N 1.296 -1.758 0 CA-C-O 125.006 2.336 . . . . 0.0 114.54 179.797 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.789 ' HD3' ' CB ' ' A' ' 25' ' ' GLU . 22.8 Cg_endo -105.69 115.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.265 -3.865 1 C-N-CA 127.463 5.442 . . . . 0.0 110.162 -176.322 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.526 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 4.3 p -102.6 100.37 10.44 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-O 123.079 1.419 . . . . 0.0 111.603 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.439 ' O ' ' C ' ' A' ' 29' ' ' ILE 0.315 34.4 mm -82.95 73.74 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 CA-C-N 113.798 -1.546 . . . . 0.0 108.974 178.272 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.515 ' O ' HG23 ' A' ' 29' ' ' ILE . 13.1 tt -40.53 119.33 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-O 122.911 1.339 . . . . 0.0 109.77 -178.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.577 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 10.9 p80 -66.82 48.51 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.148 -1.387 . . . . 0.0 112.524 -177.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.577 ' HB2' ' O ' ' A' ' 30' ' ' HIS . 14.9 mtt180 62.06 169.9 0.12 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.991 -1.068 . . . . 0.0 110.479 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.768 ' HA2' ' HA ' ' A' ' 96' ' ' LYS . . . 79.76 120.26 0.35 Allowed Glycine 0 C--N 1.305 -1.149 0 N-CA-C 105.321 -3.112 . . . . 0.0 105.321 -178.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.855 ' O ' HG22 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -118.26 97.07 50.52 Favored Pre-proline 0 C--O 1.218 -0.554 0 CA-C-N 121.278 2.539 . . . . 0.0 116.927 -174.538 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.575 ' HD3' ' O ' ' A' ' 32' ' ' GLY . 62.1 Cg_endo -106.15 144.53 0.1 OUTLIER 'Trans proline' 0 C--N 1.29 -2.531 0 C-N-CA 123.754 2.969 . . . . 0.0 108.142 176.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.675 ' CE2' HG11 ' A' ' 94' ' ' VAL . 14.6 m-85 -116.11 92.46 3.9 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 119.347 -0.941 . . . . 0.0 108.868 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.581 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 25.5 mp0 -115.9 88.86 2.97 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.06 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.635 ' HA ' HG22 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -108.83 138.46 45.13 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 120.672 -1.268 . . . . 0.0 108.479 179.115 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -139.76 128.42 23.12 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.702 ' HB2' ' CG1' ' A' ' 16' ' ' VAL . . . -143.33 151.49 40.53 Favored 'General case' 0 C--N 1.274 -2.678 0 CA-C-O 123.212 1.482 . . . . 0.0 113.801 -175.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.685 HG12 ' HB3' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -112.49 140.61 31.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 113.627 -1.624 . . . . 0.0 107.862 177.623 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.59 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 4.0 p90 -156.54 123.04 5.06 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -177.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 14.9 tt0 -68.07 154.84 40.83 Favored 'General case' 0 C--N 1.288 -2.087 0 O-C-N 120.425 -1.422 . . . . 0.0 108.521 178.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.972 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -90.47 131.61 36.12 Favored 'General case' 0 C--N 1.265 -3.082 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.821 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.539 ' OD1' ' CG ' ' A' ' 12' ' ' GLU . 0.1 OUTLIER -113.66 49.87 0.95 Allowed 'General case' 0 CA--C 1.482 -1.654 0 CA-C-O 125.508 2.575 . . . . 0.0 113.847 179.221 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.733 ' N ' ' HG3' ' A' ' 82' ' ' LYS . 5.7 pt20 167.0 -158.61 0.01 OUTLIER 'General case' 0 C--N 1.259 -3.344 0 CA-C-N 108.732 -3.849 . . . . 0.0 112.796 174.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.464 ' C ' HG22 ' A' ' 47' ' ' THR 0.278 16.7 t-20 -110.11 155.63 21.66 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-O 122.64 1.209 . . . . 0.0 108.959 -178.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.631 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -172.36 154.57 3.27 Favored 'General case' 0 C--N 1.254 -3.574 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.511 -178.831 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.952 ' O ' HG23 ' A' ' 49' ' ' THR . 9.5 mtpt -112.36 5.8 18.4 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 120.763 -1.211 . . . . 0.0 110.996 178.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.952 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.15 147.84 4.73 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.417 -1.427 . . . . 0.0 111.351 179.19 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 111' ' ' MET . . . -138.51 98.06 3.5 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-O 122.757 1.265 . . . . 0.0 110.481 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 0.9 OUTLIER -69.3 -179.71 1.71 Allowed 'General case' 0 N--CA 1.505 2.321 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.138 178.511 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.846 ' CG1' HD11 ' A' ' 88' ' ' ILE . 23.7 mt -141.6 136.72 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.514 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.418 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.476 ' C ' HG13 ' A' ' 108' ' ' VAL . 5.5 tp10 -142.61 113.44 7.49 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 123.276 1.512 . . . . 0.0 111.807 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.911 ' CA ' HG13 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -88.93 126.96 41.97 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 CA-C-N 112.783 -2.008 . . . . 0.0 109.012 178.283 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -119.81 97.43 5.62 Favored 'General case' 0 C--N 1.278 -2.518 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 177.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.93 ' HB3' HG22 ' A' ' 63' ' ' VAL . . . -110.1 127.37 54.84 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.126 -1.03 . . . . 0.0 111.79 -176.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.755 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.3 p -106.48 102.83 12.19 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.971 ' HA ' HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -114.32 95.17 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.897 0 CA-C-O 123.531 1.634 . . . . 0.0 110.143 -177.811 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.717 ' OD2' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER 36.71 69.11 0.22 Allowed 'General case' 0 N--CA 1.523 3.183 0 CA-C-N 114.463 -1.244 . . . . 0.0 113.58 179.37 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.54 -22.03 12.11 Favored Glycine 0 N--CA 1.488 2.113 0 O-C-N 121.136 -0.977 . . . . 0.0 111.864 176.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.545 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.265 0.4 OUTLIER -107.96 57.84 0.62 Allowed 'General case' 0 C--N 1.292 -1.919 0 O-C-N 121.137 -1.213 . . . . 0.0 111.877 -178.137 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.578 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.372 0.0 OUTLIER -67.97 113.59 5.79 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 122.035 0.922 . . . . 0.0 110.944 -179.573 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.93 HG22 ' HB3' ' A' ' 56' ' ' ALA . 10.2 m -78.91 145.6 9.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 122.612 1.196 . . . . 0.0 110.852 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.529 ' C ' ' CG2' ' A' ' 65' ' ' VAL 0.434 7.3 t70 -137.89 59.27 1.66 Allowed 'General case' 0 C--N 1.28 -2.444 0 CA-C-O 122.855 1.312 . . . . 0.0 110.897 -176.156 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.757 HG12 ' HD2' ' A' ' 66' ' ' PRO . 1.4 t -157.28 150.41 18.6 Favored Pre-proline 0 C--N 1.271 -2.842 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.682 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.757 ' HD2' HG12 ' A' ' 65' ' ' VAL . 46.3 Cg_endo -88.04 141.53 5.21 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 CA-C-O 123.728 1.47 . . . . 0.0 111.814 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.587 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -110.83 50.36 0.78 Allowed Glycine 0 C--N 1.271 -3.075 0 CA-C-N 112.495 -2.139 . . . . 0.0 109.33 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.636 HG23 ' N ' ' A' ' 69' ' ' ASP 0.289 2.4 tp -179.35 -164.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 O-C-N 120.03 -1.865 . . . . 0.0 109.944 -178.158 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.636 ' N ' HG23 ' A' ' 68' ' ' ILE . 11.1 t70 -114.38 85.02 10.18 Favored Pre-proline 0 N--CA 1.499 1.998 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 175.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.708 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 19.3 Cg_endo -47.52 -5.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.289 -2.583 0 C-N-CA 124.381 3.387 . . . . 0.0 115.763 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.593 ' ND2' ' N ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -109.44 93.03 4.29 Favored 'General case' 0 C--N 1.285 -2.197 0 O-C-N 119.809 -1.807 . . . . 0.0 108.843 -179.495 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.742 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . . . -78.22 12.2 2.0 Allowed 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.357 -0.84 . . . . 0.0 109.202 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.408 ' HA ' ' HG2' ' A' ' 76' ' ' MET . 7.5 t -76.74 -25.26 53.29 Favored 'General case' 0 C--N 1.311 -1.104 0 O-C-N 120.904 -1.123 . . . . 0.0 108.581 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.551 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 0.6 OUTLIER -78.75 4.13 14.69 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 118.615 -1.234 . . . . 0.0 108.546 176.114 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.742 ' CD2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -135.29 7.26 3.35 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 121.344 -0.847 . . . . 0.0 109.275 177.589 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.508 ' O ' ' N ' ' A' ' 78' ' ' CYS . 1.0 OUTLIER -148.21 125.65 11.65 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 123.859 1.79 . . . . 0.0 112.555 178.763 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.543 ' O ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -32.16 91.95 0.01 OUTLIER 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 112.453 -2.158 . . . . 0.0 111.499 -178.373 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.522 ' HA ' HD13 ' A' ' 80' ' ' LEU 0.311 0.1 OUTLIER -91.95 142.28 26.28 Favored Pre-proline 0 C--N 1.264 -3.126 0 CA-C-N 111.408 -2.633 . . . . 0.0 109.926 179.968 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.639 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 35.1 Cg_endo -82.54 166.41 69.59 Favored 'Cis proline' 0 C--N 1.314 -1.247 0 C-N-CA 123.094 -1.627 . . . . 0.0 111.861 0.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.683 ' HG ' ' CE1' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -93.67 129.75 39.86 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.352 -179.637 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.525 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.3 t -105.85 141.54 20.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-O 124.325 2.012 . . . . 0.0 112.697 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.733 ' HG3' ' N ' ' A' ' 45' ' ' GLN . 2.5 tmpt? -43.86 122.61 2.87 Favored 'General case' 0 C--N 1.273 -2.759 0 CA-C-N 111.556 -2.565 . . . . 0.0 115.933 -176.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.56 -13.61 35.76 Favored Glycine 0 C--N 1.291 -1.921 0 CA-C-N 111.98 -2.373 . . . . 0.0 108.472 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.623 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 35.7 mt-30 -78.74 126.8 31.21 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-O 123.207 1.479 . . . . 0.0 112.016 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.604 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 3.9 pt20 -63.84 142.11 58.52 Favored 'General case' 0 C--N 1.271 -2.805 0 CA-C-N 113.363 -1.744 . . . . 0.0 107.791 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.972 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 19.6 m-85 -142.74 126.12 16.65 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.685 ' HB3' HG12 ' A' ' 40' ' ' VAL . 28.4 p-10 -117.9 136.43 53.47 Favored 'General case' 0 C--N 1.277 -2.56 0 CA-C-O 122.745 1.26 . . . . 0.0 110.077 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.846 HD11 ' CG1' ' A' ' 52' ' ' ILE . 0.8 OUTLIER -113.88 160.26 13.42 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.726 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -145.63 153.54 41.15 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.522 0.677 . . . . 0.0 112.211 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.832 ' CE2' HD13 ' A' ' 54' ' ' ILE . 3.1 t80 -151.65 100.38 2.69 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.628 -0.67 . . . . 0.0 110.638 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.57 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 1.4 t -122.6 114.43 20.61 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-N 119.689 1.131 . . . . 0.0 108.234 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.686 ' HB2' ' CE1' ' A' ' 90' ' ' TYR 0.273 0.9 OUTLIER -143.12 112.72 6.9 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.508 -177.365 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 10.3 p30 -74.88 157.13 35.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 119.217 -2.177 . . . . 0.0 110.321 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.855 HG22 ' O ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -154.14 172.6 5.6 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.0 -1.063 . . . . 0.0 108.752 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.542 ' HD2' ' HB ' ' A' ' 94' ' ' VAL . 17.2 Cg_endo -36.1 149.5 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.133 0 O-C-N 123.502 1.264 . . . . 0.0 111.11 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.768 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 9.2 mptt -80.41 -25.67 38.89 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 117.332 -1.747 . . . . 0.0 115.152 -173.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.767 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -145.31 45.95 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 O-C-N 121.455 -0.778 . . . . 0.0 112.721 -178.084 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.585 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . . . -73.86 -47.07 6.8 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 120.544 -1.348 . . . . 0.0 111.325 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.701 ' C ' ' HD2' ' A' ' 100' ' ' LYS . 44.9 Cg_endo -67.73 160.16 49.44 Favored 'Trans proline' 0 CA--C 1.468 -2.813 0 CA-C-O 123.547 1.394 . . . . 0.0 111.648 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.701 ' HD2' ' C ' ' A' ' 99' ' ' PRO . 0.3 OUTLIER -107.74 106.98 17.55 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 112.031 -2.35 . . . . 0.0 110.949 -169.083 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.67 ' HB3' HG22 ' A' ' 127' ' ' ILE . 2.2 p -42.12 93.72 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.912 0 CA-C-O 123.496 1.617 . . . . 0.0 110.457 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.607 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.381 46.8 mt-10 -165.35 -52.58 0.03 OUTLIER 'General case' 0 CA--C 1.449 -2.915 0 CA-C-N 113.114 -1.857 . . . . 0.0 111.897 178.198 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.484 29.3 t30 -162.03 88.65 0.68 Allowed 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 111.095 -2.775 . . . . 0.0 115.011 -161.345 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.971 HG22 ' HA ' ' A' ' 58' ' ' ILE . 22.0 t -142.89 141.31 27.1 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.537 0 C-N-CA 118.87 -1.132 . . . . 0.0 111.961 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.948 HG22 ' CG2' ' A' ' 123' ' ' THR . 7.9 t -153.03 134.15 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.686 HG23 ' HB2' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -109.58 140.08 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-O 122.488 1.137 . . . . 0.0 112.467 -178.713 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . 1.04 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -133.13 111.29 10.8 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.55 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.911 HG13 ' CA ' ' A' ' 54' ' ' ILE . 6.1 t -125.82 142.06 43.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 119.821 -1.8 . . . . 0.0 108.969 -177.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.797 ' HB2' ' HB3' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -132.58 153.3 51.15 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.788 1.28 . . . . 0.0 112.937 -178.183 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.68 HG12 ' HB3' ' A' ' 117' ' ' LEU . 2.7 t -102.62 123.75 56.16 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.512 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 177.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.533 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -101.75 127.97 48.29 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.523 ' HA3' HD23 ' A' ' 117' ' ' LEU . . . -83.72 -129.42 1.63 Allowed Glycine 0 C--N 1.279 -2.638 0 C-N-CA 118.632 -1.746 . . . . 0.0 114.414 -176.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.631 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 4.1 p-10 -98.22 7.47 46.21 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -175.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 22.6 p30 -167.49 -13.04 0.02 OUTLIER 'General case' 0 C--N 1.261 -3.259 0 C-N-CA 117.429 -1.708 . . . . 0.0 114.437 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.42 ' O ' ' SD ' ' A' ' 111' ' ' MET . . . -153.85 -86.84 0.06 OUTLIER Glycine 0 CA--C 1.473 -2.57 0 CA-C-O 125.916 2.953 . . . . 0.0 111.723 -177.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.517 HG22 ' H ' ' A' ' 117' ' ' LEU . 1.4 p -141.49 177.54 3.38 Favored 'Isoleucine or valine' 1 C--N 1.228 -4.714 1 CA-C-N 108.054 -4.073 . . . . 0.0 110.929 -177.283 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.68 ' HB3' HG12 ' A' ' 110' ' ' VAL . 0.2 OUTLIER -145.96 -64.02 0.31 Allowed 'General case' 0 C--N 1.289 -2.064 0 O-C-N 121.793 -0.567 . . . . 0.0 110.849 -179.561 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.992 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -164.51 127.82 2.45 Favored 'General case' 0 N--CA 1.51 2.552 0 O-C-N 120.96 -1.088 . . . . 0.0 109.134 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.84 ' SG ' ' HB2' ' A' ' 9' ' ' ALA . 1.6 p -134.57 142.15 46.87 Favored 'General case' 0 C--N 1.285 -2.197 0 C-N-CA 117.823 -1.551 . . . . 0.0 113.482 -177.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.472 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -144.96 138.2 26.67 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 123.035 1.398 . . . . 0.0 112.11 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 1.04 ' HB ' HG23 ' A' ' 107' ' ' THR 0.284 0.0 OUTLIER -113.03 142.3 25.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 114.09 -1.413 . . . . 0.0 111.982 -178.697 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.899 ' N ' HD13 ' A' ' 121' ' ' ILE . . . -130.96 167.65 18.65 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.983 -1.073 . . . . 0.0 108.131 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.948 ' CG2' HG22 ' A' ' 105' ' ' VAL . 67.7 p -154.08 -128.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.423 -1.423 . . . . 0.0 110.377 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.576 ' O ' ' N ' ' A' ' 126' ' ' LYS . 57.5 m-70 60.75 -52.91 0.09 Allowed 'General case' 0 N--CA 1.516 2.833 0 O-C-N 121.043 -1.035 . . . . 0.0 112.906 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 123' ' ' THR . . . -46.87 86.92 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.991 -1.068 . . . . 0.0 110.56 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.581 ' O ' ' O ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -110.75 55.99 0.64 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.311 -0.868 . . . . 0.0 110.089 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.67 HG22 ' HB3' ' A' ' 101' ' ' SER . 0.6 OUTLIER 9.38 120.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.903 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -179.735 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.513 ' O ' ' C ' ' A' ' 129' ' ' ASP . 0.5 OUTLIER -167.5 147.08 5.1 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.643 -0.66 . . . . 0.0 111.338 178.89 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.513 ' C ' ' O ' ' A' ' 128' ' ' ARG . 3.8 m-20 . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 117.939 -1.029 . . . . 0.0 111.379 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 7.5 t . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.122 0.487 . . . . 0.0 110.151 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.513 ' CD ' ' CE ' ' A' ' 15' ' ' LYS . 10.9 mp0 58.69 165.47 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.265 -0.897 . . . . 0.0 110.97 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.765 HG12 ' HA ' ' A' ' 22' ' ' HIS 0.257 1.3 m -145.68 174.91 2.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 O-C-N 120.634 -1.291 . . . . 0.0 108.902 -179.151 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.582 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -81.83 148.13 29.0 Favored 'General case' 0 CA--C 1.477 -1.829 0 CA-C-O 122.83 1.3 . . . . 0.0 109.115 176.782 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.854 HG11 HG21 ' A' ' 16' ' ' VAL 0.428 0.4 OUTLIER -164.29 -167.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 CA-C-N 113.668 -1.605 . . . . 0.0 109.589 -170.856 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 5' ' ' VAL . 2.7 mttt -156.33 146.57 21.42 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 124.065 1.888 . . . . 0.0 113.173 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.287 8.1 t70 -86.32 147.71 25.93 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-N 112.335 -2.211 . . . . 0.0 109.771 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.654 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.1 p -136.84 14.67 3.11 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.887 -1.133 . . . . 0.0 109.07 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.846 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -126.04 -84.36 0.63 Allowed 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.075 -1.05 . . . . 0.0 109.931 -177.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 12' ' ' GLU . 4.3 t-20 -158.65 66.51 0.44 Allowed 'General case' 0 C--N 1.269 -2.901 0 C-N-CA 118.632 -1.227 . . . . 0.0 112.265 177.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.586 ' CG ' ' O ' ' A' ' 11' ' ' HIS . 10.2 t-160 36.27 30.84 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 121.958 0.885 . . . . 0.0 110.276 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.582 ' HB3' ' O ' ' A' ' 117' ' ' LEU . 0.4 OUTLIER -84.84 18.17 2.53 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 121.356 0.598 . . . . 0.0 111.428 -179.553 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.037 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.281 0.1 OUTLIER -122.91 -171.69 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-O 122.04 0.924 . . . . 0.0 110.856 -178.333 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.629 ' H ' HG23 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -162.21 -47.42 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.336 -179.562 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.561 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -142.71 133.24 25.06 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 116.192 -2.203 . . . . 0.0 113.317 179.116 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.879 HG12 ' HB2' ' A' ' 39' ' ' ALA . 3.2 m -131.78 107.15 12.64 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.323 0 CA-C-O 122.876 1.322 . . . . 0.0 111.498 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -98.75 120.54 39.36 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 114.319 -1.31 . . . . 0.0 111.302 178.883 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.725 HG22 ' HB2' ' A' ' 37' ' ' LEU . 16.1 t -142.72 146.07 36.56 Favored Pre-proline 0 C--N 1.295 -1.794 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.097 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.557 ' HD2' ' CG1' ' A' ' 18' ' ' VAL . 43.9 Cg_endo -69.66 132.34 23.29 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 O-C-N 123.834 1.439 . . . . 0.0 111.211 -178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.41 -88.82 0.2 Allowed Glycine 0 N--CA 1.495 2.57 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.519 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 19.3 m -94.27 173.27 7.73 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.243 -1.151 . . . . 0.0 110.433 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.765 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -142.01 8.42 1.87 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.764 -1.21 . . . . 0.0 110.723 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 4' ' ' ASP . . . 173.99 -146.38 8.69 Favored Glycine 0 C--N 1.286 -2.244 0 C-N-CA 118.792 -1.67 . . . . 0.0 110.221 177.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.98 -12.65 52.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.678 -1.484 . . . . 0.0 109.35 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.822 ' CB ' ' HD3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -65.01 175.45 1.01 Allowed Pre-proline 0 C--N 1.298 -1.653 0 CA-C-O 125.054 2.359 . . . . 0.0 114.884 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.822 ' HD3' ' CB ' ' A' ' 25' ' ' GLU . 28.7 Cg_endo -109.32 127.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.266 -3.809 1 C-N-CA 127.607 5.538 . . . . 0.0 111.037 -175.985 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.581 ' SG ' ' HA ' ' A' ' 124' ' ' HIS . 23.8 p -123.27 108.03 12.33 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 123.157 1.456 . . . . 0.0 111.304 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.548 ' O ' HG22 ' A' ' 28' ' ' ILE 0.305 32.2 mm -68.9 72.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.856 179.166 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.647 HD13 ' HE3' ' A' ' 33' ' ' LYS . 6.5 tt -42.32 122.07 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 122.773 1.273 . . . . 0.0 109.091 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.465 ' CG ' ' N ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -66.65 -120.27 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.204 -177.402 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.465 ' N ' ' CG ' ' A' ' 30' ' ' HIS . 50.9 mtt85 -128.91 168.93 15.26 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.088 -1.008 . . . . 0.0 110.15 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.894 ' HA2' ' HA ' ' A' ' 96' ' ' LYS . . . 83.55 118.52 0.67 Allowed Glycine 0 C--N 1.302 -1.313 0 N-CA-C 105.329 -3.108 . . . . 0.0 105.329 -177.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.827 ' HB2' HG12 ' A' ' 94' ' ' VAL . 2.4 mmmm -118.85 98.0 50.94 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 120.761 2.281 . . . . 0.0 116.391 -174.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.545 ' HD3' ' O ' ' A' ' 32' ' ' GLY . 60.3 Cg_endo -105.17 144.71 0.11 Allowed 'Trans proline' 0 C--N 1.291 -2.477 0 C-N-CA 123.642 2.894 . . . . 0.0 108.898 177.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.538 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 3.7 m-85 -117.85 91.01 3.46 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.302 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.578 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 25.6 mp0 -113.47 79.28 1.22 Allowed 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.725 ' HB2' HG22 ' A' ' 18' ' ' VAL . 3.1 pp -111.68 141.57 45.12 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.851 -1.156 . . . . 0.0 109.837 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.474 ' HB3' ' HE2' ' A' ' 89' ' ' LYS . 2.2 pp20? -140.33 137.53 34.19 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.759 1.266 . . . . 0.0 108.396 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.879 ' HB2' HG12 ' A' ' 16' ' ' VAL . . . -142.65 153.31 43.32 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-O 123.137 1.446 . . . . 0.0 113.237 -176.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.595 HG12 ' HB3' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -109.92 141.37 25.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 113.798 -1.547 . . . . 0.0 108.133 178.242 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.582 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 3.0 p90 -156.3 121.91 4.85 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -177.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 13.4 tt0 -69.71 153.6 43.16 Favored 'General case' 0 C--N 1.285 -2.233 0 O-C-N 120.441 -1.412 . . . . 0.0 108.661 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.904 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -89.01 133.38 34.36 Favored 'General case' 0 C--N 1.266 -3.049 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.302 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.594 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 14.8 p-10 -114.2 49.24 1.02 Allowed 'General case' 0 CA--C 1.484 -1.572 0 CA-C-O 125.534 2.588 . . . . 0.0 113.576 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.593 ' C ' ' HB2' ' A' ' 82' ' ' LYS . 6.7 pt20 167.1 -158.95 0.01 OUTLIER 'General case' 0 C--N 1.255 -3.514 0 CA-C-N 108.83 -3.804 . . . . 0.0 112.793 175.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.479 ' C ' HG22 ' A' ' 47' ' ' THR 0.276 7.4 t30 -110.17 154.68 23.0 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-O 122.701 1.239 . . . . 0.0 108.912 -178.793 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.618 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -172.38 151.78 2.58 Favored 'General case' 0 C--N 1.256 -3.489 0 CA-C-N 114.667 -1.151 . . . . 0.0 112.487 -178.704 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.934 ' O ' HG23 ' A' ' 49' ' ' THR . 0.2 OUTLIER -111.01 9.45 22.13 Favored 'General case' 0 N--CA 1.508 2.444 0 C-N-CA 118.507 -1.277 . . . . 0.0 110.28 178.408 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.934 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.66 146.56 4.0 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 120.653 -1.279 . . . . 0.0 111.084 178.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 111' ' ' MET . . . -140.66 94.79 2.77 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-O 122.844 1.307 . . . . 0.0 109.814 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 1.3 mmtp -65.2 -179.49 0.59 Allowed 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.193 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.934 ' CG2' HD11 ' A' ' 88' ' ' ILE . 28.7 mt -141.65 140.19 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.446 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 2.3 tm-20 -141.14 104.78 4.7 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 123.265 1.507 . . . . 0.0 109.733 178.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 1.073 ' HA ' HG13 ' A' ' 108' ' ' VAL . 0.1 OUTLIER -92.11 127.64 44.23 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.458 0 CA-C-N 112.604 -2.089 . . . . 0.0 107.602 179.271 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.882 ' N ' HD13 ' A' ' 54' ' ' ILE . 3.5 ttpt -129.75 147.27 51.51 Favored 'General case' 0 C--N 1.271 -2.823 0 C-N-CA 118.45 -1.3 . . . . 0.0 108.193 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 1.094 ' HB3' HG22 ' A' ' 63' ' ' VAL . . . -135.54 130.35 34.44 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 117.579 -1.648 . . . . 0.0 111.565 -178.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.704 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 2.8 p -103.17 95.97 6.47 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.338 -1.726 . . . . 0.0 106.338 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.889 ' HA ' HG22 ' A' ' 104' ' ' VAL . 0.1 OUTLIER -106.93 107.05 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.711 0 CA-C-O 123.008 1.385 . . . . 0.0 110.339 -176.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 103' ' ' ASN . 0.4 OUTLIER 33.74 62.77 0.41 Allowed 'General case' 0 N--CA 1.519 3.002 0 CA-C-N 115.097 -0.956 . . . . 0.0 113.08 179.427 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.59 -15.54 9.48 Favored Glycine 0 N--CA 1.487 2.061 0 O-C-N 121.335 -0.853 . . . . 0.0 111.239 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.54 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.271 0.4 OUTLIER -107.99 59.05 0.61 Allowed 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.204 -1.174 . . . . 0.0 111.353 -178.486 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.651 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.373 0.0 OUTLIER -55.09 117.17 3.24 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.975 0.893 . . . . 0.0 110.79 179.902 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 1.094 HG22 ' HB3' ' A' ' 56' ' ' ALA . 19.0 m -79.53 143.16 12.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-O 122.741 1.258 . . . . 0.0 111.657 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.447 25.1 t0 -138.78 85.27 2.07 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.193 -176.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.572 ' CG2' ' HD2' ' A' ' 66' ' ' PRO . 12.2 p -153.62 149.73 21.78 Favored Pre-proline 0 C--N 1.277 -2.573 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.684 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.572 ' HD2' ' CG2' ' A' ' 65' ' ' VAL . 42.3 Cg_endo -71.37 138.06 32.11 Favored 'Trans proline' 0 CA--C 1.501 -1.139 0 CA-C-O 123.748 1.478 . . . . 0.0 111.073 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.651 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -110.02 -71.8 0.68 Allowed Glycine 0 N--CA 1.504 3.225 0 CA-C-N 112.587 -2.097 . . . . 0.0 112.0 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.767 HG23 ' N ' ' A' ' 69' ' ' ASP . 0.8 OUTLIER -116.64 -150.66 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.013 -1.875 . . . . 0.0 109.433 -178.603 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.767 ' N ' HG23 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -105.81 143.29 26.57 Favored Pre-proline 0 C--N 1.295 -1.773 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 177.21 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.753 ' HB2' ' H ' ' A' ' 52' ' ' ILE . 22.9 Cg_endo -106.21 -3.32 0.14 Allowed 'Trans proline' 0 C--N 1.274 -3.383 0 C-N-CA 123.18 2.587 . . . . 0.0 113.908 -173.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.598 ' HB2' ' NE2' ' A' ' 74' ' ' HIS . 0.5 OUTLIER -110.34 88.78 2.85 Favored 'General case' 0 C--N 1.285 -2.222 0 O-C-N 120.839 -1.163 . . . . 0.0 108.459 -179.501 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.741 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . . . -78.45 10.77 2.86 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.222 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.4 t -77.29 -26.8 52.67 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 120.947 -1.096 . . . . 0.0 108.184 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.598 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -81.19 8.37 9.02 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 118.919 -1.113 . . . . 0.0 108.343 175.893 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.741 ' CD2' ' HA ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -132.36 -2.52 3.48 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 121.76 -0.587 . . . . 0.0 109.939 178.163 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.596 ' SD ' ' HB1' ' A' ' 72' ' ' ALA . 1.8 ptt? -157.74 132.25 8.4 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 123.866 1.793 . . . . 0.0 113.824 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.57 ' O ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -16.29 94.29 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 111.786 -2.461 . . . . 0.0 113.276 -179.136 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 48' ' ' LYS 0.327 1.8 t -106.84 144.79 29.78 Favored Pre-proline 0 C--N 1.267 -3.003 0 CA-C-N 111.596 -2.547 . . . . 0.0 109.234 179.165 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.671 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 37.5 Cg_endo -79.95 167.82 74.06 Favored 'Cis proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.847 -1.73 . . . . 0.0 111.833 0.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.713 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -93.4 127.9 39.22 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.103 -179.423 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.513 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.3 t -105.0 140.67 22.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-O 124.207 1.956 . . . . 0.0 112.211 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.594 ' HG2' ' HA ' ' A' ' 44' ' ' ASN . 1.8 tmmt? -45.08 119.42 2.01 Favored 'General case' 0 C--N 1.273 -2.741 0 CA-C-N 111.534 -2.576 . . . . 0.0 116.776 -175.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.1 -16.19 22.82 Favored Glycine 0 C--N 1.293 -1.86 0 CA-C-N 111.772 -2.467 . . . . 0.0 107.98 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.63 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 56.7 mt-30 -75.56 126.39 30.93 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-O 123.292 1.52 . . . . 0.0 111.496 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.593 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 29.4 mt-30 -65.12 144.97 56.88 Favored 'General case' 0 C--N 1.271 -2.81 0 CA-C-N 113.299 -1.773 . . . . 0.0 107.692 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.904 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 19.6 m-85 -142.56 126.7 17.45 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.595 ' HB3' HG12 ' A' ' 40' ' ' VAL . 1.4 p30 -117.15 132.46 56.65 Favored 'General case' 0 C--N 1.276 -2.611 0 CA-C-O 122.925 1.345 . . . . 0.0 110.358 -177.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 1.121 HD12 ' CG2' ' A' ' 110' ' ' VAL . 0.4 OUTLIER -104.79 158.55 5.57 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 CA-C-N 114.186 -1.37 . . . . 0.0 108.42 179.778 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.474 ' HE2' ' HB3' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -144.39 145.27 31.84 Favored 'General case' 0 C--N 1.29 -2.021 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.465 -178.293 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.606 ' CE1' ' HB2' ' A' ' 92' ' ' TRP . 12.7 t80 -145.21 108.89 4.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.171 -0.956 . . . . 0.0 109.913 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.578 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 1.2 t -127.07 111.26 13.83 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.667 ' CZ3' HG23 ' A' ' 94' ' ' VAL 0.278 0.7 OUTLIER -142.83 114.46 8.03 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.173 -177.277 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 2.4 p-10 -75.08 157.08 35.35 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 119.172 -2.205 . . . . 0.0 109.411 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.827 HG12 ' HB2' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -147.49 167.65 13.02 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.128 -0.982 . . . . 0.0 108.457 -179.158 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.743 ' HD2' HG22 ' A' ' 94' ' ' VAL . 18.3 Cg_endo -37.33 152.83 0.03 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.188 0 O-C-N 123.835 1.439 . . . . 0.0 110.677 -177.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.894 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -79.81 -25.9 40.71 Favored 'General case' 0 C--N 1.286 -2.189 0 C-N-CA 116.508 -2.077 . . . . 0.0 115.175 -173.181 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.765 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -144.9 45.47 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 O-C-N 121.517 -0.74 . . . . 0.0 112.968 -178.224 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.927 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . . . -74.0 -59.4 1.79 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.53 -1.356 . . . . 0.0 110.627 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.927 ' HD3' ' HB3' ' A' ' 98' ' ' ALA . 47.9 Cg_endo -67.2 160.32 48.06 Favored 'Trans proline' 0 CA--C 1.462 -3.084 0 O-C-N 123.897 1.472 . . . . 0.0 110.474 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.716 ' HD2' ' C ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -107.28 102.29 11.6 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 112.493 -2.139 . . . . 0.0 110.136 -169.229 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.694 ' HB2' HD12 ' A' ' 127' ' ' ILE . 2.5 p -42.06 97.67 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 123.592 1.663 . . . . 0.0 110.042 -178.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.561 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.389 47.8 mt-10 -164.4 -53.0 0.03 OUTLIER 'General case' 0 CA--C 1.45 -2.877 0 CA-C-N 112.963 -1.926 . . . . 0.0 111.543 178.878 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.483 35.0 t-20 -161.25 82.05 0.62 Allowed 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 110.876 -2.875 . . . . 0.0 113.911 -161.879 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.889 HG22 ' HA ' ' A' ' 58' ' ' ILE . 20.1 t -143.39 139.1 26.46 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.65 0 C-N-CA 118.952 -1.099 . . . . 0.0 111.912 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.896 HG22 HD11 ' A' ' 121' ' ' ILE . 0.6 OUTLIER -142.5 132.07 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.392 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.552 ' O ' HG12 ' A' ' 121' ' ' ILE . 0.4 OUTLIER -99.1 143.46 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 122.594 1.188 . . . . 0.0 111.57 -179.028 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . 1.071 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -131.59 118.34 19.96 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 179.556 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.073 HG13 ' HA ' ' A' ' 54' ' ' ILE . 3.4 t -132.38 139.53 49.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 120.22 -1.55 . . . . 0.0 108.583 -178.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.902 ' HB2' ' CB ' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -130.16 154.2 47.76 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.883 1.325 . . . . 0.0 111.623 -178.63 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 1.121 ' CG2' HD12 ' A' ' 88' ' ' ILE . 2.6 t -107.69 124.54 63.83 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.58 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 177.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.513 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 1.5 tmt? -103.71 120.39 40.85 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.554 ' HA3' HD23 ' A' ' 117' ' ' LEU . . . -74.93 -131.17 0.25 Allowed Glycine 0 C--N 1.281 -2.51 0 C-N-CA 119.06 -1.543 . . . . 0.0 114.671 -175.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.618 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 4.7 p-10 -97.94 8.65 44.4 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -175.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 33.5 p-10 -167.41 -14.89 0.02 OUTLIER 'General case' 0 C--N 1.265 -3.08 0 C-N-CA 117.475 -1.69 . . . . 0.0 114.428 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.447 ' O ' ' HG2' ' A' ' 111' ' ' MET . . . -152.39 -86.74 0.06 OUTLIER Glycine 0 CA--C 1.473 -2.572 0 CA-C-O 125.937 2.965 . . . . 0.0 111.971 -177.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.642 HG22 ' H ' ' A' ' 117' ' ' LEU . 4.2 p -141.23 178.67 2.7 Favored 'Isoleucine or valine' 1 C--N 1.228 -4.696 1 CA-C-N 108.168 -4.016 . . . . 0.0 110.807 -177.226 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.769 ' HB3' HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -148.55 -61.85 0.24 Allowed 'General case' 0 C--N 1.289 -2.06 0 O-C-N 121.873 -0.517 . . . . 0.0 111.277 -179.44 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 1.037 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -165.35 129.85 2.42 Favored 'General case' 0 N--CA 1.512 2.669 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.543 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.902 ' CB ' ' HB2' ' A' ' 109' ' ' LYS . 1.4 p -134.52 135.44 42.37 Favored 'General case' 0 C--N 1.284 -2.266 0 C-N-CA 118.064 -1.455 . . . . 0.0 113.09 -178.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.59 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -143.62 135.06 26.09 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 122.992 1.377 . . . . 0.0 112.599 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 1.071 ' HB ' HG23 ' A' ' 107' ' ' THR 0.272 0.0 OUTLIER -111.14 138.41 39.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 CA-C-N 114.143 -1.39 . . . . 0.0 110.961 -179.549 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.851 ' N ' HD13 ' A' ' 121' ' ' ILE . . . -131.14 159.76 36.73 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.858 -1.151 . . . . 0.0 109.062 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.673 ' HA ' HG23 ' A' ' 105' ' ' VAL . 25.6 p -94.15 -61.11 1.59 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.297 -1.502 . . . . 0.0 109.985 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.605 ' NE2' ' HB ' ' A' ' 18' ' ' VAL . 1.6 m-70 62.02 -55.77 0.13 Allowed 'General case' 0 N--CA 1.509 2.484 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.511 ' CB ' HG21 ' A' ' 29' ' ' ILE . . . -97.71 85.65 3.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.566 -1.334 . . . . 0.0 111.591 -178.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.551 ' HD3' ' HA ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -119.09 71.45 0.86 Allowed 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.794 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.694 HD12 ' HB2' ' A' ' 101' ' ' SER . 0.9 OUTLIER -64.52 120.99 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 O-C-N 120.669 -1.269 . . . . 0.0 111.245 -178.954 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.473 ' HD3' ' O ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -169.55 150.0 4.04 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.139 179.059 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.47 ' C ' ' O ' ' A' ' 128' ' ' ARG . 3.2 m-20 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.835 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.172 0.511 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.463 ' O ' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER 61.63 166.04 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 110.828 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.858 HG12 ' HA ' ' A' ' 22' ' ' HIS . 1.3 m -145.22 -175.64 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.45 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -77.68 133.68 38.3 Favored 'General case' 0 CA--C 1.48 -1.714 0 C-N-CA 117.839 -1.544 . . . . 0.0 108.84 178.772 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.521 ' O ' ' HG2' ' A' ' 6' ' ' LYS 0.435 0.4 OUTLIER -170.14 156.48 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 113.972 -1.467 . . . . 0.0 110.058 -169.627 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -146.76 145.77 30.06 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 123.772 1.749 . . . . 0.0 113.515 -178.671 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.276 1.9 t70 -74.28 149.3 40.78 Favored 'General case' 0 C--N 1.268 -2.956 0 CA-C-N 112.792 -2.004 . . . . 0.0 109.312 177.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.632 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 5.7 p -137.33 14.44 3.01 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.852 -1.155 . . . . 0.0 109.058 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.864 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -125.5 -82.52 0.63 Allowed 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 118.962 -1.095 . . . . 0.0 109.952 -177.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 12' ' ' GLU . 2.9 t30 -157.86 66.45 0.48 Allowed 'General case' 0 C--N 1.268 -2.952 0 C-N-CA 118.684 -1.206 . . . . 0.0 111.882 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.487 ' C ' ' O ' ' A' ' 10' ' ' ASN . 2.4 m-70 33.4 33.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.845 0.831 . . . . 0.0 110.468 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 10' ' ' ASN . 38.1 mt-10 -93.77 21.12 6.79 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.68 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.027 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.297 0.1 OUTLIER -124.39 -167.3 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.895 0.855 . . . . 0.0 110.056 -178.685 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.649 ' H ' HG23 ' A' ' 13' ' ' ILE . 13.1 ptpt -162.15 -44.89 0.04 OUTLIER 'General case' 0 C--N 1.29 -1.997 0 O-C-N 121.792 -0.567 . . . . 0.0 111.503 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.553 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 36.4 tttt -148.49 142.57 25.97 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 115.881 -2.328 . . . . 0.0 114.21 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 1.094 HG13 ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -134.45 103.07 4.48 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 CA-C-O 122.983 1.373 . . . . 0.0 110.578 178.932 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.508 ' HA ' HD23 ' A' ' 17' ' ' LEU . 1.3 mt -96.11 133.18 40.7 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 113.994 -1.457 . . . . 0.0 111.465 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.894 HG22 ' HA ' ' A' ' 37' ' ' LEU . 93.1 t -140.83 145.71 40.9 Favored Pre-proline 0 N--CA 1.499 2.018 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.514 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.605 ' HD2' HG13 ' A' ' 18' ' ' VAL . 45.9 Cg_endo -72.42 101.23 1.23 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.815 1.429 . . . . 0.0 110.76 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.412 ' C ' ' CB ' ' A' ' 27' ' ' CYS . . . 157.79 -92.21 0.12 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.519 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 33.0 m -83.95 162.04 20.59 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.32 -1.106 . . . . 0.0 111.196 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.858 ' HA ' HG12 ' A' ' 3' ' ' VAL . 1.6 p-80 -142.41 16.89 2.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.903 -1.123 . . . . 0.0 109.206 178.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 173.18 -152.8 16.67 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.12 -8.76 25.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.571 -1.547 . . . . 0.0 109.805 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.806 ' CB ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -64.15 176.97 0.59 Allowed Pre-proline 0 C--N 1.3 -1.563 0 CA-C-O 125.012 2.339 . . . . 0.0 115.22 -179.81 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.806 ' HD3' ' CB ' ' A' ' 25' ' ' GLU . 25.6 Cg_endo -106.51 125.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.269 -3.647 1 C-N-CA 127.866 5.711 . . . . 0.0 110.736 -176.137 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 21' ' ' CYS . 21.4 p -124.45 119.36 28.96 Favored 'General case' 0 N--CA 1.505 2.28 0 CA-C-O 123.036 1.398 . . . . 0.0 112.648 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.46 ' O ' HG22 ' A' ' 28' ' ' ILE 0.315 32.2 mm -80.1 74.33 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-N 113.888 -1.506 . . . . 0.0 109.139 178.562 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.629 HD11 ' HG2' ' A' ' 34' ' ' PRO . 17.1 tt -42.84 121.74 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 122.78 1.276 . . . . 0.0 110.806 -178.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.587 ' CD2' ' HG3' ' A' ' 31' ' ' ARG . 34.8 p-80 -68.27 26.31 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 114.53 -1.213 . . . . 0.0 113.148 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.587 ' HG3' ' CD2' ' A' ' 30' ' ' HIS . 23.2 mtt85 -154.67 166.6 32.9 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.646 -1.284 . . . . 0.0 108.213 178.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.893 ' HA3' ' HA ' ' A' ' 96' ' ' LYS . . . -70.36 -94.28 0.06 OUTLIER Glycine 0 C--N 1.302 -1.348 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.754 ' HB2' HG12 ' A' ' 94' ' ' VAL . 0.6 OUTLIER -125.58 88.97 53.36 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 120.983 2.392 . . . . 0.0 115.62 -179.149 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.629 ' HG2' HD11 ' A' ' 29' ' ' ILE . 60.7 Cg_endo -108.13 142.35 0.06 OUTLIER 'Trans proline' 0 C--N 1.291 -2.488 0 C-N-CA 124.521 3.481 . . . . 0.0 107.719 176.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.481 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 10.1 m-85 -124.25 93.73 4.0 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 118.553 -1.259 . . . . 0.0 109.99 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.613 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 28.1 mp0 -112.8 86.22 2.32 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.894 ' HA ' HG22 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -110.33 141.33 43.51 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 120.576 -1.328 . . . . 0.0 109.093 179.294 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.92 132.49 28.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 1.094 ' HB2' HG13 ' A' ' 16' ' ' VAL . . . -142.14 154.39 44.84 Favored 'General case' 0 C--N 1.271 -2.829 0 CA-C-O 123.219 1.485 . . . . 0.0 113.404 -175.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.553 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.38 141.06 26.8 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 CA-C-N 113.43 -1.714 . . . . 0.0 108.805 178.714 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.556 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 3.7 p90 -157.96 124.58 4.87 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 21.8 tt0 -69.29 154.79 41.47 Favored 'General case' 0 C--N 1.285 -2.213 0 O-C-N 120.305 -1.497 . . . . 0.0 108.606 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.999 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -85.69 131.39 34.34 Favored 'General case' 0 C--N 1.265 -3.068 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.447 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.633 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 0.3 OUTLIER -113.8 48.79 1.04 Allowed 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 125.775 2.702 . . . . 0.0 114.358 179.816 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.581 ' C ' ' HB2' ' A' ' 82' ' ' LYS . 0.4 OUTLIER 166.57 -161.63 0.01 OUTLIER 'General case' 0 C--N 1.26 -3.324 0 CA-C-N 108.502 -3.954 . . . . 0.0 112.845 175.152 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.422 ' C ' HG22 ' A' ' 47' ' ' THR 0.273 60.0 t30 -110.82 151.33 27.94 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-O 122.537 1.16 . . . . 0.0 108.958 -178.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.657 ' OG1' ' HB3' ' A' ' 113' ' ' ASP 0.252 0.0 OUTLIER -173.22 151.77 2.13 Favored 'General case' 0 C--N 1.255 -3.511 0 C-N-CA 118.581 -1.248 . . . . 0.0 112.545 -178.418 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.955 ' O ' HG23 ' A' ' 49' ' ' THR . 0.8 OUTLIER -111.59 10.69 21.18 Favored 'General case' 0 N--CA 1.51 2.568 0 C-N-CA 118.194 -1.402 . . . . 0.0 110.301 178.371 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.955 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -169.12 148.46 4.02 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 120.622 -1.299 . . . . 0.0 110.837 179.091 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 111' ' ' MET . . . -149.74 103.8 3.27 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 122.765 1.269 . . . . 0.0 110.949 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 0.7 OUTLIER -68.86 -174.94 0.64 Allowed 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.432 178.664 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.955 ' CG2' HD11 ' A' ' 88' ' ' ILE . 35.7 mt -141.93 140.84 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.388 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 5.6 tm-20 -139.92 107.58 5.62 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 123.284 1.516 . . . . 0.0 110.186 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 1.057 ' HA ' HG13 ' A' ' 108' ' ' VAL . 0.1 OUTLIER -92.63 128.38 44.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 CA-C-N 112.644 -2.071 . . . . 0.0 107.362 178.843 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.897 ' N ' HD13 ' A' ' 54' ' ' ILE . 1.1 tttt -128.09 141.86 51.37 Favored 'General case' 0 C--N 1.272 -2.802 0 C-N-CA 118.75 -1.18 . . . . 0.0 107.855 178.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 1.071 ' HB3' HG22 ' A' ' 63' ' ' VAL . . . -135.44 134.35 39.53 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 119.917 -1.739 . . . . 0.0 112.309 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.742 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 0.5 OUTLIER -107.22 99.5 9.04 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 177.285 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.924 ' HA ' HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -112.12 101.41 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.803 0 CA-C-O 123.305 1.526 . . . . 0.0 110.758 -176.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.544 ' N ' HG22 ' A' ' 104' ' ' VAL . 1.4 p30 37.59 64.36 0.66 Allowed 'General case' 0 N--CA 1.521 3.077 0 CA-C-N 114.991 -1.004 . . . . 0.0 113.06 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.73 -17.04 9.41 Favored Glycine 0 N--CA 1.488 2.114 0 O-C-N 121.264 -0.897 . . . . 0.0 111.546 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.532 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.272 0.2 OUTLIER -107.87 58.16 0.62 Allowed 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.197 -1.178 . . . . 0.0 111.576 -178.336 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.605 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.367 0.0 OUTLIER -60.01 116.75 4.38 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.958 0.885 . . . . 0.0 111.012 -179.904 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 1.071 HG22 ' HB3' ' A' ' 56' ' ' ALA . 13.8 m -75.8 146.61 8.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-O 122.547 1.165 . . . . 0.0 110.805 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.441 6.7 t70 -138.16 76.89 1.6 Allowed 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.192 -176.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.56 HG22 ' HD2' ' A' ' 66' ' ' PRO . 8.6 p -164.37 150.75 9.52 Favored Pre-proline 0 C--N 1.274 -2.692 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.42 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.56 ' HD2' HG22 ' A' ' 65' ' ' VAL . 44.6 Cg_endo -86.68 139.23 5.58 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 CA-C-O 123.887 1.536 . . . . 0.0 111.531 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.614 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -127.82 52.49 0.82 Allowed Glycine 0 C--N 1.273 -2.946 0 CA-C-N 112.498 -2.137 . . . . 0.0 110.432 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.642 ' HB ' ' CD2' ' A' ' 90' ' ' TYR 0.296 4.4 tp 179.96 -177.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 120.194 -1.768 . . . . 0.0 110.534 -178.677 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.523 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 12.9 t0 -112.3 83.47 5.26 Favored Pre-proline 0 N--CA 1.504 2.237 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 175.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.711 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 20.9 Cg_endo -48.59 -6.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.287 -2.706 0 C-N-CA 124.453 3.435 . . . . 0.0 116.245 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.583 ' HB2' ' NE2' ' A' ' 74' ' ' HIS . 5.1 m-80 -101.77 91.77 4.54 Favored 'General case' 0 C--N 1.284 -2.266 0 O-C-N 120.167 -1.583 . . . . 0.0 109.006 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.724 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . . . -76.33 7.29 4.47 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.431 -0.793 . . . . 0.0 109.52 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 8.3 t -79.05 -24.15 43.76 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 120.886 -1.134 . . . . 0.0 108.94 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.583 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 1.1 m-70 -80.1 8.11 7.85 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.022 -1.071 . . . . 0.0 109.066 176.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.724 ' CD2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -133.19 -2.83 3.13 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 121.365 -0.834 . . . . 0.0 110.217 177.547 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.446 ' O ' ' HG2' ' A' ' 76' ' ' MET . 2.4 ptt? -155.07 129.61 9.14 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 123.984 1.849 . . . . 0.0 113.678 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.465 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 13.9 pttt -21.85 102.6 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 111.89 -2.414 . . . . 0.0 113.365 -178.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 48' ' ' LYS 0.318 0.1 OUTLIER -99.04 146.64 32.03 Favored Pre-proline 0 C--N 1.265 -3.066 0 CA-C-N 111.522 -2.581 . . . . 0.0 108.79 178.609 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.641 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 37.2 Cg_endo -86.66 167.35 46.64 Favored 'Cis proline' 0 C--N 1.311 -1.412 0 C-N-CA 123.1 -1.625 . . . . 0.0 111.447 0.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.724 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -90.54 125.96 35.78 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 122.02 0.914 . . . . 0.0 110.95 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.507 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.3 t -104.47 137.76 32.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-O 124.248 1.975 . . . . 0.0 111.779 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.633 ' HG2' ' HA ' ' A' ' 44' ' ' ASN . 1.6 tmmt? -43.37 115.62 0.8 Allowed 'General case' 0 C--N 1.271 -2.844 0 CA-C-N 111.737 -2.483 . . . . 0.0 116.243 -175.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 118.2 -18.34 11.26 Favored Glycine 0 C--N 1.29 -1.983 0 CA-C-N 111.74 -2.482 . . . . 0.0 108.198 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.609 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 27.5 mt-30 -73.3 126.27 29.74 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-O 123.124 1.44 . . . . 0.0 111.797 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.583 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 4.4 pt20 -63.3 143.03 58.15 Favored 'General case' 0 C--N 1.271 -2.818 0 CA-C-N 113.57 -1.65 . . . . 0.0 107.855 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.999 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 21.3 m-85 -143.58 127.5 17.34 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.534 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 1.4 p-10 -117.51 132.53 56.53 Favored 'General case' 0 C--N 1.277 -2.561 0 CA-C-O 122.775 1.274 . . . . 0.0 110.401 -178.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 1.043 HD12 ' CG2' ' A' ' 110' ' ' VAL . 0.3 OUTLIER -102.31 159.98 4.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.402 179.368 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.75 144.84 32.8 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.941 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.642 ' CD2' ' HB ' ' A' ' 68' ' ' ILE . 32.3 t80 -149.02 102.36 3.25 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.772 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.613 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 0.6 OUTLIER -121.68 114.76 21.59 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 179.253 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.614 ' CD1' ' O ' ' A' ' 67' ' ' GLY 0.264 0.2 OUTLIER -141.86 108.42 5.33 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.913 -177.405 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.524 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 11.7 m120 -75.46 155.54 36.15 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 119.696 -1.878 . . . . 0.0 109.753 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.754 HG12 ' HB2' ' A' ' 33' ' ' LYS . 1.0 OUTLIER -153.79 169.98 9.07 Favored Pre-proline 0 N--CA 1.487 1.389 0 O-C-N 120.746 -1.221 . . . . 0.0 108.676 -178.924 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.751 ' CD ' HG13 ' A' ' 94' ' ' VAL . 17.8 Cg_endo -38.29 154.73 0.03 OUTLIER 'Trans proline' 0 CA--C 1.497 -1.332 0 O-C-N 123.424 1.223 . . . . 0.0 110.853 -177.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.893 ' HA ' ' HA3' ' A' ' 32' ' ' GLY . 3.1 mptt -80.73 -27.22 36.94 Favored 'General case' 0 C--N 1.283 -2.32 0 C-N-CA 116.622 -2.031 . . . . 0.0 116.201 -173.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.762 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -141.89 42.02 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.923 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.977 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . . . -62.65 -56.93 25.08 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 120.419 -1.425 . . . . 0.0 109.562 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.977 ' HD3' ' HB3' ' A' ' 98' ' ' ALA . 56.9 Cg_endo -78.12 162.78 28.53 Favored 'Trans proline' 0 CA--C 1.463 -3.063 0 O-C-N 123.896 1.472 . . . . 0.0 110.57 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.73 ' HD2' ' C ' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -107.21 112.43 25.3 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-N 112.095 -2.32 . . . . 0.0 110.28 -169.755 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.816 ' HB3' HG22 ' A' ' 127' ' ' ILE . 2.5 p -45.35 97.7 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.612 0 CA-C-O 123.606 1.669 . . . . 0.0 109.342 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.402 40.9 mt-10 -163.54 -52.01 0.04 OUTLIER 'General case' 0 CA--C 1.448 -2.975 0 CA-C-N 112.818 -1.992 . . . . 0.0 111.304 179.442 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.482 37.4 t-20 -160.29 79.73 0.67 Allowed 'General case' 0 C--N 1.285 -2.202 0 CA-C-N 110.949 -2.842 . . . . 0.0 113.932 -162.311 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.924 HG22 ' HA ' ' A' ' 58' ' ' ILE . 22.0 t -145.13 141.24 22.88 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.65 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.743 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 1.074 ' CG1' HD11 ' A' ' 121' ' ' ILE . 3.0 t -153.89 137.63 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.705 ' CG2' HD11 ' A' ' 54' ' ' ILE . 0.3 OUTLIER -105.58 148.3 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 122.653 1.216 . . . . 0.0 112.675 -178.409 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.974 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -132.04 118.98 20.4 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 178.099 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.057 HG13 ' HA ' ' A' ' 54' ' ' ILE . 3.4 t -132.54 138.72 51.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 120.186 -1.571 . . . . 0.0 108.389 -177.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 1.019 ' HB2' ' HB2' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -135.6 148.64 49.11 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 122.414 1.102 . . . . 0.0 111.549 -178.072 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 1.043 ' CG2' HD12 ' A' ' 88' ' ' ILE . 3.5 t -97.76 129.81 47.38 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.553 ' SD ' ' HA2' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -107.7 118.2 36.12 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -78.92 -138.13 1.43 Allowed Glycine 0 N--CA 1.498 2.778 0 C-N-CA 119.177 -1.487 . . . . 0.0 114.917 -174.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.657 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 6.8 p-10 -80.79 -3.66 51.81 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 122.275 1.036 . . . . 0.0 112.323 -176.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.403 ' OD2' ' OD1' ' A' ' 113' ' ' ASP . 1.4 p30 -133.21 -4.65 3.05 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.738 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.605 ' O ' ' CB ' ' A' ' 116' ' ' VAL . . . 92.29 85.9 1.51 Allowed Glycine 0 CA--C 1.471 -2.688 0 CA-C-O 124.797 2.332 . . . . 0.0 110.399 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.605 ' CB ' ' O ' ' A' ' 115' ' ' GLY . 7.2 p 137.9 148.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.25 -3.757 0 CA-C-N 108.27 -3.965 . . . . 0.0 111.837 177.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.807 ' CB ' HG12 ' A' ' 110' ' ' VAL . 0.3 OUTLIER -161.45 -59.8 0.05 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.479 -0.763 . . . . 0.0 110.739 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 1.027 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -169.88 134.29 1.3 Allowed 'General case' 0 N--CA 1.513 2.705 0 O-C-N 121.124 -0.985 . . . . 0.0 109.489 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 1.019 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 0.8 OUTLIER -133.71 139.76 46.6 Favored 'General case' 0 C--N 1.28 -2.418 0 C-N-CA 117.624 -1.63 . . . . 0.0 113.744 -178.02 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.742 ' HB2' HD13 ' A' ' 13' ' ' ILE . . . -142.61 131.58 23.01 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 123.066 1.413 . . . . 0.0 111.489 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 1.074 HD11 ' CG1' ' A' ' 105' ' ' VAL 0.272 0.0 OUTLIER -108.7 131.06 60.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.613 -179.218 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.63 ' N ' HD13 ' A' ' 121' ' ' ILE . . . -131.63 -175.04 3.58 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.827 -1.17 . . . . 0.0 108.895 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.637 ' O ' ' CG ' ' A' ' 124' ' ' HIS . 5.5 p -90.51 -65.84 0.98 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.308 -1.495 . . . . 0.0 110.307 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.637 ' CG ' ' O ' ' A' ' 123' ' ' THR . 21.2 m170 132.82 -84.88 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.253 0 C-N-CA 123.759 0.823 . . . . 0.0 110.043 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.448 ' CB ' ' HB ' ' A' ' 29' ' ' ILE . . . -167.7 171.71 9.89 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.383 0.611 . . . . 0.0 109.429 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -108.63 -177.08 3.22 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.816 HG22 ' HB3' ' A' ' 101' ' ' SER . 0.3 OUTLIER -153.22 130.07 2.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 O-C-N 120.706 -1.246 . . . . 0.0 113.061 -178.13 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.473 ' HD3' ' O ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -169.5 151.7 4.51 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.589 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.459 ' C ' ' O ' ' A' ' 128' ' ' ARG . 2.7 m-20 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.667 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.7 t . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.321 0.581 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.48 ' O ' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -47.43 169.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.321 -0.862 . . . . 0.0 111.003 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.765 HG12 ' HA ' ' A' ' 22' ' ' HIS . 1.3 m -145.8 174.03 3.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 O-C-N 120.884 -1.135 . . . . 0.0 107.967 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.481 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -80.82 140.05 35.66 Favored 'General case' 0 CA--C 1.478 -1.82 0 C-N-CA 117.968 -1.493 . . . . 0.0 108.66 177.31 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.524 HG11 ' CG2' ' A' ' 16' ' ' VAL 0.422 0.4 OUTLIER -166.44 -178.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 C-N-CA 118.021 -1.472 . . . . 0.0 110.933 -170.135 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 5' ' ' VAL . 18.5 mtmt -153.69 141.65 20.24 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 123.812 1.767 . . . . 0.0 112.823 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.271 13.8 t70 -79.09 149.45 32.08 Favored 'General case' 0 C--N 1.266 -3.049 0 CA-C-N 113.032 -1.894 . . . . 0.0 109.442 178.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.642 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 7.3 p -137.27 14.26 3.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.981 -1.074 . . . . 0.0 109.529 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.806 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -126.16 -83.98 0.62 Allowed 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 119.014 -1.074 . . . . 0.0 110.17 -177.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 12' ' ' GLU . 4.2 t-20 -155.97 64.73 0.58 Allowed 'General case' 0 C--N 1.269 -2.898 0 C-N-CA 118.519 -1.272 . . . . 0.0 111.62 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.473 ' C ' ' O ' ' A' ' 10' ' ' ASN . 6.2 m80 32.57 32.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.725 0.774 . . . . 0.0 110.697 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.9 OUTLIER -93.42 22.35 5.37 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.485 -0.886 . . . . 0.0 111.889 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.973 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.272 0.1 OUTLIER -116.76 -168.09 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 CA-C-O 122.027 0.918 . . . . 0.0 110.741 -179.035 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.659 ' N ' HG23 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -162.2 -45.46 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.732 179.831 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.569 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 28.9 tttt -146.59 136.12 22.99 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 116.116 -2.234 . . . . 0.0 113.246 178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.971 HG12 ' HB2' ' A' ' 39' ' ' ALA . 0.9 OUTLIER -132.61 102.9 5.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 CA-C-O 123.041 1.4 . . . . 0.0 110.817 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.514 ' HA ' HD23 ' A' ' 17' ' ' LEU . 1.4 mt -93.62 126.04 38.57 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.933 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.8 HG22 ' HA ' ' A' ' 37' ' ' LEU . 75.3 t -142.52 145.08 33.07 Favored Pre-proline 0 N--CA 1.502 2.137 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.756 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.656 ' HD2' HG13 ' A' ' 18' ' ' VAL . 47.4 Cg_endo -72.0 137.08 28.56 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 O-C-N 123.691 1.364 . . . . 0.0 110.893 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.437 ' C ' ' HB3' ' A' ' 27' ' ' CYS . . . 112.99 -80.1 0.27 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.564 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 2.4 m -87.81 131.31 34.57 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.553 -0.969 . . . . 0.0 109.557 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.765 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -137.4 14.83 2.99 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 119.905 -1.747 . . . . 0.0 110.865 179.489 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.88 -154.58 15.4 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 118.287 -1.911 . . . . 0.0 110.815 177.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.18 -10.84 34.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.819 -1.401 . . . . 0.0 109.457 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.789 ' CB ' ' HD3' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -64.11 177.01 0.58 Allowed Pre-proline 0 C--N 1.299 -1.61 0 CA-C-O 124.946 2.308 . . . . 0.0 114.431 179.546 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.789 ' HD3' ' CB ' ' A' ' 25' ' ' GLU . 24.7 Cg_endo -105.73 115.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.263 -3.969 1 C-N-CA 127.459 5.44 . . . . 0.0 110.333 -176.336 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.564 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 1.9 p -94.94 103.37 15.23 Favored 'General case' 0 N--CA 1.505 2.319 0 CA-C-O 123.171 1.462 . . . . 0.0 110.821 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.589 ' O ' HG22 ' A' ' 28' ' ' ILE 0.304 28.9 mm -82.17 68.25 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 113.706 -1.588 . . . . 0.0 110.369 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.608 ' O ' HG23 ' A' ' 29' ' ' ILE . 9.4 tt -43.49 115.48 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-O 122.632 1.206 . . . . 0.0 109.481 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -66.69 -89.97 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 114.704 -1.134 . . . . 0.0 111.283 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.7 mtt-85 -149.9 165.65 31.94 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.374 -0.829 . . . . 0.0 110.292 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.839 ' HA2' ' HA ' ' A' ' 96' ' ' LYS . . . 85.42 121.61 1.12 Allowed Glycine 0 C--N 1.303 -1.291 0 N-CA-C 106.112 -2.795 . . . . 0.0 106.112 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.81 ' HB2' HG12 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -116.76 96.59 48.9 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 120.666 2.233 . . . . 0.0 116.354 -175.103 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.607 ' HD3' ' O ' ' A' ' 32' ' ' GLY . 61.6 Cg_endo -107.6 144.97 0.08 OUTLIER 'Trans proline' 0 C--N 1.289 -2.588 0 C-N-CA 124.081 3.187 . . . . 0.0 109.021 177.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' A' ' 91' ' ' THR . 2.8 m-85 -117.69 98.35 6.33 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.022 -1.071 . . . . 0.0 108.538 178.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.636 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 25.6 mp0 -117.39 91.25 3.52 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.53 -0.731 . . . . 0.0 109.687 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.971 HD22 ' NE2' ' A' ' 124' ' ' HIS . 0.1 OUTLIER -108.31 135.72 49.15 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.489 -1.382 . . . . 0.0 108.341 179.496 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' A' ' 17' ' ' LEU . 0.1 OUTLIER -139.31 128.11 23.41 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.971 ' HB2' HG12 ' A' ' 16' ' ' VAL . . . -142.48 152.05 42.32 Favored 'General case' 0 C--N 1.276 -2.602 0 CA-C-O 123.067 1.413 . . . . 0.0 113.405 -175.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.569 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.74 140.77 28.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 113.763 -1.562 . . . . 0.0 108.612 178.286 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.582 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 3.5 p90 -157.21 121.47 4.32 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -178.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 12.3 tt0 -68.72 155.12 40.7 Favored 'General case' 0 C--N 1.288 -2.089 0 O-C-N 120.416 -1.428 . . . . 0.0 108.918 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.951 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -88.14 136.84 32.79 Favored 'General case' 0 C--N 1.267 -3.01 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.402 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.623 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 17.7 p-10 -117.81 49.96 1.18 Allowed 'General case' 0 CA--C 1.486 -1.506 0 CA-C-O 125.454 2.55 . . . . 0.0 114.033 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.586 ' N ' ' CG ' ' A' ' 82' ' ' LYS . 7.1 pt20 167.12 -160.52 0.01 OUTLIER 'General case' 0 C--N 1.258 -3.37 0 CA-C-N 108.914 -3.767 . . . . 0.0 112.92 175.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.457 ' OD1' ' N ' ' A' ' 47' ' ' THR 0.265 41.2 t-20 -109.2 153.69 23.43 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-O 122.588 1.185 . . . . 0.0 108.754 -178.901 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.64 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -173.14 156.21 3.16 Favored 'General case' 0 C--N 1.255 -3.541 0 C-N-CA 118.473 -1.291 . . . . 0.0 112.5 -178.28 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.958 ' O ' HG23 ' A' ' 49' ' ' THR . 9.5 mtpt -112.41 5.8 18.32 Favored 'General case' 0 N--CA 1.509 2.501 0 O-C-N 120.747 -1.221 . . . . 0.0 111.184 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.958 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.41 149.13 4.79 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.369 -1.457 . . . . 0.0 111.611 179.653 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.542 ' O ' ' O ' ' A' ' 70' ' ' PRO . . . -142.82 99.76 3.53 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 122.574 1.178 . . . . 0.0 110.871 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 9.9 mttt -69.31 -178.01 1.25 Allowed 'General case' 0 N--CA 1.506 2.338 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.913 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.983 ' CG2' HD11 ' A' ' 88' ' ' ILE . 35.8 mt -140.99 137.8 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.665 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.665 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.583 ' HB3' ' CE ' ' A' ' 109' ' ' LYS . 4.0 tt0 -141.51 112.19 7.13 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 123.261 1.505 . . . . 0.0 111.239 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 1.027 HD12 HG21 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -91.88 127.54 44.1 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 CA-C-N 112.79 -2.005 . . . . 0.0 110.296 179.476 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.435 ' HD2' ' HG2' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -122.9 101.7 7.59 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 176.594 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.911 ' HB3' HG22 ' A' ' 63' ' ' VAL . . . -112.81 133.31 54.87 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.843 -1.16 . . . . 0.0 113.178 -175.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.722 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 0.3 OUTLIER -109.49 102.35 11.23 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 177.811 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.966 ' HA ' HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -112.55 97.81 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.863 0 CA-C-O 123.423 1.582 . . . . 0.0 110.746 -177.258 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.727 ' OD1' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER 39.14 65.37 0.68 Allowed 'General case' 0 N--CA 1.52 3.061 0 CA-C-N 114.641 -1.163 . . . . 0.0 113.112 179.236 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.16 -18.34 10.22 Favored Glycine 0 N--CA 1.487 2.093 0 O-C-N 121.378 -0.826 . . . . 0.0 111.481 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.53 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.267 0.3 OUTLIER -107.7 58.67 0.62 Allowed 'General case' 0 C--N 1.293 -1.873 0 O-C-N 121.092 -1.24 . . . . 0.0 111.513 -178.453 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.365 0.0 OUTLIER -63.42 113.19 3.11 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.045 0.926 . . . . 0.0 110.912 -179.78 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.911 HG22 ' HB3' ' A' ' 56' ' ' ALA . 15.3 m -72.73 142.56 14.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-O 122.504 1.145 . . . . 0.0 110.731 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.434 7.9 t70 -138.3 64.88 1.48 Allowed 'General case' 0 C--N 1.277 -2.552 0 CA-C-O 122.619 1.199 . . . . 0.0 110.73 -176.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.583 HG22 ' HD2' ' A' ' 66' ' ' PRO . 8.2 p -164.47 151.64 10.04 Favored Pre-proline 0 C--N 1.269 -2.918 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.005 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.583 ' HD2' HG22 ' A' ' 65' ' ' VAL . 45.5 Cg_endo -82.39 139.64 10.43 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 CA-C-O 123.886 1.536 . . . . 0.0 112.221 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.615 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -133.36 60.11 0.67 Allowed Glycine 0 N--CA 1.501 2.991 0 CA-C-N 112.291 -2.231 . . . . 0.0 109.0 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.641 ' HB ' ' CD2' ' A' ' 90' ' ' TYR 0.272 0.2 OUTLIER 163.93 -177.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.326 -1.103 . . . . 0.0 108.179 -178.074 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.575 ' N ' ' CG2' ' A' ' 68' ' ' ILE . 0.4 OUTLIER -107.53 140.43 21.52 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 105.728 -1.952 . . . . 0.0 105.728 175.084 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.76 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 23.2 Cg_endo -105.39 -3.02 0.17 Allowed 'Trans proline' 0 C--N 1.273 -3.427 0 C-N-CA 122.945 2.43 . . . . 0.0 114.155 -173.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.572 ' HB2' ' NE2' ' A' ' 74' ' ' HIS . 0.2 OUTLIER -107.91 96.6 6.49 Favored 'General case' 0 C--N 1.285 -2.234 0 O-C-N 120.765 -1.209 . . . . 0.0 108.532 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.761 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . . . -77.4 10.7 2.36 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.195 -0.94 . . . . 0.0 108.897 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.7 t -77.34 -24.96 50.66 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 120.984 -1.072 . . . . 0.0 108.209 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.572 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 0.5 OUTLIER -83.25 11.62 6.37 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.444 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.761 ' CD2' ' HA ' ' A' ' 72' ' ' ALA . 1.3 m-85 -132.03 -6.18 3.5 Favored 'General case' 0 C--O 1.215 -0.731 0 O-C-N 121.744 -0.598 . . . . 0.0 110.151 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.452 ' O ' ' C ' ' A' ' 77' ' ' LYS . 2.8 ptt? -161.1 131.26 5.03 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 123.915 1.817 . . . . 0.0 113.973 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.55 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 9.3 pttt -16.76 99.36 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 111.801 -2.454 . . . . 0.0 113.462 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 48' ' ' LYS 0.325 0.5 OUTLIER -99.12 140.22 21.55 Favored Pre-proline 0 C--N 1.264 -3.124 0 CA-C-N 111.548 -2.569 . . . . 0.0 108.613 178.272 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.64 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 36.0 Cg_endo -82.68 170.01 58.21 Favored 'Cis proline' 0 C--N 1.312 -1.384 0 C-N-CA 123.457 -1.476 . . . . 0.0 112.277 0.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.69 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -95.28 129.67 42.33 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.771 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.54 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 2.4 p -108.3 138.21 36.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 124.299 2.0 . . . . 0.0 112.05 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.623 ' HG2' ' HA ' ' A' ' 44' ' ' ASN . 1.7 tmmt? -42.09 117.42 0.97 Allowed 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 111.606 -2.543 . . . . 0.0 116.614 -175.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.25 -17.6 14.44 Favored Glycine 0 C--N 1.293 -1.83 0 CA-C-N 111.714 -2.494 . . . . 0.0 107.945 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 27.0 mt-30 -72.52 126.36 29.66 Favored 'General case' 0 C--N 1.278 -2.525 0 CA-C-O 123.199 1.476 . . . . 0.0 111.633 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.607 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 14.5 mt-30 -64.57 143.31 58.01 Favored 'General case' 0 C--N 1.27 -2.872 0 CA-C-N 113.385 -1.734 . . . . 0.0 107.927 178.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.951 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 19.9 m-85 -142.3 125.25 16.16 Favored 'General case' 0 C--N 1.279 -2.472 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.545 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 1.1 p30 -117.4 132.46 56.57 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-O 122.776 1.274 . . . . 0.0 110.088 -177.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 1.053 HD12 ' CG2' ' A' ' 110' ' ' VAL . 0.3 OUTLIER -101.29 157.84 4.25 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.196 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.422 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -147.24 141.37 26.09 Favored 'General case' 0 C--N 1.286 -2.189 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.133 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.645 ' CE1' ' HB2' ' A' ' 92' ' ' TRP . 3.0 t80 -144.04 112.52 6.5 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.276 -0.89 . . . . 0.0 108.894 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.596 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 0.6 OUTLIER -131.41 115.68 16.53 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 179.09 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.645 ' HB2' ' CE1' ' A' ' 90' ' ' TYR 0.266 0.5 OUTLIER -141.89 111.81 6.78 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.513 -176.666 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 2.5 p-10 -74.67 159.49 32.02 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 119.378 -2.077 . . . . 0.0 109.361 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.84 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.8 OUTLIER -153.0 172.16 5.94 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.083 -1.011 . . . . 0.0 108.835 -178.296 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.84 ' HD2' HG22 ' A' ' 94' ' ' VAL . 17.0 Cg_endo -37.53 152.32 0.04 OUTLIER 'Trans proline' 0 CA--C 1.498 -1.286 0 O-C-N 123.785 1.413 . . . . 0.0 110.045 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.839 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -79.04 -23.22 44.44 Favored 'General case' 0 C--N 1.282 -2.362 0 C-N-CA 116.622 -2.031 . . . . 0.0 115.068 -172.721 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.763 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -138.75 43.07 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-O 121.398 0.618 . . . . 0.0 112.618 -178.977 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.943 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . . . -70.04 -67.62 0.65 Allowed Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 120.686 -1.259 . . . . 0.0 110.654 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.943 ' HD3' ' HB3' ' A' ' 98' ' ' ALA . 47.7 Cg_endo -66.51 160.4 46.01 Favored 'Trans proline' 0 CA--C 1.461 -3.133 0 O-C-N 123.676 1.356 . . . . 0.0 110.228 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.707 ' HD2' ' C ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -109.16 106.49 16.39 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-N 112.497 -2.138 . . . . 0.0 110.301 -169.453 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.664 ' O ' HG21 ' A' ' 127' ' ' ILE . 5.3 p -46.25 97.16 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 CA-C-O 123.612 1.673 . . . . 0.0 109.031 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.392 84.8 mt-10 -164.95 -52.4 0.03 OUTLIER 'General case' 0 CA--C 1.45 -2.893 0 CA-C-N 112.975 -1.921 . . . . 0.0 111.461 179.659 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.569 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.489 36.8 t-20 -160.73 83.5 0.67 Allowed 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 110.681 -2.963 . . . . 0.0 113.608 -162.045 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.966 HG22 ' HA ' ' A' ' 58' ' ' ILE . 32.4 t -143.21 134.23 23.0 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 C-N-CA 119.103 -1.039 . . . . 0.0 112.308 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 1.073 HG13 HD11 ' A' ' 121' ' ' ILE . 0.6 OUTLIER -140.54 130.61 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.555 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.801 HG23 ' HB2' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -105.46 141.9 19.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-O 122.344 1.069 . . . . 0.0 111.393 -179.271 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . 1.068 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -132.6 109.14 9.53 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 179.509 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.027 HG21 HD12 ' A' ' 54' ' ' ILE . 3.4 t -127.61 141.91 45.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 117.802 -1.559 . . . . 0.0 109.16 -177.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.851 ' HB2' ' CB ' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -131.03 152.84 49.9 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 122.904 1.335 . . . . 0.0 112.938 -178.774 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 1.053 ' CG2' HD12 ' A' ' 88' ' ' ILE . 3.8 t -102.61 124.55 56.67 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 176.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.544 ' HG2' ' O ' ' A' ' 111' ' ' MET . 2.1 ptm -104.86 121.76 44.35 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.598 ' HA3' HD23 ' A' ' 117' ' ' LEU . . . -79.83 -137.35 1.62 Allowed Glycine 0 N--CA 1.496 2.662 0 C-N-CA 118.931 -1.604 . . . . 0.0 114.01 -175.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.64 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 13.4 p-10 -79.8 -4.93 54.23 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 122.393 1.092 . . . . 0.0 111.986 -177.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 10.8 p30 -128.9 -4.61 5.12 Favored 'General case' 0 C--N 1.268 -2.96 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.933 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.58 ' O ' ' HB ' ' A' ' 116' ' ' VAL . . . 86.81 84.0 1.13 Allowed Glycine 0 CA--C 1.471 -2.718 0 CA-C-O 124.875 2.375 . . . . 0.0 109.669 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.58 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 6.9 p 145.97 145.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.246 -3.913 0 CA-C-N 108.281 -3.96 . . . . 0.0 111.204 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.742 ' CB ' HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -162.21 -59.51 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.378 -0.826 . . . . 0.0 110.651 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.973 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -168.25 129.17 1.33 Allowed 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.851 ' CB ' ' HB2' ' A' ' 109' ' ' LYS . 0.8 OUTLIER -134.29 141.32 46.91 Favored 'General case' 0 C--N 1.284 -2.274 0 C-N-CA 118.004 -1.478 . . . . 0.0 113.097 -177.703 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.69 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -146.53 137.28 24.07 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 123.159 1.456 . . . . 0.0 112.468 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 1.073 HD11 HG13 ' A' ' 105' ' ' VAL 0.265 0.1 OUTLIER -112.23 133.24 58.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 113.908 -1.497 . . . . 0.0 110.912 -179.78 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.766 ' N ' HD13 ' A' ' 121' ' ' ILE . . . -130.56 177.87 7.05 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.743 -1.223 . . . . 0.0 108.858 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.547 ' O ' ' HB2' ' A' ' 124' ' ' HIS . 16.0 p -95.78 -33.14 12.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.409 -1.432 . . . . 0.0 110.565 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.971 ' NE2' HD22 ' A' ' 37' ' ' LEU . 24.5 m80 63.09 -56.17 0.17 Allowed 'General case' 0 N--CA 1.511 2.602 0 O-C-N 121.795 -0.566 . . . . 0.0 111.687 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' A' ' 123' ' ' THR . . . -128.88 106.22 8.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.023 -1.048 . . . . 0.0 110.695 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.443 ' CG ' ' HB ' ' A' ' 123' ' ' THR . 1.8 mtpm? -114.9 79.45 1.27 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.924 -1.11 . . . . 0.0 109.296 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.664 HG21 ' O ' ' A' ' 101' ' ' SER . 0.8 OUTLIER -85.0 123.79 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 120.51 -1.368 . . . . 0.0 111.279 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.488 ' HD3' ' O ' ' A' ' 127' ' ' ILE . 4.2 tpp180 -169.08 151.01 4.59 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.162 179.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 1.3 m-20 . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.151 -0.968 . . . . 0.0 110.93 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 121.218 0.532 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.492 ' O ' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -73.98 168.18 20.01 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.209 -0.932 . . . . 0.0 110.851 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.667 HG12 ' HA ' ' A' ' 22' ' ' HIS . 1.4 m -148.72 174.7 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.496 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -80.12 139.86 36.66 Favored 'General case' 0 CA--C 1.482 -1.647 0 C-N-CA 118.097 -1.441 . . . . 0.0 108.396 177.042 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.503 ' C ' ' CG ' ' A' ' 6' ' ' LYS 0.434 0.4 OUTLIER -166.33 -175.31 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.406 -169.992 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.556 ' HB2' ' CG2' ' A' ' 121' ' ' ILE . 1.6 mttt -153.91 138.86 17.22 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 123.565 1.65 . . . . 0.0 112.577 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.285 3.5 t70 -84.67 148.83 26.2 Favored 'General case' 0 C--N 1.27 -2.881 0 CA-C-N 113.381 -1.736 . . . . 0.0 109.732 178.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.621 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 5.3 p -137.43 13.14 3.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.007 -1.058 . . . . 0.0 109.469 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.837 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -126.33 -85.58 0.61 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 118.586 -1.246 . . . . 0.0 110.026 -177.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 12' ' ' GLU . 4.1 t-20 -160.29 67.1 0.35 Allowed 'General case' 0 C--N 1.265 -3.083 0 C-N-CA 118.578 -1.249 . . . . 0.0 111.935 177.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.467 ' C ' ' O ' ' A' ' 10' ' ' ASN . 7.7 m80 34.36 32.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.765 0.793 . . . . 0.0 110.42 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.1 OUTLIER -86.92 20.4 2.64 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.475 0.655 . . . . 0.0 110.739 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.896 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.289 0.0 OUTLIER -121.79 -166.89 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-O 121.989 0.9 . . . . 0.0 110.834 -178.215 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.649 ' H ' HG23 ' A' ' 13' ' ' ILE . 1.7 pttt -161.88 -44.08 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.996 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.57 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 11.3 tttm -149.85 140.31 22.42 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 116.375 -2.13 . . . . 0.0 113.371 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 1.031 HG13 ' HB2' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -132.92 108.85 13.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 CA-C-O 122.873 1.321 . . . . 0.0 110.936 179.705 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.532 ' HA ' HD23 ' A' ' 17' ' ' LEU . 2.8 mt -102.0 122.57 44.32 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 114.164 -1.38 . . . . 0.0 110.949 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.638 HG22 ' HB2' ' A' ' 37' ' ' LEU . 58.3 t -142.11 142.51 24.73 Favored Pre-proline 0 C--N 1.292 -1.906 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.549 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.491 ' HD2' HG13 ' A' ' 18' ' ' VAL . 40.7 Cg_endo -66.19 126.65 16.08 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.752 1.396 . . . . 0.0 110.69 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 124' ' ' HIS . . . 123.19 -78.69 0.35 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.463 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 3.6 m -90.37 133.86 34.71 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.476 -1.014 . . . . 0.0 109.965 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.667 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -140.79 10.52 2.22 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.019 -1.675 . . . . 0.0 110.847 178.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.489 ' O ' ' HB3' ' A' ' 4' ' ' ASP . . . -178.47 -155.81 15.38 Favored Glycine 0 C--N 1.285 -2.258 0 C-N-CA 118.592 -1.766 . . . . 0.0 110.62 176.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.51 -8.27 18.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.877 -1.366 . . . . 0.0 109.82 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.822 ' CB ' ' HD3' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -63.3 177.07 0.49 Allowed Pre-proline 0 C--N 1.296 -1.746 0 CA-C-O 125.018 2.342 . . . . 0.0 114.341 179.599 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.822 ' HD3' ' CB ' ' A' ' 25' ' ' GLU . 21.5 Cg_endo -104.49 115.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.263 -3.943 1 C-N-CA 127.344 5.363 . . . . 0.0 110.765 -176.029 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.463 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 5.2 p -109.79 110.4 21.38 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-N 114.093 -1.412 . . . . 0.0 110.645 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.771 HG22 ' H ' ' A' ' 29' ' ' ILE 0.332 44.5 mm -83.0 -163.16 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.283 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.771 ' H ' HG22 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -126.56 114.89 39.98 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 CA-C-O 122.273 1.035 . . . . 0.0 110.216 179.168 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.603 ' CG ' ' N ' ' A' ' 31' ' ' ARG . 5.9 t-160 -67.3 -96.5 0.0 OUTLIER 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.007 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.603 ' N ' ' CG ' ' A' ' 30' ' ' HIS . 62.5 mtt-85 -161.74 165.58 27.83 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.512 -0.742 . . . . 0.0 109.788 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.864 ' HA2' ' HA ' ' A' ' 96' ' ' LYS . . . 68.43 124.74 0.03 OUTLIER Glycine 0 C--N 1.303 -1.268 0 N-CA-C 105.413 -3.075 . . . . 0.0 105.413 -178.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.731 ' HB2' HG12 ' A' ' 94' ' ' VAL . 4.5 mmmm -116.3 94.82 43.6 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 120.593 2.196 . . . . 0.0 116.57 -174.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.645 ' HD3' ' O ' ' A' ' 32' ' ' GLY . 61.3 Cg_endo -106.91 144.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.288 -2.621 0 C-N-CA 124.086 3.191 . . . . 0.0 108.136 176.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.653 ' HZ ' HG11 ' A' ' 94' ' ' VAL . 2.2 m-85 -120.8 94.59 4.4 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.002 -1.079 . . . . 0.0 109.429 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.61 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 28.1 mp0 -113.3 84.41 2.0 Allowed 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.678 HD12 ' C ' ' A' ' 37' ' ' LEU . 3.6 pp -110.24 140.97 43.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.652 -1.28 . . . . 0.0 109.718 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -140.76 139.27 34.6 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 122.73 1.252 . . . . 0.0 109.151 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 1.031 ' HB2' HG13 ' A' ' 16' ' ' VAL . . . -142.68 151.64 41.58 Favored 'General case' 0 C--N 1.277 -2.576 0 CA-C-O 123.007 1.384 . . . . 0.0 112.546 -177.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.57 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.15 141.57 25.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 113.996 -1.457 . . . . 0.0 108.908 178.89 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.593 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 3.1 p90 -155.94 121.21 4.82 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 17.0 tt0 -68.82 152.82 44.81 Favored 'General case' 0 C--N 1.286 -2.159 0 O-C-N 120.392 -1.443 . . . . 0.0 108.267 178.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.995 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -85.64 131.52 34.33 Favored 'General case' 0 C--N 1.264 -3.109 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.445 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.63 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -113.36 50.8 0.88 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 125.638 2.637 . . . . 0.0 114.074 179.454 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.605 ' C ' ' HB2' ' A' ' 82' ' ' LYS . 4.4 pt20 167.33 -162.39 0.01 OUTLIER 'General case' 0 C--N 1.266 -3.023 0 CA-C-N 108.641 -3.89 . . . . 0.0 113.462 175.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . 0.279 36.6 t30 -110.37 152.44 26.24 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 122.466 1.127 . . . . 0.0 108.712 -178.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.673 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -173.25 155.52 2.94 Favored 'General case' 0 C--N 1.255 -3.534 0 C-N-CA 118.01 -1.476 . . . . 0.0 113.257 -178.527 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.968 ' O ' HG23 ' A' ' 49' ' ' THR . 9.9 mttt -110.63 7.21 22.26 Favored 'General case' 0 N--CA 1.509 2.495 0 O-C-N 120.734 -1.229 . . . . 0.0 110.646 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.968 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.8 OUTLIER -168.01 146.1 4.43 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 120.557 -1.339 . . . . 0.0 111.262 179.255 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.529 ' O ' ' O ' ' A' ' 70' ' ' PRO . . . -143.21 97.93 3.17 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-O 122.619 1.199 . . . . 0.0 109.641 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 12.3 mtmt -68.71 -179.09 1.31 Allowed 'General case' 0 N--CA 1.504 2.237 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.719 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.989 ' CG2' HD11 ' A' ' 88' ' ' ILE . 35.6 mt -140.19 140.4 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.425 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.368 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.501 ' HB3' ' HE1' ' A' ' 111' ' ' MET . 16.3 tp10 -140.47 107.88 5.55 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 123.374 1.559 . . . . 0.0 110.313 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 1.067 HD12 HG21 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -91.16 125.6 43.89 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 CA-C-N 112.572 -2.103 . . . . 0.0 109.271 179.327 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -121.36 103.4 8.93 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 177.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.937 ' HB3' HG22 ' A' ' 63' ' ' VAL . . . -110.31 128.77 55.71 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 118.814 -1.155 . . . . 0.0 112.005 -176.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.71 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 0.4 OUTLIER -107.09 102.93 12.23 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.943 ' HA ' HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -114.51 101.91 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.868 0 CA-C-O 123.197 1.475 . . . . 0.0 110.811 -177.454 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.666 ' N ' HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER 37.46 65.16 0.56 Allowed 'General case' 0 N--CA 1.522 3.132 0 CA-C-N 114.932 -1.031 . . . . 0.0 113.074 179.304 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.87 -15.49 8.1 Favored Glycine 0 N--CA 1.488 2.133 0 O-C-N 121.278 -0.889 . . . . 0.0 111.363 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.522 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.274 0.3 OUTLIER -108.02 56.73 0.63 Allowed 'General case' 0 C--N 1.293 -1.85 0 O-C-N 121.108 -1.23 . . . . 0.0 111.417 -178.384 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.376 0.0 OUTLIER -60.38 117.48 5.29 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.918 0.866 . . . . 0.0 110.661 179.928 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.937 HG22 ' HB3' ' A' ' 56' ' ' ALA . 17.1 m -80.62 135.46 25.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-O 122.816 1.293 . . . . 0.0 111.736 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.447 26.0 t0 -140.08 67.65 1.37 Allowed 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.833 -177.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.576 HG12 ' HD2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -150.52 175.85 2.61 Favored Pre-proline 0 C--N 1.268 -2.952 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.001 -178.152 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.576 ' HD2' HG12 ' A' ' 65' ' ' VAL . 38.3 Cg_endo -65.98 139.91 58.29 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.395 1.734 . . . . 0.0 111.382 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.603 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -134.57 -73.01 0.08 OUTLIER Glycine 0 N--CA 1.503 3.11 0 CA-C-N 112.459 -2.155 . . . . 0.0 111.121 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.757 HD13 ' H ' ' A' ' 91' ' ' THR . 2.0 tp -117.42 -157.83 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.225 -1.75 . . . . 0.0 108.789 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.716 ' N ' HG23 ' A' ' 68' ' ' ILE . 0.6 OUTLIER -106.69 141.85 23.71 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 177.136 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.777 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 24.5 Cg_endo -105.76 -3.76 0.15 Allowed 'Trans proline' 0 C--N 1.276 -3.289 0 C-N-CA 123.196 2.597 . . . . 0.0 114.309 -173.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.576 ' O ' ' CE1' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -110.37 87.58 2.56 Favored 'General case' 0 C--N 1.287 -2.132 0 O-C-N 120.717 -1.24 . . . . 0.0 108.121 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.626 ' HA ' ' CD1' ' A' ' 75' ' ' TYR . . . -74.47 8.45 2.27 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.734 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.4 ' C ' ' H ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -78.11 -19.87 53.27 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 120.536 -1.352 . . . . 0.0 108.243 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.574 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -88.76 19.75 3.86 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 173.717 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.626 ' CD1' ' HA ' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -132.57 -9.07 3.22 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.798 179.703 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.468 ' O ' ' C ' ' A' ' 77' ' ' LYS . 2.1 ptt? -167.93 129.59 1.46 Allowed 'General case' 0 C--O 1.215 -0.757 0 CA-C-O 123.621 1.677 . . . . 0.0 112.489 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.526 ' O ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -9.16 94.92 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 111.99 -2.368 . . . . 0.0 113.833 -178.935 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 48' ' ' LYS 0.312 7.9 t -98.87 140.3 21.66 Favored Pre-proline 0 C--N 1.271 -2.813 0 CA-C-N 111.278 -2.692 . . . . 0.0 108.093 177.939 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.728 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 36.2 Cg_endo -78.74 171.21 66.85 Favored 'Cis proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.987 -1.672 . . . . 0.0 113.177 1.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.687 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.3 OUTLIER -99.33 129.3 45.53 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.066 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.509 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.4 t -105.12 138.68 28.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 124.202 1.953 . . . . 0.0 112.287 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.63 ' HG2' ' HA ' ' A' ' 44' ' ' ASN . 1.4 tmmt? -43.96 118.08 1.36 Allowed 'General case' 0 C--N 1.273 -2.748 0 CA-C-N 111.762 -2.472 . . . . 0.0 116.517 -175.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.26 -18.26 12.23 Favored Glycine 0 C--N 1.29 -1.988 0 CA-C-N 111.746 -2.479 . . . . 0.0 107.931 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 11.0 mt-30 -71.84 125.39 27.05 Favored 'General case' 0 C--N 1.278 -2.5 0 CA-C-O 123.13 1.443 . . . . 0.0 111.543 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.593 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 3.4 pt20 -63.67 142.89 58.23 Favored 'General case' 0 C--N 1.268 -2.938 0 CA-C-N 113.424 -1.716 . . . . 0.0 107.355 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.995 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 17.7 m-85 -142.21 126.1 17.16 Favored 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.545 ' HB3' HG12 ' A' ' 40' ' ' VAL . 19.9 p30 -117.35 132.6 56.56 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-O 122.856 1.312 . . . . 0.0 110.107 -177.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 1.058 HD12 ' CG2' ' A' ' 110' ' ' VAL . 0.4 OUTLIER -101.99 159.16 4.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 CA-C-N 114.324 -1.307 . . . . 0.0 108.13 179.513 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.456 ' HG2' ' N ' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -148.95 151.2 34.19 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.909 -178.031 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.523 ' O ' ' HA ' ' A' ' 36' ' ' GLN . 49.3 t80 -147.92 104.1 3.55 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.335 178.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.757 ' H ' HD13 ' A' ' 68' ' ' ILE . 1.1 t -121.2 113.93 20.68 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.603 ' CD1' ' O ' ' A' ' 67' ' ' GLY 0.272 0.4 OUTLIER -142.17 113.86 7.92 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.611 -177.107 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 18.7 p-10 -75.07 159.1 32.11 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 119.423 -2.048 . . . . 0.0 109.696 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.875 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.5 OUTLIER -155.59 169.19 10.77 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.05 -1.031 . . . . 0.0 108.484 -178.961 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.875 ' HD2' HG22 ' A' ' 94' ' ' VAL . 17.2 Cg_endo -36.65 154.74 0.02 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.16 0 O-C-N 123.488 1.257 . . . . 0.0 110.887 -177.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.864 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -78.71 -25.41 44.7 Favored 'General case' 0 C--N 1.285 -2.219 0 C-N-CA 116.903 -1.919 . . . . 0.0 114.889 -172.926 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.763 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -145.85 47.24 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 CA-C-O 121.802 0.81 . . . . 0.0 111.941 -178.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.833 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . . . -76.06 -60.1 1.03 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.731 -1.23 . . . . 0.0 111.31 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.833 ' HD3' ' HB3' ' A' ' 98' ' ' ALA . 45.0 Cg_endo -64.36 159.05 45.74 Favored 'Trans proline' 0 CA--C 1.466 -2.897 0 O-C-N 123.912 1.48 . . . . 0.0 111.161 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.715 ' HD2' ' C ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -109.88 105.28 14.41 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 112.404 -2.18 . . . . 0.0 110.564 -169.146 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.57 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . 4.2 p -46.49 95.24 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.5 0 CA-C-O 123.509 1.623 . . . . 0.0 109.363 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.622 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.399 92.3 mt-10 -164.26 -51.83 0.03 OUTLIER 'General case' 0 CA--C 1.453 -2.787 0 CA-C-N 112.981 -1.918 . . . . 0.0 112.029 179.8 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.552 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.49 28.0 t30 -160.49 79.45 0.65 Allowed 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 115.016 -2.674 . . . . 0.0 114.221 -161.939 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.943 HG22 ' HA ' ' A' ' 58' ' ' ILE . 36.1 t -142.44 153.53 17.99 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.577 0 C-N-CA 119.703 -0.799 . . . . 0.0 111.203 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.856 HG23 HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -167.44 134.6 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -179.651 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.706 HG23 ' HB2' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -105.02 142.84 17.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.717 0 CA-C-O 122.391 1.091 . . . . 0.0 111.772 -179.044 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . 1.09 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -132.32 107.92 8.86 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.067 HG21 HD12 ' A' ' 54' ' ' ILE . 3.2 t -125.13 142.74 41.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 117.628 -1.629 . . . . 0.0 109.136 -177.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 1.039 ' HB2' ' HB2' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -135.36 146.03 47.96 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.229 1.014 . . . . 0.0 111.169 -178.104 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 1.058 ' CG2' HD12 ' A' ' 88' ' ' ILE . 14.9 t -101.07 132.35 47.0 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.524 ' N ' ' HE2' ' A' ' 111' ' ' MET . 2.6 mtm -109.69 121.6 45.58 Favored 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.727 ' CA ' HD23 ' A' ' 117' ' ' LEU . . . -80.1 -141.66 2.65 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 119.109 -1.519 . . . . 0.0 113.846 -176.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.673 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 11.0 p-10 -77.28 -6.49 53.35 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 122.414 1.102 . . . . 0.0 111.951 -177.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -125.89 -4.98 6.91 Favored 'General case' 0 C--N 1.268 -2.961 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.703 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.939 ' O ' HG13 ' A' ' 116' ' ' VAL . . . 85.02 82.16 1.06 Allowed Glycine 0 CA--C 1.47 -2.722 0 CA-C-O 124.814 2.341 . . . . 0.0 109.834 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.939 HG13 ' O ' ' A' ' 115' ' ' GLY . 0.5 OUTLIER 152.59 143.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.247 -3.884 0 CA-C-N 108.204 -3.998 . . . . 0.0 111.622 177.871 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.759 ' CB ' HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -160.44 -57.45 0.06 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.331 -0.856 . . . . 0.0 111.319 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.896 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -174.87 131.87 0.33 Allowed 'General case' 0 N--CA 1.511 2.58 0 O-C-N 121.125 -0.984 . . . . 0.0 109.467 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 1.039 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 0.8 OUTLIER -133.97 137.94 45.14 Favored 'General case' 0 C--N 1.283 -2.283 0 C-N-CA 118.184 -1.406 . . . . 0.0 113.07 -177.863 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.673 ' HB2' HD12 ' A' ' 13' ' ' ILE . . . -148.52 136.93 21.28 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 123.077 1.418 . . . . 0.0 111.908 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 1.09 ' HB ' HG23 ' A' ' 107' ' ' THR 0.262 0.0 OUTLIER -110.54 130.29 64.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.97 -179.593 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.649 ' N ' HD13 ' A' ' 121' ' ' ILE . . . -131.42 -174.19 3.33 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.931 -1.105 . . . . 0.0 109.19 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.856 HG22 HG23 ' A' ' 105' ' ' VAL . 14.3 p -113.35 -13.03 12.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.62 -1.3 . . . . 0.0 110.471 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.592 ' CE1' ' HB3' ' A' ' 37' ' ' LEU . 10.2 m-70 59.09 -79.01 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.561 0 O-C-N 121.416 -0.802 . . . . 0.0 110.715 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.573 ' CB ' HG12 ' A' ' 29' ' ' ILE . . . -159.26 108.85 1.9 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.654 ' CD ' ' HB ' ' A' ' 104' ' ' VAL . 0.6 OUTLIER -128.4 -143.7 0.28 Allowed 'General case' 0 N--CA 1.485 1.324 0 O-C-N 120.714 -1.241 . . . . 0.0 110.924 -178.377 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.57 ' CG1' ' HB2' ' A' ' 101' ' ' SER . 0.5 OUTLIER -133.9 124.27 46.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-O 121.873 0.844 . . . . 0.0 112.044 -179.287 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.464 ' O ' ' C ' ' A' ' 129' ' ' ASP . 0.1 OUTLIER -169.17 152.25 4.97 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.042 179.325 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.464 ' C ' ' O ' ' A' ' 128' ' ' ARG . 2.9 m-20 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.902 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.444 ' OE1' ' HD2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 120.838 0.352 . . . . 0.0 111.209 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.796 HG12 ' HA ' ' A' ' 22' ' ' HIS 0.256 1.4 m -145.72 173.08 3.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.561 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -80.91 142.19 33.8 Favored 'General case' 0 CA--C 1.475 -1.921 0 O-C-N 120.281 -1.512 . . . . 0.0 107.741 176.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.62 HG12 ' H ' ' A' ' 6' ' ' LYS 0.406 0.4 OUTLIER -161.3 -50.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 C-N-CA 117.226 -1.79 . . . . 0.0 112.097 -170.121 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.62 ' H ' HG12 ' A' ' 5' ' ' VAL . 28.6 mmtm 84.86 139.46 0.06 Allowed 'General case' 0 N--CA 1.508 2.429 0 CA-C-O 124.315 2.007 . . . . 0.0 113.97 178.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.3 26.4 t70 -93.37 153.99 18.21 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 111.491 -2.595 . . . . 0.0 109.381 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.669 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.7 p -138.01 17.12 2.83 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.961 -1.087 . . . . 0.0 109.372 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.868 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -124.43 -85.81 0.64 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 118.55 -1.26 . . . . 0.0 109.722 -176.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.562 ' O ' ' N ' ' A' ' 12' ' ' GLU . 4.4 t30 -159.96 65.04 0.35 Allowed 'General case' 0 C--N 1.265 -3.07 0 C-N-CA 117.774 -1.57 . . . . 0.0 112.142 177.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.466 ' C ' ' O ' ' A' ' 10' ' ' ASN . 9.0 m-70 33.3 32.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.778 0.799 . . . . 0.0 110.507 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.562 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.1 OUTLIER -95.23 24.74 4.76 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.0 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.756 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.28 0.0 OUTLIER -117.14 -165.24 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-O 122.213 1.006 . . . . 0.0 110.993 -178.624 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.721 ' N ' HG23 ' A' ' 13' ' ' ILE . 14.8 ptpt -162.31 -48.03 0.04 OUTLIER 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.873 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.648 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 12.1 tttm -144.0 135.47 25.87 Favored 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 116.344 -2.142 . . . . 0.0 112.896 178.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.562 ' CG1' ' HB2' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -133.46 102.26 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-O 122.845 1.307 . . . . 0.0 110.603 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 17' ' ' LEU . 2.0 mt -93.41 123.44 36.71 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 114.172 -1.377 . . . . 0.0 111.253 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.688 HG13 ' HD2' ' A' ' 19' ' ' PRO . 23.7 t -143.13 145.82 34.26 Favored Pre-proline 0 N--CA 1.502 2.147 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.931 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.688 ' HD2' HG13 ' A' ' 18' ' ' VAL . 43.7 Cg_endo -68.72 109.88 2.2 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.83 1.437 . . . . 0.0 110.978 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.11 -94.99 0.12 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.1 m -93.82 174.82 6.98 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.108 -1.231 . . . . 0.0 111.415 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.796 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.3 OUTLIER -142.01 7.13 1.81 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.198 -0.939 . . . . 0.0 110.491 178.36 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.287 -2.147 0 C-N-CA 118.958 -1.591 . . . . 0.0 110.212 177.4 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.809 ' HA2' ' HA ' ' A' ' 96' ' ' LYS . . . . . . . . 0 C--O 1.214 -1.139 0 N-CA-C 105.61 -2.996 . . . . 0.0 105.61 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.744 ' HB2' HG12 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -118.41 96.8 50.27 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 121.281 2.54 . . . . 0.0 117.089 -174.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.584 ' HD3' ' O ' ' A' ' 32' ' ' GLY . 61.2 Cg_endo -107.11 144.87 0.08 OUTLIER 'Trans proline' 0 C--N 1.29 -2.504 0 C-N-CA 124.289 3.326 . . . . 0.0 107.416 175.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.543 ' O ' ' CE1' ' A' ' 90' ' ' TYR . 30.4 m-85 -119.05 97.53 5.73 Favored 'General case' 0 C--N 1.291 -1.972 0 C-N-CA 118.603 -1.239 . . . . 0.0 108.839 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.653 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 28.1 mp0 -117.65 99.8 7.2 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.668 -0.645 . . . . 0.0 109.896 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.664 ' HA ' HG22 ' A' ' 18' ' ' VAL . 2.0 mt -109.67 139.24 44.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.403 -1.436 . . . . 0.0 108.741 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.402 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -140.24 128.65 22.67 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.564 -1.335 . . . . 0.0 107.764 179.241 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.562 ' HB2' ' CG1' ' A' ' 16' ' ' VAL . . . -143.75 150.14 38.16 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-O 123.119 1.437 . . . . 0.0 113.485 -176.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.728 HG12 ' HB3' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -115.49 138.22 46.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-N 113.696 -1.593 . . . . 0.0 107.84 177.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.688 ' HE2' HG22 ' A' ' 88' ' ' ILE . 8.4 p90 -159.58 130.01 5.71 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -177.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 15.2 tt0 -73.02 155.25 40.0 Favored 'General case' 0 C--N 1.281 -2.381 0 O-C-N 120.464 -1.398 . . . . 0.0 109.127 177.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.977 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -88.97 136.56 32.95 Favored 'General case' 0 C--N 1.269 -2.924 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.65 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.599 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 0.2 OUTLIER -117.32 50.51 1.1 Allowed 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 125.408 2.528 . . . . 0.0 114.071 179.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.631 ' C ' ' HB2' ' A' ' 82' ' ' LYS . 7.0 pt20 166.87 -159.44 0.01 OUTLIER 'General case' 0 C--N 1.257 -3.416 0 CA-C-N 108.947 -3.751 . . . . 0.0 112.816 175.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.463 ' H ' ' HB2' ' A' ' 45' ' ' GLN 0.275 21.1 t-20 -110.1 154.25 23.54 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-O 122.53 1.157 . . . . 0.0 108.389 -178.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.631 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -171.84 151.05 2.73 Favored 'General case' 0 C--N 1.251 -3.675 0 C-N-CA 118.366 -1.333 . . . . 0.0 112.508 -178.25 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.953 ' O ' HG23 ' A' ' 49' ' ' THR . 0.0 OUTLIER -111.66 6.52 19.96 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 120.668 -1.27 . . . . 0.0 110.817 178.511 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.953 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.41 147.43 4.41 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 120.712 -1.243 . . . . 0.0 111.089 179.373 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 111' ' ' MET . . . -146.71 106.17 3.92 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-O 122.271 1.034 . . . . 0.0 109.981 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.599 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -75.99 -175.73 3.17 Favored 'General case' 0 N--CA 1.505 2.292 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.353 179.447 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.829 ' CG1' HD11 ' A' ' 88' ' ' ILE . 26.7 mt -140.19 135.08 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.688 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.407 ' C ' HG13 ' A' ' 108' ' ' VAL . 15.9 tt0 -141.4 114.55 8.67 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 123.428 1.585 . . . . 0.0 111.854 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 1.031 HD12 HG21 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -90.28 125.91 43.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-N 112.705 -2.043 . . . . 0.0 108.904 178.15 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -117.69 98.69 6.5 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 177.344 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.895 ' HB3' HG22 ' A' ' 63' ' ' VAL . . . -112.86 126.8 55.85 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 118.459 -1.296 . . . . 0.0 112.889 -175.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.746 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.4 p -104.28 98.37 8.18 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 177.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.89 ' HA ' HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -108.76 107.38 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.882 0 CA-C-O 122.905 1.336 . . . . 0.0 110.916 -176.676 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.634 ' N ' HG22 ' A' ' 104' ' ' VAL . 1.8 p30 35.84 62.35 0.65 Allowed 'General case' 0 N--CA 1.522 3.126 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.78 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.05 -12.04 10.16 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.284 -0.885 . . . . 0.0 111.365 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.541 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.279 0.3 OUTLIER -108.13 57.02 0.62 Allowed 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.079 -1.248 . . . . 0.0 111.162 -178.6 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.364 0.0 OUTLIER -60.79 115.09 3.41 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 122.049 0.928 . . . . 0.0 111.366 -179.411 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.895 HG22 ' HB3' ' A' ' 56' ' ' ALA . 15.2 m -75.77 143.64 12.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-O 122.494 1.14 . . . . 0.0 110.352 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.527 ' C ' ' CG2' ' A' ' 65' ' ' VAL 0.435 20.9 t0 -138.27 60.0 1.63 Allowed 'General case' 0 C--N 1.277 -2.572 0 CA-C-O 122.752 1.263 . . . . 0.0 110.901 -176.169 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.809 HG12 ' HD2' ' A' ' 66' ' ' PRO . 1.0 OUTLIER -157.39 151.86 20.49 Favored Pre-proline 0 C--N 1.269 -2.929 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.742 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.809 ' HD2' HG12 ' A' ' 65' ' ' VAL . 44.9 Cg_endo -84.47 137.38 6.9 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 CA-C-O 123.763 1.485 . . . . 0.0 111.013 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.604 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -116.66 42.52 1.85 Allowed Glycine 0 C--N 1.27 -3.136 0 CA-C-N 112.574 -2.103 . . . . 0.0 111.774 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.733 HG23 ' N ' ' A' ' 69' ' ' ASP . 3.0 tp 174.3 -163.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 O-C-N 120.379 -1.659 . . . . 0.0 108.93 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.733 ' N ' HG23 ' A' ' 68' ' ' ILE . 1.5 t70 -107.62 135.01 19.8 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 174.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.723 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 23.6 Cg_endo -106.16 -4.69 0.13 Allowed 'Trans proline' 0 C--N 1.278 -3.176 0 C-N-CA 123.445 2.763 . . . . 0.0 114.07 -173.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.608 ' O ' ' CE1' ' A' ' 75' ' ' TYR . 9.1 p30 -114.93 92.9 4.09 Favored 'General case' 0 C--N 1.285 -2.224 0 O-C-N 120.491 -1.381 . . . . 0.0 108.695 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.609 ' HA ' ' CD1' ' A' ' 75' ' ' TYR . . . -77.91 12.08 1.92 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.071 -1.018 . . . . 0.0 109.095 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.9 t -76.35 -25.22 54.46 Favored 'General case' 0 C--O 1.214 -0.773 0 O-C-N 120.802 -1.186 . . . . 0.0 107.951 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.592 ' CD2' ' OD1' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -88.1 18.68 4.1 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 174.421 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.62 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.2 OUTLIER -134.06 -10.93 2.61 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.38 179.631 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.457 ' O ' ' C ' ' A' ' 77' ' ' LYS . 2.0 ptt? -164.04 133.48 3.93 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-O 123.897 1.808 . . . . 0.0 113.277 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.524 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -12.08 95.51 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 111.761 -2.472 . . . . 0.0 113.732 -178.638 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.51 ' HA ' HD13 ' A' ' 80' ' ' LEU 0.312 1.2 t -104.86 145.13 30.12 Favored Pre-proline 0 C--N 1.268 -2.949 0 CA-C-N 111.428 -2.623 . . . . 0.0 108.491 178.341 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.659 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 36.8 Cg_endo -80.52 166.62 75.33 Favored 'Cis proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.562 -1.849 . . . . 0.0 112.513 0.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.657 ' HG ' ' CE1' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -90.95 127.76 36.52 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.816 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.518 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.4 t -104.58 141.35 20.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-O 124.253 1.977 . . . . 0.0 112.377 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.631 ' HB2' ' C ' ' A' ' 45' ' ' GLN . 1.7 tmmt? -46.55 118.32 1.95 Allowed 'General case' 0 C--N 1.272 -2.772 0 CA-C-N 111.531 -2.577 . . . . 0.0 116.578 -175.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.27 -16.84 19.67 Favored Glycine 0 C--N 1.29 -2.022 0 CA-C-N 111.827 -2.442 . . . . 0.0 107.811 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 17.7 mt-30 -72.83 126.61 30.32 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-O 123.198 1.475 . . . . 0.0 111.598 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.605 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -63.81 144.95 56.64 Favored 'General case' 0 C--N 1.271 -2.834 0 CA-C-N 113.341 -1.754 . . . . 0.0 107.074 178.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.977 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 16.1 m-85 -143.43 125.3 15.16 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.728 ' HB3' HG12 ' A' ' 40' ' ' VAL . 8.4 p30 -117.06 127.2 53.92 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-O 122.572 1.177 . . . . 0.0 109.291 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.829 HD11 ' CG1' ' A' ' 52' ' ' ILE . 0.6 OUTLIER -109.95 159.77 9.4 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.202 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -151.06 156.84 41.93 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 122.046 0.927 . . . . 0.0 111.807 -177.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.653 ' O ' ' HA ' ' A' ' 36' ' ' GLN . 3.7 t80 -150.48 138.46 20.1 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.59 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 1.5 t -154.95 116.43 4.06 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 119.595 1.089 . . . . 0.0 108.102 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.652 ' CZ3' HG23 ' A' ' 94' ' ' VAL 0.27 1.5 t90 -143.03 115.87 8.76 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 119.809 -0.756 . . . . 0.0 110.021 -177.468 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.518 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.6 OUTLIER -74.91 160.29 30.8 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 119.249 -2.157 . . . . 0.0 110.135 -178.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.81 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.7 OUTLIER -153.76 166.09 16.45 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.151 -0.968 . . . . 0.0 108.47 -179.274 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.81 ' HD2' HG22 ' A' ' 94' ' ' VAL . 18.4 Cg_endo -37.03 150.16 0.05 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.136 0 O-C-N 123.587 1.309 . . . . 0.0 110.64 -177.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.809 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.5 OUTLIER -79.27 -24.69 42.77 Favored 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 116.94 -1.904 . . . . 0.0 114.33 -173.311 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.767 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -138.52 42.85 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 O-C-N 121.658 -0.651 . . . . 0.0 112.25 -179.161 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.941 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . . . -74.14 -67.67 0.39 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 120.641 -1.287 . . . . 0.0 110.025 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.941 ' HD3' ' HB3' ' A' ' 98' ' ' ALA . 50.3 Cg_endo -67.55 160.09 49.54 Favored 'Trans proline' 0 CA--C 1.463 -3.042 0 O-C-N 123.615 1.323 . . . . 0.0 110.106 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.711 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -107.78 103.09 12.28 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 112.482 -2.144 . . . . 0.0 109.849 -169.689 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.478 ' C ' ' O ' ' A' ' 100' ' ' LYS . 6.5 p -42.96 99.62 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.723 0 CA-C-O 123.635 1.683 . . . . 0.0 108.661 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.405 88.5 mt-10 -163.67 -51.45 0.03 OUTLIER 'General case' 0 CA--C 1.45 -2.882 0 CA-C-N 113.024 -1.898 . . . . 0.0 111.674 -179.237 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.511 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.492 0.8 OUTLIER -159.3 79.22 0.74 Allowed 'General case' 0 C--N 1.283 -2.311 0 CA-C-N 110.952 -2.84 . . . . 0.0 113.378 -162.32 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.89 HG22 ' HA ' ' A' ' 58' ' ' ILE . 26.2 t -141.2 134.12 30.45 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.437 0 C-N-CA 119.811 -0.756 . . . . 0.0 111.234 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.782 ' CG1' HD11 ' A' ' 121' ' ' ILE . 53.0 t -136.55 125.03 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.793 HG23 ' HB2' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -107.15 138.12 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 CA-C-O 122.58 1.181 . . . . 0.0 111.92 -178.805 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 1.018 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -131.39 110.35 10.98 Favored 'General case' 0 C--N 1.276 -2.623 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.204 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.031 HG21 HD12 ' A' ' 54' ' ' ILE . 3.2 t -123.42 142.19 40.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 C-N-CA 117.182 -1.807 . . . . 0.0 108.811 -177.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 1.105 ' HB2' ' HB2' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -138.22 145.02 40.91 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 122.485 1.136 . . . . 0.0 111.874 -176.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.71 ' CG2' HG21 ' A' ' 88' ' ' ILE . 5.6 t -96.6 125.67 49.48 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.553 ' CG ' ' HA2' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -105.68 119.24 38.62 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -179.291 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.511 ' HA3' HD23 ' A' ' 117' ' ' LEU . . . -75.75 -135.55 0.52 Allowed Glycine 0 N--CA 1.497 2.72 0 C-N-CA 119.091 -1.528 . . . . 0.0 113.856 -176.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.631 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 5.1 p-10 -88.59 -0.77 57.6 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.1 0.953 . . . . 0.0 112.267 -176.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -133.94 -4.31 2.81 Favored 'General case' 0 C--N 1.269 -2.914 0 CA-C-O 121.429 0.633 . . . . 0.0 110.954 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.627 ' O ' ' HB ' ' A' ' 116' ' ' VAL . . . 95.54 83.36 1.64 Allowed Glycine 0 CA--C 1.47 -2.765 0 CA-C-O 124.636 2.242 . . . . 0.0 111.024 178.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.627 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 14.6 p 136.21 152.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.254 -3.586 0 CA-C-N 108.371 -3.915 . . . . 0.0 112.72 176.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.681 ' CB ' HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -162.22 -59.51 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.414 0.626 . . . . 0.0 110.281 179.109 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.756 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -164.75 126.01 2.11 Favored 'General case' 0 N--CA 1.51 2.569 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 1.105 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 0.8 OUTLIER -134.11 135.74 43.42 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 117.918 -1.513 . . . . 0.0 113.112 -177.424 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.472 ' HB3' HG11 ' A' ' 16' ' ' VAL . . . -143.62 136.51 27.51 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 122.925 1.345 . . . . 0.0 112.406 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 1.1 HD13 ' N ' ' A' ' 122' ' ' ALA 0.26 0.0 OUTLIER -107.33 162.46 5.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 114.122 -1.399 . . . . 0.0 111.076 -179.589 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 1.1 ' N ' HD13 ' A' ' 121' ' ' ILE . . . . . . . . 0 C--N 1.3 -1.546 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.517 ' OE1' ' N ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 120.818 0.342 . . . . 0.0 111.345 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.711 HG12 ' HA ' ' A' ' 22' ' ' HIS . 1.4 m -144.65 -177.72 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.473 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -78.89 134.78 36.89 Favored 'General case' 0 CA--C 1.481 -1.684 0 C-N-CA 117.723 -1.591 . . . . 0.0 108.758 178.211 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.468 ' O ' ' HG3' ' A' ' 6' ' ' LYS 0.439 0.4 OUTLIER -171.91 164.28 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 113.923 -1.49 . . . . 0.0 109.416 -169.629 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.844 ' O ' HG22 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -144.37 136.98 26.78 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 123.644 1.687 . . . . 0.0 113.143 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.259 13.5 t70 -70.72 148.97 47.41 Favored 'General case' 0 C--N 1.269 -2.907 0 CA-C-N 113.249 -1.796 . . . . 0.0 109.278 178.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.635 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.5 p -137.59 14.62 2.95 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.94 -1.1 . . . . 0.0 109.488 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.827 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -125.94 -84.54 0.63 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.687 -1.205 . . . . 0.0 110.162 -177.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 12' ' ' GLU . 2.3 t30 -159.46 66.69 0.39 Allowed 'General case' 0 C--N 1.267 -2.998 0 C-N-CA 118.649 -1.221 . . . . 0.0 111.987 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.473 ' C ' ' O ' ' A' ' 10' ' ' ASN . 9.7 m-70 33.57 33.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.848 0.832 . . . . 0.0 110.275 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.0 OUTLIER -91.78 22.0 4.46 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.324 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.87 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.28 0.0 OUTLIER -121.15 -167.39 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-O 122.31 1.052 . . . . 0.0 111.323 -178.439 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.69 ' N ' HG23 ' A' ' 13' ' ' ILE . 7.2 ptpt -162.34 -45.04 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.445 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.612 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 2.9 tttt -145.58 140.29 27.3 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 116.569 -2.052 . . . . 0.0 112.595 178.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.941 HG13 ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -138.42 104.75 2.73 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 CA-C-O 122.929 1.347 . . . . 0.0 111.109 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 17' ' ' LEU . 0.9 OUTLIER -97.95 128.18 44.36 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 114.044 -1.434 . . . . 0.0 111.45 178.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.977 HG22 ' HA ' ' A' ' 37' ' ' LEU . 43.1 t -142.16 146.26 39.13 Favored Pre-proline 0 N--CA 1.499 2.006 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.517 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.716 ' HD2' HG13 ' A' ' 18' ' ' VAL . 42.5 Cg_endo -67.63 93.83 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.821 1.432 . . . . 0.0 110.025 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.89 -93.87 0.1 OUTLIER Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.513 -1.327 . . . . 0.0 110.084 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 37.1 m -94.73 162.21 13.87 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.161 -1.2 . . . . 0.0 111.392 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.711 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -136.71 9.28 3.09 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.897 -1.127 . . . . 0.0 109.697 178.027 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' ' 4' ' ' ASP . . . . . . . . 0 C--N 1.291 -1.956 0 C-N-CA 119.383 -1.389 . . . . 0.0 109.882 176.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.858 ' HA3' ' HA ' ' A' ' 96' ' ' LYS . . . . . . . . 0 C--O 1.213 -1.186 0 N-CA-C 107.457 -2.257 . . . . 0.0 107.457 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.881 ' O ' HG22 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -125.34 91.6 48.64 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 120.883 2.342 . . . . 0.0 115.334 -179.306 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.519 ' C ' ' CD1' ' A' ' 35' ' ' PHE . 60.6 Cg_endo -108.2 145.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.291 -2.458 0 C-N-CA 124.291 3.327 . . . . 0.0 109.594 177.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.591 ' CE2' HG11 ' A' ' 94' ' ' VAL . 4.9 m-85 -119.8 90.79 3.4 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.623 ' HG2' ' CB ' ' A' ' 91' ' ' THR . 0.3 OUTLIER -116.17 88.64 2.93 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 122.006 -0.434 . . . . 0.0 110.223 -178.353 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.977 ' HA ' HG22 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -108.68 133.53 52.65 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.526 -1.359 . . . . 0.0 108.383 178.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -140.2 127.62 21.38 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.533 -1.354 . . . . 0.0 107.452 179.242 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.941 ' HB2' HG13 ' A' ' 16' ' ' VAL . . . -142.75 152.94 42.82 Favored 'General case' 0 C--N 1.274 -2.708 0 CA-C-O 122.97 1.367 . . . . 0.0 113.263 -175.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.612 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.46 139.87 32.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 113.821 -1.536 . . . . 0.0 108.711 177.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.579 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 3.5 p90 -156.87 124.07 5.26 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -178.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 13.6 tt0 -69.68 155.85 39.88 Favored 'General case' 0 C--N 1.288 -2.107 0 O-C-N 120.407 -1.433 . . . . 0.0 108.508 177.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.965 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -91.28 134.69 34.37 Favored 'General case' 0 C--N 1.265 -3.069 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.162 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.634 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -114.87 51.26 0.91 Allowed 'General case' 0 CA--C 1.486 -1.498 0 CA-C-O 125.327 2.489 . . . . 0.0 114.067 179.004 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.601 ' N ' ' CG ' ' A' ' 82' ' ' LYS . 7.0 pt20 167.34 -160.95 0.01 OUTLIER 'General case' 0 C--N 1.263 -3.173 0 CA-C-N 109.149 -3.659 . . . . 0.0 113.729 174.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.46 ' C ' HG22 ' A' ' 47' ' ' THR 0.277 6.3 t30 -110.36 153.65 24.64 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-O 122.617 1.199 . . . . 0.0 108.872 -178.483 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.672 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -173.22 157.04 3.31 Favored 'General case' 0 C--N 1.255 -3.526 0 C-N-CA 118.727 -1.189 . . . . 0.0 112.746 -178.307 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.934 ' O ' HG23 ' A' ' 49' ' ' THR . 0.4 OUTLIER -112.5 5.87 18.22 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 120.694 -1.254 . . . . 0.0 111.522 178.434 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.934 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.16 149.06 5.01 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.659 -1.276 . . . . 0.0 111.215 179.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.475 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . . . -141.37 101.64 4.05 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 122.924 1.345 . . . . 0.0 110.863 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 23.3 mmtp -73.15 -178.23 2.8 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.939 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.976 ' CG2' HD11 ' A' ' 88' ' ' ILE . 28.4 mt -140.14 136.43 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.544 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.945 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.494 ' HB3' ' HD3' ' A' ' 109' ' ' LYS . 31.9 tt0 -141.44 110.87 6.39 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 123.267 1.508 . . . . 0.0 111.3 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 1.006 HD12 HG21 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -89.99 127.07 42.8 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 CA-C-N 112.793 -2.003 . . . . 0.0 109.64 179.524 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.491 ' NZ ' ' HB2' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -120.25 98.62 6.15 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 176.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.986 ' HB3' HG22 ' A' ' 63' ' ' VAL . . . -114.53 133.61 55.66 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 118.919 -1.112 . . . . 0.0 113.187 -175.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.714 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.0 OUTLIER -105.53 100.3 9.87 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 177.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.901 ' HA ' HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -111.55 102.96 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.838 0 CA-C-O 123.004 1.383 . . . . 0.0 110.729 -176.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.658 ' N ' HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER 34.86 65.2 0.37 Allowed 'General case' 0 N--CA 1.519 3.003 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.829 179.306 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.47 -16.56 10.0 Favored Glycine 0 N--CA 1.489 2.212 0 O-C-N 121.351 -0.843 . . . . 0.0 111.761 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.551 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.268 0.5 OUTLIER -108.3 57.94 0.61 Allowed 'General case' 0 C--N 1.292 -1.896 0 O-C-N 121.027 -1.278 . . . . 0.0 111.818 -178.256 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.603 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.367 0.0 OUTLIER -59.25 115.8 3.46 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.064 0.935 . . . . 0.0 111.258 -179.913 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.986 HG22 ' HB3' ' A' ' 56' ' ' ALA . 17.7 m -80.3 146.73 7.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 122.517 1.151 . . . . 0.0 110.971 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.429 7.1 t70 -138.06 59.11 1.66 Allowed 'General case' 0 C--N 1.28 -2.428 0 CA-C-O 122.831 1.301 . . . . 0.0 111.013 -176.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.701 HG22 ' HD2' ' A' ' 66' ' ' PRO . 4.0 p -165.31 151.8 9.03 Favored Pre-proline 0 C--N 1.269 -2.927 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.053 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.701 ' HD2' HG22 ' A' ' 65' ' ' VAL . 44.5 Cg_endo -87.7 139.56 4.82 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 CA-C-O 123.706 1.461 . . . . 0.0 111.804 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -105.83 48.77 0.94 Allowed Glycine 0 C--N 1.272 -2.99 0 CA-C-N 112.568 -2.106 . . . . 0.0 109.101 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.636 HG23 ' N ' ' A' ' 69' ' ' ASP 0.293 0.0 OUTLIER 179.63 -168.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 O-C-N 119.669 -2.077 . . . . 0.0 108.544 -178.247 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.636 ' N ' HG23 ' A' ' 68' ' ' ILE . 10.0 t0 -108.86 90.61 7.85 Favored Pre-proline 0 N--CA 1.504 2.232 0 O-C-N 120.731 -1.231 . . . . 0.0 108.364 176.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.719 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 20.0 Cg_endo -48.39 -5.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.289 -2.584 0 C-N-CA 124.182 3.254 . . . . 0.0 115.461 177.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.603 ' HB2' ' NE2' ' A' ' 74' ' ' HIS . 0.6 OUTLIER -107.63 92.86 4.25 Favored 'General case' 0 C--N 1.289 -2.03 0 O-C-N 120.134 -1.604 . . . . 0.0 109.484 -179.209 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.72 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . . . -78.27 10.41 3.05 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.101 -0.999 . . . . 0.0 109.332 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.1 t -78.16 -24.53 47.24 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 120.992 -1.067 . . . . 0.0 108.944 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.603 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 0.3 OUTLIER -79.52 7.62 7.85 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 118.911 -1.116 . . . . 0.0 108.797 176.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.72 ' CD2' ' HA ' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -132.98 -1.38 3.31 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 121.488 -0.758 . . . . 0.0 110.11 177.62 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.46 ' CE ' HD21 ' A' ' 80' ' ' LEU . 1.5 ptt? -153.45 128.65 9.75 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 124.042 1.877 . . . . 0.0 113.745 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.567 ' O ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -19.88 95.98 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 111.74 -2.482 . . . . 0.0 113.213 -178.676 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.498 ' HA ' HD13 ' A' ' 80' ' ' LEU 0.32 0.3 OUTLIER -99.93 142.17 24.11 Favored Pre-proline 0 C--N 1.268 -2.948 0 CA-C-N 111.36 -2.654 . . . . 0.0 108.776 178.495 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.653 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 36.3 Cg_endo -79.58 168.27 73.86 Favored 'Cis proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.848 -1.73 . . . . 0.0 112.521 0.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.693 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -94.71 128.39 41.36 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.17 -179.731 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.528 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.4 t -105.9 139.38 27.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 124.1 1.905 . . . . 0.0 112.07 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.634 ' HG2' ' HA ' ' A' ' 44' ' ' ASN . 1.2 tmmt? -44.59 118.33 1.54 Allowed 'General case' 0 C--N 1.271 -2.823 0 CA-C-N 111.816 -2.447 . . . . 0.0 116.652 -175.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.95 -18.01 12.72 Favored Glycine 0 C--N 1.292 -1.878 0 CA-C-N 111.787 -2.461 . . . . 0.0 107.924 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.62 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 18.3 mt-30 -71.79 127.74 33.54 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-O 123.221 1.486 . . . . 0.0 111.349 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.611 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 3.2 mt-30 -66.02 144.6 56.64 Favored 'General case' 0 C--N 1.27 -2.861 0 CA-C-N 113.282 -1.781 . . . . 0.0 107.485 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.965 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 17.8 m-85 -142.72 126.07 16.62 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.553 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 0.7 OUTLIER -117.46 130.19 56.3 Favored 'General case' 0 C--N 1.279 -2.489 0 CA-C-O 122.737 1.256 . . . . 0.0 110.034 -178.34 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 1.09 HD12 ' CG2' ' A' ' 110' ' ' VAL . 0.2 OUTLIER -101.95 156.22 4.73 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.152 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.188 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.17 143.22 30.99 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 121.465 0.65 . . . . 0.0 111.343 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.67 ' CE1' ' HB2' ' A' ' 92' ' ' TRP . 2.1 t80 -143.89 99.66 3.44 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.412 -0.805 . . . . 0.0 109.123 178.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.623 ' CB ' ' HG2' ' A' ' 36' ' ' GLN . 1.3 t -122.81 116.29 23.44 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.91 -1.119 . . . . 0.0 108.616 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.67 ' HB2' ' CE1' ' A' ' 90' ' ' TYR 0.271 0.3 OUTLIER -142.64 102.31 4.03 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.035 -177.635 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.8 OUTLIER -75.62 153.66 37.12 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 119.607 -1.933 . . . . 0.0 109.461 -178.757 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.881 HG22 ' O ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -153.11 175.38 3.01 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.781 -1.199 . . . . 0.0 108.606 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.563 ' HD2' ' HB ' ' A' ' 94' ' ' VAL . 18.6 Cg_endo -37.96 154.07 0.03 OUTLIER 'Trans proline' 0 CA--C 1.498 -1.321 0 O-C-N 123.64 1.337 . . . . 0.0 110.701 -177.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.858 ' HA ' ' HA3' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -79.54 -25.3 41.72 Favored 'General case' 0 C--N 1.284 -2.277 0 C-N-CA 116.614 -2.035 . . . . 0.0 115.526 -173.173 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.754 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -140.27 39.71 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 -177.658 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.93 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . . . -62.89 -64.48 2.98 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.519 -1.363 . . . . 0.0 108.353 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.93 ' HD3' ' HB3' ' A' ' 98' ' ' ALA . 51.5 Cg_endo -69.96 163.74 37.3 Favored 'Trans proline' 0 CA--C 1.46 -3.206 0 O-C-N 123.87 1.458 . . . . 0.0 108.852 177.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.735 ' HD2' ' C ' ' A' ' 99' ' ' PRO . 1.0 OUTLIER -105.14 103.7 13.3 Favored 'General case' 0 C--N 1.269 -2.902 0 CA-C-N 112.704 -2.044 . . . . 0.0 110.92 -168.596 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.465 ' C ' ' O ' ' A' ' 100' ' ' LYS . 7.5 p -43.43 96.78 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 123.566 1.65 . . . . 0.0 108.859 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.601 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.413 78.0 mt-10 -163.64 -50.77 0.03 OUTLIER 'General case' 0 CA--C 1.451 -2.832 0 CA-C-N 112.729 -2.032 . . . . 0.0 112.01 -179.331 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.491 0.8 OUTLIER -159.07 81.58 0.78 Allowed 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 111.283 -2.69 . . . . 0.0 113.781 -162.15 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.901 HG22 ' HA ' ' A' ' 58' ' ' ILE . 34.0 t -143.22 133.91 22.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.122 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.851 ' CG1' HD11 ' A' ' 121' ' ' ILE . 60.9 t -142.48 134.56 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.967 HG23 ' HB2' ' A' ' 56' ' ' ALA . 1.3 p -112.65 146.84 16.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 122.956 1.36 . . . . 0.0 113.367 -178.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.98 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -132.82 108.52 9.02 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 178.272 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.006 HG21 HD12 ' A' ' 54' ' ' ILE . 3.6 t -125.29 141.9 43.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 120.094 -1.629 . . . . 0.0 109.056 -177.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.761 ' HB2' ' HB3' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -133.84 152.35 51.84 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.712 1.244 . . . . 0.0 113.047 -178.336 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 1.09 ' CG2' HD12 ' A' ' 88' ' ' ILE . 8.8 t -99.83 127.35 52.79 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.255 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 177.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.502 ' HG3' ' N ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -108.82 121.79 45.82 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.31 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.584 ' HA3' HD23 ' A' ' 117' ' ' LEU . . . -78.14 -137.36 1.11 Allowed Glycine 0 N--CA 1.497 2.742 0 C-N-CA 119.079 -1.534 . . . . 0.0 114.093 -175.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.672 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 10.0 p-10 -80.19 -5.11 55.52 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 122.366 1.079 . . . . 0.0 112.07 -177.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 9.7 p30 -130.05 -4.6 4.48 Favored 'General case' 0 C--N 1.266 -3.065 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.145 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.624 ' C ' HG12 ' A' ' 116' ' ' VAL . . . 88.59 85.55 1.24 Allowed Glycine 0 CA--C 1.469 -2.808 0 CA-C-O 124.886 2.381 . . . . 0.0 109.813 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.624 HG12 ' C ' ' A' ' 115' ' ' GLY . 4.5 p 145.41 145.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.245 -3.952 0 CA-C-N 108.43 -3.885 . . . . 0.0 111.833 177.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.805 ' CB ' HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -162.27 -57.43 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.495 -0.753 . . . . 0.0 110.755 179.605 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.87 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -173.81 130.09 0.41 Allowed 'General case' 0 N--CA 1.51 2.56 0 O-C-N 121.158 -0.964 . . . . 0.0 108.84 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.827 ' SG ' ' HB2' ' A' ' 9' ' ' ALA . 0.8 OUTLIER -134.44 144.31 48.06 Favored 'General case' 0 C--N 1.285 -2.23 0 C-N-CA 117.544 -1.662 . . . . 0.0 113.86 -177.469 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.541 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -147.24 138.18 23.7 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 123.034 1.397 . . . . 0.0 112.239 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.98 ' HB ' HG23 ' A' ' 107' ' ' THR 0.279 0.0 OUTLIER -109.37 132.31 57.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 CA-C-N 114.025 -1.443 . . . . 0.0 111.198 -179.19 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.753 ' N ' HD13 ' A' ' 121' ' ' ILE . . . . . . . . 0 N--CA 1.486 1.338 0 O-C-N 120.874 -1.141 . . . . 0.0 108.681 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 120.781 0.324 . . . . 0.0 111.006 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.745 HG12 ' HA ' ' A' ' 22' ' ' HIS . 1.4 m -145.59 179.56 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 O-C-N 120.836 -1.165 . . . . 0.0 108.174 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -79.47 137.02 37.08 Favored 'General case' 0 CA--C 1.48 -1.723 0 C-N-CA 118.117 -1.433 . . . . 0.0 108.693 177.881 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.584 HG11 ' CG2' ' A' ' 16' ' ' VAL 0.436 0.4 OUTLIER -169.44 -171.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.48 -169.858 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.555 ' CG ' ' O ' ' A' ' 5' ' ' VAL . 5.2 mtpp -166.2 146.95 6.46 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 123.931 1.824 . . . . 0.0 113.096 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.281 3.0 t70 -84.88 148.84 26.06 Favored 'General case' 0 C--N 1.264 -3.11 0 CA-C-N 112.58 -2.1 . . . . 0.0 109.043 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.667 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.7 p -137.27 15.95 2.99 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.94 -1.1 . . . . 0.0 109.226 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.846 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -125.65 -84.32 0.63 Allowed 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.137 -176.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.567 ' O ' ' N ' ' A' ' 12' ' ' GLU . 2.4 t30 -156.35 65.19 0.55 Allowed 'General case' 0 C--N 1.268 -2.968 0 C-N-CA 118.523 -1.271 . . . . 0.0 111.783 177.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.468 ' C ' ' O ' ' A' ' 10' ' ' ASN . 10.4 m80 33.72 31.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.773 0.796 . . . . 0.0 110.73 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.4 OUTLIER -90.8 21.26 4.2 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.002 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.777 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.272 0.1 OUTLIER -119.82 -170.31 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 122.211 1.005 . . . . 0.0 110.611 -178.785 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.631 ' H ' HG23 ' A' ' 13' ' ' ILE . 11.2 ptmm? -162.09 -46.83 0.04 OUTLIER 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.143 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.577 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 21.6 tttt -142.81 135.15 27.51 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 116.045 -2.262 . . . . 0.0 113.178 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.973 HG12 ' HB2' ' A' ' 39' ' ' ALA . 0.6 OUTLIER -132.98 101.29 4.25 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 CA-C-O 123.03 1.395 . . . . 0.0 110.76 179.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.514 ' HA ' HD23 ' A' ' 17' ' ' LEU . 1.0 OUTLIER -95.04 129.04 42.28 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 113.987 -1.461 . . . . 0.0 111.857 179.282 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.995 HG22 ' HA ' ' A' ' 37' ' ' LEU . 78.4 t -142.21 145.57 36.08 Favored Pre-proline 0 N--CA 1.5 2.049 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.105 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.657 ' HD2' HG13 ' A' ' 18' ' ' VAL . 42.1 Cg_endo -68.81 105.93 1.4 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.677 1.357 . . . . 0.0 110.624 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.44 -91.13 0.11 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 38.2 m -90.74 159.16 16.48 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.295 -1.121 . . . . 0.0 110.78 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.745 ' HA ' HG12 ' A' ' 3' ' ' VAL . 3.8 p80 -137.25 11.76 3.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.665 -1.272 . . . . 0.0 109.528 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.485 ' O ' ' HB3' ' A' ' 4' ' ' ASP . . . . . . . . 0 C--N 1.29 -2.026 0 C-N-CA 119.288 -1.434 . . . . 0.0 109.883 177.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.898 ' HA3' ' HA ' ' A' ' 96' ' ' LYS . . . . . . . . 0 C--O 1.213 -1.168 0 N-CA-C 108.09 -2.004 . . . . 0.0 108.09 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.846 ' HB2' HG12 ' A' ' 94' ' ' VAL . 2.3 mmmt -125.37 90.98 49.79 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 120.585 2.192 . . . . 0.0 115.302 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 65.0 Cg_endo -108.65 143.39 0.06 OUTLIER 'Trans proline' 0 C--N 1.291 -2.466 0 C-N-CA 124.378 3.385 . . . . 0.0 109.735 177.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.477 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 12.7 m-85 -125.05 95.68 4.58 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.07 -1.052 . . . . 0.0 109.737 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.602 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 28.2 mp0 -116.37 96.64 5.63 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.569 -0.707 . . . . 0.0 110.81 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.995 ' HA ' HG22 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -109.3 136.31 48.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.355 -1.466 . . . . 0.0 108.638 178.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -140.27 125.16 18.35 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.496 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.973 ' HB2' HG12 ' A' ' 16' ' ' VAL . . . -143.54 152.52 41.55 Favored 'General case' 0 C--N 1.274 -2.694 0 CA-C-O 122.955 1.36 . . . . 0.0 113.878 -175.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.581 ' O ' ' HG2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -110.71 140.34 30.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-N 113.766 -1.561 . . . . 0.0 108.305 177.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.584 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 4.0 p90 -159.33 125.04 4.29 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 5.5 tt0 -70.55 157.09 38.52 Favored 'General case' 0 C--N 1.286 -2.154 0 O-C-N 120.39 -1.444 . . . . 0.0 109.07 178.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.975 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -90.94 141.95 28.29 Favored 'General case' 0 C--N 1.267 -2.981 0 CA-C-N 114.217 -1.356 . . . . 0.0 108.847 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.65 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -121.49 50.42 1.4 Allowed 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 125.281 2.467 . . . . 0.0 114.31 178.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.588 ' C ' ' HB2' ' A' ' 82' ' ' LYS . 6.5 pt20 167.15 -161.49 0.01 OUTLIER 'General case' 0 C--N 1.258 -3.386 0 CA-C-N 109.109 -3.678 . . . . 0.0 113.073 175.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.456 ' C ' HG22 ' A' ' 47' ' ' THR 0.277 48.5 t30 -110.11 153.51 24.59 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-O 122.572 1.177 . . . . 0.0 108.952 -178.68 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.658 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -173.26 156.64 3.19 Favored 'General case' 0 C--N 1.254 -3.581 0 C-N-CA 118.558 -1.257 . . . . 0.0 112.53 -178.394 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.944 ' O ' HG23 ' A' ' 49' ' ' THR . 0.0 OUTLIER -115.9 9.27 14.93 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 120.811 -1.18 . . . . 0.0 111.077 178.596 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.944 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.9 OUTLIER -166.5 147.54 6.28 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.768 -1.207 . . . . 0.0 110.723 179.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 70' ' ' PRO . . . -148.41 102.22 3.31 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 122.76 1.267 . . . . 0.0 110.366 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 12.3 mmtt -75.11 -174.68 2.36 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.716 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.975 ' CG2' HD11 ' A' ' 88' ' ' ILE . 45.7 mt -140.54 139.03 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.535 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.465 ' C ' HG13 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -140.37 110.09 6.39 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 123.349 1.547 . . . . 0.0 110.56 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.999 HD12 HG21 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -89.77 126.06 42.69 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.332 0 CA-C-N 112.527 -2.124 . . . . 0.0 108.979 179.29 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.1 tttp -121.68 103.18 8.7 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 177.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.892 ' HB3' HG22 ' A' ' 63' ' ' VAL . . . -110.03 126.58 54.12 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.527 -1.269 . . . . 0.0 111.86 -176.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.749 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 4.7 p -101.48 100.86 11.36 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.996 HD13 ' CB ' ' A' ' 99' ' ' PRO . 0.6 OUTLIER -111.31 111.78 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.679 0 CA-C-O 122.695 1.236 . . . . 0.0 110.313 -177.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.506 ' N ' HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER 30.74 62.54 0.2 Allowed 'General case' 0 N--CA 1.52 3.069 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.954 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.43 -12.43 7.63 Favored Glycine 0 N--CA 1.49 2.278 0 O-C-N 121.339 -0.851 . . . . 0.0 111.379 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.533 ' O ' HG13 ' A' ' 58' ' ' ILE 0.284 0.2 OUTLIER -107.9 56.32 0.63 Allowed 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.12 -1.223 . . . . 0.0 111.171 -178.655 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.605 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.362 0.0 OUTLIER -53.95 114.09 1.46 Allowed 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 122.16 0.981 . . . . 0.0 110.565 -179.754 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.892 HG22 ' HB3' ' A' ' 56' ' ' ALA . 19.0 m -76.98 140.46 17.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-O 122.759 1.266 . . . . 0.0 111.499 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.45 21.7 t0 -139.32 85.08 2.03 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.435 -176.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.581 ' CG2' ' HD2' ' A' ' 66' ' ' PRO . 9.9 p -159.31 150.35 16.18 Favored Pre-proline 0 C--N 1.275 -2.631 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.888 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.581 ' HD2' ' CG2' ' A' ' 65' ' ' VAL . 43.5 Cg_endo -73.18 138.04 27.16 Favored 'Trans proline' 0 C--N 1.319 -0.992 0 CA-C-O 123.725 1.469 . . . . 0.0 111.342 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.598 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -117.45 -53.51 0.31 Allowed Glycine 0 N--CA 1.51 3.574 0 CA-C-N 112.542 -2.117 . . . . 0.0 113.588 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.863 HD13 ' H ' ' A' ' 91' ' ' THR . 1.3 tp -117.28 -155.65 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-N 120.643 2.221 . . . . 0.0 110.22 -178.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.715 ' N ' HG23 ' A' ' 68' ' ' ILE . 1.1 t70 -107.92 89.17 5.17 Favored Pre-proline 0 N--CA 1.508 2.44 0 CA-C-O 122.82 1.295 . . . . 0.0 108.983 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.748 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 20.8 Cg_endo -49.05 -12.77 0.25 Allowed 'Trans proline' 0 C--N 1.285 -2.773 0 C-N-CA 124.121 3.214 . . . . 0.0 115.885 178.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.648 ' ND2' ' CD2' ' A' ' 74' ' ' HIS . 0.5 OUTLIER -111.59 85.65 2.17 Favored 'General case' 0 C--N 1.288 -2.074 0 O-C-N 119.843 -1.785 . . . . 0.0 108.965 -179.297 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.664 ' HA ' ' CD1' ' A' ' 75' ' ' TYR . . . -78.38 12.1 2.11 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.644 -0.66 . . . . 0.0 109.313 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.401 ' C ' ' H ' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -77.25 -20.6 54.95 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 120.666 -1.271 . . . . 0.0 108.002 -179.593 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.648 ' CD2' ' ND2' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -87.84 19.04 3.7 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 173.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.664 ' CD1' ' HA ' ' A' ' 72' ' ' ALA . 0.4 OUTLIER -133.13 -9.78 2.97 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.032 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.475 ' O ' ' HG2' ' A' ' 76' ' ' MET . 2.3 ptt? -166.55 126.77 1.61 Allowed 'General case' 0 C--O 1.215 -0.74 0 CA-C-O 123.761 1.743 . . . . 0.0 113.219 178.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.659 ' O ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER 3.87 91.71 0.01 OUTLIER 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 111.999 -2.364 . . . . 0.0 114.134 -179.422 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.487 ' HA ' ' CD1' ' A' ' 80' ' ' LEU 0.331 7.3 t -110.21 139.26 21.26 Favored Pre-proline 0 C--N 1.269 -2.932 0 CA-C-N 111.441 -2.618 . . . . 0.0 107.614 177.519 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.671 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 36.7 Cg_endo -76.79 169.62 73.92 Favored 'Cis proline' 0 C--N 1.308 -1.555 0 C-N-CA 123.095 -1.627 . . . . 0.0 112.992 1.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.727 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -96.9 128.39 43.81 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.051 -179.4 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.527 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.9 t -106.96 138.67 31.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 124.169 1.938 . . . . 0.0 111.916 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.65 ' HG2' ' HA ' ' A' ' 44' ' ' ASN . 1.6 tmmt? -44.2 117.19 1.17 Allowed 'General case' 0 C--N 1.271 -2.837 0 CA-C-N 111.832 -2.44 . . . . 0.0 116.596 -175.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.431 ' O ' ' OE2' ' A' ' 42' ' ' GLU . . . 115.83 -17.09 15.76 Favored Glycine 0 C--N 1.292 -1.905 0 CA-C-N 111.752 -2.476 . . . . 0.0 107.963 178.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.619 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 10.4 mt-30 -71.43 127.76 33.63 Favored 'General case' 0 C--N 1.278 -2.542 0 CA-C-O 123.22 1.486 . . . . 0.0 111.766 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.596 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 0.3 OUTLIER -64.7 143.73 57.72 Favored 'General case' 0 C--N 1.272 -2.794 0 CA-C-N 113.326 -1.761 . . . . 0.0 107.072 178.454 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.975 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 17.9 m-85 -143.33 126.68 16.7 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 10.0 p30 -117.66 132.93 56.42 Favored 'General case' 0 C--N 1.275 -2.655 0 CA-C-O 122.703 1.239 . . . . 0.0 109.913 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 1.104 HD12 HG23 ' A' ' 110' ' ' VAL . 0.4 OUTLIER -102.58 157.7 4.73 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 CA-C-N 114.629 -1.168 . . . . 0.0 108.265 179.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -147.94 142.61 26.62 Favored 'General case' 0 C--N 1.283 -2.3 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.526 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.586 ' O ' ' HA ' ' A' ' 36' ' ' GLN . 17.4 t80 -151.54 108.57 3.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.148 -0.97 . . . . 0.0 110.401 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.863 ' H ' HD13 ' A' ' 68' ' ' ILE . 0.4 OUTLIER -125.11 122.26 36.63 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 120.515 -1.365 . . . . 0.0 108.093 179.163 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.598 ' CD1' ' O ' ' A' ' 67' ' ' GLY 0.27 0.1 OUTLIER -142.44 102.78 4.14 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.128 -176.933 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.504 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.6 OUTLIER -74.93 157.15 35.48 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 119.676 -1.89 . . . . 0.0 108.829 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 33' ' ' LYS . 1.1 t -153.99 171.78 6.58 Favored Pre-proline 0 N--CA 1.486 1.333 0 O-C-N 120.792 -1.193 . . . . 0.0 109.13 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.827 ' CD ' HG13 ' A' ' 94' ' ' VAL . 18.8 Cg_endo -38.74 157.7 0.03 OUTLIER 'Trans proline' 0 CA--C 1.498 -1.294 0 O-C-N 123.833 1.439 . . . . 0.0 110.352 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.898 ' HA ' ' HA3' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -79.54 -21.8 44.72 Favored 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 116.282 -2.167 . . . . 0.0 115.558 -173.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.76 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -136.73 39.16 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -177.497 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.928 ' HB3' ' CD ' ' A' ' 99' ' ' PRO . . . -64.89 -73.51 0.21 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 120.483 -1.385 . . . . 0.0 108.562 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.996 ' CB ' HD13 ' A' ' 58' ' ' ILE . 53.8 Cg_endo -70.25 162.31 42.77 Favored 'Trans proline' 0 CA--C 1.463 -3.034 0 CA-C-O 123.177 1.24 . . . . 0.0 109.659 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.739 ' HD2' ' C ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -105.72 99.23 8.84 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 112.697 -2.047 . . . . 0.0 110.735 -169.003 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.455 ' C ' ' O ' ' A' ' 100' ' ' LYS . 12.8 p -46.77 99.84 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 123.654 1.692 . . . . 0.0 108.463 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.413 95.9 mt-10 -163.43 -51.65 0.04 OUTLIER 'General case' 0 CA--C 1.449 -2.911 0 CA-C-N 112.72 -2.036 . . . . 0.0 110.562 -179.474 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.445 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.499 0.7 OUTLIER -158.31 74.76 0.71 Allowed 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 110.504 -3.043 . . . . 0.0 111.295 -163.278 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.893 HG22 ' HA ' ' A' ' 58' ' ' ILE . 14.3 t -142.1 141.06 29.25 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.543 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.924 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.975 HG13 HD11 ' A' ' 121' ' ' ILE . 1.2 t -145.5 131.21 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.789 HG23 ' HB2' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -103.91 140.9 20.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 122.288 1.042 . . . . 0.0 111.704 -178.778 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 1.023 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -132.47 110.75 10.73 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 179.427 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.999 HG21 HD12 ' A' ' 54' ' ' ILE . 3.6 t -125.73 140.83 47.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 O-C-N 120.133 -1.604 . . . . 0.0 109.229 -177.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.95 ' HB2' ' CB ' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -130.78 148.27 52.54 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 122.526 1.155 . . . . 0.0 112.057 -178.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 1.104 HG23 HD12 ' A' ' 88' ' ' ILE . 3.0 t -96.35 125.24 49.28 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 176.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.527 ' HG2' ' O ' ' A' ' 111' ' ' MET . 2.2 ptm -105.4 121.2 43.41 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.546 ' HA3' HD23 ' A' ' 117' ' ' LEU . . . -80.35 -139.31 2.21 Favored Glycine 0 N--CA 1.496 2.665 0 C-N-CA 119.031 -1.557 . . . . 0.0 114.311 -175.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.658 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 14.9 p-10 -77.8 -5.74 51.79 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 122.41 1.1 . . . . 0.0 112.051 -177.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 8.3 p30 -129.35 -5.27 4.83 Favored 'General case' 0 C--N 1.266 -3.057 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.097 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.692 ' C ' HG12 ' A' ' 116' ' ' VAL . . . 88.69 85.77 1.24 Allowed Glycine 0 CA--C 1.469 -2.844 0 CA-C-O 124.821 2.345 . . . . 0.0 109.745 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.692 HG12 ' C ' ' A' ' 115' ' ' GLY . 4.3 p 143.04 145.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.246 -3.91 0 CA-C-N 108.37 -3.915 . . . . 0.0 111.631 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.808 ' CB ' HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -162.05 -58.57 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.479 -0.763 . . . . 0.0 110.9 179.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.777 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -167.97 131.84 1.68 Allowed 'General case' 0 N--CA 1.514 2.747 0 O-C-N 121.31 -0.869 . . . . 0.0 109.161 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.95 ' CB ' ' HB2' ' A' ' 109' ' ' LYS . 0.8 OUTLIER -134.14 138.27 45.09 Favored 'General case' 0 C--N 1.28 -2.436 0 C-N-CA 117.428 -1.709 . . . . 0.0 113.595 -177.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.717 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -143.59 135.66 26.73 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 122.912 1.339 . . . . 0.0 112.248 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 1.023 ' HB ' HG23 ' A' ' 107' ' ' THR 0.277 0.0 OUTLIER -111.13 134.76 52.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 114.182 -1.372 . . . . 0.0 111.808 -178.863 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.757 ' N ' HD13 ' A' ' 121' ' ' ILE . . . . . . . . 0 N--CA 1.492 1.656 0 O-C-N 120.819 -1.176 . . . . 0.0 109.022 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.47 ' O ' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 120.628 0.251 . . . . 0.0 110.786 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.858 HG12 ' HA ' ' A' ' 22' ' ' HIS . 1.4 m -145.19 177.66 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 O-C-N 120.758 -1.214 . . . . 0.0 108.118 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.487 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -79.62 137.78 37.22 Favored 'General case' 0 CA--C 1.479 -1.761 0 C-N-CA 117.978 -1.489 . . . . 0.0 108.521 177.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.5 ' O ' ' HG2' ' A' ' 6' ' ' LYS 0.429 0.4 OUTLIER -166.16 168.67 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 C-N-CA 118.033 -1.467 . . . . 0.0 110.814 -169.785 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.52 ' HB2' HG22 ' A' ' 121' ' ' ILE . 0.8 OUTLIER -147.37 137.13 22.91 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 123.664 1.697 . . . . 0.0 112.312 -179.466 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.273 0.8 OUTLIER -80.17 146.28 31.87 Favored 'General case' 0 C--N 1.267 -2.987 0 CA-C-N 113.378 -1.737 . . . . 0.0 109.71 178.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.658 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.4 p -137.31 15.9 2.98 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.958 -1.089 . . . . 0.0 109.303 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.867 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -125.54 -85.26 0.63 Allowed 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.706 -1.197 . . . . 0.0 109.941 -177.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.565 ' O ' ' N ' ' A' ' 12' ' ' GLU . 2.3 t30 -159.95 65.23 0.35 Allowed 'General case' 0 C--N 1.265 -3.07 0 C-N-CA 118.219 -1.392 . . . . 0.0 112.174 177.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.474 ' C ' ' O ' ' A' ' 10' ' ' ASN . 28.8 m170 33.79 31.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.777 0.799 . . . . 0.0 110.807 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.1 OUTLIER -90.51 23.26 3.07 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.908 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.079 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.28 0.0 OUTLIER -119.22 -168.75 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-O 121.978 0.894 . . . . 0.0 110.733 -178.616 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.636 ' N ' HG23 ' A' ' 13' ' ' ILE . 7.0 ptpt -162.54 -44.31 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.994 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.619 ' HB3' HG23 ' A' ' 40' ' ' VAL . 28.9 tttp -149.0 139.02 22.11 Favored 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 116.556 -2.057 . . . . 0.0 113.28 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 1.027 HG13 ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -133.21 107.41 11.29 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-O 122.841 1.305 . . . . 0.0 110.21 179.029 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.504 ' HA ' HD23 ' A' ' 17' ' ' LEU . 1.8 mt -106.77 129.25 54.67 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.124 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.683 HG22 ' HA ' ' A' ' 37' ' ' LEU . 11.9 t -141.41 144.84 35.5 Favored Pre-proline 0 C--N 1.294 -1.816 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.949 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.533 ' HD2' ' CG1' ' A' ' 18' ' ' VAL . 46.9 Cg_endo -71.26 112.77 3.41 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.725 1.381 . . . . 0.0 111.42 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 128.86 -84.95 0.32 Allowed Glycine 0 N--CA 1.488 2.148 0 C-N-CA 119.486 -1.34 . . . . 0.0 109.775 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.416 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 3.5 m -74.56 108.76 7.53 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.596 -0.943 . . . . 0.0 110.12 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.858 ' HA ' HG12 ' A' ' 3' ' ' VAL . 1.0 OUTLIER -121.75 17.59 11.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.037 -1.664 . . . . 0.0 110.887 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 C-N-CA 118.43 -1.843 . . . . 0.0 110.877 177.183 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.911 ' HA3' ' HA ' ' A' ' 96' ' ' LYS . . . . . . . . 0 C--O 1.215 -1.038 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.813 ' O ' HG22 ' A' ' 94' ' ' VAL . 1.5 mmmp? -126.21 89.87 51.35 Favored Pre-proline 0 C--O 1.22 -0.448 0 CA-C-N 120.83 2.315 . . . . 0.0 115.734 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.554 ' C ' ' CD1' ' A' ' 35' ' ' PHE . 60.8 Cg_endo -109.32 141.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.29 -2.515 0 C-N-CA 124.673 3.582 . . . . 0.0 108.743 177.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.554 ' CD1' ' C ' ' A' ' 34' ' ' PRO . 1.0 OUTLIER -124.14 98.22 5.68 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 118.075 -1.45 . . . . 0.0 110.311 179.358 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.588 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 26.3 mp0 -114.15 81.28 1.51 Allowed 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.683 ' HA ' HG22 ' A' ' 18' ' ' VAL . 3.4 pp -113.07 142.46 45.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.674 -1.266 . . . . 0.0 110.181 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -140.47 138.01 34.31 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 122.595 1.188 . . . . 0.0 108.451 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 1.027 ' HB2' HG13 ' A' ' 16' ' ' VAL . . . -142.07 153.11 43.93 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-O 123.03 1.395 . . . . 0.0 113.292 -176.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.619 HG23 ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.41 141.21 26.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 113.697 -1.592 . . . . 0.0 109.007 178.47 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.578 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 3.5 p90 -155.79 121.78 5.06 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 8.8 tt0 -68.22 156.38 37.73 Favored 'General case' 0 C--N 1.287 -2.125 0 O-C-N 120.35 -1.469 . . . . 0.0 109.178 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.936 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -92.22 136.36 33.25 Favored 'General case' 0 C--N 1.269 -2.921 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.807 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.584 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 0.3 OUTLIER -116.65 49.73 1.13 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 125.376 2.512 . . . . 0.0 113.78 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.586 ' C ' ' HB2' ' A' ' 82' ' ' LYS . 6.4 pt20 166.59 -158.35 0.01 OUTLIER 'General case' 0 C--N 1.258 -3.401 0 CA-C-N 108.999 -3.728 . . . . 0.0 112.97 175.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.538 ' C ' HG22 ' A' ' 47' ' ' THR 0.285 28.7 t-20 -109.99 154.78 22.69 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-O 122.596 1.188 . . . . 0.0 108.97 -178.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.63 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.1 OUTLIER -172.85 150.97 2.15 Favored 'General case' 0 C--N 1.255 -3.535 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.202 -178.275 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.949 ' O ' HG23 ' A' ' 49' ' ' THR . 0.3 OUTLIER -112.28 11.16 20.1 Favored 'General case' 0 N--CA 1.506 2.371 0 C-N-CA 118.16 -1.416 . . . . 0.0 110.185 178.406 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.949 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.61 145.49 3.81 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 120.706 -1.246 . . . . 0.0 111.069 178.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 111' ' ' MET . . . -139.73 95.13 2.86 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-O 122.988 1.375 . . . . 0.0 109.544 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -65.92 -178.27 0.57 Allowed 'General case' 0 C--N 1.281 -2.374 0 CA-C-N 113.836 -1.529 . . . . 0.0 109.711 178.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.821 ' CG1' HD11 ' A' ' 88' ' ' ILE . 35.7 mt -142.14 144.18 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.357 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 0.4 OUTLIER -140.52 104.01 4.66 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 123.425 1.583 . . . . 0.0 109.75 178.397 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 1.057 ' HA ' HG13 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -93.06 126.29 45.51 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 CA-C-N 112.503 -2.135 . . . . 0.0 107.301 179.252 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.869 ' N ' HD13 ' A' ' 54' ' ' ILE . 0.5 OUTLIER -129.86 149.84 51.42 Favored 'General case' 0 C--N 1.272 -2.802 0 C-N-CA 118.448 -1.301 . . . . 0.0 108.145 178.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 1.05 ' HB3' HG22 ' A' ' 63' ' ' VAL . . . -135.58 127.46 29.41 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 117.694 -1.603 . . . . 0.0 111.475 -178.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.746 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 2.2 p -101.3 100.3 10.78 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 177.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.931 ' HA ' HG22 ' A' ' 104' ' ' VAL . 0.8 OUTLIER -115.47 102.4 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.738 0 CA-C-O 123.089 1.423 . . . . 0.0 110.983 -176.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.571 ' N ' HG22 ' A' ' 104' ' ' VAL . 0.1 OUTLIER 38.28 64.95 0.65 Allowed 'General case' 0 N--CA 1.521 3.121 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.326 179.055 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.53 -13.66 7.91 Favored Glycine 0 N--CA 1.489 2.176 0 O-C-N 121.263 -0.898 . . . . 0.0 111.311 177.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.495 ' HB3' HG13 ' A' ' 58' ' ' ILE 0.278 0.3 OUTLIER -108.14 54.88 0.65 Allowed 'General case' 0 C--N 1.294 -1.841 0 O-C-N 121.205 -1.173 . . . . 0.0 111.495 -178.528 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.635 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.366 0.0 OUTLIER -59.4 117.5 4.91 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 122.527 1.156 . . . . 0.0 111.397 -179.531 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 1.05 HG22 ' HB3' ' A' ' 56' ' ' ALA . 18.8 m -80.19 148.22 5.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-O 122.56 1.172 . . . . 0.0 111.103 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.441 5.9 t70 -137.8 82.11 1.9 Allowed 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.319 -176.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.602 HG22 ' HD2' ' A' ' 66' ' ' PRO . 9.8 p -164.23 151.46 10.25 Favored Pre-proline 0 C--N 1.277 -2.565 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.427 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.602 ' HD2' HG22 ' A' ' 65' ' ' VAL . 45.5 Cg_endo -85.43 139.14 6.72 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 CA-C-O 123.643 1.435 . . . . 0.0 111.719 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.588 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -127.66 48.08 0.99 Allowed Glycine 0 N--CA 1.501 3.02 0 CA-C-N 112.69 -2.05 . . . . 0.0 110.77 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.57 ' O ' ' HD2' ' A' ' 70' ' ' PRO 0.302 5.8 tp 179.68 -174.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 CA-C-N 119.476 1.638 . . . . 0.0 110.024 -178.607 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.585 ' OD2' ' CZ ' ' A' ' 75' ' ' TYR . 1.1 t70 -109.71 84.25 3.18 Favored Pre-proline 0 N--CA 1.504 2.252 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 175.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.786 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 21.0 Cg_endo -48.92 -9.64 0.1 OUTLIER 'Trans proline' 0 C--N 1.279 -3.097 0 C-N-CA 123.556 2.837 . . . . 0.0 115.312 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.551 ' HB2' ' NE2' ' A' ' 74' ' ' HIS . 1.2 m120 -105.42 83.8 2.01 Favored 'General case' 0 C--N 1.287 -2.151 0 O-C-N 120.212 -1.555 . . . . 0.0 108.699 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.644 ' HA ' ' CD1' ' A' ' 75' ' ' TYR . . . -78.44 10.79 2.84 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.505 -0.747 . . . . 0.0 109.402 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.61 -19.92 54.76 Favored 'General case' 0 C--N 1.317 -0.842 0 O-C-N 120.507 -1.371 . . . . 0.0 108.177 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.578 ' ND1' ' N ' ' A' ' 74' ' ' HIS . 0.1 OUTLIER -88.24 18.85 4.06 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 174.203 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.644 ' CD1' ' HA ' ' A' ' 72' ' ' ALA . 0.4 OUTLIER -133.18 -9.38 2.97 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.241 179.774 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.485 ' O ' ' C ' ' A' ' 77' ' ' LYS . 1.6 ptt? -162.62 128.18 3.33 Favored 'General case' 0 C--O 1.215 -0.749 0 CA-C-O 123.6 1.667 . . . . 0.0 112.859 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.578 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 0.6 OUTLIER -4.47 86.93 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 112.042 -2.345 . . . . 0.0 113.559 -178.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.472 ' HA ' HD13 ' A' ' 80' ' ' LEU 0.297 11.1 t -99.02 136.92 20.43 Favored Pre-proline 0 C--N 1.262 -3.197 0 CA-C-N 111.364 -2.653 . . . . 0.0 108.714 178.094 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.701 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 37.3 Cg_endo -78.48 165.95 81.24 Favored 'Cis proline' 0 C--N 1.312 -1.343 0 C-N-CA 123.007 -1.664 . . . . 0.0 112.906 1.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.714 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -89.1 127.39 35.71 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.44 179.445 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.528 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.7 t -106.32 139.47 27.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-O 124.129 1.918 . . . . 0.0 111.616 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.586 ' HB2' ' C ' ' A' ' 45' ' ' GLN . 1.6 tmmt? -44.38 117.97 1.4 Allowed 'General case' 0 C--N 1.271 -2.842 0 CA-C-N 111.686 -2.507 . . . . 0.0 116.924 -175.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.19 -17.6 16.77 Favored Glycine 0 C--N 1.293 -1.808 0 CA-C-N 111.693 -2.503 . . . . 0.0 107.845 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.626 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 14.7 mt-30 -72.63 128.63 36.14 Favored 'General case' 0 C--N 1.277 -2.56 0 CA-C-O 123.215 1.483 . . . . 0.0 111.585 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.581 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 0.7 OUTLIER -66.47 145.87 55.18 Favored 'General case' 0 C--N 1.27 -2.859 0 CA-C-N 113.336 -1.756 . . . . 0.0 107.437 178.341 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.936 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 19.4 m-85 -142.53 124.92 15.59 Favored 'General case' 0 C--N 1.275 -2.64 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -178.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.576 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 4.5 p30 -116.93 133.29 56.2 Favored 'General case' 0 C--N 1.278 -2.543 0 CA-C-O 122.772 1.272 . . . . 0.0 110.233 -177.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.821 HD11 ' CG1' ' A' ' 52' ' ' ILE . 1.1 tp -108.73 159.4 8.15 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 CA-C-N 114.46 -1.246 . . . . 0.0 108.335 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.521 ' HG2' ' N ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -143.24 149.63 38.18 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 120.125 -0.63 . . . . 0.0 112.182 -176.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.605 ' CE1' ' HB2' ' A' ' 92' ' ' TRP . 25.5 t80 -147.22 105.62 3.79 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.421 -0.799 . . . . 0.0 110.489 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.588 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 1.1 t -123.93 110.9 15.4 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.605 ' HB2' ' CE1' ' A' ' 90' ' ' TYR 0.272 0.0 OUTLIER -142.41 109.11 5.39 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.719 -176.662 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.6 OUTLIER -77.29 153.09 34.23 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 119.735 -1.853 . . . . 0.0 109.496 -179.476 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.813 HG22 ' O ' ' A' ' 33' ' ' LYS . 0.8 OUTLIER -154.31 175.36 3.11 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 120.682 -1.261 . . . . 0.0 108.999 -179.73 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.569 ' HD2' ' HB ' ' A' ' 94' ' ' VAL . 18.3 Cg_endo -38.12 156.38 0.03 OUTLIER 'Trans proline' 0 CA--C 1.495 -1.464 0 O-C-N 123.589 1.31 . . . . 0.0 111.127 -177.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.911 ' HA ' ' HA3' ' A' ' 32' ' ' GLY . 2.4 mptt -80.12 -27.97 39.05 Favored 'General case' 0 C--N 1.285 -2.218 0 C-N-CA 116.555 -2.058 . . . . 0.0 116.04 -173.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.774 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -145.42 43.22 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 -177.348 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.939 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . . . -60.33 -53.27 66.49 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 120.367 -1.458 . . . . 0.0 109.736 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.939 ' HD3' ' HB3' ' A' ' 98' ' ' ALA . 55.6 Cg_endo -73.67 160.78 43.3 Favored 'Trans proline' 0 CA--C 1.466 -2.904 0 O-C-N 124.145 1.603 . . . . 0.0 111.13 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.722 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -110.27 106.37 15.75 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 112.236 -2.256 . . . . 0.0 111.104 -169.392 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.473 ' C ' ' O ' ' A' ' 100' ' ' LYS . 1.5 p -40.88 95.32 0.01 OUTLIER 'General case' 0 N--CA 1.519 3.021 0 CA-C-O 123.496 1.617 . . . . 0.0 110.469 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.581 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.387 84.7 mt-10 -164.93 -52.72 0.03 OUTLIER 'General case' 0 CA--C 1.448 -2.952 0 CA-C-N 112.959 -1.928 . . . . 0.0 111.214 178.468 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.461 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.486 0.8 OUTLIER -161.25 77.62 0.56 Allowed 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 110.583 -3.008 . . . . 0.0 113.466 -162.016 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.931 HG22 ' HA ' ' A' ' 58' ' ' ILE . 21.8 t -144.28 141.44 24.37 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.63 0 C-N-CA 119.32 -0.952 . . . . 0.0 111.907 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.698 HG12 ' CD1' ' A' ' 121' ' ' ILE . 0.3 OUTLIER -153.75 133.26 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 121' ' ' ILE . 0.4 OUTLIER -94.32 143.56 11.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-O 122.357 1.075 . . . . 0.0 110.994 -179.287 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 1.074 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -131.75 116.65 17.56 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 179.642 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.057 HG13 ' HA ' ' A' ' 54' ' ' ILE . 3.5 t -132.19 139.37 50.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 O-C-N 120.247 -1.533 . . . . 0.0 108.481 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 1.009 ' HB2' ' HB2' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -132.96 146.49 51.83 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.364 1.078 . . . . 0.0 111.187 -178.44 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.655 ' CG2' HD13 ' A' ' 88' ' ' ILE . 2.9 t -99.94 127.8 52.47 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 178.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.504 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -108.29 121.99 46.03 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -179.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -74.62 -131.34 0.24 Allowed Glycine 0 C--N 1.283 -2.39 0 C-N-CA 119.22 -1.467 . . . . 0.0 114.625 -175.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.63 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 6.2 p-10 -97.76 9.56 42.3 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -175.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 32.7 p30 -167.17 -13.68 0.02 OUTLIER 'General case' 0 C--N 1.263 -3.156 0 C-N-CA 117.224 -1.791 . . . . 0.0 114.464 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -153.66 -88.15 0.06 OUTLIER Glycine 0 CA--C 1.475 -2.463 0 CA-C-O 125.879 2.933 . . . . 0.0 112.338 -177.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.629 HG22 ' H ' ' A' ' 117' ' ' LEU . 4.1 p -141.51 178.93 2.39 Favored 'Isoleucine or valine' 1 C--N 1.228 -4.692 1 CA-C-N 108.155 -4.022 . . . . 0.0 111.014 -176.785 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.642 ' HB3' HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -149.3 -62.72 0.23 Allowed 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.255 -179.422 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 1.079 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -164.15 129.66 2.91 Favored 'General case' 0 N--CA 1.51 2.526 0 O-C-N 120.872 -1.142 . . . . 0.0 109.756 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 1.009 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 1.5 p -133.98 134.73 42.85 Favored 'General case' 0 C--N 1.283 -2.321 0 C-N-CA 117.975 -1.49 . . . . 0.0 113.35 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.4 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -144.17 136.3 26.42 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 122.913 1.339 . . . . 0.0 112.153 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 1.074 ' HB ' HG23 ' A' ' 107' ' ' THR 0.268 0.1 OUTLIER -110.79 130.78 63.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.176 -179.495 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.659 ' N ' HD13 ' A' ' 121' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.536 0 O-C-N 120.862 -1.149 . . . . 0.0 108.977 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 120.715 0.293 . . . . 0.0 111.042 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.744 HG12 ' HA ' ' A' ' 22' ' ' HIS . 1.4 m -145.58 177.6 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 O-C-N 120.892 -1.13 . . . . 0.0 108.032 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.49 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -80.22 139.3 36.78 Favored 'General case' 0 CA--C 1.477 -1.864 0 C-N-CA 118.007 -1.477 . . . . 0.0 108.823 177.502 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.517 HG11 HG23 ' A' ' 16' ' ' VAL 0.425 0.4 OUTLIER -168.58 160.71 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 CA-C-N 114.029 -1.442 . . . . 0.0 110.057 -170.22 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 5' ' ' VAL . 3.5 mtpt -144.44 140.12 28.77 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 123.785 1.755 . . . . 0.0 113.116 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.27 4.4 t0 -76.36 147.81 37.83 Favored 'General case' 0 C--N 1.267 -2.994 0 CA-C-N 112.932 -1.94 . . . . 0.0 109.786 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.648 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.0 p -137.04 16.01 3.04 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.968 -1.082 . . . . 0.0 109.162 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.876 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -125.03 -82.71 0.64 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.033 -176.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.574 ' O ' ' N ' ' A' ' 12' ' ' GLU . 2.4 t30 -155.79 63.56 0.59 Allowed 'General case' 0 C--N 1.267 -2.991 0 C-N-CA 118.319 -1.352 . . . . 0.0 111.81 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.478 ' C ' ' O ' ' A' ' 10' ' ' ASN . 59.2 m-70 32.02 33.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.854 0.835 . . . . 0.0 110.573 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.6 OUTLIER -95.09 22.47 6.61 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.72 -0.792 . . . . 0.0 111.591 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.026 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.276 0.2 OUTLIER -118.42 -170.36 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.413 -0.804 . . . . 0.0 110.001 -179.116 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.62 ' H ' HG23 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -161.86 -41.43 0.04 OUTLIER 'General case' 0 C--N 1.29 -2.011 0 O-C-N 121.731 -0.605 . . . . 0.0 111.492 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.586 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 11.6 tttm -147.72 138.13 23.08 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 115.89 -2.324 . . . . 0.0 113.145 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.829 HG13 ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -134.52 104.11 5.25 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 CA-C-O 122.897 1.332 . . . . 0.0 110.363 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.501 ' HB2' ' OE2' ' A' ' 38' ' ' GLU . 1.2 mt -99.52 125.65 45.32 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.776 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.706 HG22 ' CB ' ' A' ' 37' ' ' LEU . 40.5 t -141.72 145.4 36.85 Favored Pre-proline 0 N--CA 1.5 2.03 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.025 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.542 ' HD2' ' CG1' ' A' ' 18' ' ' VAL . 44.7 Cg_endo -68.64 134.87 31.6 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 O-C-N 123.772 1.406 . . . . 0.0 111.312 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.48 -76.24 0.22 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.2 m -85.7 134.05 33.99 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.468 -1.019 . . . . 0.0 109.651 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.744 ' HA ' HG12 ' A' ' 3' ' ' VAL . 4.0 p80 -142.26 12.55 1.98 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 119.998 -1.689 . . . . 0.0 110.948 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 C-N-CA 118.364 -1.874 . . . . 0.0 110.931 177.102 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.888 ' HA2' ' HA ' ' A' ' 96' ' ' LYS . . . . . . . . 0 C--O 1.213 -1.178 0 N-CA-C 105.887 -2.885 . . . . 0.0 105.887 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.973 ' HB2' HG12 ' A' ' 94' ' ' VAL . 0.7 OUTLIER -117.28 96.77 49.84 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 120.66 2.23 . . . . 0.0 116.577 -175.059 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.592 ' HD3' ' O ' ' A' ' 32' ' ' GLY . 60.8 Cg_endo -107.02 145.39 0.08 OUTLIER 'Trans proline' 0 C--N 1.288 -2.631 0 C-N-CA 123.864 3.042 . . . . 0.0 108.546 176.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.73 ' HZ ' HG11 ' A' ' 94' ' ' VAL . 0.5 OUTLIER -120.53 96.52 5.17 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 118.582 -1.247 . . . . 0.0 109.182 179.002 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.594 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 28.0 mp0 -113.82 83.71 1.9 Allowed 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.706 ' CB ' HG22 ' A' ' 18' ' ' VAL . 2.1 pp -110.17 144.68 38.45 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.686 -1.258 . . . . 0.0 109.768 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.546 ' CB ' ' HG2' ' A' ' 89' ' ' LYS . 1.5 pp20? -140.44 139.07 35.14 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 122.7 1.238 . . . . 0.0 108.816 -178.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.829 ' HB2' HG13 ' A' ' 16' ' ' VAL . . . -142.56 148.74 38.04 Favored 'General case' 0 C--N 1.275 -2.649 0 CA-C-O 122.986 1.374 . . . . 0.0 112.968 -176.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.586 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.35 140.07 31.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 113.817 -1.538 . . . . 0.0 108.87 178.535 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.607 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 6.7 p90 -157.19 126.93 6.17 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -178.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 17.3 tt0 -70.41 156.96 38.64 Favored 'General case' 0 C--N 1.283 -2.319 0 O-C-N 120.388 -1.445 . . . . 0.0 108.815 178.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.982 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -89.41 136.07 33.24 Favored 'General case' 0 C--N 1.265 -3.089 0 CA-C-N 114.21 -1.359 . . . . 0.0 107.996 178.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.569 ' C ' ' HG2' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -117.43 49.93 1.16 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 125.398 2.523 . . . . 0.0 114.242 179.535 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.748 ' N ' ' HG3' ' A' ' 82' ' ' LYS . 7.0 pt20 167.54 -159.18 0.01 OUTLIER 'General case' 0 C--N 1.258 -3.393 0 CA-C-N 108.77 -3.832 . . . . 0.0 112.901 174.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.445 ' C ' HG22 ' A' ' 47' ' ' THR 0.274 20.3 t-20 -108.78 153.55 23.32 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-O 122.622 1.201 . . . . 0.0 108.408 -178.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.615 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -172.65 154.33 3.01 Favored 'General case' 0 C--N 1.254 -3.569 0 C-N-CA 118.588 -1.245 . . . . 0.0 112.836 -178.215 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.956 ' O ' HG23 ' A' ' 49' ' ' THR . 1.2 mtpm? -115.07 7.03 15.35 Favored 'General case' 0 N--CA 1.508 2.452 0 O-C-N 120.74 -1.225 . . . . 0.0 110.926 178.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.956 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.93 149.81 4.45 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.608 -1.307 . . . . 0.0 111.194 179.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 70' ' ' PRO . . . -150.59 109.07 3.8 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-O 122.55 1.167 . . . . 0.0 110.954 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 1.2 ptpt -77.24 -173.39 2.81 Favored 'General case' 0 N--CA 1.506 2.327 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.368 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.817 ' CG1' HD11 ' A' ' 88' ' ' ILE . 35.0 mt -141.84 139.92 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.368 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.419 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.428 ' C ' HG13 ' A' ' 108' ' ' VAL . 3.5 tp10 -140.79 110.03 6.22 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 123.343 1.544 . . . . 0.0 111.168 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 1.013 HD12 HG21 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -91.12 128.59 42.82 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 CA-C-N 112.746 -2.024 . . . . 0.0 109.934 179.373 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.418 ' HD2' ' C ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -123.77 103.85 8.62 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 176.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.847 ' HB2' HG23 ' A' ' 106' ' ' VAL . . . -113.75 134.41 54.78 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 118.708 -1.197 . . . . 0.0 113.183 -175.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.7 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.1 p -106.64 100.79 10.28 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 178.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.867 ' CA ' HG13 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -110.68 107.84 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.939 0 CA-C-O 122.986 1.374 . . . . 0.0 110.774 -177.259 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.655 ' N ' HG22 ' A' ' 104' ' ' VAL . 0.5 OUTLIER 33.06 63.49 0.33 Allowed 'General case' 0 N--CA 1.519 2.992 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.977 179.634 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.72 -14.31 10.3 Favored Glycine 0 N--CA 1.489 2.2 0 O-C-N 121.352 -0.842 . . . . 0.0 111.525 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.511 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.274 0.3 OUTLIER -108.19 57.68 0.62 Allowed 'General case' 0 C--N 1.292 -1.897 0 O-C-N 121.087 -1.243 . . . . 0.0 111.175 -178.536 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.519 ' O ' ' CG ' ' A' ' 62' ' ' GLU 0.366 0.0 OUTLIER -58.61 114.44 2.49 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 122.1 0.952 . . . . 0.0 111.139 -179.696 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.836 HG22 ' HB3' ' A' ' 56' ' ' ALA . 15.0 m -74.95 144.89 11.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 122.586 1.184 . . . . 0.0 110.573 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.435 19.2 t0 -138.07 68.94 1.39 Allowed 'General case' 0 C--N 1.278 -2.526 0 CA-C-O 122.621 1.2 . . . . 0.0 110.572 -176.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.722 HG22 ' HD2' ' A' ' 66' ' ' PRO . 4.8 p -164.03 151.89 10.87 Favored Pre-proline 0 C--N 1.272 -2.797 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.952 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.722 ' HD2' HG22 ' A' ' 65' ' ' VAL . 43.4 Cg_endo -83.26 137.84 8.49 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 CA-C-O 123.804 1.502 . . . . 0.0 111.719 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -125.19 50.14 0.88 Allowed Glycine 0 C--N 1.273 -2.963 0 CA-C-N 112.461 -2.154 . . . . 0.0 110.253 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.578 ' HB ' ' CD2' ' A' ' 90' ' ' TYR 0.304 6.4 tp -178.78 -176.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 O-C-N 120.532 -1.569 . . . . 0.0 110.061 -178.56 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.497 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 29.9 t0 -112.35 83.64 5.45 Favored Pre-proline 0 N--CA 1.502 2.154 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 175.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.71 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 19.1 Cg_endo -47.68 -8.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.289 -2.601 0 C-N-CA 124.275 3.317 . . . . 0.0 115.826 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.578 ' HB2' ' NE2' ' A' ' 74' ' ' HIS . 2.4 m-80 -101.62 90.41 4.04 Favored 'General case' 0 C--N 1.286 -2.167 0 O-C-N 120.2 -1.562 . . . . 0.0 109.74 -178.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.784 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . . . -78.02 7.14 6.52 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.295 -0.878 . . . . 0.0 109.478 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.9 t -79.11 -26.58 42.9 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 121.034 -1.041 . . . . 0.0 109.044 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.578 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -79.71 6.78 9.9 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.895 -1.122 . . . . 0.0 108.943 177.217 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.784 ' CD2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -133.68 -0.48 3.17 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 121.364 -0.835 . . . . 0.0 109.966 177.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.631 ' HE3' HD21 ' A' ' 80' ' ' LEU . 2.6 ptt? -150.34 126.81 10.79 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 123.89 1.805 . . . . 0.0 112.86 178.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.541 ' O ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -20.07 95.25 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 112.006 -2.361 . . . . 0.0 113.159 -178.255 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.508 ' HA ' HD13 ' A' ' 80' ' ' LEU 0.311 0.5 OUTLIER -100.77 144.47 28.58 Favored Pre-proline 0 C--N 1.268 -2.968 0 CA-C-N 111.437 -2.62 . . . . 0.0 109.128 179.01 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.647 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 35.8 Cg_endo -81.37 168.81 68.08 Favored 'Cis proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.792 -1.753 . . . . 0.0 112.16 0.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.722 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -96.75 130.25 44.03 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.25 -179.389 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.541 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.8 t -106.35 139.41 27.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-O 124.109 1.909 . . . . 0.0 111.954 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.748 ' HG3' ' N ' ' A' ' 45' ' ' GLN . 2.3 tmpt? -42.65 120.96 1.86 Allowed 'General case' 0 C--N 1.271 -2.841 0 CA-C-N 111.902 -2.408 . . . . 0.0 115.955 -175.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.35 -16.63 24.43 Favored Glycine 0 C--N 1.291 -1.957 0 CA-C-N 111.97 -2.377 . . . . 0.0 108.38 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 16.6 mt-30 -73.61 126.42 30.25 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-O 123.223 1.487 . . . . 0.0 111.786 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.608 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -64.04 143.18 58.07 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 113.271 -1.786 . . . . 0.0 107.539 179.084 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.982 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 18.7 m-85 -143.29 126.01 16.02 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.58 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 1.2 p-10 -117.12 132.55 56.64 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-O 122.712 1.244 . . . . 0.0 109.902 -178.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.817 HD11 ' CG1' ' A' ' 52' ' ' ILE . 0.9 OUTLIER -110.55 160.79 9.46 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.24 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.546 ' HG2' ' CB ' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -148.15 161.15 42.03 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-O 122.031 0.92 . . . . 0.0 113.203 -177.209 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.578 ' CD2' ' HB ' ' A' ' 68' ' ' ILE . 28.0 t80 -151.17 105.62 3.24 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.559 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.594 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 0.6 OUTLIER -122.3 111.51 17.0 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 178.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.577 ' CD1' ' O ' ' A' ' 67' ' ' GLY 0.271 0.3 OUTLIER -141.99 116.81 9.84 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.446 -176.824 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.3 OUTLIER -75.16 161.72 29.13 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 119.237 -2.164 . . . . 0.0 109.795 -179.014 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.973 HG12 ' HB2' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -151.48 165.84 16.5 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.896 ' HD2' HG22 ' A' ' 94' ' ' VAL . 19.8 Cg_endo -38.26 154.26 0.03 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.178 0 O-C-N 123.586 1.309 . . . . 0.0 110.505 -177.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.888 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 8.5 mptt -79.35 -28.15 42.03 Favored 'General case' 0 C--N 1.285 -2.228 0 C-N-CA 116.566 -2.053 . . . . 0.0 114.725 -173.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.758 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -143.41 43.07 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 CA-C-O 121.402 0.62 . . . . 0.0 112.541 -178.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.941 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . . . -76.53 -64.48 0.48 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 120.562 -1.336 . . . . 0.0 109.903 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.941 ' HD3' ' HB3' ' A' ' 98' ' ' ALA . 47.2 Cg_endo -66.13 159.87 47.48 Favored 'Trans proline' 0 CA--C 1.463 -3.057 0 O-C-N 123.94 1.495 . . . . 0.0 110.045 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.71 ' HD2' ' C ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -108.58 105.39 14.99 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-N 112.517 -2.129 . . . . 0.0 109.874 -169.587 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.472 ' C ' ' O ' ' A' ' 100' ' ' LYS . 5.5 p -46.2 98.62 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 123.37 1.557 . . . . 0.0 108.195 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.593 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.402 88.1 mt-10 -164.0 -51.54 0.03 OUTLIER 'General case' 0 CA--C 1.448 -2.945 0 CA-C-N 113.195 -1.82 . . . . 0.0 111.987 -179.115 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.481 0.8 OUTLIER -159.52 78.27 0.71 Allowed 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 111.159 -2.746 . . . . 0.0 114.01 -162.073 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.867 HG13 ' CA ' ' A' ' 58' ' ' ILE . 28.5 t -142.31 137.8 29.45 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.875 178.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 1.092 HG12 HD11 ' A' ' 121' ' ' ILE . 22.0 t -147.14 133.93 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.847 HG23 ' HB2' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -106.87 146.73 12.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-O 122.806 1.288 . . . . 0.0 113.033 -178.26 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 1.045 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -132.86 109.57 9.71 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.432 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.013 HG21 HD12 ' A' ' 54' ' ' ILE . 3.9 t -127.07 144.88 35.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 119.954 -1.716 . . . . 0.0 109.043 -177.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 1.014 ' HB2' ' HB2' ' A' ' 119' ' ' CYS . 0.1 OUTLIER -136.48 143.05 43.61 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.137 0.97 . . . . 0.0 111.571 -178.018 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.643 ' CG2' HD13 ' A' ' 88' ' ' ILE . 20.9 t -96.28 130.97 44.2 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.622 ' CG ' ' HA2' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -110.69 119.53 39.45 Favored 'General case' 0 N--CA 1.509 2.506 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -178.717 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.483 ' HA3' HD23 ' A' ' 117' ' ' LEU . . . -81.69 -140.41 3.12 Favored Glycine 0 N--CA 1.5 2.946 0 C-N-CA 119.449 -1.357 . . . . 0.0 115.195 -174.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.615 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 4.4 p-10 -82.38 -6.44 59.27 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 122.267 1.032 . . . . 0.0 112.743 -176.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -128.86 -5.24 5.1 Favored 'General case' 0 C--N 1.262 -3.218 0 CA-C-O 121.747 0.784 . . . . 0.0 110.3 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.622 ' HA2' ' CG ' ' A' ' 111' ' ' MET . . . 94.43 85.3 1.64 Allowed Glycine 0 CA--C 1.471 -2.662 0 CA-C-O 124.595 2.219 . . . . 0.0 110.871 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.612 HG12 ' C ' ' A' ' 115' ' ' GLY . 7.5 p 137.11 153.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.251 -3.695 0 CA-C-N 108.409 -3.895 . . . . 0.0 112.451 176.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.632 ' CB ' HG12 ' A' ' 110' ' ' VAL . 0.2 OUTLIER -160.94 -59.97 0.06 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.284 0.564 . . . . 0.0 110.232 179.376 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 1.026 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -170.86 130.1 0.8 Allowed 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.204 -0.935 . . . . 0.0 109.085 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 1.014 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 0.9 OUTLIER -132.92 131.68 41.15 Favored 'General case' 0 C--N 1.28 -2.455 0 C-N-CA 117.769 -1.573 . . . . 0.0 112.52 -178.131 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.704 ' HB2' HD13 ' A' ' 13' ' ' ILE . . . -143.05 138.22 29.79 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 123.105 1.431 . . . . 0.0 111.866 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 1.092 HD11 HG12 ' A' ' 105' ' ' VAL 0.274 0.0 OUTLIER -111.03 132.39 59.65 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 113.891 -1.504 . . . . 0.0 111.634 -178.837 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.76 ' N ' HD13 ' A' ' 121' ' ' ILE . . . . . . . . 0 N--CA 1.489 1.523 0 O-C-N 120.936 -1.102 . . . . 0.0 109.022 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.473 ' OE1' ' N ' ' A' ' 2' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 120.703 0.287 . . . . 0.0 111.418 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.761 HG12 ' HA ' ' A' ' 22' ' ' HIS . 1.5 m -147.41 178.51 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.475 ' O ' HG23 ' A' ' 3' ' ' VAL . 7.1 t0 -80.01 137.17 36.76 Favored 'General case' 0 CA--C 1.473 -1.999 0 C-N-CA 117.509 -1.677 . . . . 0.0 108.681 177.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.5 ' C ' ' CG ' ' A' ' 6' ' ' LYS 0.434 0.4 OUTLIER -167.49 178.81 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.101 -169.795 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.668 ' O ' HG22 ' A' ' 121' ' ' ILE . 19.4 mtpt -153.31 132.68 12.83 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 123.657 1.694 . . . . 0.0 112.46 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.264 2.2 t70 -71.95 146.5 47.73 Favored 'General case' 0 C--N 1.267 -3.014 0 CA-C-N 113.42 -1.718 . . . . 0.0 109.224 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.657 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.8 p -137.32 16.07 2.98 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.03 -1.044 . . . . 0.0 109.519 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.84 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -125.3 -84.91 0.64 Allowed 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 118.815 -1.154 . . . . 0.0 110.024 -176.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 12' ' ' GLU . 2.7 t30 -158.74 65.1 0.42 Allowed 'General case' 0 C--N 1.266 -3.04 0 C-N-CA 118.249 -1.38 . . . . 0.0 112.529 177.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.608 ' CG ' ' O ' ' A' ' 11' ' ' HIS . 30.1 t-80 36.44 30.79 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 122.053 0.93 . . . . 0.0 110.266 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.539 ' CG ' ' OD1' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -92.07 21.99 4.66 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.403 -0.811 . . . . 0.0 111.847 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.992 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.268 0.0 OUTLIER -120.1 -170.31 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 122.151 0.977 . . . . 0.0 111.133 -178.794 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.637 ' N ' HG23 ' A' ' 13' ' ' ILE . 0.8 OUTLIER -162.59 -48.07 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.223 -179.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.628 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 20.5 tttp -142.28 135.8 29.13 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 116.436 -2.106 . . . . 0.0 112.621 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.702 ' CG1' ' HB2' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -133.2 102.75 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 122.903 1.335 . . . . 0.0 110.928 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.513 ' HA ' HD23 ' A' ' 17' ' ' LEU . 0.6 OUTLIER -92.56 126.11 37.5 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 114.096 -1.411 . . . . 0.0 111.52 178.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.635 HG22 ' HA ' ' A' ' 37' ' ' LEU . 59.6 t -142.85 140.96 18.84 Favored Pre-proline 0 N--CA 1.498 1.973 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.347 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.418 ' HD2' HG13 ' A' ' 18' ' ' VAL . 47.7 Cg_endo -70.72 132.73 22.35 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.629 1.331 . . . . 0.0 111.039 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 118.3 -75.37 0.29 Allowed Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.9 m -91.16 139.27 30.91 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.541 -0.976 . . . . 0.0 110.192 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.761 ' HA ' HG12 ' A' ' 3' ' ' VAL . 7.2 p80 -139.66 6.38 2.26 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.112 -1.617 . . . . 0.0 110.774 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 C-N-CA 118.506 -1.807 . . . . 0.0 111.126 176.981 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.768 ' HA2' ' HA ' ' A' ' 96' ' ' LYS . . . . . . . . 0 C--O 1.214 -1.111 0 N-CA-C 105.321 -3.112 . . . . 0.0 105.321 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.855 ' O ' HG22 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -118.26 97.07 50.52 Favored Pre-proline 0 C--O 1.218 -0.554 0 CA-C-N 121.278 2.539 . . . . 0.0 116.927 -174.538 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.575 ' HD3' ' O ' ' A' ' 32' ' ' GLY . 62.1 Cg_endo -106.15 144.53 0.1 OUTLIER 'Trans proline' 0 C--N 1.29 -2.531 0 C-N-CA 123.754 2.969 . . . . 0.0 108.142 176.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.675 ' CE2' HG11 ' A' ' 94' ' ' VAL . 14.6 m-85 -116.11 92.46 3.9 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 119.347 -0.941 . . . . 0.0 108.868 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.581 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 25.5 mp0 -115.9 88.86 2.97 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.06 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.635 ' HA ' HG22 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -108.83 138.46 45.13 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 120.672 -1.268 . . . . 0.0 108.479 179.115 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -139.76 128.42 23.12 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.702 ' HB2' ' CG1' ' A' ' 16' ' ' VAL . . . -143.33 151.49 40.53 Favored 'General case' 0 C--N 1.274 -2.678 0 CA-C-O 123.212 1.482 . . . . 0.0 113.801 -175.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.685 HG12 ' HB3' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -112.49 140.61 31.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 113.627 -1.624 . . . . 0.0 107.862 177.623 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.59 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 4.0 p90 -156.54 123.04 5.06 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -177.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 14.9 tt0 -68.07 154.84 40.83 Favored 'General case' 0 C--N 1.288 -2.087 0 O-C-N 120.425 -1.422 . . . . 0.0 108.521 178.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.972 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -90.47 131.61 36.12 Favored 'General case' 0 C--N 1.265 -3.082 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.821 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.539 ' OD1' ' CG ' ' A' ' 12' ' ' GLU . 0.1 OUTLIER -113.66 49.87 0.95 Allowed 'General case' 0 CA--C 1.482 -1.654 0 CA-C-O 125.508 2.575 . . . . 0.0 113.847 179.221 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.733 ' N ' ' HG3' ' A' ' 82' ' ' LYS . 5.7 pt20 167.0 -158.61 0.01 OUTLIER 'General case' 0 C--N 1.259 -3.344 0 CA-C-N 108.732 -3.849 . . . . 0.0 112.796 174.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.464 ' C ' HG22 ' A' ' 47' ' ' THR 0.278 16.7 t-20 -110.11 155.63 21.66 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-O 122.64 1.209 . . . . 0.0 108.959 -178.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.631 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -172.36 154.57 3.27 Favored 'General case' 0 C--N 1.254 -3.574 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.511 -178.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.952 ' O ' HG23 ' A' ' 49' ' ' THR . 9.5 mtpt -112.36 5.8 18.4 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 120.763 -1.211 . . . . 0.0 110.996 178.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.952 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.15 147.84 4.73 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.417 -1.427 . . . . 0.0 111.351 179.19 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 111' ' ' MET . . . -138.51 98.06 3.5 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-O 122.757 1.265 . . . . 0.0 110.481 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 0.9 OUTLIER -69.3 -179.71 1.71 Allowed 'General case' 0 N--CA 1.505 2.321 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.138 178.511 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.846 ' CG1' HD11 ' A' ' 88' ' ' ILE . 23.7 mt -141.6 136.72 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.514 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.418 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.476 ' C ' HG13 ' A' ' 108' ' ' VAL . 5.5 tp10 -142.61 113.44 7.49 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 123.276 1.512 . . . . 0.0 111.807 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.911 ' CA ' HG13 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -88.93 126.96 41.97 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 CA-C-N 112.783 -2.008 . . . . 0.0 109.012 178.283 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -119.81 97.43 5.62 Favored 'General case' 0 C--N 1.278 -2.518 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 177.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.93 ' HB3' HG22 ' A' ' 63' ' ' VAL . . . -110.1 127.37 54.84 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.126 -1.03 . . . . 0.0 111.79 -176.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.755 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.3 p -106.48 102.83 12.19 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.971 ' HA ' HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -114.32 95.17 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.897 0 CA-C-O 123.531 1.634 . . . . 0.0 110.143 -177.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.717 ' OD2' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER 36.71 69.11 0.22 Allowed 'General case' 0 N--CA 1.523 3.183 0 CA-C-N 114.463 -1.244 . . . . 0.0 113.58 179.37 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.54 -22.03 12.11 Favored Glycine 0 N--CA 1.488 2.113 0 O-C-N 121.136 -0.977 . . . . 0.0 111.864 176.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.545 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.265 0.4 OUTLIER -107.96 57.84 0.62 Allowed 'General case' 0 C--N 1.292 -1.919 0 O-C-N 121.137 -1.213 . . . . 0.0 111.877 -178.137 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.578 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.372 0.0 OUTLIER -67.97 113.59 5.79 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 122.035 0.922 . . . . 0.0 110.944 -179.573 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.93 HG22 ' HB3' ' A' ' 56' ' ' ALA . 10.2 m -78.91 145.6 9.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 122.612 1.196 . . . . 0.0 110.852 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.529 ' C ' ' CG2' ' A' ' 65' ' ' VAL 0.434 7.3 t70 -137.89 59.27 1.66 Allowed 'General case' 0 C--N 1.28 -2.444 0 CA-C-O 122.855 1.312 . . . . 0.0 110.897 -176.156 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.757 HG12 ' HD2' ' A' ' 66' ' ' PRO . 1.4 t -157.28 150.41 18.6 Favored Pre-proline 0 C--N 1.271 -2.842 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.682 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.757 ' HD2' HG12 ' A' ' 65' ' ' VAL . 46.3 Cg_endo -88.04 141.53 5.21 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 CA-C-O 123.728 1.47 . . . . 0.0 111.814 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.587 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -110.83 50.36 0.78 Allowed Glycine 0 C--N 1.271 -3.075 0 CA-C-N 112.495 -2.139 . . . . 0.0 109.33 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.636 HG23 ' N ' ' A' ' 69' ' ' ASP 0.289 2.4 tp -179.35 -164.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 O-C-N 120.03 -1.865 . . . . 0.0 109.944 -178.158 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.636 ' N ' HG23 ' A' ' 68' ' ' ILE . 11.1 t70 -114.38 85.02 10.18 Favored Pre-proline 0 N--CA 1.499 1.998 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 175.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.708 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 19.3 Cg_endo -47.52 -5.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.289 -2.583 0 C-N-CA 124.381 3.387 . . . . 0.0 115.763 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.593 ' ND2' ' N ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -109.44 93.03 4.29 Favored 'General case' 0 C--N 1.285 -2.197 0 O-C-N 119.809 -1.807 . . . . 0.0 108.843 -179.495 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.742 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . . . -78.22 12.2 2.0 Allowed 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.357 -0.84 . . . . 0.0 109.202 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.408 ' HA ' ' HG2' ' A' ' 76' ' ' MET . 7.5 t -76.74 -25.26 53.29 Favored 'General case' 0 C--N 1.311 -1.104 0 O-C-N 120.904 -1.123 . . . . 0.0 108.581 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.551 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 0.6 OUTLIER -78.75 4.13 14.69 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 118.615 -1.234 . . . . 0.0 108.546 176.114 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.742 ' CD2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -135.29 7.26 3.35 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 121.344 -0.847 . . . . 0.0 109.275 177.589 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.508 ' O ' ' N ' ' A' ' 78' ' ' CYS . 1.0 OUTLIER -148.21 125.65 11.65 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 123.859 1.79 . . . . 0.0 112.555 178.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.543 ' O ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -32.16 91.95 0.01 OUTLIER 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 112.453 -2.158 . . . . 0.0 111.499 -178.373 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.522 ' HA ' HD13 ' A' ' 80' ' ' LEU 0.311 0.1 OUTLIER -91.95 142.28 26.28 Favored Pre-proline 0 C--N 1.264 -3.126 0 CA-C-N 111.408 -2.633 . . . . 0.0 109.926 179.968 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.639 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 35.1 Cg_endo -82.54 166.41 69.59 Favored 'Cis proline' 0 C--N 1.314 -1.247 0 C-N-CA 123.094 -1.627 . . . . 0.0 111.861 0.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.683 ' HG ' ' CE1' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -93.67 129.75 39.86 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.352 -179.637 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.525 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.3 t -105.85 141.54 20.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-O 124.325 2.012 . . . . 0.0 112.697 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.733 ' HG3' ' N ' ' A' ' 45' ' ' GLN . 2.5 tmpt? -43.86 122.61 2.87 Favored 'General case' 0 C--N 1.273 -2.759 0 CA-C-N 111.556 -2.565 . . . . 0.0 115.933 -176.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.56 -13.61 35.76 Favored Glycine 0 C--N 1.291 -1.921 0 CA-C-N 111.98 -2.373 . . . . 0.0 108.472 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.623 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 11.3 mt-30 -78.74 126.8 31.21 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-O 123.207 1.479 . . . . 0.0 112.016 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.604 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 0.3 OUTLIER -63.84 142.11 58.52 Favored 'General case' 0 C--N 1.271 -2.805 0 CA-C-N 113.363 -1.744 . . . . 0.0 107.791 179.035 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.972 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 19.6 m-85 -142.74 126.12 16.65 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.685 ' HB3' HG12 ' A' ' 40' ' ' VAL . 28.4 p-10 -117.9 136.43 53.47 Favored 'General case' 0 C--N 1.277 -2.56 0 CA-C-O 122.745 1.26 . . . . 0.0 110.077 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.846 HD11 ' CG1' ' A' ' 52' ' ' ILE . 0.8 OUTLIER -113.88 160.26 13.42 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.726 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -145.63 153.54 41.15 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.522 0.677 . . . . 0.0 112.211 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.832 ' CE2' HD13 ' A' ' 54' ' ' ILE . 3.1 t80 -151.65 100.38 2.69 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.628 -0.67 . . . . 0.0 110.638 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.57 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 1.4 t -122.6 114.43 20.61 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-N 119.689 1.131 . . . . 0.0 108.234 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.686 ' HB2' ' CE1' ' A' ' 90' ' ' TYR 0.273 0.9 OUTLIER -143.12 112.72 6.9 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.508 -177.365 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.5 OUTLIER -74.88 157.13 35.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 119.217 -2.177 . . . . 0.0 110.321 -178.78 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.855 HG22 ' O ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -154.14 172.6 5.6 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.0 -1.063 . . . . 0.0 108.752 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.542 ' HD2' ' HB ' ' A' ' 94' ' ' VAL . 17.2 Cg_endo -36.1 149.5 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.133 0 O-C-N 123.502 1.264 . . . . 0.0 111.11 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.768 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 9.2 mptt -80.41 -25.67 38.89 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 117.332 -1.747 . . . . 0.0 115.152 -173.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.767 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -145.31 45.95 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 O-C-N 121.455 -0.778 . . . . 0.0 112.721 -178.084 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.585 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . . . -73.86 -47.07 6.8 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 120.544 -1.348 . . . . 0.0 111.325 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.701 ' C ' ' HD2' ' A' ' 100' ' ' LYS . 44.9 Cg_endo -67.73 160.16 49.44 Favored 'Trans proline' 0 CA--C 1.468 -2.813 0 CA-C-O 123.547 1.394 . . . . 0.0 111.648 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.701 ' HD2' ' C ' ' A' ' 99' ' ' PRO . 0.3 OUTLIER -107.74 106.98 17.55 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 112.031 -2.35 . . . . 0.0 110.949 -169.083 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.451 ' C ' ' O ' ' A' ' 100' ' ' LYS . 2.2 p -42.12 93.72 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.912 0 CA-C-O 123.496 1.617 . . . . 0.0 110.457 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.607 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.381 46.8 mt-10 -165.35 -52.58 0.03 OUTLIER 'General case' 0 CA--C 1.449 -2.915 0 CA-C-N 113.114 -1.857 . . . . 0.0 111.897 178.198 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.484 0.8 OUTLIER -162.03 88.65 0.68 Allowed 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 111.095 -2.775 . . . . 0.0 115.011 -161.345 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.971 HG22 ' HA ' ' A' ' 58' ' ' ILE . 22.0 t -142.89 141.31 27.1 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.537 0 C-N-CA 118.87 -1.132 . . . . 0.0 111.961 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.858 ' CG1' HD11 ' A' ' 121' ' ' ILE . 7.9 t -153.03 134.15 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.686 HG23 ' HB2' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -109.58 140.08 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-O 122.488 1.137 . . . . 0.0 112.467 -178.713 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 1.04 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -133.13 111.29 10.8 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.55 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.911 HG13 ' CA ' ' A' ' 54' ' ' ILE . 6.1 t -125.82 142.06 43.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 119.821 -1.8 . . . . 0.0 108.969 -177.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.797 ' HB2' ' HB3' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -132.58 153.3 51.15 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.788 1.28 . . . . 0.0 112.937 -178.183 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.68 HG12 ' HB3' ' A' ' 117' ' ' LEU . 2.7 t -102.62 123.75 56.16 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.512 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 177.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.533 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -101.75 127.97 48.29 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.523 ' HA3' HD23 ' A' ' 117' ' ' LEU . . . -83.72 -129.42 1.63 Allowed Glycine 0 C--N 1.279 -2.638 0 C-N-CA 118.632 -1.746 . . . . 0.0 114.414 -176.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.631 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 4.1 p-10 -98.22 7.47 46.21 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -175.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 22.6 p30 -167.49 -13.04 0.02 OUTLIER 'General case' 0 C--N 1.261 -3.259 0 C-N-CA 117.429 -1.708 . . . . 0.0 114.437 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.42 ' O ' ' SD ' ' A' ' 111' ' ' MET . . . -153.85 -86.84 0.06 OUTLIER Glycine 0 CA--C 1.473 -2.57 0 CA-C-O 125.916 2.953 . . . . 0.0 111.723 -177.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.517 HG22 ' H ' ' A' ' 117' ' ' LEU . 1.4 p -141.49 177.54 3.38 Favored 'Isoleucine or valine' 1 C--N 1.228 -4.714 1 CA-C-N 108.054 -4.073 . . . . 0.0 110.929 -177.283 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.68 ' HB3' HG12 ' A' ' 110' ' ' VAL . 0.2 OUTLIER -145.96 -64.02 0.31 Allowed 'General case' 0 C--N 1.289 -2.064 0 O-C-N 121.793 -0.567 . . . . 0.0 110.849 -179.561 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.992 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -164.51 127.82 2.45 Favored 'General case' 0 N--CA 1.51 2.552 0 O-C-N 120.96 -1.088 . . . . 0.0 109.134 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.84 ' SG ' ' HB2' ' A' ' 9' ' ' ALA . 1.6 p -134.57 142.15 46.87 Favored 'General case' 0 C--N 1.285 -2.197 0 C-N-CA 117.823 -1.551 . . . . 0.0 113.482 -177.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.472 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -144.96 138.2 26.67 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 123.035 1.398 . . . . 0.0 112.11 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 1.04 ' HB ' HG23 ' A' ' 107' ' ' THR 0.284 0.0 OUTLIER -113.03 142.3 25.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 114.09 -1.413 . . . . 0.0 111.982 -178.697 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.899 ' N ' HD13 ' A' ' 121' ' ' ILE . . . . . . . . 0 N--CA 1.487 1.389 0 O-C-N 120.983 -1.073 . . . . 0.0 108.131 178.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.513 ' CD ' ' CE ' ' A' ' 15' ' ' LYS . 10.9 mp0 . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 120.528 0.204 . . . . 0.0 110.97 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.765 HG12 ' HA ' ' A' ' 22' ' ' HIS 0.257 1.3 m -145.68 174.91 2.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 O-C-N 120.634 -1.291 . . . . 0.0 108.902 -179.151 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.582 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -81.83 148.13 29.0 Favored 'General case' 0 CA--C 1.477 -1.829 0 CA-C-O 122.83 1.3 . . . . 0.0 109.115 176.782 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.854 HG11 HG21 ' A' ' 16' ' ' VAL 0.428 0.4 OUTLIER -164.29 -167.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 CA-C-N 113.668 -1.605 . . . . 0.0 109.589 -170.856 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 5' ' ' VAL . 2.7 mttt -156.33 146.57 21.42 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 124.065 1.888 . . . . 0.0 113.173 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.287 8.1 t70 -86.32 147.71 25.93 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-N 112.335 -2.211 . . . . 0.0 109.771 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.654 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.1 p -136.84 14.67 3.11 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.887 -1.133 . . . . 0.0 109.07 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.846 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -126.04 -84.36 0.63 Allowed 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.075 -1.05 . . . . 0.0 109.931 -177.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.538 ' ND2' ' O ' ' A' ' 10' ' ' ASN . 2.6 t30 -158.65 66.51 0.44 Allowed 'General case' 0 C--N 1.269 -2.901 0 C-N-CA 118.632 -1.227 . . . . 0.0 112.265 177.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.586 ' CG ' ' O ' ' A' ' 11' ' ' HIS . 10.2 t-160 36.27 30.84 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 121.958 0.885 . . . . 0.0 110.276 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.582 ' HB3' ' O ' ' A' ' 117' ' ' LEU . 0.4 OUTLIER -84.84 18.17 2.53 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 121.356 0.598 . . . . 0.0 111.428 -179.553 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.037 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.281 0.1 OUTLIER -122.91 -171.69 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-O 122.04 0.924 . . . . 0.0 110.856 -178.333 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.629 ' H ' HG23 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -162.21 -47.42 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.336 -179.562 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.561 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -142.71 133.24 25.06 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 116.192 -2.203 . . . . 0.0 113.317 179.116 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.879 HG12 ' HB2' ' A' ' 39' ' ' ALA . 3.2 m -131.78 107.15 12.64 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.323 0 CA-C-O 122.876 1.322 . . . . 0.0 111.498 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -98.75 120.54 39.36 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 114.319 -1.31 . . . . 0.0 111.302 178.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.725 HG22 ' HB2' ' A' ' 37' ' ' LEU . 16.1 t -142.72 146.07 36.56 Favored Pre-proline 0 C--N 1.295 -1.794 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.097 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.557 ' HD2' ' CG1' ' A' ' 18' ' ' VAL . 43.9 Cg_endo -69.66 132.34 23.29 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 O-C-N 123.834 1.439 . . . . 0.0 111.211 -178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.41 -88.82 0.2 Allowed Glycine 0 N--CA 1.495 2.57 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.3 m -94.27 173.27 7.73 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.243 -1.151 . . . . 0.0 110.433 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.765 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -142.01 8.42 1.87 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.764 -1.21 . . . . 0.0 110.723 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 4' ' ' ASP . . . . . . . . 0 C--N 1.286 -2.244 0 C-N-CA 118.792 -1.67 . . . . 0.0 110.221 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.894 ' HA2' ' HA ' ' A' ' 96' ' ' LYS . . . . . . . . 0 C--O 1.214 -1.112 0 N-CA-C 105.329 -3.108 . . . . 0.0 105.329 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.827 ' HB2' HG12 ' A' ' 94' ' ' VAL . 2.4 mmmm -118.85 98.0 50.94 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 120.761 2.281 . . . . 0.0 116.391 -174.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.545 ' HD3' ' O ' ' A' ' 32' ' ' GLY . 60.3 Cg_endo -105.17 144.71 0.11 Allowed 'Trans proline' 0 C--N 1.291 -2.477 0 C-N-CA 123.642 2.894 . . . . 0.0 108.898 177.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.538 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 3.7 m-85 -117.85 91.01 3.46 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.302 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.578 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 25.6 mp0 -113.47 79.28 1.22 Allowed 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.725 ' HB2' HG22 ' A' ' 18' ' ' VAL . 3.1 pp -111.68 141.57 45.12 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.851 -1.156 . . . . 0.0 109.837 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.474 ' HB3' ' HE2' ' A' ' 89' ' ' LYS . 2.2 pp20? -140.33 137.53 34.19 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.759 1.266 . . . . 0.0 108.396 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.879 ' HB2' HG12 ' A' ' 16' ' ' VAL . . . -142.65 153.31 43.32 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-O 123.137 1.446 . . . . 0.0 113.237 -176.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.595 HG12 ' HB3' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -109.92 141.37 25.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 113.798 -1.547 . . . . 0.0 108.133 178.242 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.582 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 3.0 p90 -156.3 121.91 4.85 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -177.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 13.4 tt0 -69.71 153.6 43.16 Favored 'General case' 0 C--N 1.285 -2.233 0 O-C-N 120.441 -1.412 . . . . 0.0 108.661 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.904 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -89.01 133.38 34.36 Favored 'General case' 0 C--N 1.266 -3.049 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.302 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.594 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 0.4 OUTLIER -114.2 49.24 1.02 Allowed 'General case' 0 CA--C 1.484 -1.572 0 CA-C-O 125.534 2.588 . . . . 0.0 113.576 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.593 ' C ' ' HB2' ' A' ' 82' ' ' LYS . 6.7 pt20 167.1 -158.95 0.01 OUTLIER 'General case' 0 C--N 1.255 -3.514 0 CA-C-N 108.83 -3.804 . . . . 0.0 112.793 175.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.479 ' C ' HG22 ' A' ' 47' ' ' THR 0.276 7.4 t30 -110.17 154.68 23.0 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-O 122.701 1.239 . . . . 0.0 108.912 -178.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.618 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -172.38 151.78 2.58 Favored 'General case' 0 C--N 1.256 -3.489 0 CA-C-N 114.667 -1.151 . . . . 0.0 112.487 -178.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.934 ' O ' HG23 ' A' ' 49' ' ' THR . 0.2 OUTLIER -111.01 9.45 22.13 Favored 'General case' 0 N--CA 1.508 2.444 0 C-N-CA 118.507 -1.277 . . . . 0.0 110.28 178.408 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.934 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.66 146.56 4.0 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 120.653 -1.279 . . . . 0.0 111.084 178.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 111' ' ' MET . . . -140.66 94.79 2.77 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-O 122.844 1.307 . . . . 0.0 109.814 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 1.3 mmtp -65.2 -179.49 0.59 Allowed 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.193 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.934 ' CG2' HD11 ' A' ' 88' ' ' ILE . 28.7 mt -141.65 140.19 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.446 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 2.3 tm-20 -141.14 104.78 4.7 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 123.265 1.507 . . . . 0.0 109.733 178.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 1.073 ' HA ' HG13 ' A' ' 108' ' ' VAL . 0.1 OUTLIER -92.11 127.64 44.23 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.458 0 CA-C-N 112.604 -2.089 . . . . 0.0 107.602 179.271 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.882 ' N ' HD13 ' A' ' 54' ' ' ILE . 3.5 ttpt -129.75 147.27 51.51 Favored 'General case' 0 C--N 1.271 -2.823 0 C-N-CA 118.45 -1.3 . . . . 0.0 108.193 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 1.094 ' HB3' HG22 ' A' ' 63' ' ' VAL . . . -135.54 130.35 34.44 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 117.579 -1.648 . . . . 0.0 111.565 -178.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.704 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 2.8 p -103.17 95.97 6.47 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.338 -1.726 . . . . 0.0 106.338 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.889 ' HA ' HG22 ' A' ' 104' ' ' VAL . 0.1 OUTLIER -106.93 107.05 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.711 0 CA-C-O 123.008 1.385 . . . . 0.0 110.339 -176.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 103' ' ' ASN . 0.4 OUTLIER 33.74 62.77 0.41 Allowed 'General case' 0 N--CA 1.519 3.002 0 CA-C-N 115.097 -0.956 . . . . 0.0 113.08 179.427 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.59 -15.54 9.48 Favored Glycine 0 N--CA 1.487 2.061 0 O-C-N 121.335 -0.853 . . . . 0.0 111.239 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.54 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.271 0.4 OUTLIER -107.99 59.05 0.61 Allowed 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.204 -1.174 . . . . 0.0 111.353 -178.486 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.651 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.373 0.0 OUTLIER -55.09 117.17 3.24 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.975 0.893 . . . . 0.0 110.79 179.902 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 1.094 HG22 ' HB3' ' A' ' 56' ' ' ALA . 19.0 m -79.53 143.16 12.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-O 122.741 1.258 . . . . 0.0 111.657 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.447 25.1 t0 -138.78 85.27 2.07 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.193 -176.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.572 ' CG2' ' HD2' ' A' ' 66' ' ' PRO . 12.2 p -153.62 149.73 21.78 Favored Pre-proline 0 C--N 1.277 -2.573 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.684 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.572 ' HD2' ' CG2' ' A' ' 65' ' ' VAL . 42.3 Cg_endo -71.37 138.06 32.11 Favored 'Trans proline' 0 CA--C 1.501 -1.139 0 CA-C-O 123.748 1.478 . . . . 0.0 111.073 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.651 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -110.02 -71.8 0.68 Allowed Glycine 0 N--CA 1.504 3.225 0 CA-C-N 112.587 -2.097 . . . . 0.0 112.0 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.767 HG23 ' N ' ' A' ' 69' ' ' ASP . 0.8 OUTLIER -116.64 -150.66 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.013 -1.875 . . . . 0.0 109.433 -178.603 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.767 ' N ' HG23 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -105.81 143.29 26.57 Favored Pre-proline 0 C--N 1.295 -1.773 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 177.21 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.753 ' HB2' ' H ' ' A' ' 52' ' ' ILE . 22.9 Cg_endo -106.21 -3.32 0.14 Allowed 'Trans proline' 0 C--N 1.274 -3.383 0 C-N-CA 123.18 2.587 . . . . 0.0 113.908 -173.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.598 ' HB2' ' NE2' ' A' ' 74' ' ' HIS . 0.4 OUTLIER -110.34 88.78 2.85 Favored 'General case' 0 C--N 1.285 -2.222 0 O-C-N 120.839 -1.163 . . . . 0.0 108.459 -179.501 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.741 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . . . -78.45 10.77 2.86 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.222 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.4 t -77.29 -26.8 52.67 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 120.947 -1.096 . . . . 0.0 108.184 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.598 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -81.19 8.37 9.02 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 118.919 -1.113 . . . . 0.0 108.343 175.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.741 ' CD2' ' HA ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -132.36 -2.52 3.48 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 121.76 -0.587 . . . . 0.0 109.939 178.163 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.596 ' SD ' ' HB1' ' A' ' 72' ' ' ALA . 1.8 ptt? -157.74 132.25 8.4 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 123.866 1.793 . . . . 0.0 113.824 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.57 ' O ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -16.29 94.29 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 111.786 -2.461 . . . . 0.0 113.276 -179.136 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 48' ' ' LYS 0.327 1.8 t -106.84 144.79 29.78 Favored Pre-proline 0 C--N 1.267 -3.003 0 CA-C-N 111.596 -2.547 . . . . 0.0 109.234 179.165 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.671 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 37.5 Cg_endo -79.95 167.82 74.06 Favored 'Cis proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.847 -1.73 . . . . 0.0 111.833 0.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.713 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -93.4 127.9 39.22 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.103 -179.423 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.513 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.3 t -105.0 140.67 22.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-O 124.207 1.956 . . . . 0.0 112.211 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.594 ' HG2' ' HA ' ' A' ' 44' ' ' ASN . 1.8 tmmt? -45.08 119.42 2.01 Favored 'General case' 0 C--N 1.273 -2.741 0 CA-C-N 111.534 -2.576 . . . . 0.0 116.776 -175.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.1 -16.19 22.82 Favored Glycine 0 C--N 1.293 -1.86 0 CA-C-N 111.772 -2.467 . . . . 0.0 107.98 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.63 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 16.2 mt-30 -75.56 126.39 30.93 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-O 123.292 1.52 . . . . 0.0 111.496 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.593 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 6.1 mt-30 -65.12 144.97 56.88 Favored 'General case' 0 C--N 1.271 -2.81 0 CA-C-N 113.299 -1.773 . . . . 0.0 107.692 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.904 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 19.6 m-85 -142.56 126.7 17.45 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.595 ' HB3' HG12 ' A' ' 40' ' ' VAL . 1.4 p30 -117.15 132.46 56.65 Favored 'General case' 0 C--N 1.276 -2.611 0 CA-C-O 122.925 1.345 . . . . 0.0 110.358 -177.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 1.121 HD12 ' CG2' ' A' ' 110' ' ' VAL . 0.4 OUTLIER -104.79 158.55 5.57 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 CA-C-N 114.186 -1.37 . . . . 0.0 108.42 179.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.474 ' HE2' ' HB3' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -144.39 145.27 31.84 Favored 'General case' 0 C--N 1.29 -2.021 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.465 -178.293 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.606 ' CE1' ' HB2' ' A' ' 92' ' ' TRP . 12.7 t80 -145.21 108.89 4.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.171 -0.956 . . . . 0.0 109.913 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.578 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 1.2 t -127.07 111.26 13.83 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.667 ' CZ3' HG23 ' A' ' 94' ' ' VAL 0.278 0.7 OUTLIER -142.83 114.46 8.03 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.173 -177.277 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 2.4 p-10 -75.08 157.08 35.35 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 119.172 -2.205 . . . . 0.0 109.411 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.827 HG12 ' HB2' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -147.49 167.65 13.02 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.128 -0.982 . . . . 0.0 108.457 -179.158 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.743 ' HD2' HG22 ' A' ' 94' ' ' VAL . 18.3 Cg_endo -37.33 152.83 0.03 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.188 0 O-C-N 123.835 1.439 . . . . 0.0 110.677 -177.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.894 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -79.81 -25.9 40.71 Favored 'General case' 0 C--N 1.286 -2.189 0 C-N-CA 116.508 -2.077 . . . . 0.0 115.175 -173.181 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.765 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -144.9 45.47 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 O-C-N 121.517 -0.74 . . . . 0.0 112.968 -178.224 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.927 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . . . -74.0 -59.4 1.79 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.53 -1.356 . . . . 0.0 110.627 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.927 ' HD3' ' HB3' ' A' ' 98' ' ' ALA . 47.9 Cg_endo -67.2 160.32 48.06 Favored 'Trans proline' 0 CA--C 1.462 -3.084 0 O-C-N 123.897 1.472 . . . . 0.0 110.474 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.716 ' HD2' ' C ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -107.28 102.29 11.6 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 112.493 -2.139 . . . . 0.0 110.136 -169.229 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.465 ' C ' ' O ' ' A' ' 100' ' ' LYS . 2.5 p -42.06 97.67 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 123.592 1.663 . . . . 0.0 110.042 -178.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.561 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.389 47.8 mt-10 -164.4 -53.0 0.03 OUTLIER 'General case' 0 CA--C 1.45 -2.877 0 CA-C-N 112.963 -1.926 . . . . 0.0 111.543 178.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.483 0.8 OUTLIER -161.25 82.05 0.62 Allowed 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 110.876 -2.875 . . . . 0.0 113.911 -161.879 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.889 HG22 ' HA ' ' A' ' 58' ' ' ILE . 20.1 t -143.39 139.1 26.46 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.65 0 C-N-CA 118.952 -1.099 . . . . 0.0 111.912 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.896 HG22 HD11 ' A' ' 121' ' ' ILE . 0.6 OUTLIER -142.5 132.07 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.392 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.552 ' O ' HG12 ' A' ' 121' ' ' ILE . 0.4 OUTLIER -99.1 143.46 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 122.594 1.188 . . . . 0.0 111.57 -179.028 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 1.071 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -131.59 118.34 19.96 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 179.556 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.073 HG13 ' HA ' ' A' ' 54' ' ' ILE . 3.4 t -132.38 139.53 49.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 120.22 -1.55 . . . . 0.0 108.583 -178.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.902 ' HB2' ' CB ' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -130.16 154.2 47.76 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.883 1.325 . . . . 0.0 111.623 -178.63 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 1.121 ' CG2' HD12 ' A' ' 88' ' ' ILE . 2.6 t -107.69 124.54 63.83 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.58 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 177.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.513 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 1.5 tmt? -103.71 120.39 40.85 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.554 ' HA3' HD23 ' A' ' 117' ' ' LEU . . . -74.93 -131.17 0.25 Allowed Glycine 0 C--N 1.281 -2.51 0 C-N-CA 119.06 -1.543 . . . . 0.0 114.671 -175.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.618 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 4.7 p-10 -97.94 8.65 44.4 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -175.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 33.5 p-10 -167.41 -14.89 0.02 OUTLIER 'General case' 0 C--N 1.265 -3.08 0 C-N-CA 117.475 -1.69 . . . . 0.0 114.428 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.447 ' O ' ' HG2' ' A' ' 111' ' ' MET . . . -152.39 -86.74 0.06 OUTLIER Glycine 0 CA--C 1.473 -2.572 0 CA-C-O 125.937 2.965 . . . . 0.0 111.971 -177.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.642 HG22 ' H ' ' A' ' 117' ' ' LEU . 4.2 p -141.23 178.67 2.7 Favored 'Isoleucine or valine' 1 C--N 1.228 -4.696 1 CA-C-N 108.168 -4.016 . . . . 0.0 110.807 -177.226 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.769 ' HB3' HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -148.55 -61.85 0.24 Allowed 'General case' 0 C--N 1.289 -2.06 0 O-C-N 121.873 -0.517 . . . . 0.0 111.277 -179.44 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 1.037 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -165.35 129.85 2.42 Favored 'General case' 0 N--CA 1.512 2.669 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.543 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.902 ' CB ' ' HB2' ' A' ' 109' ' ' LYS . 1.4 p -134.52 135.44 42.37 Favored 'General case' 0 C--N 1.284 -2.266 0 C-N-CA 118.064 -1.455 . . . . 0.0 113.09 -178.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.59 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -143.62 135.06 26.09 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 122.992 1.377 . . . . 0.0 112.599 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 1.071 ' HB ' HG23 ' A' ' 107' ' ' THR 0.272 0.0 OUTLIER -111.14 138.41 39.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 CA-C-N 114.143 -1.39 . . . . 0.0 110.961 -179.549 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.851 ' N ' HD13 ' A' ' 121' ' ' ILE . . . . . . . . 0 N--CA 1.486 1.367 0 O-C-N 120.858 -1.151 . . . . 0.0 109.062 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.463 ' O ' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 120.646 0.26 . . . . 0.0 110.828 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.858 HG12 ' HA ' ' A' ' 22' ' ' HIS . 1.3 m -145.22 -175.64 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.45 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -77.68 133.68 38.3 Favored 'General case' 0 CA--C 1.48 -1.714 0 C-N-CA 117.839 -1.544 . . . . 0.0 108.84 178.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.521 ' O ' ' HG2' ' A' ' 6' ' ' LYS 0.435 0.4 OUTLIER -170.14 156.48 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 113.972 -1.467 . . . . 0.0 110.058 -169.627 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -146.76 145.77 30.06 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 123.772 1.749 . . . . 0.0 113.515 -178.671 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.276 1.9 t70 -74.28 149.3 40.78 Favored 'General case' 0 C--N 1.268 -2.956 0 CA-C-N 112.792 -2.004 . . . . 0.0 109.312 177.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.632 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 5.7 p -137.33 14.44 3.01 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.852 -1.155 . . . . 0.0 109.058 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.864 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -125.5 -82.52 0.63 Allowed 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 118.962 -1.095 . . . . 0.0 109.952 -177.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 12' ' ' GLU . 2.9 t30 -157.86 66.45 0.48 Allowed 'General case' 0 C--N 1.268 -2.952 0 C-N-CA 118.684 -1.206 . . . . 0.0 111.882 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.487 ' C ' ' O ' ' A' ' 10' ' ' ASN . 49.7 m170 33.4 33.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.845 0.831 . . . . 0.0 110.468 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 10' ' ' ASN . 38.1 mt-10 -93.77 21.12 6.79 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.68 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.027 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.297 0.1 OUTLIER -124.39 -167.3 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.895 0.855 . . . . 0.0 110.056 -178.685 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.649 ' H ' HG23 ' A' ' 13' ' ' ILE . 13.1 ptpt -162.15 -44.89 0.04 OUTLIER 'General case' 0 C--N 1.29 -1.997 0 O-C-N 121.792 -0.567 . . . . 0.0 111.503 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.553 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 36.4 tttt -148.49 142.57 25.97 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 115.881 -2.328 . . . . 0.0 114.21 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 1.094 HG13 ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -134.45 103.07 4.48 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 CA-C-O 122.983 1.373 . . . . 0.0 110.578 178.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.508 ' HA ' HD23 ' A' ' 17' ' ' LEU . 1.3 mt -96.11 133.18 40.7 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 113.994 -1.457 . . . . 0.0 111.465 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.894 HG22 ' HA ' ' A' ' 37' ' ' LEU . 93.1 t -140.83 145.71 40.9 Favored Pre-proline 0 N--CA 1.499 2.018 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.514 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.605 ' HD2' HG13 ' A' ' 18' ' ' VAL . 45.9 Cg_endo -72.42 101.23 1.23 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.815 1.429 . . . . 0.0 110.76 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 157.79 -92.21 0.12 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.0 m -83.95 162.04 20.59 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.32 -1.106 . . . . 0.0 111.196 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.858 ' HA ' HG12 ' A' ' 3' ' ' VAL . 1.6 p-80 -142.41 16.89 2.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.903 -1.123 . . . . 0.0 109.206 178.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.081 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 177.734 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.893 ' HA3' ' HA ' ' A' ' 96' ' ' LYS . . . . . . . . 0 C--O 1.215 -1.073 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.754 ' HB2' HG12 ' A' ' 94' ' ' VAL . 0.6 OUTLIER -125.58 88.97 53.36 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 120.983 2.392 . . . . 0.0 115.62 -179.149 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 60.7 Cg_endo -108.13 142.35 0.06 OUTLIER 'Trans proline' 0 C--N 1.291 -2.488 0 C-N-CA 124.521 3.481 . . . . 0.0 107.719 176.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.481 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 10.1 m-85 -124.25 93.73 4.0 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 118.553 -1.259 . . . . 0.0 109.99 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.613 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 28.1 mp0 -112.8 86.22 2.32 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.894 ' HA ' HG22 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -110.33 141.33 43.51 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 120.576 -1.328 . . . . 0.0 109.093 179.294 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.92 132.49 28.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 1.094 ' HB2' HG13 ' A' ' 16' ' ' VAL . . . -142.14 154.39 44.84 Favored 'General case' 0 C--N 1.271 -2.829 0 CA-C-O 123.219 1.485 . . . . 0.0 113.404 -175.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.553 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.38 141.06 26.8 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 CA-C-N 113.43 -1.714 . . . . 0.0 108.805 178.714 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.556 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 3.7 p90 -157.96 124.58 4.87 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 21.8 tt0 -69.29 154.79 41.47 Favored 'General case' 0 C--N 1.285 -2.213 0 O-C-N 120.305 -1.497 . . . . 0.0 108.606 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.999 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -85.69 131.39 34.34 Favored 'General case' 0 C--N 1.265 -3.068 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.447 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.633 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 0.3 OUTLIER -113.8 48.79 1.04 Allowed 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 125.775 2.702 . . . . 0.0 114.358 179.816 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.581 ' C ' ' HB2' ' A' ' 82' ' ' LYS . 4.2 pt20 166.57 -161.63 0.01 OUTLIER 'General case' 0 C--N 1.26 -3.324 0 CA-C-N 108.502 -3.954 . . . . 0.0 112.845 175.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.422 ' C ' HG22 ' A' ' 47' ' ' THR 0.273 60.0 t30 -110.82 151.33 27.94 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-O 122.537 1.16 . . . . 0.0 108.958 -178.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.657 ' OG1' ' HB3' ' A' ' 113' ' ' ASP 0.252 0.0 OUTLIER -173.22 151.77 2.13 Favored 'General case' 0 C--N 1.255 -3.511 0 C-N-CA 118.581 -1.248 . . . . 0.0 112.545 -178.418 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.955 ' O ' HG23 ' A' ' 49' ' ' THR . 0.8 OUTLIER -111.59 10.69 21.18 Favored 'General case' 0 N--CA 1.51 2.568 0 C-N-CA 118.194 -1.402 . . . . 0.0 110.301 178.371 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.955 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -169.12 148.46 4.02 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 120.622 -1.299 . . . . 0.0 110.837 179.091 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 111' ' ' MET . . . -149.74 103.8 3.27 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 122.765 1.269 . . . . 0.0 110.949 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 0.7 OUTLIER -68.86 -174.94 0.64 Allowed 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.432 178.664 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.955 ' CG2' HD11 ' A' ' 88' ' ' ILE . 35.7 mt -141.93 140.84 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.388 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 5.6 tm-20 -139.92 107.58 5.62 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 123.284 1.516 . . . . 0.0 110.186 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 1.057 ' HA ' HG13 ' A' ' 108' ' ' VAL . 0.1 OUTLIER -92.63 128.38 44.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 CA-C-N 112.644 -2.071 . . . . 0.0 107.362 178.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.897 ' N ' HD13 ' A' ' 54' ' ' ILE . 1.1 tttt -128.09 141.86 51.37 Favored 'General case' 0 C--N 1.272 -2.802 0 C-N-CA 118.75 -1.18 . . . . 0.0 107.855 178.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 1.071 ' HB3' HG22 ' A' ' 63' ' ' VAL . . . -135.44 134.35 39.53 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 119.917 -1.739 . . . . 0.0 112.309 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.742 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 0.5 OUTLIER -107.22 99.5 9.04 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 177.285 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.924 ' HA ' HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -112.12 101.41 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.803 0 CA-C-O 123.305 1.526 . . . . 0.0 110.758 -176.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.544 ' N ' HG22 ' A' ' 104' ' ' VAL . 1.4 p30 37.59 64.36 0.66 Allowed 'General case' 0 N--CA 1.521 3.077 0 CA-C-N 114.991 -1.004 . . . . 0.0 113.06 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.73 -17.04 9.41 Favored Glycine 0 N--CA 1.488 2.114 0 O-C-N 121.264 -0.897 . . . . 0.0 111.546 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.532 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.272 0.2 OUTLIER -107.87 58.16 0.62 Allowed 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.197 -1.178 . . . . 0.0 111.576 -178.336 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.605 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.367 0.0 OUTLIER -60.01 116.75 4.38 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.958 0.885 . . . . 0.0 111.012 -179.904 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 1.071 HG22 ' HB3' ' A' ' 56' ' ' ALA . 13.8 m -75.8 146.61 8.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-O 122.547 1.165 . . . . 0.0 110.805 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.441 6.7 t70 -138.16 76.89 1.6 Allowed 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.192 -176.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.56 HG22 ' HD2' ' A' ' 66' ' ' PRO . 8.6 p -164.37 150.75 9.52 Favored Pre-proline 0 C--N 1.274 -2.692 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.42 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.56 ' HD2' HG22 ' A' ' 65' ' ' VAL . 44.6 Cg_endo -86.68 139.23 5.58 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 CA-C-O 123.887 1.536 . . . . 0.0 111.531 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.614 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -127.82 52.49 0.82 Allowed Glycine 0 C--N 1.273 -2.946 0 CA-C-N 112.498 -2.137 . . . . 0.0 110.432 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.642 ' HB ' ' CD2' ' A' ' 90' ' ' TYR 0.296 4.4 tp 179.96 -177.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 120.194 -1.768 . . . . 0.0 110.534 -178.677 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.523 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 12.9 t0 -112.3 83.47 5.26 Favored Pre-proline 0 N--CA 1.504 2.237 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 175.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.711 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 20.9 Cg_endo -48.59 -6.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.287 -2.706 0 C-N-CA 124.453 3.435 . . . . 0.0 116.245 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.583 ' HB2' ' NE2' ' A' ' 74' ' ' HIS . 5.1 m-80 -101.77 91.77 4.54 Favored 'General case' 0 C--N 1.284 -2.266 0 O-C-N 120.167 -1.583 . . . . 0.0 109.006 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.724 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . . . -76.33 7.29 4.47 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.431 -0.793 . . . . 0.0 109.52 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 8.3 t -79.05 -24.15 43.76 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 120.886 -1.134 . . . . 0.0 108.94 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.583 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 1.1 m-70 -80.1 8.11 7.85 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.022 -1.071 . . . . 0.0 109.066 176.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.724 ' CD2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -133.19 -2.83 3.13 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 121.365 -0.834 . . . . 0.0 110.217 177.547 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.446 ' O ' ' HG2' ' A' ' 76' ' ' MET . 2.4 ptt? -155.07 129.61 9.14 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 123.984 1.849 . . . . 0.0 113.678 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.465 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 13.9 pttt -21.85 102.6 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 111.89 -2.414 . . . . 0.0 113.365 -178.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 48' ' ' LYS 0.318 0.1 OUTLIER -99.04 146.64 32.03 Favored Pre-proline 0 C--N 1.265 -3.066 0 CA-C-N 111.522 -2.581 . . . . 0.0 108.79 178.609 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.641 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 37.2 Cg_endo -86.66 167.35 46.64 Favored 'Cis proline' 0 C--N 1.311 -1.412 0 C-N-CA 123.1 -1.625 . . . . 0.0 111.447 0.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.724 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -90.54 125.96 35.78 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 122.02 0.914 . . . . 0.0 110.95 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.507 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.3 t -104.47 137.76 32.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-O 124.248 1.975 . . . . 0.0 111.779 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.633 ' HG2' ' HA ' ' A' ' 44' ' ' ASN . 1.6 tmmt? -43.37 115.62 0.8 Allowed 'General case' 0 C--N 1.271 -2.844 0 CA-C-N 111.737 -2.483 . . . . 0.0 116.243 -175.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 118.2 -18.34 11.26 Favored Glycine 0 C--N 1.29 -1.983 0 CA-C-N 111.74 -2.482 . . . . 0.0 108.198 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.609 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 8.4 mt-30 -73.3 126.27 29.74 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-O 123.124 1.44 . . . . 0.0 111.797 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.583 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -63.3 143.03 58.15 Favored 'General case' 0 C--N 1.271 -2.818 0 CA-C-N 113.57 -1.65 . . . . 0.0 107.855 179.225 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.999 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 21.3 m-85 -143.58 127.5 17.34 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.534 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 1.4 p-10 -117.51 132.53 56.53 Favored 'General case' 0 C--N 1.277 -2.561 0 CA-C-O 122.775 1.274 . . . . 0.0 110.401 -178.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 1.043 HD12 ' CG2' ' A' ' 110' ' ' VAL . 0.3 OUTLIER -102.31 159.98 4.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.402 179.368 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.75 144.84 32.8 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.941 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.642 ' CD2' ' HB ' ' A' ' 68' ' ' ILE . 32.3 t80 -149.02 102.36 3.25 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.772 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.613 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 0.6 OUTLIER -121.68 114.76 21.59 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 179.253 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.614 ' CD1' ' O ' ' A' ' 67' ' ' GLY 0.264 0.2 OUTLIER -141.86 108.42 5.33 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.913 -177.405 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.524 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 11.7 m120 -75.46 155.54 36.15 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 119.696 -1.878 . . . . 0.0 109.753 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.754 HG12 ' HB2' ' A' ' 33' ' ' LYS . 1.0 OUTLIER -153.79 169.98 9.07 Favored Pre-proline 0 N--CA 1.487 1.389 0 O-C-N 120.746 -1.221 . . . . 0.0 108.676 -178.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.751 ' CD ' HG13 ' A' ' 94' ' ' VAL . 17.8 Cg_endo -38.29 154.73 0.03 OUTLIER 'Trans proline' 0 CA--C 1.497 -1.332 0 O-C-N 123.424 1.223 . . . . 0.0 110.853 -177.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.893 ' HA ' ' HA3' ' A' ' 32' ' ' GLY . 3.1 mptt -80.73 -27.22 36.94 Favored 'General case' 0 C--N 1.283 -2.32 0 C-N-CA 116.622 -2.031 . . . . 0.0 116.201 -173.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.762 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -141.89 42.02 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.977 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . . . -62.65 -56.93 25.08 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 120.419 -1.425 . . . . 0.0 109.562 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.977 ' HD3' ' HB3' ' A' ' 98' ' ' ALA . 56.9 Cg_endo -78.12 162.78 28.53 Favored 'Trans proline' 0 CA--C 1.463 -3.063 0 O-C-N 123.896 1.472 . . . . 0.0 110.57 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.73 ' HD2' ' C ' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -107.21 112.43 25.3 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-N 112.095 -2.32 . . . . 0.0 110.28 -169.755 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 100' ' ' LYS . 2.5 p -45.35 97.7 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.612 0 CA-C-O 123.606 1.669 . . . . 0.0 109.342 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.402 40.9 mt-10 -163.54 -52.01 0.04 OUTLIER 'General case' 0 CA--C 1.448 -2.975 0 CA-C-N 112.818 -1.992 . . . . 0.0 111.304 179.442 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.482 0.8 OUTLIER -160.29 79.73 0.67 Allowed 'General case' 0 C--N 1.285 -2.202 0 CA-C-N 110.949 -2.842 . . . . 0.0 113.932 -162.311 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.924 HG22 ' HA ' ' A' ' 58' ' ' ILE . 22.0 t -145.13 141.24 22.88 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.65 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.743 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 1.074 ' CG1' HD11 ' A' ' 121' ' ' ILE . 3.0 t -153.89 137.63 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.705 ' CG2' HD11 ' A' ' 54' ' ' ILE . 0.3 OUTLIER -105.58 148.3 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 122.653 1.216 . . . . 0.0 112.675 -178.409 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.974 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -132.04 118.98 20.4 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 178.099 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.057 HG13 ' HA ' ' A' ' 54' ' ' ILE . 3.4 t -132.54 138.72 51.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 120.186 -1.571 . . . . 0.0 108.389 -177.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 1.019 ' HB2' ' HB2' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -135.6 148.64 49.11 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 122.414 1.102 . . . . 0.0 111.549 -178.072 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 1.043 ' CG2' HD12 ' A' ' 88' ' ' ILE . 3.5 t -97.76 129.81 47.38 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.553 ' SD ' ' HA2' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -107.7 118.2 36.12 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -78.92 -138.13 1.43 Allowed Glycine 0 N--CA 1.498 2.778 0 C-N-CA 119.177 -1.487 . . . . 0.0 114.917 -174.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.657 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 6.8 p-10 -80.79 -3.66 51.81 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 122.275 1.036 . . . . 0.0 112.323 -176.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.403 ' OD2' ' OD1' ' A' ' 113' ' ' ASP . 1.4 p30 -133.21 -4.65 3.05 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.738 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.605 ' O ' ' CB ' ' A' ' 116' ' ' VAL . . . 92.29 85.9 1.51 Allowed Glycine 0 CA--C 1.471 -2.688 0 CA-C-O 124.797 2.332 . . . . 0.0 110.399 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.605 ' CB ' ' O ' ' A' ' 115' ' ' GLY . 7.2 p 137.9 148.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.25 -3.757 0 CA-C-N 108.27 -3.965 . . . . 0.0 111.837 177.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.807 ' CB ' HG12 ' A' ' 110' ' ' VAL . 0.3 OUTLIER -161.45 -59.8 0.05 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.479 -0.763 . . . . 0.0 110.739 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 1.027 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -169.88 134.29 1.3 Allowed 'General case' 0 N--CA 1.513 2.705 0 O-C-N 121.124 -0.985 . . . . 0.0 109.489 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 1.019 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 0.8 OUTLIER -133.71 139.76 46.6 Favored 'General case' 0 C--N 1.28 -2.418 0 C-N-CA 117.624 -1.63 . . . . 0.0 113.744 -178.02 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.742 ' HB2' HD13 ' A' ' 13' ' ' ILE . . . -142.61 131.58 23.01 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 123.066 1.413 . . . . 0.0 111.489 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 1.074 HD11 ' CG1' ' A' ' 105' ' ' VAL 0.272 0.0 OUTLIER -108.7 131.06 60.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.613 -179.218 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.63 ' N ' HD13 ' A' ' 121' ' ' ILE . . . . . . . . 0 N--CA 1.486 1.358 0 O-C-N 120.827 -1.17 . . . . 0.0 108.895 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.48 ' O ' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 120.681 0.277 . . . . 0.0 111.003 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.765 HG12 ' HA ' ' A' ' 22' ' ' HIS . 1.3 m -145.8 174.03 3.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 O-C-N 120.884 -1.135 . . . . 0.0 107.967 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.481 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -80.82 140.05 35.66 Favored 'General case' 0 CA--C 1.478 -1.82 0 C-N-CA 117.968 -1.493 . . . . 0.0 108.66 177.31 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.524 HG11 ' CG2' ' A' ' 16' ' ' VAL 0.422 0.4 OUTLIER -166.44 -178.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 C-N-CA 118.021 -1.472 . . . . 0.0 110.933 -170.135 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 5' ' ' VAL . 18.5 mtmt -153.69 141.65 20.24 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 123.812 1.767 . . . . 0.0 112.823 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.271 13.8 t70 -79.09 149.45 32.08 Favored 'General case' 0 C--N 1.266 -3.049 0 CA-C-N 113.032 -1.894 . . . . 0.0 109.442 178.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.642 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 7.3 p -137.27 14.26 3.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.981 -1.074 . . . . 0.0 109.529 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.806 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -126.16 -83.98 0.62 Allowed 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 119.014 -1.074 . . . . 0.0 110.17 -177.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 12' ' ' GLU . 2.4 t30 -155.97 64.73 0.58 Allowed 'General case' 0 C--N 1.269 -2.898 0 C-N-CA 118.519 -1.272 . . . . 0.0 111.62 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.473 ' C ' ' O ' ' A' ' 10' ' ' ASN . 6.2 m80 32.57 32.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.725 0.774 . . . . 0.0 110.697 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.9 OUTLIER -93.42 22.35 5.37 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.485 -0.886 . . . . 0.0 111.889 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.973 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.272 0.1 OUTLIER -116.76 -168.09 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 CA-C-O 122.027 0.918 . . . . 0.0 110.741 -179.035 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.659 ' N ' HG23 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -162.2 -45.46 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.732 179.831 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.569 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 28.9 tttt -146.59 136.12 22.99 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 116.116 -2.234 . . . . 0.0 113.246 178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.971 HG12 ' HB2' ' A' ' 39' ' ' ALA . 0.9 OUTLIER -132.61 102.9 5.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 CA-C-O 123.041 1.4 . . . . 0.0 110.817 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.514 ' HA ' HD23 ' A' ' 17' ' ' LEU . 1.4 mt -93.62 126.04 38.57 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.933 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.8 HG22 ' HA ' ' A' ' 37' ' ' LEU . 75.3 t -142.52 145.08 33.07 Favored Pre-proline 0 N--CA 1.502 2.137 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.756 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.656 ' HD2' HG13 ' A' ' 18' ' ' VAL . 47.4 Cg_endo -72.0 137.08 28.56 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 O-C-N 123.691 1.364 . . . . 0.0 110.893 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.99 -80.1 0.27 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.4 m -87.81 131.31 34.57 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.553 -0.969 . . . . 0.0 109.557 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.765 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -137.4 14.83 2.99 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 119.905 -1.747 . . . . 0.0 110.865 179.489 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 C-N-CA 118.287 -1.911 . . . . 0.0 110.815 177.115 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.839 ' HA2' ' HA ' ' A' ' 96' ' ' LYS . . . . . . . . 0 C--O 1.212 -1.242 0 N-CA-C 106.112 -2.795 . . . . 0.0 106.112 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.81 ' HB2' HG12 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -116.76 96.59 48.9 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 120.666 2.233 . . . . 0.0 116.354 -175.103 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.607 ' HD3' ' O ' ' A' ' 32' ' ' GLY . 61.6 Cg_endo -107.6 144.97 0.08 OUTLIER 'Trans proline' 0 C--N 1.289 -2.588 0 C-N-CA 124.081 3.187 . . . . 0.0 109.021 177.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' A' ' 91' ' ' THR . 2.8 m-85 -117.69 98.35 6.33 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.022 -1.071 . . . . 0.0 108.538 178.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.636 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 25.6 mp0 -117.39 91.25 3.52 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.53 -0.731 . . . . 0.0 109.687 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.8 ' HA ' HG22 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -108.31 135.72 49.15 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.489 -1.382 . . . . 0.0 108.341 179.496 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' A' ' 17' ' ' LEU . 0.1 OUTLIER -139.31 128.11 23.41 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.971 ' HB2' HG12 ' A' ' 16' ' ' VAL . . . -142.48 152.05 42.32 Favored 'General case' 0 C--N 1.276 -2.602 0 CA-C-O 123.067 1.413 . . . . 0.0 113.405 -175.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.569 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.74 140.77 28.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 113.763 -1.562 . . . . 0.0 108.612 178.286 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.582 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 3.5 p90 -157.21 121.47 4.32 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -178.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 12.3 tt0 -68.72 155.12 40.7 Favored 'General case' 0 C--N 1.288 -2.089 0 O-C-N 120.416 -1.428 . . . . 0.0 108.918 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.951 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -88.14 136.84 32.79 Favored 'General case' 0 C--N 1.267 -3.01 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.402 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.623 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -117.81 49.96 1.18 Allowed 'General case' 0 CA--C 1.486 -1.506 0 CA-C-O 125.454 2.55 . . . . 0.0 114.033 179.318 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.586 ' N ' ' CG ' ' A' ' 82' ' ' LYS . 7.1 pt20 167.12 -160.52 0.01 OUTLIER 'General case' 0 C--N 1.258 -3.37 0 CA-C-N 108.914 -3.767 . . . . 0.0 112.92 175.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.457 ' OD1' ' N ' ' A' ' 47' ' ' THR 0.265 41.2 t-20 -109.2 153.69 23.43 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-O 122.588 1.185 . . . . 0.0 108.754 -178.901 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.64 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -173.14 156.21 3.16 Favored 'General case' 0 C--N 1.255 -3.541 0 C-N-CA 118.473 -1.291 . . . . 0.0 112.5 -178.28 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.958 ' O ' HG23 ' A' ' 49' ' ' THR . 9.5 mtpt -112.41 5.8 18.32 Favored 'General case' 0 N--CA 1.509 2.501 0 O-C-N 120.747 -1.221 . . . . 0.0 111.184 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.958 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.41 149.13 4.79 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.369 -1.457 . . . . 0.0 111.611 179.653 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.542 ' O ' ' O ' ' A' ' 70' ' ' PRO . . . -142.82 99.76 3.53 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 122.574 1.178 . . . . 0.0 110.871 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 9.9 mttt -69.31 -178.01 1.25 Allowed 'General case' 0 N--CA 1.506 2.338 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.913 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.983 ' CG2' HD11 ' A' ' 88' ' ' ILE . 35.8 mt -140.99 137.8 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.665 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.665 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.583 ' HB3' ' CE ' ' A' ' 109' ' ' LYS . 4.0 tt0 -141.51 112.19 7.13 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 123.261 1.505 . . . . 0.0 111.239 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 1.027 HD12 HG21 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -91.88 127.54 44.1 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 CA-C-N 112.79 -2.005 . . . . 0.0 110.296 179.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.435 ' HD2' ' HG2' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -122.9 101.7 7.59 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 176.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.911 ' HB3' HG22 ' A' ' 63' ' ' VAL . . . -112.81 133.31 54.87 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.843 -1.16 . . . . 0.0 113.178 -175.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.722 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 0.3 OUTLIER -109.49 102.35 11.23 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 177.811 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.966 ' HA ' HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -112.55 97.81 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.863 0 CA-C-O 123.423 1.582 . . . . 0.0 110.746 -177.258 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.727 ' OD1' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER 39.14 65.37 0.68 Allowed 'General case' 0 N--CA 1.52 3.061 0 CA-C-N 114.641 -1.163 . . . . 0.0 113.112 179.236 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.16 -18.34 10.22 Favored Glycine 0 N--CA 1.487 2.093 0 O-C-N 121.378 -0.826 . . . . 0.0 111.481 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.53 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.267 0.3 OUTLIER -107.7 58.67 0.62 Allowed 'General case' 0 C--N 1.293 -1.873 0 O-C-N 121.092 -1.24 . . . . 0.0 111.513 -178.453 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.365 0.0 OUTLIER -63.42 113.19 3.11 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.045 0.926 . . . . 0.0 110.912 -179.78 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.911 HG22 ' HB3' ' A' ' 56' ' ' ALA . 15.3 m -72.73 142.56 14.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-O 122.504 1.145 . . . . 0.0 110.731 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.434 7.9 t70 -138.3 64.88 1.48 Allowed 'General case' 0 C--N 1.277 -2.552 0 CA-C-O 122.619 1.199 . . . . 0.0 110.73 -176.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.583 HG22 ' HD2' ' A' ' 66' ' ' PRO . 8.2 p -164.47 151.64 10.04 Favored Pre-proline 0 C--N 1.269 -2.918 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.005 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.583 ' HD2' HG22 ' A' ' 65' ' ' VAL . 45.5 Cg_endo -82.39 139.64 10.43 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 CA-C-O 123.886 1.536 . . . . 0.0 112.221 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.615 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -133.36 60.11 0.67 Allowed Glycine 0 N--CA 1.501 2.991 0 CA-C-N 112.291 -2.231 . . . . 0.0 109.0 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.641 ' HB ' ' CD2' ' A' ' 90' ' ' TYR 0.272 0.2 OUTLIER 163.93 -177.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.326 -1.103 . . . . 0.0 108.179 -178.074 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.575 ' N ' ' CG2' ' A' ' 68' ' ' ILE . 0.4 OUTLIER -107.53 140.43 21.52 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 105.728 -1.952 . . . . 0.0 105.728 175.084 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.76 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 23.2 Cg_endo -105.39 -3.02 0.17 Allowed 'Trans proline' 0 C--N 1.273 -3.427 0 C-N-CA 122.945 2.43 . . . . 0.0 114.155 -173.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.572 ' HB2' ' NE2' ' A' ' 74' ' ' HIS . 0.2 OUTLIER -107.91 96.6 6.49 Favored 'General case' 0 C--N 1.285 -2.234 0 O-C-N 120.765 -1.209 . . . . 0.0 108.532 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.761 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . . . -77.4 10.7 2.36 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.195 -0.94 . . . . 0.0 108.897 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.7 t -77.34 -24.96 50.66 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 120.984 -1.072 . . . . 0.0 108.209 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.572 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 0.5 OUTLIER -83.25 11.62 6.37 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.444 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.761 ' CD2' ' HA ' ' A' ' 72' ' ' ALA . 1.3 m-85 -132.03 -6.18 3.5 Favored 'General case' 0 C--O 1.215 -0.731 0 O-C-N 121.744 -0.598 . . . . 0.0 110.151 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.452 ' O ' ' C ' ' A' ' 77' ' ' LYS . 2.8 ptt? -161.1 131.26 5.03 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 123.915 1.817 . . . . 0.0 113.973 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.55 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 9.3 pttt -16.76 99.36 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 111.801 -2.454 . . . . 0.0 113.462 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 48' ' ' LYS 0.325 0.5 OUTLIER -99.12 140.22 21.55 Favored Pre-proline 0 C--N 1.264 -3.124 0 CA-C-N 111.548 -2.569 . . . . 0.0 108.613 178.272 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.64 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 36.0 Cg_endo -82.68 170.01 58.21 Favored 'Cis proline' 0 C--N 1.312 -1.384 0 C-N-CA 123.457 -1.476 . . . . 0.0 112.277 0.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.69 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -95.28 129.67 42.33 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.771 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.54 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 2.4 p -108.3 138.21 36.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 124.299 2.0 . . . . 0.0 112.05 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.623 ' HG2' ' HA ' ' A' ' 44' ' ' ASN . 1.7 tmmt? -42.09 117.42 0.97 Allowed 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 111.606 -2.543 . . . . 0.0 116.614 -175.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.25 -17.6 14.44 Favored Glycine 0 C--N 1.293 -1.83 0 CA-C-N 111.714 -2.494 . . . . 0.0 107.945 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 8.2 mt-30 -72.52 126.36 29.66 Favored 'General case' 0 C--N 1.278 -2.525 0 CA-C-O 123.199 1.476 . . . . 0.0 111.633 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.607 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 3.5 mt-30 -64.57 143.31 58.01 Favored 'General case' 0 C--N 1.27 -2.872 0 CA-C-N 113.385 -1.734 . . . . 0.0 107.927 178.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.951 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 19.9 m-85 -142.3 125.25 16.16 Favored 'General case' 0 C--N 1.279 -2.472 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.545 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 1.1 p30 -117.4 132.46 56.57 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-O 122.776 1.274 . . . . 0.0 110.088 -177.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 1.053 HD12 ' CG2' ' A' ' 110' ' ' VAL . 0.3 OUTLIER -101.29 157.84 4.25 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.196 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.422 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -147.24 141.37 26.09 Favored 'General case' 0 C--N 1.286 -2.189 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.133 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.645 ' CE1' ' HB2' ' A' ' 92' ' ' TRP . 3.0 t80 -144.04 112.52 6.5 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.276 -0.89 . . . . 0.0 108.894 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.596 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 0.6 OUTLIER -131.41 115.68 16.53 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 179.09 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.645 ' HB2' ' CE1' ' A' ' 90' ' ' TYR 0.266 0.5 OUTLIER -141.89 111.81 6.78 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.513 -176.666 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 2.5 p-10 -74.67 159.49 32.02 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 119.378 -2.077 . . . . 0.0 109.361 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.84 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.8 OUTLIER -153.0 172.16 5.94 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.083 -1.011 . . . . 0.0 108.835 -178.296 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.84 ' HD2' HG22 ' A' ' 94' ' ' VAL . 17.0 Cg_endo -37.53 152.32 0.04 OUTLIER 'Trans proline' 0 CA--C 1.498 -1.286 0 O-C-N 123.785 1.413 . . . . 0.0 110.045 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.839 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -79.04 -23.22 44.44 Favored 'General case' 0 C--N 1.282 -2.362 0 C-N-CA 116.622 -2.031 . . . . 0.0 115.068 -172.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.763 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -138.75 43.07 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-O 121.398 0.618 . . . . 0.0 112.618 -178.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.943 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . . . -70.04 -67.62 0.65 Allowed Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 120.686 -1.259 . . . . 0.0 110.654 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.943 ' HD3' ' HB3' ' A' ' 98' ' ' ALA . 47.7 Cg_endo -66.51 160.4 46.01 Favored 'Trans proline' 0 CA--C 1.461 -3.133 0 O-C-N 123.676 1.356 . . . . 0.0 110.228 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.707 ' HD2' ' C ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -109.16 106.49 16.39 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-N 112.497 -2.138 . . . . 0.0 110.301 -169.453 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.451 ' C ' ' HG3' ' A' ' 102' ' ' GLU . 5.3 p -46.25 97.16 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 CA-C-O 123.612 1.673 . . . . 0.0 109.031 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.392 84.8 mt-10 -164.95 -52.4 0.03 OUTLIER 'General case' 0 CA--C 1.45 -2.893 0 CA-C-N 112.975 -1.921 . . . . 0.0 111.461 179.659 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.569 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.489 0.7 OUTLIER -160.73 83.5 0.67 Allowed 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 110.681 -2.963 . . . . 0.0 113.608 -162.045 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.966 HG22 ' HA ' ' A' ' 58' ' ' ILE . 32.4 t -143.21 134.23 23.0 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 C-N-CA 119.103 -1.039 . . . . 0.0 112.308 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 1.073 HG13 HD11 ' A' ' 121' ' ' ILE . 0.6 OUTLIER -140.54 130.61 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.555 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.801 HG23 ' HB2' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -105.46 141.9 19.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-O 122.344 1.069 . . . . 0.0 111.393 -179.271 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 1.068 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -132.6 109.14 9.53 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 179.509 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.027 HG21 HD12 ' A' ' 54' ' ' ILE . 3.4 t -127.61 141.91 45.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 117.802 -1.559 . . . . 0.0 109.16 -177.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.851 ' HB2' ' CB ' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -131.03 152.84 49.9 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 122.904 1.335 . . . . 0.0 112.938 -178.774 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 1.053 ' CG2' HD12 ' A' ' 88' ' ' ILE . 3.8 t -102.61 124.55 56.67 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 176.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.544 ' HG2' ' O ' ' A' ' 111' ' ' MET . 2.1 ptm -104.86 121.76 44.35 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.598 ' HA3' HD23 ' A' ' 117' ' ' LEU . . . -79.83 -137.35 1.62 Allowed Glycine 0 N--CA 1.496 2.662 0 C-N-CA 118.931 -1.604 . . . . 0.0 114.01 -175.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.64 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 13.4 p-10 -79.8 -4.93 54.23 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 122.393 1.092 . . . . 0.0 111.986 -177.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 10.8 p30 -128.9 -4.61 5.12 Favored 'General case' 0 C--N 1.268 -2.96 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.933 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.58 ' O ' ' HB ' ' A' ' 116' ' ' VAL . . . 86.81 84.0 1.13 Allowed Glycine 0 CA--C 1.471 -2.718 0 CA-C-O 124.875 2.375 . . . . 0.0 109.669 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.58 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 6.9 p 145.97 145.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.246 -3.913 0 CA-C-N 108.281 -3.96 . . . . 0.0 111.204 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.742 ' CB ' HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -162.21 -59.51 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.378 -0.826 . . . . 0.0 110.651 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.973 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -168.25 129.17 1.33 Allowed 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.851 ' CB ' ' HB2' ' A' ' 109' ' ' LYS . 0.8 OUTLIER -134.29 141.32 46.91 Favored 'General case' 0 C--N 1.284 -2.274 0 C-N-CA 118.004 -1.478 . . . . 0.0 113.097 -177.703 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.69 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -146.53 137.28 24.07 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 123.159 1.456 . . . . 0.0 112.468 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 1.073 HD11 HG13 ' A' ' 105' ' ' VAL 0.265 0.1 OUTLIER -112.23 133.24 58.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 113.908 -1.497 . . . . 0.0 110.912 -179.78 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.766 ' N ' HD13 ' A' ' 121' ' ' ILE . . . . . . . . 0 N--CA 1.486 1.367 0 O-C-N 120.743 -1.223 . . . . 0.0 108.858 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.492 ' O ' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 120.75 0.31 . . . . 0.0 110.851 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.667 HG12 ' HA ' ' A' ' 22' ' ' HIS . 1.4 m -148.72 174.7 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.496 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -80.12 139.86 36.66 Favored 'General case' 0 CA--C 1.482 -1.647 0 C-N-CA 118.097 -1.441 . . . . 0.0 108.396 177.042 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.503 ' C ' ' CG ' ' A' ' 6' ' ' LYS 0.434 0.4 OUTLIER -166.33 -175.31 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.406 -169.992 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.556 ' HB2' ' CG2' ' A' ' 121' ' ' ILE . 1.6 mttt -153.91 138.86 17.22 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 123.565 1.65 . . . . 0.0 112.577 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.285 3.5 t70 -84.67 148.83 26.2 Favored 'General case' 0 C--N 1.27 -2.881 0 CA-C-N 113.381 -1.736 . . . . 0.0 109.732 178.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.621 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 5.3 p -137.43 13.14 3.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.007 -1.058 . . . . 0.0 109.469 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.837 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -126.33 -85.58 0.61 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 118.586 -1.246 . . . . 0.0 110.026 -177.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 12' ' ' GLU . 2.5 t30 -160.29 67.1 0.35 Allowed 'General case' 0 C--N 1.265 -3.083 0 C-N-CA 118.578 -1.249 . . . . 0.0 111.935 177.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.467 ' C ' ' O ' ' A' ' 10' ' ' ASN . 11.0 m-70 34.36 32.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.765 0.793 . . . . 0.0 110.42 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.1 OUTLIER -86.92 20.4 2.64 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.475 0.655 . . . . 0.0 110.739 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.896 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.289 0.0 OUTLIER -121.79 -166.89 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-O 121.989 0.9 . . . . 0.0 110.834 -178.215 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.649 ' H ' HG23 ' A' ' 13' ' ' ILE . 1.7 pttt -161.88 -44.08 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.996 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.57 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 11.3 tttm -149.85 140.31 22.42 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 116.375 -2.13 . . . . 0.0 113.371 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 1.031 HG13 ' HB2' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -132.92 108.85 13.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 CA-C-O 122.873 1.321 . . . . 0.0 110.936 179.705 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.532 ' HA ' HD23 ' A' ' 17' ' ' LEU . 2.8 mt -102.0 122.57 44.32 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 114.164 -1.38 . . . . 0.0 110.949 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.638 HG22 ' HB2' ' A' ' 37' ' ' LEU . 58.3 t -142.11 142.51 24.73 Favored Pre-proline 0 C--N 1.292 -1.906 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.549 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.491 ' HD2' HG13 ' A' ' 18' ' ' VAL . 40.7 Cg_endo -66.19 126.65 16.08 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.752 1.396 . . . . 0.0 110.69 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 123.19 -78.69 0.35 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.6 m -90.37 133.86 34.71 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.476 -1.014 . . . . 0.0 109.965 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.667 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -140.79 10.52 2.22 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.019 -1.675 . . . . 0.0 110.847 178.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.489 ' O ' ' HB3' ' A' ' 4' ' ' ASP . . . . . . . . 0 C--N 1.285 -2.258 0 C-N-CA 118.592 -1.766 . . . . 0.0 110.62 176.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.864 ' HA2' ' HA ' ' A' ' 96' ' ' LYS . . . . . . . . 0 C--O 1.213 -1.165 0 N-CA-C 105.413 -3.075 . . . . 0.0 105.413 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.731 ' HB2' HG12 ' A' ' 94' ' ' VAL . 4.5 mmmm -116.3 94.82 43.6 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 120.593 2.196 . . . . 0.0 116.57 -174.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.645 ' HD3' ' O ' ' A' ' 32' ' ' GLY . 61.3 Cg_endo -106.91 144.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.288 -2.621 0 C-N-CA 124.086 3.191 . . . . 0.0 108.136 176.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.653 ' HZ ' HG11 ' A' ' 94' ' ' VAL . 2.2 m-85 -120.8 94.59 4.4 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.002 -1.079 . . . . 0.0 109.429 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.61 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 28.1 mp0 -113.3 84.41 2.0 Allowed 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.678 HD12 ' C ' ' A' ' 37' ' ' LEU . 3.6 pp -110.24 140.97 43.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.652 -1.28 . . . . 0.0 109.718 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -140.76 139.27 34.6 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 122.73 1.252 . . . . 0.0 109.151 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 1.031 ' HB2' HG13 ' A' ' 16' ' ' VAL . . . -142.68 151.64 41.58 Favored 'General case' 0 C--N 1.277 -2.576 0 CA-C-O 123.007 1.384 . . . . 0.0 112.546 -177.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.57 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.15 141.57 25.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 113.996 -1.457 . . . . 0.0 108.908 178.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.593 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 3.1 p90 -155.94 121.21 4.82 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 17.0 tt0 -68.82 152.82 44.81 Favored 'General case' 0 C--N 1.286 -2.159 0 O-C-N 120.392 -1.443 . . . . 0.0 108.267 178.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.995 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -85.64 131.52 34.33 Favored 'General case' 0 C--N 1.264 -3.109 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.445 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.63 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -113.36 50.8 0.88 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 125.638 2.637 . . . . 0.0 114.074 179.454 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.605 ' C ' ' HB2' ' A' ' 82' ' ' LYS . 4.4 pt20 167.33 -162.39 0.01 OUTLIER 'General case' 0 C--N 1.266 -3.023 0 CA-C-N 108.641 -3.89 . . . . 0.0 113.462 175.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . 0.279 36.6 t30 -110.37 152.44 26.24 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 122.466 1.127 . . . . 0.0 108.712 -178.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.673 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -173.25 155.52 2.94 Favored 'General case' 0 C--N 1.255 -3.534 0 C-N-CA 118.01 -1.476 . . . . 0.0 113.257 -178.527 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.968 ' O ' HG23 ' A' ' 49' ' ' THR . 9.9 mttt -110.63 7.21 22.26 Favored 'General case' 0 N--CA 1.509 2.495 0 O-C-N 120.734 -1.229 . . . . 0.0 110.646 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.968 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.8 OUTLIER -168.01 146.1 4.43 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 120.557 -1.339 . . . . 0.0 111.262 179.255 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.529 ' O ' ' O ' ' A' ' 70' ' ' PRO . . . -143.21 97.93 3.17 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-O 122.619 1.199 . . . . 0.0 109.641 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 12.3 mtmt -68.71 -179.09 1.31 Allowed 'General case' 0 N--CA 1.504 2.237 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.719 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.989 ' CG2' HD11 ' A' ' 88' ' ' ILE . 35.6 mt -140.19 140.4 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.425 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.368 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.501 ' HB3' ' HE1' ' A' ' 111' ' ' MET . 16.3 tp10 -140.47 107.88 5.55 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 123.374 1.559 . . . . 0.0 110.313 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 1.067 HD12 HG21 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -91.16 125.6 43.89 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 CA-C-N 112.572 -2.103 . . . . 0.0 109.271 179.327 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -121.36 103.4 8.93 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 177.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.937 ' HB3' HG22 ' A' ' 63' ' ' VAL . . . -110.31 128.77 55.71 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 118.814 -1.155 . . . . 0.0 112.005 -176.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.71 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 0.4 OUTLIER -107.09 102.93 12.23 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.943 ' HA ' HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -114.51 101.91 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.868 0 CA-C-O 123.197 1.475 . . . . 0.0 110.811 -177.454 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.666 ' N ' HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER 37.46 65.16 0.56 Allowed 'General case' 0 N--CA 1.522 3.132 0 CA-C-N 114.932 -1.031 . . . . 0.0 113.074 179.304 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.87 -15.49 8.1 Favored Glycine 0 N--CA 1.488 2.133 0 O-C-N 121.278 -0.889 . . . . 0.0 111.363 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.522 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.274 0.3 OUTLIER -108.02 56.73 0.63 Allowed 'General case' 0 C--N 1.293 -1.85 0 O-C-N 121.108 -1.23 . . . . 0.0 111.417 -178.384 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.376 0.0 OUTLIER -60.38 117.48 5.29 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.918 0.866 . . . . 0.0 110.661 179.928 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.937 HG22 ' HB3' ' A' ' 56' ' ' ALA . 17.1 m -80.62 135.46 25.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-O 122.816 1.293 . . . . 0.0 111.736 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.447 26.0 t0 -140.08 67.65 1.37 Allowed 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.833 -177.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.576 HG12 ' HD2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -150.52 175.85 2.61 Favored Pre-proline 0 C--N 1.268 -2.952 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.001 -178.152 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.576 ' HD2' HG12 ' A' ' 65' ' ' VAL . 38.3 Cg_endo -65.98 139.91 58.29 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.395 1.734 . . . . 0.0 111.382 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.603 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -134.57 -73.01 0.08 OUTLIER Glycine 0 N--CA 1.503 3.11 0 CA-C-N 112.459 -2.155 . . . . 0.0 111.121 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.757 HD13 ' H ' ' A' ' 91' ' ' THR . 2.0 tp -117.42 -157.83 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.225 -1.75 . . . . 0.0 108.789 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.716 ' N ' HG23 ' A' ' 68' ' ' ILE . 0.6 OUTLIER -106.69 141.85 23.71 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 177.136 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.777 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 24.5 Cg_endo -105.76 -3.76 0.15 Allowed 'Trans proline' 0 C--N 1.276 -3.289 0 C-N-CA 123.196 2.597 . . . . 0.0 114.309 -173.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.576 ' O ' ' CE1' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -110.37 87.58 2.56 Favored 'General case' 0 C--N 1.287 -2.132 0 O-C-N 120.717 -1.24 . . . . 0.0 108.121 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.626 ' HA ' ' CD1' ' A' ' 75' ' ' TYR . . . -74.47 8.45 2.27 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.734 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.4 ' C ' ' H ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -78.11 -19.87 53.27 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 120.536 -1.352 . . . . 0.0 108.243 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.574 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -88.76 19.75 3.86 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 173.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.626 ' CD1' ' HA ' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -132.57 -9.07 3.22 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.798 179.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.468 ' O ' ' C ' ' A' ' 77' ' ' LYS . 2.1 ptt? -167.93 129.59 1.46 Allowed 'General case' 0 C--O 1.215 -0.757 0 CA-C-O 123.621 1.677 . . . . 0.0 112.489 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.526 ' O ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -9.16 94.92 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 111.99 -2.368 . . . . 0.0 113.833 -178.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 48' ' ' LYS 0.312 7.9 t -98.87 140.3 21.66 Favored Pre-proline 0 C--N 1.271 -2.813 0 CA-C-N 111.278 -2.692 . . . . 0.0 108.093 177.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.728 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 36.2 Cg_endo -78.74 171.21 66.85 Favored 'Cis proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.987 -1.672 . . . . 0.0 113.177 1.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.687 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.3 OUTLIER -99.33 129.3 45.53 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.066 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.509 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.4 t -105.12 138.68 28.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 124.202 1.953 . . . . 0.0 112.287 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.63 ' HG2' ' HA ' ' A' ' 44' ' ' ASN . 1.4 tmmt? -43.96 118.08 1.36 Allowed 'General case' 0 C--N 1.273 -2.748 0 CA-C-N 111.762 -2.472 . . . . 0.0 116.517 -175.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.26 -18.26 12.23 Favored Glycine 0 C--N 1.29 -1.988 0 CA-C-N 111.746 -2.479 . . . . 0.0 107.931 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 11.0 mt-30 -71.84 125.39 27.05 Favored 'General case' 0 C--N 1.278 -2.5 0 CA-C-O 123.13 1.443 . . . . 0.0 111.543 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.593 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -63.67 142.89 58.23 Favored 'General case' 0 C--N 1.268 -2.938 0 CA-C-N 113.424 -1.716 . . . . 0.0 107.355 178.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.995 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 17.7 m-85 -142.21 126.1 17.16 Favored 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.545 ' HB3' HG12 ' A' ' 40' ' ' VAL . 19.9 p30 -117.35 132.6 56.56 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-O 122.856 1.312 . . . . 0.0 110.107 -177.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 1.058 HD12 ' CG2' ' A' ' 110' ' ' VAL . 0.4 OUTLIER -101.99 159.16 4.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 CA-C-N 114.324 -1.307 . . . . 0.0 108.13 179.513 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.456 ' HG2' ' N ' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -148.95 151.2 34.19 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.909 -178.031 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.523 ' O ' ' HA ' ' A' ' 36' ' ' GLN . 49.3 t80 -147.92 104.1 3.55 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.335 178.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.757 ' H ' HD13 ' A' ' 68' ' ' ILE . 1.1 t -121.2 113.93 20.68 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.603 ' CD1' ' O ' ' A' ' 67' ' ' GLY 0.272 0.4 OUTLIER -142.17 113.86 7.92 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.611 -177.107 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 18.7 p-10 -75.07 159.1 32.11 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 119.423 -2.048 . . . . 0.0 109.696 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.875 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.5 OUTLIER -155.59 169.19 10.77 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.05 -1.031 . . . . 0.0 108.484 -178.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.875 ' HD2' HG22 ' A' ' 94' ' ' VAL . 17.2 Cg_endo -36.65 154.74 0.02 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.16 0 O-C-N 123.488 1.257 . . . . 0.0 110.887 -177.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.864 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -78.71 -25.41 44.7 Favored 'General case' 0 C--N 1.285 -2.219 0 C-N-CA 116.903 -1.919 . . . . 0.0 114.889 -172.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.763 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -145.85 47.24 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 CA-C-O 121.802 0.81 . . . . 0.0 111.941 -178.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.833 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . . . -76.06 -60.1 1.03 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.731 -1.23 . . . . 0.0 111.31 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.833 ' HD3' ' HB3' ' A' ' 98' ' ' ALA . 45.0 Cg_endo -64.36 159.05 45.74 Favored 'Trans proline' 0 CA--C 1.466 -2.897 0 O-C-N 123.912 1.48 . . . . 0.0 111.161 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.715 ' HD2' ' C ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -109.88 105.28 14.41 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 112.404 -2.18 . . . . 0.0 110.564 -169.146 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.422 ' C ' ' HG3' ' A' ' 102' ' ' GLU . 4.2 p -46.49 95.24 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.5 0 CA-C-O 123.509 1.623 . . . . 0.0 109.363 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.622 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.399 92.3 mt-10 -164.26 -51.83 0.03 OUTLIER 'General case' 0 CA--C 1.453 -2.787 0 CA-C-N 112.981 -1.918 . . . . 0.0 112.029 179.8 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.552 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.49 0.8 OUTLIER -160.49 79.45 0.65 Allowed 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 115.016 -2.674 . . . . 0.0 114.221 -161.939 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.943 HG22 ' HA ' ' A' ' 58' ' ' ILE . 36.1 t -142.44 153.53 17.99 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.577 0 C-N-CA 119.703 -0.799 . . . . 0.0 111.203 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.832 HG13 HD11 ' A' ' 121' ' ' ILE . 0.4 OUTLIER -167.44 134.6 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -179.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.706 HG23 ' HB2' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -105.02 142.84 17.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.717 0 CA-C-O 122.391 1.091 . . . . 0.0 111.772 -179.044 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 1.09 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -132.32 107.92 8.86 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.067 HG21 HD12 ' A' ' 54' ' ' ILE . 3.2 t -125.13 142.74 41.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 117.628 -1.629 . . . . 0.0 109.136 -177.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 1.039 ' HB2' ' HB2' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -135.36 146.03 47.96 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.229 1.014 . . . . 0.0 111.169 -178.104 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 1.058 ' CG2' HD12 ' A' ' 88' ' ' ILE . 14.9 t -101.07 132.35 47.0 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.524 ' N ' ' HE2' ' A' ' 111' ' ' MET . 2.6 mtm -109.69 121.6 45.58 Favored 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.727 ' CA ' HD23 ' A' ' 117' ' ' LEU . . . -80.1 -141.66 2.65 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 119.109 -1.519 . . . . 0.0 113.846 -176.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.673 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 11.0 p-10 -77.28 -6.49 53.35 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 122.414 1.102 . . . . 0.0 111.951 -177.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -125.89 -4.98 6.91 Favored 'General case' 0 C--N 1.268 -2.961 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.703 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.939 ' O ' HG13 ' A' ' 116' ' ' VAL . . . 85.02 82.16 1.06 Allowed Glycine 0 CA--C 1.47 -2.722 0 CA-C-O 124.814 2.341 . . . . 0.0 109.834 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.939 HG13 ' O ' ' A' ' 115' ' ' GLY . 0.5 OUTLIER 152.59 143.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.247 -3.884 0 CA-C-N 108.204 -3.998 . . . . 0.0 111.622 177.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.759 ' CB ' HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -160.44 -57.45 0.06 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.331 -0.856 . . . . 0.0 111.319 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.896 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -174.87 131.87 0.33 Allowed 'General case' 0 N--CA 1.511 2.58 0 O-C-N 121.125 -0.984 . . . . 0.0 109.467 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 1.039 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 0.8 OUTLIER -133.97 137.94 45.14 Favored 'General case' 0 C--N 1.283 -2.283 0 C-N-CA 118.184 -1.406 . . . . 0.0 113.07 -177.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.673 ' HB2' HD12 ' A' ' 13' ' ' ILE . . . -148.52 136.93 21.28 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 123.077 1.418 . . . . 0.0 111.908 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 1.09 ' HB ' HG23 ' A' ' 107' ' ' THR 0.262 0.0 OUTLIER -110.54 130.29 64.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.97 -179.593 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.649 ' N ' HD13 ' A' ' 121' ' ' ILE . . . . . . . . 0 N--CA 1.488 1.436 0 O-C-N 120.931 -1.105 . . . . 0.0 109.19 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.226 0.536 . . . . 0.0 110.218 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 1' ' ' SER . 0.0 OUTLIER 64.0 157.02 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 111.209 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.796 HG12 ' HA ' ' A' ' 22' ' ' HIS 0.256 1.4 m -145.72 173.08 3.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.561 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -80.91 142.19 33.8 Favored 'General case' 0 CA--C 1.475 -1.921 0 O-C-N 120.281 -1.512 . . . . 0.0 107.741 176.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.62 HG12 ' H ' ' A' ' 6' ' ' LYS 0.406 0.4 OUTLIER -161.3 -50.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 C-N-CA 117.226 -1.79 . . . . 0.0 112.097 -170.121 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.62 ' H ' HG12 ' A' ' 5' ' ' VAL . 28.6 mmtm 84.86 139.46 0.06 Allowed 'General case' 0 N--CA 1.508 2.429 0 CA-C-O 124.315 2.007 . . . . 0.0 113.97 178.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.3 26.4 t70 -93.37 153.99 18.21 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 111.491 -2.595 . . . . 0.0 109.381 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.669 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.7 p -138.01 17.12 2.83 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.961 -1.087 . . . . 0.0 109.372 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.868 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -124.43 -85.81 0.64 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 118.55 -1.26 . . . . 0.0 109.722 -176.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.562 ' O ' ' N ' ' A' ' 12' ' ' GLU . 4.4 t30 -159.96 65.04 0.35 Allowed 'General case' 0 C--N 1.265 -3.07 0 C-N-CA 117.774 -1.57 . . . . 0.0 112.142 177.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.466 ' C ' ' O ' ' A' ' 10' ' ' ASN . 9.0 m-70 33.3 32.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.778 0.799 . . . . 0.0 110.507 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.562 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.1 OUTLIER -95.23 24.74 4.76 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.0 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.756 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.28 0.0 OUTLIER -117.14 -165.24 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-O 122.213 1.006 . . . . 0.0 110.993 -178.624 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.721 ' N ' HG23 ' A' ' 13' ' ' ILE . 14.8 ptpt -162.31 -48.03 0.04 OUTLIER 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.873 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.648 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 12.1 tttm -144.0 135.47 25.87 Favored 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 116.344 -2.142 . . . . 0.0 112.896 178.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.562 ' CG1' ' HB2' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -133.46 102.26 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-O 122.845 1.307 . . . . 0.0 110.603 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 17' ' ' LEU . 2.0 mt -93.41 123.44 36.71 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 114.172 -1.377 . . . . 0.0 111.253 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.688 HG13 ' HD2' ' A' ' 19' ' ' PRO . 23.7 t -143.13 145.82 34.26 Favored Pre-proline 0 N--CA 1.502 2.147 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.931 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.688 ' HD2' HG13 ' A' ' 18' ' ' VAL . 43.7 Cg_endo -68.72 109.88 2.2 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.83 1.437 . . . . 0.0 110.978 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.11 -94.99 0.12 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.511 ' SG ' ' HB3' ' A' ' 124' ' ' HIS . 14.1 m -93.82 174.82 6.98 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.108 -1.231 . . . . 0.0 111.415 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.796 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.3 OUTLIER -142.01 7.13 1.81 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.198 -0.939 . . . . 0.0 110.491 178.36 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.68 -151.21 10.19 Favored Glycine 0 C--N 1.287 -2.147 0 C-N-CA 118.958 -1.591 . . . . 0.0 110.212 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.75 -8.8 23.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.739 -1.448 . . . . 0.0 110.055 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.819 ' CB ' ' HD3' ' A' ' 26' ' ' PRO . 1.2 mt-10 -64.46 176.35 0.74 Allowed Pre-proline 0 C--N 1.299 -1.622 0 CA-C-O 124.962 2.315 . . . . 0.0 115.077 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.819 ' HD3' ' CB ' ' A' ' 25' ' ' GLU . 25.8 Cg_endo -107.25 123.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.267 -3.738 1 C-N-CA 127.714 5.609 . . . . 0.0 111.14 -175.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.5 ' SG ' ' N ' ' A' ' 21' ' ' CYS . 25.0 p -137.32 120.56 16.82 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 122.816 1.293 . . . . 0.0 111.639 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.712 HG22 ' H ' ' A' ' 29' ' ' ILE 0.335 46.9 mm -79.37 -166.03 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.712 ' H ' HG22 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -115.06 121.6 67.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 CA-C-O 122.584 1.183 . . . . 0.0 111.059 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.457 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 1.1 p-80 -70.36 33.19 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.836 -178.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 30' ' ' HIS . 43.6 mtt85 58.1 170.39 0.05 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.471 -1.393 . . . . 0.0 110.225 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.809 ' HA2' ' HA ' ' A' ' 96' ' ' LYS . . . 69.19 117.58 0.03 OUTLIER Glycine 0 C--O 1.214 -1.139 0 N-CA-C 105.61 -2.996 . . . . 0.0 105.61 -178.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.744 ' HB2' HG12 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -118.41 96.8 50.27 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 121.281 2.54 . . . . 0.0 117.089 -174.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.584 ' HD3' ' O ' ' A' ' 32' ' ' GLY . 61.2 Cg_endo -107.11 144.87 0.08 OUTLIER 'Trans proline' 0 C--N 1.29 -2.504 0 C-N-CA 124.289 3.326 . . . . 0.0 107.416 175.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.543 ' O ' ' CE1' ' A' ' 90' ' ' TYR . 30.4 m-85 -119.05 97.53 5.73 Favored 'General case' 0 C--N 1.291 -1.972 0 C-N-CA 118.603 -1.239 . . . . 0.0 108.839 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.653 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 28.1 mp0 -117.65 99.8 7.2 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.668 -0.645 . . . . 0.0 109.896 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.664 ' HA ' HG22 ' A' ' 18' ' ' VAL . 2.0 mt -109.67 139.24 44.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.403 -1.436 . . . . 0.0 108.741 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.402 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -140.24 128.65 22.67 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.564 -1.335 . . . . 0.0 107.764 179.241 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.562 ' HB2' ' CG1' ' A' ' 16' ' ' VAL . . . -143.75 150.14 38.16 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-O 123.119 1.437 . . . . 0.0 113.485 -176.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.728 HG12 ' HB3' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -115.49 138.22 46.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-N 113.696 -1.593 . . . . 0.0 107.84 177.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.688 ' HE2' HG22 ' A' ' 88' ' ' ILE . 8.4 p90 -159.58 130.01 5.71 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -177.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 15.2 tt0 -73.02 155.25 40.0 Favored 'General case' 0 C--N 1.281 -2.381 0 O-C-N 120.464 -1.398 . . . . 0.0 109.127 177.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.977 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -88.97 136.56 32.95 Favored 'General case' 0 C--N 1.269 -2.924 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.65 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.599 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 0.2 OUTLIER -117.32 50.51 1.1 Allowed 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 125.408 2.528 . . . . 0.0 114.071 179.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.631 ' C ' ' HB2' ' A' ' 82' ' ' LYS . 7.0 pt20 166.87 -159.44 0.01 OUTLIER 'General case' 0 C--N 1.257 -3.416 0 CA-C-N 108.947 -3.751 . . . . 0.0 112.816 175.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.463 ' H ' ' HB2' ' A' ' 45' ' ' GLN 0.275 21.1 t-20 -110.1 154.25 23.54 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-O 122.53 1.157 . . . . 0.0 108.389 -178.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.631 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -171.84 151.05 2.73 Favored 'General case' 0 C--N 1.251 -3.675 0 C-N-CA 118.366 -1.333 . . . . 0.0 112.508 -178.25 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.953 ' O ' HG23 ' A' ' 49' ' ' THR . 0.0 OUTLIER -111.66 6.52 19.96 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 120.668 -1.27 . . . . 0.0 110.817 178.511 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.953 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.41 147.43 4.41 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 120.712 -1.243 . . . . 0.0 111.089 179.373 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 111' ' ' MET . . . -146.71 106.17 3.92 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-O 122.271 1.034 . . . . 0.0 109.981 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.599 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -75.99 -175.73 3.17 Favored 'General case' 0 N--CA 1.505 2.292 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.353 179.447 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.829 ' CG1' HD11 ' A' ' 88' ' ' ILE . 26.7 mt -140.19 135.08 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.688 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.407 ' C ' HG13 ' A' ' 108' ' ' VAL . 15.9 tt0 -141.4 114.55 8.67 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 123.428 1.585 . . . . 0.0 111.854 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 1.031 HD12 HG21 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -90.28 125.91 43.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-N 112.705 -2.043 . . . . 0.0 108.904 178.15 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -117.69 98.69 6.5 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 177.344 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.895 ' HB3' HG22 ' A' ' 63' ' ' VAL . . . -112.86 126.8 55.85 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 118.459 -1.296 . . . . 0.0 112.889 -175.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.746 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.4 p -104.28 98.37 8.18 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 177.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.89 ' HA ' HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -108.76 107.38 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.882 0 CA-C-O 122.905 1.336 . . . . 0.0 110.916 -176.676 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.634 ' N ' HG22 ' A' ' 104' ' ' VAL . 1.8 p30 35.84 62.35 0.65 Allowed 'General case' 0 N--CA 1.522 3.126 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.78 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.05 -12.04 10.16 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.284 -0.885 . . . . 0.0 111.365 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.541 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.279 0.3 OUTLIER -108.13 57.02 0.62 Allowed 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.079 -1.248 . . . . 0.0 111.162 -178.6 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.364 0.0 OUTLIER -60.79 115.09 3.41 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 122.049 0.928 . . . . 0.0 111.366 -179.411 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.895 HG22 ' HB3' ' A' ' 56' ' ' ALA . 15.2 m -75.77 143.64 12.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-O 122.494 1.14 . . . . 0.0 110.352 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.527 ' C ' ' CG2' ' A' ' 65' ' ' VAL 0.435 20.9 t0 -138.27 60.0 1.63 Allowed 'General case' 0 C--N 1.277 -2.572 0 CA-C-O 122.752 1.263 . . . . 0.0 110.901 -176.169 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.809 HG12 ' HD2' ' A' ' 66' ' ' PRO . 1.0 OUTLIER -157.39 151.86 20.49 Favored Pre-proline 0 C--N 1.269 -2.929 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.742 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.809 ' HD2' HG12 ' A' ' 65' ' ' VAL . 44.9 Cg_endo -84.47 137.38 6.9 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 CA-C-O 123.763 1.485 . . . . 0.0 111.013 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.604 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -116.66 42.52 1.85 Allowed Glycine 0 C--N 1.27 -3.136 0 CA-C-N 112.574 -2.103 . . . . 0.0 111.774 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.733 HG23 ' N ' ' A' ' 69' ' ' ASP . 3.0 tp 174.3 -163.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 O-C-N 120.379 -1.659 . . . . 0.0 108.93 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.733 ' N ' HG23 ' A' ' 68' ' ' ILE . 1.5 t70 -107.62 135.01 19.8 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 174.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.723 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 23.6 Cg_endo -106.16 -4.69 0.13 Allowed 'Trans proline' 0 C--N 1.278 -3.176 0 C-N-CA 123.445 2.763 . . . . 0.0 114.07 -173.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.608 ' O ' ' CE1' ' A' ' 75' ' ' TYR . 9.1 p30 -114.93 92.9 4.09 Favored 'General case' 0 C--N 1.285 -2.224 0 O-C-N 120.491 -1.381 . . . . 0.0 108.695 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.609 ' HA ' ' CD1' ' A' ' 75' ' ' TYR . . . -77.91 12.08 1.92 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.071 -1.018 . . . . 0.0 109.095 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.9 t -76.35 -25.22 54.46 Favored 'General case' 0 C--O 1.214 -0.773 0 O-C-N 120.802 -1.186 . . . . 0.0 107.951 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.592 ' CD2' ' OD1' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -88.1 18.68 4.1 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 174.421 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.62 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.2 OUTLIER -134.06 -10.93 2.61 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.38 179.631 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.457 ' O ' ' C ' ' A' ' 77' ' ' LYS . 2.0 ptt? -164.04 133.48 3.93 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-O 123.897 1.808 . . . . 0.0 113.277 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.524 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -12.08 95.51 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 111.761 -2.472 . . . . 0.0 113.732 -178.638 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.51 ' HA ' HD13 ' A' ' 80' ' ' LEU 0.312 1.2 t -104.86 145.13 30.12 Favored Pre-proline 0 C--N 1.268 -2.949 0 CA-C-N 111.428 -2.623 . . . . 0.0 108.491 178.341 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.659 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 36.8 Cg_endo -80.52 166.62 75.33 Favored 'Cis proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.562 -1.849 . . . . 0.0 112.513 0.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.657 ' HG ' ' CE1' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -90.95 127.76 36.52 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.816 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.518 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.4 t -104.58 141.35 20.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-O 124.253 1.977 . . . . 0.0 112.377 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.631 ' HB2' ' C ' ' A' ' 45' ' ' GLN . 1.7 tmmt? -46.55 118.32 1.95 Allowed 'General case' 0 C--N 1.272 -2.772 0 CA-C-N 111.531 -2.577 . . . . 0.0 116.578 -175.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.27 -16.84 19.67 Favored Glycine 0 C--N 1.29 -2.022 0 CA-C-N 111.827 -2.442 . . . . 0.0 107.811 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 17.7 mt-30 -72.83 126.61 30.32 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-O 123.198 1.475 . . . . 0.0 111.598 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.605 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -63.81 144.95 56.64 Favored 'General case' 0 C--N 1.271 -2.834 0 CA-C-N 113.341 -1.754 . . . . 0.0 107.074 178.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.977 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 16.1 m-85 -143.43 125.3 15.16 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.728 ' HB3' HG12 ' A' ' 40' ' ' VAL . 8.4 p30 -117.06 127.2 53.92 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-O 122.572 1.177 . . . . 0.0 109.291 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.829 HD11 ' CG1' ' A' ' 52' ' ' ILE . 0.6 OUTLIER -109.95 159.77 9.4 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.202 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -151.06 156.84 41.93 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 122.046 0.927 . . . . 0.0 111.807 -177.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.653 ' O ' ' HA ' ' A' ' 36' ' ' GLN . 3.7 t80 -150.48 138.46 20.1 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.59 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 1.5 t -154.95 116.43 4.06 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 119.595 1.089 . . . . 0.0 108.102 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.652 ' CZ3' HG23 ' A' ' 94' ' ' VAL 0.27 1.5 t90 -143.03 115.87 8.76 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 119.809 -0.756 . . . . 0.0 110.021 -177.468 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.518 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.6 OUTLIER -74.91 160.29 30.8 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 119.249 -2.157 . . . . 0.0 110.135 -178.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.81 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.7 OUTLIER -153.76 166.09 16.45 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.151 -0.968 . . . . 0.0 108.47 -179.274 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.81 ' HD2' HG22 ' A' ' 94' ' ' VAL . 18.4 Cg_endo -37.03 150.16 0.05 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.136 0 O-C-N 123.587 1.309 . . . . 0.0 110.64 -177.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.809 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.5 OUTLIER -79.27 -24.69 42.77 Favored 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 116.94 -1.904 . . . . 0.0 114.33 -173.311 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.767 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -138.52 42.85 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 O-C-N 121.658 -0.651 . . . . 0.0 112.25 -179.161 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.941 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . . . -74.14 -67.67 0.39 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 120.641 -1.287 . . . . 0.0 110.025 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.941 ' HD3' ' HB3' ' A' ' 98' ' ' ALA . 50.3 Cg_endo -67.55 160.09 49.54 Favored 'Trans proline' 0 CA--C 1.463 -3.042 0 O-C-N 123.615 1.323 . . . . 0.0 110.106 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.711 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -107.78 103.09 12.28 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 112.482 -2.144 . . . . 0.0 109.849 -169.689 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.667 ' O ' ' HB ' ' A' ' 127' ' ' ILE . 6.5 p -42.96 99.62 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.723 0 CA-C-O 123.635 1.683 . . . . 0.0 108.661 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.405 88.5 mt-10 -163.67 -51.45 0.03 OUTLIER 'General case' 0 CA--C 1.45 -2.882 0 CA-C-N 113.024 -1.898 . . . . 0.0 111.674 -179.237 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.511 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.492 0.8 OUTLIER -159.3 79.22 0.74 Allowed 'General case' 0 C--N 1.283 -2.311 0 CA-C-N 110.952 -2.84 . . . . 0.0 113.378 -162.32 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.89 HG22 ' HA ' ' A' ' 58' ' ' ILE . 26.2 t -141.2 134.12 30.45 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.437 0 C-N-CA 119.811 -0.756 . . . . 0.0 111.234 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.958 HG22 HG22 ' A' ' 123' ' ' THR . 53.0 t -136.55 125.03 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.793 HG23 ' HB2' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -107.15 138.12 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 CA-C-O 122.58 1.181 . . . . 0.0 111.92 -178.805 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 1.018 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -131.39 110.35 10.98 Favored 'General case' 0 C--N 1.276 -2.623 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.204 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.031 HG21 HD12 ' A' ' 54' ' ' ILE . 3.2 t -123.42 142.19 40.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 C-N-CA 117.182 -1.807 . . . . 0.0 108.811 -177.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 1.105 ' HB2' ' HB2' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -138.22 145.02 40.91 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 122.485 1.136 . . . . 0.0 111.874 -176.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.71 ' CG2' HG21 ' A' ' 88' ' ' ILE . 5.6 t -96.6 125.67 49.48 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.553 ' CG ' ' HA2' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -105.68 119.24 38.62 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -179.291 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.511 ' HA3' HD23 ' A' ' 117' ' ' LEU . . . -75.75 -135.55 0.52 Allowed Glycine 0 N--CA 1.497 2.72 0 C-N-CA 119.091 -1.528 . . . . 0.0 113.856 -176.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.631 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 5.1 p-10 -88.59 -0.77 57.6 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.1 0.953 . . . . 0.0 112.267 -176.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -133.94 -4.31 2.81 Favored 'General case' 0 C--N 1.269 -2.914 0 CA-C-O 121.429 0.633 . . . . 0.0 110.954 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.627 ' O ' ' HB ' ' A' ' 116' ' ' VAL . . . 95.54 83.36 1.64 Allowed Glycine 0 CA--C 1.47 -2.765 0 CA-C-O 124.636 2.242 . . . . 0.0 111.024 178.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.627 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 14.6 p 136.21 152.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.254 -3.586 0 CA-C-N 108.371 -3.915 . . . . 0.0 112.72 176.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.681 ' CB ' HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -162.22 -59.51 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.414 0.626 . . . . 0.0 110.281 179.109 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.756 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -164.75 126.01 2.11 Favored 'General case' 0 N--CA 1.51 2.569 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 1.105 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 0.8 OUTLIER -134.11 135.74 43.42 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 117.918 -1.513 . . . . 0.0 113.112 -177.424 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.472 ' HB3' HG11 ' A' ' 16' ' ' VAL . . . -143.62 136.51 27.51 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 122.925 1.345 . . . . 0.0 112.406 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 1.1 HD13 ' N ' ' A' ' 122' ' ' ALA 0.26 0.0 OUTLIER -107.33 162.46 5.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 114.122 -1.399 . . . . 0.0 111.076 -179.589 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 1.1 ' N ' HD13 ' A' ' 121' ' ' ILE . . . -152.28 157.88 42.01 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.958 HG22 HG22 ' A' ' 105' ' ' VAL . 32.1 p -148.7 -87.31 0.09 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.346 -1.471 . . . . 0.0 110.5 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.568 ' C ' ' O ' ' A' ' 123' ' ' THR . 8.4 m-70 8.68 82.69 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.866 0 CA-C-O 121.438 0.637 . . . . 0.0 112.438 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.475 ' C ' ' HG3' ' A' ' 126' ' ' LYS . . . -173.51 79.2 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.622 ' O ' HG23 ' A' ' 28' ' ' ILE . 2.9 mtpt -130.63 -155.81 0.72 Allowed 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 122.065 0.936 . . . . 0.0 109.965 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.667 ' HB ' ' O ' ' A' ' 101' ' ' SER . 0.6 OUTLIER -147.93 134.46 12.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 121.763 0.792 . . . . 0.0 111.551 -179.37 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.476 ' HD3' ' O ' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -168.91 152.92 5.46 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.132 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 128' ' ' ARG . 2.9 m-20 . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.046 -1.033 . . . . 0.0 110.618 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 27.0 t . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.382 0.61 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.517 ' OE1' ' N ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -52.82 166.1 0.23 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.338 -0.851 . . . . 0.0 111.345 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.711 HG12 ' HA ' ' A' ' 22' ' ' HIS . 1.4 m -144.65 -177.72 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.473 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -78.89 134.78 36.89 Favored 'General case' 0 CA--C 1.481 -1.684 0 C-N-CA 117.723 -1.591 . . . . 0.0 108.758 178.211 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.468 ' O ' ' HG3' ' A' ' 6' ' ' LYS 0.439 0.4 OUTLIER -171.91 164.28 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 113.923 -1.49 . . . . 0.0 109.416 -169.629 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.844 ' O ' HG22 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -144.37 136.98 26.78 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 123.644 1.687 . . . . 0.0 113.143 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.259 13.5 t70 -70.72 148.97 47.41 Favored 'General case' 0 C--N 1.269 -2.907 0 CA-C-N 113.249 -1.796 . . . . 0.0 109.278 178.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.635 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.5 p -137.59 14.62 2.95 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.94 -1.1 . . . . 0.0 109.488 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.827 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -125.94 -84.54 0.63 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.687 -1.205 . . . . 0.0 110.162 -177.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 12' ' ' GLU . 2.3 t30 -159.46 66.69 0.39 Allowed 'General case' 0 C--N 1.267 -2.998 0 C-N-CA 118.649 -1.221 . . . . 0.0 111.987 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.473 ' C ' ' O ' ' A' ' 10' ' ' ASN . 9.7 m-70 33.57 33.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.848 0.832 . . . . 0.0 110.275 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.0 OUTLIER -91.78 22.0 4.46 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.324 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.87 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.28 0.0 OUTLIER -121.15 -167.39 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-O 122.31 1.052 . . . . 0.0 111.323 -178.439 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.69 ' N ' HG23 ' A' ' 13' ' ' ILE . 7.2 ptpt -162.34 -45.04 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.445 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.612 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 2.9 tttt -145.58 140.29 27.3 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 116.569 -2.052 . . . . 0.0 112.595 178.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.941 HG13 ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -138.42 104.75 2.73 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 CA-C-O 122.929 1.347 . . . . 0.0 111.109 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 17' ' ' LEU . 0.9 OUTLIER -97.95 128.18 44.36 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 114.044 -1.434 . . . . 0.0 111.45 178.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.977 HG22 ' HA ' ' A' ' 37' ' ' LEU . 43.1 t -142.16 146.26 39.13 Favored Pre-proline 0 N--CA 1.499 2.006 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.517 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.716 ' HD2' HG13 ' A' ' 18' ' ' VAL . 42.5 Cg_endo -67.63 93.83 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.821 1.432 . . . . 0.0 110.025 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.476 ' O ' ' CB ' ' A' ' 27' ' ' CYS . . . 173.89 -93.87 0.1 OUTLIER Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.513 -1.327 . . . . 0.0 110.084 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.557 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 37.1 m -94.73 162.21 13.87 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.161 -1.2 . . . . 0.0 111.392 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.711 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -136.71 9.28 3.09 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.897 -1.127 . . . . 0.0 109.697 178.027 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' ' 4' ' ' ASP . . . -178.68 -151.18 9.33 Favored Glycine 0 C--N 1.291 -1.956 0 C-N-CA 119.383 -1.389 . . . . 0.0 109.882 176.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.1 m -65.59 -9.57 27.9 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.744 -1.445 . . . . 0.0 109.954 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.824 ' CB ' ' HD3' ' A' ' 26' ' ' PRO . 1.2 mt-10 -64.51 176.35 0.75 Allowed Pre-proline 0 C--N 1.297 -1.708 0 CA-C-O 125.06 2.362 . . . . 0.0 115.256 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.824 ' HD3' ' CB ' ' A' ' 25' ' ' GLU . 25.1 Cg_endo -106.76 124.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.269 -3.641 1 C-N-CA 127.846 5.697 . . . . 0.0 110.716 -176.324 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.557 ' SG ' ' N ' ' A' ' 21' ' ' CYS . 25.7 p -126.82 129.11 47.65 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 122.705 1.241 . . . . 0.0 111.41 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.87 HG22 ' H ' ' A' ' 29' ' ' ILE 0.333 41.7 mm -80.68 -146.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 178.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.87 ' H ' HG22 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -127.7 117.29 46.05 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.74 0 CA-C-O 122.377 1.084 . . . . 0.0 111.074 179.504 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.63 ' CG ' ' N ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -67.05 -90.98 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.49 -179.066 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.63 ' N ' ' CG ' ' A' ' 30' ' ' HIS . 27.7 mtt85 -60.04 171.69 0.93 Allowed 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.858 ' HA3' ' HA ' ' A' ' 96' ' ' LYS . . . -62.13 -95.75 0.01 OUTLIER Glycine 0 C--N 1.296 -1.677 0 C-N-CA 117.361 -2.352 . . . . 0.0 107.457 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.881 ' O ' HG22 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -125.34 91.6 48.64 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 120.883 2.342 . . . . 0.0 115.334 -179.306 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.597 ' HG3' ' HB2' ' A' ' 31' ' ' ARG . 60.6 Cg_endo -108.2 145.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.291 -2.458 0 C-N-CA 124.291 3.327 . . . . 0.0 109.594 177.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.591 ' CE2' HG11 ' A' ' 94' ' ' VAL . 4.9 m-85 -119.8 90.79 3.4 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.623 ' HG2' ' CB ' ' A' ' 91' ' ' THR . 0.3 OUTLIER -116.17 88.64 2.93 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 122.006 -0.434 . . . . 0.0 110.223 -178.353 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.977 ' HA ' HG22 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -108.68 133.53 52.65 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.526 -1.359 . . . . 0.0 108.383 178.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -140.2 127.62 21.38 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.533 -1.354 . . . . 0.0 107.452 179.242 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.941 ' HB2' HG13 ' A' ' 16' ' ' VAL . . . -142.75 152.94 42.82 Favored 'General case' 0 C--N 1.274 -2.708 0 CA-C-O 122.97 1.367 . . . . 0.0 113.263 -175.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.612 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.46 139.87 32.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 113.821 -1.536 . . . . 0.0 108.711 177.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.579 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 3.5 p90 -156.87 124.07 5.26 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -178.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 13.6 tt0 -69.68 155.85 39.88 Favored 'General case' 0 C--N 1.288 -2.107 0 O-C-N 120.407 -1.433 . . . . 0.0 108.508 177.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.965 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -91.28 134.69 34.37 Favored 'General case' 0 C--N 1.265 -3.069 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.162 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.634 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -114.87 51.26 0.91 Allowed 'General case' 0 CA--C 1.486 -1.498 0 CA-C-O 125.327 2.489 . . . . 0.0 114.067 179.004 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.601 ' N ' ' CG ' ' A' ' 82' ' ' LYS . 7.0 pt20 167.34 -160.95 0.01 OUTLIER 'General case' 0 C--N 1.263 -3.173 0 CA-C-N 109.149 -3.659 . . . . 0.0 113.729 174.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.46 ' C ' HG22 ' A' ' 47' ' ' THR 0.277 6.3 t30 -110.36 153.65 24.64 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-O 122.617 1.199 . . . . 0.0 108.872 -178.483 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.672 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -173.22 157.04 3.31 Favored 'General case' 0 C--N 1.255 -3.526 0 C-N-CA 118.727 -1.189 . . . . 0.0 112.746 -178.307 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.934 ' O ' HG23 ' A' ' 49' ' ' THR . 0.4 OUTLIER -112.5 5.87 18.22 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 120.694 -1.254 . . . . 0.0 111.522 178.434 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.934 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.16 149.06 5.01 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.659 -1.276 . . . . 0.0 111.215 179.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.475 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . . . -141.37 101.64 4.05 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 122.924 1.345 . . . . 0.0 110.863 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 23.3 mmtp -73.15 -178.23 2.8 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.939 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.976 ' CG2' HD11 ' A' ' 88' ' ' ILE . 28.4 mt -140.14 136.43 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.544 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.945 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.494 ' HB3' ' HD3' ' A' ' 109' ' ' LYS . 31.9 tt0 -141.44 110.87 6.39 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 123.267 1.508 . . . . 0.0 111.3 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 1.006 HD12 HG21 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -89.99 127.07 42.8 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 CA-C-N 112.793 -2.003 . . . . 0.0 109.64 179.524 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.491 ' NZ ' ' HB2' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -120.25 98.62 6.15 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 176.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.986 ' HB3' HG22 ' A' ' 63' ' ' VAL . . . -114.53 133.61 55.66 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 118.919 -1.112 . . . . 0.0 113.187 -175.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.714 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.0 OUTLIER -105.53 100.3 9.87 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 177.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.901 ' HA ' HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -111.55 102.96 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.838 0 CA-C-O 123.004 1.383 . . . . 0.0 110.729 -176.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.658 ' N ' HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER 34.86 65.2 0.37 Allowed 'General case' 0 N--CA 1.519 3.003 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.829 179.306 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.47 -16.56 10.0 Favored Glycine 0 N--CA 1.489 2.212 0 O-C-N 121.351 -0.843 . . . . 0.0 111.761 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.551 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.268 0.5 OUTLIER -108.3 57.94 0.61 Allowed 'General case' 0 C--N 1.292 -1.896 0 O-C-N 121.027 -1.278 . . . . 0.0 111.818 -178.256 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.603 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.367 0.0 OUTLIER -59.25 115.8 3.46 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.064 0.935 . . . . 0.0 111.258 -179.913 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.986 HG22 ' HB3' ' A' ' 56' ' ' ALA . 17.7 m -80.3 146.73 7.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 122.517 1.151 . . . . 0.0 110.971 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.429 7.1 t70 -138.06 59.11 1.66 Allowed 'General case' 0 C--N 1.28 -2.428 0 CA-C-O 122.831 1.301 . . . . 0.0 111.013 -176.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.701 HG22 ' HD2' ' A' ' 66' ' ' PRO . 4.0 p -165.31 151.8 9.03 Favored Pre-proline 0 C--N 1.269 -2.927 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.053 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.701 ' HD2' HG22 ' A' ' 65' ' ' VAL . 44.5 Cg_endo -87.7 139.56 4.82 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 CA-C-O 123.706 1.461 . . . . 0.0 111.804 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -105.83 48.77 0.94 Allowed Glycine 0 C--N 1.272 -2.99 0 CA-C-N 112.568 -2.106 . . . . 0.0 109.101 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.636 HG23 ' N ' ' A' ' 69' ' ' ASP 0.293 0.0 OUTLIER 179.63 -168.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 O-C-N 119.669 -2.077 . . . . 0.0 108.544 -178.247 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.636 ' N ' HG23 ' A' ' 68' ' ' ILE . 10.0 t0 -108.86 90.61 7.85 Favored Pre-proline 0 N--CA 1.504 2.232 0 O-C-N 120.731 -1.231 . . . . 0.0 108.364 176.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.719 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 20.0 Cg_endo -48.39 -5.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.289 -2.584 0 C-N-CA 124.182 3.254 . . . . 0.0 115.461 177.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.603 ' HB2' ' NE2' ' A' ' 74' ' ' HIS . 0.6 OUTLIER -107.63 92.86 4.25 Favored 'General case' 0 C--N 1.289 -2.03 0 O-C-N 120.134 -1.604 . . . . 0.0 109.484 -179.209 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.72 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . . . -78.27 10.41 3.05 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.101 -0.999 . . . . 0.0 109.332 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.1 t -78.16 -24.53 47.24 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 120.992 -1.067 . . . . 0.0 108.944 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.603 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 0.3 OUTLIER -79.52 7.62 7.85 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 118.911 -1.116 . . . . 0.0 108.797 176.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.72 ' CD2' ' HA ' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -132.98 -1.38 3.31 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 121.488 -0.758 . . . . 0.0 110.11 177.62 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.46 ' CE ' HD21 ' A' ' 80' ' ' LEU . 1.5 ptt? -153.45 128.65 9.75 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 124.042 1.877 . . . . 0.0 113.745 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.567 ' O ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -19.88 95.98 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 111.74 -2.482 . . . . 0.0 113.213 -178.676 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.498 ' HA ' HD13 ' A' ' 80' ' ' LEU 0.32 0.3 OUTLIER -99.93 142.17 24.11 Favored Pre-proline 0 C--N 1.268 -2.948 0 CA-C-N 111.36 -2.654 . . . . 0.0 108.776 178.495 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.653 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 36.3 Cg_endo -79.58 168.27 73.86 Favored 'Cis proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.848 -1.73 . . . . 0.0 112.521 0.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.693 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -94.71 128.39 41.36 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.17 -179.731 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.528 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.4 t -105.9 139.38 27.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 124.1 1.905 . . . . 0.0 112.07 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.634 ' HG2' ' HA ' ' A' ' 44' ' ' ASN . 1.2 tmmt? -44.59 118.33 1.54 Allowed 'General case' 0 C--N 1.271 -2.823 0 CA-C-N 111.816 -2.447 . . . . 0.0 116.652 -175.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.95 -18.01 12.72 Favored Glycine 0 C--N 1.292 -1.878 0 CA-C-N 111.787 -2.461 . . . . 0.0 107.924 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.62 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 18.3 mt-30 -71.79 127.74 33.54 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-O 123.221 1.486 . . . . 0.0 111.349 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.611 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 3.2 mt-30 -66.02 144.6 56.64 Favored 'General case' 0 C--N 1.27 -2.861 0 CA-C-N 113.282 -1.781 . . . . 0.0 107.485 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.965 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 17.8 m-85 -142.72 126.07 16.62 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.553 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 0.7 OUTLIER -117.46 130.19 56.3 Favored 'General case' 0 C--N 1.279 -2.489 0 CA-C-O 122.737 1.256 . . . . 0.0 110.034 -178.34 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 1.09 HD12 ' CG2' ' A' ' 110' ' ' VAL . 0.2 OUTLIER -101.95 156.22 4.73 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.152 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.188 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.17 143.22 30.99 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 121.465 0.65 . . . . 0.0 111.343 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.67 ' CE1' ' HB2' ' A' ' 92' ' ' TRP . 2.1 t80 -143.89 99.66 3.44 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.412 -0.805 . . . . 0.0 109.123 178.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.623 ' CB ' ' HG2' ' A' ' 36' ' ' GLN . 1.3 t -122.81 116.29 23.44 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.91 -1.119 . . . . 0.0 108.616 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.67 ' HB2' ' CE1' ' A' ' 90' ' ' TYR 0.271 0.3 OUTLIER -142.64 102.31 4.03 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.035 -177.635 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.8 OUTLIER -75.62 153.66 37.12 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 119.607 -1.933 . . . . 0.0 109.461 -178.757 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.881 HG22 ' O ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -153.11 175.38 3.01 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.781 -1.199 . . . . 0.0 108.606 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.563 ' HD2' ' HB ' ' A' ' 94' ' ' VAL . 18.6 Cg_endo -37.96 154.07 0.03 OUTLIER 'Trans proline' 0 CA--C 1.498 -1.321 0 O-C-N 123.64 1.337 . . . . 0.0 110.701 -177.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.858 ' HA ' ' HA3' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -79.54 -25.3 41.72 Favored 'General case' 0 C--N 1.284 -2.277 0 C-N-CA 116.614 -2.035 . . . . 0.0 115.526 -173.173 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.754 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -140.27 39.71 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 -177.658 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.93 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . . . -62.89 -64.48 2.98 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.519 -1.363 . . . . 0.0 108.353 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.93 ' HD3' ' HB3' ' A' ' 98' ' ' ALA . 51.5 Cg_endo -69.96 163.74 37.3 Favored 'Trans proline' 0 CA--C 1.46 -3.206 0 O-C-N 123.87 1.458 . . . . 0.0 108.852 177.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.735 ' HD2' ' C ' ' A' ' 99' ' ' PRO . 1.0 OUTLIER -105.14 103.7 13.3 Favored 'General case' 0 C--N 1.269 -2.902 0 CA-C-N 112.704 -2.044 . . . . 0.0 110.92 -168.596 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.615 ' CB ' HD12 ' A' ' 127' ' ' ILE . 7.5 p -43.43 96.78 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 123.566 1.65 . . . . 0.0 108.859 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.601 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.413 78.0 mt-10 -163.64 -50.77 0.03 OUTLIER 'General case' 0 CA--C 1.451 -2.832 0 CA-C-N 112.729 -2.032 . . . . 0.0 112.01 -179.331 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.491 0.8 OUTLIER -159.07 81.58 0.78 Allowed 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 111.283 -2.69 . . . . 0.0 113.781 -162.15 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.901 HG22 ' HA ' ' A' ' 58' ' ' ILE . 34.0 t -143.22 133.91 22.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.122 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.851 ' CG1' HD11 ' A' ' 121' ' ' ILE . 60.9 t -142.48 134.56 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.967 HG23 ' HB2' ' A' ' 56' ' ' ALA . 1.3 p -112.65 146.84 16.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 122.956 1.36 . . . . 0.0 113.367 -178.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.98 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -132.82 108.52 9.02 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 178.272 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.006 HG21 HD12 ' A' ' 54' ' ' ILE . 3.6 t -125.29 141.9 43.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 120.094 -1.629 . . . . 0.0 109.056 -177.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.761 ' HB2' ' HB3' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -133.84 152.35 51.84 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.712 1.244 . . . . 0.0 113.047 -178.336 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 1.09 ' CG2' HD12 ' A' ' 88' ' ' ILE . 8.8 t -99.83 127.35 52.79 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.255 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 177.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.502 ' HG3' ' N ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -108.82 121.79 45.82 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.31 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.584 ' HA3' HD23 ' A' ' 117' ' ' LEU . . . -78.14 -137.36 1.11 Allowed Glycine 0 N--CA 1.497 2.742 0 C-N-CA 119.079 -1.534 . . . . 0.0 114.093 -175.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.672 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 10.0 p-10 -80.19 -5.11 55.52 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 122.366 1.079 . . . . 0.0 112.07 -177.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 9.7 p30 -130.05 -4.6 4.48 Favored 'General case' 0 C--N 1.266 -3.065 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.145 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.624 ' C ' HG12 ' A' ' 116' ' ' VAL . . . 88.59 85.55 1.24 Allowed Glycine 0 CA--C 1.469 -2.808 0 CA-C-O 124.886 2.381 . . . . 0.0 109.813 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.624 HG12 ' C ' ' A' ' 115' ' ' GLY . 4.5 p 145.41 145.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.245 -3.952 0 CA-C-N 108.43 -3.885 . . . . 0.0 111.833 177.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.805 ' CB ' HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -162.27 -57.43 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.495 -0.753 . . . . 0.0 110.755 179.605 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.87 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -173.81 130.09 0.41 Allowed 'General case' 0 N--CA 1.51 2.56 0 O-C-N 121.158 -0.964 . . . . 0.0 108.84 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.827 ' SG ' ' HB2' ' A' ' 9' ' ' ALA . 0.8 OUTLIER -134.44 144.31 48.06 Favored 'General case' 0 C--N 1.285 -2.23 0 C-N-CA 117.544 -1.662 . . . . 0.0 113.86 -177.469 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.541 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -147.24 138.18 23.7 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 123.034 1.397 . . . . 0.0 112.239 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.98 ' HB ' HG23 ' A' ' 107' ' ' THR 0.279 0.0 OUTLIER -109.37 132.31 57.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 CA-C-N 114.025 -1.443 . . . . 0.0 111.198 -179.19 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.753 ' N ' HD13 ' A' ' 121' ' ' ILE . . . -131.05 -173.37 3.08 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.874 -1.141 . . . . 0.0 108.681 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 125' ' ' ALA . 13.8 p -104.39 -7.6 19.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.441 -1.412 . . . . 0.0 111.676 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.908 ' NE2' HG11 ' A' ' 106' ' ' VAL . 23.8 m170 61.6 -72.29 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.626 0 O-C-N 121.236 -0.915 . . . . 0.0 110.428 -178.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.818 ' HB2' ' CG1' ' A' ' 29' ' ' ILE . . . -136.96 146.49 45.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.496 -0.753 . . . . 0.0 109.397 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.668 ' O ' HD13 ' A' ' 28' ' ' ILE . 1.3 mmpt? -131.6 93.43 3.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.132 -0.98 . . . . 0.0 109.368 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.615 HD12 ' CB ' ' A' ' 101' ' ' SER . 1.0 OUTLIER -88.69 135.91 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.317 -1.49 . . . . 0.0 111.743 -179.544 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.48 ' HD2' ' N ' ' A' ' 129' ' ' ASP . 0.0 OUTLIER -168.16 -140.75 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.47 0.652 . . . . 0.0 111.625 179.291 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.48 ' N ' ' HD2' ' A' ' 128' ' ' ARG . 1.3 m-20 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.926 -1.035 . . . . 0.0 110.856 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.196 0.522 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -82.9 167.62 17.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -0.888 . . . . 0.0 111.006 -179.757 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.745 HG12 ' HA ' ' A' ' 22' ' ' HIS . 1.4 m -145.59 179.56 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 O-C-N 120.836 -1.165 . . . . 0.0 108.174 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -79.47 137.02 37.08 Favored 'General case' 0 CA--C 1.48 -1.723 0 C-N-CA 118.117 -1.433 . . . . 0.0 108.693 177.881 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.584 HG11 ' CG2' ' A' ' 16' ' ' VAL 0.436 0.4 OUTLIER -169.44 -171.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.48 -169.858 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.555 ' CG ' ' O ' ' A' ' 5' ' ' VAL . 5.2 mtpp -166.2 146.95 6.46 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 123.931 1.824 . . . . 0.0 113.096 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.281 3.0 t70 -84.88 148.84 26.06 Favored 'General case' 0 C--N 1.264 -3.11 0 CA-C-N 112.58 -2.1 . . . . 0.0 109.043 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.667 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.7 p -137.27 15.95 2.99 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.94 -1.1 . . . . 0.0 109.226 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.846 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -125.65 -84.32 0.63 Allowed 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.137 -176.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.567 ' O ' ' N ' ' A' ' 12' ' ' GLU . 2.4 t30 -156.35 65.19 0.55 Allowed 'General case' 0 C--N 1.268 -2.968 0 C-N-CA 118.523 -1.271 . . . . 0.0 111.783 177.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.468 ' C ' ' O ' ' A' ' 10' ' ' ASN . 10.4 m80 33.72 31.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.773 0.796 . . . . 0.0 110.73 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.4 OUTLIER -90.8 21.26 4.2 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.002 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.777 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.272 0.1 OUTLIER -119.82 -170.31 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 122.211 1.005 . . . . 0.0 110.611 -178.785 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.631 ' H ' HG23 ' A' ' 13' ' ' ILE . 11.2 ptmm? -162.09 -46.83 0.04 OUTLIER 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.143 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.577 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 21.6 tttt -142.81 135.15 27.51 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 116.045 -2.262 . . . . 0.0 113.178 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.973 HG12 ' HB2' ' A' ' 39' ' ' ALA . 0.6 OUTLIER -132.98 101.29 4.25 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 CA-C-O 123.03 1.395 . . . . 0.0 110.76 179.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.514 ' HA ' HD23 ' A' ' 17' ' ' LEU . 1.0 OUTLIER -95.04 129.04 42.28 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 113.987 -1.461 . . . . 0.0 111.857 179.282 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.995 HG22 ' HA ' ' A' ' 37' ' ' LEU . 78.4 t -142.21 145.57 36.08 Favored Pre-proline 0 N--CA 1.5 2.049 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.105 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.657 ' HD2' HG13 ' A' ' 18' ' ' VAL . 42.1 Cg_endo -68.81 105.93 1.4 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.677 1.357 . . . . 0.0 110.624 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.433 ' C ' ' CB ' ' A' ' 27' ' ' CYS . . . 160.44 -91.13 0.11 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.552 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 38.2 m -90.74 159.16 16.48 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.295 -1.121 . . . . 0.0 110.78 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.745 ' HA ' HG12 ' A' ' 3' ' ' VAL . 3.8 p80 -137.25 11.76 3.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.665 -1.272 . . . . 0.0 109.528 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.485 ' O ' ' HB3' ' A' ' 4' ' ' ASP . . . 176.4 -148.85 9.37 Favored Glycine 0 C--N 1.29 -2.026 0 C-N-CA 119.288 -1.434 . . . . 0.0 109.883 177.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.7 -9.33 26.73 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.704 -1.468 . . . . 0.0 109.895 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.802 ' CB ' ' HD3' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -64.44 176.04 0.8 Allowed Pre-proline 0 C--N 1.298 -1.635 0 CA-C-O 124.953 2.311 . . . . 0.0 115.178 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.802 ' HD3' ' CB ' ' A' ' 25' ' ' GLU . 25.3 Cg_endo -107.11 124.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.268 -3.661 1 C-N-CA 127.709 5.606 . . . . 0.0 110.98 -176.021 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.552 ' SG ' ' N ' ' A' ' 21' ' ' CYS . 28.2 p -127.69 127.71 44.19 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.659 1.218 . . . . 0.0 110.906 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.876 HG22 ' H ' ' A' ' 29' ' ' ILE 0.331 44.1 mm -79.55 -152.37 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.308 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.876 ' H ' HG22 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -126.87 116.62 45.39 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.59 0 CA-C-O 122.45 1.119 . . . . 0.0 111.45 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.1 m80 -67.32 -101.6 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.283 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.538 ' HB2' ' HG3' ' A' ' 34' ' ' PRO . 60.3 mtt-85 -51.62 171.8 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.898 ' HA3' ' HA ' ' A' ' 96' ' ' LYS . . . -61.5 -93.04 0.01 OUTLIER Glycine 0 C--N 1.298 -1.548 0 C-N-CA 117.756 -2.164 . . . . 0.0 108.09 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.846 ' HB2' HG12 ' A' ' 94' ' ' VAL . 2.3 mmmt -125.37 90.98 49.79 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 120.585 2.192 . . . . 0.0 115.302 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.538 ' HG3' ' HB2' ' A' ' 31' ' ' ARG . 65.0 Cg_endo -108.65 143.39 0.06 OUTLIER 'Trans proline' 0 C--N 1.291 -2.466 0 C-N-CA 124.378 3.385 . . . . 0.0 109.735 177.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.477 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 12.7 m-85 -125.05 95.68 4.58 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.07 -1.052 . . . . 0.0 109.737 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.602 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 28.2 mp0 -116.37 96.64 5.63 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.569 -0.707 . . . . 0.0 110.81 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.995 ' HA ' HG22 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -109.3 136.31 48.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.355 -1.466 . . . . 0.0 108.638 178.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -140.27 125.16 18.35 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.496 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.973 ' HB2' HG12 ' A' ' 16' ' ' VAL . . . -143.54 152.52 41.55 Favored 'General case' 0 C--N 1.274 -2.694 0 CA-C-O 122.955 1.36 . . . . 0.0 113.878 -175.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.581 ' O ' ' HG2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -110.71 140.34 30.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-N 113.766 -1.561 . . . . 0.0 108.305 177.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.584 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 4.0 p90 -159.33 125.04 4.29 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 5.5 tt0 -70.55 157.09 38.52 Favored 'General case' 0 C--N 1.286 -2.154 0 O-C-N 120.39 -1.444 . . . . 0.0 109.07 178.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.975 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -90.94 141.95 28.29 Favored 'General case' 0 C--N 1.267 -2.981 0 CA-C-N 114.217 -1.356 . . . . 0.0 108.847 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.65 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -121.49 50.42 1.4 Allowed 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 125.281 2.467 . . . . 0.0 114.31 178.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.588 ' C ' ' HB2' ' A' ' 82' ' ' LYS . 6.5 pt20 167.15 -161.49 0.01 OUTLIER 'General case' 0 C--N 1.258 -3.386 0 CA-C-N 109.109 -3.678 . . . . 0.0 113.073 175.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.456 ' C ' HG22 ' A' ' 47' ' ' THR 0.277 48.5 t30 -110.11 153.51 24.59 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-O 122.572 1.177 . . . . 0.0 108.952 -178.68 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.658 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -173.26 156.64 3.19 Favored 'General case' 0 C--N 1.254 -3.581 0 C-N-CA 118.558 -1.257 . . . . 0.0 112.53 -178.394 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.944 ' O ' HG23 ' A' ' 49' ' ' THR . 0.0 OUTLIER -115.9 9.27 14.93 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 120.811 -1.18 . . . . 0.0 111.077 178.596 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.944 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.9 OUTLIER -166.5 147.54 6.28 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.768 -1.207 . . . . 0.0 110.723 179.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 70' ' ' PRO . . . -148.41 102.22 3.31 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 122.76 1.267 . . . . 0.0 110.366 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 12.3 mmtt -75.11 -174.68 2.36 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.716 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.975 ' CG2' HD11 ' A' ' 88' ' ' ILE . 45.7 mt -140.54 139.03 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.535 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.465 ' C ' HG13 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -140.37 110.09 6.39 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 123.349 1.547 . . . . 0.0 110.56 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.999 HD12 HG21 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -89.77 126.06 42.69 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.332 0 CA-C-N 112.527 -2.124 . . . . 0.0 108.979 179.29 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.1 tttp -121.68 103.18 8.7 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 177.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.892 ' HB3' HG22 ' A' ' 63' ' ' VAL . . . -110.03 126.58 54.12 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.527 -1.269 . . . . 0.0 111.86 -176.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.749 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 4.7 p -101.48 100.86 11.36 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.996 HD13 ' CB ' ' A' ' 99' ' ' PRO . 0.6 OUTLIER -111.31 111.78 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.679 0 CA-C-O 122.695 1.236 . . . . 0.0 110.313 -177.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.506 ' N ' HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER 30.74 62.54 0.2 Allowed 'General case' 0 N--CA 1.52 3.069 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.954 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.43 -12.43 7.63 Favored Glycine 0 N--CA 1.49 2.278 0 O-C-N 121.339 -0.851 . . . . 0.0 111.379 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.533 ' O ' HG13 ' A' ' 58' ' ' ILE 0.284 0.2 OUTLIER -107.9 56.32 0.63 Allowed 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.12 -1.223 . . . . 0.0 111.171 -178.655 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.605 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.362 0.0 OUTLIER -53.95 114.09 1.46 Allowed 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 122.16 0.981 . . . . 0.0 110.565 -179.754 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.892 HG22 ' HB3' ' A' ' 56' ' ' ALA . 19.0 m -76.98 140.46 17.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-O 122.759 1.266 . . . . 0.0 111.499 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.45 21.7 t0 -139.32 85.08 2.03 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.435 -176.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.581 ' CG2' ' HD2' ' A' ' 66' ' ' PRO . 9.9 p -159.31 150.35 16.18 Favored Pre-proline 0 C--N 1.275 -2.631 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.888 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.581 ' HD2' ' CG2' ' A' ' 65' ' ' VAL . 43.5 Cg_endo -73.18 138.04 27.16 Favored 'Trans proline' 0 C--N 1.319 -0.992 0 CA-C-O 123.725 1.469 . . . . 0.0 111.342 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.598 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -117.45 -53.51 0.31 Allowed Glycine 0 N--CA 1.51 3.574 0 CA-C-N 112.542 -2.117 . . . . 0.0 113.588 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.863 HD13 ' H ' ' A' ' 91' ' ' THR . 1.3 tp -117.28 -155.65 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-N 120.643 2.221 . . . . 0.0 110.22 -178.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.715 ' N ' HG23 ' A' ' 68' ' ' ILE . 1.1 t70 -107.92 89.17 5.17 Favored Pre-proline 0 N--CA 1.508 2.44 0 CA-C-O 122.82 1.295 . . . . 0.0 108.983 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.748 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 20.8 Cg_endo -49.05 -12.77 0.25 Allowed 'Trans proline' 0 C--N 1.285 -2.773 0 C-N-CA 124.121 3.214 . . . . 0.0 115.885 178.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.648 ' ND2' ' CD2' ' A' ' 74' ' ' HIS . 0.5 OUTLIER -111.59 85.65 2.17 Favored 'General case' 0 C--N 1.288 -2.074 0 O-C-N 119.843 -1.785 . . . . 0.0 108.965 -179.297 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.664 ' HA ' ' CD1' ' A' ' 75' ' ' TYR . . . -78.38 12.1 2.11 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.644 -0.66 . . . . 0.0 109.313 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.401 ' C ' ' H ' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -77.25 -20.6 54.95 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 120.666 -1.271 . . . . 0.0 108.002 -179.593 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.648 ' CD2' ' ND2' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -87.84 19.04 3.7 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 173.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.664 ' CD1' ' HA ' ' A' ' 72' ' ' ALA . 0.4 OUTLIER -133.13 -9.78 2.97 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.032 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.475 ' O ' ' HG2' ' A' ' 76' ' ' MET . 2.3 ptt? -166.55 126.77 1.61 Allowed 'General case' 0 C--O 1.215 -0.74 0 CA-C-O 123.761 1.743 . . . . 0.0 113.219 178.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.659 ' O ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER 3.87 91.71 0.01 OUTLIER 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 111.999 -2.364 . . . . 0.0 114.134 -179.422 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.487 ' HA ' ' CD1' ' A' ' 80' ' ' LEU 0.331 7.3 t -110.21 139.26 21.26 Favored Pre-proline 0 C--N 1.269 -2.932 0 CA-C-N 111.441 -2.618 . . . . 0.0 107.614 177.519 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.671 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 36.7 Cg_endo -76.79 169.62 73.92 Favored 'Cis proline' 0 C--N 1.308 -1.555 0 C-N-CA 123.095 -1.627 . . . . 0.0 112.992 1.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.727 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -96.9 128.39 43.81 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.051 -179.4 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.527 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.9 t -106.96 138.67 31.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 124.169 1.938 . . . . 0.0 111.916 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.65 ' HG2' ' HA ' ' A' ' 44' ' ' ASN . 1.6 tmmt? -44.2 117.19 1.17 Allowed 'General case' 0 C--N 1.271 -2.837 0 CA-C-N 111.832 -2.44 . . . . 0.0 116.596 -175.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.431 ' O ' ' OE2' ' A' ' 42' ' ' GLU . . . 115.83 -17.09 15.76 Favored Glycine 0 C--N 1.292 -1.905 0 CA-C-N 111.752 -2.476 . . . . 0.0 107.963 178.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.619 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 10.4 mt-30 -71.43 127.76 33.63 Favored 'General case' 0 C--N 1.278 -2.542 0 CA-C-O 123.22 1.486 . . . . 0.0 111.766 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.596 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 0.3 OUTLIER -64.7 143.73 57.72 Favored 'General case' 0 C--N 1.272 -2.794 0 CA-C-N 113.326 -1.761 . . . . 0.0 107.072 178.454 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.975 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 17.9 m-85 -143.33 126.68 16.7 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 10.0 p30 -117.66 132.93 56.42 Favored 'General case' 0 C--N 1.275 -2.655 0 CA-C-O 122.703 1.239 . . . . 0.0 109.913 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 1.104 HD12 HG23 ' A' ' 110' ' ' VAL . 0.4 OUTLIER -102.58 157.7 4.73 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 CA-C-N 114.629 -1.168 . . . . 0.0 108.265 179.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -147.94 142.61 26.62 Favored 'General case' 0 C--N 1.283 -2.3 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.526 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.586 ' O ' ' HA ' ' A' ' 36' ' ' GLN . 17.4 t80 -151.54 108.57 3.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.148 -0.97 . . . . 0.0 110.401 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.863 ' H ' HD13 ' A' ' 68' ' ' ILE . 0.4 OUTLIER -125.11 122.26 36.63 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 120.515 -1.365 . . . . 0.0 108.093 179.163 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.598 ' CD1' ' O ' ' A' ' 67' ' ' GLY 0.27 0.1 OUTLIER -142.44 102.78 4.14 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.128 -176.933 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.504 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.6 OUTLIER -74.93 157.15 35.48 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 119.676 -1.89 . . . . 0.0 108.829 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 33' ' ' LYS . 1.1 t -153.99 171.78 6.58 Favored Pre-proline 0 N--CA 1.486 1.333 0 O-C-N 120.792 -1.193 . . . . 0.0 109.13 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.827 ' CD ' HG13 ' A' ' 94' ' ' VAL . 18.8 Cg_endo -38.74 157.7 0.03 OUTLIER 'Trans proline' 0 CA--C 1.498 -1.294 0 O-C-N 123.833 1.439 . . . . 0.0 110.352 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.898 ' HA ' ' HA3' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -79.54 -21.8 44.72 Favored 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 116.282 -2.167 . . . . 0.0 115.558 -173.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.76 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -136.73 39.16 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -177.497 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.928 ' HB3' ' CD ' ' A' ' 99' ' ' PRO . . . -64.89 -73.51 0.21 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 120.483 -1.385 . . . . 0.0 108.562 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.996 ' CB ' HD13 ' A' ' 58' ' ' ILE . 53.8 Cg_endo -70.25 162.31 42.77 Favored 'Trans proline' 0 CA--C 1.463 -3.034 0 CA-C-O 123.177 1.24 . . . . 0.0 109.659 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.739 ' HD2' ' C ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -105.72 99.23 8.84 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 112.697 -2.047 . . . . 0.0 110.735 -169.003 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.801 ' HB2' ' HB ' ' A' ' 127' ' ' ILE . 12.8 p -46.77 99.84 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 123.654 1.692 . . . . 0.0 108.463 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.413 95.9 mt-10 -163.43 -51.65 0.04 OUTLIER 'General case' 0 CA--C 1.449 -2.911 0 CA-C-N 112.72 -2.036 . . . . 0.0 110.562 -179.474 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.445 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.499 0.7 OUTLIER -158.31 74.76 0.71 Allowed 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 110.504 -3.043 . . . . 0.0 111.295 -163.278 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.893 HG22 ' HA ' ' A' ' 58' ' ' ILE . 14.3 t -142.1 141.06 29.25 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.543 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.924 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.975 HG13 HD11 ' A' ' 121' ' ' ILE . 1.2 t -145.5 131.21 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.789 HG23 ' HB2' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -103.91 140.9 20.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 122.288 1.042 . . . . 0.0 111.704 -178.778 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 1.023 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -132.47 110.75 10.73 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 179.427 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.999 HG21 HD12 ' A' ' 54' ' ' ILE . 3.6 t -125.73 140.83 47.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 O-C-N 120.133 -1.604 . . . . 0.0 109.229 -177.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.95 ' HB2' ' CB ' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -130.78 148.27 52.54 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 122.526 1.155 . . . . 0.0 112.057 -178.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 1.104 HG23 HD12 ' A' ' 88' ' ' ILE . 3.0 t -96.35 125.24 49.28 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 176.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.527 ' HG2' ' O ' ' A' ' 111' ' ' MET . 2.2 ptm -105.4 121.2 43.41 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.546 ' HA3' HD23 ' A' ' 117' ' ' LEU . . . -80.35 -139.31 2.21 Favored Glycine 0 N--CA 1.496 2.665 0 C-N-CA 119.031 -1.557 . . . . 0.0 114.311 -175.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.658 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 14.9 p-10 -77.8 -5.74 51.79 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 122.41 1.1 . . . . 0.0 112.051 -177.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 8.3 p30 -129.35 -5.27 4.83 Favored 'General case' 0 C--N 1.266 -3.057 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.097 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.692 ' C ' HG12 ' A' ' 116' ' ' VAL . . . 88.69 85.77 1.24 Allowed Glycine 0 CA--C 1.469 -2.844 0 CA-C-O 124.821 2.345 . . . . 0.0 109.745 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.692 HG12 ' C ' ' A' ' 115' ' ' GLY . 4.3 p 143.04 145.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.246 -3.91 0 CA-C-N 108.37 -3.915 . . . . 0.0 111.631 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.808 ' CB ' HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -162.05 -58.57 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.479 -0.763 . . . . 0.0 110.9 179.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.777 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -167.97 131.84 1.68 Allowed 'General case' 0 N--CA 1.514 2.747 0 O-C-N 121.31 -0.869 . . . . 0.0 109.161 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.95 ' CB ' ' HB2' ' A' ' 109' ' ' LYS . 0.8 OUTLIER -134.14 138.27 45.09 Favored 'General case' 0 C--N 1.28 -2.436 0 C-N-CA 117.428 -1.709 . . . . 0.0 113.595 -177.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.717 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -143.59 135.66 26.73 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 122.912 1.339 . . . . 0.0 112.248 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 1.023 ' HB ' HG23 ' A' ' 107' ' ' THR 0.277 0.0 OUTLIER -111.13 134.76 52.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 114.182 -1.372 . . . . 0.0 111.808 -178.863 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.757 ' N ' HD13 ' A' ' 121' ' ' ILE . . . -131.61 -176.56 4.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.819 -1.176 . . . . 0.0 109.022 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.602 ' O ' ' HB2' ' A' ' 124' ' ' HIS . 5.7 p -106.34 -21.93 12.96 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.342 -1.474 . . . . 0.0 110.824 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.648 ' CE1' HD22 ' A' ' 37' ' ' LEU . 0.3 OUTLIER 67.09 -74.52 0.07 Allowed 'General case' 0 N--CA 1.513 2.717 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.836 ' HB2' ' CG1' ' A' ' 29' ' ' ILE . . . -122.07 146.91 46.74 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.07 -1.019 . . . . 0.0 111.268 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.5 mmmm -132.54 86.04 2.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.278 -0.889 . . . . 0.0 110.406 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.801 ' HB ' ' HB2' ' A' ' 101' ' ' SER . 1.0 OUTLIER -90.33 119.58 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.169 -1.582 . . . . 0.0 111.203 179.476 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.493 ' HD3' ' O ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -169.48 150.87 4.27 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.98 -0.45 . . . . 0.0 111.089 179.142 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.468 ' C ' ' O ' ' A' ' 128' ' ' ARG . 3.7 m-20 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.84 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.404 ' HB2' ' HZ1' ' A' ' 15' ' ' LYS . 70.1 m . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.254 0.55 . . . . 0.0 110.261 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.47 ' O ' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER 176.79 169.25 0.51 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.185 -0.947 . . . . 0.0 110.786 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.858 HG12 ' HA ' ' A' ' 22' ' ' HIS . 1.4 m -145.19 177.66 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 O-C-N 120.758 -1.214 . . . . 0.0 108.118 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.487 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -79.62 137.78 37.22 Favored 'General case' 0 CA--C 1.479 -1.761 0 C-N-CA 117.978 -1.489 . . . . 0.0 108.521 177.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.5 ' O ' ' HG2' ' A' ' 6' ' ' LYS 0.429 0.4 OUTLIER -166.16 168.67 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 C-N-CA 118.033 -1.467 . . . . 0.0 110.814 -169.785 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.52 ' HB2' HG22 ' A' ' 121' ' ' ILE . 0.8 OUTLIER -147.37 137.13 22.91 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 123.664 1.697 . . . . 0.0 112.312 -179.466 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.273 0.8 OUTLIER -80.17 146.28 31.87 Favored 'General case' 0 C--N 1.267 -2.987 0 CA-C-N 113.378 -1.737 . . . . 0.0 109.71 178.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.658 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.4 p -137.31 15.9 2.98 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.958 -1.089 . . . . 0.0 109.303 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.867 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -125.54 -85.26 0.63 Allowed 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.706 -1.197 . . . . 0.0 109.941 -177.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.565 ' O ' ' N ' ' A' ' 12' ' ' GLU . 2.3 t30 -159.95 65.23 0.35 Allowed 'General case' 0 C--N 1.265 -3.07 0 C-N-CA 118.219 -1.392 . . . . 0.0 112.174 177.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.474 ' C ' ' O ' ' A' ' 10' ' ' ASN . 28.8 m170 33.79 31.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.777 0.799 . . . . 0.0 110.807 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.1 OUTLIER -90.51 23.26 3.07 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.908 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.079 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.28 0.0 OUTLIER -119.22 -168.75 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-O 121.978 0.894 . . . . 0.0 110.733 -178.616 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.636 ' N ' HG23 ' A' ' 13' ' ' ILE . 7.0 ptpt -162.54 -44.31 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.994 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.619 ' HB3' HG23 ' A' ' 40' ' ' VAL . 28.9 tttp -149.0 139.02 22.11 Favored 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 116.556 -2.057 . . . . 0.0 113.28 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 1.027 HG13 ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -133.21 107.41 11.29 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-O 122.841 1.305 . . . . 0.0 110.21 179.029 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.504 ' HA ' HD23 ' A' ' 17' ' ' LEU . 1.8 mt -106.77 129.25 54.67 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.124 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.683 HG22 ' HA ' ' A' ' 37' ' ' LEU . 11.9 t -141.41 144.84 35.5 Favored Pre-proline 0 C--N 1.294 -1.816 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.949 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.533 ' HD2' ' CG1' ' A' ' 18' ' ' VAL . 46.9 Cg_endo -71.26 112.77 3.41 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.725 1.381 . . . . 0.0 111.42 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.481 ' C ' ' HB3' ' A' ' 27' ' ' CYS . . . 128.86 -84.95 0.32 Allowed Glycine 0 N--CA 1.488 2.148 0 C-N-CA 119.486 -1.34 . . . . 0.0 109.775 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.555 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 3.5 m -74.56 108.76 7.53 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.596 -0.943 . . . . 0.0 110.12 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.858 ' HA ' HG12 ' A' ' 3' ' ' VAL . 1.0 OUTLIER -121.75 17.59 11.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.037 -1.664 . . . . 0.0 110.887 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.43 -156.34 21.91 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 118.43 -1.843 . . . . 0.0 110.877 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.53 -9.89 30.16 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.943 -1.327 . . . . 0.0 109.722 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.784 ' CB ' ' CD ' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -64.07 178.27 0.45 Allowed Pre-proline 0 C--N 1.295 -1.795 0 CA-C-O 125.034 2.35 . . . . 0.0 114.562 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.784 ' CD ' ' CB ' ' A' ' 25' ' ' GLU . 20.9 Cg_endo -104.05 113.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.264 -3.917 1 C-N-CA 127.524 5.483 . . . . 0.0 109.057 -177.126 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.555 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 1.7 p -94.75 107.19 19.2 Favored 'General case' 0 N--CA 1.505 2.295 0 CA-C-O 123.068 1.413 . . . . 0.0 112.366 -177.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.608 ' O ' HG22 ' A' ' 28' ' ' ILE 0.303 33.5 mm -79.94 61.14 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-N 113.816 -1.538 . . . . 0.0 109.249 178.696 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.05 HG21 ' HB1' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -43.39 129.98 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-O 122.845 1.307 . . . . 0.0 110.285 -179.138 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.504 ' O ' ' O ' ' A' ' 31' ' ' ARG . 19.0 m80 -65.49 -86.82 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 114.53 -1.213 . . . . 0.0 112.39 -177.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.637 ' O ' HD13 ' A' ' 29' ' ' ILE . 48.6 mtt-85 -43.36 165.83 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.46 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.417 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.911 ' HA3' ' HA ' ' A' ' 96' ' ' LYS . . . -62.88 -88.46 0.04 OUTLIER Glycine 0 C--N 1.297 -1.631 0 C-N-CA 118.062 -2.018 . . . . 0.0 108.922 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.813 ' O ' HG22 ' A' ' 94' ' ' VAL . 1.5 mmmp? -126.21 89.87 51.35 Favored Pre-proline 0 C--O 1.22 -0.448 0 CA-C-N 120.83 2.315 . . . . 0.0 115.734 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.77 ' CD ' HD11 ' A' ' 29' ' ' ILE . 60.8 Cg_endo -109.32 141.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.29 -2.515 0 C-N-CA 124.673 3.582 . . . . 0.0 108.743 177.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.554 ' CD1' ' C ' ' A' ' 34' ' ' PRO . 1.0 OUTLIER -124.14 98.22 5.68 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 118.075 -1.45 . . . . 0.0 110.311 179.358 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.588 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 26.3 mp0 -114.15 81.28 1.51 Allowed 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.683 ' HA ' HG22 ' A' ' 18' ' ' VAL . 3.4 pp -113.07 142.46 45.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.674 -1.266 . . . . 0.0 110.181 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -140.47 138.01 34.31 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 122.595 1.188 . . . . 0.0 108.451 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 1.027 ' HB2' HG13 ' A' ' 16' ' ' VAL . . . -142.07 153.11 43.93 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-O 123.03 1.395 . . . . 0.0 113.292 -176.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.619 HG23 ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.41 141.21 26.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 113.697 -1.592 . . . . 0.0 109.007 178.47 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.578 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 3.5 p90 -155.79 121.78 5.06 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 8.8 tt0 -68.22 156.38 37.73 Favored 'General case' 0 C--N 1.287 -2.125 0 O-C-N 120.35 -1.469 . . . . 0.0 109.178 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.936 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -92.22 136.36 33.25 Favored 'General case' 0 C--N 1.269 -2.921 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.807 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.584 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 0.3 OUTLIER -116.65 49.73 1.13 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 125.376 2.512 . . . . 0.0 113.78 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.586 ' C ' ' HB2' ' A' ' 82' ' ' LYS . 6.4 pt20 166.59 -158.35 0.01 OUTLIER 'General case' 0 C--N 1.258 -3.401 0 CA-C-N 108.999 -3.728 . . . . 0.0 112.97 175.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.538 ' C ' HG22 ' A' ' 47' ' ' THR 0.285 28.7 t-20 -109.99 154.78 22.69 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-O 122.596 1.188 . . . . 0.0 108.97 -178.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.63 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.1 OUTLIER -172.85 150.97 2.15 Favored 'General case' 0 C--N 1.255 -3.535 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.202 -178.275 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.949 ' O ' HG23 ' A' ' 49' ' ' THR . 0.3 OUTLIER -112.28 11.16 20.1 Favored 'General case' 0 N--CA 1.506 2.371 0 C-N-CA 118.16 -1.416 . . . . 0.0 110.185 178.406 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.949 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.61 145.49 3.81 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 120.706 -1.246 . . . . 0.0 111.069 178.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 111' ' ' MET . . . -139.73 95.13 2.86 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-O 122.988 1.375 . . . . 0.0 109.544 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -65.92 -178.27 0.57 Allowed 'General case' 0 C--N 1.281 -2.374 0 CA-C-N 113.836 -1.529 . . . . 0.0 109.711 178.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.821 ' CG1' HD11 ' A' ' 88' ' ' ILE . 35.7 mt -142.14 144.18 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.357 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 0.4 OUTLIER -140.52 104.01 4.66 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 123.425 1.583 . . . . 0.0 109.75 178.397 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 1.057 ' HA ' HG13 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -93.06 126.29 45.51 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 CA-C-N 112.503 -2.135 . . . . 0.0 107.301 179.252 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.869 ' N ' HD13 ' A' ' 54' ' ' ILE . 0.5 OUTLIER -129.86 149.84 51.42 Favored 'General case' 0 C--N 1.272 -2.802 0 C-N-CA 118.448 -1.301 . . . . 0.0 108.145 178.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 1.05 ' HB3' HG22 ' A' ' 63' ' ' VAL . . . -135.58 127.46 29.41 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 117.694 -1.603 . . . . 0.0 111.475 -178.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.746 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 2.2 p -101.3 100.3 10.78 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 177.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.931 ' HA ' HG22 ' A' ' 104' ' ' VAL . 0.8 OUTLIER -115.47 102.4 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.738 0 CA-C-O 123.089 1.423 . . . . 0.0 110.983 -176.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.571 ' N ' HG22 ' A' ' 104' ' ' VAL . 0.1 OUTLIER 38.28 64.95 0.65 Allowed 'General case' 0 N--CA 1.521 3.121 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.326 179.055 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.53 -13.66 7.91 Favored Glycine 0 N--CA 1.489 2.176 0 O-C-N 121.263 -0.898 . . . . 0.0 111.311 177.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.495 ' HB3' HG13 ' A' ' 58' ' ' ILE 0.278 0.3 OUTLIER -108.14 54.88 0.65 Allowed 'General case' 0 C--N 1.294 -1.841 0 O-C-N 121.205 -1.173 . . . . 0.0 111.495 -178.528 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.635 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.366 0.0 OUTLIER -59.4 117.5 4.91 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 122.527 1.156 . . . . 0.0 111.397 -179.531 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 1.05 HG22 ' HB3' ' A' ' 56' ' ' ALA . 18.8 m -80.19 148.22 5.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-O 122.56 1.172 . . . . 0.0 111.103 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.441 5.9 t70 -137.8 82.11 1.9 Allowed 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.319 -176.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.602 HG22 ' HD2' ' A' ' 66' ' ' PRO . 9.8 p -164.23 151.46 10.25 Favored Pre-proline 0 C--N 1.277 -2.565 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.427 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.602 ' HD2' HG22 ' A' ' 65' ' ' VAL . 45.5 Cg_endo -85.43 139.14 6.72 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 CA-C-O 123.643 1.435 . . . . 0.0 111.719 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.588 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -127.66 48.08 0.99 Allowed Glycine 0 N--CA 1.501 3.02 0 CA-C-N 112.69 -2.05 . . . . 0.0 110.77 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.57 ' O ' ' HD2' ' A' ' 70' ' ' PRO 0.302 5.8 tp 179.68 -174.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 CA-C-N 119.476 1.638 . . . . 0.0 110.024 -178.607 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.585 ' OD2' ' CZ ' ' A' ' 75' ' ' TYR . 1.1 t70 -109.71 84.25 3.18 Favored Pre-proline 0 N--CA 1.504 2.252 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 175.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.786 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 21.0 Cg_endo -48.92 -9.64 0.1 OUTLIER 'Trans proline' 0 C--N 1.279 -3.097 0 C-N-CA 123.556 2.837 . . . . 0.0 115.312 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.551 ' HB2' ' NE2' ' A' ' 74' ' ' HIS . 1.2 m120 -105.42 83.8 2.01 Favored 'General case' 0 C--N 1.287 -2.151 0 O-C-N 120.212 -1.555 . . . . 0.0 108.699 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.644 ' HA ' ' CD1' ' A' ' 75' ' ' TYR . . . -78.44 10.79 2.84 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.505 -0.747 . . . . 0.0 109.402 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.61 -19.92 54.76 Favored 'General case' 0 C--N 1.317 -0.842 0 O-C-N 120.507 -1.371 . . . . 0.0 108.177 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.578 ' ND1' ' N ' ' A' ' 74' ' ' HIS . 0.1 OUTLIER -88.24 18.85 4.06 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 174.203 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.644 ' CD1' ' HA ' ' A' ' 72' ' ' ALA . 0.4 OUTLIER -133.18 -9.38 2.97 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.241 179.774 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.485 ' O ' ' C ' ' A' ' 77' ' ' LYS . 1.6 ptt? -162.62 128.18 3.33 Favored 'General case' 0 C--O 1.215 -0.749 0 CA-C-O 123.6 1.667 . . . . 0.0 112.859 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.578 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 0.6 OUTLIER -4.47 86.93 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 112.042 -2.345 . . . . 0.0 113.559 -178.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.472 ' HA ' HD13 ' A' ' 80' ' ' LEU 0.297 11.1 t -99.02 136.92 20.43 Favored Pre-proline 0 C--N 1.262 -3.197 0 CA-C-N 111.364 -2.653 . . . . 0.0 108.714 178.094 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.701 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 37.3 Cg_endo -78.48 165.95 81.24 Favored 'Cis proline' 0 C--N 1.312 -1.343 0 C-N-CA 123.007 -1.664 . . . . 0.0 112.906 1.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.714 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -89.1 127.39 35.71 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.44 179.445 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.528 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.7 t -106.32 139.47 27.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-O 124.129 1.918 . . . . 0.0 111.616 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.586 ' HB2' ' C ' ' A' ' 45' ' ' GLN . 1.6 tmmt? -44.38 117.97 1.4 Allowed 'General case' 0 C--N 1.271 -2.842 0 CA-C-N 111.686 -2.507 . . . . 0.0 116.924 -175.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.19 -17.6 16.77 Favored Glycine 0 C--N 1.293 -1.808 0 CA-C-N 111.693 -2.503 . . . . 0.0 107.845 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.626 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 14.7 mt-30 -72.63 128.63 36.14 Favored 'General case' 0 C--N 1.277 -2.56 0 CA-C-O 123.215 1.483 . . . . 0.0 111.585 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.581 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 0.7 OUTLIER -66.47 145.87 55.18 Favored 'General case' 0 C--N 1.27 -2.859 0 CA-C-N 113.336 -1.756 . . . . 0.0 107.437 178.341 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.936 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 19.4 m-85 -142.53 124.92 15.59 Favored 'General case' 0 C--N 1.275 -2.64 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -178.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.576 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 4.5 p30 -116.93 133.29 56.2 Favored 'General case' 0 C--N 1.278 -2.543 0 CA-C-O 122.772 1.272 . . . . 0.0 110.233 -177.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.821 HD11 ' CG1' ' A' ' 52' ' ' ILE . 1.1 tp -108.73 159.4 8.15 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 CA-C-N 114.46 -1.246 . . . . 0.0 108.335 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.521 ' HG2' ' N ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -143.24 149.63 38.18 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 120.125 -0.63 . . . . 0.0 112.182 -176.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.605 ' CE1' ' HB2' ' A' ' 92' ' ' TRP . 25.5 t80 -147.22 105.62 3.79 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.421 -0.799 . . . . 0.0 110.489 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.588 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 1.1 t -123.93 110.9 15.4 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.605 ' HB2' ' CE1' ' A' ' 90' ' ' TYR 0.272 0.0 OUTLIER -142.41 109.11 5.39 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.719 -176.662 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.6 OUTLIER -77.29 153.09 34.23 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 119.735 -1.853 . . . . 0.0 109.496 -179.476 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.813 HG22 ' O ' ' A' ' 33' ' ' LYS . 0.8 OUTLIER -154.31 175.36 3.11 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 120.682 -1.261 . . . . 0.0 108.999 -179.73 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.569 ' HD2' ' HB ' ' A' ' 94' ' ' VAL . 18.3 Cg_endo -38.12 156.38 0.03 OUTLIER 'Trans proline' 0 CA--C 1.495 -1.464 0 O-C-N 123.589 1.31 . . . . 0.0 111.127 -177.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.911 ' HA ' ' HA3' ' A' ' 32' ' ' GLY . 2.4 mptt -80.12 -27.97 39.05 Favored 'General case' 0 C--N 1.285 -2.218 0 C-N-CA 116.555 -2.058 . . . . 0.0 116.04 -173.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.774 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -145.42 43.22 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 -177.348 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.939 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . . . -60.33 -53.27 66.49 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 120.367 -1.458 . . . . 0.0 109.736 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.939 ' HD3' ' HB3' ' A' ' 98' ' ' ALA . 55.6 Cg_endo -73.67 160.78 43.3 Favored 'Trans proline' 0 CA--C 1.466 -2.904 0 O-C-N 124.145 1.603 . . . . 0.0 111.13 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.722 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -110.27 106.37 15.75 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 112.236 -2.256 . . . . 0.0 111.104 -169.392 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.614 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 1.5 p -40.88 95.32 0.01 OUTLIER 'General case' 0 N--CA 1.519 3.021 0 CA-C-O 123.496 1.617 . . . . 0.0 110.469 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.581 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.387 84.7 mt-10 -164.93 -52.72 0.03 OUTLIER 'General case' 0 CA--C 1.448 -2.952 0 CA-C-N 112.959 -1.928 . . . . 0.0 111.214 178.468 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.461 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.486 0.8 OUTLIER -161.25 77.62 0.56 Allowed 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 110.583 -3.008 . . . . 0.0 113.466 -162.016 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.931 HG22 ' HA ' ' A' ' 58' ' ' ILE . 21.8 t -144.28 141.44 24.37 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.63 0 C-N-CA 119.32 -0.952 . . . . 0.0 111.907 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.698 HG12 ' CD1' ' A' ' 121' ' ' ILE . 0.3 OUTLIER -153.75 133.26 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.597 HG11 ' CD2' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -94.32 143.56 11.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-O 122.357 1.075 . . . . 0.0 110.994 -179.287 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 1.074 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -131.75 116.65 17.56 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 179.642 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.057 HG13 ' HA ' ' A' ' 54' ' ' ILE . 3.5 t -132.19 139.37 50.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 O-C-N 120.247 -1.533 . . . . 0.0 108.481 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 1.009 ' HB2' ' HB2' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -132.96 146.49 51.83 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.364 1.078 . . . . 0.0 111.187 -178.44 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.655 ' CG2' HD13 ' A' ' 88' ' ' ILE . 2.9 t -99.94 127.8 52.47 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 178.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.504 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -108.29 121.99 46.03 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -179.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -74.62 -131.34 0.24 Allowed Glycine 0 C--N 1.283 -2.39 0 C-N-CA 119.22 -1.467 . . . . 0.0 114.625 -175.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.63 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 6.2 p-10 -97.76 9.56 42.3 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -175.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 32.7 p30 -167.17 -13.68 0.02 OUTLIER 'General case' 0 C--N 1.263 -3.156 0 C-N-CA 117.224 -1.791 . . . . 0.0 114.464 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -153.66 -88.15 0.06 OUTLIER Glycine 0 CA--C 1.475 -2.463 0 CA-C-O 125.879 2.933 . . . . 0.0 112.338 -177.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.629 HG22 ' H ' ' A' ' 117' ' ' LEU . 4.1 p -141.51 178.93 2.39 Favored 'Isoleucine or valine' 1 C--N 1.228 -4.692 1 CA-C-N 108.155 -4.022 . . . . 0.0 111.014 -176.785 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.642 ' HB3' HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -149.3 -62.72 0.23 Allowed 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.255 -179.422 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 1.079 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -164.15 129.66 2.91 Favored 'General case' 0 N--CA 1.51 2.526 0 O-C-N 120.872 -1.142 . . . . 0.0 109.756 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 1.009 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 1.5 p -133.98 134.73 42.85 Favored 'General case' 0 C--N 1.283 -2.321 0 C-N-CA 117.975 -1.49 . . . . 0.0 113.35 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.4 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -144.17 136.3 26.42 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 122.913 1.339 . . . . 0.0 112.153 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 1.074 ' HB ' HG23 ' A' ' 107' ' ' THR 0.268 0.1 OUTLIER -110.79 130.78 63.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.176 -179.495 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.659 ' N ' HD13 ' A' ' 121' ' ' ILE . . . -131.6 178.57 6.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.862 -1.149 . . . . 0.0 108.977 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 124' ' ' HIS . 15.9 p -82.61 -43.98 16.35 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.211 -1.556 . . . . 0.0 109.963 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.597 ' CD2' HG11 ' A' ' 106' ' ' VAL . 0.3 OUTLIER 59.53 107.92 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.386 0 O-C-N 121.554 -0.716 . . . . 0.0 112.224 179.327 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 1.05 ' HB1' HG21 ' A' ' 29' ' ' ILE . . . 49.89 109.71 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.41 0 O-C-N 121.731 -0.606 . . . . 0.0 111.665 178.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.47 ' O ' ' C ' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -110.23 62.46 0.6 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.809 -1.182 . . . . 0.0 108.616 178.411 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.657 HD12 HG13 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -31.03 130.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.668 0 CA-C-O 122.13 0.967 . . . . 0.0 112.579 -178.565 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.476 ' O ' ' C ' ' A' ' 129' ' ' ASP . 0.0 OUTLIER -169.76 150.19 3.93 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.967 178.483 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' ' 128' ' ' ARG . 3.1 m-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.869 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.483 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 1.3 m . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 121.34 0.591 . . . . 0.0 110.393 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -92.63 169.51 10.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.386 -0.821 . . . . 0.0 111.042 -179.693 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.744 HG12 ' HA ' ' A' ' 22' ' ' HIS . 1.4 m -145.58 177.6 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 O-C-N 120.892 -1.13 . . . . 0.0 108.032 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.49 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -80.22 139.3 36.78 Favored 'General case' 0 CA--C 1.477 -1.864 0 C-N-CA 118.007 -1.477 . . . . 0.0 108.823 177.502 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.517 HG11 HG23 ' A' ' 16' ' ' VAL 0.425 0.4 OUTLIER -168.58 160.71 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 CA-C-N 114.029 -1.442 . . . . 0.0 110.057 -170.22 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 5' ' ' VAL . 3.5 mtpt -144.44 140.12 28.77 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 123.785 1.755 . . . . 0.0 113.116 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.27 4.4 t0 -76.36 147.81 37.83 Favored 'General case' 0 C--N 1.267 -2.994 0 CA-C-N 112.932 -1.94 . . . . 0.0 109.786 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.648 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.0 p -137.04 16.01 3.04 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.968 -1.082 . . . . 0.0 109.162 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.876 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -125.03 -82.71 0.64 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.033 -176.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.574 ' O ' ' N ' ' A' ' 12' ' ' GLU . 2.4 t30 -155.79 63.56 0.59 Allowed 'General case' 0 C--N 1.267 -2.991 0 C-N-CA 118.319 -1.352 . . . . 0.0 111.81 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.478 ' C ' ' O ' ' A' ' 10' ' ' ASN . 59.2 m-70 32.02 33.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.854 0.835 . . . . 0.0 110.573 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.6 OUTLIER -95.09 22.47 6.61 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.72 -0.792 . . . . 0.0 111.591 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.026 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.276 0.2 OUTLIER -118.42 -170.36 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.413 -0.804 . . . . 0.0 110.001 -179.116 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.62 ' H ' HG23 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -161.86 -41.43 0.04 OUTLIER 'General case' 0 C--N 1.29 -2.011 0 O-C-N 121.731 -0.605 . . . . 0.0 111.492 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.586 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 11.6 tttm -147.72 138.13 23.08 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 115.89 -2.324 . . . . 0.0 113.145 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.829 HG13 ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -134.52 104.11 5.25 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 CA-C-O 122.897 1.332 . . . . 0.0 110.363 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.501 ' HB2' ' OE2' ' A' ' 38' ' ' GLU . 1.2 mt -99.52 125.65 45.32 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.776 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.706 HG22 ' CB ' ' A' ' 37' ' ' LEU . 40.5 t -141.72 145.4 36.85 Favored Pre-proline 0 N--CA 1.5 2.03 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.025 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.542 ' HD2' ' CG1' ' A' ' 18' ' ' VAL . 44.7 Cg_endo -68.64 134.87 31.6 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 O-C-N 123.772 1.406 . . . . 0.0 111.312 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.459 ' C ' ' HB3' ' A' ' 27' ' ' CYS . . . 110.48 -76.24 0.22 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.586 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 2.2 m -85.7 134.05 33.99 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.468 -1.019 . . . . 0.0 109.651 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.744 ' HA ' HG12 ' A' ' 3' ' ' VAL . 4.0 p80 -142.26 12.55 1.98 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 119.998 -1.689 . . . . 0.0 110.948 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.41 -154.89 13.81 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 118.364 -1.874 . . . . 0.0 110.931 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.96 -12.16 46.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.822 -1.399 . . . . 0.0 109.414 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.798 ' CB ' ' HD3' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -64.36 177.44 0.56 Allowed Pre-proline 0 C--N 1.297 -1.696 0 CA-C-O 124.974 2.321 . . . . 0.0 114.454 179.292 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.798 ' HD3' ' CB ' ' A' ' 25' ' ' GLU . 23.7 Cg_endo -106.11 117.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.263 -3.953 1 C-N-CA 127.531 5.488 . . . . 0.0 110.102 -176.53 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.586 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 1.8 p -93.42 98.18 11.04 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-O 123.357 1.551 . . . . 0.0 111.227 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.484 ' O ' HG22 ' A' ' 28' ' ' ILE 0.317 36.3 mm -82.93 66.3 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 CA-C-N 113.36 -1.745 . . . . 0.0 109.663 179.328 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.804 HG21 ' HB1' ' A' ' 125' ' ' ALA . 16.4 tt -43.05 129.27 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 122.616 1.198 . . . . 0.0 109.952 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.522 ' NE2' ' NH2' ' A' ' 31' ' ' ARG . 16.3 t-160 -66.37 -87.15 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.205 -177.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.522 ' NH2' ' NE2' ' A' ' 30' ' ' HIS . 63.7 mtt180 -150.06 166.88 28.41 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.335 -0.853 . . . . 0.0 110.681 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.888 ' HA2' ' HA ' ' A' ' 96' ' ' LYS . . . 78.12 122.04 0.26 Allowed Glycine 0 C--O 1.213 -1.178 0 N-CA-C 105.887 -2.885 . . . . 0.0 105.887 -178.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.973 ' HB2' HG12 ' A' ' 94' ' ' VAL . 0.7 OUTLIER -117.28 96.77 49.84 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 120.66 2.23 . . . . 0.0 116.577 -175.059 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.592 ' HD3' ' O ' ' A' ' 32' ' ' GLY . 60.8 Cg_endo -107.02 145.39 0.08 OUTLIER 'Trans proline' 0 C--N 1.288 -2.631 0 C-N-CA 123.864 3.042 . . . . 0.0 108.546 176.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.73 ' HZ ' HG11 ' A' ' 94' ' ' VAL . 0.5 OUTLIER -120.53 96.52 5.17 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 118.582 -1.247 . . . . 0.0 109.182 179.002 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.594 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 28.0 mp0 -113.82 83.71 1.9 Allowed 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.706 ' CB ' HG22 ' A' ' 18' ' ' VAL . 2.1 pp -110.17 144.68 38.45 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.686 -1.258 . . . . 0.0 109.768 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.546 ' CB ' ' HG2' ' A' ' 89' ' ' LYS . 1.5 pp20? -140.44 139.07 35.14 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 122.7 1.238 . . . . 0.0 108.816 -178.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.829 ' HB2' HG13 ' A' ' 16' ' ' VAL . . . -142.56 148.74 38.04 Favored 'General case' 0 C--N 1.275 -2.649 0 CA-C-O 122.986 1.374 . . . . 0.0 112.968 -176.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.586 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.35 140.07 31.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 113.817 -1.538 . . . . 0.0 108.87 178.535 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.607 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 6.7 p90 -157.19 126.93 6.17 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -178.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 17.3 tt0 -70.41 156.96 38.64 Favored 'General case' 0 C--N 1.283 -2.319 0 O-C-N 120.388 -1.445 . . . . 0.0 108.815 178.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.982 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -89.41 136.07 33.24 Favored 'General case' 0 C--N 1.265 -3.089 0 CA-C-N 114.21 -1.359 . . . . 0.0 107.996 178.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.569 ' C ' ' HG2' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -117.43 49.93 1.16 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 125.398 2.523 . . . . 0.0 114.242 179.535 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.748 ' N ' ' HG3' ' A' ' 82' ' ' LYS . 7.0 pt20 167.54 -159.18 0.01 OUTLIER 'General case' 0 C--N 1.258 -3.393 0 CA-C-N 108.77 -3.832 . . . . 0.0 112.901 174.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.445 ' C ' HG22 ' A' ' 47' ' ' THR 0.274 20.3 t-20 -108.78 153.55 23.32 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-O 122.622 1.201 . . . . 0.0 108.408 -178.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.615 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -172.65 154.33 3.01 Favored 'General case' 0 C--N 1.254 -3.569 0 C-N-CA 118.588 -1.245 . . . . 0.0 112.836 -178.215 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.956 ' O ' HG23 ' A' ' 49' ' ' THR . 1.2 mtpm? -115.07 7.03 15.35 Favored 'General case' 0 N--CA 1.508 2.452 0 O-C-N 120.74 -1.225 . . . . 0.0 110.926 178.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.956 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.93 149.81 4.45 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.608 -1.307 . . . . 0.0 111.194 179.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 70' ' ' PRO . . . -150.59 109.07 3.8 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-O 122.55 1.167 . . . . 0.0 110.954 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 1.2 ptpt -77.24 -173.39 2.81 Favored 'General case' 0 N--CA 1.506 2.327 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.368 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.817 ' CG1' HD11 ' A' ' 88' ' ' ILE . 35.0 mt -141.84 139.92 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.368 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.419 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.428 ' C ' HG13 ' A' ' 108' ' ' VAL . 3.5 tp10 -140.79 110.03 6.22 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 123.343 1.544 . . . . 0.0 111.168 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 1.013 HD12 HG21 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -91.12 128.59 42.82 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 CA-C-N 112.746 -2.024 . . . . 0.0 109.934 179.373 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.418 ' HD2' ' C ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -123.77 103.85 8.62 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 176.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.847 ' HB2' HG23 ' A' ' 106' ' ' VAL . . . -113.75 134.41 54.78 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 118.708 -1.197 . . . . 0.0 113.183 -175.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.7 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.1 p -106.64 100.79 10.28 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 178.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.867 ' CA ' HG13 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -110.68 107.84 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.939 0 CA-C-O 122.986 1.374 . . . . 0.0 110.774 -177.259 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.655 ' N ' HG22 ' A' ' 104' ' ' VAL . 0.5 OUTLIER 33.06 63.49 0.33 Allowed 'General case' 0 N--CA 1.519 2.992 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.977 179.634 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.72 -14.31 10.3 Favored Glycine 0 N--CA 1.489 2.2 0 O-C-N 121.352 -0.842 . . . . 0.0 111.525 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.511 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.274 0.3 OUTLIER -108.19 57.68 0.62 Allowed 'General case' 0 C--N 1.292 -1.897 0 O-C-N 121.087 -1.243 . . . . 0.0 111.175 -178.536 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.519 ' O ' ' CG ' ' A' ' 62' ' ' GLU 0.366 0.0 OUTLIER -58.61 114.44 2.49 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 122.1 0.952 . . . . 0.0 111.139 -179.696 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.836 HG22 ' HB3' ' A' ' 56' ' ' ALA . 15.0 m -74.95 144.89 11.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 122.586 1.184 . . . . 0.0 110.573 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.435 19.2 t0 -138.07 68.94 1.39 Allowed 'General case' 0 C--N 1.278 -2.526 0 CA-C-O 122.621 1.2 . . . . 0.0 110.572 -176.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.722 HG22 ' HD2' ' A' ' 66' ' ' PRO . 4.8 p -164.03 151.89 10.87 Favored Pre-proline 0 C--N 1.272 -2.797 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.952 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.722 ' HD2' HG22 ' A' ' 65' ' ' VAL . 43.4 Cg_endo -83.26 137.84 8.49 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 CA-C-O 123.804 1.502 . . . . 0.0 111.719 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -125.19 50.14 0.88 Allowed Glycine 0 C--N 1.273 -2.963 0 CA-C-N 112.461 -2.154 . . . . 0.0 110.253 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.578 ' HB ' ' CD2' ' A' ' 90' ' ' TYR 0.304 6.4 tp -178.78 -176.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 O-C-N 120.532 -1.569 . . . . 0.0 110.061 -178.56 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.497 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 29.9 t0 -112.35 83.64 5.45 Favored Pre-proline 0 N--CA 1.502 2.154 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 175.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.71 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 19.1 Cg_endo -47.68 -8.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.289 -2.601 0 C-N-CA 124.275 3.317 . . . . 0.0 115.826 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.578 ' HB2' ' NE2' ' A' ' 74' ' ' HIS . 2.4 m-80 -101.62 90.41 4.04 Favored 'General case' 0 C--N 1.286 -2.167 0 O-C-N 120.2 -1.562 . . . . 0.0 109.74 -178.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.784 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . . . -78.02 7.14 6.52 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.295 -0.878 . . . . 0.0 109.478 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.9 t -79.11 -26.58 42.9 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 121.034 -1.041 . . . . 0.0 109.044 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.578 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -79.71 6.78 9.9 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.895 -1.122 . . . . 0.0 108.943 177.217 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.784 ' CD2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -133.68 -0.48 3.17 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 121.364 -0.835 . . . . 0.0 109.966 177.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.631 ' HE3' HD21 ' A' ' 80' ' ' LEU . 2.6 ptt? -150.34 126.81 10.79 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 123.89 1.805 . . . . 0.0 112.86 178.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.541 ' O ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -20.07 95.25 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 112.006 -2.361 . . . . 0.0 113.159 -178.255 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.508 ' HA ' HD13 ' A' ' 80' ' ' LEU 0.311 0.5 OUTLIER -100.77 144.47 28.58 Favored Pre-proline 0 C--N 1.268 -2.968 0 CA-C-N 111.437 -2.62 . . . . 0.0 109.128 179.01 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.647 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 35.8 Cg_endo -81.37 168.81 68.08 Favored 'Cis proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.792 -1.753 . . . . 0.0 112.16 0.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.722 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -96.75 130.25 44.03 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.25 -179.389 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.541 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.8 t -106.35 139.41 27.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-O 124.109 1.909 . . . . 0.0 111.954 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.748 ' HG3' ' N ' ' A' ' 45' ' ' GLN . 2.3 tmpt? -42.65 120.96 1.86 Allowed 'General case' 0 C--N 1.271 -2.841 0 CA-C-N 111.902 -2.408 . . . . 0.0 115.955 -175.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.35 -16.63 24.43 Favored Glycine 0 C--N 1.291 -1.957 0 CA-C-N 111.97 -2.377 . . . . 0.0 108.38 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 16.6 mt-30 -73.61 126.42 30.25 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-O 123.223 1.487 . . . . 0.0 111.786 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.608 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -64.04 143.18 58.07 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 113.271 -1.786 . . . . 0.0 107.539 179.084 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.982 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 18.7 m-85 -143.29 126.01 16.02 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.58 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 1.2 p-10 -117.12 132.55 56.64 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-O 122.712 1.244 . . . . 0.0 109.902 -178.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.817 HD11 ' CG1' ' A' ' 52' ' ' ILE . 0.9 OUTLIER -110.55 160.79 9.46 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.24 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.546 ' HG2' ' CB ' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -148.15 161.15 42.03 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-O 122.031 0.92 . . . . 0.0 113.203 -177.209 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.578 ' CD2' ' HB ' ' A' ' 68' ' ' ILE . 28.0 t80 -151.17 105.62 3.24 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.559 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.594 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 0.6 OUTLIER -122.3 111.51 17.0 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 178.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.577 ' CD1' ' O ' ' A' ' 67' ' ' GLY 0.271 0.3 OUTLIER -141.99 116.81 9.84 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.446 -176.824 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.3 OUTLIER -75.16 161.72 29.13 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 119.237 -2.164 . . . . 0.0 109.795 -179.014 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.973 HG12 ' HB2' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -151.48 165.84 16.5 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.896 ' HD2' HG22 ' A' ' 94' ' ' VAL . 19.8 Cg_endo -38.26 154.26 0.03 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.178 0 O-C-N 123.586 1.309 . . . . 0.0 110.505 -177.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.888 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 8.5 mptt -79.35 -28.15 42.03 Favored 'General case' 0 C--N 1.285 -2.228 0 C-N-CA 116.566 -2.053 . . . . 0.0 114.725 -173.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.758 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -143.41 43.07 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 CA-C-O 121.402 0.62 . . . . 0.0 112.541 -178.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.941 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . . . -76.53 -64.48 0.48 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 120.562 -1.336 . . . . 0.0 109.903 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.941 ' HD3' ' HB3' ' A' ' 98' ' ' ALA . 47.2 Cg_endo -66.13 159.87 47.48 Favored 'Trans proline' 0 CA--C 1.463 -3.057 0 O-C-N 123.94 1.495 . . . . 0.0 110.045 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.71 ' HD2' ' C ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -108.58 105.39 14.99 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-N 112.517 -2.129 . . . . 0.0 109.874 -169.587 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.943 ' OG ' HD12 ' A' ' 127' ' ' ILE . 5.5 p -46.2 98.62 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 123.37 1.557 . . . . 0.0 108.195 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.593 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.402 88.1 mt-10 -164.0 -51.54 0.03 OUTLIER 'General case' 0 CA--C 1.448 -2.945 0 CA-C-N 113.195 -1.82 . . . . 0.0 111.987 -179.115 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.481 0.8 OUTLIER -159.52 78.27 0.71 Allowed 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 111.159 -2.746 . . . . 0.0 114.01 -162.073 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.867 HG13 ' CA ' ' A' ' 58' ' ' ILE . 28.5 t -142.31 137.8 29.45 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.875 178.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 1.092 HG12 HD11 ' A' ' 121' ' ' ILE . 22.0 t -147.14 133.93 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.847 HG23 ' HB2' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -106.87 146.73 12.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-O 122.806 1.288 . . . . 0.0 113.033 -178.26 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 1.045 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -132.86 109.57 9.71 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.432 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.013 HG21 HD12 ' A' ' 54' ' ' ILE . 3.9 t -127.07 144.88 35.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 119.954 -1.716 . . . . 0.0 109.043 -177.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 1.014 ' HB2' ' HB2' ' A' ' 119' ' ' CYS . 0.1 OUTLIER -136.48 143.05 43.61 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.137 0.97 . . . . 0.0 111.571 -178.018 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.643 ' CG2' HD13 ' A' ' 88' ' ' ILE . 20.9 t -96.28 130.97 44.2 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.622 ' CG ' ' HA2' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -110.69 119.53 39.45 Favored 'General case' 0 N--CA 1.509 2.506 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -178.717 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.483 ' HA3' HD23 ' A' ' 117' ' ' LEU . . . -81.69 -140.41 3.12 Favored Glycine 0 N--CA 1.5 2.946 0 C-N-CA 119.449 -1.357 . . . . 0.0 115.195 -174.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.615 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 4.4 p-10 -82.38 -6.44 59.27 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 122.267 1.032 . . . . 0.0 112.743 -176.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -128.86 -5.24 5.1 Favored 'General case' 0 C--N 1.262 -3.218 0 CA-C-O 121.747 0.784 . . . . 0.0 110.3 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.622 ' HA2' ' CG ' ' A' ' 111' ' ' MET . . . 94.43 85.3 1.64 Allowed Glycine 0 CA--C 1.471 -2.662 0 CA-C-O 124.595 2.219 . . . . 0.0 110.871 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.612 HG12 ' C ' ' A' ' 115' ' ' GLY . 7.5 p 137.11 153.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.251 -3.695 0 CA-C-N 108.409 -3.895 . . . . 0.0 112.451 176.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.632 ' CB ' HG12 ' A' ' 110' ' ' VAL . 0.2 OUTLIER -160.94 -59.97 0.06 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.284 0.564 . . . . 0.0 110.232 179.376 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 1.026 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -170.86 130.1 0.8 Allowed 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.204 -0.935 . . . . 0.0 109.085 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 1.014 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 0.9 OUTLIER -132.92 131.68 41.15 Favored 'General case' 0 C--N 1.28 -2.455 0 C-N-CA 117.769 -1.573 . . . . 0.0 112.52 -178.131 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.704 ' HB2' HD13 ' A' ' 13' ' ' ILE . . . -143.05 138.22 29.79 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 123.105 1.431 . . . . 0.0 111.866 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 1.092 HD11 HG12 ' A' ' 105' ' ' VAL 0.274 0.0 OUTLIER -111.03 132.39 59.65 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 113.891 -1.504 . . . . 0.0 111.634 -178.837 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.76 ' N ' HD13 ' A' ' 121' ' ' ILE . . . -131.28 -178.03 4.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.936 -1.102 . . . . 0.0 109.022 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.54 ' O ' ' HB2' ' A' ' 124' ' ' HIS . 12.9 p -93.43 -30.69 14.94 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.365 -1.459 . . . . 0.0 111.1 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.639 ' CE1' HG11 ' A' ' 18' ' ' VAL . 0.3 OUTLIER 63.44 -57.79 0.18 Allowed 'General case' 0 N--CA 1.508 2.468 0 O-C-N 121.499 -0.751 . . . . 0.0 112.07 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.804 ' HB1' HG21 ' A' ' 29' ' ' ILE . . . -158.29 115.31 2.86 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.653 -1.279 . . . . 0.0 111.633 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -130.74 -174.16 3.29 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 120.84 -1.162 . . . . 0.0 108.043 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.943 HD12 ' OG ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -153.72 137.21 8.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 120.893 -1.129 . . . . 0.0 112.391 -179.391 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.461 ' HD3' ' O ' ' A' ' 127' ' ' ILE . 1.3 tpp180 -168.94 151.48 4.89 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.011 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 128' ' ' ARG . 4.4 m-20 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.581 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 4.6 m . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.159 0.504 . . . . 0.0 110.424 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.48 ' HB2' ' O ' ' A' ' 1' ' ' SER . 0.5 OUTLIER 62.31 157.06 0.05 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.405 -0.809 . . . . 0.0 111.418 179.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.761 HG12 ' HA ' ' A' ' 22' ' ' HIS . 1.5 m -147.41 178.51 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.475 ' O ' HG23 ' A' ' 3' ' ' VAL . 7.1 t0 -80.01 137.17 36.76 Favored 'General case' 0 CA--C 1.473 -1.999 0 C-N-CA 117.509 -1.677 . . . . 0.0 108.681 177.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.5 ' C ' ' CG ' ' A' ' 6' ' ' LYS 0.434 0.4 OUTLIER -167.49 178.81 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.101 -169.795 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.668 ' O ' HG22 ' A' ' 121' ' ' ILE . 19.4 mtpt -153.31 132.68 12.83 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 123.657 1.694 . . . . 0.0 112.46 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.264 2.2 t70 -71.95 146.5 47.73 Favored 'General case' 0 C--N 1.267 -3.014 0 CA-C-N 113.42 -1.718 . . . . 0.0 109.224 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.657 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.8 p -137.32 16.07 2.98 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.03 -1.044 . . . . 0.0 109.519 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.84 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -125.3 -84.91 0.64 Allowed 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 118.815 -1.154 . . . . 0.0 110.024 -176.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 12' ' ' GLU . 2.7 t30 -158.74 65.1 0.42 Allowed 'General case' 0 C--N 1.266 -3.04 0 C-N-CA 118.249 -1.38 . . . . 0.0 112.529 177.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.608 ' CG ' ' O ' ' A' ' 11' ' ' HIS . 30.1 t-80 36.44 30.79 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 122.053 0.93 . . . . 0.0 110.266 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.539 ' CG ' ' OD1' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -92.07 21.99 4.66 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.403 -0.811 . . . . 0.0 111.847 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.992 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.268 0.0 OUTLIER -120.1 -170.31 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 122.151 0.977 . . . . 0.0 111.133 -178.794 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.637 ' N ' HG23 ' A' ' 13' ' ' ILE . 0.8 OUTLIER -162.59 -48.07 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.223 -179.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.628 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 20.5 tttp -142.28 135.8 29.13 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 116.436 -2.106 . . . . 0.0 112.621 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.702 ' CG1' ' HB2' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -133.2 102.75 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 122.903 1.335 . . . . 0.0 110.928 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.513 ' HA ' HD23 ' A' ' 17' ' ' LEU . 0.6 OUTLIER -92.56 126.11 37.5 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 114.096 -1.411 . . . . 0.0 111.52 178.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.635 HG22 ' HA ' ' A' ' 37' ' ' LEU . 59.6 t -142.85 140.96 18.84 Favored Pre-proline 0 N--CA 1.498 1.973 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.347 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.418 ' HD2' HG13 ' A' ' 18' ' ' VAL . 47.7 Cg_endo -70.72 132.73 22.35 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.629 1.331 . . . . 0.0 111.039 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 118.3 -75.37 0.29 Allowed Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.526 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 1.9 m -91.16 139.27 30.91 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.541 -0.976 . . . . 0.0 110.192 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.761 ' HA ' HG12 ' A' ' 3' ' ' VAL . 7.2 p80 -139.66 6.38 2.26 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.112 -1.617 . . . . 0.0 110.774 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.21 -152.53 9.39 Favored Glycine 0 N--CA 1.489 2.224 0 C-N-CA 118.506 -1.807 . . . . 0.0 111.126 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.39 -9.49 25.56 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.755 -1.438 . . . . 0.0 109.909 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.789 ' CB ' ' HD3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -64.07 176.99 0.58 Allowed Pre-proline 0 C--N 1.296 -1.758 0 CA-C-O 125.006 2.336 . . . . 0.0 114.54 179.797 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.789 ' HD3' ' CB ' ' A' ' 25' ' ' GLU . 22.8 Cg_endo -105.69 115.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.265 -3.865 1 C-N-CA 127.463 5.442 . . . . 0.0 110.162 -176.322 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.526 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 4.3 p -102.6 100.37 10.44 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-O 123.079 1.419 . . . . 0.0 111.603 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.439 ' O ' ' C ' ' A' ' 29' ' ' ILE 0.315 34.4 mm -82.95 73.74 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 CA-C-N 113.798 -1.546 . . . . 0.0 108.974 178.272 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.515 ' O ' HG23 ' A' ' 29' ' ' ILE . 13.1 tt -40.53 119.33 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-O 122.911 1.339 . . . . 0.0 109.77 -178.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.599 ' CD2' ' O ' ' A' ' 30' ' ' HIS . 33.0 p-80 -66.82 48.51 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.148 -1.387 . . . . 0.0 112.524 -177.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.577 ' HB2' ' O ' ' A' ' 30' ' ' HIS . 14.9 mtt180 62.06 169.9 0.12 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.991 -1.068 . . . . 0.0 110.479 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.768 ' HA2' ' HA ' ' A' ' 96' ' ' LYS . . . 79.76 120.26 0.35 Allowed Glycine 0 C--N 1.305 -1.149 0 N-CA-C 105.321 -3.112 . . . . 0.0 105.321 -178.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.855 ' O ' HG22 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -118.26 97.07 50.52 Favored Pre-proline 0 C--O 1.218 -0.554 0 CA-C-N 121.278 2.539 . . . . 0.0 116.927 -174.538 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.575 ' HD3' ' O ' ' A' ' 32' ' ' GLY . 62.1 Cg_endo -106.15 144.53 0.1 OUTLIER 'Trans proline' 0 C--N 1.29 -2.531 0 C-N-CA 123.754 2.969 . . . . 0.0 108.142 176.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.675 ' CE2' HG11 ' A' ' 94' ' ' VAL . 14.6 m-85 -116.11 92.46 3.9 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 119.347 -0.941 . . . . 0.0 108.868 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.581 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 25.5 mp0 -115.9 88.86 2.97 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.06 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.635 ' HA ' HG22 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -108.83 138.46 45.13 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 120.672 -1.268 . . . . 0.0 108.479 179.115 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -139.76 128.42 23.12 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.702 ' HB2' ' CG1' ' A' ' 16' ' ' VAL . . . -143.33 151.49 40.53 Favored 'General case' 0 C--N 1.274 -2.678 0 CA-C-O 123.212 1.482 . . . . 0.0 113.801 -175.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.685 HG12 ' HB3' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -112.49 140.61 31.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 113.627 -1.624 . . . . 0.0 107.862 177.623 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.59 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 4.0 p90 -156.54 123.04 5.06 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -177.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 14.9 tt0 -68.07 154.84 40.83 Favored 'General case' 0 C--N 1.288 -2.087 0 O-C-N 120.425 -1.422 . . . . 0.0 108.521 178.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.972 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -90.47 131.61 36.12 Favored 'General case' 0 C--N 1.265 -3.082 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.821 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.539 ' OD1' ' CG ' ' A' ' 12' ' ' GLU . 0.1 OUTLIER -113.66 49.87 0.95 Allowed 'General case' 0 CA--C 1.482 -1.654 0 CA-C-O 125.508 2.575 . . . . 0.0 113.847 179.221 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.733 ' N ' ' HG3' ' A' ' 82' ' ' LYS . 5.7 pt20 167.0 -158.61 0.01 OUTLIER 'General case' 0 C--N 1.259 -3.344 0 CA-C-N 108.732 -3.849 . . . . 0.0 112.796 174.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.464 ' C ' HG22 ' A' ' 47' ' ' THR 0.278 16.7 t-20 -110.11 155.63 21.66 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-O 122.64 1.209 . . . . 0.0 108.959 -178.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.631 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -172.36 154.57 3.27 Favored 'General case' 0 C--N 1.254 -3.574 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.511 -178.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.952 ' O ' HG23 ' A' ' 49' ' ' THR . 9.5 mtpt -112.36 5.8 18.4 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 120.763 -1.211 . . . . 0.0 110.996 178.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.952 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.15 147.84 4.73 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.417 -1.427 . . . . 0.0 111.351 179.19 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 111' ' ' MET . . . -138.51 98.06 3.5 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-O 122.757 1.265 . . . . 0.0 110.481 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 0.9 OUTLIER -69.3 -179.71 1.71 Allowed 'General case' 0 N--CA 1.505 2.321 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.138 178.511 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.846 ' CG1' HD11 ' A' ' 88' ' ' ILE . 23.7 mt -141.6 136.72 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.514 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.418 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.476 ' C ' HG13 ' A' ' 108' ' ' VAL . 5.5 tp10 -142.61 113.44 7.49 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 123.276 1.512 . . . . 0.0 111.807 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.911 ' CA ' HG13 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -88.93 126.96 41.97 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 CA-C-N 112.783 -2.008 . . . . 0.0 109.012 178.283 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -119.81 97.43 5.62 Favored 'General case' 0 C--N 1.278 -2.518 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 177.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.93 ' HB3' HG22 ' A' ' 63' ' ' VAL . . . -110.1 127.37 54.84 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.126 -1.03 . . . . 0.0 111.79 -176.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.755 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.3 p -106.48 102.83 12.19 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.971 ' HA ' HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -114.32 95.17 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.897 0 CA-C-O 123.531 1.634 . . . . 0.0 110.143 -177.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.717 ' OD2' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER 36.71 69.11 0.22 Allowed 'General case' 0 N--CA 1.523 3.183 0 CA-C-N 114.463 -1.244 . . . . 0.0 113.58 179.37 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.54 -22.03 12.11 Favored Glycine 0 N--CA 1.488 2.113 0 O-C-N 121.136 -0.977 . . . . 0.0 111.864 176.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.545 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.265 0.4 OUTLIER -107.96 57.84 0.62 Allowed 'General case' 0 C--N 1.292 -1.919 0 O-C-N 121.137 -1.213 . . . . 0.0 111.877 -178.137 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.578 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.372 0.0 OUTLIER -67.97 113.59 5.79 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 122.035 0.922 . . . . 0.0 110.944 -179.573 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.93 HG22 ' HB3' ' A' ' 56' ' ' ALA . 10.2 m -78.91 145.6 9.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 122.612 1.196 . . . . 0.0 110.852 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.529 ' C ' ' CG2' ' A' ' 65' ' ' VAL 0.434 7.3 t70 -137.89 59.27 1.66 Allowed 'General case' 0 C--N 1.28 -2.444 0 CA-C-O 122.855 1.312 . . . . 0.0 110.897 -176.156 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.757 HG12 ' HD2' ' A' ' 66' ' ' PRO . 1.4 t -157.28 150.41 18.6 Favored Pre-proline 0 C--N 1.271 -2.842 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.682 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.757 ' HD2' HG12 ' A' ' 65' ' ' VAL . 46.3 Cg_endo -88.04 141.53 5.21 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 CA-C-O 123.728 1.47 . . . . 0.0 111.814 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.587 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -110.83 50.36 0.78 Allowed Glycine 0 C--N 1.271 -3.075 0 CA-C-N 112.495 -2.139 . . . . 0.0 109.33 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.636 HG23 ' N ' ' A' ' 69' ' ' ASP 0.289 2.4 tp -179.35 -164.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 O-C-N 120.03 -1.865 . . . . 0.0 109.944 -178.158 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.636 ' N ' HG23 ' A' ' 68' ' ' ILE . 11.1 t70 -114.38 85.02 10.18 Favored Pre-proline 0 N--CA 1.499 1.998 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 175.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.708 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 19.3 Cg_endo -47.52 -5.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.289 -2.583 0 C-N-CA 124.381 3.387 . . . . 0.0 115.763 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.593 ' ND2' ' N ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -109.44 93.03 4.29 Favored 'General case' 0 C--N 1.285 -2.197 0 O-C-N 119.809 -1.807 . . . . 0.0 108.843 -179.495 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.742 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . . . -78.22 12.2 2.0 Allowed 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.357 -0.84 . . . . 0.0 109.202 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.408 ' HA ' ' HG2' ' A' ' 76' ' ' MET . 7.5 t -76.74 -25.26 53.29 Favored 'General case' 0 C--N 1.311 -1.104 0 O-C-N 120.904 -1.123 . . . . 0.0 108.581 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.551 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 0.6 OUTLIER -78.75 4.13 14.69 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 118.615 -1.234 . . . . 0.0 108.546 176.114 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.742 ' CD2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -135.29 7.26 3.35 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 121.344 -0.847 . . . . 0.0 109.275 177.589 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.508 ' O ' ' N ' ' A' ' 78' ' ' CYS . 1.0 OUTLIER -148.21 125.65 11.65 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 123.859 1.79 . . . . 0.0 112.555 178.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.543 ' O ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -32.16 91.95 0.01 OUTLIER 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 112.453 -2.158 . . . . 0.0 111.499 -178.373 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.522 ' HA ' HD13 ' A' ' 80' ' ' LEU 0.311 0.1 OUTLIER -91.95 142.28 26.28 Favored Pre-proline 0 C--N 1.264 -3.126 0 CA-C-N 111.408 -2.633 . . . . 0.0 109.926 179.968 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.639 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 35.1 Cg_endo -82.54 166.41 69.59 Favored 'Cis proline' 0 C--N 1.314 -1.247 0 C-N-CA 123.094 -1.627 . . . . 0.0 111.861 0.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.683 ' HG ' ' CE1' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -93.67 129.75 39.86 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.352 -179.637 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.525 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.3 t -105.85 141.54 20.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-O 124.325 2.012 . . . . 0.0 112.697 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.733 ' HG3' ' N ' ' A' ' 45' ' ' GLN . 2.5 tmpt? -43.86 122.61 2.87 Favored 'General case' 0 C--N 1.273 -2.759 0 CA-C-N 111.556 -2.565 . . . . 0.0 115.933 -176.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.56 -13.61 35.76 Favored Glycine 0 C--N 1.291 -1.921 0 CA-C-N 111.98 -2.373 . . . . 0.0 108.472 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.623 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 11.3 mt-30 -78.74 126.8 31.21 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-O 123.207 1.479 . . . . 0.0 112.016 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.604 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 0.3 OUTLIER -63.84 142.11 58.52 Favored 'General case' 0 C--N 1.271 -2.805 0 CA-C-N 113.363 -1.744 . . . . 0.0 107.791 179.035 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.972 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 19.6 m-85 -142.74 126.12 16.65 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.685 ' HB3' HG12 ' A' ' 40' ' ' VAL . 28.4 p-10 -117.9 136.43 53.47 Favored 'General case' 0 C--N 1.277 -2.56 0 CA-C-O 122.745 1.26 . . . . 0.0 110.077 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.846 HD11 ' CG1' ' A' ' 52' ' ' ILE . 0.8 OUTLIER -113.88 160.26 13.42 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.726 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -145.63 153.54 41.15 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.522 0.677 . . . . 0.0 112.211 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.832 ' CE2' HD13 ' A' ' 54' ' ' ILE . 3.1 t80 -151.65 100.38 2.69 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.628 -0.67 . . . . 0.0 110.638 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.57 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 1.4 t -122.6 114.43 20.61 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-N 119.689 1.131 . . . . 0.0 108.234 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.686 ' HB2' ' CE1' ' A' ' 90' ' ' TYR 0.273 0.9 OUTLIER -143.12 112.72 6.9 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.508 -177.365 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.5 OUTLIER -74.88 157.13 35.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 119.217 -2.177 . . . . 0.0 110.321 -178.78 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.855 HG22 ' O ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -154.14 172.6 5.6 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.0 -1.063 . . . . 0.0 108.752 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.542 ' HD2' ' HB ' ' A' ' 94' ' ' VAL . 17.2 Cg_endo -36.1 149.5 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.133 0 O-C-N 123.502 1.264 . . . . 0.0 111.11 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.768 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 9.2 mptt -80.41 -25.67 38.89 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 117.332 -1.747 . . . . 0.0 115.152 -173.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.767 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -145.31 45.95 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 O-C-N 121.455 -0.778 . . . . 0.0 112.721 -178.084 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.585 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . . . -73.86 -47.07 6.8 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 120.544 -1.348 . . . . 0.0 111.325 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.701 ' C ' ' HD2' ' A' ' 100' ' ' LYS . 44.9 Cg_endo -67.73 160.16 49.44 Favored 'Trans proline' 0 CA--C 1.468 -2.813 0 CA-C-O 123.547 1.394 . . . . 0.0 111.648 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.701 ' HD2' ' C ' ' A' ' 99' ' ' PRO . 0.3 OUTLIER -107.74 106.98 17.55 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 112.031 -2.35 . . . . 0.0 110.949 -169.083 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.67 ' HB3' HG22 ' A' ' 127' ' ' ILE . 2.2 p -42.12 93.72 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.912 0 CA-C-O 123.496 1.617 . . . . 0.0 110.457 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.607 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.381 46.8 mt-10 -165.35 -52.58 0.03 OUTLIER 'General case' 0 CA--C 1.449 -2.915 0 CA-C-N 113.114 -1.857 . . . . 0.0 111.897 178.198 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.484 0.8 OUTLIER -162.03 88.65 0.68 Allowed 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 111.095 -2.775 . . . . 0.0 115.011 -161.345 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.971 HG22 ' HA ' ' A' ' 58' ' ' ILE . 22.0 t -142.89 141.31 27.1 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.537 0 C-N-CA 118.87 -1.132 . . . . 0.0 111.961 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.948 HG22 ' CG2' ' A' ' 123' ' ' THR . 7.9 t -153.03 134.15 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.686 HG23 ' HB2' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -109.58 140.08 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-O 122.488 1.137 . . . . 0.0 112.467 -178.713 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 1.04 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -133.13 111.29 10.8 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.55 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.911 HG13 ' CA ' ' A' ' 54' ' ' ILE . 6.1 t -125.82 142.06 43.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 119.821 -1.8 . . . . 0.0 108.969 -177.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.797 ' HB2' ' HB3' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -132.58 153.3 51.15 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.788 1.28 . . . . 0.0 112.937 -178.183 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.68 HG12 ' HB3' ' A' ' 117' ' ' LEU . 2.7 t -102.62 123.75 56.16 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.512 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 177.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.533 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -101.75 127.97 48.29 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.523 ' HA3' HD23 ' A' ' 117' ' ' LEU . . . -83.72 -129.42 1.63 Allowed Glycine 0 C--N 1.279 -2.638 0 C-N-CA 118.632 -1.746 . . . . 0.0 114.414 -176.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.631 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 4.1 p-10 -98.22 7.47 46.21 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -175.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 22.6 p30 -167.49 -13.04 0.02 OUTLIER 'General case' 0 C--N 1.261 -3.259 0 C-N-CA 117.429 -1.708 . . . . 0.0 114.437 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.42 ' O ' ' SD ' ' A' ' 111' ' ' MET . . . -153.85 -86.84 0.06 OUTLIER Glycine 0 CA--C 1.473 -2.57 0 CA-C-O 125.916 2.953 . . . . 0.0 111.723 -177.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.517 HG22 ' H ' ' A' ' 117' ' ' LEU . 1.4 p -141.49 177.54 3.38 Favored 'Isoleucine or valine' 1 C--N 1.228 -4.714 1 CA-C-N 108.054 -4.073 . . . . 0.0 110.929 -177.283 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.68 ' HB3' HG12 ' A' ' 110' ' ' VAL . 0.2 OUTLIER -145.96 -64.02 0.31 Allowed 'General case' 0 C--N 1.289 -2.064 0 O-C-N 121.793 -0.567 . . . . 0.0 110.849 -179.561 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.992 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -164.51 127.82 2.45 Favored 'General case' 0 N--CA 1.51 2.552 0 O-C-N 120.96 -1.088 . . . . 0.0 109.134 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.84 ' SG ' ' HB2' ' A' ' 9' ' ' ALA . 1.6 p -134.57 142.15 46.87 Favored 'General case' 0 C--N 1.285 -2.197 0 C-N-CA 117.823 -1.551 . . . . 0.0 113.482 -177.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.472 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -144.96 138.2 26.67 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 123.035 1.398 . . . . 0.0 112.11 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 1.04 ' HB ' HG23 ' A' ' 107' ' ' THR 0.284 0.0 OUTLIER -113.03 142.3 25.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 114.09 -1.413 . . . . 0.0 111.982 -178.697 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.899 ' N ' HD13 ' A' ' 121' ' ' ILE . . . -130.96 167.65 18.65 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.983 -1.073 . . . . 0.0 108.131 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.948 ' CG2' HG22 ' A' ' 105' ' ' VAL . 67.7 p -154.08 -128.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.423 -1.423 . . . . 0.0 110.377 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.576 ' O ' ' N ' ' A' ' 126' ' ' LYS . 57.5 m-70 60.75 -52.91 0.09 Allowed 'General case' 0 N--CA 1.516 2.833 0 O-C-N 121.043 -1.035 . . . . 0.0 112.906 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 123' ' ' THR . . . -46.87 86.92 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.991 -1.068 . . . . 0.0 110.56 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.581 ' O ' ' O ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -110.75 55.99 0.64 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.311 -0.868 . . . . 0.0 110.089 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.67 HG22 ' HB3' ' A' ' 101' ' ' SER . 0.6 OUTLIER 9.38 120.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.903 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -179.735 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.513 ' O ' ' C ' ' A' ' 129' ' ' ASP . 0.5 OUTLIER -167.5 147.08 5.1 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.643 -0.66 . . . . 0.0 111.338 178.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.513 ' C ' ' O ' ' A' ' 128' ' ' ARG . 3.8 m-20 . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 117.939 -1.029 . . . . 0.0 111.379 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 7.5 t . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.122 0.487 . . . . 0.0 110.151 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.513 ' CD ' ' CE ' ' A' ' 15' ' ' LYS . 10.9 mp0 58.69 165.47 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.265 -0.897 . . . . 0.0 110.97 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.765 HG12 ' HA ' ' A' ' 22' ' ' HIS 0.257 1.3 m -145.68 174.91 2.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 O-C-N 120.634 -1.291 . . . . 0.0 108.902 -179.151 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.582 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -81.83 148.13 29.0 Favored 'General case' 0 CA--C 1.477 -1.829 0 CA-C-O 122.83 1.3 . . . . 0.0 109.115 176.782 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.854 HG11 HG21 ' A' ' 16' ' ' VAL 0.428 0.4 OUTLIER -164.29 -167.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 CA-C-N 113.668 -1.605 . . . . 0.0 109.589 -170.856 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 5' ' ' VAL . 2.7 mttt -156.33 146.57 21.42 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 124.065 1.888 . . . . 0.0 113.173 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.287 8.1 t70 -86.32 147.71 25.93 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-N 112.335 -2.211 . . . . 0.0 109.771 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.654 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 6.1 p -136.84 14.67 3.11 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.887 -1.133 . . . . 0.0 109.07 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.846 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -126.04 -84.36 0.63 Allowed 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.075 -1.05 . . . . 0.0 109.931 -177.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.538 ' ND2' ' O ' ' A' ' 10' ' ' ASN . 2.6 t30 -158.65 66.51 0.44 Allowed 'General case' 0 C--N 1.269 -2.901 0 C-N-CA 118.632 -1.227 . . . . 0.0 112.265 177.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.586 ' CG ' ' O ' ' A' ' 11' ' ' HIS . 10.2 t-160 36.27 30.84 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 121.958 0.885 . . . . 0.0 110.276 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.582 ' HB3' ' O ' ' A' ' 117' ' ' LEU . 0.4 OUTLIER -84.84 18.17 2.53 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 121.356 0.598 . . . . 0.0 111.428 -179.553 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.037 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.281 0.1 OUTLIER -122.91 -171.69 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-O 122.04 0.924 . . . . 0.0 110.856 -178.333 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.629 ' H ' HG23 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -162.21 -47.42 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.336 -179.562 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.561 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -142.71 133.24 25.06 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 116.192 -2.203 . . . . 0.0 113.317 179.116 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.879 HG12 ' HB2' ' A' ' 39' ' ' ALA . 3.2 m -131.78 107.15 12.64 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.323 0 CA-C-O 122.876 1.322 . . . . 0.0 111.498 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -98.75 120.54 39.36 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 114.319 -1.31 . . . . 0.0 111.302 178.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.725 HG22 ' HB2' ' A' ' 37' ' ' LEU . 16.1 t -142.72 146.07 36.56 Favored Pre-proline 0 C--N 1.295 -1.794 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.097 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.557 ' HD2' ' CG1' ' A' ' 18' ' ' VAL . 43.9 Cg_endo -69.66 132.34 23.29 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 O-C-N 123.834 1.439 . . . . 0.0 111.211 -178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.41 -88.82 0.2 Allowed Glycine 0 N--CA 1.495 2.57 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.519 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 19.3 m -94.27 173.27 7.73 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.243 -1.151 . . . . 0.0 110.433 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.765 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -142.01 8.42 1.87 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.764 -1.21 . . . . 0.0 110.723 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 4' ' ' ASP . . . 173.99 -146.38 8.69 Favored Glycine 0 C--N 1.286 -2.244 0 C-N-CA 118.792 -1.67 . . . . 0.0 110.221 177.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.98 -12.65 52.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.678 -1.484 . . . . 0.0 109.35 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.822 ' CB ' ' HD3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -65.01 175.45 1.01 Allowed Pre-proline 0 C--N 1.298 -1.653 0 CA-C-O 125.054 2.359 . . . . 0.0 114.884 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.822 ' HD3' ' CB ' ' A' ' 25' ' ' GLU . 28.7 Cg_endo -109.32 127.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.266 -3.809 1 C-N-CA 127.607 5.538 . . . . 0.0 111.037 -175.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.581 ' SG ' ' HA ' ' A' ' 124' ' ' HIS . 23.8 p -123.27 108.03 12.33 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 123.157 1.456 . . . . 0.0 111.304 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.548 ' O ' HG22 ' A' ' 28' ' ' ILE 0.305 32.2 mm -68.9 72.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.856 179.166 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.647 HD13 ' HE3' ' A' ' 33' ' ' LYS . 6.5 tt -42.32 122.07 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 122.773 1.273 . . . . 0.0 109.091 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.465 ' CG ' ' N ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -66.65 -120.27 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.204 -177.402 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.465 ' N ' ' CG ' ' A' ' 30' ' ' HIS . 50.9 mtt85 -128.91 168.93 15.26 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.088 -1.008 . . . . 0.0 110.15 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.894 ' HA2' ' HA ' ' A' ' 96' ' ' LYS . . . 83.55 118.52 0.67 Allowed Glycine 0 C--N 1.302 -1.313 0 N-CA-C 105.329 -3.108 . . . . 0.0 105.329 -177.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.827 ' HB2' HG12 ' A' ' 94' ' ' VAL . 2.4 mmmm -118.85 98.0 50.94 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 120.761 2.281 . . . . 0.0 116.391 -174.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.545 ' HD3' ' O ' ' A' ' 32' ' ' GLY . 60.3 Cg_endo -105.17 144.71 0.11 Allowed 'Trans proline' 0 C--N 1.291 -2.477 0 C-N-CA 123.642 2.894 . . . . 0.0 108.898 177.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.538 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 3.7 m-85 -117.85 91.01 3.46 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.302 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.578 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 25.6 mp0 -113.47 79.28 1.22 Allowed 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.725 ' HB2' HG22 ' A' ' 18' ' ' VAL . 3.1 pp -111.68 141.57 45.12 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.851 -1.156 . . . . 0.0 109.837 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.474 ' HB3' ' HE2' ' A' ' 89' ' ' LYS . 2.2 pp20? -140.33 137.53 34.19 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.759 1.266 . . . . 0.0 108.396 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.879 ' HB2' HG12 ' A' ' 16' ' ' VAL . . . -142.65 153.31 43.32 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-O 123.137 1.446 . . . . 0.0 113.237 -176.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.595 HG12 ' HB3' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -109.92 141.37 25.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 113.798 -1.547 . . . . 0.0 108.133 178.242 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.582 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 3.0 p90 -156.3 121.91 4.85 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -177.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 13.4 tt0 -69.71 153.6 43.16 Favored 'General case' 0 C--N 1.285 -2.233 0 O-C-N 120.441 -1.412 . . . . 0.0 108.661 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.904 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -89.01 133.38 34.36 Favored 'General case' 0 C--N 1.266 -3.049 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.302 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.594 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 0.4 OUTLIER -114.2 49.24 1.02 Allowed 'General case' 0 CA--C 1.484 -1.572 0 CA-C-O 125.534 2.588 . . . . 0.0 113.576 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.593 ' C ' ' HB2' ' A' ' 82' ' ' LYS . 6.7 pt20 167.1 -158.95 0.01 OUTLIER 'General case' 0 C--N 1.255 -3.514 0 CA-C-N 108.83 -3.804 . . . . 0.0 112.793 175.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.479 ' C ' HG22 ' A' ' 47' ' ' THR 0.276 7.4 t30 -110.17 154.68 23.0 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-O 122.701 1.239 . . . . 0.0 108.912 -178.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.618 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -172.38 151.78 2.58 Favored 'General case' 0 C--N 1.256 -3.489 0 CA-C-N 114.667 -1.151 . . . . 0.0 112.487 -178.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.934 ' O ' HG23 ' A' ' 49' ' ' THR . 0.2 OUTLIER -111.01 9.45 22.13 Favored 'General case' 0 N--CA 1.508 2.444 0 C-N-CA 118.507 -1.277 . . . . 0.0 110.28 178.408 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.934 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.66 146.56 4.0 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 120.653 -1.279 . . . . 0.0 111.084 178.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 111' ' ' MET . . . -140.66 94.79 2.77 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-O 122.844 1.307 . . . . 0.0 109.814 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 1.3 mmtp -65.2 -179.49 0.59 Allowed 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.193 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.934 ' CG2' HD11 ' A' ' 88' ' ' ILE . 28.7 mt -141.65 140.19 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.446 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 2.3 tm-20 -141.14 104.78 4.7 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 123.265 1.507 . . . . 0.0 109.733 178.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 1.073 ' HA ' HG13 ' A' ' 108' ' ' VAL . 0.1 OUTLIER -92.11 127.64 44.23 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.458 0 CA-C-N 112.604 -2.089 . . . . 0.0 107.602 179.271 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.882 ' N ' HD13 ' A' ' 54' ' ' ILE . 3.5 ttpt -129.75 147.27 51.51 Favored 'General case' 0 C--N 1.271 -2.823 0 C-N-CA 118.45 -1.3 . . . . 0.0 108.193 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 1.094 ' HB3' HG22 ' A' ' 63' ' ' VAL . . . -135.54 130.35 34.44 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 117.579 -1.648 . . . . 0.0 111.565 -178.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.704 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 2.8 p -103.17 95.97 6.47 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.338 -1.726 . . . . 0.0 106.338 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.889 ' HA ' HG22 ' A' ' 104' ' ' VAL . 0.1 OUTLIER -106.93 107.05 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.711 0 CA-C-O 123.008 1.385 . . . . 0.0 110.339 -176.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 103' ' ' ASN . 0.4 OUTLIER 33.74 62.77 0.41 Allowed 'General case' 0 N--CA 1.519 3.002 0 CA-C-N 115.097 -0.956 . . . . 0.0 113.08 179.427 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.59 -15.54 9.48 Favored Glycine 0 N--CA 1.487 2.061 0 O-C-N 121.335 -0.853 . . . . 0.0 111.239 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.54 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.271 0.4 OUTLIER -107.99 59.05 0.61 Allowed 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.204 -1.174 . . . . 0.0 111.353 -178.486 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.651 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.373 0.0 OUTLIER -55.09 117.17 3.24 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.975 0.893 . . . . 0.0 110.79 179.902 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 1.094 HG22 ' HB3' ' A' ' 56' ' ' ALA . 19.0 m -79.53 143.16 12.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-O 122.741 1.258 . . . . 0.0 111.657 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.447 25.1 t0 -138.78 85.27 2.07 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.193 -176.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.572 ' CG2' ' HD2' ' A' ' 66' ' ' PRO . 12.2 p -153.62 149.73 21.78 Favored Pre-proline 0 C--N 1.277 -2.573 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.684 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.572 ' HD2' ' CG2' ' A' ' 65' ' ' VAL . 42.3 Cg_endo -71.37 138.06 32.11 Favored 'Trans proline' 0 CA--C 1.501 -1.139 0 CA-C-O 123.748 1.478 . . . . 0.0 111.073 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.651 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -110.02 -71.8 0.68 Allowed Glycine 0 N--CA 1.504 3.225 0 CA-C-N 112.587 -2.097 . . . . 0.0 112.0 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.767 HG23 ' N ' ' A' ' 69' ' ' ASP . 0.8 OUTLIER -116.64 -150.66 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.013 -1.875 . . . . 0.0 109.433 -178.603 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.767 ' N ' HG23 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -105.81 143.29 26.57 Favored Pre-proline 0 C--N 1.295 -1.773 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 177.21 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.753 ' HB2' ' H ' ' A' ' 52' ' ' ILE . 22.9 Cg_endo -106.21 -3.32 0.14 Allowed 'Trans proline' 0 C--N 1.274 -3.383 0 C-N-CA 123.18 2.587 . . . . 0.0 113.908 -173.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.598 ' HB2' ' NE2' ' A' ' 74' ' ' HIS . 0.4 OUTLIER -110.34 88.78 2.85 Favored 'General case' 0 C--N 1.285 -2.222 0 O-C-N 120.839 -1.163 . . . . 0.0 108.459 -179.501 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.741 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . . . -78.45 10.77 2.86 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.222 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.4 t -77.29 -26.8 52.67 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 120.947 -1.096 . . . . 0.0 108.184 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.598 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -81.19 8.37 9.02 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 118.919 -1.113 . . . . 0.0 108.343 175.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.741 ' CD2' ' HA ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -132.36 -2.52 3.48 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 121.76 -0.587 . . . . 0.0 109.939 178.163 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.596 ' SD ' ' HB1' ' A' ' 72' ' ' ALA . 1.8 ptt? -157.74 132.25 8.4 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 123.866 1.793 . . . . 0.0 113.824 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.57 ' O ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -16.29 94.29 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 111.786 -2.461 . . . . 0.0 113.276 -179.136 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 48' ' ' LYS 0.327 1.8 t -106.84 144.79 29.78 Favored Pre-proline 0 C--N 1.267 -3.003 0 CA-C-N 111.596 -2.547 . . . . 0.0 109.234 179.165 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.671 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 37.5 Cg_endo -79.95 167.82 74.06 Favored 'Cis proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.847 -1.73 . . . . 0.0 111.833 0.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.713 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -93.4 127.9 39.22 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.103 -179.423 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.513 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.3 t -105.0 140.67 22.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-O 124.207 1.956 . . . . 0.0 112.211 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.594 ' HG2' ' HA ' ' A' ' 44' ' ' ASN . 1.8 tmmt? -45.08 119.42 2.01 Favored 'General case' 0 C--N 1.273 -2.741 0 CA-C-N 111.534 -2.576 . . . . 0.0 116.776 -175.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.1 -16.19 22.82 Favored Glycine 0 C--N 1.293 -1.86 0 CA-C-N 111.772 -2.467 . . . . 0.0 107.98 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.63 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 16.2 mt-30 -75.56 126.39 30.93 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-O 123.292 1.52 . . . . 0.0 111.496 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.593 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 6.1 mt-30 -65.12 144.97 56.88 Favored 'General case' 0 C--N 1.271 -2.81 0 CA-C-N 113.299 -1.773 . . . . 0.0 107.692 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.904 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 19.6 m-85 -142.56 126.7 17.45 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.595 ' HB3' HG12 ' A' ' 40' ' ' VAL . 1.4 p30 -117.15 132.46 56.65 Favored 'General case' 0 C--N 1.276 -2.611 0 CA-C-O 122.925 1.345 . . . . 0.0 110.358 -177.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 1.121 HD12 ' CG2' ' A' ' 110' ' ' VAL . 0.4 OUTLIER -104.79 158.55 5.57 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 CA-C-N 114.186 -1.37 . . . . 0.0 108.42 179.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.474 ' HE2' ' HB3' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -144.39 145.27 31.84 Favored 'General case' 0 C--N 1.29 -2.021 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.465 -178.293 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.606 ' CE1' ' HB2' ' A' ' 92' ' ' TRP . 12.7 t80 -145.21 108.89 4.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.171 -0.956 . . . . 0.0 109.913 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.578 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 1.2 t -127.07 111.26 13.83 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.667 ' CZ3' HG23 ' A' ' 94' ' ' VAL 0.278 0.7 OUTLIER -142.83 114.46 8.03 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.173 -177.277 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 2.4 p-10 -75.08 157.08 35.35 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 119.172 -2.205 . . . . 0.0 109.411 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.827 HG12 ' HB2' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -147.49 167.65 13.02 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.128 -0.982 . . . . 0.0 108.457 -179.158 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.743 ' HD2' HG22 ' A' ' 94' ' ' VAL . 18.3 Cg_endo -37.33 152.83 0.03 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.188 0 O-C-N 123.835 1.439 . . . . 0.0 110.677 -177.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.894 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -79.81 -25.9 40.71 Favored 'General case' 0 C--N 1.286 -2.189 0 C-N-CA 116.508 -2.077 . . . . 0.0 115.175 -173.181 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.765 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -144.9 45.47 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 O-C-N 121.517 -0.74 . . . . 0.0 112.968 -178.224 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.927 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . . . -74.0 -59.4 1.79 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.53 -1.356 . . . . 0.0 110.627 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.927 ' HD3' ' HB3' ' A' ' 98' ' ' ALA . 47.9 Cg_endo -67.2 160.32 48.06 Favored 'Trans proline' 0 CA--C 1.462 -3.084 0 O-C-N 123.897 1.472 . . . . 0.0 110.474 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.716 ' HD2' ' C ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -107.28 102.29 11.6 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 112.493 -2.139 . . . . 0.0 110.136 -169.229 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.694 ' HB2' HD12 ' A' ' 127' ' ' ILE . 2.5 p -42.06 97.67 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 123.592 1.663 . . . . 0.0 110.042 -178.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.561 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.389 47.8 mt-10 -164.4 -53.0 0.03 OUTLIER 'General case' 0 CA--C 1.45 -2.877 0 CA-C-N 112.963 -1.926 . . . . 0.0 111.543 178.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.483 0.8 OUTLIER -161.25 82.05 0.62 Allowed 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 110.876 -2.875 . . . . 0.0 113.911 -161.879 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.889 HG22 ' HA ' ' A' ' 58' ' ' ILE . 20.1 t -143.39 139.1 26.46 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.65 0 C-N-CA 118.952 -1.099 . . . . 0.0 111.912 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.896 HG22 HD11 ' A' ' 121' ' ' ILE . 0.6 OUTLIER -142.5 132.07 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.392 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.552 ' O ' HG12 ' A' ' 121' ' ' ILE . 0.4 OUTLIER -99.1 143.46 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 122.594 1.188 . . . . 0.0 111.57 -179.028 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 1.071 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -131.59 118.34 19.96 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 179.556 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.073 HG13 ' HA ' ' A' ' 54' ' ' ILE . 3.4 t -132.38 139.53 49.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 120.22 -1.55 . . . . 0.0 108.583 -178.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.902 ' HB2' ' CB ' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -130.16 154.2 47.76 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.883 1.325 . . . . 0.0 111.623 -178.63 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 1.121 ' CG2' HD12 ' A' ' 88' ' ' ILE . 2.6 t -107.69 124.54 63.83 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.58 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 177.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.513 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 1.5 tmt? -103.71 120.39 40.85 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.554 ' HA3' HD23 ' A' ' 117' ' ' LEU . . . -74.93 -131.17 0.25 Allowed Glycine 0 C--N 1.281 -2.51 0 C-N-CA 119.06 -1.543 . . . . 0.0 114.671 -175.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.618 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 4.7 p-10 -97.94 8.65 44.4 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -175.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 33.5 p-10 -167.41 -14.89 0.02 OUTLIER 'General case' 0 C--N 1.265 -3.08 0 C-N-CA 117.475 -1.69 . . . . 0.0 114.428 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.447 ' O ' ' HG2' ' A' ' 111' ' ' MET . . . -152.39 -86.74 0.06 OUTLIER Glycine 0 CA--C 1.473 -2.572 0 CA-C-O 125.937 2.965 . . . . 0.0 111.971 -177.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.642 HG22 ' H ' ' A' ' 117' ' ' LEU . 4.2 p -141.23 178.67 2.7 Favored 'Isoleucine or valine' 1 C--N 1.228 -4.696 1 CA-C-N 108.168 -4.016 . . . . 0.0 110.807 -177.226 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.769 ' HB3' HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -148.55 -61.85 0.24 Allowed 'General case' 0 C--N 1.289 -2.06 0 O-C-N 121.873 -0.517 . . . . 0.0 111.277 -179.44 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 1.037 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -165.35 129.85 2.42 Favored 'General case' 0 N--CA 1.512 2.669 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.543 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.902 ' CB ' ' HB2' ' A' ' 109' ' ' LYS . 1.4 p -134.52 135.44 42.37 Favored 'General case' 0 C--N 1.284 -2.266 0 C-N-CA 118.064 -1.455 . . . . 0.0 113.09 -178.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.59 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -143.62 135.06 26.09 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 122.992 1.377 . . . . 0.0 112.599 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 1.071 ' HB ' HG23 ' A' ' 107' ' ' THR 0.272 0.0 OUTLIER -111.14 138.41 39.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 CA-C-N 114.143 -1.39 . . . . 0.0 110.961 -179.549 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.851 ' N ' HD13 ' A' ' 121' ' ' ILE . . . -131.14 159.76 36.73 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.858 -1.151 . . . . 0.0 109.062 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.673 ' HA ' HG23 ' A' ' 105' ' ' VAL . 25.6 p -94.15 -61.11 1.59 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.297 -1.502 . . . . 0.0 109.985 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.605 ' NE2' ' HB ' ' A' ' 18' ' ' VAL . 1.6 m-70 62.02 -55.77 0.13 Allowed 'General case' 0 N--CA 1.509 2.484 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.511 ' CB ' HG21 ' A' ' 29' ' ' ILE . . . -97.71 85.65 3.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.566 -1.334 . . . . 0.0 111.591 -178.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.551 ' HD3' ' HA ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -119.09 71.45 0.86 Allowed 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.694 HD12 ' HB2' ' A' ' 101' ' ' SER . 0.9 OUTLIER -64.52 120.99 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 O-C-N 120.669 -1.269 . . . . 0.0 111.245 -178.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.473 ' HD3' ' O ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -169.55 150.0 4.04 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.139 179.059 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.47 ' C ' ' O ' ' A' ' 128' ' ' ARG . 3.2 m-20 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.835 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.172 0.511 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.463 ' O ' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER 61.63 166.04 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 110.828 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.858 HG12 ' HA ' ' A' ' 22' ' ' HIS . 1.3 m -145.22 -175.64 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.45 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -77.68 133.68 38.3 Favored 'General case' 0 CA--C 1.48 -1.714 0 C-N-CA 117.839 -1.544 . . . . 0.0 108.84 178.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.521 ' O ' ' HG2' ' A' ' 6' ' ' LYS 0.435 0.4 OUTLIER -170.14 156.48 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 113.972 -1.467 . . . . 0.0 110.058 -169.627 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -146.76 145.77 30.06 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 123.772 1.749 . . . . 0.0 113.515 -178.671 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.276 1.9 t70 -74.28 149.3 40.78 Favored 'General case' 0 C--N 1.268 -2.956 0 CA-C-N 112.792 -2.004 . . . . 0.0 109.312 177.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.632 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 5.7 p -137.33 14.44 3.01 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.852 -1.155 . . . . 0.0 109.058 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.864 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -125.5 -82.52 0.63 Allowed 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 118.962 -1.095 . . . . 0.0 109.952 -177.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 12' ' ' GLU . 2.9 t30 -157.86 66.45 0.48 Allowed 'General case' 0 C--N 1.268 -2.952 0 C-N-CA 118.684 -1.206 . . . . 0.0 111.882 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.487 ' C ' ' O ' ' A' ' 10' ' ' ASN . 49.7 m170 33.4 33.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.845 0.831 . . . . 0.0 110.468 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 10' ' ' ASN . 38.1 mt-10 -93.77 21.12 6.79 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.68 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.027 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.297 0.1 OUTLIER -124.39 -167.3 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.895 0.855 . . . . 0.0 110.056 -178.685 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.649 ' H ' HG23 ' A' ' 13' ' ' ILE . 13.1 ptpt -162.15 -44.89 0.04 OUTLIER 'General case' 0 C--N 1.29 -1.997 0 O-C-N 121.792 -0.567 . . . . 0.0 111.503 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.553 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 36.4 tttt -148.49 142.57 25.97 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 115.881 -2.328 . . . . 0.0 114.21 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 1.094 HG13 ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -134.45 103.07 4.48 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 CA-C-O 122.983 1.373 . . . . 0.0 110.578 178.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.508 ' HA ' HD23 ' A' ' 17' ' ' LEU . 1.3 mt -96.11 133.18 40.7 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 113.994 -1.457 . . . . 0.0 111.465 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.894 HG22 ' HA ' ' A' ' 37' ' ' LEU . 93.1 t -140.83 145.71 40.9 Favored Pre-proline 0 N--CA 1.499 2.018 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.514 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.605 ' HD2' HG13 ' A' ' 18' ' ' VAL . 45.9 Cg_endo -72.42 101.23 1.23 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.815 1.429 . . . . 0.0 110.76 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.412 ' C ' ' CB ' ' A' ' 27' ' ' CYS . . . 157.79 -92.21 0.12 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.519 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 33.0 m -83.95 162.04 20.59 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.32 -1.106 . . . . 0.0 111.196 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.858 ' HA ' HG12 ' A' ' 3' ' ' VAL . 1.6 p-80 -142.41 16.89 2.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.903 -1.123 . . . . 0.0 109.206 178.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 173.18 -152.8 16.67 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.12 -8.76 25.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.571 -1.547 . . . . 0.0 109.805 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.806 ' CB ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -64.15 176.97 0.59 Allowed Pre-proline 0 C--N 1.3 -1.563 0 CA-C-O 125.012 2.339 . . . . 0.0 115.22 -179.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.806 ' HD3' ' CB ' ' A' ' 25' ' ' GLU . 25.6 Cg_endo -106.51 125.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.269 -3.647 1 C-N-CA 127.866 5.711 . . . . 0.0 110.736 -176.137 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 21' ' ' CYS . 21.4 p -124.45 119.36 28.96 Favored 'General case' 0 N--CA 1.505 2.28 0 CA-C-O 123.036 1.398 . . . . 0.0 112.648 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.46 ' O ' HG22 ' A' ' 28' ' ' ILE 0.315 32.2 mm -80.1 74.33 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-N 113.888 -1.506 . . . . 0.0 109.139 178.562 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.629 HD11 ' HG2' ' A' ' 34' ' ' PRO . 17.1 tt -42.84 121.74 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 122.78 1.276 . . . . 0.0 110.806 -178.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.587 ' CD2' ' HG3' ' A' ' 31' ' ' ARG . 34.8 p-80 -68.27 26.31 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 114.53 -1.213 . . . . 0.0 113.148 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.587 ' HG3' ' CD2' ' A' ' 30' ' ' HIS . 23.2 mtt85 -154.67 166.6 32.9 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.646 -1.284 . . . . 0.0 108.213 178.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.893 ' HA3' ' HA ' ' A' ' 96' ' ' LYS . . . -70.36 -94.28 0.06 OUTLIER Glycine 0 C--N 1.302 -1.348 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.754 ' HB2' HG12 ' A' ' 94' ' ' VAL . 0.6 OUTLIER -125.58 88.97 53.36 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 120.983 2.392 . . . . 0.0 115.62 -179.149 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.629 ' HG2' HD11 ' A' ' 29' ' ' ILE . 60.7 Cg_endo -108.13 142.35 0.06 OUTLIER 'Trans proline' 0 C--N 1.291 -2.488 0 C-N-CA 124.521 3.481 . . . . 0.0 107.719 176.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.481 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 10.1 m-85 -124.25 93.73 4.0 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 118.553 -1.259 . . . . 0.0 109.99 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.613 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 28.1 mp0 -112.8 86.22 2.32 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.894 ' HA ' HG22 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -110.33 141.33 43.51 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 120.576 -1.328 . . . . 0.0 109.093 179.294 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.92 132.49 28.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 1.094 ' HB2' HG13 ' A' ' 16' ' ' VAL . . . -142.14 154.39 44.84 Favored 'General case' 0 C--N 1.271 -2.829 0 CA-C-O 123.219 1.485 . . . . 0.0 113.404 -175.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.553 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.38 141.06 26.8 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 CA-C-N 113.43 -1.714 . . . . 0.0 108.805 178.714 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.556 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 3.7 p90 -157.96 124.58 4.87 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 21.8 tt0 -69.29 154.79 41.47 Favored 'General case' 0 C--N 1.285 -2.213 0 O-C-N 120.305 -1.497 . . . . 0.0 108.606 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.999 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -85.69 131.39 34.34 Favored 'General case' 0 C--N 1.265 -3.068 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.447 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.633 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 0.3 OUTLIER -113.8 48.79 1.04 Allowed 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 125.775 2.702 . . . . 0.0 114.358 179.816 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.581 ' C ' ' HB2' ' A' ' 82' ' ' LYS . 4.2 pt20 166.57 -161.63 0.01 OUTLIER 'General case' 0 C--N 1.26 -3.324 0 CA-C-N 108.502 -3.954 . . . . 0.0 112.845 175.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.422 ' C ' HG22 ' A' ' 47' ' ' THR 0.273 60.0 t30 -110.82 151.33 27.94 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-O 122.537 1.16 . . . . 0.0 108.958 -178.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.657 ' OG1' ' HB3' ' A' ' 113' ' ' ASP 0.252 0.0 OUTLIER -173.22 151.77 2.13 Favored 'General case' 0 C--N 1.255 -3.511 0 C-N-CA 118.581 -1.248 . . . . 0.0 112.545 -178.418 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.955 ' O ' HG23 ' A' ' 49' ' ' THR . 0.8 OUTLIER -111.59 10.69 21.18 Favored 'General case' 0 N--CA 1.51 2.568 0 C-N-CA 118.194 -1.402 . . . . 0.0 110.301 178.371 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.955 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -169.12 148.46 4.02 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 120.622 -1.299 . . . . 0.0 110.837 179.091 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 111' ' ' MET . . . -149.74 103.8 3.27 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 122.765 1.269 . . . . 0.0 110.949 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 0.7 OUTLIER -68.86 -174.94 0.64 Allowed 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.432 178.664 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.955 ' CG2' HD11 ' A' ' 88' ' ' ILE . 35.7 mt -141.93 140.84 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.388 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 5.6 tm-20 -139.92 107.58 5.62 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 123.284 1.516 . . . . 0.0 110.186 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 1.057 ' HA ' HG13 ' A' ' 108' ' ' VAL . 0.1 OUTLIER -92.63 128.38 44.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 CA-C-N 112.644 -2.071 . . . . 0.0 107.362 178.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.897 ' N ' HD13 ' A' ' 54' ' ' ILE . 1.1 tttt -128.09 141.86 51.37 Favored 'General case' 0 C--N 1.272 -2.802 0 C-N-CA 118.75 -1.18 . . . . 0.0 107.855 178.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 1.071 ' HB3' HG22 ' A' ' 63' ' ' VAL . . . -135.44 134.35 39.53 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 119.917 -1.739 . . . . 0.0 112.309 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.742 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 0.5 OUTLIER -107.22 99.5 9.04 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 177.285 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.924 ' HA ' HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -112.12 101.41 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.803 0 CA-C-O 123.305 1.526 . . . . 0.0 110.758 -176.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.544 ' N ' HG22 ' A' ' 104' ' ' VAL . 1.4 p30 37.59 64.36 0.66 Allowed 'General case' 0 N--CA 1.521 3.077 0 CA-C-N 114.991 -1.004 . . . . 0.0 113.06 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.73 -17.04 9.41 Favored Glycine 0 N--CA 1.488 2.114 0 O-C-N 121.264 -0.897 . . . . 0.0 111.546 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.532 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.272 0.2 OUTLIER -107.87 58.16 0.62 Allowed 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.197 -1.178 . . . . 0.0 111.576 -178.336 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.605 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.367 0.0 OUTLIER -60.01 116.75 4.38 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.958 0.885 . . . . 0.0 111.012 -179.904 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 1.071 HG22 ' HB3' ' A' ' 56' ' ' ALA . 13.8 m -75.8 146.61 8.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-O 122.547 1.165 . . . . 0.0 110.805 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.441 6.7 t70 -138.16 76.89 1.6 Allowed 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.192 -176.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.56 HG22 ' HD2' ' A' ' 66' ' ' PRO . 8.6 p -164.37 150.75 9.52 Favored Pre-proline 0 C--N 1.274 -2.692 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.42 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.56 ' HD2' HG22 ' A' ' 65' ' ' VAL . 44.6 Cg_endo -86.68 139.23 5.58 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 CA-C-O 123.887 1.536 . . . . 0.0 111.531 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.614 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -127.82 52.49 0.82 Allowed Glycine 0 C--N 1.273 -2.946 0 CA-C-N 112.498 -2.137 . . . . 0.0 110.432 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.642 ' HB ' ' CD2' ' A' ' 90' ' ' TYR 0.296 4.4 tp 179.96 -177.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 120.194 -1.768 . . . . 0.0 110.534 -178.677 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.523 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 12.9 t0 -112.3 83.47 5.26 Favored Pre-proline 0 N--CA 1.504 2.237 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 175.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.711 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 20.9 Cg_endo -48.59 -6.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.287 -2.706 0 C-N-CA 124.453 3.435 . . . . 0.0 116.245 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.583 ' HB2' ' NE2' ' A' ' 74' ' ' HIS . 5.1 m-80 -101.77 91.77 4.54 Favored 'General case' 0 C--N 1.284 -2.266 0 O-C-N 120.167 -1.583 . . . . 0.0 109.006 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.724 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . . . -76.33 7.29 4.47 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.431 -0.793 . . . . 0.0 109.52 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 8.3 t -79.05 -24.15 43.76 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 120.886 -1.134 . . . . 0.0 108.94 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.583 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 1.1 m-70 -80.1 8.11 7.85 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.022 -1.071 . . . . 0.0 109.066 176.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.724 ' CD2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -133.19 -2.83 3.13 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 121.365 -0.834 . . . . 0.0 110.217 177.547 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.446 ' O ' ' HG2' ' A' ' 76' ' ' MET . 2.4 ptt? -155.07 129.61 9.14 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 123.984 1.849 . . . . 0.0 113.678 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.465 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 13.9 pttt -21.85 102.6 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 111.89 -2.414 . . . . 0.0 113.365 -178.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 48' ' ' LYS 0.318 0.1 OUTLIER -99.04 146.64 32.03 Favored Pre-proline 0 C--N 1.265 -3.066 0 CA-C-N 111.522 -2.581 . . . . 0.0 108.79 178.609 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.641 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 37.2 Cg_endo -86.66 167.35 46.64 Favored 'Cis proline' 0 C--N 1.311 -1.412 0 C-N-CA 123.1 -1.625 . . . . 0.0 111.447 0.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.724 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -90.54 125.96 35.78 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 122.02 0.914 . . . . 0.0 110.95 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.507 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.3 t -104.47 137.76 32.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-O 124.248 1.975 . . . . 0.0 111.779 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.633 ' HG2' ' HA ' ' A' ' 44' ' ' ASN . 1.6 tmmt? -43.37 115.62 0.8 Allowed 'General case' 0 C--N 1.271 -2.844 0 CA-C-N 111.737 -2.483 . . . . 0.0 116.243 -175.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 118.2 -18.34 11.26 Favored Glycine 0 C--N 1.29 -1.983 0 CA-C-N 111.74 -2.482 . . . . 0.0 108.198 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.609 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 8.4 mt-30 -73.3 126.27 29.74 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-O 123.124 1.44 . . . . 0.0 111.797 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.583 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -63.3 143.03 58.15 Favored 'General case' 0 C--N 1.271 -2.818 0 CA-C-N 113.57 -1.65 . . . . 0.0 107.855 179.225 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.999 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 21.3 m-85 -143.58 127.5 17.34 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.534 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 1.4 p-10 -117.51 132.53 56.53 Favored 'General case' 0 C--N 1.277 -2.561 0 CA-C-O 122.775 1.274 . . . . 0.0 110.401 -178.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 1.043 HD12 ' CG2' ' A' ' 110' ' ' VAL . 0.3 OUTLIER -102.31 159.98 4.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.402 179.368 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.75 144.84 32.8 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.941 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.642 ' CD2' ' HB ' ' A' ' 68' ' ' ILE . 32.3 t80 -149.02 102.36 3.25 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.772 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.613 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 0.6 OUTLIER -121.68 114.76 21.59 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 179.253 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.614 ' CD1' ' O ' ' A' ' 67' ' ' GLY 0.264 0.2 OUTLIER -141.86 108.42 5.33 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.913 -177.405 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.524 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 11.7 m120 -75.46 155.54 36.15 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 119.696 -1.878 . . . . 0.0 109.753 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.754 HG12 ' HB2' ' A' ' 33' ' ' LYS . 1.0 OUTLIER -153.79 169.98 9.07 Favored Pre-proline 0 N--CA 1.487 1.389 0 O-C-N 120.746 -1.221 . . . . 0.0 108.676 -178.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.751 ' CD ' HG13 ' A' ' 94' ' ' VAL . 17.8 Cg_endo -38.29 154.73 0.03 OUTLIER 'Trans proline' 0 CA--C 1.497 -1.332 0 O-C-N 123.424 1.223 . . . . 0.0 110.853 -177.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.893 ' HA ' ' HA3' ' A' ' 32' ' ' GLY . 3.1 mptt -80.73 -27.22 36.94 Favored 'General case' 0 C--N 1.283 -2.32 0 C-N-CA 116.622 -2.031 . . . . 0.0 116.201 -173.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.762 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -141.89 42.02 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.977 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . . . -62.65 -56.93 25.08 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 120.419 -1.425 . . . . 0.0 109.562 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.977 ' HD3' ' HB3' ' A' ' 98' ' ' ALA . 56.9 Cg_endo -78.12 162.78 28.53 Favored 'Trans proline' 0 CA--C 1.463 -3.063 0 O-C-N 123.896 1.472 . . . . 0.0 110.57 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.73 ' HD2' ' C ' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -107.21 112.43 25.3 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-N 112.095 -2.32 . . . . 0.0 110.28 -169.755 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.816 ' HB3' HG22 ' A' ' 127' ' ' ILE . 2.5 p -45.35 97.7 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.612 0 CA-C-O 123.606 1.669 . . . . 0.0 109.342 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.402 40.9 mt-10 -163.54 -52.01 0.04 OUTLIER 'General case' 0 CA--C 1.448 -2.975 0 CA-C-N 112.818 -1.992 . . . . 0.0 111.304 179.442 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.482 0.8 OUTLIER -160.29 79.73 0.67 Allowed 'General case' 0 C--N 1.285 -2.202 0 CA-C-N 110.949 -2.842 . . . . 0.0 113.932 -162.311 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.924 HG22 ' HA ' ' A' ' 58' ' ' ILE . 22.0 t -145.13 141.24 22.88 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.65 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.743 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 1.074 ' CG1' HD11 ' A' ' 121' ' ' ILE . 3.0 t -153.89 137.63 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.705 ' CG2' HD11 ' A' ' 54' ' ' ILE . 0.3 OUTLIER -105.58 148.3 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 122.653 1.216 . . . . 0.0 112.675 -178.409 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.974 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -132.04 118.98 20.4 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 178.099 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.057 HG13 ' HA ' ' A' ' 54' ' ' ILE . 3.4 t -132.54 138.72 51.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 120.186 -1.571 . . . . 0.0 108.389 -177.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 1.019 ' HB2' ' HB2' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -135.6 148.64 49.11 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 122.414 1.102 . . . . 0.0 111.549 -178.072 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 1.043 ' CG2' HD12 ' A' ' 88' ' ' ILE . 3.5 t -97.76 129.81 47.38 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.553 ' SD ' ' HA2' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -107.7 118.2 36.12 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -78.92 -138.13 1.43 Allowed Glycine 0 N--CA 1.498 2.778 0 C-N-CA 119.177 -1.487 . . . . 0.0 114.917 -174.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.657 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 6.8 p-10 -80.79 -3.66 51.81 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 122.275 1.036 . . . . 0.0 112.323 -176.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.403 ' OD2' ' OD1' ' A' ' 113' ' ' ASP . 1.4 p30 -133.21 -4.65 3.05 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.738 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.605 ' O ' ' CB ' ' A' ' 116' ' ' VAL . . . 92.29 85.9 1.51 Allowed Glycine 0 CA--C 1.471 -2.688 0 CA-C-O 124.797 2.332 . . . . 0.0 110.399 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.605 ' CB ' ' O ' ' A' ' 115' ' ' GLY . 7.2 p 137.9 148.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.25 -3.757 0 CA-C-N 108.27 -3.965 . . . . 0.0 111.837 177.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.807 ' CB ' HG12 ' A' ' 110' ' ' VAL . 0.3 OUTLIER -161.45 -59.8 0.05 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.479 -0.763 . . . . 0.0 110.739 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 1.027 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -169.88 134.29 1.3 Allowed 'General case' 0 N--CA 1.513 2.705 0 O-C-N 121.124 -0.985 . . . . 0.0 109.489 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 1.019 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 0.8 OUTLIER -133.71 139.76 46.6 Favored 'General case' 0 C--N 1.28 -2.418 0 C-N-CA 117.624 -1.63 . . . . 0.0 113.744 -178.02 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.742 ' HB2' HD13 ' A' ' 13' ' ' ILE . . . -142.61 131.58 23.01 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 123.066 1.413 . . . . 0.0 111.489 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 1.074 HD11 ' CG1' ' A' ' 105' ' ' VAL 0.272 0.0 OUTLIER -108.7 131.06 60.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.613 -179.218 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.63 ' N ' HD13 ' A' ' 121' ' ' ILE . . . -131.63 -175.04 3.58 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.827 -1.17 . . . . 0.0 108.895 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.637 ' O ' ' CG ' ' A' ' 124' ' ' HIS . 5.5 p -90.51 -65.84 0.98 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.308 -1.495 . . . . 0.0 110.307 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.637 ' CG ' ' O ' ' A' ' 123' ' ' THR . 21.2 m170 132.82 -84.88 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.253 0 C-N-CA 123.759 0.823 . . . . 0.0 110.043 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.448 ' CB ' ' HB ' ' A' ' 29' ' ' ILE . . . -167.7 171.71 9.89 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.383 0.611 . . . . 0.0 109.429 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -108.63 -177.08 3.22 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.816 HG22 ' HB3' ' A' ' 101' ' ' SER . 0.3 OUTLIER -153.22 130.07 2.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 O-C-N 120.706 -1.246 . . . . 0.0 113.061 -178.13 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.473 ' HD3' ' O ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -169.5 151.7 4.51 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.589 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.459 ' C ' ' O ' ' A' ' 128' ' ' ARG . 2.7 m-20 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.667 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.7 t . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.321 0.581 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.48 ' O ' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -47.43 169.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.321 -0.862 . . . . 0.0 111.003 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.765 HG12 ' HA ' ' A' ' 22' ' ' HIS . 1.3 m -145.8 174.03 3.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 O-C-N 120.884 -1.135 . . . . 0.0 107.967 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.481 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -80.82 140.05 35.66 Favored 'General case' 0 CA--C 1.478 -1.82 0 C-N-CA 117.968 -1.493 . . . . 0.0 108.66 177.31 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.524 HG11 ' CG2' ' A' ' 16' ' ' VAL 0.422 0.4 OUTLIER -166.44 -178.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 C-N-CA 118.021 -1.472 . . . . 0.0 110.933 -170.135 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 5' ' ' VAL . 18.5 mtmt -153.69 141.65 20.24 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 123.812 1.767 . . . . 0.0 112.823 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.271 13.8 t70 -79.09 149.45 32.08 Favored 'General case' 0 C--N 1.266 -3.049 0 CA-C-N 113.032 -1.894 . . . . 0.0 109.442 178.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.642 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 7.3 p -137.27 14.26 3.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.981 -1.074 . . . . 0.0 109.529 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.806 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -126.16 -83.98 0.62 Allowed 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 119.014 -1.074 . . . . 0.0 110.17 -177.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 12' ' ' GLU . 2.4 t30 -155.97 64.73 0.58 Allowed 'General case' 0 C--N 1.269 -2.898 0 C-N-CA 118.519 -1.272 . . . . 0.0 111.62 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.473 ' C ' ' O ' ' A' ' 10' ' ' ASN . 6.2 m80 32.57 32.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.725 0.774 . . . . 0.0 110.697 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.9 OUTLIER -93.42 22.35 5.37 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.485 -0.886 . . . . 0.0 111.889 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.973 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.272 0.1 OUTLIER -116.76 -168.09 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 CA-C-O 122.027 0.918 . . . . 0.0 110.741 -179.035 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.659 ' N ' HG23 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -162.2 -45.46 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.732 179.831 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.569 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 28.9 tttt -146.59 136.12 22.99 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 116.116 -2.234 . . . . 0.0 113.246 178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.971 HG12 ' HB2' ' A' ' 39' ' ' ALA . 0.9 OUTLIER -132.61 102.9 5.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 CA-C-O 123.041 1.4 . . . . 0.0 110.817 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.514 ' HA ' HD23 ' A' ' 17' ' ' LEU . 1.4 mt -93.62 126.04 38.57 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.933 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.8 HG22 ' HA ' ' A' ' 37' ' ' LEU . 75.3 t -142.52 145.08 33.07 Favored Pre-proline 0 N--CA 1.502 2.137 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.756 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.656 ' HD2' HG13 ' A' ' 18' ' ' VAL . 47.4 Cg_endo -72.0 137.08 28.56 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 O-C-N 123.691 1.364 . . . . 0.0 110.893 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.437 ' C ' ' HB3' ' A' ' 27' ' ' CYS . . . 112.99 -80.1 0.27 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.564 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 2.4 m -87.81 131.31 34.57 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.553 -0.969 . . . . 0.0 109.557 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.765 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -137.4 14.83 2.99 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 119.905 -1.747 . . . . 0.0 110.865 179.489 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.88 -154.58 15.4 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 118.287 -1.911 . . . . 0.0 110.815 177.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.18 -10.84 34.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.819 -1.401 . . . . 0.0 109.457 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.789 ' CB ' ' HD3' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -64.11 177.01 0.58 Allowed Pre-proline 0 C--N 1.299 -1.61 0 CA-C-O 124.946 2.308 . . . . 0.0 114.431 179.546 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.789 ' HD3' ' CB ' ' A' ' 25' ' ' GLU . 24.7 Cg_endo -105.73 115.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.263 -3.969 1 C-N-CA 127.459 5.44 . . . . 0.0 110.333 -176.336 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.564 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 1.9 p -94.94 103.37 15.23 Favored 'General case' 0 N--CA 1.505 2.319 0 CA-C-O 123.171 1.462 . . . . 0.0 110.821 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.589 ' O ' HG22 ' A' ' 28' ' ' ILE 0.304 28.9 mm -82.17 68.25 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 113.706 -1.588 . . . . 0.0 110.369 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.608 ' O ' HG23 ' A' ' 29' ' ' ILE . 9.4 tt -43.49 115.48 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-O 122.632 1.206 . . . . 0.0 109.481 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -66.69 -89.97 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 114.704 -1.134 . . . . 0.0 111.283 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.7 mtt-85 -149.9 165.65 31.94 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.374 -0.829 . . . . 0.0 110.292 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.839 ' HA2' ' HA ' ' A' ' 96' ' ' LYS . . . 85.42 121.61 1.12 Allowed Glycine 0 C--N 1.303 -1.291 0 N-CA-C 106.112 -2.795 . . . . 0.0 106.112 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.81 ' HB2' HG12 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -116.76 96.59 48.9 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 120.666 2.233 . . . . 0.0 116.354 -175.103 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.607 ' HD3' ' O ' ' A' ' 32' ' ' GLY . 61.6 Cg_endo -107.6 144.97 0.08 OUTLIER 'Trans proline' 0 C--N 1.289 -2.588 0 C-N-CA 124.081 3.187 . . . . 0.0 109.021 177.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' A' ' 91' ' ' THR . 2.8 m-85 -117.69 98.35 6.33 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.022 -1.071 . . . . 0.0 108.538 178.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.636 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 25.6 mp0 -117.39 91.25 3.52 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.53 -0.731 . . . . 0.0 109.687 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.971 HD22 ' NE2' ' A' ' 124' ' ' HIS . 0.1 OUTLIER -108.31 135.72 49.15 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.489 -1.382 . . . . 0.0 108.341 179.496 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' A' ' 17' ' ' LEU . 0.1 OUTLIER -139.31 128.11 23.41 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.971 ' HB2' HG12 ' A' ' 16' ' ' VAL . . . -142.48 152.05 42.32 Favored 'General case' 0 C--N 1.276 -2.602 0 CA-C-O 123.067 1.413 . . . . 0.0 113.405 -175.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.569 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.74 140.77 28.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 113.763 -1.562 . . . . 0.0 108.612 178.286 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.582 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 3.5 p90 -157.21 121.47 4.32 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -178.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 12.3 tt0 -68.72 155.12 40.7 Favored 'General case' 0 C--N 1.288 -2.089 0 O-C-N 120.416 -1.428 . . . . 0.0 108.918 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.951 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -88.14 136.84 32.79 Favored 'General case' 0 C--N 1.267 -3.01 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.402 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.623 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -117.81 49.96 1.18 Allowed 'General case' 0 CA--C 1.486 -1.506 0 CA-C-O 125.454 2.55 . . . . 0.0 114.033 179.318 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.586 ' N ' ' CG ' ' A' ' 82' ' ' LYS . 7.1 pt20 167.12 -160.52 0.01 OUTLIER 'General case' 0 C--N 1.258 -3.37 0 CA-C-N 108.914 -3.767 . . . . 0.0 112.92 175.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.457 ' OD1' ' N ' ' A' ' 47' ' ' THR 0.265 41.2 t-20 -109.2 153.69 23.43 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-O 122.588 1.185 . . . . 0.0 108.754 -178.901 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.64 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -173.14 156.21 3.16 Favored 'General case' 0 C--N 1.255 -3.541 0 C-N-CA 118.473 -1.291 . . . . 0.0 112.5 -178.28 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.958 ' O ' HG23 ' A' ' 49' ' ' THR . 9.5 mtpt -112.41 5.8 18.32 Favored 'General case' 0 N--CA 1.509 2.501 0 O-C-N 120.747 -1.221 . . . . 0.0 111.184 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.958 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -168.41 149.13 4.79 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.369 -1.457 . . . . 0.0 111.611 179.653 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.542 ' O ' ' O ' ' A' ' 70' ' ' PRO . . . -142.82 99.76 3.53 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 122.574 1.178 . . . . 0.0 110.871 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 9.9 mttt -69.31 -178.01 1.25 Allowed 'General case' 0 N--CA 1.506 2.338 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.913 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.983 ' CG2' HD11 ' A' ' 88' ' ' ILE . 35.8 mt -140.99 137.8 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.665 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.665 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.583 ' HB3' ' CE ' ' A' ' 109' ' ' LYS . 4.0 tt0 -141.51 112.19 7.13 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 123.261 1.505 . . . . 0.0 111.239 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 1.027 HD12 HG21 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -91.88 127.54 44.1 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 CA-C-N 112.79 -2.005 . . . . 0.0 110.296 179.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.435 ' HD2' ' HG2' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -122.9 101.7 7.59 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 176.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.911 ' HB3' HG22 ' A' ' 63' ' ' VAL . . . -112.81 133.31 54.87 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.843 -1.16 . . . . 0.0 113.178 -175.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.722 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 0.3 OUTLIER -109.49 102.35 11.23 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 177.811 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.966 ' HA ' HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -112.55 97.81 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.863 0 CA-C-O 123.423 1.582 . . . . 0.0 110.746 -177.258 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.727 ' OD1' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER 39.14 65.37 0.68 Allowed 'General case' 0 N--CA 1.52 3.061 0 CA-C-N 114.641 -1.163 . . . . 0.0 113.112 179.236 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.16 -18.34 10.22 Favored Glycine 0 N--CA 1.487 2.093 0 O-C-N 121.378 -0.826 . . . . 0.0 111.481 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.53 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.267 0.3 OUTLIER -107.7 58.67 0.62 Allowed 'General case' 0 C--N 1.293 -1.873 0 O-C-N 121.092 -1.24 . . . . 0.0 111.513 -178.453 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.365 0.0 OUTLIER -63.42 113.19 3.11 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.045 0.926 . . . . 0.0 110.912 -179.78 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.911 HG22 ' HB3' ' A' ' 56' ' ' ALA . 15.3 m -72.73 142.56 14.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-O 122.504 1.145 . . . . 0.0 110.731 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.434 7.9 t70 -138.3 64.88 1.48 Allowed 'General case' 0 C--N 1.277 -2.552 0 CA-C-O 122.619 1.199 . . . . 0.0 110.73 -176.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.583 HG22 ' HD2' ' A' ' 66' ' ' PRO . 8.2 p -164.47 151.64 10.04 Favored Pre-proline 0 C--N 1.269 -2.918 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.005 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.583 ' HD2' HG22 ' A' ' 65' ' ' VAL . 45.5 Cg_endo -82.39 139.64 10.43 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 CA-C-O 123.886 1.536 . . . . 0.0 112.221 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.615 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -133.36 60.11 0.67 Allowed Glycine 0 N--CA 1.501 2.991 0 CA-C-N 112.291 -2.231 . . . . 0.0 109.0 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.641 ' HB ' ' CD2' ' A' ' 90' ' ' TYR 0.272 0.2 OUTLIER 163.93 -177.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.326 -1.103 . . . . 0.0 108.179 -178.074 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.575 ' N ' ' CG2' ' A' ' 68' ' ' ILE . 0.4 OUTLIER -107.53 140.43 21.52 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 105.728 -1.952 . . . . 0.0 105.728 175.084 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.76 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 23.2 Cg_endo -105.39 -3.02 0.17 Allowed 'Trans proline' 0 C--N 1.273 -3.427 0 C-N-CA 122.945 2.43 . . . . 0.0 114.155 -173.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.572 ' HB2' ' NE2' ' A' ' 74' ' ' HIS . 0.2 OUTLIER -107.91 96.6 6.49 Favored 'General case' 0 C--N 1.285 -2.234 0 O-C-N 120.765 -1.209 . . . . 0.0 108.532 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.761 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . . . -77.4 10.7 2.36 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.195 -0.94 . . . . 0.0 108.897 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.7 t -77.34 -24.96 50.66 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 120.984 -1.072 . . . . 0.0 108.209 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.572 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 0.5 OUTLIER -83.25 11.62 6.37 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.444 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.761 ' CD2' ' HA ' ' A' ' 72' ' ' ALA . 1.3 m-85 -132.03 -6.18 3.5 Favored 'General case' 0 C--O 1.215 -0.731 0 O-C-N 121.744 -0.598 . . . . 0.0 110.151 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.452 ' O ' ' C ' ' A' ' 77' ' ' LYS . 2.8 ptt? -161.1 131.26 5.03 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 123.915 1.817 . . . . 0.0 113.973 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.55 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 9.3 pttt -16.76 99.36 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 111.801 -2.454 . . . . 0.0 113.462 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 48' ' ' LYS 0.325 0.5 OUTLIER -99.12 140.22 21.55 Favored Pre-proline 0 C--N 1.264 -3.124 0 CA-C-N 111.548 -2.569 . . . . 0.0 108.613 178.272 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.64 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 36.0 Cg_endo -82.68 170.01 58.21 Favored 'Cis proline' 0 C--N 1.312 -1.384 0 C-N-CA 123.457 -1.476 . . . . 0.0 112.277 0.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.69 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -95.28 129.67 42.33 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.771 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.54 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 2.4 p -108.3 138.21 36.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 124.299 2.0 . . . . 0.0 112.05 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.623 ' HG2' ' HA ' ' A' ' 44' ' ' ASN . 1.7 tmmt? -42.09 117.42 0.97 Allowed 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 111.606 -2.543 . . . . 0.0 116.614 -175.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.25 -17.6 14.44 Favored Glycine 0 C--N 1.293 -1.83 0 CA-C-N 111.714 -2.494 . . . . 0.0 107.945 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 8.2 mt-30 -72.52 126.36 29.66 Favored 'General case' 0 C--N 1.278 -2.525 0 CA-C-O 123.199 1.476 . . . . 0.0 111.633 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.607 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 3.5 mt-30 -64.57 143.31 58.01 Favored 'General case' 0 C--N 1.27 -2.872 0 CA-C-N 113.385 -1.734 . . . . 0.0 107.927 178.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.951 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 19.9 m-85 -142.3 125.25 16.16 Favored 'General case' 0 C--N 1.279 -2.472 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.545 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 1.1 p30 -117.4 132.46 56.57 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-O 122.776 1.274 . . . . 0.0 110.088 -177.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 1.053 HD12 ' CG2' ' A' ' 110' ' ' VAL . 0.3 OUTLIER -101.29 157.84 4.25 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.196 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.422 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -147.24 141.37 26.09 Favored 'General case' 0 C--N 1.286 -2.189 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.133 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.645 ' CE1' ' HB2' ' A' ' 92' ' ' TRP . 3.0 t80 -144.04 112.52 6.5 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.276 -0.89 . . . . 0.0 108.894 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.596 ' CB ' ' HG3' ' A' ' 36' ' ' GLN . 0.6 OUTLIER -131.41 115.68 16.53 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 179.09 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.645 ' HB2' ' CE1' ' A' ' 90' ' ' TYR 0.266 0.5 OUTLIER -141.89 111.81 6.78 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.513 -176.666 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 2.5 p-10 -74.67 159.49 32.02 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 119.378 -2.077 . . . . 0.0 109.361 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.84 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.8 OUTLIER -153.0 172.16 5.94 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.083 -1.011 . . . . 0.0 108.835 -178.296 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.84 ' HD2' HG22 ' A' ' 94' ' ' VAL . 17.0 Cg_endo -37.53 152.32 0.04 OUTLIER 'Trans proline' 0 CA--C 1.498 -1.286 0 O-C-N 123.785 1.413 . . . . 0.0 110.045 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.839 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -79.04 -23.22 44.44 Favored 'General case' 0 C--N 1.282 -2.362 0 C-N-CA 116.622 -2.031 . . . . 0.0 115.068 -172.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.763 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -138.75 43.07 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-O 121.398 0.618 . . . . 0.0 112.618 -178.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.943 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . . . -70.04 -67.62 0.65 Allowed Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 120.686 -1.259 . . . . 0.0 110.654 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.943 ' HD3' ' HB3' ' A' ' 98' ' ' ALA . 47.7 Cg_endo -66.51 160.4 46.01 Favored 'Trans proline' 0 CA--C 1.461 -3.133 0 O-C-N 123.676 1.356 . . . . 0.0 110.228 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.707 ' HD2' ' C ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -109.16 106.49 16.39 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-N 112.497 -2.138 . . . . 0.0 110.301 -169.453 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.664 ' O ' HG21 ' A' ' 127' ' ' ILE . 5.3 p -46.25 97.16 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 CA-C-O 123.612 1.673 . . . . 0.0 109.031 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.392 84.8 mt-10 -164.95 -52.4 0.03 OUTLIER 'General case' 0 CA--C 1.45 -2.893 0 CA-C-N 112.975 -1.921 . . . . 0.0 111.461 179.659 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.569 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.489 0.7 OUTLIER -160.73 83.5 0.67 Allowed 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 110.681 -2.963 . . . . 0.0 113.608 -162.045 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.966 HG22 ' HA ' ' A' ' 58' ' ' ILE . 32.4 t -143.21 134.23 23.0 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 C-N-CA 119.103 -1.039 . . . . 0.0 112.308 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 1.073 HG13 HD11 ' A' ' 121' ' ' ILE . 0.6 OUTLIER -140.54 130.61 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.555 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.801 HG23 ' HB2' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -105.46 141.9 19.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-O 122.344 1.069 . . . . 0.0 111.393 -179.271 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 1.068 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -132.6 109.14 9.53 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 179.509 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.027 HG21 HD12 ' A' ' 54' ' ' ILE . 3.4 t -127.61 141.91 45.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 117.802 -1.559 . . . . 0.0 109.16 -177.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.851 ' HB2' ' CB ' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -131.03 152.84 49.9 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 122.904 1.335 . . . . 0.0 112.938 -178.774 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 1.053 ' CG2' HD12 ' A' ' 88' ' ' ILE . 3.8 t -102.61 124.55 56.67 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 176.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.544 ' HG2' ' O ' ' A' ' 111' ' ' MET . 2.1 ptm -104.86 121.76 44.35 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.598 ' HA3' HD23 ' A' ' 117' ' ' LEU . . . -79.83 -137.35 1.62 Allowed Glycine 0 N--CA 1.496 2.662 0 C-N-CA 118.931 -1.604 . . . . 0.0 114.01 -175.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.64 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 13.4 p-10 -79.8 -4.93 54.23 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 122.393 1.092 . . . . 0.0 111.986 -177.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 10.8 p30 -128.9 -4.61 5.12 Favored 'General case' 0 C--N 1.268 -2.96 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.933 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.58 ' O ' ' HB ' ' A' ' 116' ' ' VAL . . . 86.81 84.0 1.13 Allowed Glycine 0 CA--C 1.471 -2.718 0 CA-C-O 124.875 2.375 . . . . 0.0 109.669 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.58 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 6.9 p 145.97 145.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.246 -3.913 0 CA-C-N 108.281 -3.96 . . . . 0.0 111.204 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.742 ' CB ' HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -162.21 -59.51 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.378 -0.826 . . . . 0.0 110.651 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.973 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -168.25 129.17 1.33 Allowed 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.851 ' CB ' ' HB2' ' A' ' 109' ' ' LYS . 0.8 OUTLIER -134.29 141.32 46.91 Favored 'General case' 0 C--N 1.284 -2.274 0 C-N-CA 118.004 -1.478 . . . . 0.0 113.097 -177.703 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.69 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -146.53 137.28 24.07 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 123.159 1.456 . . . . 0.0 112.468 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 1.073 HD11 HG13 ' A' ' 105' ' ' VAL 0.265 0.1 OUTLIER -112.23 133.24 58.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 113.908 -1.497 . . . . 0.0 110.912 -179.78 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.766 ' N ' HD13 ' A' ' 121' ' ' ILE . . . -130.56 177.87 7.05 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.743 -1.223 . . . . 0.0 108.858 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.547 ' O ' ' HB2' ' A' ' 124' ' ' HIS . 16.0 p -95.78 -33.14 12.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.409 -1.432 . . . . 0.0 110.565 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.971 ' NE2' HD22 ' A' ' 37' ' ' LEU . 24.5 m80 63.09 -56.17 0.17 Allowed 'General case' 0 N--CA 1.511 2.602 0 O-C-N 121.795 -0.566 . . . . 0.0 111.687 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' A' ' 123' ' ' THR . . . -128.88 106.22 8.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.023 -1.048 . . . . 0.0 110.695 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.443 ' CG ' ' HB ' ' A' ' 123' ' ' THR . 1.8 mtpm? -114.9 79.45 1.27 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.924 -1.11 . . . . 0.0 109.296 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.664 HG21 ' O ' ' A' ' 101' ' ' SER . 0.8 OUTLIER -85.0 123.79 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 120.51 -1.368 . . . . 0.0 111.279 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.488 ' HD3' ' O ' ' A' ' 127' ' ' ILE . 4.2 tpp180 -169.08 151.01 4.59 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.162 179.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 1.3 m-20 . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.151 -0.968 . . . . 0.0 110.93 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 121.218 0.532 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.492 ' O ' ' O ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -73.98 168.18 20.01 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.209 -0.932 . . . . 0.0 110.851 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.667 HG12 ' HA ' ' A' ' 22' ' ' HIS . 1.4 m -148.72 174.7 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.496 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -80.12 139.86 36.66 Favored 'General case' 0 CA--C 1.482 -1.647 0 C-N-CA 118.097 -1.441 . . . . 0.0 108.396 177.042 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.503 ' C ' ' CG ' ' A' ' 6' ' ' LYS 0.434 0.4 OUTLIER -166.33 -175.31 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.406 -169.992 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.556 ' HB2' ' CG2' ' A' ' 121' ' ' ILE . 1.6 mttt -153.91 138.86 17.22 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 123.565 1.65 . . . . 0.0 112.577 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . 0.285 3.5 t70 -84.67 148.83 26.2 Favored 'General case' 0 C--N 1.27 -2.881 0 CA-C-N 113.381 -1.736 . . . . 0.0 109.732 178.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.621 ' C ' ' SG ' ' A' ' 119' ' ' CYS . 5.3 p -137.43 13.14 3.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.007 -1.058 . . . . 0.0 109.469 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.837 ' HB2' ' SG ' ' A' ' 119' ' ' CYS . . . -126.33 -85.58 0.61 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 118.586 -1.246 . . . . 0.0 110.026 -177.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 12' ' ' GLU . 2.5 t30 -160.29 67.1 0.35 Allowed 'General case' 0 C--N 1.265 -3.083 0 C-N-CA 118.578 -1.249 . . . . 0.0 111.935 177.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.467 ' C ' ' O ' ' A' ' 10' ' ' ASN . 11.0 m-70 34.36 32.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.765 0.793 . . . . 0.0 110.42 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 10' ' ' ASN . 0.1 OUTLIER -86.92 20.4 2.64 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.475 0.655 . . . . 0.0 110.739 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.896 HG13 ' HB1' ' A' ' 118' ' ' ALA 0.289 0.0 OUTLIER -121.79 -166.89 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-O 121.989 0.9 . . . . 0.0 110.834 -178.215 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.649 ' H ' HG23 ' A' ' 13' ' ' ILE . 1.7 pttt -161.88 -44.08 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.996 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.57 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 11.3 tttm -149.85 140.31 22.42 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 116.375 -2.13 . . . . 0.0 113.371 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 1.031 HG13 ' HB2' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -132.92 108.85 13.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 CA-C-O 122.873 1.321 . . . . 0.0 110.936 179.705 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.532 ' HA ' HD23 ' A' ' 17' ' ' LEU . 2.8 mt -102.0 122.57 44.32 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 114.164 -1.38 . . . . 0.0 110.949 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.638 HG22 ' HB2' ' A' ' 37' ' ' LEU . 58.3 t -142.11 142.51 24.73 Favored Pre-proline 0 C--N 1.292 -1.906 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.549 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.491 ' HD2' HG13 ' A' ' 18' ' ' VAL . 40.7 Cg_endo -66.19 126.65 16.08 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.752 1.396 . . . . 0.0 110.69 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 124' ' ' HIS . . . 123.19 -78.69 0.35 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.463 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 3.6 m -90.37 133.86 34.71 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.476 -1.014 . . . . 0.0 109.965 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.667 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -140.79 10.52 2.22 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.019 -1.675 . . . . 0.0 110.847 178.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.489 ' O ' ' HB3' ' A' ' 4' ' ' ASP . . . -178.47 -155.81 15.38 Favored Glycine 0 C--N 1.285 -2.258 0 C-N-CA 118.592 -1.766 . . . . 0.0 110.62 176.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.51 -8.27 18.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.877 -1.366 . . . . 0.0 109.82 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.822 ' CB ' ' HD3' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -63.3 177.07 0.49 Allowed Pre-proline 0 C--N 1.296 -1.746 0 CA-C-O 125.018 2.342 . . . . 0.0 114.341 179.599 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.822 ' HD3' ' CB ' ' A' ' 25' ' ' GLU . 21.5 Cg_endo -104.49 115.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.263 -3.943 1 C-N-CA 127.344 5.363 . . . . 0.0 110.765 -176.029 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.463 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 5.2 p -109.79 110.4 21.38 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-N 114.093 -1.412 . . . . 0.0 110.645 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.771 HG22 ' H ' ' A' ' 29' ' ' ILE 0.332 44.5 mm -83.0 -163.16 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.283 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.771 ' H ' HG22 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -126.56 114.89 39.98 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 CA-C-O 122.273 1.035 . . . . 0.0 110.216 179.168 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.603 ' CG ' ' N ' ' A' ' 31' ' ' ARG . 5.9 t-160 -67.3 -96.5 0.0 OUTLIER 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.007 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.603 ' N ' ' CG ' ' A' ' 30' ' ' HIS . 62.5 mtt-85 -161.74 165.58 27.83 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.512 -0.742 . . . . 0.0 109.788 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.864 ' HA2' ' HA ' ' A' ' 96' ' ' LYS . . . 68.43 124.74 0.03 OUTLIER Glycine 0 C--N 1.303 -1.268 0 N-CA-C 105.413 -3.075 . . . . 0.0 105.413 -178.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.731 ' HB2' HG12 ' A' ' 94' ' ' VAL . 4.5 mmmm -116.3 94.82 43.6 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 120.593 2.196 . . . . 0.0 116.57 -174.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.645 ' HD3' ' O ' ' A' ' 32' ' ' GLY . 61.3 Cg_endo -106.91 144.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.288 -2.621 0 C-N-CA 124.086 3.191 . . . . 0.0 108.136 176.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.653 ' HZ ' HG11 ' A' ' 94' ' ' VAL . 2.2 m-85 -120.8 94.59 4.4 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.002 -1.079 . . . . 0.0 109.429 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.61 ' HG3' ' CB ' ' A' ' 91' ' ' THR . 28.1 mp0 -113.3 84.41 2.0 Allowed 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.678 HD12 ' C ' ' A' ' 37' ' ' LEU . 3.6 pp -110.24 140.97 43.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.652 -1.28 . . . . 0.0 109.718 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -140.76 139.27 34.6 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 122.73 1.252 . . . . 0.0 109.151 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 1.031 ' HB2' HG13 ' A' ' 16' ' ' VAL . . . -142.68 151.64 41.58 Favored 'General case' 0 C--N 1.277 -2.576 0 CA-C-O 123.007 1.384 . . . . 0.0 112.546 -177.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.57 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.15 141.57 25.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 113.996 -1.457 . . . . 0.0 108.908 178.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.593 ' CE1' ' O ' ' A' ' 86' ' ' TYR . 3.1 p90 -155.94 121.21 4.82 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 17.0 tt0 -68.82 152.82 44.81 Favored 'General case' 0 C--N 1.286 -2.159 0 O-C-N 120.392 -1.443 . . . . 0.0 108.267 178.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.995 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -85.64 131.52 34.33 Favored 'General case' 0 C--N 1.264 -3.109 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.445 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.63 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -113.36 50.8 0.88 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 125.638 2.637 . . . . 0.0 114.074 179.454 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.605 ' C ' ' HB2' ' A' ' 82' ' ' LYS . 4.4 pt20 167.33 -162.39 0.01 OUTLIER 'General case' 0 C--N 1.266 -3.023 0 CA-C-N 108.641 -3.89 . . . . 0.0 113.462 175.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . 0.279 36.6 t30 -110.37 152.44 26.24 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 122.466 1.127 . . . . 0.0 108.712 -178.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.673 ' OG1' ' HB3' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -173.25 155.52 2.94 Favored 'General case' 0 C--N 1.255 -3.534 0 C-N-CA 118.01 -1.476 . . . . 0.0 113.257 -178.527 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.968 ' O ' HG23 ' A' ' 49' ' ' THR . 9.9 mttt -110.63 7.21 22.26 Favored 'General case' 0 N--CA 1.509 2.495 0 O-C-N 120.734 -1.229 . . . . 0.0 110.646 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.968 HG23 ' O ' ' A' ' 48' ' ' LYS . 0.8 OUTLIER -168.01 146.1 4.43 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 120.557 -1.339 . . . . 0.0 111.262 179.255 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.529 ' O ' ' O ' ' A' ' 70' ' ' PRO . . . -143.21 97.93 3.17 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-O 122.619 1.199 . . . . 0.0 109.641 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 12.3 mtmt -68.71 -179.09 1.31 Allowed 'General case' 0 N--CA 1.504 2.237 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.719 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.989 ' CG2' HD11 ' A' ' 88' ' ' ILE . 35.6 mt -140.19 140.4 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.425 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.368 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.501 ' HB3' ' HE1' ' A' ' 111' ' ' MET . 16.3 tp10 -140.47 107.88 5.55 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 123.374 1.559 . . . . 0.0 110.313 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 1.067 HD12 HG21 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -91.16 125.6 43.89 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 CA-C-N 112.572 -2.103 . . . . 0.0 109.271 179.327 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -121.36 103.4 8.93 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 177.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.937 ' HB3' HG22 ' A' ' 63' ' ' VAL . . . -110.31 128.77 55.71 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 118.814 -1.155 . . . . 0.0 112.005 -176.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.71 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 0.4 OUTLIER -107.09 102.93 12.23 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.943 ' HA ' HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -114.51 101.91 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.868 0 CA-C-O 123.197 1.475 . . . . 0.0 110.811 -177.454 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.666 ' N ' HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER 37.46 65.16 0.56 Allowed 'General case' 0 N--CA 1.522 3.132 0 CA-C-N 114.932 -1.031 . . . . 0.0 113.074 179.304 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.87 -15.49 8.1 Favored Glycine 0 N--CA 1.488 2.133 0 O-C-N 121.278 -0.889 . . . . 0.0 111.363 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.522 ' HB3' HG12 ' A' ' 58' ' ' ILE 0.274 0.3 OUTLIER -108.02 56.73 0.63 Allowed 'General case' 0 C--N 1.293 -1.85 0 O-C-N 121.108 -1.23 . . . . 0.0 111.417 -178.384 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 56' ' ' ALA 0.376 0.0 OUTLIER -60.38 117.48 5.29 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.918 0.866 . . . . 0.0 110.661 179.928 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.937 HG22 ' HB3' ' A' ' 56' ' ' ALA . 17.1 m -80.62 135.46 25.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-O 122.816 1.293 . . . . 0.0 111.736 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.447 26.0 t0 -140.08 67.65 1.37 Allowed 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.833 -177.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.576 HG12 ' HD2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -150.52 175.85 2.61 Favored Pre-proline 0 C--N 1.268 -2.952 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.001 -178.152 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.576 ' HD2' HG12 ' A' ' 65' ' ' VAL . 38.3 Cg_endo -65.98 139.91 58.29 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.395 1.734 . . . . 0.0 111.382 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.603 ' O ' ' CD1' ' A' ' 92' ' ' TRP . . . -134.57 -73.01 0.08 OUTLIER Glycine 0 N--CA 1.503 3.11 0 CA-C-N 112.459 -2.155 . . . . 0.0 111.121 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.757 HD13 ' H ' ' A' ' 91' ' ' THR . 2.0 tp -117.42 -157.83 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.225 -1.75 . . . . 0.0 108.789 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.716 ' N ' HG23 ' A' ' 68' ' ' ILE . 0.6 OUTLIER -106.69 141.85 23.71 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 177.136 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.777 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 24.5 Cg_endo -105.76 -3.76 0.15 Allowed 'Trans proline' 0 C--N 1.276 -3.289 0 C-N-CA 123.196 2.597 . . . . 0.0 114.309 -173.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.576 ' O ' ' CE1' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -110.37 87.58 2.56 Favored 'General case' 0 C--N 1.287 -2.132 0 O-C-N 120.717 -1.24 . . . . 0.0 108.121 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.626 ' HA ' ' CD1' ' A' ' 75' ' ' TYR . . . -74.47 8.45 2.27 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.734 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.4 ' C ' ' H ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -78.11 -19.87 53.27 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 120.536 -1.352 . . . . 0.0 108.243 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.574 ' NE2' ' HB2' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -88.76 19.75 3.86 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 173.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.626 ' CD1' ' HA ' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -132.57 -9.07 3.22 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.798 179.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.468 ' O ' ' C ' ' A' ' 77' ' ' LYS . 2.1 ptt? -167.93 129.59 1.46 Allowed 'General case' 0 C--O 1.215 -0.757 0 CA-C-O 123.621 1.677 . . . . 0.0 112.489 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.526 ' O ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -9.16 94.92 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 111.99 -2.368 . . . . 0.0 113.833 -178.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 48' ' ' LYS 0.312 7.9 t -98.87 140.3 21.66 Favored Pre-proline 0 C--N 1.271 -2.813 0 CA-C-N 111.278 -2.692 . . . . 0.0 108.093 177.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.728 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 36.2 Cg_endo -78.74 171.21 66.85 Favored 'Cis proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.987 -1.672 . . . . 0.0 113.177 1.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.687 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.3 OUTLIER -99.33 129.3 45.53 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.066 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.509 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 1.4 t -105.12 138.68 28.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 124.202 1.953 . . . . 0.0 112.287 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.63 ' HG2' ' HA ' ' A' ' 44' ' ' ASN . 1.4 tmmt? -43.96 118.08 1.36 Allowed 'General case' 0 C--N 1.273 -2.748 0 CA-C-N 111.762 -2.472 . . . . 0.0 116.517 -175.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.26 -18.26 12.23 Favored Glycine 0 C--N 1.29 -1.988 0 CA-C-N 111.746 -2.479 . . . . 0.0 107.931 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 86' ' ' TYR . 11.0 mt-30 -71.84 125.39 27.05 Favored 'General case' 0 C--N 1.278 -2.5 0 CA-C-O 123.13 1.443 . . . . 0.0 111.543 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.593 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -63.67 142.89 58.23 Favored 'General case' 0 C--N 1.268 -2.938 0 CA-C-N 113.424 -1.716 . . . . 0.0 107.355 178.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.995 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 17.7 m-85 -142.21 126.1 17.16 Favored 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.545 ' HB3' HG12 ' A' ' 40' ' ' VAL . 19.9 p30 -117.35 132.6 56.56 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-O 122.856 1.312 . . . . 0.0 110.107 -177.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 1.058 HD12 ' CG2' ' A' ' 110' ' ' VAL . 0.4 OUTLIER -101.99 159.16 4.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 CA-C-N 114.324 -1.307 . . . . 0.0 108.13 179.513 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.456 ' HG2' ' N ' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -148.95 151.2 34.19 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.909 -178.031 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.523 ' O ' ' HA ' ' A' ' 36' ' ' GLN . 49.3 t80 -147.92 104.1 3.55 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.335 178.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.757 ' H ' HD13 ' A' ' 68' ' ' ILE . 1.1 t -121.2 113.93 20.68 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.603 ' CD1' ' O ' ' A' ' 67' ' ' GLY 0.272 0.4 OUTLIER -142.17 113.86 7.92 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.611 -177.107 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 18.7 p-10 -75.07 159.1 32.11 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 119.423 -2.048 . . . . 0.0 109.696 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.875 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.5 OUTLIER -155.59 169.19 10.77 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.05 -1.031 . . . . 0.0 108.484 -178.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.875 ' HD2' HG22 ' A' ' 94' ' ' VAL . 17.2 Cg_endo -36.65 154.74 0.02 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.16 0 O-C-N 123.488 1.257 . . . . 0.0 110.887 -177.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.864 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -78.71 -25.41 44.7 Favored 'General case' 0 C--N 1.285 -2.219 0 C-N-CA 116.903 -1.919 . . . . 0.0 114.889 -172.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.763 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -145.85 47.24 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 CA-C-O 121.802 0.81 . . . . 0.0 111.941 -178.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.833 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . . . -76.06 -60.1 1.03 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.731 -1.23 . . . . 0.0 111.31 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.833 ' HD3' ' HB3' ' A' ' 98' ' ' ALA . 45.0 Cg_endo -64.36 159.05 45.74 Favored 'Trans proline' 0 CA--C 1.466 -2.897 0 O-C-N 123.912 1.48 . . . . 0.0 111.161 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.715 ' HD2' ' C ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -109.88 105.28 14.41 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 112.404 -2.18 . . . . 0.0 110.564 -169.146 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.57 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . 4.2 p -46.49 95.24 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.5 0 CA-C-O 123.509 1.623 . . . . 0.0 109.363 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.622 ' N ' ' O ' ' A' ' 100' ' ' LYS 0.399 92.3 mt-10 -164.26 -51.83 0.03 OUTLIER 'General case' 0 CA--C 1.453 -2.787 0 CA-C-N 112.981 -1.918 . . . . 0.0 112.029 179.8 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.552 ' O ' ' N ' ' A' ' 59' ' ' ASP 0.49 0.8 OUTLIER -160.49 79.45 0.65 Allowed 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 115.016 -2.674 . . . . 0.0 114.221 -161.939 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.943 HG22 ' HA ' ' A' ' 58' ' ' ILE . 36.1 t -142.44 153.53 17.99 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.577 0 C-N-CA 119.703 -0.799 . . . . 0.0 111.203 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.856 HG23 HG22 ' A' ' 123' ' ' THR . 0.4 OUTLIER -167.44 134.6 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -179.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.706 HG23 ' HB2' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -105.02 142.84 17.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.717 0 CA-C-O 122.391 1.091 . . . . 0.0 111.772 -179.044 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 1.09 HG23 ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -132.32 107.92 8.86 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.067 HG21 HD12 ' A' ' 54' ' ' ILE . 3.2 t -125.13 142.74 41.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 117.628 -1.629 . . . . 0.0 109.136 -177.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 1.039 ' HB2' ' HB2' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -135.36 146.03 47.96 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.229 1.014 . . . . 0.0 111.169 -178.104 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 1.058 ' CG2' HD12 ' A' ' 88' ' ' ILE . 14.9 t -101.07 132.35 47.0 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.524 ' N ' ' HE2' ' A' ' 111' ' ' MET . 2.6 mtm -109.69 121.6 45.58 Favored 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.727 ' CA ' HD23 ' A' ' 117' ' ' LEU . . . -80.1 -141.66 2.65 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 119.109 -1.519 . . . . 0.0 113.846 -176.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.673 ' HB3' ' OG1' ' A' ' 47' ' ' THR . 11.0 p-10 -77.28 -6.49 53.35 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 122.414 1.102 . . . . 0.0 111.951 -177.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -125.89 -4.98 6.91 Favored 'General case' 0 C--N 1.268 -2.961 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.703 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.939 ' O ' HG13 ' A' ' 116' ' ' VAL . . . 85.02 82.16 1.06 Allowed Glycine 0 CA--C 1.47 -2.722 0 CA-C-O 124.814 2.341 . . . . 0.0 109.834 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.939 HG13 ' O ' ' A' ' 115' ' ' GLY . 0.5 OUTLIER 152.59 143.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.247 -3.884 0 CA-C-N 108.204 -3.998 . . . . 0.0 111.622 177.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.759 ' CB ' HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -160.44 -57.45 0.06 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.331 -0.856 . . . . 0.0 111.319 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.896 ' HB1' HG13 ' A' ' 13' ' ' ILE . . . -174.87 131.87 0.33 Allowed 'General case' 0 N--CA 1.511 2.58 0 O-C-N 121.125 -0.984 . . . . 0.0 109.467 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 1.039 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 0.8 OUTLIER -133.97 137.94 45.14 Favored 'General case' 0 C--N 1.283 -2.283 0 C-N-CA 118.184 -1.406 . . . . 0.0 113.07 -177.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.673 ' HB2' HD12 ' A' ' 13' ' ' ILE . . . -148.52 136.93 21.28 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 123.077 1.418 . . . . 0.0 111.908 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 1.09 ' HB ' HG23 ' A' ' 107' ' ' THR 0.262 0.0 OUTLIER -110.54 130.29 64.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.97 -179.593 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.649 ' N ' HD13 ' A' ' 121' ' ' ILE . . . -131.42 -174.19 3.33 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.931 -1.105 . . . . 0.0 109.19 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.856 HG22 HG23 ' A' ' 105' ' ' VAL . 14.3 p -113.35 -13.03 12.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.62 -1.3 . . . . 0.0 110.471 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.592 ' CE1' ' HB3' ' A' ' 37' ' ' LEU . 10.2 m-70 59.09 -79.01 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.561 0 O-C-N 121.416 -0.802 . . . . 0.0 110.715 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.573 ' CB ' HG12 ' A' ' 29' ' ' ILE . . . -159.26 108.85 1.9 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.654 ' CD ' ' HB ' ' A' ' 104' ' ' VAL . 0.6 OUTLIER -128.4 -143.7 0.28 Allowed 'General case' 0 N--CA 1.485 1.324 0 O-C-N 120.714 -1.241 . . . . 0.0 110.924 -178.377 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.57 ' CG1' ' HB2' ' A' ' 101' ' ' SER . 0.5 OUTLIER -133.9 124.27 46.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-O 121.873 0.844 . . . . 0.0 112.044 -179.287 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.464 ' O ' ' C ' ' A' ' 129' ' ' ASP . 0.1 OUTLIER -169.17 152.25 4.97 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.042 179.325 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.464 ' C ' ' O ' ' A' ' 128' ' ' ARG . 2.9 m-20 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.902 179.423 . . . . . . . . 1 1 . 1 stop_ save_